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Abstract
Cardiovascular risk prediction tools are becoming increasing available on the web for 
people to use at home. However, research into the most effective ways of 
communicating cardiovascular risk has been limited. This thesis examined how well 
web>based cardiovascular risk prediction tools present cardiovascular risk and 
encourage risk reduction. Variation was found in both the quality of the risk 
communication and the number of features incorporated into the tools to facilitate 
decisions about lifestyle change and treatment. Additionally, past literature into the 
effectiveness of cardiovascular risk representation formats was systematically 
reviewed. This highlighted the need for more methodologically sound studies, using 
actual risk assessment rather than hypothetical risk scenarios.
This thesis also described a four-armed web-based randomised controlled trial (RCT) 
conducted to examine the effects of different cardiovascular risk representation 
formats on patient-based outcomes. It comprised a cardiovascular risk formatter that 
presented risk in one of three formats: bar graph, pictogram and metonym (e.g. 
image depicting the seriousness of having a myocardial infarction). There were two 
control groups to examine the Hawthorne effect. In total, 903 respondents took part 
in the trial. The most successful recruitment methods were web-based, including staff 
electronic noticeboards and social networking sites.
v
The RCT found that viewing cardiovascular risk significantly reduces negative 
emotions in the ‘worried well’, thus helping to correct inaccurate risk perceptions. 
There were no main effects of risk representation formats, suggesting that the way 
risk is presented had little influence on the population that were recruited, in terms of 
motivating behaviour change, facilitating understanding of risk information or altering 
emotion. However, a possible type II error occurred as the sample was 
unrepresentative, highly educated and biased towards those of low cardiovascular 
risk. Further research is needed to reach target audiences and engage those who 
would benefit the most from using risk assessment tools.
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Chapter 1. Introduction to thesis.
1.1 Introduction to thesis
This thesis describes work carried out for a PhD in cardiovascular risk 
communication. The aims and objectives of the thesis are described below:
This chapter defines cardiovascular disease and describes how cardiovascular risk is 
predicted. It will also explain the challenges and complexities surrounding the 
communication of cardiovascular risk.
1.2 Aims of thesis
This thesis aims to gain a deeper understanding of cardiovascular risk prediction and 
communication from a patient’s perspective. It comprises three main studies into 
cardiovascular risk communication: (1) a critical appraisal of web-based 
cardiovascular risk prediction tools, (2) a systematic review into ways of 
communicating cardiovascular risk to patients, and (3) a web-based randomised 
controlled trial (RCT) into the effects of graphical risk representation formats.
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1.2.1 Critical Appraisal
The aim of the critical appraisal was to determine which cardiovascular risk 
prediction tools are most likely to be found by people on-line, assess the quality of 
the risk communication of the tools and determine the extent that they encourage risk 
reduction behaviour.
The following research questions were assessed:
• What tools were most likely to be found by people on-line when they are 
searching for a cardiovascular risk assessment at home?
• How well did the retrieved web-based cardiovascular risk prediction tools 
communicate cardiovascular risk to users, according to the research 
evidence?
• How, and to what extent did the web-based cardiovascular risk prediction 
tools encourage and facilitate risk reduction through lifestyle modification and 
treatment options?
1.2.2 Systematic Review
The systematic review of the effectiveness of cardiovascular risk communication 
assessed past research conducted into cardiovascular risk communication, to see 
which risk representation formats are most effective for communicating 
cardiovascular risk to patients. The following research objectives were investigated:
(1) to compare the effectiveness of different interventions used to communicate 
cardiovascular risk, and (2) to assess the impact of the risk representation formats 
used in these interventions on patient related outcomes, such as understanding, 
affect, intention to modify behaviour and reduction in actual risk.
1.2.3 Randomised Controlled Trial
The overall aim of the RCT was to use a web-based risk calculator and risk 
representation formatter, to compare the effects of different graphical cardiovascular 
risk representation formats on individuals’ intention to change behaviour to reduce 
cardiovascular risk, understanding of risk information, affect and worry about future 
heart disease.
The primary objectives were:
• To assess which format led to the greatest intention to change behaviour.
• To determine which format best facilitated understanding of risk information.
• To analyse which format altered emotion.
• To assess which format induces worry about future heart disease the most.
• To examine the correlational validity between intention to change behaviour, 
understanding of risk and worry about future heart risk. To find out if 
understanding led to more appropriate intentions regarding cardiovascular risk 
and what level of worry increases intention to change behaviour.
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• To determine whether intention to change behaviour, understanding of risk, 
and affect were mediated by a person’s risk category.
The secondary objectives of this study were:
• To examine the existence of the Hawthorne effect using two control groups.
• To analyse within-group changes between pre and post-intervention 
responses in the group who completed both questionnaires.
• To evaluate the use of the internet-provided risk formatter (process 
evaluation), including analysis of web-logs.
• To assess the efficacy of the Theory of Planned Behaviour at predicting 
intention to change behaviour to reduce future cardiovascular risk.
1.3 Outline of thesis
This thesis comprises 10 chapters. The following chapter (chapter 2) describes a 
critical appraisal of web-based cardiovascular risk prediction tools. Chapter 3 
comprises a systematic review into effective ways of communicating cardiovascular 
risk to patients. Chapter 4 provides an overview of past research into the 
communication of risk.
The subsequent section of the thesis will describe a web-based randomised 
controlled trial into the effects of cardiovascular risk representation formats. 
Methodology is presented in chapter 5 and the piloting of the web-based risk
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formatter in chapter 6. The results of the primary objectives are described in chapter 
7 and the results from the secondary objectives in chapter 8. The trial is evaluated in 
chapter 9, which includes comparison with previous research and highlighting the 
strengths and weaknesses.
Lastly, chapter 10 discusses the thesis as a whole (e.g. the critical appraisal, 
systematic review and RCT). It will provide comment on future directions for research 
and implications for policy and practice.
1.4 MRC framework for developing and evaluating complex interventions
In 2000 the Medical Research Council (MRC) proposed a guidance framework to 
assist with the development and evaluation of complex interventions. This comprised 
a number of sequential phases of investigation in the evaluation of a complex 
intervention: theorectical (pre-clinical) phase, modelling (phase I), exploratory trial 
(phase II), definitive RCT (phase III) and long-term implementation (phase IV) 
(Medical Research Council 2000). However, in 2008 a revised guidance was 
published addressing limitations that were noted with the original framework, such as 
a need to pay greater attention to early phase piloting and development work, a less 
linear model of evaluation process and integration of outcome evaluation (Medical 
Research Council 2008; Craig et al. 2008). The updated framework consists of four 
stages (Development, Feasibility/Piloting, Evaluation and Implementation), it 
highlights the main interactions between the stages, emphasising that these stages 
do not follow a linear or cyclical sequence (Medical Research Council 2008).
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This thesis follows the MRC framework in the development and evaluation of the 
web-based cardiovascular risk prediction tool. For example, the Development stage 
(which explores the theory and identifies the evidence base) was followed by 
critically appraising publicly available web-based cardiovascular risk prediction tools 
and systematically reviewing literature into effective strategies to communicate 
cardiovascular risk to patients (Chapters 2 and 3). The Feasibility / Piloting phase (or 
exploratory phase II), which tests procedures, was followed by the pilot study that 
preceded the main RCT of cardiovascular risk representation formats (Chapter 6). 
The Evaluation phase (or phase III main trial), consisting of an adequately controlled 
study with appropriate statistical power, relates to the main RCT on cardiovascular 
risk representation formats (Chapters 7 to 9). This includes evaluating the RCT by 
addressing standard design issues, such as identifying potential problems of bias 
that may limit the external validity of the trial (e.g. the extent that the trial results are 
generalisable to a wider population), or reduce the internal validity (e.g. the extent 
that the difference between the study intervention and control is real and not a 
product of bias) (Medical Research Council 2000; Medical Research Council 2008).
1.5 Introduction to cardiovascular risk
This section will provide a definition of cardiovascular disease and prevalence rates. 
It introduces the concept of cardiovascular risk prediction and explains some of the 
challenges and complexities surrounding the communication of cardiovascular risk to 
patients.
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1.5.1 Definition and prevalence of cardiovascular disease
Cardiovascular disease (CVD) is a general term used to describe disorders relating 
to the heart and vascular system. These cardiovascular problems can result in 
chronic conditions persisting over a long period of time; they can also lead to acute 
events such as myocardial infarctions (heart attacks) and strokes. Coronary heart 
disease (CHD) and coronary artery disease (CAD) encompass angina, myocardial 
infarctions and heart failure, whereas cerebrovascular disease comprises transient 
ischemic attacks and strokes (South East Public Health Observatory 2010).
The British Heart Foundation statistics (derived from data from routinely collected 
national datasets) reports that 38% of all deaths in the UK result from CVD (British 
Heart Foundation 2009). This makes it the main cause of death in the UK. In 2003 
approximately 233,000 people died from CVD, around half Gust under 114,000) of 
these were caused by CHD and a quarter from stroke. Comparing this to other 
diseases, around 33,000 deaths in the UK in 2003 were from lung cancer, 16,000 
deaths were from colorectal cancer and 13,000 deaths were from breast cancer 
(British Heart Foundation 2009).
Due to favourable changes in risk factors (described below) in developed countries 
including the UK, the incidence of myocardial infarction has decreased over the past 
three decades; however, it is estimated that there are still 124,000 heart attacks in 
the UK every year (Scarborough et al. 2010). Furthermore, CVD cost the UK 
economy £29.1 billion in 2004, including healthcare and productivity losses due to 
mortality and morbidity (Luengo-Fernandez et al. 2006). This suggests that more
needs to be done at educating people about their risk and encouraging primary 
prevention.
1.5.2 Risk factors for cardiovascular disease
Cardiovascular disease (CVD) has a multi-factorial aetiology, and a variety of risk 
factors act synergistically (Anderson et al. 1990). Factors that increase the likelihood 
of developing CVD are both non-modifiable and modifiable.
Non-modifiable risk factors can include age, sex and ethnicity. According to recent 
national survey data for the UK, the British Heart Foundation reports that the 
prevalence of cardiovascular conditions such as myocardial infarction, stroke and 
angina increases sharply with age and is higher in men than women. Furthermore, 
there are differences in prevalence rates across regions in the UK. For example, 
Scotland and the North of England have the highest number of deaths from CHD, 
while the South of England has the lowest (Scarborough et al. 2010).
Modifiable risk factors have also been identified. These include cigarette smoking, 
lack of exercise, poor diet, high cholesterol (hypercholesterolemia), high blood 
pressure (hypertension) and obesity (Anderson et al. 1990; Grundy et al. 1999). The 
most important and modifiable cause of the majority of deaths from CVD is an 
unhealthy lifestyle, as opposed to medical conditions or genetic predispositions 
(Mokad et al. 2004; World Health Organisation 2002).
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1.5.3 Cardiovascular risk prediction
The modifiable and non-modifiable risk factors have been identified by research 
carried out over the last few decades into predicting CVD. Risk prediction tools have 
been developed that use algorithms estimating the probability of developing future 
CVD according to a person’s risk factors. The algorithms are derived from large 
prospective cohort studies. For example, the longitudinal Framingham Heart study, 
which started in 1948 in the USA, consisted of a cohort of 2489 men and 2856 
women aged 30 to 74 years at baseline, who were followed for up to 12 years. This 
led to the development of the Framingham Risk function which estimates 10-year risk 
of CHD (e.g. fatal or non-fatal CHD event), using risk factors found to be significant 
predictors such as age, sex, blood pressure, cholesterol level and smoking status 
(D'Agostino et al. 2008; Wilson et al. 1998).
Additional cardiovascular risk prediction tools include the Prospective Cardiovascular 
Munster (PROCAM) risk calculator. This is based on a scoring system derived from 
10-year follow up data from the PROCAM study of participants from the Munster and 
Northern Ruhr areas of Germany. It was initially developed and validated in 5389 
men aged 35-65, of whom 325 developed acute coronary events. It was later 
extended to include female participants. It identifies 8 risk factors. In order of 
decreasing importance these are: age, LDL-cholesterol, smoking, HDL-cholesterol, 
systolic blood pressure, family history of myocardial infarction, diagnosis of diabetes 
and triglycerides. It predicts 10-year risk of an acute coronary event (Assmann 2005).
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Systematic Coronary Risk Evaluation (SCORE) algorithm is based on data from 12 
European cohort studies in general population settings. Risk estimates for high risk 
and low populations have been developed. SCORE provides assessment of CVD 
risk defined as the risk of developing a fatal cardiovascular event in the next 10 years 
(Conroy et al. 2003; Toth 2007). Other cardiovascular risk prediction algorithms 
include Reynolds Risk score (Ridker et al. 2007), Copenhagen Risk score for 
myocardial infarction (Thomesen et al. 2001), ASSIGN score (Woodward et al. 2007) 
and the Cardiovascular Disease Risk Prediction Charts recommended in the Joint 
British Societies’ guidelines (Joint British Societies 2005).
The accuracy of these algorithms varies considerably between populations. For 
example, data from the Framingham study severely underestimates cardiovascular 
risk in African-American patients, and those from lower socio-economic areas 
(Hippisley-Cox et al. 2007). Better accuracy is achieved when the tool is used on a 
similar population that was used during the development and validation (Brindle et al. 
2006). A recently developed and validated tool in the UK is QRISK (Hippisley-Cox 
et al. 2007). This was derived from the QResearch database of health records of 10 
million patients. QRISK includes variables such as age, sex, social deprivation (using 
the Townsend deprivation score), body mass index (BMI) and use of 
antihypertensive medication. It has been shown to more accurately predict risk in the 
UK population than the Framingham and ASSIGN models. The Framingham 
equation over-predicted risk at 10 years by 35%, ASSIGN by 36%, whilst QRISK only 
over-predicted by 0.4% (Hippisley-Cox et al. 2007).
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QRISK 2 has been developed as a progression of QRISK. It incorporates ethnicity, 
and other clinical conditions into the algorithm, such as rheumatoid arthritis and 
chronic renal disease. It has improved accuracy of identification of those at high risk 
in a nationally representative population compared to the original QRISK (Hippisley- 
Cox et al. 2008). This has been confirmed by an independent validation (Collins and 
Altman 2010).
Cardiovascular risk prediction tools are available in various formats. More calculators 
are becoming increasingly becoming available, and freely accessible through the 
internet, including PROCAM, SCORE, QRISK2 (Assmann 2005; Conroy et al. 2003; 
Hippisley-Cox et al. 2007).
1.5.4 Treatment and screening
Primary prevention programmes in many developed countries aim to reduce the 
mortality and morbidity caused by CVD through modification of risk factors (Ebrahim 
et al. 2006). All preventive guidelines on CVD and diabetes focus on multiple risk 
factors. It is agreed that risk factors increase the likelihood of a cardiovascular event 
and that risk is additive (Ballantyne et al. 2005). Clinical guidelines on CVD risk factor 
management recommend that treatment decisions should be informed by short-term 
estimates of absolute CVD risk (e.g. 5 or 10 years). This is because the clinician’s 
first priority should be deciding how intensively to manage a patient’s current risk. For 
example, if a patient’s short-term risk is high, intensive management with 
medical/drug treatment and lifestyle changes is recommended. If risk is moderately
increased, less intensive intervention strategies involving lifestyle changes are 
appropriate, such as patient education and counselling regarding diet, smoking, 
physical activity and alcohol consumption, as there is more time to safely change 
behaviour and risk (Koelewijn-van Loon 2010; Wells et al. 2010).
Lifestyle modification interventions for the prevention of CVD have shown moderate 
but significant effects, as well as being cost-effective (Ades et al. 1997; Jolliffe et al. 
2001; World Health Organisation 1998). One study has shown that the most cost 
effective interventions for the primary prevention of CVD (measured by the number of 
deaths averted and life-years saved within a 10-year period) is smoking cessation 
therapy; whereas a medical intervention, statins, is the least cost-effective (Franco et 
al. 2007). Therefore, it is important to emphasise the importance of lifestyle 
modification to the general population.
The UK government aims to reduce future risk of CVD, stroke, renal disease, type 2 
diabetes and peripheral vascular disease in the population, and has coordinated a 
vascular disease control programme that involves vascular screening (Gray 2006). 
This programme focuses on disease prevention by early detection and treatment of 
the disease. A variety of risk management strategies have been put forward, such as 
the identification of high-risk individuals from general practice records using a 
computer risk calculation tool. A patient at increased risk will be presented with 
various strategies to reduce their risk (Davies et al. 2008; Gray 2006). The vascular 
screening programme recognises the importance of risk communication to ensure 
patients are well informed and knowledgeable about their risk, but also to increase 
the likelihood of them adhering to their chosen treatment plan. However, it is
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acknowledged that there is little evidence of the effectiveness of aids in 
communicating CVD risk (Davies et al. 2008).
1.6 Cardiovascular risk communication
This section will give a brief insight into the issues surrounding risk communication 
and will explain why the communication of cardiovascular risk in particular is more 
complex and challenging.
1.6.1 General risk communication
As described in more detail in Chapter 4, there are various ways statistical risk 
information can be communicated to patients. Numerical expressions include 
percentages, natural frequencies and numbers needed to treat (Edwards et al. 2002; 
Gigerenzer and Edwards 2003). Graphical representations can also be used. These 
include bar graphs and pictograms or icon arrays (Lipkus and Hollands 1999). Much 
research has been done into the effects of risk presentation on patients (Covey 2007; 
Cuitie et al. 2008; Lipkus 2007; Politi 2007). For example, the perceptions and 
behaviours of patients are sensitive to the way the risk information is formatted and 
framed (Edwards et al. 2001; Lloyd 2001; Weinstein 1999). Risk information needs to 
be presented in a simple, balanced and appropriate way. It should address the 
patient’s perception of the probability of an event as well as the importance of the 
event for that individual. Poor representation of statistical information may result in
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sub-optimal choices and treatment (Edwards et al. 2001; Edwards et al. 2002; 
Gigerenzer and Edwards 2003).
1.6.2 Communication of cardiovascular risk
In addition to the general difficulties faced when communicating health risks to 
patients, the communication of cardiovascular risk is further complicated and 
complex for a number of reasons. The main ones will be described below.
Multiple risk factors
Multiple risk factors that contribute to CVD include age, cholesterol levels and 
smoking. It is thought that at least 80% of all CVD, stroke and type 2 diabetes, and 
over 50% of deaths from CVD, are attributable to the existence of modifiable risk 
factors such as a poor diet, lack of physical activity and tobacco use (Epping-Jordan 
et al. 2005). The atherosclerotic process underlying ischaemic events results from an 
interaction of many risk factors, with modest increases in multiple risk factors being 
more harmful than a significantly raised level of any single factor (Wells et al. 2010). 
The risk factors act synergistically, leading to minor modifications in one lifestyle 
factor in the presence of other risk factors, having large effects on overall risk. It is 
unclear whether patients understand this compounding risk effect (Sutton 1998).
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Extended time horizons
Secondly, extended time horizons need to be considered. Heart disease is an 
insidious process and reducing its risk is work that has to be carried out over many 
decades, including multiple changes to lifestyle (Ballantyne et al. 2005). The 
optimum time to reduce risk is when aged in the early 20s and certainly in the 30s 
(McGill et al. 2008). However, most risk calculations are done much later and the 
methods almost always assume that the issue of risk is addressed in later life. For 
example, CVD risk calculations usually present anticipated risk over the coming 10 
years and are highly dependent on age as a variable. Age is the single strongest risk 
factor for future cardiovascular events, but by emphasising the impact of ageing in 
risk prediction models, modifiable risk factors, such as blood pressure are 
underemphasised (Ridker and Cook 2005).
Some argue against the use of age in cardiovascular risk communication because of 
a danger that using it as such a strong risk factor may dishearten certain patients. 
What patients really want to know is whether stopping smoking, losing weight or 
taking statins and other medication is going to reduce their risk of CVD (Durrington 
2009). However, others disagree and suggest removing age from risk calculations is 
not necessary and would be inappropriate (Vasan and D'Agostino 2005).
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Abstract concept
Lastly, patients find CVD an abstract concept. They have difficulty interpreting 
personal candidacy and consider it a ‘sneaky disease’ (Angus et al. 2005). The 
abstractness of CVD is partly attributable to the numerical constructs or risk 
estimates derived from mathematical algorithms. The applicability of these risk 
estimates at an individual level is limited as they involve population data. The precise 
meaning of risk estimates is lost with respect to individuals as they are dichotomous, 
where they either occur or they do not, and patients will either be affected or not 
affected. Patients perceive cardiovascular risk as a dichotomous variable and do not 
appreciate the grey areas between the extremes, or acknowledge the spectrum of 
disease symptoms that could be experienced (van der Weijden et al. 2008). The lack 
of understanding of cardiovascular risk estimates by both patients and practitioners is 
believed to a barrier in the implementation of absolute CVD risk-based management 
(Wells et al. 2010).
Furthermore, patients’ understanding of how CVD risk is made up is generally poor 
and insufficient. For example, interviews with patients found that many showed 
insufficient insight into cardiovascular diseases to be able to really understand their 
GP’s explanation. There was a lack of knowledge about the aetiology, consequences 
and prevention options. The importance of cholesterol as a risk factor was 
overestimated, and some patients failed to realise that smoking makes the greatest 
impact on overall CVD risk (van Steenkiste et al. 2004a).
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This lack of knowledge regarding CVD and a lack of understanding of the risk 
presented in prediction tools leads to unrealistic perceptions of risk. Misperceptions 
occur when the perceived risk does not correspond with actual risk. This can be an 
underestimation (incorrect optimism or optimistic bias) or overestimation (incorrect 
pessimism) (Frijling et al. 2004; van der Weijden et al. 2008). Misperceptions 
increase the difficulty in accurately interpreting and acting upon the risk information in 
an appropriate way (Erhardt and Hobbs 2002; van Steenkiste et al. 2004b).
However, a systematic review on the effects of presenting coronary risk information 
concluded that coronary risk information can improve accuracy of risk perceptions 
and increase intention to initiate prevention strategies (Sheridan et al. 2010).
1.7 Summary
This chapter has introduced the work that has been conducted for this thesis in 
cardiovascular risk communication. The aims and objectives of the thesis and a 
breakdown of thesis chapters were given. Challenges and complexities surrounding 
the communication of cardiovascular risk were highlighted, such as the multiple risk 
factors involved, the extended time horizons that need to be considered, the 
abstractness of risk estimates derived from mathematical algorithms, and the 
difficulty patients have in understanding the risk information. Due to these 
complexities, there is a gap in the literature into how to effectively communicate 
cardiovascular risk to patients. Therefore, this thesis attempts to address this issue 
by determining how well existing cardiovascular risk prediction tools present risk to 
patients, and to further the knowledge of what representation formats are most 
effective in presenting risk to patients.
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Chapter 2. A Critical Appraisal of the quality of risk communication 
of publicly available tools most likely to be found on the World 
Wide Web.
2.1 Introduction
Risk prediction tools use algorithms that estimate the probability of developing future 
CVD according to a person’s risk factors. These algorithms are derived from large 
prospective cohort studies. A best known example is the Framingham Heart Study, 
which led to the Framingham Risk Function which estimates 10-year risk of CHD 
(D'Agostino et al. 2008; Wilson et al. 1998). Web-based versions of CVD risk 
prediction tools are becoming increasingly available, including PROCAM, SCORE 
and QRISK2 (Assmann 2005; Conroy et al. 2003; Hippisley-Cox et al. 2008).
It is common for internet users to seek health information on the World Wide Web. 
Recent figures suggest this may be around 60% of users (Fox 2009), and health- 
related websites are among the most widely used websites on the internet (Wilson 
2002). Furthermore, over 20% of patients search the internet for information on CVD, 
which is greater than those seeking cancer or diabetes related information (Diaz et 
al. 2002). General search engines appear to be the first point of call for those 
searching for on-line health information, instead of medical portals or sites relating to 
medical societies and libraries (Eysenbach and Kohler 2002). An example of a 
general search engine is Google.com, which is the market leader in the Western 
world. An average of 34% of all global internet users visit Google.com on a daily
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basis (Alexa 2009; Nielsen 2009; Search Engine Watch 2009). The quality of the 
information found on the web varies. This is a concern as users rarely pay attention 
to the origin of health information they find on the web and do not search for 
information about who stands behind the websites (Eysenbach and Kohler 2002).
The World Wide Web is changing the way people access health information and how 
they interact with this information. For example, web-based risk prediction tools are 
interactive and can offer decision support. They help users assess their individual 
risk and can provide personal feedback on options to reduce risk through treatment 
and/or changes to behaviour. Research into risk prediction tools proposes that the 
personalisation and interactivity of risk calculators may influence users to be more 
attentive, motivate systematic processing of health information and increase 
accuracy of risk perceptions and therefore, improve decision-making (Kreuter 1999).
Previous research into web-based cardiovascular risk prediction tools has been 
conducted. For example, when searching for cardiovascular risk prediction tools 
using different search engines, variation was found in the number of ‘hits’ that were 
retrieved (e.g. between 47 and 700,000,). However, the first five risk prediction tools 
retrieved by the search engines were similar. Of the six tools that were assessed, 
there was broad agreement in the risk output results, apart from one that gave 
inconsistent risk scores (Roberts et al. 2007).
Another study evaluated cardiovascular risk prediction websites for their validity, type
of information presented and usefulness of the information for physicians or patients.
Of the eight sites included, two provided calculation of cardiovascular risk using the
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Framingham equation. The others proposed guidelines or general information on 
cardiovascular health. The majority of sites lacked information to appraise the quality 
of the site’s content (Gillois et al. 1999).
Furthermore, a web and literature search of cardiovascular risk calculators found 
variability in the different calculators, in terms of the target population, risk factors 
measured and the endpoints predicted. For example, some calculators did not 
specify exactly what they were predicting (e.g. cardiac risk only or cardiac plus 
cerebral risk), did not give advice about the eligible population (age range, past 
clinical history, family history etc.) or did not provide reference to the algorithm used 
by the tool. Also, there was variation in the risk representation used in the 
calculators. Some provided risk estimates as percentages, some used natural 
frequencies and some used risk categories (the exact numbers were not reported). 
The timeframes ranged from 5 to 10-years or could be specified by the user (Quaglini 
et al. 2005).
The portrayal of cancer risk in web-based prediction calculators has also been
examined. In a content analysis (Waters et al. 2009), 47 web-based cancer risk
prediction tools were assessed on the extent that they provided risk information that
facilitated comprehension of probabilistic information and reduced biased
interpretations. This included whether the tools described risk using words and
numbers, used natural frequencies (e.g. n in 1000 or 1 in N) or percentages,
provided absolute and comparative risk information (e.g. how your risk compares to
the average person of the same age/sex) and included a graphical representation of
risk. In general, the tools varied in their use of risk communication formats. Just over
20
half of the tools (n=24) provided a worded description of risk, such as ‘Low’ without a 
numerical estimate of probability. 16 (34%) provided numerical estimates alone and 
5 provided both numerical estimate and worded description. Percentages were used 
by 17 of the tools and natural frequencies were used by 10 tools. Nearly half of the 
tools (n=21) provided estimates as absolute risk, 10 tools (21%) provided 
comparative risk information and 14 tools (30%) provided both absolute and 
comparative risk. Lastly, 18 tools (38%) provided a graphical representation of risk, 
such as bar graphs, line graphs or tables. These tools also varied in their affiliations, 
8 were from cancer centres, 6 were from government organisations, 6 were by 
advocacy/non profit organisations, 3 were from educational institutions and 3 were 
commercial (Waters et al. 2009).
Apart from the variation in risk representation found by Quaglini et al 2005 (Quaglini 
et al. 2005), little is known about how well risk is being portrayed in web-based 
cardiovascular risk prediction tools, in terms of whether it adheres to evidence-based 
best practice and research evidence for risk communication, including recommended 
guidelines (Covey 2007; Cuitie et al. 2008; Edwards et al. 2006a; IPDAS 2005; 
Lipkus 2007; Politi 2007), and the extent that the tools offer feedback and decision 
support for reducing cardiovascular risk.
As new communication technology becomes freely available for the public to use, 
there is a concern that the risk presented could be unbalanced and without context; 
therefore, not giving a complete picture and having the potential to mislead 
(Woloshin et al. 2003). Balanced risk communication is important as different formats 
and framing can influence understanding, perceptions and the behaviour of an
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individual (Edwards and Bastian 2001; Gigerenzer and Edwards 2003; Lloyd 2001; 
Weinstein 1999).
2.2 Aims and Objectives
The purpose of this critical appraisal was (1) to determine which cardiovascular risk 
prediction tools are most likely to be found on the World Wide Web when people 
seek to have their risk assessed on-line; (2) to assess the quality of the risk 
communication portrayals, and (3) to examine how, and to what extent, risk reduction 
is encouraged.
2.3 Methods and Design
2.3.1 Design
The World Wide Web was searched for cardiovascular risk prediction tools, using 
Mozilla Firefox version 3.5.5 browser software.
2.3.2 Method
Cross-sectional, criterion-based appraisal of web-based cardiovascular risk 
prediction tools most likely to be found on the internet.
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2.3.3 Search term generation
Two types of searches were conducted. One using specific search terms relating to 
cardiovascular risk prediction, and the other using general keywords that people 
might use, generated from an elicitation survey. This was because although previous 
studies searching for web-based risk prediction tools have used terms specifically 
tailored to their topic of interest (Gurmankin Levy et al. 2008; Roberts et al. 2007), it 
is unclear whether these terms would actually be used by lay people when 
conducting their searches on the World Wide Web. Therefore, it was felt important to 
conduct the two different types of searches to enable a comparison of the results, 
given the likelihood of the different outputs.
General layman search
The first search was the general layman search. Search terms were generated from 
a search term elicitation survey, which asked people what search terms they would 
enter into a search engine if they were looking to assess their cardiovascular risk on­
line. The elicitation survey was conducted using members of the general population, 
naive to the purpose of the research. 24 individuals were asked to indicate which 
search terms they would enter into Google or other search engines, if they were 
interested in finding out their risk of heart disease. The survey was constructed using 
Google docs, which sends an email invitation comprising a hyperlink to the survey 
(Appendix 1). Respondents click on the link and are taken to the survey page 
(Appendix 2), they complete the survey then press the submit button. The
anonymous results were compiled in a Microsoft Office Excel Spreadsheet. Appendix
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3 shows the responses from each respondent. The survey generated 46 search 
terms in total. The most common search term was Heart disease risk, suggested by 
11 respondents. Heart disease was suggested by 4 respondents, Risk of heart 
disease by 3 respondents and What is my risk of heart disease? by 3 respondents. 
As there was variation in the other 43 search terms it was felt necessary to include all 
of them in the final search (Appendix 4).
Search specific to cardiovascular risk prediction tools
The second search comprised a list of search terms that specifically related to 
cardiovascular risk prediction tools. These comprised two stems, one describing 
cardiovascular disease (e.g. heart risk, heart disease and heart attack) and the other 
containing words that could be used when searching for prediction tools (e.g. 
calculator, prediction, assessment and tool). A brief pilot of the search terms was 
conducted on 8th January 2010 (Appendix 5). A noticeable difference in the results 
was found according to the order of presentation of the word stems. Therefore, it 
was decided that the order of presentation of the word stems would be altered in the 
main study to produce logical keywords, for example, ‘heart risk calculator3 and 
‘calculate heart risk’. 22 searches were conducted in total. A list of the search terms 
is presented in Appendix 6. These will be explained in more detail below.
Figure 2.1 demonstrates the differences in the two types of searches: the terms 
specific to cardiovascular risk prediction tools (on the left) and the general layman 
search (on the right). Only two search terms were common to both searches, these
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were Calculate heart disease and Heart risk calculator. This demonstrates that the 
public tend not to tailor their searches and opt for more general search terms.
General layman search terms
Heart disease risk calculator 
Heart disease risk factors ,
Heart disease risk ,
management ,
Heart failure risk 
Heart risk 
Heart risk advice
Risks leading to heart disease 
What is my risk of heart attack? 
What is my risk of heart disease? 
Work out my risk of heart disease
Search terms specific to 
cardiovascular risk 
prediction tools
Assess heart attack 
Assess heart disease 
Assess heart risk 
Calculate heart attack 
Calculate heart risk
Predict heart attack /  Calculate
Predict heart disease /  heart
Predict heart risk /  disease
Heart attack assessment 
Heart disease assessment Heart risk 
Heart risk assessment I calculator 
Heart attack calculator 
Heart disease calculator 
Heart attack prediction 
Heart disease prediction 
Heart risk prediction 
Heart attack tool 
Heart attack risk tool 
Heart disease tool 
Heart risk tool
Am I at risk of heart disease? 
Calculate my risk of heart 
disease 
Cardiac arrest 
Cardiac disease risk 
Cardiac failure 
Cardiac risk score 
Cardiovascular risk 
calculator
Cardiovascular risk score 
Causes of heart disease 
Chance of heart attack 
Developing heart disease 
Have I got heart disease? 
Heart attack 
Heart attack risk 
Heart disease 
Heart disease info 
Heart disease risk 
Heart disease risk 
assessment
Heart risk score 
How can I find out my risk of heart 
disease?
Identify my risk of heart disease 
My risk of heart attack 
My risk of heart disease 
Myocardial infarction 
Questionnaire risk factors heart 
disease 
Risk cardiac
Risk factors and heart disease 
Risk factors cardiac condition 
Risk factors for heart disease 
Risk factors heart 
Risk heart 
Risk heart attack 
Risk of heart disease 
Risk tool heart condition
Figure 2.1 Search terms used in the search specific to cardiovascular risk 
prediction tools and the general layman search.
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2.4 Procedure
2.4.1 Selection of cardiovascular risk prediction tools
The selected search terms were entered into Google.com search engine. This was 
chosen as it is the most popular general search engine globally (Nielsen 2009; 
Search Engine Watch 2009); and because general search engines are usually the 
first point of call for health-information seekers using the internet, as opposed to the 
medically related search engines or portals (Eysenbach and Kohler 2002). The 
results retrieved from a search term query make up the Search Engine Results Page 
(SERP); this is a page of links to relevant websites and web pages. The SERP rank 
determines the order that the results appear on the page. A higher placement on the 
page means a higher SERP rank. This ranking is based on an algorithm comprising 
over 200 continuously adjusted factors that are not publicly known. However, criteria 
may include keyword density, content and links (Google 2010). This algorithm is not 
stable and the order of SERP results is subject to change (even on a daily basis). 
Therefore, the Google search engine was queried daily over a period of 5 days, 
using the same search terms, to obtain the mean ranking score.
Only the first page of the SERP (comprising approximately 10-12 hits) was analysed; 
as it is generally acknowledged that people do not go beyond this first page of 
results. Studies have shown that the first page of results from search engines is 
significantly more likely to be accessed by health information seekers, with access to 
the subsequent pages exponentially declining thereafter. Users prefer to rephrase
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their search terms, rather than consulting the additional pages (Eysenbach and 
Kohler 2002; Hansen et al. 2003).
The first page of SERP results for each search term was recorded via a screenshot. 
Each result on the first page of the SERP was visited and assessed for eligibility. The 
SERP scores of eligible websites retrieved from the five day searches were 
converted into ranks. A result appearing first on a page received a ranking score of 
12, whilst a result appearing 12th on the page received a ranking score of 1 (See 
Table 2.1). The mean Google ranking score was obtained by summing the new ranks 
and dividing by 5.
The mean ranking scores of the eligible websites retrieved by all search terms were 
summed to give a total ranking score for that website / cardiovascular risk prediction 
tool. A higher total score meant the cardiovascular risk prediction tool was more likely 
to found by users, as it was retrieved by more search terms and/or appeared higher 
up the SERP. Figure 2.2 demonstrates the process of web-based cardiovascular risk 
prediction tool selection.
Table 2.1 Conversion of a SERP rank into a ranking score.
SERP rank 
on page 1st 2nd 3rd 4th 5th 6th 7th 8th 9th 10th 11th 12th
Ranking
Score 12 11 10 9 8 7 6 5 4 3 2 1
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Specific search terms relating to 
cardiovascular risk prediction tools 
and general layman search terms 
entered into Google.com search 
engine on 5 consecutive days.
▼
1s* page of Search engine results 
pages assessed for eligibility.
Mean ran ki n g score of th e 5 day 
con secutive search es determined.
Ran king scores for both searches 
summed to give total overall 
combined score.
Critical appraisal of the top 10 
tools most likely to be fou n d by 
both types of search (i.e. general 
layman searches and searches 
specific cardiovascu lar risk 
prediction tools).
Eligible risk prediction tools 
ran ked accordin g to order of 
appearance on webpage (e.g. 
SERP rank result).
Aggregation of all ranking scores 
to determin e th e risk prediction 
tools most likely to be retrieved.
Irrelevant
websites
excluded.
Websites not 
ranked in the top 
10 excluded.
Duplicates
removed.
Figure 2.2 Process of selecting the cardiovascular risk prediction tools most likely
to be retrieved by users: Flowchart.
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2.4.2 Inclusion and exclusion criteria
The inclusion criteria for this study consisted of any interactive patient facing website, 
comprising a functional cardiovascular risk prediction tool (questionnaire, algorithm 
etc.) to assess personalised risk of any cardiovascular disease event (such as 
myocardial infarction, cardiac death or angina), by the user inputting risk factor 
variables. Tools that were in English language and freely accessible were included.
Web pages that had a visible internal or external hyperlink to a cardiovascular risk 
prediction tool (including sponsored links) were also included, as it was clear that the 
purpose of the page was to direct people straight to that risk prediction tool.
However, results were excluded if they were not interactive (e.g. did not allow the 
user to input risk factor variables for a personalised assessment) or did not give a 
personalised risk estimate.
Web pages that discussed cardiovascular risk, but did not contain links to a 
functional cardiovascular risk prediction tool (such as journal papers relating to 
development of tool) were also excluded. This extended to web pages on a website 
that had a risk prediction tool present, such as a Frequently Asked Questions page. 
This was because a new visitor to the page would not necessarily know that a risk 
prediction tool was available on that site.
Web articles or blogs that had hyperlinks to cardiovascular risk prediction tools were 
also excluded, as the main purpose of the page was not to direct people to the risk
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prediction tool but another reason. Furthermore, web pages with more than one link 
to different risk prediction tools were excluded as it was not possible to determine 
which link would be chosen by the user. Tools requiring subscription charges or pay- 
to-view were excluded, as were tools not in English Language (due to the inability to 
assess them).
2.5 Analysis
For both the tailored search specific to cardiovascular risk prediction tools and 
general layman search, the 10 highest ranked cardiovascular risk prediction tools 
(deemed most likely to be found on Google) were critically appraised.
Hypothetical patient profiles (Table 2.2) for those at high and low risk were devised 
and inputted into the risk prediction tools to create a risk output. A standardised 
critical appraisal template was used (Appendix 7). This was designed by adapting 
existing guidelines and evaluation tools (Bedell et al. 2004; Gillois et al. 1999; IPDAS 
2005).
30
Table 2.2 Hypothetical high and low risk patient profiles.
Risk factors High risk patient profile Low risk patient
profile
Age 59 45
Sex Male Female
Ethnicity White White
SBP 160 mm/Hg 120 mm Hg
DBP 100 mm/Hg 80 mm Hg
HDL-C 50 mg/dL or 1.3 mmol/L 60 mg/dL or 1.5 
mmol/L
LDL-C 189 mg/dL or 4.9 mmol/L 80 mg/dL or 4.4 
mmol/L
Total chol 240 mg/dL or 6.2 mmol/L 200 mg/dL or 5.2 
mmol/L
total-C to HDL-C ratio 4.8 3.5
Smoking status Regular heavy smoker/ 
+20 a day
Non-smoker
Family history of CVD, high Yes No
BP or diabetes
Had a heart attack, angina, No No
stroke or TIA?
Have chronic kidney No No
disease?
Have Atrial fibrillation? No No
Have rheumatoid arthritis? No No
Have left ventricular No No
hypertrophy?
On blood pressure Yes No
treatment?
Physical activity / exercise Little or no physical Regular physical
activity activity / exercise
BMI 33 19
Height 5’6” / 168cms 5’8” /173 cm
Weight 200 lbs / 91 kgs 125 lb s /57 kgs
Healthy diet No Yes
Waist measurement >40” >35 ”
Triglycerides >150mg/dl <150 mg/d I
Fasting blood sugar >100mg/dl < 100mg/dl
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Three criteria were assessed:
1) The characteristics of the risk prediction tool, including whether the algorithm was 
declared, whether any research evidence or information regarding the development 
or validation of the prediction tool was given, and whether the authors were 
identified.
2) The communication methods used to portray the risk, including the type of 
numerical format, presence of graphical representation, the timeframe/s available 
and type of risk (such as absolute, relative, comparison with peer-group etc).
3) The extent to which the tools encourage risk reduction by providing information 
about behaviour change and/or treatment options, including whether the main 
contributing risk factors or achievable risk reduction are reported, whether treatment 
goals are provided and whether progress can be recorded.
2.6 Results
2.6.1 Search terms results
In order to retrieve the cardiovascular risk prediction tools most likely to be found on 
the World Wide Web, two types of searches were conducted. The first was a tailored 
search using terms specific to cardiovascular risk prediction tools and the second 
was a general layman search.
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For the search tailored to cardiovascular risk prediction tools, 22 search terms were 
used in total. However, four search terms did not retrieve any eligible cardiovascular 
risk prediction tools, these were: Heart disease prediction, Predict heart attack, 
Predict heart disease and Predict heart risk.
Figure 2.3 shows the number of eligible cardiovascular risk prediction tools retrieved 
by each search term. Heart attack risk tool and Heart disease calculator search 
terms retrieved the highest number of eligilble cardiovascular risk prediction tools on 
average (n=9). Heart attack calculator retrieved 7 risk prediction tools on average.
In the general layman search, all 46 search terms generated by the elicitation survey 
were used. 17 search terms did not retrieve any eligible web-based cardiovascular 
risk prediction tools, these were: Identify my risk of heart disease, Heart disease info, 
Have I got heart disease?, Cardiac arrest, Cardiac failure, Causes of heart disease, 
Developing heart disease, Heart attack, Myocardial infarction, Heart failure risk, 
Heart disease, Risk factors for heart disease, Risk factors heart, Risk factors cardiac 
condition, Risk factors and heart disease, Heart disease risk factors and Heart risk 
advice. The search terms retrieving the highest number of eligilble web-based 
cardiovascular risk prediction tools on average were Risk tool heart condition (n=9), 
Heart disease risk calculator (n=8), Cardiovascular risk calculator (n=8) and Heart 
risk score (n=7) (see Figure 2.4).
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Am I at risk of heart disease? 
Calculate heart disease 
Calculate my risk of heart diisease 
Cardiac disease risk 
Cardiac risk score 
Cardiovascualrrisk calculator 
Cardiovascualrrisk score 
Chance of heart attack 
Heart attack risk 
Heart disease risk 
Heart disease risk assessment 
Heart disease risk calculator 
Heart disease risk management 
Heart risk 
Heart risk calculator 
Heart risk score 
How can I find out my risk of heart disease?
My risk of heart attack 
My risk of heart disease 
Questionnaire risk factors heart disease
Risk cardiac 
Risk heart 
Risk heart attack 
Risk of heart disease 
Risk tool heart condition 
Risks leading to heart disease 
What is my risk of heart attack? 
What is my risk of heart disease? 
Work out my risk of heart disease
2.6.2 Web-based cardiovascular risk prediction tools retrieved
The ranking scores of the eligible web-based cardiovascular risk prediction tools 
retrieved by the tailored search and the general layman search over the 5 days are 
shown in Appendix 8 and Appendix 9 respectively.
Overall, both searches retrieved 37 different risk prediction tools. 25 tools were 
retrieved by the search tailored to cardiovascular risk prediction tools and 28 were 
retrieved by the general layman search terms. 15 tools were common to both 
searches. Nine tools were unique to the tailored searches, as they were not retrieved 
by the general layman search terms. Conversely, the general layman search 
retrieved 12 calculators that the tailored search did not.
Thirteen web-based cardiovascular risk prediction tools were excluded as they did 
not meet the inclusion criteria. For example, one tool (British Hypertension Society) 
was excluded as it was not interactive and did not allow users to input their personal 
risk factor information. Four tools (Healthline; NHS Choices; Rush University Medical 
Center; Woman’s Heart Foundation) did not provide a personalised risk estimate, but 
provided users with a list of risk factors or a total number of acquired risk factors that 
may increase cardiovascular risk. Another four were excluded (British Hypertension 
Society; Framingham Heart Study; National Prescribing Service Limited; 
PreventDisease.com) as they provided links to more than one risk prediction tool, 
and therefore it cannot be determined which link a user would use to assess their 
risk. Lastly, another four (Detsky and Goldman calculators; EuroScore; md+calc; 
Physical Health Assessments) were excluded as they predicted specific forms of
CVD or risk of complications during surgery (such as unstable angina and non-ST 
Elevation Ml, slow heart attack and cardiac surgical risk and risk of complications).
The ranking scores of the eligible web-based cardiovascular risk prediction tools 
were summed and divided by 5 to give the mean ranking score (see Appendix 10 for 
the mean ranking scores of the tools retrieved by the tailored search and Appendix 
11 for the mean ranking scores of tools retrieved by the general layman search). 
Then, for each eligible web-based cardiovascular risk prediction tool, the mean 
ranking scores obtained from each search term used in the searches were 
aggregated to give a total ranking score (Appendix 12 for the total ranking scores of 
the tools retrieved by the tailored search and Appendix 13 for the total ranking scores 
of the tools retrieved by the general layman search terms).
The 10 cardiovascular risk prediction tools with the highest total ranking scores 
according to both types of search were critically appraised, as these were thought to 
be the tools most likely to be retrieved by web users. Due to joint scores and an 
overlap in the tools retrieved by both types of search, thirteen tools were critically 
appraised in total (see Table 2.3).
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Table 2.3 The 10 highest ranking web-based cardiovascular risk prediction tools 
for both the tailored search specific to cardiovascular risk prediction tools and
the general layman search.
Total ranking 
score
1st NCEP (public) - Risk assessment 
tool for estimating your 10 year risk 
of having a heart attack.
115 1st NCEP (public) - Risk assessment tool for 
estimating your 10 year risk of having a 
heart attack.
2nd American Heart Association -  Heart 
attack, coronary heart disease, 
metabolic syndrome risk 
assessment.
94 2nd American Heart Association -  Heart 
attack, coronary heart disease, 
metabolic syndrome risk assessment.
3rd NCEP (prof) - Risk assessment tool 
for estimating 10 year risk of 
developing Hard coronary heart 
disease (myocardial infarction and 
coronary death).
90 3rd London School of Health and Tropical 
M edicine -  A risk score for 
cardiovascular disease.
4th Healthwise -  Interactive Health, 
heart attack risk.
60 4th M y Optum Health -  Heart attack risk 
calculator.
5th My Optum Health -  Heart attack 
risk calculator.
48 5th NCEP (prof) - Risk assessment tool for 
estimating 10 year risk of developing 
Hard coronary heart disease (myocardial 
infarction and coronary death).
6th London School of Health and 
Tropical Medicine -  A risk score for 
cardiovascular disease.
40 6th Patient UK -  primary cardiovascular 
using algorithm.
7th Mayo clinic -  Heart disease risk 
calculator.
39 7th Healthwise -  Interactive Health, heart 
attack risk.
8th Patient UK -  primary cardiovascular 
using algorithm.
33 8th University of Edinburgh -  Cardiovascular 
risk calculator.
Joint
gth
University of Edinburgh -  
Cardiovascular risk calculator.
e-tools Age -  Heart attack risk 
calculator.
20
gth Siteman Cancer Center - Your disease 
risk heart disease questionnaire.
10th Reynolds risk score -  calculating 
heart disease and stroke for men 
and women.
19 Joint
10th
Mayo clinic -  Heart disease risk 
calculator.
QRisk 2 -  Cardiovascular disease risk 
calculator.
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The same nine tools (American Heart Association; Healthwise; London School of 
Health and Tropical Medicine; Mayo Clinic; MyOptumHealth.com; National 
Cholesterol Education Program (prof); National Cholesterol Education Program 
(public); Patient UK; University of Edinburgh) were retrieved by both types of search. 
The two highest ranking tools (American Heart Association; National Cholesterol 
Education Program (public)) were the same across searches. Screenshots of the 
homepages of the included cardiovascular risk prediction tools are displayed in 
Appendix 14.
2.6.3 Results from the hypothetical high and low risk profiles
Hypothetical high and low risk patient profiles (Table 2.2) were devised and inputted 
into the risk prediction tools. The output results and details about the reported 
algorithms used in the tools are shown in Table 2.4. Most tools reported using 
algorithms from the Framingham Heart Study (American Heart Association; 
MyOptumHealth.com; National Cholesterol Education Program (prof); National 
Cholesterol Education Program (public); Patient UK; University of Edinburgh). Two 
tools (Healthwise; Mayo Clinic) indicated that their tools were adapted from National 
Heart, Lung and Blood Institute and National Education Cholesterol Program (Adult 
Treatment Panel III) guidelines. Two tools (Patient UK; University of Edinburgh) had 
the option of choosing the algorithm to be used. Patient UK tool gave Framingham 
and Joint British Societies (JBS) calculations, and University of Edinburgh tool gave 
the option of Framingham, JBS and Assign calculations.
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Four tools (London School of Health and Tropical Medicine; QRISK2; Reynolds Risk 
Score; Siteman Cancer Center) used algorithms they had developed themselves. 
One tool (e-tools Age) did not specify which algorithm was used. However, looking at 
the different risk factors that it measured, it is surmised that it might be a 
Framingham algorithm.
There was disparity in the risk results when the hypothetical risk profiles were 
inputted into the risk prediction tools, but this was because the different algorithms 
predicted different cardiovascular end points. Risk ranged from 18.8-35% for the 
high risk patient profile and 0 -  1 % for the low risk patient profile. Moreover, there 
was a lack of consistency in the results of tools that appeared to incorporate the 
same algorithms into their tools and measured the same endpoints (American Heart 
Association; MyOptumHealth.com; National Cholesterol Education Program (prof); 
National Cholesterol Education Program (public)), as risk ranged from 26 to 30%. 
However, the exact version of the algorithm that was used was not stated and 
therefore different versions of the same algorithm may account for this finding.
There was variation in the cardiovascular endpoints that were measured by the risk 
prediction tools. The risk of having a myocardial infarction / heart attack was the 
most commonly predicted. One tool (Patient UK) gave the choice of three algorithms 
to calculate risk. It was the only tool that allowed the users to choose the 
cardiovascular endpoint being predicted. However, this tool was intended to be used 
in consultation with health professionals, who would be able to define and give an 
explanation of the different manifestations of CVD.
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Table 2.4 Summary of the algorithms used in the web-based prediction tools and results from the hypothetical risk profiles.
1
1 NCEP (public) - Risk Framingham heart study 10 year risk of having a '26% 'Less than 1%
assessment tool for (year unspecified) heart attack.
estimating your 10 year risk Means 26 out of 100 people with Means less than 1 of 100 people
of having a heart attack. this risk will have a heart attack in with this risk level will have a
the next 10 years'. heart attack in the next 10 years'.
2 American Heart Association Framingham Heart study 10 year risk of having a '30% '1%
-  Heart attack, coronary (year unspecified) heart attack or dying of
heart disease, metabolic coronary heart disease. High risk'. Very low risk'.
syndrome risk assessment.
3 NCEP (prof) - Risk Framingham Heart study 10 year risk for'hard' '26%'. 'Less than 1%'.
assessment tool for (recent) coronary heart disease
estimating 10 year risk of outcomes (myocardial
developing Hard coronary infarction and coronary
heart disease (myocardial death.
infarction and coronary
death).
4 Healthwise -  Interactive Adapted from NCEP / 10 year risk of heart '30% of higher. '1%
Health, heart attack risk. National Heart, Lung and attack.
Blood Institute 30 (or more) people in 100 with 1 person in 100 with these risk
these risk factors will have a heart factors will have a heart attack in
attack in the next 10 years'. the next 10 years'.
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Risk calculator Reported algorithm Cardiovascular end point 
predicted
5 My Optum Health -  Heart 
attack risk calculator.
6 London School of Health and 
Tropical Medicine -  A risk 
score for cardiovascular 
disease.
7 Patient UK -  primary 
cardiovascular using 
algorithm.
Framingham and NCEP 
(ATPiii)
Pocock et al Risk score for 
predicting risk of 
cardiovascular death in 
adults with elevated blood 
pressure.
JBS2 (2004)
And non JBS risk 
calculations by Anderson et 
al 1991 (Framingham)
10 year risk of having a 
heart attack.
5 year risk of dying from 
cardiovascular disease, 
including both stroke and 
heart disease.
10-year risk of 
cardiovascular disease, 
cardiovascular death, 
stroke, coronary heart 
disease death, 
myocardial infarction or 
coronary heart disease.
High risk patient result Low risk patient result
'30% or higher
30 or more people in 100 with 
these risk factors will have a heart 
attack in the next 10 years'.
'The patient's risk score is 47.71. 
This compares to the average risk 
score for a man in this age range 
(55-59) of 40.24.
The predicted risk of death due to 
cardiovascular cause in the next 5 
years for this patient is 4.86%, 
compared to the average risk of 
2.33% for a man of similar age.
The patient is therefore in the very 
high risk category'.
'Using Systolic BP prediction, the 10 
year risk of JBS CVD is 50%.
The equivalent risk calculation with 
diastolic BP is 49%'.
' 1%
1 person in 100 with these risk 
factors will have a heart attack in 
the next 10 years'.
'The patient's risk score is 11.29. 
This compares to the average risk 
score for a woman in this age 
range (45-49) of 20.48.
The predicted risk of death due 
to cardiovascular cause in the 
next 5 years for this patient is 
0.13%, compared to the average 
risk of 0.33% for a woman of 
similar age.
The patient is therefore in the 
low risk category'.
'Using Systolic BP prediction, the 
10 year risk of JBS CVD is 2%.
The equivalent risk calculation 
with diastolic BP is 2%'.
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Mayo clinic -  Heart disease 
risk calculator.
NHLBI /  ATPiil adapted by 
Mayo Foundation for 
Medical Education and 
Research.
10 year risk of having a 
heart attack or dying of 
heart disease.
University of Edinburgh -  
Cardiovascular risk 
calculator.
BNF/JBS 10 year risk of developing 
cardiovascular disease.
Assign 10 year risk of developing 
cardiovascular disease.
Framingham 4-11 year risk of 
cardiovascular disease, 
coronary heart disease, 
myocardial infarction, 
stroke, cardiovascular 
death, coronary heart 
disease death.
'Your risk score is 30 percent or 
greater. This means about one or 
more out of three people with this 
level of risk will have a heart attack 
or die of heart disease within the 
next 10 years'.
'Probability of developing 
cardiovascular disease in the next 
10 years is 33.3%'.
'Probability of developing 
cardiovascular disease in the next 
10 years is 24.5%
The probability of developing 
cardiovascular disease in the next 
10 years is 40%'.
'Your risk score is 1 percent. This 
means about one of 100 people 
with this level of risk will have a 
heart attack or die of heart 
disease within the next 10 years'.
'Probability of developing 
cardiovascular disease in the next 
10 years is 0.6%'.
'Probability of developing 
cardiovascular disease in the next 
10 years is 0.5%
Probability of developing 
cardiovascular disease in the next 
10 years is 0.6%
Probability of developing 
coronary heart disease in the 
next 10 years is 0.2%'.
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Risk calculator Reported algorithm Cardiovascular end point 
predicted
10 QRisk 2 -Cardiovascular
disease risk calculator.
11 Siteman Cancer Center - 
Your disease risk heart 
disease questionnaire.
12 e-tools Age -  Heart attack 
risk calculator.
QRISK2 1-10 year risk of
developing heart disease 
or having a stroke /T IA .
Harvard Your disease risk 
algorithm.
Doesn't specify
Estimated risk of 
developing coronary 
heart disease compared 
to an average person 
who's the same age and 
sex.
10 year risk of Having a 
heart attack.
High risk patient result Low risk patient result
'Your 10 year QRISK2 score is 41%.
In other words, in a crowd of 100 
people like you, 41 will develop 
heart disease or have a stroke/TIA 
in the next 10 years.
The score of a typical person with 
the same age, sex, and ethnicity 
12.4%
Relative risk 3.3
Your QHeartAge >84
(e.g. cardiovascular age equivalent)
'Compared to a typical man your 
age, your risk is very much above 
average'.
'Your estimated 10 year risk of 
heart attack is more than 30%'.
'Your 10 year QRISK2 score is 2%.
In other words, in a crowd of 100 
people like you, 2 will develop 
heart disease or have a 
stroke/TIA in the next 10 years.
The score of a typical person with 
the same age, sex, and ethnicity 
1.6%
Relative risk 1.3 
Your QHeartAge 48'.
'Compared to a typical woman 
your age, your risk is very much 
below average'.
'Your estimated 10 year risk of 
heart attack is 1%'.
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Reynolds risk score -  Reynolds risk score
calculating heart disease and 
stroke for women and men.
Also, 10 year risk 
projected if the patient 
was 10,20, 30 years 
older.
10 year risk of having a 
future heart attack, 
stroke, or major heart 
disease.
'As shown in the graph below, at 
age 59, your chance of having a 
heart attack, stroke, or other heart 
disease event at some point in the 
next 10 years is 35 percent.
This risk is approximately 6 times 
higher than that of a Man the same 
age who has optimal levels of all 
modifiable risk factors'.
'As shown in the graph below, at 
age 45, your chance of having a 
heart attack, stroke, or other 
heart disease event at some 
point in the next 10 years is 1 
percent'.
45
Summary
There is no consensus between tools in the cardiovascular endpoints that are used 
in the risk prediction tools. This leads to an inconsistency in results and may paint a 
confusing picture for both health professionals and patients. This is a concern for 
those who use web-based risk prediction tools at home (especially if a number of risk 
prediction tools are consulted). Users may not fully appreciate the different results 
that can be achieved when certain endpoints are predicted. For example, the risk of 
a specific endpoint such as cardiovascular death will be lower than the risk of an 
endpoint that encompasses a number of manifestations, such as coronary heart 
disease.
2.6.4 Characteristics of the web-based cardiovascular risk prediction
tools
The characteristics of the web-based cardiovascular risk prediction tools were 
assessed and ordered according to their ‘quality’. The tools were compared against 
12 features deemed to increase the quality of the website and the information 
provided, such as whether the tools was intended for patient use, whether additional 
relevant information was provided, whether information regarding the development 
and validation of the algorithm used by the tool was provided, whether the user could 
contact the authors for further information or help and whether the website was free 
from commercial adverts. A ‘quality’ score was derived from summing the number of 
these features that were present. A higher score indicated a better quality website
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that comprised the cardiovascular risk prediction tool. As seen in Table 2.5 the tools 
varied in terms of their quality. Scores ranged from 1 to 10, meaning the tools 
encompassed between 1 and 10 of the ‘quality’ features.
The highest ranking tools in terms of quality were Patient UK, QRISK 2 and Siteman 
Cancer Center. These possessed 10 out of 12 of the features deemed to increase 
the quality of the website and cardiovascular risk prediction tool. One tool (e-tools 
Age) scored one, possessing only one ‘quality’ feature (e.g. tool intended for patient 
use as opposed to health professional use). Thus, its usefulness to the user and the 
trustworthiness of this site content can be questioned. Eight tools were designed 
specifically for patient use, three were intended to be used by both patients or health 
professionals (Patient UK; University of Edinburgh), and two tools were explicitly 
designed for health professionals to use (London School of Health and Tropical 
Medicine; National Cholesterol Education Program (prof)). The tools designed for 
health professional use are considered not as useful to a user seeking on-line risk 
assessment outside of a clinical setting, mainly due to the possibility that the 
terminology used in the tools might not be understandable to the lay public.
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Table 2.5 Characteristics of the included risk prediction tools ordered by 'quality' scores.
Patient UK / / ✓ / / / ✓ - / - / / 10
QRisk 2 / ✓ / / / / / - - ✓ / / 10
Siteman 
Cancer Center
✓ / / / / / ✓ / - / - / 10
University of 
Edinburgh
✓ ✓ / - ✓ / / - - / / / 9
London School 
of Health and 
Tropical 
Medicine
- / ✓ / / / ✓ - - / / - 8
American
Heart
Association
/ / ✓ - / - - / ✓ - / / 8
Reynolds risk 
score
/ / / ✓ / - - / - ✓ - / 8
Cont
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Mayo clinic
My Optum  
Health
Health-wise
NCEP (public)
NCEP (prof)
e-tools Age
Total No. of 
tools pocessing 
each 
characteristic
Tool
intended
for
patient
use?
✓
✓
11
Creator of the 
tool from a 
professional 
organisation 
such as 
university or 
charity?
✓
✓
10
Details about 
development 
and
validation?
Reference
to
academic
papers
relating
to the
prediction
tool?
✓
/
✓
External links 
to additional 
relevant 
information?
/
/
✓
/
✓
12
Authors
of
website/
tool
reported?
✓
Option to 
contact the 
authors for 
additional 
help or 
information?
Any Any
affiliation conflict of 
/  funding interest
reported? or no
conflict of
interest
declared?
Website Date
free from stated
commercial when
adverts? website
was last 
updated?
Target 
audience or 
who is not
suitable to Total
use the tool quality
identified? score
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The most common feature was providing links to additional relevant information. This 
was done by 12 out of the 13 tools. The further information included websites of 
heart-related organisations (such as National Cholesterol Education Program, 
American College of Cardiology and High Blood Pressure Foundation), fact sheets 
and articles about heart disease and prevention, and options to sign up for electronic 
newsletters. This ease of access to relevant information increases the usefulness of 
the site, encouraging the user to seek information about prevention and enabling 
informed decisions to be made regarding risk reduction.
Specifying the target audience or who was not suitable to use the tools was another 
common feature of 10 tools. For example, four tools (e-tools Age; Healthwise;
London School of Health and Tropical Medicine; Reynolds Risk Score) specified that 
the algorithm was suitable for people who did not have any manifestation of heart 
disease and/or diabetes. Providing this information increases the accuracy of the 
results, as people who are not suitable to use the tools are discouraged from 
assessing their risk, and thus reducing the possibility of under or over-estimating 
their risk. Two tools (e-tools Age; Healthwise) did not provide this information.
Most tools were from known reputable sources. For example, six were developed in
a research/academic setting (London School of Health and Tropical Medicine; Mayo
Clinic; QRISK2; Reynolds Risk Score; Siteman Cancer Center; University of
Edinburgh). Three tools (American Heart Association; National Cholesterol
Education Program (prof); National Cholesterol Education Program (public)) were
from National organisations or charities. Three (Healthwise; MyOptumHealth.com;
Patient UK) were tools from health-related websites. One tool (e-tools Age) was from
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a general website that had a number of on-line tools such as currency converters. 
Additionally, the e-tools Age tool gave no information on the algorithm used in the 
risk assessment and did not provide links to further information.
Eight tools (American Heart Association; London School of Health and Tropical 
Medicine; Mayo Clinic; Patient UK; QRISK2; Reynolds Risk Score; Siteman Cancer 
Center; University of Edinburgh) provided information regarding the algorithm that 
was used in the risk prediction tool. This is reassuring to the user and strengthens 
the reliability of the results. Moreover, an interested user can research how their risk 
was calculated. References or hyperlinks to academic papers relating to the 
development or validation of the algorithms were provided by 7 of these tools (all 
except the American Heart Association tool), making the research easy for the 
interested user.
Seven tools gave details about when the site was last updated, indicating that their 
content was reviewed periodically. However, five tools (e-tools Age; 
MyOptumHealth.com; National Cholesterol Education Program (prof); National 
Cholesterol Education Program (public); Reynolds Risk Score) did not provide this 
information, and therefore may not include the most up-to-date version of the 
algorithm.
Furthermore, six tools (American Heart Association; e-tools Age; Healthwise; Mayo
Clinic; MyOptumHealth.com; Patient UK) had advertisements present.
Advertisements can be distracting to the user, and adverts for pharmaceutical
products which may influence decisions made about risk reduction. For example, the
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Healthwise tool included an advert for Lipitor ® (a cholesterol lowering medication) 
and the American Heart Association tool advertises the Pharmaceutical roundtable, 
which is a forum for pharmaceutical companies. This increases the possibility of 
bias, as a user may be persuaded by the option of medication rather than lifestyle 
modification to reduce risk.
Summary
In summary, there was variation on the quality of the web-based cardiovascular risk 
prediction tools. Only three of the tools were considered to be of high quality. 
However, most tools provided information about who was suitable or not suitable to 
use the algorithm for risk assessment, which reduces the possibility of an over or 
under-estimation of risk that contributes to inaccurate risk perceptions. Additionally, 
all but one provided links to further information regarding CVD and risk reduction. 
However, adverts for pharmaceutical products were sometimes used, which may 
influence decisions made about risk reduction and lead to a bias towards medication 
over lifestyle modification. Furthermore, wide variation in results across tools 
resulted, as the predicted risk for the high risk profile ranged from 18.8 to 35%. It is 
concluded that the variable quality of the websites visited when seeking on-line 
cardiovascular risk assessment justifies a consideration for standardisation in this 
field, in order to avoid misleading or confusing patients.
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2.6.5 Methods of risk communication
The web-based cardiovascular risk prediction tools were appraised on the method of 
risk communication used (Table 2.6). This was broken down into four elements:
1) The type of risk that is being predicted such as absolute, relative (i.e. your risk 
divided by the risk of an average persons of the same age and sex with optimal risk 
factors) or comparative (i.e. the risk of an average person of the same age and sex 
with optimal risk factors).
2) The numerical formats that were used to represent the risk such as percentages, 
natural frequencies or cardiovascular age equivalent (e.g. an analogy to demonstrate 
that a person’s risk may be equivalent to someone older who has optimal risk factors 
and therefore, has a heart that is ‘older’ than their biological age).
3) Graphical risk representation formats used, such as bar charts and pictograms of 
smiley faces.
4) The timeframes used in the prediction of future risk, such as shorter 1-5 year 
timeframes or longer time spans of 10 years and over.
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Table 2.6 Summary of characteristics of risk communication presented in the included web-based cardiovascular risk
prediction tool ordered by 'risk communication' scores.
Characteristics of risk representation present in the web-based cardiovascular risk prediction tools.
Type of risk Numerical format Graphical format Timeframe
<D to  to  0 0
>  oj -c:
X 2 £
£  o « °CL. l a
c  u
i/l i/lg) -c ^
Q. 2 £
o ro RO »_ ru
t o  CD
Risk prediction tool
QRisk 2
/ ✓  / 3 / ✓ / 3 - / - 1 / ✓ ✓ 3 10
University of 
Edinburgh
/ - 1 / - - 1 /  / / 4 / / ✓ 3 9
London School of 
Health and Tropical 
Medicine ✓ / 2 / - %
i V 3 - -
/
2 - ✓ - 1 8
Reynolds risk score
/ / 2 / - - 1 ✓ - - 1 - - /  .  .  / h 2 6
American Heart 
Association ✓ - 1 / - / 2 / - - 1 - - ✓ 1 5
Mayo clinic / - 1 / / - 2 - ✓ - - 1 - - / 1 5
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Type of risk Numerical format Graphical format Timeframe
QJ ( / ) < / )  CO> at -z
o  <u OJ
TO O .  ■*->u o QJ o ro u~ </> TO
NCEP (public) / - / ✓ - - 2 - - 0 / -
1
4
Healthwise
✓ - ✓ / - - 2 - - 0 ✓ - 1 4
Siteman Cancer 
Center - / - - ✓ - 1 / - 1 - / g 1 4
NCEP (prof)
✓ - ✓ - - - 1 - - 0 / - 1 3
Patient UK
/ - / - - - 1 - - 0 ✓ - 1 3
e-tools Age
✓ : ✓ - - - 1 - - 0 / . - 1 3
My Optum Health
/ - / / - - 2 - - 0 / - 1 1
Total No. of tools 
possessing each 
characteristic
12 3 2 12 5 3 1 1 4 3 1 2 2 3 11 0 0 2
a risk score;D line graph showing how risk increases exponentially with the risk score;c plot graph showing distribution of risk scores /  risk categories;d for 
high risk patient only;e no numerical explanation;f risk chart; 8current risk;h risk demonstrated if patient was 10, 20 or 30 years older.
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Each cardiovascular risk prediction tool was scored on each of these elements by a 
simple summation of the number of present characteristics. For example, a tool just 
reporting a user’s absolute risk would score one for the first element ‘type of risk’ but 
a tool presenting absolute and relative risk would score two. The scores for the four 
elements were summed to give an overall ‘risk communication’ score. The higher the 
score, the greater the quality of the risk communication used by the web-based 
cardiovascular risk prediction tools.
Three tools (London School of Health and Tropical Medicine; QRISK2; University of 
Edinburgh) scored the highest (between 8 and10) and incorporated many of the 
features considered to enhance risk communication according to the research 
evidence. However, the other tools scored poorly in comparison, (scores ranged 
from 1 to 6 out of a possible 19).
1) Type of risk
All tools (apart from the Siteman Cancer Center tool) displayed absolute risk. This
was the only type of risk displayed by nine of these tools (American Heart
Association; e-tools Age; Healthwise; Mayo Clinic; MyOptumHealth.com; National
Cholesterol Education Program (prof); National Cholesterol Education Program
(public); Patient UK; University of Edinburgh) and therefore, they scored one for this
element. Three tools (London School of Health and Tropical Medicine; QRISK2;
Siteman Cancer Center) presented comparative risk, and two tools (QRISK2;
Reynolds Risk Score) provided relative risk. These help users interpret their risk by
56
demonstrating how their risk compares to the ‘average’ same aged/sex person with 
optimal risk factors. One tool (QRISK2) scored three, as it presented all three types 
of risk (absolute, comparative and relative), increasing the chance of the risk being 
understood by users.
2) Numerical risk representation formats
Six tools (e-tools Age; National Cholesterol Education Program (prof); Patient UK; 
Reynolds Risk Score; Siteman Cancer Center; University of Edinburgh) scored one 
on the numerical risk representation element, as they only provided one numerical 
format in their risk output. In all but one case (Siteman Cancer Center) this was 
percentages. The Siteman Cancer Center tool did not give a numerical probability 
estimate, but used risk categories instead (see Figure 2.5). Users may find this 
format helpful as it indicates whether risk was above or below the ‘average’. The 
American Heart Association tool and London School of Health and Tropical Medicine 
tool also provided risk categories, such as ‘Very low risk’ or ‘High risk’.
Five out of the 13 tools (Healthwise; Mayo Clinic; MyOptumHealth.com; National 
Cholesterol Education Program (public); QRISK2) used natural frequencies as well 
as percentages, which are useful in explaining what the percentage figures actually 
mean in terms of the number of people similar to the user who will be affected by 
CVD in the future.
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patient profile.
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The London School of Health and Tropical Medicine and QRISK2 tools scored three 
on the numerical risk representation format element, as they provided three ways of 
expressing the probability estimates. QRISK2 tool additionally provided the 
cardiovascular age equivalent (the age at which an ‘average’ person of the same 
age, sex and ethnicity has the same risk) and the London School of Health and 
Tropical Medicine tool additionally used a risk score to be interpreted using the 
provided graphs.
3) Graphical Risk Communication formats
Just over half of the tools (n=6) (e-tools Age; Healthwise; MyOptumHealth.com; 
National Cholesterol Education Program (prof); National Cholesterol Education 
Program (public); Patient UK) scored zero for the graphical risk communication 
element as they did not provide any visual or graphical accompaniment with their risk 
outputs. It is generally accepted that numerical and graphical representations should 
be used when depicting risk as this increase the chances that the risk information is 
understood, particularly for those with lower numeracy skills.
The University of Edinburgh tool scored the highest for the graphical risk 
communication element and had the greatest number of graphical risk 
representation formats (n=4) for presenting risk information (BNF risk charts, 
pictogram of smiley faces, a comparison thermometer or horizontal bar graphs). This 
function is useful to users, as they can choose which graphical format they prefer 
and find easiest to interpret.
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Bar graphs were the most commonly used graphical risk representation format, used 
by four tools (American Heart Association; Reynolds Risk Score; Siteman Cancer 
Center; University of Edinburgh). It is congruent to use this format to depict 
percentages, as was done by three of these tools (American Heart Association; 
Reynolds Risk Score; University of Edinburgh).
Pictograms were used by three tools in total (Mayo Clinic; QRISK2; University of 
Edinburgh) as displayed in Figure 2.6; although the Mayo Clinic tool did this for high 
risk patients only. This format is most suitable for displaying natural frequencies 
which were used by two tools (Mayo Clinic; QRISK2). However, the University of 
Edinburgh tool did not provide a numerical explanation with their pictogram, which 
would make interpretation of this format difficult for users who are not familiar with 
the concept of icon arrays of smiley faces to demonstrate the number of people 
affected by CVD.
One tool (London School of Health and Tropical Medicine) was unique in showing a 
line graph to show how risk exponentially increases with the corresponding risk 
score. This enables the user to see the risk thresholds for the given risk scores. 
However, it must be noted that this tool was intended for health professional use and 
this function may be of more value to them rather than the general public.
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Figure 2.6 QRISK2 tool - Risk output result for the high risk patient profile.
4) Timeframe used in risk prediction
Three tools (QRISK2; Reynolds Risk Score; University of Edinburgh) scored over
one for the timeframe element as they provided more than one timeframe option.
QRISK2 tool had the choice of predicting 1-year to 10-year risk; and the Framingham
algorithm from the University of Edinburgh tool had a choice of 4 to 11-years. A
choice of timeframes enables users to see how their risk increases over time. This
was also demonstrated by the Reynolds Risk Score tool as it projected the risk of the
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user if they were 10, 20 or 30 years older. Conversely, the Siteman Cancer Center 
tool was concerned with comparative risk and no timeframe was specified, therefore 
this tool scored zero for the timeframe element.
The most commonly used timeframe was 10-year risk, used by 11 of the 
cardiovascular risk prediction tools (American Heart Association; e-tools Age; 
Healthwise; Mayo Clinic; MyOptumHealth.com; National Cholesterol Education 
Program (prof); National Cholesterol Education Program (public); Patient UK; 
QRISK2; Reynolds Risk Score; University of Edinburgh). However, it must be noted 
that the timeframe used in the risk prediction tool is dependent on the algorithm that 
is used, which commonly assessl0-year risk.
Two tools (London School of Health and Tropical Medicine; QRISK2) used 
timeframes that were less than 10 years. London School of Health and Tropical 
Medicine tools used 5-year risk and QRISK2 tool used 1 year to 10-year risk. A 
user’s risk displayed in a shorter timeframe may be easier to imagine and 
comprehend, than their future risk displayed in longer timeframes. This is because 
risk portrayed in the long-term is of little relevance to people as they are generally 
poor at forecasting how they will feel in the future and do not adjust their risk 
perceptions to account for the longer time spans (Fagerlin et al. 2007a; Kassam et 
al. 2008).
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Summary
In summary, the quality of the risk communication used by the web-based 
cardiovascular risk prediction tools varied. Three tools (London School of Health and 
Tropical Medicine; QRISK2; University of Edinburgh) were considered as providing 
good quality risk communication, by incorporating many of the features considered to 
enhance risk communication according to the research evidence. The other tools 
scored poorly overall in comparison. However, different tools possessed different 
features shown in the research evidence to help the communication of risk.
For example, nearly all tools presented absolute risk; but just over one third
presented alternative types of risk, which allow users to evaluate their risk by
comparing it with the risk of others of the same age and sex who posses’ optimal risk
factors. This is more desirable than displaying absolute risk on its own as the user
has a way of knowing whether their risk is good or bad / high or low etc. The most
commonly used numerical risk representation format was percentages. Natural
frequencies were the second most commonly used. The majority of tools provided
more than one way of expressing probability of cardiovascular risk. Two tools
provided three numerical formats. Under half of the tools provided graphical risk
representation. In general, graphical formats were used that were congruous with the
numerical probability estimates presented in the risk outputs. One tool (University of
Edinburgh) allowed users to choose one of four graphical formats for viewing their
results. The majority of tools provided risk in a 10-year timeframe only. Two tools
demonstrated short-term risk less than 10 years, and one tool projected longer term
risk by demonstrating 10-year risk if the user was 10, 20 or 30 years older than their
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current age. Lastly, three tools had the facility of displaying risk in more than one 
timeframe option.
2.6.6 Focus on risk reduction and behaviour change
This critical appraisal assessed the extent that the risk prediction tools focused on 
risk reduction through behaviour change or treatment options (Table 2.8). A ‘focus 
on risk reduction’ score was derived from the number of characteristics present that 
facilitate risk reduction, such as whether the results could be printed out, whether 
there was an option to record progress as risk reduction is attempted, and whether 
treatment goals are provided. A higher score indicated that the tool had a greater 
focus of risk reduction, by providing more features that help with decisions about 
reducing cardiovascular risk. As seen in Table 2.7 the tools varied in terms of their 
focus on risk reduction.
The highest scoring tool was the American Heart Association. This tool focused on 
risk reduction the most, by providing all the features considered to be important 
when considering options to reduce cardiovascular risk. Four tools (American Heart 
Association; Reynolds Risk Score; Siteman Cancer Center; University of Edinburgh) 
possessed half or more of the risk reduction features. One tool (National Cholesterol 
Education Program (prof)) provided only one feature, which was the provision of 
further information. The e-tools Age tool scored zero and did not focus on risk 
reduction at all.
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The most common risk reduction features were the option to print out a copy of the 
results and the provision of further information. The option to print out results was 
included by eight of the tools (American Heart Association; Healthwise; London 
School of Health and Tropical Medicine; Mayo Clinic; MyOptumHealth.com; Patient 
UK; Reynolds Risk Score; University of Edinburgh). This is useful as it can be used 
in consultations with health professionals, providing a useful starting point for 
discussing cardiovascular risk and the risk reduction options available. Further 
information about risk reduction was provided by eight tools (American Heart 
Association; London School of Health and Tropical Medicine; Mayo Clinic; National 
Cholesterol Education Program (prof); National Cholesterol Education Program 
(public); Reynolds Risk Score; Siteman Cancer Center; University of Edinburgh).
This information included websites of relevant organisations (such as the British 
Heart Foundation), articles relating to risk factors (such as C-reactive protein level) 
and tips on reducing risk (such as guides to lowering cholesterol). A user motivated 
to reduce their risk may find it helpful to be directed to further information regarding 
risk reduction, before making any decisions about what they are going to do to 
achieve this.
Six of the thirteen tools (American Heart Association; Healthwise; QRISK2; Reynolds 
Risk Score; Siteman Cancer Center; University of Edinburgh) had the option to 
recalculate the risk output result by modifying the risk profile. This is useful as users 
can interact with the tool and work out how their risk changes by inputting different 
risk factors. However, five tools (American Heart Association; London School of 
Health and Tropical Medicine; Reynolds Risk Score; Siteman Cancer Center; 
University of Edinburgh) provided a function that already demonstrates this
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information. They showed which of the user’s risk factors contributed to their overall 
risk. For example, the Siteman Cancer Center tool included a section entitled ‘ What 
makes up my risk?’. Moreover, six tools (American Heart Association; Mayo Clinic; 
National Cholesterol Education Program (public); Patient UK; Siteman Cancer 
Center; University of Edinburgh) actually worked out which risk factors could be 
modified to reduce risk and provided possible options. This included a ‘What should I 
do7 section and a personalised list of modifiable risk factors. This information is 
valuable when taking the first steps in deciding whether risk reduction can be 
achieved, and which of the main risk factors might be worth tackling first.
A further function that is useful in decision making for cardiovascular risk reduction is 
demonstrating the exact risk reduction possible by different behaviour change and 
treatment options. Four tools (American Heart Association; Reynolds Risk Score; 
Siteman Cancer Center; University of Edinburgh) did this and some of these tools 
displayed the different risks together to enable a comparison. Bar charts showing the 
changes in risk when the risk factors were modified, were used by three of the tools 
(American Heart Association; Reynolds Risk Score; Siteman Cancer Center) and the 
University of Edinburgh tool used a thermometer (See Figure 2.7). Only two tools 
(American Heart Association; Siteman Cancer Center) were interactive letting users 
choose their own risk factors to be modified and view the corresponding result. For 
example, the American Heart Association tool had plus and minus buttons that 
changed the risk factor values, whilst displaying both current risk and the risk 
achievable (see Figure 2.8).
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As patients should consult with their health practitioner before undertaking any 
lifestyle changes or to seek treatment, it is important for risk prediction tools to 
remind users to do this. Six tools (American Heart Association; London School of 
Health and Tropical Medicine; Mayo Clinic; MyOptumHealth.com; QRISK2; Siteman 
Cancer Center) did advise users to contact a health professional for information 
about reducing risk. The Healthwise tool stated that ‘Information does not replace 
advice of a Doctor\ The American Heart Association tool provided treatment goals 
based on National Cholesterol Education Program/Adult Treatment Panel guidelines. 
However, three tools (London School of Health and Tropical Medicine; National 
Cholesterol Education Program (prof); QRISK2), which were intended to be used by 
health professionals, did not provide reference to treatment guidelines. If these tools 
are to be used by health professional in consultation with patients, having all the 
information readily available in one place would be beneficial and time efficient.
The majority of these tools are intended to assess risk at one time point. They did 
not allow for long-term, returned use as changes are made to lifestyle or treatment 
adherence. The American Heart Association tool was the only one that enabled you 
to save the output result and return at a later date. It also had the option to record 
progress as risk reduction is attempted and provided a ‘My History’ report showing 
changes in risk over time. This is a useful function that helps users stay motivated, 
by reinforcing and confirming the decisions they have made to reduce their risk.
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Summary
To summarise, features considered to facilitate risk reduction through lifestyle 
change and/or treatment options were compiled by collating existing guidelines and 
evaluation tools. All but one tool possessed at least one characteristic that focused 
on cardiovascular risk reduction. The most common features included the option to 
print out results and direction to further information sources about CVD and risk 
reduction. The University of Edinburgh tool focused on cardiovascular risk reduction 
the most and provided all the features deemed helpful when considering risk 
reduction. It is concluded that the more features incorporated in the tools that 
facilitate risk reduction, the greater the likelihood of motivating the user to reduce 
their risk if required. It appears that risk reduction strategies have been given less 
attention than the calculation of risk and how the risk is communicated, meaning the 
final aim of reducing cardiovascular risk is sometimes missed.
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Table 2.7 Summary of the extent to which the web-based cardiovascular risk prediction tools focus on risk reduction through
behaviour change and treatment options ordered by 'focus on risk reduction' scores.
Focus on risk reduction through behaviour change/ treatm ent options questions.
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2.7 Discussion
This section will summarise the main findings, present the strengths and 
weaknesses of the study, and compare the findings with the research 
evidence and guidelines on risk communication and research conducted into 
web-based cardiovascular risk prediction tools.
2.7.1 Summary of findings
This study critically appraised the web-based cardiovascular risk prediction 
tools most likely to be found when using the Google search engine. Due to an 
overlap in the ranking scores, 13 tools were appraised in total. The tools were 
assessed on (1) the quality of the website, (2) the risk communication used, 
such as the type of risk representation format and the timeframe/s used, and 
(3) the extent that risk reduction was encouraged, by providing information 
about behaviour change and/or treatment options, such as reporting the main 
contributing risk factors or providing treatment goals.
A number of different algorithms were used by the tools, meaning there was 
variance in the cardiovascular endpoints predicted and the risk factors 
assessed. The most popular algorithm was from the Framingham Heart Study 
and the risk of having a myocardial infarction / heart attack was most 
commonly predicted. Moreover, there was little consistency in results of the 
tools that appeared to use the same algorithms and measured the same
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endpoints, as risk ranged from 26 to 30% in these tools. The majority of tools 
were from reputable sources such as academic institutions or national 
organisations. They provided clear information about who was suitable to use 
the tool, and all but one of the tools provided links to further information 
regarding CVD and risk reduction. Eight of the tools were intended for patient 
use and the others were for collaborative use between patients and 
professionals.
Many principles of effective risk communication were used in the tools; 
however, they varied in how they communicated risk consistent with the 
research evidence and best practice guidelines. Nearly all tools presented 
absolute risk; but just over one third presented alternative types of risk, which 
allow users to evaluate their risk by comparing it with the risk of others of the 
same age and sex who possess optimal risk factors. Three tools 
demonstrated comparative risk and two tools provided relative risk. The 
majority of tools provided more than one way of expressing probability of 
cardiovascular risk. Two tools provided three numerical formats. The most 
commonly used was percentages. Natural frequencies were the second most 
commonly used numerical format, used in five tools. Under half of the tools 
provided graphical risk representation. One tool allowed users to choose one 
of four graphical formats for viewing their results. Four tools used bar charts 
and three used pictograms of smiley faces; a comparison thermometer and 
line graph were also used. The majority of tools provided risk in a 10-year 
timeframe only. Two tools demonstrated short-term risk less than 10 years, 
and one tool projected longer term risk by demonstrating 10-year risk if the
user was 10, 20 or 30 years older than their current age. Lastly, three tools 
had the facility of displaying risk in more than one timeframe option.
Some tools provided more features deemed beneficial and helpful in 
facilitating risk communication than others and no tool addressed all the 
issues surrounding cardiovascular risk communication. One tool (American 
Heart Association) stood out as focusing on cardiovascular risk reduction the 
most, as it provided all the features deemed helpful when considering risk 
reduction. Most commonly used features included the option to print out result 
and direction to further information sources about cardiovascular disease and 
risk reduction. It was apparent that risk reduction strategies have been given 
less attention than the calculation of risk and how the risk is communicated, 
meaning the final aim of reducing cardiovascular risk is sometimes missed.
To conclude, there is a need for a standardisation of risk prediction tools 
available of the World Wide Web, as the variation in quality of the risk 
communication may lead to confusion for users at home seeking on-line risk 
assessment independent of their GP. This may contribute to inaccurate risk 
perceptions and inappropriate action taken.
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2.7.2 Strengths and weaknesses
A strength of this study is that it selected and appraised cardiovascular risk 
prediction tools most likely to be retrieved by Google.com on the World Wide 
Web. Due to the unstable nature of Google SERPs, searches were conducted 
over a five day period to determine the mean overall ranking score.
Furthermore, it compared the tools retrieved by two different types of 
searches, a tailored search and a general keyword search. The tailored 
search used terms specifically related to cardiovascular risk assessment that 
were used in previous research into web-based risk prediction tools 
(Gurmankin Levy et al. 2008; Roberts et al. 2007). The general keyword 
search used results of an elicitation survey that asked people what search 
terms they would enter into Google or other search engines if they were 
interested in finding out their risk of heart disease. Only two search terms 
were common to both searches, suggesting that the public use general 
keywords rather than tailoring their searches using more specific search 
terms.
The results from both types of searches were compared to see if the web- 
based cardiovascular risk prediction tools retrieved differed in any way. 
Although the search terms for each of the types of search differed, there was 
considerable overlap, as 15 tools were common to both searches. The same 
nine tools (American Heart Association; Healthwise; London School of Health 
and Tropical Medicine; Mayo Clinic; MyOptumHealth.com; National
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Cholesterol Education Program (prof); National Cholesterol Education 
Program (public); Patient UK; University of Edinburgh) that were retrieved by 
both types of search appeared in the top 10 that were critically appraised. The 
two highest ranking tools (American Heart Association; National Cholesterol 
Education Program (public)) for both searches were the same. This suggests 
that results retrieved by search engines are determined not only by the 
keywords entered into the search engine, but by a number of factors. These 
factors include the number of links that a site has from credible sources, age 
of the domain and the actual frequency that keywords appear in the content 
contained within the site. Search Engine Optimisation techniques can be 
employed that increase the visibility and ranking of a website, making it more 
likely to be found.
A weakness of this study is that is unable to determine whether the risk 
prediction tools most likely to be found are actually the most visited. It was 
originally intended to compare the tools most likely to be retrieved with a 
measure of how many visitors (traffic) the hosting website receives, to 
determine whether the sites most likely to be found are the most popular. This 
was because the SERP ranking comprises a number of influencing factors 
and is not solely based on popularity, so it is likely that the top ranking 
websites on the SERP may not actually be the most visited. There is no 
definitive measure of website popularity; however, there are methods that can 
be used such as Alexa Traffic rankings. This measures the popularity of a 
website from the millions of Aiexa toolbar users and other data sources (Alexa 
2010). This study intended to compare the included sites with their
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corresponding Alexa Traffic rankings, however, this appeared impossible as 
only overarching websites are ranked. For example, the National Cholesterol 
Education Program website (http://hp2010.nhlbihin.net/atpiii/calculator.asp) is 
ranked under the National Institute of Health website (http://nih.gov/). 
Therefore, it was beyond the means of this study to determine whether the 
tools that are most likely to be retrieved by Google are actually what users use 
to assess their cardiovascular risk at home. Further research could contact 
the authors of each website to see whether they have data available on the 
number of visits to their websites.
2.7.3 Comparison with guidelines and research evidence
The formats used by the cardiovascular risk prediction tools will be discussed 
in relation to guidelines and research evidence to determine how well these 
tools are portraying risk in-line with best practice and recommendations.
1) It has been widely accepted that graphical accompaniments to risk 
information can help with understanding (Lipkus 2007). However, still 
nearly half of the risk prediction tools included in the critical appraisal 
failed to provide any graphical representation with their numerical 
formats.
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Additionally, a tool by the University of Edinburgh was the only one to allow 
users to choose between four graphical formats to view the risk output. This 
should be acknowledged as a desirable criterion for publicly available risk 
prediction tools, because people will have individual preferences for one 
format over another.
2) Natural frequencies are the natural way people think about risk 
probabilities and are effective in correcting inappropriate risk 
perceptions (Cuitie et al. 2008; Gigerenzer and Hoffrage 1995; van der 
Weijden et al. 2008). Five tools in the critical appraisal gave a 
probability estimate in the form of a natural frequency. Three tools also 
used pictograms of smiley faces to demonstrate this; however, one did 
not provide the numerical explanation as an accompaniment and 
another only provided a graphical format for high-risk patients.
3) Age is the single strongest risk factor for future cardiovascular events 
(Ridker and Cook 2005). Two tools attempted to illustrate this by 
showing how risk exponentially increases with age using a line graph 
and offering the projection of risk if the user was 10,20 or 30 years 
older, demonstrating how risk increases if you do not improve your 
modifiable risk factors.
4) An alternate method for addressing the timeframe issue in 
cardiovascular risk communication is by using the cardiovascular age 
equivalent format (‘Heart Age’). This has been shown to be more
memorable, emotionally impactful and motivating in making lifestyle 
changes than more conventional methods such as percentages 
(Goldman et al. 2006; Soureti et al. 2010). Only one of the 
cardiovascular risk prediction tools in this critical appraisal provided this 
as a format for presenting risk (QRISK2).
5) The majority of risk prediction tools in this study used 10-year 
timeframes and three used timeframes less than 10 years. This is in­
line with the findings from the systematic review (Chapter 3) that found 
shorter timeframes (less than 10 years) lead to more accurate risk 
perceptions and increased intention to change behaviour, than 
timeframes longer than 10 years (Asimakopoulou et al. 2008a; Frileux 
et al. 2004).
6) Communication about risk reduction: in this critical appraisal, just under 
half of the tools reported the possible options to reduce risk. Some 
tools did provide means to compare the risk achievable from modifying 
risk factors (such as the comparison thermometer by University of 
Edinburgh tool). However, provision of material to help with the 
decision making of changing behaviour and treatment options was 
scarce; only one tool (American Heart Association) had the option to 
print out an action plan. This is not in-line with current insights such as
I PDAS, which provides criteria for good practice in facilitating decision 
making (IPDAS 2005). These include stating possible treatment 
options, the comparison of different outcome probabilities, and the
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provision of tools to enable discussion with others (such as a health 
professional).
2.7.4 Comparison with previous research into web-based 
cardiovascular risk prediction tools
Studies into web-based cardiovascular risk prediction tools have found 
variation in the numbers of tools that readily provided the information needed 
to assess the quality and suitability of these tools (Gillois et al. 1999; Quaglini 
et al. 2005). This was also found in this critical appraisal. For example, 
different tools had different target populations, measured different risk factors 
and predicted different endpoints. Some tools did not provide reference to the 
algorithm used, did not specify exactly what they were predicting (e.g. cardiac 
risk only or cardiac plus cerebral risk); and did not give advice about the 
eligible population.
The variation of risk representation formats used by the web-based 
cardiovascular risk prediction tools found in this critical appraisal mirrors what 
has been found by previous research into web-based cancer risk prediction 
tools. For example, the study by Waters et al (2009) reported that 
percentages, natural frequencies and relative risk ratios were used by the 
cancer risk prediction tools. However, a lower percentage (38%) of cancer risk 
prediction tools provided graphical representation of risk compared to the 
cardiovascular risk prediction tools in this study (54%). Of the cancer risk
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prediction tools, nearly half (n=21) presented absolute risk compared to 69% 
(n=9) of the cardiovascular risk prediction tools. 21% (n=10) presented 
comparative risk information only compared to 8% (n=1) of the cardiovascular 
risk prediction tools; and 30% (n=14) provided both absolute and comparative 
risk together, which was greater than the percentage of cardiovascular risk 
prediction tools (15%, n=2) (Waters et al. 2009).
2.7.5 Conclusion
To conclude, some recommendations and best practices are being adopted 
by some of the web-based cardiovascular risk prediction tools. Although 
variation was found in the risk communication, as some tools provided a 
number of different ways of expressing the probability estimates that facilitate 
accurate perception and enhance understanding, and others did not.
The value of web-based risk prediction tools intended to be used outside of 
consultations with health practitioners is reduced if users do not fully 
understand or appreciate the reasons behind their risk result. Although some 
tools in this appraisal did attempt to define and explain the risk result, more 
tools should consider doing this. Also, the tools need to have consensus in the 
endpoints they predict, so that results are more consistent across tools. Users 
of more than one tool will have their risk result validated and will have more 
faith in their results.
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Little attention has been paid to risk reduction strategies. The tools could be 
improved by incorporating important features that help with the decision 
making process of cardiovascular risk reduction, such as the option to revisit 
the tools and record progress as attempt is made to reduce cardiovascular 
risk. It is concluded that the more features incorporated in the tools that 
facilitate risk reduction, the greater the likelihood of motivating the user to 
reduce their risk if required. However, to achieve unbiased informed decision 
making, the tools should be unbiased and remain impartial. They should not 
endorse certain products or favour one option for reducing risk over another.
Standardisation of risk prediction tools available on the World Wide Web is 
needed, as the variation in quality of the risk communication may lead to 
confusion for users at home seeking on-line risk assessment independent of 
their GP. This may contribute to inaccurate risk perceptions. Lastly, future 
developers of web-based cardiovascular risk prediction tools should pay more 
attention to research evidence and guidelines, and incorporate as many of the 
‘best practice’ principles as possible. This will enable the development of a 
fully comprehensive risk prediction tool that could be considered the ‘gold 
standard’ of cardiovascular risk communication.
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Chapter 3. What are effective strategies to communicate 
cardiovascular risk information to patients? A Systematic 
Review.
3.1 Introduction
This chapter describes a systematic review of studies which have compared 
different ways of communicating cardiovascular risk to patients and have 
assessed their impact on patient-related outcomes. It describes the literature 
search, study inclusion and narrative synthesis of results. This systematic 
review has been written as a paper for Patient Education and Counseling 
Journal (Waldron et al. 2011). It was peer-reviewed and accepted for 
publication. A copy of this paper has been presented in Appendix 15.
3.2 Aim of review
The aim of this review was to compare the effectiveness of different 
interventions used to communicate cardiovascular risk and assess the impact 
of the formats used in these interventions on patient-related outcomes, such 
as understanding, emotion, intention to modify behaviour and reduction in 
actual risk.
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3.3 Methods
3.3.1 Data sources and search strategy
Preceding the systematic review, the Cochrane Consumers and 
Communication group and the Cochrane Heart group were contacted to 
ensure that no other review on the effectiveness of cardiovascular risk 
communication existed. An initial scoping review found that the presentation 
of health-related risk information has been debated for some time, with a 
considerable gap in the literature relating specifically to the communication of 
cardiovascular risk.
Systematic searches of six electronic databases: ASSIA, EMBASE,
MEDLINE, CINAHL, PsyclNFO and Science Citation Index Expanded were 
conducted from January 1980 up to November 2008. Comprehensive search 
strategies (aiming for high recall, low precision) were adapted from Cochrane 
Heart Filter mesh terms. The search strategies included subject heading and 
keyword searching. Terms (such as cardiovascular disease, heart disease, 
risk communication, risk assessment) were combined. Searches were 
adapted to each of the databases used (Appendix 16). In addition, the 
‘snowballing’ technique of hand searching the citations of the retrieved papers 
was used to identify further relevant studies.
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3.3.2 Study inclusion and selection
Studies were eligible for inclusion if they: (1) were published in peer-reviewed 
journals written in English; (2) involved adult population (over 18 years old);
(3) were of any quantitative design, such as randomised controlled trials 
(RCT) or observational; and (4) compared risk communication interventions 
(of any format) for individualised cardiovascular risk assessment in primary or 
secondary care, against other interventions, with a control or usual care.
Non peer-reviewed, unpublished or non-English language papers, qualitative 
designs, and those solely reporting the preferences patients had for risk 
representation formats were excluded.
A title and abstract screen was conducted to select relevant studies. The 
selection was validated by two additional reviewers, who each checked half of 
the abstracts. Disagreement was resolved by discussion. Full text papers 
were obtained for included studies.
3.3.3 Data extraction and analysis plan
Data extraction was undertaken using a 64-item template (Appendix 17), 
comprising population characteristics, risk communication strategies, outcome 
measures and results. Methodological quality was assessed using a checklist 
for both randomised and non-randomised studies (Downs and Black 1998).
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This has been identified as a useful tool for assessing risk of bias (Higgins 
and Green 2009). It was chosen due to the broad inclusion criteria in the 
design of the studies.
The data were extracted, and as validation, two additional reviewers each 
extracted data from a random half of the studies. A meta-analysis was not 
feasible due to the heterogeneity in study outcomes, and therefore a narrative 
synthesis of findings was conducted.
Studies were categorised into those that assessed individuals’ actual risk and 
analogue studies that used hypothetical risk profiles. Furthermore, the 
intention of each study was assessed and validated by an additional reviewer. 
They were classed as having either a ‘persuasive’ or ‘non-persuasive’ intent. 
For example, persuasive studies were those that reported having the explicit 
aim of reducing cardiovascular risk; or for those that did not openly declare 
but measured outcomes that related to reducing cardiovascular risk (such as 
behavioural intention to accept treatment or improve lifestyle), an inferred 
persuasive intention was given. Studies were classed as non-persuasive if 
they were solely concerned with comparing the presentations of 
cardiovascular risk.
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3.4 Results
3.4.1 Included studies
Figure 3.1 summarises the study selection and extraction process. 56 full 
papers were retrieved for further assessment and 29 were excluded. Of the 27 
studies included for detailed data extraction, four were subsequently excluded 
because they only varied the degree of risk rather than the presentation or 
communication of risk formats (Dahl et al. 2007; Kristiansen et al. 2002; 
Marshall et al. 2006; Nexoe et al. 2005). Another five were excluded because 
the risk communication elements were embedded in a decision aid that had 
other components, and therefore, the outcomes could not be attributed to the 
risk communication strategy alone (Benner et al. 2008; Krones et al. 2008; 
Man-Son-Hing et al. 1999; Sheridan et al. 2006; van Steekiste et al. 2007). 
Lastly, three were excluded because they were not comparative studies of risk 
formats or did not report their comparison group (Christian et al. 2005;
Lalonde et al. 2006; Paterson et al. 2002). No additional studies were found in 
the hand searching of the included studies’ citations.
In summary, fifteen studies were included. Only four studies assessed 
individual’s actual risk, as the majority (n=11) were analogue studies asking 
individuals to imagine a hypothetical risk profile. Table 3.1 provides a detailed 
description of each study in terms of design, sample, risk communication 
intervention, outcomes and main findings.
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389 studies excluded.
29 studies excluded.
15 studies included.
27 studies selected for data extraction.
12,806 studies excluded.
4,005 duplicates.
56 full papers retrieved for further 
assessment.
445 studies independently reviewed by 
CAW and GE orTvdW on basis of title 
and abstract.
Disagreements resolved by discussion.
4 studies excluded where varying risk 
levels are assessed only.
3 non-comparative studies excluded.
5 studies excluded where risk 
communication formed part of 
interventions such as decision aids.
ASSIA......
CINAHL....
EMBASE..
MEDLINE.
PsydNFO
Science Citation Index Expanded.,1427
17,256 Studies identified from electronic 
searchesfor title and abstract 
assessment).
.1052
.2808
.3684
.6436
.1849
Figure 3.1 Study selection and extraction process: flowchart.
88
Table 3.1 Design characteristics and principal results of included studies, by type of risk assessment.
Author, year, Sample, Context Design, Aim Type of Variables of the risk Main outcome Main conclusions
country cardiovascular risk communication measure(s)
Actual risk assessment in patients
Asimakopoulou 
et al, 2008a, 
UK.
Charlson et al 
2008, USA
95 patients with 
Type 2 diabetes 
and without 
existing 
cardiovascular 
disease (CVD), 
Diabetic Clinics 
and General 
Practitioner 
Surgeries.
660 patients 
undergoing 
coronary artery 
catheterization, 
Hospital.
Observational- 
factorial design, To 
examine the impact 
of communicating 
risk of CHD and 
stroke, using 3 time 
frames, on patients' 
perception, 
understanding of 
risk of CHD/stroke 
and their 
subsequent 
recall/memory for 
these risks.
Randomised 
controlled Trial, To 
test whether an 
innovative approach 
of framing risk, 
based on ’net 
present value’ 
economic theory 
(what patients can 
gain now), would be 
more effective in
Absolute 1, 5 or 10- 
year risk of 
developing 
CHD/stroke as a 
result of having 
diabetes, using the 
UKPDS Risk Engine 
v2.0.
Relative potential to 
improve current 
health status and 
quality of life, when 
modifying risk 
factors in
intervention group; 
and value of 
preventing future 
health problems in 
control group.______
Numerical and 
graphical presentation: 
Percentage of risk in 
given time-frame (1, 5, 
10 years). Bar charts, 
with 10-slice pie chart 
and pictogram of 100 
smiley faces used as 
supplements.
Numerical presentation: 
Net present value 
(biologic age reduction 
achievable, if each risk 
factor was changed). 
Future risk (risk 
reduction framed as 
value of preventing 
future health problems).
Risk perception, Originally inflated risk perceptions of
understanding CHD were successfully corrected
and memory. with the help of the graphical tools
(^1,92=73.01; p<0.001), as was 
inflated stroke risk (F191=119.05; 
p<0.001), but 10-year risk group 
was the most resistant to correction 
for both CHD and stroke as they 
were the only group who recalled 
much higher risk at 6 week follow up 
than they understood at the 
consultation (F4-176=4.73; p<0.001).
Freedom from 
death, Ml, stroke, 
angina or severe 
asymptomatic 
ischemia at 2 
years, discrete 
stage of change 
and behaviour 
specific self- 
efficacy.
No significant differences were 
found between groups for the rates 
of death, stroke, Ml, class ll-IV 
angina or severe ischemia between 
the net present value group and 
future value group (p=non 
significant); or stage of change and 
self-efficacy (p=non significant). 
Over the 2 year follow-up, patients 
in both groups reached action on 
1.5 risk factors.
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Author, year, Sample, Context Design, Aim
country
Type of
cardiovascular risk
Charlson et al 
2008, USA 
cont.
Grover et al, 
2007, Canada
3053 men and 
women aged 30- 
70 years with 
diabetes or CVD; 
or men (aged 45- 
70) and women 
(aged 55-70) 
without CVD who 
had a 10 year 
coronary risk of at 
least 10% based 
on Framingham 
equations, 
Primary Care.
behavioural 
intervention than the 
standard 'future 
value approach' in 
reducing 
cardiovascular 
morbidity and 
mortality following 
angioplasty.
Randomised 
controlled Trial, To 
determine whether 
showing physicians 
and patient’s the 
patient’s calculated 
coronary risk can 
improve the 
effectiveness of 
treating dyslipidemia 
in a primary care 
setting.
Absolute and 
comparative 8- year 
cardiovascular risk, 
evidenced by 
increased 
cardiovascular age 
in intervention 
group; usual care in 
the control.
Variables of the risk Main outcome Main conclusions
communication measure(s)
Numerical and 
graphical presentation: 
Percentages and 
cardiovascular age. 
Comparative risk 
graphically summarised 
by population risk 
tertiles, so patient could 
see his/her absolute 
risk compared with that 
of peers. Vertical bar 
graphs showing risk 
change after each lipid 
profile was taken.
Changes in blood 
lipid levels and 
non-lipid risk 
factors, 
percentage of 
patients reaching 
lipid targets and 
global 10 year 
risk.
Over the 12 month follow-up the 
intervention (i.e. coronary risk 
profile) led to greater cholesterol 
reductions (OR= 1.26 (95% Cl;
1.07-1.48, p value not reported). 
After adjustment for baseline 
difference between groups, the 
intervention group was more likely 
to reach the recommended lipid 
targets (OR= 1.26 (95% Cl;
1.04-1.53, p value not reported). 
There was a significant interaction 
effect between the risk profile and 
cardiovascular age, in that the 
higher a patient's risk (evidenced by 
increased cardiovascular age) the 
greater the impact associated with 
the risk profile (OR= 1.69 (95% Cl; 
1.21-2.36; p<0.05).
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Straus, 2002, 
UK and 
Canada
17 patients 
admitted for 
nonvalvular atrial 
fibrillation, 
Hospital
Observational - pre­
post design, To test 
a patient-centred 
measure of the 
likelihood of being 
helped or harmed by 
an intervention.
Analogue studies
Fair et al, 
2008, UK.
740 respondents 
from general 
population who 
had not 
previously 
suffered from a 
medically 
diagnosed heart 
condition (heart 
attack or angina), 
Location not 
stated.
Quasi -experimental 
-  factorial design, 
To test the 
hypothesis that 
responses to CHD 
risk estimates are 
heightened by use 
of ratio formats, 
peer group risk 
information, and 
long timeframes.
Ratios of being 
helped or harmed by 
warfarin medication 
(e.g. decreased risk 
of stroke and 
increased risk of 
haemorrhage).
Absolute and 
comparative 10 or 
30 risk of CHD, 
based on risk tables 
published by the 
Framingham Heart 
Study.
Numerical presentation: Patients’ choice to
• Absolute risk take medication, 
reduction/absolute
risk increase 
(ARR/ARI).
• Relative risk 
reduction/relative 
risk increase 
(RRR/RRI).
•  Number needed to 
treat / numbers 
needed to harm 
(NNT/NNH).
• Likelihood of being 
helped or harmed)
(LHH).
LLH had the highest percentage of 
patients choosing warfarin (76.4%, 
n=13). 70.4% (n=12) accepted 
treatment when presented with the 
ARR/ARI format, 47.1% (n=8) 
accepted treatment when presented 
with NNT/NNH. ARR/ARI had the 
lowest percentage of patients 
choosing warfarin (17.6%, n=3). 
Whether differences were significant 
was not reported.
Numerical presentation: 
Natural frequencies and 
percentages, either with 
or without comparative/ 
peer group risk.
Risk perception, 
emotional 
response to risk 
information and 
intention to make 
lifestyle changes.
No main effect of time-frame on risk 
perception was observed. A 
significantly higher proportion of 
respondents perceived their risk to 
be higher when risk were presented 
in frequency formats (OR= 2.471 
(95% Cl; 1.692-3.609), p<0.001), or 
if those risks were supplemented 
with peer group risk information 
(p=.006). Respondents presented 
with risks in the form of a 
frequencies reported feeling more 
worried (p=.0004) and disturbed 
(p=.001) than those presented 
percentages._____________________
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Author, year, Sample, Context Design, Aim
country
Fair et al, 
2008, UK 
cont.
French et al, 
2004, UK
970 adults aged 
40-60 with no 
history of heart 
disease, Location 
not stated.
Observational -  
factorial design, To 
examine the 
emotional and 
cognitive impact of 
personal and social 
comparison 
information about 
health risk and to 
examine the effect 
of presenting this 
risk information 
using different 
probability formats, 
and the presence or 
absence of format- 
congruent visual 
representations.
Type of
cardiovascular risk
Absolute and 
comparative 10-year 
risk of having a 
cardiac event (heart 
attack, angina, heart 
failure).
Variables of the risk Main outcome Main conclusions
communication measure(s)
Numerical and 
graphical presentation: 
Vignettes of risk of 
having a cardiac event, 
with 4 factors 
manipulated: format 
(percentages or natural 
frequency); visual 
representation e.g. bar 
chart for percentages, 
pictogram for natural 
frequencies (presence 
or absence); level of 
social comparison risk 
(favourable or 
unfavourable) and level 
of personal risk (low or 
high).______________
Ratings of 
disturbance/worry, 
ratings of 
reassurance, 
likelihood of 
having a cardiac 
event,
comparison of 
own risk 
compared to 
others and 
confidence in 
understanding of 
information given.
Respondents who saw both 
personal and peer group risk 
information said they felt more 
worried (p=.002) and disturbed 
(p=.006) and less reassured 
(p=.016) than those who were 
presented with risk over a 10-year 
period. Presentation with 
frequencies also increased intention 
to make lifestyle changes (p=.047). 
Peer group risk information failed to 
have an impact on intention to 
change (p=non significant).
There were no main effects of 
frequency versus percentage format 
(p=non significant). Respondents 
who received a visual presentation 
gave lower ratings of being 
disturbed/worried (M=9.37) than 
those who did not received a visual 
representation (M=10.98) (F 
(1,313=8.74; p<0.01). This main 
effect was not found for the ratings 
of being reassured. Favourable 
social comparison information led to 
significantly less disturbance/worry, 
more reassurance and lower 
personal susceptibility ratings than 
unfavourable information (p<.05). 
Unfavourable social comparison 
information had no discernible
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Frileux et al, 
2004, France.
150 respondents 
from a 
convenience 
sample without 
established heart 
disease, Location 
not stated.
Observational -  
factorial design, To 
explore the impact 
of a preventive 
medical message on 
intention to change 
behaviour; the 
impact of the 
severity, its 
likelihood, time 
frame of risk, 
effectiveness of 
preventive 
behaviour, nature of 
behaviour on 
intention to change.
5, 10, 15, 20-year 
risk of coronary 
artery disease 
(presented as 2 
severities: angina 
pectoris or heart 
attack).
Numerical presentation: 
Percentages. Four 
different components of 
a message about 
preventing CAD were 
manipulated: severity 
(angina pectoris and 
Ml); probability 
occurrence (5 ,10 ,15 , 
20%); time horizon (5, 
10,15, 20 years); level 
of controllability 
(entirely under your 
control or not much you 
can do to reduce it).
impact, relative to not providing any 
social comparison information. No 
difference in the comparison of own 
risk compared to others, between 
those who received unfavourable, 
favourable or no social comparison 
information. Personal risk had more 
of an impact on reassurance (x\2 = 
0.08) than social comparison risk 
(r|2 = 0.06). This was also seen for 
disturbance/worry (ti2 = 0.09 vs. r\2 = 
0.05) and perceived risk (r|2 = 0.07 
vs. ti2 = 0.03).
Intention to adopt All 4 main factors had a significant
a specific effect on the intention to adopt a
behaviour. preventive behaviour. Greater
severity (Ml) produced greater 
intentions than lower severity 
(angina pectoris) (p<0.001). The 
higher the probability the higher the 
estimated level of intention (effect 
stronger at low probabilities than at 
higher probabilities) (p<0.00001). 
The shorter the time horizon the 
higher the intention (7r3i414=229.33; 
p<0.001). The lower the 
controllability, the lower the 
estimated level of intention to 
change behaviour. (p<0.00001).
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Author, year, 
country
Goodyear- 
Smith et al, 
2008, New 
Zealand.
Hux and 
Naylor, 1995, 
USA
Sample, Context Design, Aim Type of Variables of the risk Main outcome
100 patients with 
existing heart 
disease (Ml, 
angina or both), 
taking statins and 
who had 
experience with 
taking
medications and 
making decisions 
regarding 
medications, 
Family Practice.
100 outpatients of 
family practice, 
hypertension and 
cardiology 
centres, Private 
setting.
Quasi-experimental, 
explorative study,
To determine which 
methods of 
expressing a 
preventive 
medication's benefit 
encourage patients 
with known 
cardiovascular 
disease to decide to 
take the medication 
and which methods 
patients prefer.
Quasi-experimental- 
cross-sectional 
design, To assess 
how three different 
formats of the same 
data affected the 
willingness to take 
what were implied to 
be different lipid- 
lowering drugs.
cardiovascular risk communication
5-year risk of a heart Numerical and
attack with and 
without medication 
(16% with and 23% 
without medication).
Data on
effectiveness of a 
drug to prevent 
myocardial infarction 
and heart disease.
graphical presentation:
• Relative and 
absolute risk 
(positive and 
negative framing)- 
percentages.
• Detailed and 
simplified natural 
frequencies.
• NNT.
• Odds ratios.
• Vertical bar graphs- 
natural frequencies 
of those who have 
and do not have a 
heart attack with and 
without medication.
Numerical presentation:
• RRR and ARR- 
percentages.
•  NNT.
• Average gain on 
disease free years - 
number of extra 15 
weeks free of heart 
disease.
• Stratified gain in 
disease-free survival 
-  percentages.
measure(s)
Acceptance of 
treatment.
Acceptance of 
treatment.
Main conclusions
81% were willing to take medication 
regardless of the way the benefit of 
medication was expressed. 
Absolute risk (negative framing) 
encouraged acceptance of 
treatment the most, with 89% of 
respondents accepting treatment. 
NNT least encouraged acceptance 
of treatment, with 67% of 
respondents accepting treatment. 
Natural frequency bar graph 
produced a higher acceptance rate 
(86%) compared to its numerical 
equivalent (75%), it is not reported 
whether this was significant (p=not 
reported).
RRR format had highest proportion 
accepting treatment (88%, n=88). 
NNT had lowest acceptance (31%, 
n=31). Average gain in disease free 
years had a 40% (n=40) acceptance 
rate and stratified gain in disease- 
free survival had a 56% (n=56) 
acceptance rate. A significantly 
higher percentage of patients 
accepted treatment on the basis of 
RRR (88%) than absolute risk 
reduction (42%) and NNT (31%) 
(p<0.001).________________________
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Man-Son-Hing 
et al, 2002, 
Canada.
198 Volunteers 
aged 60-80 years 
without atrial 
fibrillation, 
Recruitment from 
outpatient 
geriatric and 
medical clinics.
Observational -  
factorial design, To 
compare the impact 
of quantitative vs. 
qualitative 
descriptions of 
probability risk 
estimates in 
decision aids on the 
clinical decision­
making process, 
regarding stroke 
prevention in atrial 
fibrillation.
Absolute 2-year 
probabilities of 
stroke and major 
haemorrhage with 
no antithrombotic 
therapy. Set at low 
(3%) or moderate 
(8%) risk.
Numerical and 
graphical presentation: 
Natural frequencies and 
pictogram of 100 faces 
in the quantitative 
(numerical) condition; 
Category phrases 
describing the risk of 
stroke and bleeding 
(e.g. low, moderate 
etc.) in the qualitative 
condition.
Choice of 
antithrombotic 
therapy, rank 
order of stroke 
risk and realistic 
expectations of 
outcomes.
No significant difference between 
treatment choices for the low risk 
arm. In the moderate risk arm, 
respondents in the qualitative group 
were more likely to choose therapy 
at the extremes of effectiveness 
(warfarin or not therapy) (p=0.01). 
Also, more persons in the qualitative 
group chose the options of aspirin 
and were ‘unsure’ than those in the 
quantitative group. The use of 
qualitative or quantitative decision 
aid made no significant difference in 
respondents’ ability to rank-order 
their stroke risk in a quantitative or 
qualitative manner (all comparison 
p- values >0.10). The quantitative 
(numerical) decision aid resulted in 
a significantly higher percentage of 
respondents having realistic 
estimates of the numerical 
probabilities for all outcomes 
compared to the qualitative decision 
aid (all values p<0.01) e.g. when 
estimating the chance of stroke 
while taking warfarin, 76 and 32% of 
the quantitative and qualitative 
groups gave correct answers, 
respectively.
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Author, year, Sample, Context Design, Aim Type of Variables of the risk Main outcome Main conclusions
country cardiovascular risk communication measure(s)
Mason et al, 
2008, USA.
683 respondents 
from a reactive 
sample of people 
who weren’t 
teachers or 
researchers,
Internet survey 
completed 
remotely.
personal risk was higher than 
comparison risk), so did negative 
affect, independently of personal 
risk ( F  -1,530= 9.10, p<.01, riP2 =
.044). When maintaining constant 
absolute differences between 
personal risk and comparison risk, 
there was no significant main effect 
of level of personal risk (p=non 
significant). Affective responses to 
comparison difference were 
sensitive to relative difference 
between personal and comparison 
risk. Relative differences correlated 
negatively with personal risk (F 
3,530= 8.19, p<.01, r|p 2 = .044. At 
higher levels of personal risk, the 
role of comparison information 
becomes less. Judgements of the 
severity and prevalence of cardiac
_________________________________________________________________________________________________________ events was not affected by personal
Observational- 
factorial design, To 
determine whether 
people focus 
primarily on 
information about 
their own risk status 
or on a comparison 
with others.
Absolute and 
comparative 10-year 
risk of having a 
cardiac event (heart 
attack, angina, heart 
failure).
Numerical presentation: 
Percentages, absolute 
risk and 4 levels of 
increasing comparison 
risk difference.
Negative affect 
responses to the 
risk information 
(disturbed and 
worried) and 
seriousness of a 
cardiac event in a 
person of the 
same age and 
sex.
When maintaining constant relative 
differences between personal risk 
and comparison risk, negative affect 
was higher at high personal risk 
(20%) than at low personal risk 
(10%) (p<.01). Respondents 
responded to the magnitude of the 
difference between personal and 
comparison risk, such that, as the 
difference increased (in which
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Misselbrook 
and Armstrong, 
2001, UK.
Scott, and 
Curbow, 2006, 
USA
274 hypertensive 
patients and 
age/sex matched 
non-hypertensive 
patients, General 
Practice.
Quasi-experimental- 
cross-sectional 
design, To examine 
patients' choice 
about treatment in 
response to different 
forms of risk 
presentation of the 
benefits of treating 
mild hypertension.
Benefit of treatment 
in reducing stroke.
395
College/University
women,
University
classrooms.
Observational study 
-  factorial design,
To examine the 
interactive effects of 
message frames 
and CVD risk factors 
on women's 
knowledge, beliefs, 
efficacy and 
behavioural 
intentions.
No individualised 
risk estimates, 
generalised 
descriptive 
statements 
regarding the 
prevention of heart 
disease.
risk and comparison difference 
whether controlling for relative or 
absolute differences.
Numerical presentation:
• RRR and personal 
probability of benefit 
from treatment 
model- percentages.
• NNT.
•  ARR- natural 
frequencies.
4 messages comprising 
either the probable 
benefits/gains of 
engaging in healthy 
behaviours or the 
probable costs/losses 
of not doing so, in 
either the short-term or 
long-term future, e.g.
• Gain x Present
• Gain x Future
• Loss x Present
• Loss x Future
Acceptance of 
treatment.
Susceptibility, 
self-efficacy to 
prevent heart 
disease, 
perceived 
efficacy of 
behavioural 
interventions and 
behavioural 
intent.
For RRR most patients would 
accept treatment (92% Cl; 89-96, 
n=255). For absolute risk reduction 
75% (95% Cl; 70-80, n=208) would 
accept treatment. For NNT 68% 
(95% Cl; 63-74, n=188) would 
accept treatment.
Personal probability of benefit had 
least patients accepting treatment 
(44%, 95% Cl; 38-50, n=121) with 
the narrow majority declining 
treatment.
There were no main or interactive 
effects of time orientation on any 
outcomes (p=non significant). Those 
who read a gain-framed message 
showed a significantly greater mean 
increase in self-efficacy to prevent 
heart disease compared to those 
who read a loss-framed message (F  
1291 =8.21, p< .05, effect size =.02). 
There was a significant interactive 
effect of message frame and 
P3rental history of high blood 
pressure for intention to check blood 
pressure (F=5.13, p< .05, effect 
size =0.01). Intention was 
significantly increased only in those 
with a family history exposed to the 
loss-framed message.____________
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Author, year, Sample, Context Design, Aim
country
Type of
cardiovascular risk
Scott, and 
Curbow, 2006, 
USA cont.
Sorensen et al, 
2008, Denmark
1519 non­
institutionalised 
Danes over 40 
randomly drawn 
from a national 
database at 
Statistics 
Denmark, 
Location not 
stated.
Observational- Death of a heart
cross-sectional attack within 3
design, To explore years.
whether lay people
can discriminate
between preventive
interventions when
effectiveness is
presented in terms
of relative risk
reduction, and
whether such
discrimination is
influenced by
presentation of
baseline risk.
Variables of the risk Main outcome Main conclusions
communication measure(s)
Numerical presentation: 
percentages and 
natural frequencies (for 
baseline risk of heart 
attack). RRR achieved 
by a hypothetical drug 
treatment to prevent 
heart attacks presented 
as 10, 20,30,40,50 or 
60% in order to test 
whether baseline risk 
had an effect on 
acceptance of 
treatment. Baseline 
numeric risk information 
was either present or 
not.
Acceptance of 
treatment and 
perceived 
difficulty of 
understanding the 
size of the 
treatment effect.
Conversely, only the gain-framed 
message significantly increased 
intention in those without a family 
history. No other significant main or 
interactive effects of message and 
health history variables on any other 
outcomes.
No significant difference in 
acceptance rates across 
respondents who were and were not 
presented with baseline risk 
information (p=non significant). 76% 
of respondents reported that RRR 
was not difficult to understand.
There was no difference in reported 
understanding of RRR across 
respondents who were or were not 
presented with baseline risk 
information (p=non significant). 
Respondents, who reported no 
difficulties understanding the 
concept, were more likely to accept 
the hypothetical treatment 
irrespective of RRR-level and 
whether baseline risk had been 
presented (p<0.05).
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Stovring et al,
2008,
Denmark.
1169 respondents 
from a
representative 
sample of 
individuals aged 
40-59 with or 
without 
experience of 
CVD, University 
building
Observational - pre­
post design, To 
study the 
concordance of 
decisions based on 
one of four single 
information formats 
for treatment 
effectiveness with 
subsequent 
decisions based on 
all four formats 
combined with a 
pictorial 
representation.
Absolute and 
relative 10-year risk 
of a fatal heart 
attack (5% and 19% 
risk).
Numerical and 
graphical presentation:
•  ARR and RRR - 
percentages.
• NNT.
•  Number of months 
for prolongation of 
life without heart 
attack (POL) (e.g. 
postponement of 
adverse outcomes).
• Smiley face 
pictograms showing 
numbers affected 
with and without 
treatment and 
natural frequencies 
bar graph.
Information on 
treatment effectiveness 
presented in terms of 
(1) single information 
format and 
subsequently (2) 
picture in combination 
with data on NNT, RRR 
and life extension
(POL).____________
Consent to 
therapy after the 
initial and final 
information, 
concordance of 
decision and 
difficulty in 
understanding.
Respondents initially presented with 
RRR generally became less likely to 
consent to treatment after receiving 
comprehensive information (73% 
(Cl; 67-78) initial concordance rate 
and 67% (Cl; 62-73) final 
concordance rate). While 
respondents initially presented with 
POL became more willing to accept 
treatment after having been given 
the fuller picture (56% (Cl; 51-62) 
initial concordance rate and 64%
(Cl; 62-73) final concordance rate). 
However, it was not reported 
whether these differences were 
significant. ARR gave highest 
concordance (94%, Cl; 91-97) 
between initial and final decision but 
was not statistically superior to the 
other formats (p=non significant). 
Followed by RRR, POL and NNT 
but differences were small. Difficulty 
in understanding did not affect the 
concordance of decision to accept 
treatment.
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3.4.2 Quality of studies
Methodological quality of studies was assessed (Appendix 18), using the 
Downs and Black checklist (Downs and Black 1998) to assess internal and 
external validity. Two studies were determined to be of good quality (Charlson 
et al. 2008; Grover et al. 2007). The other studies were deemed to be of 
medium quality (Asimakopoulou et al. 2008a; Fair et al. 2008; French et al. 
2004; Frileux et al. 2004; Goodyear-Smith et al. 2008; Hux and Naylor 1995; 
Man-Son-Hing et al. 2002; Mason et al. 2008; Misselbrook and Armstrong 
2001; Scott and Curbow 2006; Sorensen et al. 2008; Stovring et al. 2008; 
Straus 2002) (Appendix 19).
Of the four studies where individuals’ actual risk was calculated 
(Asimakopoulou et al. 2008a; Charlson et al. 2008; Grover et al. 2007; Straus 
2002), two were RCTs (Charlson et al. 2008; Grover et al. 2007) and two 
were observational (Asimakopoulou et al. 2008a; Straus 2002). The RCTs 
were of good quality, both were adequately powered and compared groups to 
identify possible confounders. In one trial, the outcome assessor was blinded 
to the randomisation groups (Charlson et al. 2008). However, in the other trial, 
contamination of the control group may have occurred due to the 
randomisation at a patient and not physician level (Grover et al. 2007). The 
two observational studies achieved lower quality scores.
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Eleven analogue studies asked individuals to imagine a hypothetical risk 
profile. They were predominantly observational studies with a factorial design. 
Six studies randomised groups (French et al. 2004; Man-Son-Hing et al. 2002; 
Mason et al. 2008; Scott and Curbow 2006; Sorensen et al. 2008; Stovring et 
al. 2008); six attempted to identify principal confounders by comparing groups 
(Fair et al. 2008; Goodyear-Smith et al. 2008; Man-Son-Hing et al. 2002; Scott 
and Curbow 2006; Sorensen et al. 2008; Stovring et al. 2008) and two blinded 
participants to the manipulations (Man-Son-Hing et al. 2002; Misselbrook and 
Armstrong 2001). However, six studies did not report power calculations for 
sample sizes (Fair et al. 2008; French et al. 2004; Frileux et al. 2004; 
Goodyear-Smith et al. 2008; Mason et al. 2008; Misselbrook and Armstrong 
2001), one was underpowered (Stovring et al. 2008), and one reported 
concerns about the reliability of the findings because participants failed to 
follow questionnaire instructions (Scott and Curbow 2006).
There was variation of included studies in terms of risk representation 
formats, type of cardiovascular risk, timeframe and outcomes measured (see 
Table 3.2)
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Table 3.2 Summary of cardiovascular risk manipulation of included studies, by type of risk assessment.
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French et al 2004 • • - - • 0 0  • - - 0 0 • • - - - -
Frileux et al 2004 • - - - - - • - - 0 0 - - - • - - -
Man-son-Hing et 
al 2002 - • - • 8 - • • - - 0 - - - - - •
#9,10
Mason et al 2008 • - - - - - •  • - - 0 • • - - - - -
Scott and Curbow
•  1 1 12,132006 • 0 0 •
Goodyear-Smith 
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Hux and Naylor
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1 Pie chart,2 Memory/Recall,3 Net present value approach (biologic age reduction), 4 Future value approach,5 Self-efficacy,6 Stage of change,
7 Cardiovascular age,8 Categories,9 Rank order of stroke risk,10 Outcome expectation,11 Descriptive statements (gain/loss and present/ future
framing),12 Self-efficacy,13 Perceived efficacy of interventions,14 Gain in disease free years,15 Stratified gain in disease free survival,16
Prolongation of life.
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3.5 Summary of findings
3.5.1 Numerical formats
One study assessing patients’ actual risk (Straus 2002) and seven analogue 
studies (Fair et al. 2008; French et al. 2004; Goodyear-Smith et al. 2008; Hux 
and Naylor 1995; Misselbrook and Armstrong 2001; Sorensen et al. 2008; 
Stovring et al. 2008) compared a number of different numerical risk 
representation formats with each other. Additionally, one actual risk study 
used a combination of two numerical formats in an intervention and compared 
it with usual care (Grover et al. 2007). One analogue study compared a 
numerical format with risk categories (Man-Son-Hing et al. 2002).
Two analogue studies were concerned with whether perceptions of risk and 
emotional responses were sensitive to numerical risk presentation (Fair et al. 
2008; French et al. 2004). Fair and colleagues examined the effect of two 
formats (percentages and frequencies, e.g. n in 100) on responses to 
messages regarding the risk of coronary heart disease (CHD). Risk 
perceptions, emotions and behavioural intentions were sensitive to the format 
used. Frequencies led to higher perceived risk (OR= 2.471 (95% Cl; 
1.692-3.609), p<0.001), more worry (p<0.001), more disturbance (p<0.001), 
and increased intention to make lifestyle changes (p<0.05), than did 
percentages (Fair et al. 2008). Conversely, French et al used vignettes that 
presented risk of having a cardiac event in either percentage or frequency
104
formats, and found no differing effect on risk perception, emotion or 
understanding (French et al. 2004).
One study assessing actual risk (Straus 2002) and five analogue studies 
(Goodyear-Smith et al. 2008; Hux and Naylor 1995; Misselbrook and 
Armstrong 2001; Sorensen et al. 2008; Stovring et al. 2008) were mainly 
concerned with presenting treatment effectiveness in differing numerical 
formats. These studies evaluated how different formats lead to differing 
acceptance rates of medication. Straus compared formats for presenting the 
ratio of the benefits and costs of taking warfarin medication, and measured 
patients’ intention to take warfarin. The highest percentage of patients (76.4%, 
n=13) chose to take warfarin when they were presented with the likelihood 
ratio of being helped or harmed. Conversely, the absolute risk reduction 
versus absolute risk increase ratio had the lowest percentage of patients 
choosing to take warfarin (17.6%, n=3). It was not reported whether 
differences were significant, and no confidence intervals were given.
However, this study had a small sample (n=17) and needs to be interpreted 
with caution (Straus 2002).
In a cross-sectional study by Goodyear-Smith, respondents with existing CVD
were presented with descriptions of the benefit of a hypothetical medication to
reduce the risk of a future heart attack. The same information was expressed
in different formats. Their willingness to accept the medication was measured.
The presentation of negatively framed 5-year absolute risk (expressed as
percentages) encouraged acceptance the most, with 89% (n=89) consenting
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format was supplemented with baseline risk information (expressed as natural 
frequencies), which would enable a calculation to determine perspective 
(Sorensen et al. 2008).
In the study that compared a numerical intervention with usual care, Grover 
gave patients a copy of their coronary risk profile. This comprised eight-year 
absolute cardiovascular risk presented as increased cardiovascular age (e.g. 
an analogy that combines absolute and relative CVD risk, described in more 
detail below), comparative risk (expressed as percentages), and bar graphs 
(to demonstrate the changes in patients’ lipid levels over time). At 12-month 
follow-up, patients receiving their risk profile were more likely to reach lipid 
targets (OR= 1.26 (95% Cl; 1.04-1.53, p value not reported) and achieve 
greater cholesterol reductions (OR= 1.26 (95% Cl; 1.07-1.48, p value not 
reported) than those who received usual care (Grover et al. 2007).
Cardiovascular age is calculated from a model that estimates the life 
expectancy of individual patients based on their annual risk of fatal coronary 
disease, fatal stroke and non-CVD death, and compares it with the average 
life expectancy of individuals of the same age and sex. The difference 
between the two numbers is then added or subtracted from the patient’s 
chronological age to provide the cardiovascular age. The difference between 
chronological age and cardiovascular age is the ‘age gap’. This measure 
combines both a relative component e.g. finding out if you are older or
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younger than your cardiovascular age, and an absolute component e.g. the 
size of the age gap (Grover et al. 2007).
Man-Son-Hing et al compared two versions of a decision aid that differed in 
the way they presented risk, using a factorial design. The purpose of the 
decision aid was to help with choices regarding antithrombotic therapy to 
prevent stroke; the risk information was presented in either quantitative 
numerical formats (e.g. frequencies) with graphical representations (e.g. 
pictograms with smiley faces); or in a more qualitative way (e.g. high to low 
risk categories). When the risk of stroke without antithrombotic therapy was 
presented as ‘moderate’ (e.g. 8%), participants receiving the numerical 
information were significantly more likely to choose the therapy with the 
extremes of effectiveness (e.g. warfarin or no therapy) (p<0.01). Those 
receiving the risk category information were more likely to choose aspirin 
(middle of the range effectiveness) and be more uncertain about their choice. 
This difference was not seen when a low (e.g. 3%) risk of having a stroke with 
no therapy was presented. Additionally, those receiving the numerical 
decision aid were significantly more likely to have realistic risk perceptions, by 
giving correct estimates of the numerical probabilities for the outcomes 
achievable from therapy, than those who received the alternative risk category 
version (p<0.01) (Man-Son-Hing et al. 2002).
To summarise, studies looking at numerical risk representation formats have
found that making patients aware of their risk can encourage risk reduction
action to be taken, especially if this risk is high. There is conflicting evidence
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regarding whether numerical representation formats can affect patients’ 
perceptions or emotions. However, numerical representation of risk as 
opposed to simple risk categories (e.g. high, moderate, low) appears to lead 
to more accurate risk perceptions. Additionally, treatment decisions are 
sensitive to the way a treatment’s effectiveness is presented. The RRR format 
appears to ‘encourage’ treatment the most and the NNT format leads to the 
least acceptance.
3.5.2 Graphical formats
Six studies in this review used graphical representations, mainly bar graphs 
and pictograms. Two used actual risk assessment (Asimakopoulou et al. 
2008a; Grover et al. 2007) and four were analogue studies (French et al.
2004; Goodyear-Smith et al. 2008; Man-Son-Hing et al. 2002; Sorensen et al. 
2008). No study compared different graphical formats with each other. Two 
studies compared a graphical format against its numerical equivalent (French 
et al. 2004; Goodyear-Smith et al. 2008). Four studies used numerical and 
graphical formats collectively (Asimakopoulou et al. 2008a; Grover et al. 2007; 
Man-Son-Hing et al. 2002; Stovring et al. 2008); two of which used more than 
one graphical representation and reported the effect resulting from a 
combination of the graphical formats (Asimakopoulou et al. 2008a; Stovring et 
al. 2008).
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Four studies incorporated both graphical and numerical formats into their 
interventions. Asimakopoulou and colleagues found patients’ perceived risk 
was grossly inflated compared to their actual risk. The graphical tools helped 
to correct these inflated risk perceptions of CHD risk ( F i , 92= 73.01 ; p<0.001), 
as well as inflated stroke risk (Fi , 9 1 = 1 19.05; p<0.001) (Asimakopoulou et al. 
2008a). Additionally, Grover presented patients with a risk profile comprising 
bar graphs to demonstrate the changes in patients’ lipid levels over time. This 
was more successful in reducing cholesterol (OR= 1.26 (95% Cl; 1.07-1.48, p 
value not reported) and meeting lipid targets (OR= 1.26 (95% Cl; 1.04-1.53, p 
value not reported), than usual care (Grover et al. 2007).
Man-son-Hing et al found that when the risk of a stroke without antithrombotic 
medication was moderate and presented as a pictogram of natural 
frequencies, as opposed to risk categories, more realistic risk perceptions 
resulted (p<0.01) and therapy with extremes of effectiveness (e.g. warfarin or 
no therapy) was more likely to be chosen (Man-Son-Hing et al. 2002).
Stovring et al presented comprehensive information about the effectiveness of 
a pharmaceutical drug, using a combination of four numerical formats and a 
pictogram showing number of people affected with and without treatment. 
Initial decisions to accept treatment made when one numerical format was 
presented first did not change after subsequent presentation of the more 
comprehensive risk information (Stovring et al. 2008). This finding is 
contradicted by Goodyear-Smith and colleagues who found that acceptance
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of medication to reduce the risk of a heart attack increased by 11 % (from 75% 
to 86%) when bar graphs were presented (showing the number of people who 
do and do not have a heart attack when taking the medication, compared to 
those who do not take it), as opposed to when the same information was 
expressed only numerically as natural frequencies. However, it is not reported 
whether this was significant (Goodyear-Smith et al. 2008).
Lastly, the effect of the presence or absence of graphical representation was 
compared by French et al. When the risk of having a cardiac event was 
accompanied with visual representation (e.g. bar graphs for the percentage 
format, pictograms for the natural frequency format), significantly less 
disturbance and worry resulted, compared to those who did not receive visual 
representations ( F i , 3 1 3 = 8 .74; p<0.01). However, greater feelings of 
reassurance were not reported, which would intuitively be expected, and 
perceptions and behavioural intentions remained unaffected (French et al. 
2004).
To summarise, studies that have used graphical representation in their 
interventions have shown that presenting risk both graphically and numerically 
can lead to more accurate perceptions of risk, favourable changes in risk 
factors (such as lipid levels and cholesterol) and can help reduce negative 
emotions. However, whether treatment decisions are sensitive to numerical or 
graphical formats used in the presentation of medication effectiveness is not 
clear.
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3.5.3 Presentation of comparative risk
Comparative or peer-group risk can be used to demonstrate how an 
individual’s risk compares to that of the average person of the same age and 
sex. The effects of presenting comparative risk information were examined by 
four studies. Three were analogue (Fair et al. 2008; French et al. 2004;
Mason et al. 2008). Two of these compared the presentation of both personal 
and comparative risk against presentation of personal risk only (Fair et al. 
2008; French et al. 2004). One of these also examined the effect of 
presenting comparative risk higher or lower than personal risk (French et al. 
2004). One study examined the effects of relative differences between 
personal and comparison risk (Mason et al. 2008). Assessment of actual risk 
was used in one study, which incorporated comparative risk into an 
intervention comprising numerical and graphical presentations (Grover et al. 
2007).
Of the two studies that compared the presentation of personal and 
comparative risk against personal risk only, Fair et al found that risk 
perceptions and emotions were sensitive to the presence of comparative risk 
information. When messages about CHD contained information about both 
personal and comparative risk, respondents perceived their risk to be 
significantly higher (OR= 1.578 (95% Cl; 1.144-2.177), p<0.01), and reported 
more worry (p<0.01), more disturbance (p<0.01), and less reassurance
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(p<0.01), than presentation of personal risk information only. However, 
behaviour intentions did not differ significantly (Fair et al. 2008).
The other study by French et al assessed respondents’ perceptions and 
emotions. Personal risk had more of an impact on reassurance (rj2 = 0.08) 
than social comparison risk (ti2 = 0.06). This was also seen for disturbance 
and worry (r | 2 = 0.09 vs. ti2 = 0.05) and perceived risk (r)2 = 0.07 vs. rj2 = 0.03). 
This study also distinguished between the presentation of favourable and 
unfavourable comparative risk information, and compared this against not 
providing any comparative risk information. Those presented with favourable 
comparison information (e.g. average or below average risk) reported being 
significantly more reassured, less disturbed and worried and thought they 
were less likely to have a cardiac event, than those who received 
unfavourable information (e.g. above average risk) (p<.05). However, 
unfavourable comparison information had no discernible impact on risk 
perceptions or emotions, relative to not providing any comparison information 
(French et al. 2004).
Mason et al 2008 examined whether people attend mainly to information 
regarding personal risk or comparative risk. They presented hypothetical 
scenarios about the risk of a cardiac event. Levels of personal and 
comparison risk varied in these scenarios. As the difference between personal 
risk and comparison risk increased (in which personal risk was higher than 
comparison risk), so did worry and disturbance. (F  1,5 3 0= 9.10, p<0.01, r| p2 =
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.044). Furthermore, responses to the varying relative differences between 
personal risk and comparison risk correlated negatively with personal risk 
(F3,53o= 8.19, p<0.01, r|p2 = .044), suggesting that at higher levels of personal 
risk, the role of comparison information becomes less (Mason et al. 2008).
The study by Grover showed how an individual’s risk compares to the 
average person by using the concept of cardiovascular age equivalent. This is 
calculated using the equivalent risk of a person who has no modifiable risk 
factors. In cases where an individual has modifiable risk factors, their risk will 
be higher than a person of the same age and sex without those factors; 
therefore their risk will be equivalent to someone older. When a risk profile 
was given to patients that presented comparative 8-year cardiovascular risk 
as cardiovascular age equivalent and percentages, patients had greater 
cholesterol reductions (OR= 1.26 (95% Cl; 1.07-1.48, p value not reported) 
and were more likely to reach lipid targets (OR= 1.26 (95% Cl; 1.04-1.53, p 
value not reported) over the 12 month follow-up, than those who did not 
receive their risk profile. In particular, an interaction effect was found where 
the higher the patient’s risk (evidenced by increased cardiovascular age), the 
greater the impact of the risk profile (OR=1.69 (95% Cl; 1.21-2.36), p<0.05) 
(Grover et al. 2007).
To summarise, using comparative risk together with personal risk affects risk 
perceptions, emotions and can influence behavioural change for reducing risk 
factors. However, the impact of comparison risk depends on the level of
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personal risk; when personal risk is high, negative emotions are heightened 
and less attention is paid to comparative risk.
3.5.4 Framing of risk information
One analogue study investigated the impact of risk message framing (Scott 
and Curbow 2006). Scott and Curbow evaluated framing of messages 
regarding the probable benefits or costs of engaging in healthy behaviours 
relating to heart disease or not engaging in them. These were presented as 
‘gain-framed’ (e.g. benefits of engaging in healthy behaviours) or ‘loss-framed’ 
(e.g. costs of not engaging in healthy behaviours). Gain-framed messages led 
to a significant increase in perceived self-efficacy to prevent heart disease as 
opposed to loss-framed messages (F 1,291 =8.21, p<0.05, effect size=.02). 
Moreover, there was a significant interactive effect of message frame and 
parental history of high blood pressure for reported intention to check blood 
pressure (F=5.13, p<0 .05, effect size=.01). Intention was significantly 
increased only in those with a family history exposed to the loss-framed 
message. Conversely, only the gain-framed message significantly increased 
intention in those without a family history (Scott and Curbow 2006).
3.5.5 Timeframe manipulations
The timeframe used when presenting cardiovascular risk information (i.e. 5- 
year or 10-year) was manipulated in one study assessing actual risk
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(Charlson et al. 2008) and four analogue studies (Asimakopoulou et al. 
2008a; Fair et al. 2008; Frileux et al. 2004; Scott and Curbow 2006). Specific 
timeframes were not used in two studies, only present vs. future (Charlson et 
al. 2008) and short-term vs. long-term (Scott and Curbow 2006). One study 
examined time horizons less than 10-years (Asimakopoulou et al. 2008a). 
Two studies (Fair et al. 2008; French et al. 2004) considered the presentation 
of risk over longer time horizons greater than 10 years.
Charlson et al presented information about the reduction of cardiovascular 
morbidity risk achievable by modifying risk factors, using the ‘net present 
value’ approach (biologic age reduction one could achieve either in three 
months or two years, e.g. respondents told that changing behaviour would 
decrease their biological age) or the ‘future value’ approach (risk reduction 
framed as the value of preventing future health problems, e.g. respondents 
told changing behaviour would increase lifespan). However, at 2 year follow- 
up no differences between the two groups were found in rates of death, 
stroke, myocardial infarction, angina or severe ischemia, stages of change or 
self-efficacy (Charlson et al. 2008).
Also, Scott and Curbow framed information about the costs and benefits of 
engaging in or not engaging in healthy behaviours, in relation to heart 
disease, in the short or long-term. The timeframe of the messages did not 
have an effect on behavioural intentions, self-efficacy or perceived 
susceptibility. It is argued that this may have been due to the young sample
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used and the future-oriented nature of heart disease (Scott and Curbow 
2006).
Asimakopoulou and colleagues presented the risk of developing CHD or 
stroke as a result of having diabetes in 1, 5 or 10-years, using percentages 
with graphical accompaniments. Originally inflated risk perceptions of CHD 
were successfully corrected with the help of the graphical tools (Fi,92=73.01; 
p<0.001), as was inflated stroke risk (Fi,91=119.05; p<0.001). However, the 
10-year time frame was most resistant to correction, and those who received 
this timeframe recalled a much higher risk at 6 week follow-up than they 
understood at the initial consultation (F4176=4.73; p<0 .001 ), possibly 
suggesting they did not understand the concept of accrual of risk over time 
(Asimakopoulou et al. 2008a).
Frileux and colleagues found that when individuals indicated their intention to 
adopt a specific behaviour for a number of scenarios about coronary artery 
disease risk varying in terms of the level of probability occurrence (5,10,15, or 
20%) and the timeframe presented (either short 5 or 10-years, or long 15 or 
20 years), shorter timeframes (i.e. 5 or 10 years) led to greater intention to 
change behaviour (F1i138=29.66; p<0.001). In fact, the shorter the timeframe, 
the greater the intention to change behaviour (F3>414=229.33; p<0.001). 
Furthermore, an interaction between age and timeframe was found, where 
intention to adopt a preventive behaviour was greater for older participants 
(aged between 60 and 80) when shorter timeframes were used, and for 
younger participants (aged between 20 and 30) when longer time frames
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were used (Frileux et al. 2004). Conversely, Fair et al found no effect of 
timeframe manipulation on perceptions, emotion or behavioural intentions, 
when 10 or 30-year timeframes were used in messages regarding CHD risk 
(Fair et al. 2008).
To summarise, evidence is unclear, but it appears that patients are insensitive 
to the framing of risk information when presented as merely ‘short-term’ or 
‘long-term’. However, presentation of specific timeframes does have an effect; 
shorter timeframes (less than 10 years) may lead to more accurate risk 
perceptions and increased intention to change behaviour, than 10 year risk or 
longer, especially for older patients.
3.6 Discussion and Conclusion
3.6.1 Discussion
This review demonstrates that compared to the intensive and ongoing 
investment in the calculation of cardiovascular risk estimates, there is a 
poverty of research on how to convey these estimates in a meaningful way, 
so as to motivate people to modify their risk of developing heart disease. The 
review comprised broad inclusion criteria, yet only found 15 studies, 11 of 
which were analogue studies and only 4 studies which dealt with the 
presentation of actual risk to patients. The methodological quality of studies 
varied, the majority had observational designs and were heterogeneous with
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respect to the conceptualisation, formats and framing of cardiovascular risk 
probabilities. Therefore, only a few meaningful subgroups could be formulated 
(real or hypothesised risk, type of cardiovascular risk manipulation etc.).
The conclusions drawn from these few studies are tentative and need further 
exploration. Nevertheless, the results from individual studies are summarised. 
Making patients aware of their risk can encourage risk reduction action to be 
taken, especially if this risk is high. Numerical presentation of risk as opposed 
to simple risk categories leads to more accurate risk perceptions and can 
influence treatment decisions. Relative risk reduction format ‘encourages’ 
acceptance of treatment the most and numbers needed to treat (NNT) format 
encourages the least. The presentation of absolute and comparative risk, both 
graphically and numerically, affects risk perceptions and emotions and can 
lead to reduction in patient risk factors. However, the impact of comparison 
risk depends on the level of personal risk; comparative risk is attended to less 
when personal risk is high. Lastly, shorter timeframes (less than 10 years) 
lead to more accurate risk perceptions and increased intention to change 
behaviour, than timeframes longer than 10 years.
A strength of this review is that it comprised a comprehensive systematic 
literature search that aimed for high recall. Study inclusion and data extraction 
were agreed and validated by at least two reviewers throughout the reviewing 
process. Weaknesses include possible selection bias from the exclusion of 
unpublished literature and non-English language studies; and the fact that 
data extraction was not independent, but involved a validation procedure
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(however, consensus between reviewers was very high). Caution needs to be 
taken when interpreting this review’s findings as it incorporated studies that 
used actual risk assessment and analogue studies. Real patients differ from 
participants in hypothetical studies (Lloyd 2001). Additionally, multiple types of 
cardiovascular risk were included (such as those for primary CHD prevention, 
secondary prevention, and stroke prevention in Atrial Fibrillation). Therefore, 
there may be an interaction effect of format by type of CVD risk, in which 
investigation is beyond the scope of this review.
The principal findings of this review confirm previous research indicating that:
1) Visual displays have desirable properties that are helpful for 
representing risk, enhance understanding of risk and are favourably 
evaluated by patients (Hill et al. 2010; Lipkus and Hollands 1999; Price 
et al. 2009).
2) Cardiovascular age equivalent formats are clear, memorable and 
considered an ‘eye-opener’ or ‘wake-up call’ and have the potential to 
motivate people to make beneficial health-related behaviour change. 
This is in contrast to the more traditional statistical probability formats 
for communicating risks that were viewed as being confusing and 
uninspiring (Goldman et al. 2006).
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3) Frequencies are the natural way people think about risk probabilities, 
and are effective in correcting inappropriate risk perceptions (Cuitie et 
al. 2008; Gigerenzer and Hoffrage 1995; van der Weijden et al. 2008).
Additionally, the results from a randomised trial published after this review 
was conducted, confirm the positive evaluation of frequencies (Carling et al. 
2009b). When summary statistics for communicating the effects of statins on 
the risk of coronary heart disease were presented in different formats, natural 
frequencies were best understood (8 6 % of participants reported they 
understood them well or very well) and participants were most satisfied with 
this information, compared to the other formats, such as absolute risk 
reduction and NNT (Carling et al. 2009b).
4) The relative risk format, despite being more persuasive, is more 
favourably evaluated than other formats (such as absolute risk or 
NNT) (Covey 2007; Cranney and Walley 1996).
Furthermore, the randomised trial by Carling et al found that treatment 
decisions were also influenced by the relative risk reduction format. The 
relative risk reduction format lead to a 21% higher probability of choosing to 
take statins compared to other formats (Carling et al. 2009b).
Studies in this review provided inconclusive evidence of the effect of
presenting patients with comparative risk information. They demonstrated that
individuals attend to risk information based on the magnitude of personal risk
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and their risk in comparison to others. These appear to be independent and 
additive, as comparing individual risk with the ‘average’ may be less important 
when ones’ personal risk is high; possibly because the salience of the 
personal risk overrides the comparative information in these circumstances 
(Mason et al. 2008). However, the exact nature of the effect on behavioural 
intentions, perceptions and emotion is unclear. This format is potentially 
important as it puts individualised risk into context and is a way demonstrating 
the risk attributable to non-modifiable risk factors, such as age. Previous 
studies have shown it to influence treatment decisions (Fagerlin et al. 2007b). 
However, comparative risk information has been found to make no differences 
to emotional responses or behavioural intentions (Lipkus et al. 1999).
Furthermore, the cardiovascular age equivalent format should be an effective 
motivator in reducing risk (Goldman et al. 2006), because in cases where an 
individual has multiple risk factors, their ‘heart age’ will be higher than their 
biological age. In this review, the cardiovascular age equivalent format was 
assessed by one RCT (Grover et al. 2007). An effect on the reduction of risk 
factors was found, especially when cardiovascular age was high; but this was 
only compared against not providing risk information to patients, not against 
alternative formats.
However, since conducting this review, a randomised trial assessing patients
actual risk has been published (Soureti et al. 2010). It compared the
traditional percentage format with the cardiovascular age equivalent or Heart-
Age analogy format. Perceptions of absolute individual risk and comparative
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risk, cognitive evaluation, affective reaction and intention to change lifestyle 
were assessed. There were no significant differences in individual or 
comparative risk perceptions between those who received the percentage and 
Heart-Age formats. However, those who received the Heart-Age format had 
risk perceptions more consistent with their actual risk. Furthermore, the Heart- 
Age format had greater emotional impact in younger individuals at higher CVD 
risk, where they were significantly more worried (p=.005) and were more likely 
to view it as a ‘wake-up’ call (p=.004) than those who received the percentage 
format. Emotional reactions mediated the relationship between risk 
perceptions and intention to change behaviour, and it was suggested that 
further research is needed into how to convert modified risk perceptions and 
emotional reactions into lifestyle behaviour change (Soureti et al. 2010). It is 
felt that more research should be conducted into the effects of providing 
cardiovascular age equivalent formats before any firm conclusions can be 
made regarding the benefits of this analogy format.
The inconsistency found in this review regarding the effect of longer 
timeframes (such as 15, 20 and 30-years) could be attributed to the fact that 
individuals are poorly attuned to how risk accumulates over time, are not good 
at forecasting the future, fail to take account of the timeframes used to 
represent risk and do not adjust their risk perceptions to account for the longer 
time spans (Fagerlin et al. 2007a; Kassam et al. 2008; Lipkus 2007; Zikmund- 
Fisher et al. 2005).
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However, a recent focus group study comprising consumer and GP 
participants asked for preferences for timeframes presenting cardiovascular 
risk (Hill et al. 2010). It was found that most participants said they preferred 
knowing their CVD risk within 5-years rather than 10-year risk, as this was 
seen as being too far away and would act as an ‘excuse’ to put off making any 
lifestyle changes, or would not be relevant after a certain age. The GP 
participants argued for shorter timeframes as well (such as risk calculated 
over one or two years), as this would be a suitable length of time that would 
most motivate patients to reduce their risk. They thought that the increase in 
risk as the patient ages means that the risk calculation becomes bigger and 
‘too remote’ and can become meaningless if calculated over a longer period 
of time; and also unhelpful in promoting behaviour change or appreciating 
degree of risk. However, it must be noted that this preference for the 5-year 
timeframes over 10-years may have been due to the fact that the format 
examples presented in the focus groups used 5-year time frames (Hill et al. 
20 1 0 ).
The few studies in this review that measured understanding, did so by recall 
immediately after presentation, self reported confidence or perceived difficulty 
in understanding (Asimakopoulou et al. 2008a; French et al. 2004; Sorensen 
et al. 2008; Stovring et al. 2008). A question has to be asked as to whether 
these methods really do measure a patient’s understanding of their risk, or 
mere recall of information. If this is the case, is there a more suitable way to 
measure understanding? Furthermore, only a small number of studies in this 
review used graphical representations, these being mainly bar graphs and
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pictograms; and no study compared graphical formats with each other (only 
graphics used collectively with numeric representation).
This review highlights the tension between providing patients with neutral and 
unbiased risk information whilst presenting risk in a way that encourages 
behaviour change and risk reduction. During analysis, a distinction between 
two types of studies emerged; studies that seemed to use risk communication 
to achieve risk reduction by modifying lifestyle or taking medication and those 
that did not. Two studies assessing real patients’ risk, communicated risk in 
order to explicitly ‘persuade’ and reduce risk. They measured changes in risk 
factors or overall reduction of risk (Charlson et al. 2008; Grover et al. 2007). 
Three analogue studies had a persuasive motive as well as they measured 
intention to change behaviour (Fair et al. 2008; Frileux et al. 2004; Scott and 
Curbow 2006). Seven studies, six analogue (Goodyear-Smith et al. 2008; Hux 
and Naylor 1995; Man-Son-Hing et al. 2002; Misselbrook and Armstrong 
2001; Sorensen et al. 2008; Stovring et al. 2008) and one using actual risk 
assessment (Straus 2002) also persuaded to a lesser extent, and measured 
the acceptance of treatment to reduce cardiovascular risk.
This raises debate as to how legitimate it is to persuade people to make
decisions regarding their health, such as changing their behaviour or taking
medication, versus providing information. It is sometimes difficult to
distinguish between the two. In contrast, three studies, one real
(Asimakopoulou et al. 2008a) and two analogue (French et al. 2004; Mason et
al. 2008), were concerned only with the emotional and cognitive aspects of
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the risk communication, such as what people thought about the risk 
presentation not how they acted upon it. The difference in outcomes 
measured by risk communication studies has been highlighted previously 
(Edwards and Elwyn 1999).
Although more weight should be given to studies involving the assessment 
individuals’ real risk, the results from hypothetical studies included in this 
review have been more informative about the best ways to communicate risk. 
More of these studies addressed the main issues associated with 
cardiovascular risk, such as comparative risk information, comparing one 
format with another and framing of risk information. However, it must be noted 
that patients’ perceptions of the risks of their disease differ from those 
participants in studies using hypothetical scenarios (Edwards et al. 2002). 
Therefore, more research with methodologically sound trials, assessing 
patients’ actual cardiovascular risk that also compare different risk 
presentation formats need to be conducted before firm conclusions can be 
drawn as to the most effective ways to communicate cardiovascular risk to 
patients.
3.6.2 Conclusion
This review demonstrates a lack of well-designed studies in cardiovascular 
risk communication. This has been due to a combination of diverse 
methodological quality and contradictory results. It is likely that the
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heterogeneity of study characteristics, such as the design, sample and type of 
cardiovascular risk presented have contributed to this. A wide range of 
outcomes have been measured and there has been little consistency in risk 
representation formats used; therefore, it is difficult to draw firm conclusions.
Two different aims were identified in the communication of cardiovascular risk; 
first, risk communication to influence patient awareness and correct 
inappropriate risk perceptions to facilitate the decision to reduce risk or not to 
reduce risk; and second, the impact of different risk reduction strategies to 
facilitate the decision on how to reduce the risk.
3.6.3 Practice implications
There is a need for more research into communication of actual risk to real 
patients. RCTs comparing different risk representation formats are needed to 
examine whether peoples’ intentions, perceptions and understanding of risk 
vary by graphical format. Projecting risk over longer time horizons to show 
increase in risk as the patient ages was attempted in the studies included in 
this review, but failed to have any desirable impact. It needs to be accepted 
that patients have difficulty in forecasting their future risk, and more 
meaningful projections should be used instead of presenting risk in an 
abstract 10-year horizon. This could be in the form of more salient outcomes 
and forecasts of loss in the future, such as not being able to achieve important 
milestones, birth of grandchildren or similar.
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Future research needs to present patients with the cardiovascular risk 
adjusted age format and compare it with other formats; to see whether it is an 
effective way to demonstrate the magnitude of risk, and whether it is more 
effective in changing behaviour than other ‘more conventional’, less 
meaningful representations. Further investigation into the framing of 
information regarding the benefits and harms of treatment should also be 
conducted. Lastly, the provision of comparison risk information that shows 
baseline risk and puts personal risk into context should be examined in more 
depth.
Determining how best to present cardiovascular risk information to patients 
strongly depends on the intended aims of the communication. Is the purpose 
to raise awareness and improve understanding, or to persuade those at risk to 
adopt new behaviours to reduce risk? Being clear about the communication 
aims would help clarify research in this complex area. If communication 
informs patients of their risk and gently persuades them about the fact that 
their risk is higher than average due to increased but modifiable risk factors, 
then it is time to provide neutral and balanced risk information about the 
impact of modifying risk factors through lifestyle and/or drug treatment, thus 
reducing their risk. This will free-up the burden on healthcare services and 
reduce the population incidence of this disease.
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3.7 Summary
This chapter has described a systematic review into the effects of presenting 
cardiovascular risk information to patients. It found little consistency in risk 
presentation formats, and highlighted the need for better quality trials that 
compare different risk presentation formats, before conclusions can be drawn 
as to the most effective ways to communicate cardiovascular risk to patients.
It concluded that more attention should be paid to the effective presentation of 
risk, to help patients reduce risk by lifestyle change or active treatment, 
instead of directing all the attention to the accuracy of cardiovascular risk 
prediction.
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Chapter 4 - Risk communication literature overview and rationale 
for conducting a randomised controlled trial of cardiovascular risk 
representation formats.
4.1 Introduction
This chapter presents an overview of the research that has been conducted in the 
area of risk communication. It is not a comprehensive review, but a selection of 
studies demonstrating issues relevant to this thesis, such as framing effects and the 
differing outcomes resulting from numerical and graphical representation formats. 
Prominence has been given to the evidence from existing recent systematic reviews 
and other relevant overviews. The second section of this chapter provides rationale 
for conducting further research into cardiovascular risk representation formats. It 
proposes three risk representation formats that should be assessed in a randomised 
controlled trial (RCT) and suggests the outcomes measures that would be of interest.
4.2 Definition of risk communication
Risk communication in healthcare is defined as communication with individuals (not 
necessarily face-to-face) which addresses knowledge, perceptions, attitudes or 
behaviour relating to risk. The communication should include an element of weighing 
up of risks and benefits of a treatment choice or behavioural risk-reducing change 
(Edwards and Bastian 2001).
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The interpretation of risks varies because communication about risk is usually 
framed in terms of language of chance or probability (Edwards and Prior 1997). The 
best method for presenting risk information continues to be an area of considerable 
debate. Few overall evidence-based recommendations can be suggested for 
communicating risk magnitudes. This is due to the different outcome measures that 
have been used to assess the effectiveness of risk communication interventions, 
inconsistency in the representation formats used, lack of critical tests using RCTs 
pitting formats against one another, and lack of theoretical progress in identifying 
why one format should be more effective in a specific context than another (Edwards 
and Elwyn 2001; Elwyn et al. 1999; Lipkus 2007).
4.3 Type of risk used in risk communication
Risk can be presented in different ways, such as absolute risk, relative risk and 
comparative risk in relation to peers. This section will describe these in turn.
4.3.1 Absolute and Relative risk
Risk can be presented as an absolute probability (e.g. the chance that a specified 
event will occur in a specified population over a specific period) and also as relative 
risk (e.g. the ratio of the risk of disease among those exposed to a risk factor, to the 
risk among those not exposed). There has been some debate as to which should be 
used to communicate risk information to patients, as differing effects on risk 
perceptions, understanding, preferences and treatment decisions have been found.
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For example, framing of benefit and risk information in relative versus absolute terms 
has a major influence on patient preference (Malenka et al. 1993). Additionally, 
systematic reviews have concluded that relative risk reduction is misleading and 
more persuasive than absolute risk data (Edwards et al. 2001; Epstein et al. 2004).
When treatment risks and benefits are presented as relative risk reduction, the 
benefits of the treatments are often overestimated and can lead to an increased 
willingness to consent, compared to formats that use absolute risk data or other 
formats, such as numbers needed to treat (NNT) (Gigerenzer 2003).
For example, when relative and absolute forms of presenting risk information about 
influenza were compared, relative risk information presented on its own led to higher 
ratings of satisfaction, perceived effectiveness of the vaccination and a greater 
willingness to have the vaccination. However, absolute risk that presents baseline 
information (i.e. the predicted number of adult population affect by the flu), led to 
more accurate probability estimates and more positive evaluations of the risk 
message.
Furthermore, a recent Cochrane review of different statistical formats for presenting 
health information concluded that people perceive risk reductions to be larger and 
are more persuaded to adopt a health intervention when its effect is presented in 
relative terms (e.g. using relative risk reduction which represents a proportional 
reduction) rather than in absolute terms (e.g. using absolute risk reduction which 
represents a simple difference) (Akl et al. 2011).
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This demonstrates the importance of presenting baseline risk information to prevent 
inaccurate perceptions of the absolute size of risk reductions (Natter and Berry
2005). Decisions are often made by making comparisons, and presenting absolute 
or relative risk in isolation can be criticised for only presenting half of the picture. 
Therefore, a way of minimising these biased effects is to present absolute and 
relative risk both together (Edwards and Elwyn 2001).
4.3.2 Comparative risk
Risk information can also be presented as comparative risk; this is the absolute risk 
of a person of the same age and sex with optimal risk factors (e.g. self versus 
others). Comparative risk can be helpful in enabling the recipient of the risk 
communication to interpret the information and make comparisons. However, there 
is contradictory evidence of the effects of presenting comparative risk information.
For example, it has been demonstrated that providing comparative risk information 
changes risk perceptions. Participants given comparative risk information about the 
hypothetical risk of breast cancer were significantly more likely to endorse taking a 
pill and were more likely to believe the pill provided a significant risk reduction in 
breast cancer, than those not provided with comparative risk information, even 
though the risks were equivalent (Fagerlin et al. 2007b).
Additionally, a study into the presentation of absolute and comparative risk of 
colorectal cancer found that comparative risk information led to an increased
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awareness and higher perceived risk, than absolute risk information. However, no 
influence on emotional reactions and screening intentions was seen, as there were 
no differences between conditions for how worried, anxious and fearful participants 
felt about getting colorectal cancer, or intentions to get screened (Lipkus et al. 1999).
4.4 Issues surrounding risk communication
This section describes two issues that influence how risk information is intercepted, 
understood and acted upon. These are: (1) how the risk information is framed, and 
(2) the formats used to present the risk.
4.4.1 Framing of risk information
One issue that contributes to the effectiveness of risk communication is how 
information regarding the probability of an event occurring is framed. Framing is 
defined as presenting logically equivalent information in different ways (Wilson et al. 
1988). Framing includes narrow manipulations of data, such as expressing the risk 
probability of harm and benefit associated with treatment options, in either positive or 
negative terms (e.g. a l10 percent chance o f the treatment being beneficiaf 
compared to a ‘90 percent chance that the treatment will be of no benefit at all’) 
(Epstein et al. 2004).
The way risk information is framed can have significant effects on decisions made in 
clinical settings. For example, a study by Rothman et al (1993) found that
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participants who were given positively framed information regarding skin cancer, 
such as ‘/'fa cancerous growth is detected, 19 out of 20 growths are less deadly than 
nonmelonoma’, were more likely to adopt preventive health behaviour (i.e. attending 
a skin cancer screening programme), than those given the negatively framed 
information, such as ‘if a cancerous growth is detected, 1 out of 20 growths are the 
more deadly melanoma cancer’. It is thought that this was because positively framed 
information emphasises the gains and advantages that can come from performing 
the behaviour, in this instance, finding out you do not have deadly nonmelonoma 
growth (Rothman et al. 1993).
However, negatively framed information can be more persuasive, as the dangers of 
not performing the behaviour are emphasised. A review into manipulations of 
information about the harms and benefits of treatment found that negative or loss 
framing (emphasising the presence of disease) leads to an increased willingness to 
participate in screening or adhere to treatment (odds ratio 1.18 [95% Cl 1.01-1.38]), 
compared to positive or gain framing (e.g. emphasising the absence of disease); 
whereas, positive framing leads to unwillingness to participate in screening, and is 
more effective in persuading people to take risky options (Edwards et al. 2001). 
Furthermore, a meta-analysis found that loss (negatively) framed appeals are 
statistically significantly more persuasive than gain (positively) framed appeals for 
screening behaviours such as breast cancer detection (O'Keefe and Jensen 2009).
Framing effects of presenting information as survival (e.g. chance of survival) as
opposed to mortality (e.g. risk of death) have also been found. For example,
participants receiving vignettes about a hypothetical treatment framed as a survival
135
curve graph (e.g. chance of survival over time) were significantly more accurate in 
their understanding of the information given to them and were more likely to chose 
the preventative surgery, than those who received mortality curve graph (e.g. the risk 
of death over time) (Armstrong et al. 2002).
Methods for minimising the effects of framing have been proposed. These include 
presenting ‘balanced’ information as ‘dual representation’, i.e. positive and negative, 
mortality and survival, or loss and gain data (Wills and Holmes-Rovner 2003). 
Additionally, using both absolute and relative risk data, and providing comparative 
frames of reference has been suggested, as this makes the magnitude of the risk 
easier to judge (Edwards et al. 2002).
4.4.2 Risk representation formats
There are various ways risk information can be communicated to patients. This 
includes numerical and graphical formats. Although there is no mathematical 
difference in presenting data as percentages (e.g. 5%), odds ratios (e.g. 5/100) or 
natural frequencies (e.g. 5- in-100), presentations have different cognitive impact.
The format used to convey risk information is important because individuals often do 
not have a priori and stable opinions about risk magnitudes; as such, their beliefs 
and feelings about risk are likely to be influenced by format (Lichtenstein and Slovic
2006).
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Information about risks and uncertainties is not well understood by the majority of 
people, including experts. The way statistical information is presented is sometimes 
confusing and can result in statistical innumeracy. This is defined as a difficulty in 
understanding and combining statistical information effectively, an inability to perform 
calculations involving percentages and fractions to compare risks, and being unable 
to comprehend the likelihood of adverse events or favourable outcomes (Dudley 
2001; Hoffrage et al. 2000). This can lead to patients making misinformed decisions 
regarding their treatment or lifestyle choices (Gigerenzer and Edwards 2003).
The different formats for representing risk information vary in the ease that they 
facilitate understanding. For example, it is thought that percentages (e.g. 40% of 
people will reduce their risk of heart disease by taking statins) actually hinder 
understanding and interpretation, as opposed to natural frequencies (e.g. 4 out of 10 
people will reduce their risk of heart disease by taking statins) that offer insight, are 
easier to assimilate and facilitate statistical inferences. Natural frequencies involve 
Bayesian reasoning and facilitate inferences because they correspond to the way 
that humans have experienced and have learnt to process information. Also, they 
refer to the same class of observation and possess implicit information about base 
rates, which reduces the number of computations required for interpretation 
(Gigerenzer 2003; Gigerenzer and Hoffrage 1995; Hoffrage et al. 2000).
Support for natural frequencies comes from a focus group study that presented risk
reduction estimates of breast cancer mortality from mammography in either
frequency formats (i.e. those that present the chance of occurrence as a proportion
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of discrete cases over those at risk of an occurrence) or probability formats (i.e. 
those displaying the chance of occurrence as a percentage). It was found that 
frequency formats were regarded as simpler and easier to interpret (Schapira et al. 
2001).
It is suggested that the misunderstanding and miscommunication of risk information 
can be minimised by stating the reference class or using alternative formats where 
the reference class is explicitly stated in all instances, such as natural frequencies 
(Gigerenzer and Edwards 2003).
4.5 Examples of different risk representation formats
As described above there are a number of ways that risk information can be 
presented. Research into descriptive words, numerical and graphical formats will be 
presented in this section.
4.5.1 Descriptive terms
Risk can be communicated using qualitative verbal statements, rather than using 
numerical probability information. People vary in their preferences for probability 
information given as words, numbers or both (Wills and Holmes-Rovner 2003). 
Lipkus (2007) argues that using verbal terms to denote risk allow for fluidity in 
communication, as they are easy and natural to use. They also express the level, 
source and imprecision of uncertainly (Lipkus 2007). However, it has been shown
that consultations regarding the communication of cancer risk that used verbal 
descriptions (e.g. ‘there is a possibility that this is prostate cancer’) were regarded as 
less comfortable, and the information less trustworthy, as opposed to when 
numerical risk information (e.g. ‘there is a 25% chance that this is prostate cancer’) 
was used (Gurmankin et al. 2004).
Describing risk magnitudes and benefits of treatments using words is challenging 
because the words, such as unlikely, rare and probable, are ‘elastic’ concepts, have 
different meanings and are interpreted differently by different people (Wills and 
Holmes-Rovner 2003). They reflect the communicator’s perspective which may be a 
different order of magnitude to that of the patient. For example, the term ‘likely’ may 
mean a chance of 1 in 10 to one person, but a chance of 1 in 2 to another (Pauling
2003).
4.5.2 Numerical formats
Numerical representations of risk information include percentages, odds, natural 
frequencies and concepts such as NNT (Edwards et al. 2002; Gigerenzer and 
Edwards 2003). An advantage of using numerical formats to communicate risk 
information is that they allow for more precision in the risk estimate (Lipkus 2007).
As described previously, it has been shown that health outcomes are better 
understood and easier to interpret when presented as a natural frequency than a 
probability (Akl et al. 2011; Gigerenzer 2002). However, some findings are
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contradictory. For example, when risk information regarding hypothetical medical 
trade-off situations (where treatment would decrease the risk of one condition at the 
expense of increasing the risk of another) was presented as percentages or natural 
frequencies, accuracy in interpreting the increase or decrease in risk by the 
treatment was significantly greater when probability information was presented as 
percentages rather than natural frequencies (Waters et al. 2006). Additionally, a 
recent RCT found that percentages led to better comprehension than natural 
frequencies, and concluded that natural frequencies are not the best format for 
communicating the absolute benefits and harms of treatment (Woloshin and 
Schwartz 2011).
In a study of three numerical risk representation formats (percentages, natural 
frequencies or odds ratios), it was concluded that some formats are better for certain 
mathematical operations than others. For instance, the percentage format is best 
when people have to sum two risk likelihoods or perform a sequence task; whereas 
the frequency format is best if people must calculate an increase or decrease in risk 
by computing a simple multiplication, division or trade-off. Additionally, it was found 
that overall accuracy of the operations performed was similar for the percentage and 
frequency formats; whereas, the odds ratio format was significantly more difficult to 
use, resulting in lower accuracy rates (Cuitie et al. 2008).
Some studies have not shown any differences between risk representation formats. 
For example, when presenting risk about influenza and the need for vaccination, no 
differences in how accurate respondents were at interpreting the risk estimates were 
seen between frequency and percentage formats (Natter and Berry 2005).
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Additionally, a web-based RCT examining the effects of different risk formats (such 
as detailed numerical information that included absolute and relative risk, NNT, 
anchoring information by matching it to everyday or familiar risks/descriptions, and 
graphical presentations including bar graphs, thermometer scales, population/ crowd 
diagrams) in people with diabetes, found no significant effects of the interventions on 
decisional conflict (e.g. patients’ confidence or uncertainty about whether they feel 
their treatment choice is the best for them personally) or satisfaction with the 
information. However, the qualitative component of the trial concluded that numerical 
formats were helpful, with natural frequencies being most preferred (Edwards et al. 
2006b).
No consensus in preferences for methods used by clinicians to explain personal risk 
has been found. Some prefer numbers (mainly percentages and proportions, but 
rarely odds ratios) and some preferred words. It is concluded that a variety of 
techniques should be used by clinicians when communicating evidence about 
diagnosis, treatment, risk and prognosis to patients (Lobb et al. 2003).
Despite the inconsistent evidence for the effects of different risk representation 
formats on understanding and preferences for different formats, there is still limited 
research into how different formats affect actual behaviour (Akl et al. 2011).
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4.5.3 Graphical risk representation formats
Risk information can be presented graphically such as bar graphs, crowd figures 
(also known as pictograms or icon arrays), thermometer scales, survival curves and 
pie charts. Graphical displays can improve understanding of probability information, 
by attracting attention, showing patterns that might not otherwise be detected, 
facilitating numerical computations and allowing for faster information processing 
than is possible with numbers alone (Lipkus and Hollands 1999; Wills and Holmes- 
Rovner 2003). Furthermore, recent research has demonstrated that risk information 
presented graphically attracts and holds attention for longer periods of time, and 
requires relatively little cognitive effort to extract elicit information, leading to better 
comprehension compared to textual risk information (Smerecnick et al. 2010).
Numerous studies have been conducted into the effects of different graphical risk 
representation formats. Graphs can affect risk perceptions (Lipkus and Hollands 
1999), lead to greater risk aversion (Stone et al. 1997), and are associated with 
better understanding of risk information (Connelly and Knuth 1998; Epstein et al.
2004).
For example, graphical displays of frequency and probability formats, such as 
pictograms of human figures and bar graphs have been examined. Human figures 
presented as pictograms were easy to understand and conveyed a meaningful and 
contextual message to the numeric information; whereas, bar graphs were perceived 
as analytical, difficult to understand and having less impact (Schapira et al. 2001).
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Additionally, an experiment into the accuracy and speed of processing of the 
probability of treatment risks and benefits, found that when interpreting ‘gross-level 
information’ (i.e. deciding which quantity is larger/smaller), bar graphs and 
pictograms appear to be best. Conversely, pie charts cause heavier processing 
burden and result in less accurate perceptions (Feldman-Stewart et al. 2000).
Further support for pictograms comes from a study that presented the benefits of 
treatment options in one of the six formats (including bar graphs, pictograms and pie 
charts). Verbatim knowledge (e.g. ability to correctly read numbers from graphs) and 
gist knowledge (e.g. ability to identify the essential point of the information 
presented) were measured. Pictograms were trusted by respondents of both high 
and low numeracy, and were consistently associated with achieving adequate levels 
of both verbatim and gist knowledge across the numeracy levels. Again, the pie 
chart was viewed negatively as being least trustworthy (Hawley et al. 2008).
Contradictory to previous research, Timmermans et al (2008) found that pictogram/ 
population figures were not evaluated as being the easiest format to understand. 
However, risks presented in this format were evaluated as significantly greater, and 
were regarded as the most frightening, worrisome and serious, compared to 
numerical formats (e.g. percentages and frequencies) (Timmermans et al. 2008). 
Additionally, patients have expressed preferences for simple bar charts, as opposed 
to other formats including pictograms or pie charts (Edwards et al. 2002).
The lack of consistent evidence in the area of risk communication may be because
certain graphs are more suited for specific tasks. For example, a line graph conveys
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trends in the data well, whereas divided bar graphs and pie charts are best for 
conveying proportions. Moreover, if people are asked to evaluate the magnitude of a 
risk or asked to compare risks, line graphs, bar graphs, histograms and dot charts 
are likely to lead to greater accuracy in estimation than other graphical formats 
(Lipkus and Hollands 1999).
It has been suggested that no single graphical format will perform optimally in all 
situations. The effectiveness of a display will be affected by several factors including 
the display characteristics (e.g. use of colours, width of lines etc), conditions of 
presentation (e.g. lighting or time pressure), data complexity (e.g. number of data 
points or configuration of the display), the task (i.e. purpose), user characteristics 
(e.g. cognitive styles) and the criterion for choosing the display (e.g. speed of 
performance or accuracy) (Lipkus and Hollands 1999). Visual representations, such 
as graphs or pictograms / population crowd figures, may improve the presentation 
and understanding of risk, although they can be manipulative as well. Therefore, it 
has been suggested that risk should be presented in the format that is most 
preferred by the patient (Gigerenzer and Edwards 2003).
There are some disadvantages of graphical risk representation. For example, some 
graphs are not well understood because they are poorly designed, complex and/or 
unfamiliar, or individuals may not possess the skills to use and interpret graphs. 
Additionally, graphs have the potential to mislead by calling attention to certain 
elements and away from others (such as graphs that present the numerator but not 
the denominator) (Lipkus 2007; Wills and Holmes-Rovner 2003).
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Lipkus and Hollands (1999) suggest that most research using graphs and other 
visuals to communicate risk has been atheoretical (Lipkus and Hollands 1999). 
Furthermore, there is little experimental research testing whether the lay people’s 
perceptions and understanding of risk vary by graphical format and whether the 
addition of graphical displays improves comprehension significantly beyond 
numerical or narrative translations of risk.
The evidence is contradictory and it is still not clear which format is the most 
effective in terms of understanding. Furthermore, not much is known about which 
graphical format is best for patients making medical treatment decisions (Feldman- 
Stewart et al. 2000).
4.5.4 Expressing treatment risks and benefits
The risks and benefits of different treatment options can be presented in various 
ways. Such as relative risk reduction (e.g. a medical intervention results in a 34% 
relative decrease in the incidence of fatal and nonfatal myocardial infarction), 
absolute risk reduction (e.g. a medical intervention results in a 1.4% decrease in the 
incidence of fatal and nonfatal myocardial infarction, 2.5% versus 3.9%) and number 
needed to treat (77 persons must be treated for an average of just over 5 years to 
prevent 1 fatal or nonfatal myocardial infarction).
A meta-analysis examined the effects of these formats on people’s views towards 
healthcare decisions. The relative risk format led to more favourable evaluations
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towards treatments, than absolute risk reduction or number needed to treat (NNT) 
format (Covey 2007). Furthermore, when information about treatment benefits 
regarding a hypothetical disease were presented as NNT, absolute risk reduction 
(ARR) as natural frequencies, and relative risk reduction (RRR) as percentages, 
patients were best able to interpret the benefits of treatment when they were 
presented in the RRR format and accompanied with the baseline risk. NNT was 
often misinterpreted and it was concluded that this format should not be used in 
isolation to communicate risks to patients (Sheridan et al. 2003).
Further support for the persuasiveness of the RRR format is demonstrated in a pilot 
web-based RCT comparing summary statistics for communicating the effects of 
statins on the risk of coronary heart disease. Information was presented in six 
formats (RRR, ARR, NNT, event rates, tablets needed to take and natural 
frequencies). Over half the respondents preferred the RRR format and were 
significantly more likely to decide to take statins compared with participants who 
were shown any of the five other summary statistics (Carling et al. 2009b)
Politi et al (2007) concludes that research has not yet identified best practices for 
communicating harms and benefits of treatment to patients. The best method of 
presenting uncertainty depends on the task required of the patient and the type of 
uncertainty presented. Additionally, there is little evidence about the effect of 
alternate types or presentations of uncertainty on patient understanding, satisfaction, 
and informed decision making in clinical medicine (Politi 2007).
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4.6 Summary
To summarise, the misleading effects of presenting relative and comparative risk 
information have been described. It has been suggested to avoid presenting relative 
risk in isolation from absolute risk, or at least to provide baseline risk information. 
Furthermore, there appears to contradictory evidence as to whether providing people 
with comparative risk information changes their risk perceptions and behavioural 
intentions. More research is needed before firm conclusions can be drawn.
Furthermore, it was concluded that the use of purely descriptive terms to 
communicate risk information should be avoided as there is a high degree of 
variability in interpretation, and a patient’s interpretations of these terms does not 
correlate with the probabilities they are meant to be conveying. Estimated numbers 
should be used instead (Pauling 2003), as evidence demonstrates that showing 
numbers increase trust, comfort and belief in what the physician has said 
(Gurmankin et al. 2004).
It has been suggested that different numerical formats may facilitate cognitive work 
of performing mathematical operations needed to comprehend interpreting risk 
information. There is debate as to whether a frequency format should be used over a 
percentage format. It was concluded that more attempt should be made to employ 
strategies that reduce misunderstandings during discussions of treatment options. 
However, some studies have not found that different numerical representations of 
risk information result in differing effects.
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In relation to graphical representations of risk, there is support that pictograms / 
population diagrams are easy to understand, convey a meaningful picture and impart 
knowledge. They have also been shown to have the biggest affective impact in terms 
of worry, seriousness and evoking fear. In contrast, bar graphs have been viewed as 
difficult to understand and having less of an impact, whilst pie charts are regarded as 
least trustworthy. There is a lack of evidence suggesting which graphical risk 
representation format is best for making medical decisions, and which format best 
facilities understanding. However, it has been suggested that the impact of the 
format in which information is delivered may influence medical decisions by first 
affecting the type and amount of knowledge gained by patients. Lastly, the 
effectiveness of different graphical risk representation formats may be dependent on 
numerous factors, such as the level of information that needs to be interpreted from 
the graphical format.
Finally, the evidence highlights the dangers of potentially misleading patients about 
the benefits of a treatment, such as providing relative risk reduction information in 
isolation without absolute risk information. Therefore, it is concluded that it is 
important when communicating the benefits of treatment to present absolute risk 
changes, baseline risk, or information regarding numbers needed to treat, as they 
allow the information to be put into perspective (Covey 2007).
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4.7 Rationale for conducting a randomised controlled trial of cardiovascular 
risk representation formats
This section highlights the risk representation formats that warrant further 
investigation. This was done by considering the previous literature in risk 
communication (described above), along with the previous chapters of this thesis 
describing the critical appraisal in web-based cardiovascular risk prediction tools 
(Chapter 2) and the systematic review on methods of communicating cardiovascular 
risk to patents (Chapter 3). This section also explains why these formats should be 
assessed in a RCT of cardiovascular risk representation formats, and justifies the 
outcomes that should be measured.
4.7.1 Selection of risk representation formats
Three risk representation formats are proposed that should be further researched 
and compared in the RCT. These are: bar graph, pictogram and metonym (defined 
below). Justification for their selection is described.
Bar graph
A bar graph (graphically depicting percentages) should be assessed in the RCT, 
because previous chapters in this thesis have found that this format is the standard 
graphical presentation commonly used in cardiovascular risk research and current 
cardiovascular risk prediction tools. For example, 12 out of 13 cardiovascular risk
prediction tools most likely to be retrieved by internet users searching for online 
cardiovascular risk assessment, presented risk as percentages, and four out of the 
six tools that had graphical representation, used the bar graph format to graphically 
depict risk (Chapter 2). Additionally, the systematic literature review (Chapter 3) 
found that this format was used in half of the studies that assessed graphical 
representation. Recent research has found it to be one of the most preferred 
methods of risk communication (Hill et al. 2010). Therefore, the popularity of this 
format makes it a good control, enabling a comparison with other formats to see 
whether the current extensive use is justified.
Pictogram
Pictogram representing cardiovascular risk as natural frequencies should also be
assessed in the RCT. The critical appraisal (Chapter 2) found that the format was
used in half of the cardiovascular risk prediction tools that used graphical
representation. Additionally, this format was found to be the second most commonly
assessed graphical representation format in the systematic review (Chapter 3), used
in four of the ten studies. Furthermore, past research shows that natural frequencies
are better understood by patients and intuitively offer more insight than other formats
(Gigerenzer and Edwards 2003; Weinstein 1999). Pictograms help the viewer see
the risk in context and facilitate accurate judgements of probability (Lipkus 2007;
Pauling 2003). However, more recent research contradicts this suggesting that
pictograms can be viewed as confusing or misleading (Hill et al. 2010; Price et al.
2009). Therefore, due to the conflicting research, it was felt that this format should be
included in the RCT, so it could be researched further and compared against other
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risk representation formats, before any firm conclusions can be made regarding this 
format.
Metonym
A metonym is a type of metaphor and involves part and whole relations and 
associations. It is a word for a part of something, used to refer to the whole entity; or 
the whole is referred to in terms of something associated with it (Knowles and Moon 
2006). An example of a metonym is representing heart disease by using the concept 
of a myocardial infarction. Metonyms are important to everyday life as their concepts 
structure thoughts, attitudes and actions, as well as language (Lakoff and Johnson 
2003).
There are a number of reasons why the metonym may serve as an alternative way of 
presenting future risk of a disease. Firstly, it is not a numerically-based, precise 
estimate; but a more qualitative, gist representation. It is argued that gist 
information, and its bottom-line meaning, is used when making judgements and 
decision making, such as ‘interpreting’ risk information, as opposed to verbatim 
details (Reyna 2008).
Secondly, a metonym could be a way of improving affective forecasting. This is a 
term used to describe when people imagine themselves in the future. They envisage 
the external events and outcomes they are likely to encounter, and also contemplate 
how they will feel when the particular event takes place, such as the kinds of 
emotions they will experience, as well as the intensity and duration of the emotion
151
(Buehler et al. 2007). People are poor affective forecasters, as they are not good at 
predicting the future (Kassam et al. 2008). They find it difficult to place themselves in 
the future and imagine what it will be like and how they will feel. They are not adept 
at predicting the intensity and duration of their future emotional reactions, and are 
routinely wrong about how positive or negative their reactions to future events will be 
(Wilson and Gilbert 2005). Affective forecasting has implications on people’s 
choices, decisions and behaviours regarding health conditions (Buehler et al. 2007; 
Halpern and Arnold 2008), such as the decision not to attempt to reduce elevated 
cardiovascular risk, because of a difficulty imagining what developing CVD would be 
like the future and how it would feel. Therefore, the metonym may help improve 
affective forecasting by acting as a striking symbolisation of what the disease 
encompasses in the future, compared to more conventional risk estimates that use 
abstract numerical values.
Lastly, the metonym may be beneficial to those with poor numeracy and literacy 
skills. It is found that patients with low literacy are up to three times more likely to 
experience a poor health outcome. This includes poorer knowledge, poorer health 
status, higher morbidity and limited use of health resources (DeWalt et al. 2004). 
Additionally, patients with poor numeracy and literacy are more likely to suffer from 
chronic conditions, such as CVD (Safeer et al. 2006).
People with low literacy and numeracy skills have difficulties interpreting risk 
information, as they have difficulty in understanding the meaning of the numbers that 
are being conveyed in the risk communication (Keller and Siegrist 2009). This can 
impair risk communication and affects risk perceptions and medical decisions
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(Lipkus and Hollands 1999; Nelson et al. 2008). This could be due to the difficulties 
faced when using simple decimal places and ratio concepts (including fractions, 
proportions and probabilities), and can lead to reduced understanding of health- 
related risk information (Reyna and Brainerd 1994; Reyna and Brainerd 2007). For 
example, smokers with lower literacy skills are less likely to understand their risk of 
heart disease and stroke (Strecher et al. 1995). This may be because interpreting 
risk information involves a hierarchy of skills ranging from calculation, inferences and 
interpreting tables and charts, which are challenging for those with lower levels of 
numeracy (Peters et al. 2007). Therefore, less numerate individuals may benefit 
more from visual communication of risk (Brown et al. 2011; Lipkus and Hollands 
1999; Pauling 2003). Furthermore, a review assessing the effects of pictures on 
health communication found that pictures can increase attention to and recall of 
health information and can improve comprehension (Houts et al. 2006). Therefore, 
metonyms presented as pictures are particularly likely to benefit those with low 
numeracy and literacy skills.
As far as it is known, there are no existing studies that have used the concept of a 
metonym to present risk information. Therefore, it is felt that this format should be 
tested in a trial where it could be compared against other more conventional formats, 
to see whether it is a promising, suitable alternative, and thus improving the 
communication of risk without reliance on abstract numerical risk estimates.
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4.7.2 Outcomes to be measured
This thesis has previously identified the differing aims of risk communication. One 
aim is to achieve a desired behavioural change in a ‘paternalistic’ approach, e.g. 
motivating or persuading people to reduce their cardiovascular risk. The other aim is 
to facilitate informed choice with greater autonomy for the patient (Edwards and 
Bastian 2001; Elwyn et al. 1999). This involves informing people of their 
cardiovascular risk by providing balanced, unbiased information. These aims are 
distinct and are sometimes not made clear by previous risk communication research. 
A trial that measures outcomes suitable for assessing risk communication intended 
for both purposes is needed. For example, a suitable way to assess risk 
communication that has the aim of motivating behaviour change would be to 
measure actual behaviour change or intention to change behaviour; whereas, risk 
communication aiming to inform people of their risk would be suitably assessed by 
measuring factors such as whether the patient understands their risk, and how the 
risk information affects them emotionally, such as providing reassurance or evoking 
worry.
Intention to change behaviour
Numerous psychological theories and theoretical approaches attempt to explain 
health behaviour and behaviour change. These models are used when designing 
interventions aimed at encouraging lifestyle modification, or by research interested in 
measuring behaviour and behaviour change. They comprise a number of different 
components that are thought to predict health behaviour and behaviour change.
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One example is the Theory of Planned Behaviour (TPB) (Ajzen 1991). This is an 
extended version of the Theory of Reasoned Action (TRA) (Ajzen and Fishbein 
1980), which explains behaviour under control of the individual. The TPB additionally 
attempts to explain the goals, outcomes and behaviours that are not under full 
volitional control. The TPB postulates that behaviour is determined by a small 
number of factors: attitudes, subjective norms and perceived behavioural control 
(Figure 4.1). These belief based measures of the TPB follow the expectancy-value 
format.
Attitudes
Subjective
norms
Intention Behaviour
Perceived
Behavioural
Control
Figure 4.1 Theory of Planned Behaviour Model - Ajzen 1991.
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The TPB predicts intention, which is generally regarded as a strong predictor of 
behaviour, as people tend to engage in behaviours that they plan to perform (Conner 
and Sparks 2005). In instances where it is not feasible to measure actual 
behaviours, intention can be an adequate proxy. Intentions capture the motivational 
factors that influence a behaviour and to indicate how hard people are willing to try, 
or how much effort they would exert to perform the behaviour (Ajzen 1991).
The TPB has been widely utilised in research and has empirical support for 
predicting a wide range of behaviours (Armitage and Conner 2001; Godin and Kok 
1996). Previous meta-analyses have found the relationships among variables in the 
TRA and the TPB explain between 39-50% of the variance in behavioural intention, 
and between 19-38% of variance in behaviour (Armitage and Conner 2001; Sutton 
1998). Therefore, it appears to be a good theoretical basis for assessing intention to 
change behaviour in a trial assessing the effects of different risk representation 
formats.
Understanding of risk information
As described previously in this chapter, understanding of risk information can vary
depending on the risk representation format used to present the risk, and the
characteristics of the recipient of the risk communication. Understanding of risk is
generally poor (Harris and Smith 2005) and there is evidence to show that the data
presented in cardiovascular risk prediction tools is often misunderstood (van
Steenkiste et al. 2004a). This can inhibit people from making informed decisions
regarding their health and behaviour. There is no consensus as to which format is
156
most effective in terms of facilitating patient understanding of their risk information 
(Timmermans et al. 2008); and also what the most appropriate way to measure 
understanding actually is.
Currently, attempts to measure understanding of risk use recall (i.e. asking 
participants to repeat the risk information that was presented to them), self-reported 
confidence in understanding (i.e. asking participants to report how confident they are 
that they understand the risk information), and perceived difficulty in understanding 
(i.e. asking participants how difficult they found it to understand the risk information). 
These may not be the most suitable methods to assess understanding of risk 
information, as it is unclear whether repetition and personal judgements actually 
indicate that people have derived the correct meaning of the risk and possess a true 
understanding of the information given to them (Edwards and Elwyn 1999). 
Therefore, the RCT should assess whether these commonly used methods (i.e. 
recall and confidence in understanding) are appropriate measures for determining 
whether a recipient has true understanding of their risk. Also, alternative methods 
should be devised and examined to see whether the measurement of understanding 
of risk information can be improved.
Emotions
Emotion and mood are types of affect. Emotions are relatively intense reactions to 
stimuli, whereas mood is milder, but a longer lasting experience that influences 
thoughts and behaviours (Isen 1984). As the concepts of affect, emotion and moods 
are inter-related there has been an inconsistency in the use of affective-based
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terminology by previous research. This has limited the conclusions that can be made 
regarding the relationship between affect and other constructs such as risk 
perception (Townsend 2006). Most health behaviour theories fail to consider emotion 
or affect in the form of ‘feelings’ as opposed to ‘affective judgements’ (McCaul and 
Goetz). However, theorists in risk perception are acknowledging affect and other 
subjective intrapersonal experiences can influence a person’s perceived risk 
(Loewenstein et al. 2001; Slovic et al. 2004; Slovic et al. 2005).
There is some evidence for the effects of emotion on risk perceptions (van 
Steenkiste et al. 2004b; Waters 2008). For example, a review of the literature on the 
influence of emotion and mood on risk perceptions and likelihood estimates of health 
hazards and life events, found that people are more likely to make optimistic 
likelihood estimates of a health hazard when they are experiencing positive affective 
states (such as happiness), and are more likely to make pessimistic likelihood 
estimates when experiencing negative affect (such as sadness) (Waters 2008). Risk 
perceptions in turn, can effect health-related behaviours and behavioural intentions 
(Brewer et al. 2007; Houts et al. 2006).Therefore, emotions are important when 
considering behaviour relating to the reduction of cardiovascular risk and should be 
considered an important factor when assessing the effects of cardiovascular risk 
representation formats.
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Worry about future risk of heart disease
‘Worry’ is a specific emotion and is extremely relevant when thinking about one’s 
future risk of heart disease. It has been associated with risk perception and is 
referred to as cognition ‘coloured by affect’ (Constans 2001; McCaul et al. 2007).
Some suggest that worry contains an appraisal of risk elements (such as likelihood 
and loss) (Tallis and Eysenck 1994) and is not necessarily maladaptive. Specifically, 
previous research has found that worry positively predicts behavioural intentions 
(Schmiege et al. 2009). When at high levels, worry can lead to the uptake of 
screening behaviour (Hay et al. 2006). It has also found to be the strongest predictor 
of contemplation to quit smoking (Magnan et al. 2009). However, evidence exists for 
an inverted-U or curvilinear relationship between worry and consequent behaviour 
(Consedine et al. 2004), where too much worry can lead to the activation of 
defensive mechanisms, resulting in incoming information being ignored or distorted 
(Witte 1998).
It is not currently known how much worry is beneficial and would lead to increase in 
a person’s motivation to reduce risk, versus denial of the risk information presented. 
Therefore, it is important to further research the effects of worry when 
communicating cardiovascular risk, by investigating the level of worry that induces a 
positive intention to reduce risk, and whether there is an optimum level before the 
risk communication process becomes inhibitory.
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4.8 Summary
This chapter has highlighted some of the issues that need to be considered when 
communicating risk, such as framing biases. It provided examples of studies looking 
into the effectiveness of risk communication, the differing effects of numerical and 
graphical risk representation formats, and type of risk used in the communication.
Some of the studies into risk communication have been of poor methodological 
quality, using analogue designs with hypothetical scenarios or relying on 
unrepresentative convenience samples (such as undergraduate/ student samples), 
instead of using patients facing real-life risk medical decisions.
The contradictory findings and conflicting evidence regarding the gold standard for 
communicating health risks to individuals, suggests there is no ‘one size fits all’ 
approach to risk communication, and there is no perfect risk communication format 
that can be applied to all situations. An underlying reason for this may be the 
important need to establish the goal of the risk communication. Is it to achieve a 
desired behavioural change in a ‘paternalistic’ approach (i.e. from a practitioner or 
population health perspective) or is it to facilitate informed choice with greater 
autonomy for the patient? (Edwards et al. 2001; Elwyn et al. 1999).
In addition, this chapter has also presented the rationale for conducting a RCT in 
graphical cardiovascular risk representation formats, it provided justification for the 
selection of bar graph, pictogram and metonym risk representation formats. It also
justified the important outcome measures that should be assessed, such as intention 
to change behaviour, understanding of risk information and emotions including 
worry. The following chapters in this thesis describe the methodology, results and 
evaluation of the RCT on cardiovascular risk representation.
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Chapter 5. Methodology of Web-based Randomised Controlled 
Trial of the effect of cardiovascular risk presentation formats.
5.1 Introduction
This chapter will describe the methodology of the web-based randomised controlled 
trial (RCT) on the effects of different cardiovascular risk representation formats on 
intentions to change behaviour, understanding of risk information, positive and 
negative affect and worry about future risk of heart disease. The methodology has 
been written as a protocol paper for BMC Medical Informatics and Decision Making 
Journal (Waldron et al. 2010). It was peer-reviewed and accepted for publication. A 
copy of this paper has been presented in Appendix 20.
5.2 Design
RCT with a between-subjects design was used to compare the effect of each risk 
representation format on the specified outcomes. There were four conditions in total, 
comprising two intervention groups and two control groups. This was to address the 
possibility of the Hawthorne effect (Adair 1984) of the four groups, and the effect of 
thinking about cardiovascular risk before viewing actual risk. Ethical approval was 
granted by the Medical Dental School Research Ethics Committee at Cardiff 
University (Appendix 21). The RCT was registered with Current Controlled Trials 
database (Appendix 22) (Current Controlled Trials ISRCTN91319318).
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5.3 Setting
The trial was web-based meaning participation could be done by any person from 
any location with access to a computer and the internet. This placed no time or 
locality constraints on respondents as they could participate at their convenience.
5.4 Participant eligibility
Respondents were eligible for inclusion in the trial if aged between 45 and 64 and 
had not been previously diagnosed with CVD. This was because the risk calculator 
algorithm was unsuitable for use in a population with existing heart disease, due to 
the possibility that it would underestimate risk. However, those with hypertension, 
hypercholesterolemia and diabetes were still eligible. Respondents must also have 
had access to a computer with the internet, adequate IT skills and the ability to read 
English.
5.5 Intervention
This web-based trial comprised a cardiovascular risk formatter (predicting future risk 
of CVD) and on-line questionnaires. The purpose of this tool was to enable the 
different risk representation formats to be randomly assigned to respondents, 
creating a platform to measure the outcomes of interest. The risk formatter was 
available at http://www.myheartrisk.co.uk. It was developed in four steps; the last 
three steps are described in Chapter 6.
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1. Decision made to determine which cardiovascular risk algorithm was used in the 
trial.
2. Assessment of methods used in current cardiovascular risk prediction tools 
(Chapter 2), and systematic review of effective methods to communicate 
cardiovascular risk (Chapter 3), to determine which cardiovascular risk 
representation formats were used in the trial (described in Chapter 4).
3. Design of selected cardiovascular risk representation formats.
4. Programming of the web-based formatter by website developer.
5. Initial pilot testing and refinement of web-based risk formatter.
5.5.1 Risk calculation used the web-based cardiovascular risk formatter
The web-based risk formatter used the Personal Heart Score (Mainous et al. 2007) 
to predict an individual’s future cardiovascular risk. This assesses 10-year risk of 
having a CHD event (myocardial infarction, fatal CHD or cardiac procedure). It uses 
self-reported, non-laboratory measurements such as age, gender, previous 
diagnosis of hypertension, hypercholesterolemia or diabetes, smoking status, family 
history of premature CHD (e.g. a parent who was under the age of 50 when they 
were told by their physician that they had a heart attack), level of physical activity 
(e.g. exercising or playing sport in leisure time) and BMI. There are slight differences 
in the risk factors used by the algorithm to predict risk in males and females. For 
example, BMI is only used in the prediction of risk in females and not males, 
whereas level of exercise is only assessed in males. A point scoring system
categorises risk into three groups (low risk <10%; intermediate risk 10-20%; high risk 
>20%) (Table 5.1).
Table 5.1 Personal Heart Score point scoring system.
Age 45-49 0 0
50-54 0 2
55-59 2 2
60-64 2 2
Does your family have a Yes 2 0
history of heart disease? 
Has your doctor diagnosed 
you with any of the 
following?
No 0 0
High blood pressure Yes 1 2
No 0 0
High Cholesterol Yes 2 2
No 0 0
Diabetes Yes 2 4
No 0 0
Do you smoke? Current 2 3
Former 0 0
Never 0 0
Do you exercise? Often/very often 0 0
Sometimes 0 0
Seldom/never 1 0
BMI >30 kg/m2 0 0
<30 kg/m 2 0 1
Risk category Low (<10%) 0-2 0-6
Moderate (10-20%) 3-5 7-9
High (>20%) 6-12 10-14
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It was recognised that other algorithms such as Framingham Risk Score, SCORE or 
QRISK2 (Conroy et al. 2003; D'Agostino et al. 2008; Hippisley-Cox et al. 2008), 
provide a more precise risk estimation, especially if they include physiological 
measurements such as blood pressure. However, it was believed that the Personal 
Heart Score was most appropriate for the purpose of this study, as it provides an 
estimation of risk level which could easily be presented in different formats to enable 
a head-to-head comparison. More importantly, it enables assessment of individuals 
who have not thought about their cardiovascular risk before and are unaware that 
they may be at high risk; most of whom are unlikely to have visited a health 
professional to undergo formal clinical assessment. The website recommended that 
respondents concerned about their risk were to visit their GP for more formal clinical 
investigation and before under taking lifestyle changes. Links to useful websites such 
as the British Heart Foundation were provided.
5.5.2 Risk representation formats used in the web-based cardiovascular
risk formatter
As described in Chapter 4, the graphical risk representation formats in this trial were 
chosen after critically appraising the risk communication methods used by publicly 
available web-based cardiovascular risk prediction tools (Chapter 2), reviewing how 
to effectively communicate cardiovascular risk to patients (Chapter 3) and reviewing 
the past research into risk communication (Chapter 4). For control groups 1 and 2, a 
bar graph was chosen as it is the risk representation format most commonly used in 
current risk prediction tools. A pictogram of 100 hearts depicting natural frequencies
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of those affected and not affected by CVD was chosen for the first intervention 
group. A metonym was the risk representation format used in intervention group 2. 
This is an image representing heart disease by using the concept of a myocardial 
infarction. The development and pilot testing of the graphical risk representation 
formats is described in Chapter 6.
5.5.3 Randomisation technique used in the web-based cardiovascular 
risk formatter
Each time a respondent visited the homepage of the website, the cardiovascular risk 
formatter called an inbuilt Adobe Acrobat Flash function called Math.random. This 
generated a random number between 0 and 1 that is inputted into an algorithm 
resulting in a number between 1 and 4 (Appendix 23), which represent the four 
different conditions of the trial: bar graph with pre-intervention questionnaire (control 
group 1), bar graph only (control group 2), pictogram (intervention group 1) or 
metonym (intervention group 2) (see Figure 5.1).
5.6 Procedure
A respondent visiting the website homepage, was allocated to one of the four arms 
of the trial, ensuring allocation concealment. A ‘click to continue’ button took the 
respondent to the subsequent web page which gave participant information and brief 
details about the study (Appendix 24). Respondents were then asked to indicate 
their informed consent electronically, and were assessed for eligibility to take part in
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the trial. Eligible respondents who gave their informed consent were directed to the 
cardiovascular risk assessment pages. Following the risk assessment, all 
respondents were given their risk category (low, moderate or high) and the 
corresponding percentage figure (<10%, 10-20% or >20%) along with the main 
comparators, the graphical risk representation formats (bar graph, pictogram and 
metonym).
5.7 Outcome Assessment
Outcomes were assessed by means of a self-complete on-line questionnaire 
integrated into the website. The data were collected by an SQL-server database, 
transferred to Excel spreadsheets and analysed using SPSS version 16 (SPSS Inc, 
Chicago, IL, USA). The coding document used to create a database in SPSS is 
presented in Appendix 25. It shows the questions and numerical values assigned to 
the response options.
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Figure 5.1 Flowchart of the RCT with intervention and control groups.
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5.7.1 Primary Outcome Measure
intention to change behaviour
The primary outcome measure was intention to change behaviour. This outcome 
was used to calculate the needed sample size (see section 5.8).
The intention to change behaviour comprised three cardiovascular risk reducing 
behaviours: exercising more, losing weight and stopping smoking cessation. These 
were the modifiable risk factors assessed by the Personal Heart Score (Mainous et 
al. 2007). The relevance of these risk reducing options was assessed and questions 
relating to smoking cessation were only presented to those reporting that they were 
current smokers.
AH respondents received questions about their intention to exercise more and iose 
weight. It was originally intended to assess the appropriateness of intention to lose 
weight by comparing it with BMI scores, to determine whether those who did not 
report an intention to lose weight had a low BMI and therefore, did not actually need 
to lose weight. However, it was decided against this as BMI is not an accurate 
measure of being overweight (as described in Chapter 9, Section 9.5.8).
Items such as 7 intend to exercise more’ with a 7-point Likert scale were used, as 
shown in Table 5.2. An indirect measure of intention to change behaviour was also 
assessed, by examining whether individuals take the opportunity to obtain a copy of 
their risk output suggested to take to their GP (as shown on Appendix 26).
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Table 5.2 Questionnaire items measuring intention to stop smoking, exercise
more and lose weight.
Q34 Stop smoking To what extent are you prepared to 
stop smoking?
1 (completely unprepared) to 7 
(completely prepared)
Q35 Stop smoking How likely are you to stop smoking? 1 (very unlikely) to 7 (very likely)
Q41 Stop smoking 1 intend to stop smoking. 1 (strongly disagree) to 7 
(strongly agree)
Q47 Exercising
more
To what extent are you prepared to 
exercise more?
1 (completely unprepared) to 7 
(completely prepared)
Q48 Exercising
more
How likely are you to exercise more? 1 (very unlikely) to 7 (very likely)
Q54 Exercising
more
1 intend to exercise more. 1 (strongly disagree) to 7 
(strongly agree)
Q60 Losing
weight
To what extent are you prepared to 
stop smoking?
1 (completely unprepared) to 7 
(completely prepared)
Q61 Losing
weight
How likely are you to lose weight? 1 (very unlikely) to 7 (very likely)
Q67 Losing
weight
1 intend to lose weight. 1 (strongly disagree) to 7 
(strongly agree)
5.7.2 Secondary Outcome Measures
Secondary outcome measures comprised understanding of risk information, positive 
and negative affect and worry about future risk of heart disease.
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Understanding of risk information
Item s specific to the understanding of cardiovascular risk information w ere  
developed for the purpose of this study as no suitable validated scale existed. Items  
com prised absolute probability perception, subjective understanding o f the risk 
information and confidence in understanding the risk information (T ab le  5.3). A t the 
data analysis stage, a level o f understanding variable w as calculated by assessing  
the accuracy of the probability perception and subjective understanding responses. 
For exam ple, it w as considered that respondents possessed no understanding if they  
incorrectly answ ered both probability perception and subjective understanding items; 
that they possessed partial understanding if they correctly answ ered one o f the  
probability perception or subjective understanding items; and that they possessed  
complete understanding if both item s w ere  correct.
Table 5.3 Questionnaire items measuring understanding of risk information.
Q31 Probability
perception
What are your chances of having a 
coronary heart disease event in the 
next 10 years?
1= I am at low risk 
2= I am at moderate risk 
3 = I am at high risk
Q33 Subjective
understanding
What should someone in your risk 
category do to change their risk of 
heart disease?
1= Do nothing
2 = Try and do a little
3 = Do as much as they can
Q32 Confidence in 
understanding
How confident are you that you have 
understood the risk information 
given to you?
1 (not at all confident) to 7 (v 
confident
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Affect after viewing cardiovascular risk
The Positive and Negative Affect Schedule- Short Form (PANAS-SF) was used 
(Thompson 2007). This is a 10-item truncated version of the PANAS, which has 
been well validated and cited in over 2,000 scholarly papers (Watson et al. 1988). It 
was felt that the original 20-item PANAS would be too time-consuming and 
cognitively demanding for respondents, which may have led to high dropout rates. 
Affect was measured at baseline (Table 5.4a), as well as after viewing the risk 
portrayal (Table 5.4b) to measure within-group changes.
The baseline instructions started with ‘ Thinking about yourself and how you normally 
feel, to what extent do you feel.... ’, with a 5-point Likert scale anchored ‘not at all’ to 
‘extremely’. This was adapted slightly to make it more logical for post-intervention, 
e.g. ‘At this present moment to what extent do you feel...’, with a 5-point Likert scale 
anchored ‘notata lf to ‘extremely’.
173
Table 5.4 Questionnaire items measuring affect and worry about future risk of
heart disease.
a. Baseline questionnaire.
■
Q 1 Pre PANAS To what extent do you feel... Upset 1 (never) to 7 (always)
Q2 Pre PANAS To what extent do you feel... Hostile 1 (never) to 7 (always)
Q3 Pre PANAS To what extent do you feel... Alert 1 (never) to 7 (always)
Q4 Pre PANAS To what extent do you feel... 
Ashamed
1 (never) to 7 (always)
Q5 Pre PANAS To what extent do you feel... 
Inspired
1 (never) to 7 (always)
Q6 Pre PANAS To what extent do you feel... 
Nervous
1 (never) to 7 (always)
Q7 Pre PANAS To what extent do you feel... 
Determined
1 (never) to 7 (always)
Q8 Pre PANAS To what extent do you feel... 
Attentive
1 (never) to 7 (always)
Q9 Pre PANAS To what extent do you feel... Afraid 1 (never) to 7 (always)
Q10 Pre PANAS To what extent do you feel... Active 1 (never) to 7 (always)
Q11 Pre worry How worried do you feel about 
developing heart disease in the 
future?
1 (not at all worried) to 5 (very 
worried)
b .  P o s t  i n t e r v e n t i o n  Q u e s t i o n n a i r e .
Q20 Post PANAS At this present moment to what 
extent do you feel... Upset
1 (not at all) to 7 (extremely)
Q21 Post PANAS At this present moment to what 
extent do you feel... Hostile
1 (not at all) to 7 (extremely)
Q22 Post PANAS At this present moment to what 
extent do you feel... Alert
1 (not at all) to 7 (extremely)
Q23 Post PANAS At this present moment to what 
extent do you feel... Ashamed
1 (not at all) to 7 (extremely)
Q24 Post PANAS At this present moment to what 
extent do you feel... Inspired
1 (not at all) to 7 (extremely)
Q25 Post PANAS At this present moment to what 
extent do you feel... Nervous
1 (not at all) to 7 (extremely)
Q26 Post PANAS At this present moment to what 
extent do you feel... Determined
1 (not at all) to 7 (extremely)
Q27 Post PANAS At this present moment to what 
extent do you feel... Attentive
1 (not at all) to 7 (extremely)
Q28 Post PANAS At this present moment to what 
extent do you feel... Afraid
1 (not at all) to 7 (extremely)
Q29 Post PANAS At this present moment to what 
extent do you feel... Active
1 (not at all) to 7 (extremely)
Q30 Post worry After viewing your results how 
worried do you feel about developing 
heart disease in the future?
1 (not at all worried) to 5 (very 
worried)
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Worry about future heart disease
One item was used to measure this construct, in order to keep the total time needed 
to complete the questionnaires to a minimum. Again, this trial was interested in 
changes in worry about future risk of heart disease after viewing risk output, and was 
measured at baseline (Table 5.4a) and post intervention (Table 5.4b). No previously 
developed and validated scale regarding worry about future risk of heart disease 
existed. Therefore, the item was developed by examining previously validated scales 
relating to other health conditions, such the Lerman Breast Cancer Worry Scale 
(Lerman et al. 1991) and constructing the item along similar lines e.g. ‘How worried 
do you feel about developing heart disease in the future?’ with a 5-point Likert scale 
anchored ‘not at all worried to ‘very worried’.
5.7.3 Tertiary Outcome Measures
The following tertiary outcomes were also assessed. These comprised the sub­
components of the Theory of Planned Behaviour (TPB) (Ajzen 1991): attitudes, 
perceived behavioural control and subjective norms. They measured the three risk 
reducing options (exercising more, losing weight and stopping smoking). Again, the 
appropriateness of the risk reducing options was assessed (e.g. omitting intention to 
stop smoking items to those who do not smoke).
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Attitudes
This comprises evaluative (i.e. evaluation using bipolar opposites), instrumental (i.e. 
whether the behaviour achieves something) and experiential (i.e. how it feels to
perform the behaviour) items. An example is ‘Forme, stopping smoking would be ’
with a 7-point Likert scale anchored ‘pleasant to ‘unpleasant, shown in Table 5.5.
Perceived Behaviourai Control
Perceived behavioural control (PBC) items relate to either self-efficacy or the 
controllability of the behaviour. An example of a controllability item is ‘Whether I lose 
weight or not is entirely up to me’ with a 7-point Likert scale to indicate the extent to 
which the respondent agrees with the statement. An example of a self-efficacy item 
is 7 am confident that I can exercise more’ with ‘very confident to ‘not at all 
confident anchored on a 7-point Likert scale (Table 5.6).
Subjective Norms
These relate to the perceptions of the preferences held by significant others about 
whether one should or should not engage in a specific behaviour. An example is 7 
feel under social pressure to lose weight’ with a 7-point Likert scale to indicate the 
extent to which the respondent agrees with the statement (Table 5.7).
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Table 5.5 Questionnaire items measuring attitudes towards stopping smoking,
exercising more and losing weight.
Q37 Stop smoking For me stopping smoking would be... 
Bad/ Good.
-3 (Bad) to +3 (Good)
Q38 Stop smoking For me stopping smoking would be... 
Harmful /  Beneficial.
-3 (Harmful) to +3 (Beneficial)
Q39 Stop smoking For me stopping smoking would be... 
Unpleasant /  Pleasant.
-3 (Unpleasant) to +3 (Pleasant)
Q50 Exercising
more
For me exercising more would be... a 
negative thing to do / a positive thing 
to do.
-3 (Negative) to +3 (Positive)
Q51 Exercising
more
For me exercising more would be... 
Unenjoyable / Enjoyable.
-3 (unenjoyable) to +3 (Enjoyable)
Q53 Exercising
more
For me exercising more would be... 
Useless / Useful.
-3 (Useless) to +3 (Useful)
Q63 Losing
weight
For me losing weight would be... the 
wrong thing to do / the right thing to 
do.
-3 (Wrong thing) to +3 (Right thing)
Q64 Losing
weight
For me losing weight would be... 
unsatisfying / Satisfying.
-3 (Unsatisfying) to +3 (Satisfying)
Q65 Losing
weight
For me losing weight would be... 
Unhelpful / Helpful.
-3 (Unhelpful) to +3 (Helpful)
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Table 5.6 Questionnaire items measuring perceived behavioural control over
stopping smoking, exercising more and losing weight.
Q40 Stop smoking 
(self-efficacy)
For me stopping smoking would be... 
Difficult /  Easy.
-3 (Difficult) to +3 (Easy)
Q45 Stop smoking 
(self-efficacy)
1 am confident that 1 can stop 
smoking.
1 (strongly disagree) to 7 (str 
agree)
Q42 Stop smoking 
(controllability)
Whether 1 stop smoking or not is 
entirely up to me.
1 (strongly disagree) to 7 (str 
agree)
Q44 Stop smoking 
(controllability)
The decision to stop smoking is 
beyond my control.
1 (strongly disagree) to 7 (str 
agree)
Q52 Exercising 
more (self- 
efficacy)
For me exercising more would be... 
Difficult / Easy.
-3 (Difficult) to +3 (Easy)
Q58 Exercising 
more (self- 
efficacy)
1 am confident that 1 can exercise 
more.
1 (strongly disagree) to 7 (str 
agree)
Q55 Exercising
more
(controllability)
Whether 1 exercise more or not is 
entirely up to me.
1 (strongly disagree) to 7 (str 
agree)
Q57 Exercising
more
(controllability)
The decision to exercise more is 
beyond my control.
1 (strongly disagree) to 7 (sti 
agree)
Q66 Losing weight 
(self-efficacy)
For me losing weight would be... 
Difficult / Easy.
-3 (Difficult) to +3 (Easy)
Q71 Losing weight 
(self-efficacy)
1 am confident that 1 can lose weight. 1 (strongly disagree) to 7 (str 
agree)
Q68 Losing weight 
(controllability)
Whether 1 lose weight or not is entirely 
up to me.
1 (strongly disagree) to 7 (stn 
agree)
Q70 Losing weight 
(controllability)
The decision to lose weight is beyond 
my control.
1 (strongly disagree) to 7 (stn 
agree)
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Table 5.7 Questionnaire items measuring subjective norms to stopping smoking,
exercising more and losing weight.
Q36 Stop smoking Most people who are important to me 
think that /... should not stop smoking 
/  should stop smoking.
3 (should not) to +3 (should)
Q43 Stop smoking 1 feel under social pressure to stop 
smoking.
1 (strongly disagree) to 7 (strongly 
agree)
Q46 Stop smoking It is expected of me to stop smoking. 1 (strongly disagree) to 7 (strongly 
agree)
Q49 Exercising
more
Most people who are important to me 
think that!... should exercise more/ 
should not exercise more.
-3 (should not) to +3 (should)
056 Exercising 1 feel under social pressure to 1 (strongly disagree) to 7 (strongly
more exercise more. agree)
Q59 Exercising
more
It is expected of me to exercise more. 1 (strongly disagree) to 7 (strongly 
agree)
Q62 Losing
weight
Most people who are important to me 
think that /... Should not lose weight / 
Should lose weight.
-3 (should not) to +3 (should)
Q69 Losing 1 feel under social pressure to lose 1 (strongly disagree) to 7 (strongly
weight weight. agree)
Q72 Losing
weight
It is expected of me to lose weight. 1 (strongly disagree) to 7 (strongly 
agree)
Pre-intervention questionnaire given to control group 1
Those in the bar graph and pre-intervention questionnaire group (control group 1) 
(see Figure 5.1) also completed a questionnaire before viewing their cardiovascular 
risk. This was a partially parallel version of the post-intervention questionnaire (Table 
5.8, enabling an assessment of the Hawthorne effect of the four groups, and a
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comparison of those who are asked to think about their cardiovascular risk and 
provide their baseline intentions to reduce this, against those who are not. However, 
to keep the total number of items to a minimum, the focus was on reducing overall 
cardiovascular risk, instead of specific behaviours that lead to risk reduction.
Theory of Planned Behaviour Item construction
Items relating to cardiovascular risk reduction were developed using guidance from 
the Manual for constructing questionnaires based on the TPB from the Centre of 
Health Services Research, University of Newcastle (Francis et al. 2004). It was 
developed to assist psychologists and non-psychologists produce an effective 
questionnaire to measure TPB constructs. The manual integrates advice from 
previous literature on the TPB and has gone through a process of extensive 
reviewing and trialling (Francis et al. 2004).
This manual was chosen as it has been widely used in previous research that has 
required TPB questionnaire development (Frosch et al. 2008; Giles et al. 2007; 
Tavousi et al. 2009). Additionally, it also demonstrates a way of measuring the TPB 
constructs directly, as opposed to indirectly. Direct measures assess intention by 
using three generalised intention items and three predictor variables. This is 
sufficient if the purpose of the research is to predict the variance in behavioural 
intentions (as with this trial). However, if the research seeks to identify specific 
beliefs that contribute to the predictor variables, indirect measures are needed as 
well. For example, the research would need to measure behavioural beliefs and
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outcome evaluations for the attitude component; normative beliefs and motivation to 
comply for the subjective norms component; control beliefs and influence of control 
beliefs for the perceived behavioural control component (Francis et al. 2004).
Table 5.8 Pre-intervention questionnaire items measuring risk perception, 
intention to reduce future risk of heart disease and sub-components of TPB.
Q12 Pre risk
perception
probability
1 think my risk of heart disease in the 
next 10 years is..
1 = low 
2= moderate 
3= High
Q13 Pre intention 
to reduce 
heart disease
/ want to reduce my risk of heart 
disease.
1 (strongly agree) to 7 (strongly 
disagree)
Q15 Pre subjective 
norms
People who are important to me want 
me to reduce my risk of heart disease.
1 (strongly agree) to 7 (strongly 
disagree)
Q14 Pre perceived
behavioural
control
(controllability)
The decision to reduce my risk of 
heart disease is mostly up to me.
1 (strongly agree) to 7 (strongly 
disagree)
Q16 Pre perceived 
behavioural 
control (self- 
efficacy)
Reducing my risk of heart disease 
would be Easy /  Difficult.
-3 (easy) to +3 (difficult)
Q17 Pre attitudes Reducing my risk of heart disease 
would be Rewarding/Unrewarding.
-3 (rewarding) to +3 (unrewarding)
Q18 Pre attitudes Reducing my risk of heart disease 
would be Undesirable /  Desirable.
-3 (undesirable) to +3 (desirable)
Q19 Pre attitudes Reducing my risk of heart disease 
would be Worthless /  Worthwhile.
-3 (worthless) to +3 (worthwhile)
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Direct measures also have the advantage of reducing the number of items in the 
questionnaire, and thus keeping the cognitive demand of the participants to a 
minimum, reducing the possibility of drop-out (attrition). Furthermore, recent 
research has demonstrated no difference in direct and indirect measures of the TPB 
in predicting teaching behaviour, where the proportion of variance of the behaviour 
that was accounted for was 24% for the direct measures and 23% for the indirect 
measures (Jeong 2011).
Questionnaire scoring
In accordance with guidelines from Francis et al 2004, items where the response 
format completes an otherwise incomplete sentence (e.g. I should not / 1 should) 
comprised a mix of positive and negative endpoints (Francis et al. 2004). Therefore, 
at the data analysis stage, items with negatively worded anchors to the left of the 
scale were re-coded by reversing their scores using the transform vales function in 
SPSS. These items were pre-intention to reduce heart disease, pre-subjective 
norms, pre-perceived behavioural control, pre-attitudes, stopping smoking PBC 
(controllability), exercising more PBC (controllability), losing weight PBC 
(controllability).
Furthermore, it was suggested that bipolar items, defined as evaluative questions 
with pairs of opposites, are scored -3 to +3, as opposed to unipolar items requiring 
the respondent to make a judgement about the probability that the item is true, which 
are scored 1 to 7 (Francis et al. 2004). This enables a score of zero to represent a 
neutral opinion, negative scores to represent views against the behaviour, and
positive scores to represent views in favour of the behaviour. The bipolar items were 
pre-PBC (self-efficacy), stopping smoking PBC (self-efficacy), smoking subjective 
norm, exercising more PBC (self-efficacy), exercising more subjective norm, losing 
weight PBC (self-efficacy), losing weight subjective norm. However, at the data 
analysis stage these scores had to be converted into 1 to 7 to make a calculation of 
the mean score possible. This was because there were other items measuring the 
same components that were unipolar. Therefore, a higher score on the 1 to 7 scale 
indicated a more positive opinion towards the behaviour.
To address possible response bias occurring from fatigue, items measuring the 
different outcomes and components of the TPB were mixed up in the questionnaire, 
with exception of the primary outcome which was always posed first, as 
recommended by Ajzen (Ajzen [no date]). This is demonstrated in the SPSS 
database coding document (Appendix 25).
At the data analysis stage the mean intention, attitudes, perceived behavioural 
control and subjective norm scores were calculated, so that higher scores represent 
a greater intention to perform the target behaviour, more positive attitude towards the 
targeted behaviour, a greater level of control over the targeted behaviour, a greater 
social pressure to do the targeted behaviour.
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5.7.3 Other data collection
Other data collection comprised:
• Respondent characteristics (risk category, gender, age, family history of heart 
disease, diagnosis of hypertension, hypercholesterolemia, diabetes, smoking 
status, physical activity status, height and weight for BMI calculation and 
whether the respondent requests an electronic copy of their risk output for 
their GP).
• Web logs examining how long respondents took to complete the study and 
how long they spent on each page.
5.8 Sample size calculation
For simplicity, the sample size calculation was based on a comparison of means, 
though the analysis recognises the ordinal nature of the data. It was hard to 
speculate on the difference between the groups and so the sample size was based 
on comparing two groups on the primary outcome measure (intention to change 
behaviour); this gave a group size which was used for all the groups. It was 
proposed that recruitment continue until 800 respondents (200 in each group) 
completed the trial. The likely uptake rate was unknown and a number of the 
recruitment methods were implemented (see section 5.10). Based on a study that 
used a similar Likert Scale scoring system for a different risk context (Wright et al.
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2008), the scores on intention to change behaviour within a group should have an 
SD of about 1.5. Therefore, it was calculated that the total sample size in each group 
of 200 would then be sufficient to detect a difference of 0.5 point between two 
groups, with 90% power and significance value of a= 0.05.
5.9 Analysis
The results were stored on a SQL database and fed back to the researcher via the 
server that hosted the website. The data was stored on the shared drive, and was 
password protected; only accessible to the researcher. Data was retrieved, coded 
and inputted into computer software. Microsoft Office Excel 2007 was used for data 
manipulation and SPSS version 16 for the main data analyses. The trial was 
reported according to Consolidated Standards of Reporting Trials (CONSORT) 
guidelines (Schulz et al. 2010).
5.9.1 Plan of analysis
Descriptive statistics were presented to summarise baseline characteristics of the 
study sample. Continuous variables such as age and level of cardiovascular risk 
were summarised using mean and SD and/or median and quartiles. Binary variables 
such as gender and whether the respondent requested an electronic copy of their 
risk output were summarised by counts and proportions. Summary statistics were 
obtained for the study population as a whole and for the four randomised groups.
The main analyses of efficacy relate to the primary outcome measure: intention to 
change behaviour, and the secondary outcome measures: understanding of risk 
information, affect and worry about future heart disease. Summary statistics for the 
four groups were presented. The four groups were first compared on an equal 
footing using one-way ANOVA. The three selected pairwise contrasts between the 
specified groups were constructed (e.g. bar graph only v. pictogram; bar graph only 
v. Metonym; bar graph and pre-intervention questionnaire v. bar graph only).
Several secondary analyses were performed. For the bar graph and pre-intervention 
questionnaire group (control group 1), paired analyses were used to assess serial 
changes in outcome measures between pre- and post-intervention questionnaires.
A multiple regression model was used to look for correlations between risk category 
on intention to change behaviour, understanding of risk information and post worry 
about future heart disease outcomes, to see if responses were mediated by risk 
category. The model was also used to assess the correlational validity between 
intention to change behaviour, worry about future heart disease and understanding 
of risk information', to determine what level of worry increases intention to change 
behaviours and whether understanding also results in appropriate intentions. The 
subcomponents of the TPB (attitudes, perceived behavioural control and subjective 
norms) were also examined, to see if they predicted intention to change behaviour 
(in order to test the efficacy of the TPB in predicting cardiovascular-related behaviour 
change).
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The direct and indirect measures of intention to change behaviour were correlated, 
to see whether those who report that they intend to change their behaviour actually 
take the opportunity to obtain their risk results to take to their GP. Furthermore, a 
correlation between accurate understanding of risk information and confidence in 
understanding was conducted. Lastly, paired T-tests compared baseline and post­
intervention affect and worry about future heart disease scores, to determine 
whether scores generally decreased after viewing the risk representation formats, or 
increase demonstrating a possible negative emotional impact.
For all analyses, point estimates and confidence intervals were obtained, as well as 
p-values. In the event of substantial departure from Gaussian distributional form, 
transformation of scale and/or analogous non-parametric methods were considered.
5.9.2 Comparisons
There were two main comparisons:
1. (a) Bar graph only v. Pictogram
(b) Bar graph only v. Metonym
This enabled a head-to-head comparison of the outcomes resulting from the different 
risk representation formats as shown in Figure 5.2.
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2. Bar graph and pre-intervention questionnaire v. Bar graph only
Responses from viewing the bar graph and completing the baseline questionnaire 
were compared with those from viewing the bar graph only. Additionally, within group 
changes between baseline and post-intervention questionnaires were analysed in 
the group who completed both questionnaires (control group 1).
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Figure 5.2 Comparison of Bar graph only v. Pictogram and 
Bar graph only v. Metonym conditions.
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The two control groups were compared (e.g. control group 1 comprising a bar graph 
format and pre-intervention questionnaire, and control group 2 comprising a bar 
graph without questionnaire) to assess the Hawthorne effect of the questionnaire on 
reducing cardiovascular risk. It was expected that answering the questionnaire and 
consequently thinking about cardiovascular risk before viewing actual risk, would 
itself encourage intention to change behaviours in order to reduce cardiovascular 
risk. See Figure 5.3 for diagrammatical representation of these comparisons.
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Figure 5.3 Comparison of Bar graph and pre-intervention questionnaire v.
Bar graph only conditions.
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5.10 Recruitment strategy
Respondents were invited to take part in the study using a number of methods: 
emails to educational institutions, co-operation with large organisations where the 
workforce has access to a computer; social networking websites (such as 
Facebook), emails to personal contacts and advertisements in the form of pocket 
sized cards and posters. In order to maximise publicity about the trial, it was 
promoted by offering to donate £1 to the British Heart Foundation for every person 
who completed the study. Due to the nature of web-based recruitment there was a 
possibility that people from outside of the UK participated in the study. This was 
examined in the process evaluation of the trial.
Firstly, a press release (Cardiff University 2010) was issued to national and local 
newspaper and magazine publications (Appendix 27). This resulted in articles being 
printed in two newspapers, the South Wales Echo on 13th February 2010 and the 
Western Mail on 22nd February 2010. Figure 5.4 demonstrates the electronic 
versions of these articles accessed via Wales Online website (Wales online.co.uk 
2010).
The press release also generated interest from BBC Radio Wales who requested an 
interview for the Science Cafe programme. This interview was intended to promote 
the study and provide the website address. Figure 5.5 shows the Science Cafe 
programme synopsis, which included a hyperlink to the myHeartRisk website 
(BBC.co.uk 2010). The interview was aired on 21st February 2010. Additionally, a
web blog (Appendix 28) entitled What’s your Heart Risk? (Healthy 2010) was written 
for Healthy Magazine (an on-line publication by the company Holland and Barrett, a 
health food retailer).
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The study aims to exam ne people s perceptions and atttudes tow ards heart 
disease and provide insight sito w hat people think about their risk when t  s  
presented to them in a certain w ay.
Prof Etwyn said: 'myHeartRsk is a Quick and easy to use w e b ste  that 
provides an estimation to those who may not have thought about their risk o f  
heart disease before.'
The study •  looking for volunteers, aged 45 to 64  who have not been 
previously diagnosed with a heart disease or suffered a cardiac event -  
such as a heart attack or angina -  or had a  stroke, to vist the s te .
The university w i  donate C l to the British Heart Foundation for every person 
who takes part and completes the study.
Share
Q O
Have your say or?
Wales news r  our 
Forums.
O  News
O Business n*«.'s.
f # * ,  ThomasV N Co°* ■*mJsss
travel 
agent businesses C«2S
* SMEs cell for realistic 
WAG h e lp e r  
lowering emissions
* Business minoter 
welcomes EU
regulation reform
► John Lewis sales up 
as Wafcose takes on
► AstJa axes final salary 
perssion scheme
* More business news 
O  Football
Figure 5.4 Electronic versions of the articles that appeared in the South Wales 
Echo and Western Mail newspapers accessed via Wales Online website.
Secondly, a mail shot of A5 sized posters and pocket-sized cards (Appendix 29) 
were sent to 21 Libraries and 20 Adult Learning and Community Centres in the local 
area, with a letter asking permission for them to be placed in display areas. It is not
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possible to determine how many of the libraries and centres actually displayed the 
promotional material as no follow up was made. The posters and cards were also 
distributed in public places, including Leisure Centres, Gyms and a Football stadium.
□ S B Home News Sport Weather iPlayer T V  Radio More.
W  Listen Live to Celtic Heartbeatradiowales
Radio Wales Home Shows Presenters Schedule Podcasts Video Ways To Listen
7 1 - ■ I  32?
Daytime
Entertainment
Factual
Music
News and 
Current Affairs
Sport
All programmes
21 st February, 2010 _____
Last updated 21 February 2010
Our regular presenter Adam Walton, was hit by a virus this week so Atari 
Oautby is standing in for him in this technology special 
Money talks
Is there money to be made in virtual worlds? That's the question we are 
asking in this week's Science Cafe as a Virtual Enterprise Conference comes 
to Wrexham. We'll hear from Welsh virtual entrepreneur Amy Louise 
Matthews whose answer is a resounding yes.
Buzz off
Our regular technology guru. Bill Thompson, join the programme to talk 
about Google Buzz, the newest social networking tool. There were a few bips 
at launch, but Bill tells us why he thinks Buzz isn't facing extinction yet
Fat file
Dagfinn Bach. The Norwegian who helped create MP3 players back in 1993. 
joins Science Cafe to talk about his latest project - MusicDNA tfs a 
new-genefBtion MP3 file, offering lots of other content which can be updated 
after the initial download 
Heart health
Heart disease is the biggest killer in the UK and yet many people simply 
don't know that they are at risk from it Cardiff University's Department of Care 
and Public Health have set up a website with a ride calculator, which should 
help with research
If you want to take part in the survey, d it*  here to access My Heart Risk
Science Cafe
> Homepage
> Adam Walton profile
> Recent programmes: Listen online
> Adam's Sunday night show
Updates
Centre For Alternative Technology 
10 October 2010
Bloodhound SSC 
21 September 2010
Treborth Botanic Garden  
14 September 2010
Full archive
Listen Again
Don’t miss a th in g .. 
Catch up with Radic 
Wales programmes 
you've missed with 
BBC iPlayer Radio
iPlayer
Figure 5.5 BBC Radio Wales Science Cafe Programme Synopsis.
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Furthermore, 14 Universities in Wales and South West / South East England were 
contacted to see if a message could be posted on the staff intranet notice boards 
(Cardiff University; Swansea University; University of Glamorgan; Swansea 
Metropolitan University; Bangor University; University of Wales Institute Cardiff; 
Aberystwyth University; University of Wales Newport; Bristol University; University of 
West of England; Reading University; University of Gloucestershire; Buckingham 
New University and Thames Valley University). A telephone call was made to the 
University switchboard asking to be put through to the IT or Information Services 
departments. The details of the study were explained and permission was requested 
to post a message on the staff intranet or electronic notice board. An email was sent 
containing the intended message to be posted. Numerous attempts were made to 
speak to the relevant staff members and departments. If no progress was made after 
three or four telephone calls and/or emails, the University was not perused any 
further.
Four Universities (Cardiff University; University of Wales Newport; Bangor University 
and University of Glamorgan) obliged and allowed a posting to be made. However, 
one University (University of Glamorgan) posted a message on their staff intranet but 
retracted it approximately three hours later, when it was suggested that the study 
would need ethical approval from their Ethics Committee before the message could 
be re-posted. Due to time constraints this was not sought. Upon assessing the 
responses to the question asking where respondents had heard about the study, 
there was no evidence of anybody participating from one of the Universities (Bangor 
University), so it cannot be certain that a message actually got posted on that notice 
board. Additionally, one University (University of Gloucestershire) did not allow a
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message to be posted on their notice board, but did send an email to staff in their 
Public Relations department. An example of a posting on a University electronic 
notice board is shown in Figure 5.6.
NoticeBoard - Hysbysfwrdd
NoticeBoard - HysbysFwrdd
£ -5  New s & Events Student N ew s ► A rch ive  ► How to use ► Language options
Newyddion a Digwyddiadau Newyddion Myfyrwyr ► Archif ► Sut i ddefnyddio i  O ew isiadau iaith
•  Lontano, University Concert Hall, Corbett Road, 7.30p.m. - 9 Mar
• Lontano, Neuadd Gyngerdd y Brifysgol, Ffordd Corbett, 7.30 y.h. - 9 Maw
•  Careers in Engineering Event, Trevithick Building -16 and 17 Mar
•  Digwyddiad Gyrfaoedd mewn Peirianneg, Adeilad Trevithick -16 a 17 Maw
•  Wales Governance Centre Seminar -18 Mar
•  Seminar Canolfan Llywodraethiant Cymru -18 Maw
• BBC Casting Session
•  Sesiwn Gastio gan y BBC
• Not going home for the holidays? - Coping with Stress
• Ddim yn mynd adref dros y gwyliau? - Ymdopi a straen
•  Going home for the holiday?
•  Yn mynd adref dros y gwyliau?
•  For the Attention of COM SC, SOCSI, EUROS, PHARMS, MEDIC, BIOSI and SOMNS
• Er Sylw COMSC, SOCSI, EUROS, PHARMS, MEDIC, BIOS! a SOMNS_______________________________
• Participants needed to try out new Cardiff University website which predicts future risk of heart diseas
• Yr ydym yn edrych am unigolion sy'n fodlon ymuno mewn ymchwil i helpu leihau clefyd y galon
• Free lecture - Prof. Mike Parker Pearson on Stonehenge: New discoveries -11 Mar
• Darlith gyhoeddus - Yr Athro Mike Parker Pearson ar Stonehenge: New discoveries -11 Maw
•  Financial Contingency Fund for home final year students
• Cronfa Ariannol Wrth Gefn ar gyfer myfyrwyr yn eu blwyddyn olaf
•  Call for Papers: (Re)-Constmcting Multiculturalism Conference
•  CAIS AM BAPURAU: (Ail)-Adeiladu Amlddiwylliannaeth
• Postgraduate Summer Trip to Snowdon & North Wales -15/18 Jul
•  Taith yr Haf i*r Wyddfa a Gogledd Cymru -15/18 Gor
Figure 5.6 Posting on Cardiff University electronic notice board.
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Another method of recruitment was Social Networking. This included Facebook 
(www.facebook.com), Twitter (www.twitter.com), on-line discussion forums dedicated 
to users over 50 years of age, and social bookmarking sites (where users save links 
to websites they wish to share with other users). MyHeartRisk Facebook group was 
created (Figure 5.7) which promoted the study and provided a hyperlink to the 
website. People were invited to join to group, who in turn invited their friends to join, 
raising awareness of the study and enabling interested users to participate. Twitter 
(where users communicate to their followers using 140 characters known as Tweets) 
was also used to promote the study. Known Twitter users were asked to Tweet 
about the study and requested their followers to re-Tweet the message, which 
disseminates the message to other users in a snowballing effect. An example of a 
Tweet posted by a Twitter user is shown in Figure 5.8. Figure 5.9 provides further 
examples of Tweets and re-Tweets made by a selection of Twitter users.
On-line discussion forums were also targeted, in particular those designed for an 
audience of people over the age of 50. In order to comment in the discussion boards, 
one must become a member. Once membership has been granted, a user is free to 
start a new discussion on a certain topic or comment on an existing thread of 
conversation. The discussion board is split into different sections such as health, 
money, chat, travel etc. Eight forums designed for users over 50 years of age were 
joined (Age Concern Baby Boom Bistro; SagaZone; 50 Connect; Over50s forum; My 
Prime; Not Dead Yet; Caerphilly 50+ forum; I Don’t Feel 50 forum).
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facebook Search Home
myHeartRisk
myHeartRlsk.co.uk B  
Wall Info Discussions Photos Video Events
Inform ation
Category:
Common Interest -  Health & 
Wellbeing
Description:
Internet use's can now assess their 
future risk o f having heart disease 
by visiting a new website 
developed by Cardiff University'.
H e a t disease s the biggest k ie r in 
the UK and lots o f people do not 
know they a-e at risk form it. H e a t 
disease risk can be reduced by 
making smaS changes to lifestyle, 
such as adopting healthier 
behaviours o ' taking medication. 
Therefore, it is important to have 
an assessment to know if you are 
at risk.
m y H e a t Risk is a web-site that 
assesses nsk of developing h ea t 
disease in the future, by using 
information about health status and 
lifestyle. There ts also an electronic 
questionnaire which asks peoples' 
opinions about their risk. It  has 
been developed as p a t of a 
research study' by Principle 
Investigator Professo' Glyn Etwyn 
and Cherry-Ann Waldron from the 
Department of Primary Care and 
PubSc Health at Cardiff University'. 
I t  has support from Professor 3ulian 
Halcox of the Wales H eat Research 
Institute.
The aim of the research study' is to 
examine perceptions and attitudes 
towards h ea t disease, and provide 
insight into what people think about 
their risk when it is presentee to 
them m a certain w ay. (read less)
Privacy type:
Open: All content is pubic.
Cherry-Ann Waldron I f  you haven't already done so, please forward this 
link to your friends who may be interested in having their risk o f heart 
disease assessed and take part in this study. We are so dose to our target, 
but ju st need 60 more people! Many thanks.
http://wYyw.myheartrisk.co.uk/
17 April at 13:22 Flag
Cherry-Ann Waldron http://www.walesonline.co.uk/news/cardif 
f-news/2010/02/  13/website-can-help-calculate-heart-risk-91-166-25824829/
17 February at 15:05 Flag
Cherry-Ann Waldron This study is for my PhD- A small donation will be 
made to the British Heart Foundation, for every legitimate person who takes 
part and completes the study. Please invite all your friends to p in .
12 February' at 14:25 Flag
Hi all, you are welcome to use this wall f ix  your thoughts 
and feedback after trying out www.myheartrisk.co.uk 
M y H e a rtR is k
www.m yheartrisk.co.uk
Q  12 February at 06:26 Share Flag
myHeartRisk.co.uk has no more posts.
Figure 5.7 myHeartRisk Facebook group.
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*u
v "  Following
4 *
X ]  Home Proftie Find People Settings Help Sign out
ill J J ||
i LSI*'* Q
These people want 45-64 yr oWs on behalf of ©glvnelwyn
http.'/dlvr it/23V6
4 2 2  AM Feb 17:h vie d l» r*
Venn el...
Figure 5.8 A Tweet from a Twitter user.
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What’s happening?
Home Profile Find Peopie Settings Help Start out
Tweet
•  Asking people Detween 45-65 to join astudy about nsk of heart disease http myheartrisk co uk Only need 140 more! Please RT! #researcn•boul 4 no«n» ago ftom w *b
D Asking people between 45-65to join a study about nsk of heart disease nttp myheartrisk co uk. Please RT! ^research
sbcut £ sco'« ago from UbefTwttor
»  Asking people between 45-65 to join
k  *  a study about risk of heart d sease http myhaartrisk co.uk' Only 
▼  i  need 140 more!
stout 5 tours ago «r«m w e t
Asking people between 45-65 to 
■ H  |oin a study about nsk of heart disease http myheartrisk co uk 
T R B  Only need 140 more'
stoui S tottfs ago frea TwettCsa
B Asking people between 45-65to join a study about nsk of heartdisease http myheartrisk cc uk Only need 140 more! PleaseRT! ^research 
stout S sou"* age from wee
■ Asking people between 45-65 to joma study about risk of heart dsease http myheartrisk :o uk Only need 140 more1 Please RT! »*research atout 5 hcura ego
S RT Asking people between 45-65 to join a study about risk of heart diseased::; myheartrisk co uk Only i need 140 more' Pise RTi research
etosri 5 hours age hem Scesitc
■ Asking people between 45-65 to joina study about risk of heart d-sease http myheartrisk co.uk Only need 140 more! Please RT! ^research stoutC tours age ftsm w«t
* RT Asking people between 45-65 to join a studs- about risk of heart dteease.htip myheartrisk co uto Only need 140 more! Pise RT! ^researchatout 6 tours ago hen Sees n c
Asking people Detween 45-65 to jom a study about 
risk of heart disease http myheartrisk co uk/ Only need 140 
more! Please RT! ^research
stout 6 tours age frc-n w et
n Asking people between 45-65 to join astudy about risk of heart disease please re tweet http /'myheartrisk co.uk/Bfccut ? hours ft$o fro'* Tweehe
r Askmg people between 45-65 to join a
study about risk of heart disease please retweet 
B R  http myheartrisk co uk'
•bout 7 tours sgo I t o t  wee
A M  Asking people between 45-65 to join a
_  ■  study about risk of heart disease please retweet 
i ^ R R  http myheartrisk co.uk/
about 7 hours ago So® wee
■ Asking peopie between 45-66 to jom a study about nskof heart disease please retweet http /myheartrisk co uk/atout 7 hours ago from w et
Real-time results for m yh eartrisk O  Save this starch
Older tweets are temporarily unavailable
Figure 5.9 Further examples of Tweets and re-Tweets from T w itte r  users.
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The moderators of these forums were contacted to ask for permission to post 
information about the study. This was done because sometimes posts can be 
removed by the moderators if they suspect spam or phishing scams. Additionally, if 
stated in the post that permission has been granted from the moderators, forum 
members can see that the post has been checked and is from a reliable trustworthy 
source.
Six of the forum moderators gave permission for a post to be made (Age Concern 
Baby Boom Bistro; SagaZone; 50 Connect; Over50s forum; My Prime; Not Dead 
yet). One (SagaZone) requested further details about the study, so an electronic 
copy of the Participant Information was sent. See Figure 5.10 for an example of a 
posting made on one of the forums. The same procedure was carried out for another 
three general forums (Net Weather (www.netweather.tv); Big Soccer 
(www.bigsoccer.com) and Big Footy (www.bigfooty.com)). These were chosen as 
they were popular and had a large number of members.
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SAGA
Doing things properly
SAGA Group I Magazine j Health | Travel & Leisure | Insurance | Finance
Before you set off /
call AA Roadwatch /#***•■,00 84322 ~ /><>■' ^  J
My Zone About Me Things To Do Search Help Contact Us House Rules
Media Centre
The Media Centre is a dedicated forum which will contain requests for case studies or requests for member participation in 
conjunction with various media companies. AH posts here have been vetted and agreed with the site owners. Please note, 
it is not obligatory to take part.
Log out
Cherry-Ann
F o ru m  in d e x  -  S A G A  Zocile N ew s -  M ed ia  C e n tre mryggi
Participants needed to  try  out new Cardiff U n ivers ity  website th a t predicts 
fu tu re  risk  o f h e art d isease. ( i  posts)
P artic ipants needed to  try  .
Cherry-Ann 
09/ 03/2010 10:41:31
Sidney De Haan Research Centre fo r Arts k  Health ( l  posts) 
Silver Song Club Research Project in Kent 
Started  by: *  •
University of Manchester require over 40s for contact lens study (4  posts)  
S tarted  by:
ITV 's  Tonight program m e Is looking fo r a re tire d  couple to  appear in a  
program m e about our superm arkets. [2 posts)
V  We want to find out more about our relationships with our favourite supermarkets and 
ask how loyalty to  those supermarkets has helped them beat the recession.
Sidney De Haan Research ...
01/ 03/2010 17:11:43
Re: University of Manchester
26/ 02/2010 21:36:24 
Re: ITV 's  Tonight program m e
26/ 02/2010 17:59:08
o
Forum  index  ~ SAGA Z o n e  New s » M ed ia  c e n tre  -  P a rtic ip a n ts  needed to  try  o u t new  C a rd iff U n iv e rs ity  w e b s ite  th a t  p re d ic ts  fu tu re  r is k  o f  
h e a rt disease.
Participants needed to try., out new Cardiff University website that 
predicts future risk of heart disease.
Cherry-Ann
myHeartRisk
$
Posts 3
Jum p to  P age: 1
Subject: Participants needed to try out new Cardiff University website that predicts future risk of heart 
disease.
Pasted Afc 0 9 /0 3 /2 0 1 0  10:41:31_____________________________________________________________________________________
I'm a researcher at Cardiff University looking for volunteers to try a new website we 
have developed, which predicts future risk of heart disease.
m yHeartR isk is a website that assesses risk of developing heart disease in the future, 
by using information about health status and lifestyle.
The study is looking for volunteers to visit the website, who are aged between 45 and 64 
years of age, have not been previously diagnosed with heart disease, had a cardiac 
event (such as a heart attack or angina) or had a stroke.
The aim of the research study is to examine perceptions and attitudes towards heart 
disease, and provide insight into what people think about their risk when it is presented 
to them in a certain way.
£1 will be donated to the British H eart Foundation for every person who takes part 
and completes the study. The University is hoping to raise over £1,000.
If  you are interested in taking part please visit: m vHeartR isk w ebsite
Many thanks in advance, 
Cherry-Ann
Figure 5.10 A posting on SagaZone.
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A hyperlink to the study’s website was placed on four Social Bookmarking websites 
(Digg (www.digg.com), Reddit (www.redditt.com), Delicious (www.delicious.com) 
and Stumble Upon (www.stumbleupon.com)). Figure 5.11 shows an example the 
bookmarks made on Delicious.com where the study’s website was bookmarked by 
five different people (delicious.com 2010).
f  delicious
LI
w  S  inbox Settings Help Sign Out
Ivi ! ll
Everyone'* Bookm ark* for.
My Heart Risk
m yteartri5 lico .uk
▼ My Bookmark
oe apr 10 My Heart Risk
EXT CCLETI h e m . risk health. reaseanXi. c a n  Iff uni
Saved 5 tune*, fir * !  caved by on 17 Feb 10 V iew  Chart v  ►
etudy about nsk of heart disease [people 4E-65 years] mtp-jVmyheartnsfccc.utRT m Join
- FT
19 FEB 10 0  | v  
17 FEB 10 on behalf o f
□  RSS feed
: Asians people between *5-65 to join a study about risk o f  heart disease please retw eet http:0iiiy1ieartrlsic.cc.ukf
via:paOnt> us 
ri*-calcuiator
M  Look up another URL
T ag s
▼ Top Tags
via.pabcrati us 
rim
uni
rtak-calcuiator
hoart
haalth.
Figure 5.11 A social bookmark made on Delicious.com.
Another recruitment method involved contacting large organisations where 
employees had access to a computer. Four organisations (Welsh Assembly 
Government, Driver and Vehicle Licensing Agency, HM Revenue and Customs Tax
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Office and Cardiff Council) were telephoned to ask whether they would be willing to 
send employees an invitation to participate in the study. A description was given 
about what the study entailed and the benefits of the on-line cardiovascular risk 
assessment. Upon trying to contact the Human Resources departments of three of 
the government based organisations, they were found to be managed by an 
independent company called Shared Services. Shared Services offered to send an 
invitation to their employees but were not authorised to send an invitation out to 
employees of the other organisations. Attempts were made to speak to the relevant 
people that would be able to authorise such action, however, this was not successful 
for two of the organisations (Driver and Vehicle Licensing Agency and HM Revenue 
and Customs Tax Office). The Occupational Health Department of the Welsh 
Assembly were contacted but they declined as they had recently performed a 
cardiovascular screening of their employees. However, Cardiff Council did send an 
invitation in their staff weekly email and posted a hyperlink to the study website on 
their staff intranet.
Lastly, a snowballing technique was employed where personal contacts were 
emailed the details of the study and website address, they were asked to forward 
this information to their friends and work colleagues who might have been interested 
in taking part in the study. It is not known how many people passed the email on or 
who it was passed on to; the only information that could be gained was from the 
questionnaire asking respondents to indicate where they heard about the study; 
which was examined in the process evaluation of the trial.
2 0 2
5.11 Conclusion
To conclude, this chapter has described the methods used in the RCT on the effects 
of cardiovascular risk representation formats on intention to change behaviour, 
understanding of risk information and affect (effect evaluation), and the use of the 
website by the respondents (process evaluation). It has described the design, 
procedure, plan of analysis and recruitment strategy. The following chapter 
describes the development and pilot testing of the web-based risk formatter used in 
this trial.
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Chapter 6. Development and pilot testing of the myHeartRisk 
website.
6.1 Introduction
This chapter will present the development and pilot testing of the myHeartRisk 
website, comprising the web-based cardiovascular risk formatter and on-line 
questionnaires used in the RCT.
6.2 Development of the myHeartRisk website
The development of the website commenced in June 2009, a project specification 
document and storyboard of web pages were presented to a web developer 
(Appendix 30). Information was given to the web developer about who the website 
was intended for (e.g. people aged 45 to 64 years, of varying educational and 
computer literacy levels), and the considerations that needed to be made, such as 
making the website as user-friendly and self-explanatory as possible, simple layout, 
minimal text, use of plain language, clear instructions, use of colours that 
complement each other, and large sans serif font no smaller than size 14 that is easy 
to read (such as Veranda or Ariel). Additionally, the website needed to allow for easy 
navigation, with big easy-to-use buttons, check boxes and sliding scale response 
options. The project specification document also explained about the wide 
confidence intervals of the risk categories that needed to be depicted by the
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graphical representation formats. The bar graph and pictogram formats needed to 
have an element of simple animation to show the range in the risk of future heart 
disease represented in each of the risk categories. For example, the bar graph 
needed to grow slowly from 0% to 9% in low risk category; 10% to 20% in moderate 
risk category and from 20% upwards in the high risk category. For the pictogram 
format, each heart symbol representing the frequency of risk needed to be 
highlighted or flash in succession. The web developer circulated the graphical 
formats and off-line versions of the web pages for approval, before constructing the 
website in Adobe Acrobat Flash software. A functional website was ready for pilot 
testing in December 2009.
6.2.1 Graphical Risk Representation formats
The two control groups in this trial consisted of vertical bar graphs depicting future 
risk of cardiovascular disease in percentages. This was animated (growing upwards) 
to demonstrate the wide confidence intervals of the risk categories in the Personal 
Risk Score (Mainous et al. 2007). Screenshots of the original bar graph formats for 
each of the risk categories (before pilot testing and refinement) are presented in 
Figures 6.1 to 6.3.
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Your calculated risk of having a
event in the next 10 years is Low (under 10%)
100 -
90 -
80 -
70 - 
Risk% £.g\ 60 -
50 -
40 -
30 -
20 -
y  Risk = Low (under 10%)
years
Figure 6.1 Original Bar graph format for Low risk category.
Your calculated risk of having a coronary heart disease :CHD 
event in the next 10 years is Moderate (between 10 and 20%)
1 0 0  -i
90 - 
80 -
70 -
Risk % 60 - 
5 0 -  
40 -
30 -
Risk = Moderate 
(between 10% and 20%)
10
years
Figure 6.2 Original Bar graph format for Moderate risk category.
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Your calculated risk of having a
event in the next 10 years is High (over 20%)
Risk %
100  -  
90 - 
80 - 
70 - 
60 - 
5 0 -  
40 - 
30 
20 
10 
0
-  Risk = High (over 20%)
years
Figure 6.3 Original Bar graph format for High risk category.
For the first intervention group, future risk of cardiovascular disease was presented 
as a pictogram of 100 hearts depicting natural frequencies. This was animated, 
highlighting each affected heart in turn, to account for the range of numbers affected 
in the risk category. Screenshots of the original pictogram formats for each of the risk 
categories are presented in Figures 6.4 to 6.6.
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Your calculated risk of having a ;oronary heart disease (CHD) 
event in the next 10 years is Low (under 10%)
This means under 10 out of 100 people who are like you will have a coronary heart 
disease event in the next 10 years.
W W W W W
▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼
▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼
Figure 6.4 Original Pictogram format for Low risk category.
Your calculated risk of having a :oronary heart disease (CHD)
event in the next 10 years is Moderate (between 10 and 20%)
This means between 10 and 20 out of 100 people who are like you will have a 
coronary heart disease event in the next 10 years.
▼  ▼ ▼ ▼ ■ W W W
\!/\’y  ■ • } / \ ! /  \J/
m r w w
w w w w
w w w v
w w w w
W ' T W ' W W
Figure 6.5 Original Pictogram format for Moderate risk category.
Your calculated risk of having a
event in the next 10 years is High (over 20%)
This means over 20 out of 100 people who are like you will have a coronary heart 
disease event in the next 10 years.
? ? ? ? ? ? ? ? ? ?
▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼  
▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼
Figure 6.6 Original Pictogram format for High risk category.
The metonym format, used in the second intervention group, comprised an image 
that depicts the seriousness of an emergency admission for a myocardial infarction. 
This was chosen as heart disease is generally associated with having a myocardial 
infarction (Emslie et al. 2001). An animated image demonstrating healthy longevity 
was shown to those in the low risk category; the gentleman’s foot slowly rocks back 
and forth and there is the sound of waves crashing in the background and birds 
cheeping. Those at moderate risk were presented with an ambulance travelling 
towards a person’s house; the siren lights flash and the rain pours down, with the 
sound of thunder and lightning in the background. A person being defibrillated (with 
the appropriate sound effect) was shown to the high risk category. Screenshots of 
the original metonym formats for each of the risk categories are presented in Figures 
6.7 to 6.9.
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Your calculated risk o f having a
event in the next 10 years is Low (under io «m
highriffc
Figure 6.7 Original Metonym format for low risk category.
Your calculated risk of having a coronary heart disease (CHD) 
event in the next 10 years is Moderate (between 10 and 20%)
Figure 6.8 Original Metonym format for moderate risk category.
Your calculated risk of having a
event in the next 10 years is High (over 20%)
low risk
m o d era te  n ik
HHSffiBSiSSi
Figure 6.9 Original Metonym format for High risk category.
6.3 Pilot testing of the myHeartRisk website.
The aim of the pilot study was to assess the internal logic and usability of the 
website. It comprised two phases: the first, sought general feedback on the 
cardiovascular risk representation formats and wording of the questionnaires; the 
second phase was concerned with the functionality and internal logic of the site. Both 
phases indentified limitations and/or computer glitches.
2 1 1
6.3.1 Phase 1 of pilot testing
Design
An on-line evaluation and simulation study, using hypothetical risk profiles of varying 
degrees of cardiovascular risk (Appendix 31).
Participants
A convenience sample of peers invited to take part in the pilot study via University 
Departmental email.
Procedure
An email was sent to members of a Decision Laboratory research group at Cardiff 
University, asking whether they would be willing to take part in the piloting of the 
myHeartRisk website (Appendix 32).
Respondents agreeing to participate in phase 1 of the pilot testing were given a link 
to the pilot website (http://www.myheartrisk.co.uk/pilot.html) and instructions that 
comprised one of a selection of hypothetical risk profiles created to test the different 
risk categories (An example is given in Appendix 33). Respondents were asked to 
vividly imagine that they were the person in the profile with those particular risk 
factors. They were asked to navigate through the website, inputting the information 
from the hypothetical profile, view the output and complete the on-line
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questionnaires. They were asked to comment on their opinions about the risk 
representation format they were allocated to.
When completing the on-line questionnaire, respondents were asked to answer the 
questions in a way they thought the person described in the hypothetical risk profile 
would answer them. They were also asked to highlight any difficulties they had in 
interpreting the wording of the questions and identify any computer glitches or 
limitations with the website on the feedback page.
The SQL database storage and transferring of data were assessed after 
respondents had visited the website, to make sure completed responses were 
successfully fed back to the host Server.
Results
Eleven respondents participated in the first phase of piloting. Comments from each 
of the reviewers are presented in Appendix 34. Comments were categorised into 
those regarding functionality of the website, layout of the web pages, risk 
representation formats or miscellaneous.
Functionality of the website
Reviewers assessed the functionality of the website to identify any computer 
glitches. They commented that they could not use the back button on the browser to 
view previous web pages. However, as the website was constructed using Abode
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Acrobat Flash software, it was not possible to rectify this. Additionally, reviewers 
reported difficulty selecting their exact height and weight on the sliding height scale 
and weighing scales of the risk assessment page, and the progress bar did not 
continue to the end on the last page of the website. This was reported back to the 
web developer for amendment.
Additionally, reviewers had difficulty printing out a copy of their results for a number 
of reasons e.g. the print function would not work at all, the risk category on the 
printout would change from what was shown on their risk output results page, or the 
website would not print out the results and took users straight to the next page. The 
web developers attempted to rectify this, however it was not successful and an 
alternative method for respondents to obtain their results had to be implemented. 
This involved asking respondents to leave their contact details on the last page so an 
electronic copy could be emailed to them in Adobe Acrobat Portable Document 
Format (pdf).
Layout of the web pages
Abnormalities with the layout of a questionnaire page were identified by the 
reviewers. For example, one of the questionnaire pages comprised anchors on the 
Likert scales that were negative on both sides. This was corrected. Smoking 
cessation questions were given to respondents who ticked that they were former 
smokers on the risk assessment page. This was amended so that only current 
smokers received these questions. In the original weighing scales the maximum 
weight was presented on the left, so users selected their weight by decreasing the
value on the weighing scale. It was felt this was counterintuitive, and was reversed 
so when the arrow was dragged upwards the weight increased.
Figure 6.10 demonstrates the revised layout of the risk assessment pages of the 
website. Additionally, a suggestion was made to change the colour of the hyperlinks 
from beige to a more recognisable format associated with hyperlinks (i.e. blue and 
underlined). This was done. Lastly, it was felt that users needed guidance on how 
they answered the question regarding family history when this information was not 
known to them. Therefore, wording was added to this question that suggested users 
should answer ‘no’ if this information was unknown.
Graphical risk representation formats
Four reviewers commented on the question marks being used in the bar graph and 
pictogram formats to represent the wide confidence intervals of the risk categories 
(see Figures 6.1 - 6.6). They were not understood as reviewers did not comprehend 
the message they were supposed to be conveying and did not see the purpose of 
them.
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In order for us to calculate your risk profile, 
please answer the following questions.
Arc you male or female?
{Please d ick  o n  th e  ap p ro p ria te  box)
What is your age?
(D rag th e  m arker over th e  scale to  
show  your correct age) 50 55 60  6 4
Does your family have a history of heart disease?
(By fam ily history we mean d id you have a parent w ho was under the age o f 50, 
w hen they were to ld  by their GP/Physician that they had a heart attack. If this is 
unknown please answer no .)
Has your doctor diagnosed you with any of the 
following?
H igh Blood pressure (H ypertension)
H igh  cholesterol (H ypercho lesterolem ia)
D iabetes
mmo
m ■
mm■31
m ■
■ ■
■ ■
Just a couple more questions—
Please check the box that most applies to you.
Do you smoke?
No, I have never 
smoked
I have smoked in the  
past but no longer
Yes. 1 smoke regularly 
or l have smoked 
w ithin the  last year
■ ■ ■
Do you exercise or play sport in your leisure time?
Often or Very Often Sometimes Seldom or Never
Drag the marker to 
show your correct 
height.
Drag the arrow to 
show your correct 
weight.
Stone 13 lbs
Figure 6.10 Revised cardiovascular risk assessment web page
A possible solution to representing the degree of uncertainly and wide confidence 
intervals was suggested (see Reviewer 10 in Appendix 34), where two colours 
should be used; a darker red to represent the people who will definitely be affected 
by a future coronary heart disease event and a lighter pink to represent the number 
of people who may be affected. For example, for moderate risk, 9 hearts would be a 
darkened colour as they represent the ‘less than 10 people’ who will be affected, 
whereas hearts 10-20 highlighted in a lighter pink to represent those who may be 
affected. A diagram key would be used to demonstrate what the two colours mean. 
The only alteration made to the metonym formats was changing the colour of the 
hyperlink of the CHD definition page. Figures 6.11 to 6.19 demonstrate the revised 
risk representation formats.
Your calculated risk of having a coronary heart disease event 
in the next 10 years is Low (under 10%)
Risk%
100 
90 
80 
70 - 
60 
50 - 
40 
30 
20 H 
10 
0 J- Risk = Low(Somewhere under 10%)
10 years
Figure 6.11 Revised Bar graph format for Low risk category.
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Your calculated risk of having a coronary heart disease event
in the next 10 years is M oderate (between 10 and 20% )
Risk%
100 
90 
80 
70 
60 
50 
40 
30
20 ~i Risk = Moderate
10 - (Somewhere between 10% and 20%)
10 years
Figure 6.12 Revised Bar graph format for Moderate risk category.
Your calculated risk of having a coronary heart disease event 
in the next 10 years is High (over 20%)
Risk%
100 -j
90 -
80 -
70 _
60 -
50 _
40 '
30 _
20
10
0
-  Risk = High 
(Somewhere over 20%)
10 years
Figure 6.13 Revised Bar graph format for High risk category.
Your calculated risk of having a coronary heart disease event
in the next 10 years is Low (under 10% )
This means that less than 10 people in every 100 like you will have a coronary 
heart disease event in the next 10 years.
vv w v v  w v
▼
▼
▼
people like you who may 
have a coronary heart 
disease event.
Figure 6.14 Revised Pictogram format for Low risk category.
Your calculated risk of having a coronary heart disease event
in the next 10 years is Moderate (between 10 and 20%)
This means that somewhere between 10 and 20 people in every 100 like you will 
have a coronary heart disease event in the next 10 years.
v ' s / v ' h p ' v ' V v ' v ' v ' V  
▼ ▼ ▼ ▼ ▼ ▼  
W W W *
v w w v v v
people like you who will 
definitely have a coronary 
heart disease event.
people like you who may 
have a coronary heart 
disease event.
Figure 6.15 Revised Pictogram format for Moderate risk category.
Your calculated risk of having a coronary heart disease event 
in the next 10 years is High (over 20%)
This means that more than 20 people in every 100 like you will have a coronary
heart disease event in the next 10 years.
people like you who will
definitely have a coronary
heart disease event.
people like you who may
have a coronary heart
disease event.
Figure 6.16 Revised Pictogram format for High risk category.
Your calculated risk of having a coronary heart disease event 
in the next 10 years is Low (under 10%)
Figure 6.17 Revised Metonym format for Low risk category.
Your calculated risk of having a coronary heart disease event
in the next 10 years is M oderate  (betw een 10 and 20% )
high risk
I-----------------   ■■------------
Figure 6.18 Revised Metonym format for Moderate risk category.
Your calculated risk of having a coronary heart disease event 
in the next 10 years is High (over 20%)
low risk
moderate risk
Figure 6.19 Revised Metonym format for High risk category.
2 2 1
Miscellaneous
Three reviewers provided comments that were categorised as miscellaneous. 
A positive comment was made about the website working well with a 
favourable opinion of the use of a progress bar. One reviewer was concerned 
about the interpretation of the PANAS-SF scale measuring positive and 
negative affect. However, no action was taken to address this comment as it 
was personal opinion and not reflected by the piloting group as a whole. One 
reviewer commented on the content of the participant information pages; 
amendments were made where necessary.
6.3.2 Phase 2 of pilot testing 
Design
A pragmatic on-line evaluation to assess usability of the website.
A pragmatic approach to assess the usability of the website was chosen.
More sophisticated methods, such as in-depth or focus group interviews, 
cognitive interviewing using think aloud technique, or systematic testing in 
standardised laboratory conditions were not considered necessary as 
navigation through the website was linear and straightforward.
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Participants
Personal contacts and members of the Clinical Epidemiology Interdisciplinary 
Research Group at Cardiff University aged 45 to 64 years without existing 
heart disease (i.e. respondents who would be eligible to take part in the main 
RCT).
Procedure
Personal contacts and peers were invited by email to participate in a pilot 
study preceding the main trial (Appendix 35).
Respondents who replied to the invitation email were given a link to the 
myHeartRisk pilot website (http://www.myheartrisk.co.uk/pilot.html) with 
instructions regarding what was required (Appendix 36). For example, 
respondents were asked to navigate through the website and give free text 
feedback, comments and suggestions on all aspects of the website. They 
were also asked to identify any difficulties, glitches or limitations they found. It 
was stressed that the purpose of the pilot study was to improve the usability of 
the material and all comments were welcome. Additionally, the web-logs 
stored by the SQL host Server were assessed to identify any problems 
regarding the data storage and transfer processes.
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Results
In total, there were 19 reviewers who took part in phase 2 of the pilot testing. 
Six were personal contacts, considered as non-experts or members of the 
general public, 13 were recruited from the Clinical Epidemiology 
Interdisciplinary Research Group and were considered to be ‘experts’ with 
experience of research and web-based studies.
Comments made by the reviewers were dichotomised into those that were 
positive and those that were negative. Appendix 37 shows reviewers 
responses of a positive nature. Generally, reviewers had favourable opinions 
regarding the layout, which they thought was attractive, easy to use and easy 
to navigate. They liked the use of graphics and the interactive tools with 
dragging options. They also commented that it did not take too much time to 
complete the post-intervention questionnaires.
Appendix 38 shows reviewers responses of a negative nature. These were 
categorised by the corresponding section of the website that they referred to: 
participant information, disclaimer, consent and eligibility assessment pages, 
baseline and pre-intervention questionnaires, risk assessment, risk output 
results, post-intervention questionnaires, end of study and contact details 
pages, and general comments. Tables 6.1 to 6.8 demonstrate the comments 
concerning the different sections of the website and the appropriate action 
that was taken. The feedback and comments regarding the functionality and
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internal logic of the web-site were compiled into a list of alterations given to 
the web developer.
Participant information pages
Comments regarding the participant information pages (Table 6.1) mainly 
concerned its layout, such as inappropriate line-breaks, typographical errors, 
clickable hyperlinks not working etc. These were all amended. Additionally, 
four reviewers gave unfavourable opinions regarding how each question and 
answer was presented in the participant information page. In the original 
layout (Figure 6.20) users were required to roll their mouse over the question 
and click to open up a pop-up box displaying the answer. Reviewers 
commented that they would lose track of which questions they had visited and 
found it very long, ‘off-putting’ and intimidating. Therefore, the layout of this 
page was improved by displaying the questions and answers on one page 
that users scrolled down. The revised participant information page is 
presented in Figure 6.21.
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myHeartRisk M I
Roll the  mouse over the questions and click once to  view  the  
in form ation.
Introduction CD
What is the purpose of this study?
Why have I been chosen?
Do I have to take part?
What will happen to me if I decide to take part?
What do I have to do?
Will my taking part in the study be kept confidential?
What are the disadvantages or risks of taking part?
What are the possible benefits of taking part?
What will happen if I don't want to carry on with the study?
What if something goes wrong?
What will happen to the results of the research study?
Who is organising and funding this research?
Who has reviewed this study?
What do I need to do now?
What if I have other concerns?
Who should I contact for further information?
Progress
i into public perceptions of heart disease risk
Figure 6.20 Original layout of the Participant Information page.
myHeartRisk iff]
Partic ipant In fo rm ation  Sheet
Please read this information carefully.
Click on th e  arrows to  m ove dow n the  page and d ick  'continue' w hen you  
are ready to  proceed.
Introduction
You are being invited to take part in a research study by Cardiff University. 
Before you make a decision about whether to take part, it is important for you 
to understand why the research is being done and what it will involve. Please 
read the following information carefully and discuss with others if you wish. 
Take time to decide whether or not you wish to take part You are welcome to 
contact us if you have any questions or require further information.
dVhot is the purpose o f this study?
Heart disease is the biggest killer in the UK and lots of people are unaware they 
are at risk from i t  Heart disease risk can be reduced by making changes to 
lifestyle, such as adopting healthier behaviours or taking medication.
M M  BMBMIHU■ b h i
Figure 6.21 Revised layout of the Participant Information page.
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Table 6.1 Comments regarding the participant information pages.
Reviewer 3 
(non-expert)
‘When 1 was reading through each of the information items from the list at the start, each time 1 
closed a particular item it took me back towards the top of the list, not on the item 1 had just been 
on so 1 could move on to the next one. ’
The layout of this page has been improved.
Reviewer 6 
(expert)
‘The introduction list, 1 seemed to have to step back and select each item, rather than flick 
forward through it, each one seemed clear and short, so 1 would have preferred that. ’
The layout of this page has been improved.
Reviewer 7 
(expert)
‘What is the purpose of this study’ you give the url of the website but it is not the same as the 
URL that displays in the browser status bar.
The pilot website had a different website address to 
the main study. No action was taken.
‘Will my taking part be kept confidential’ you say ‘..at an agreed period’ rather than ‘..after an 
agreed period. This has been amended.
‘What do 1 need to do now?’ you instruct to navigate to the electronic consent page, yet the only 
button available is a ‘continue’ button. It would be better to say press continue button which will 
take you to the consent page.
This has been amended.
Reviewer 8 
(expert)
‘Scrolling is still a pain’.
‘This really needs to retain and indicate where the participant has visited; otherwise they won’t 
know where they have been. A ‘next’ option would be handy, but there is a lot to wade through.'
The layout of this page has been improved. 
The layout of this page has been improved.
‘What are the disadvantages or risks of taking part? Typo: ‘we recognise that viewing you risk... ’ This has been amended.
‘What if something goes wrong? -  professor Glyn Elwyn, line break’ This has been amended.
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Reviewer Comment Action taken
Reviewer 10 
(expert)
Under disadvantages, in line 1 it should be your, not you.
In the ‘what if something goes wrong, the formatting of Glyn is a bit odd.
This has been amended. 
This has been amended.
In the ‘what will happen to the results’, the punctuation is a bit odd in the second paragraph. This has been amended.
In the ‘what do 1 need to do now?’ you instruct to navigate to the electronic consent page, yet the 
only button available is a ‘continue’ button. It would be better to say press continue button which 
will take you to the consent page.
Wording instructing users to click on the continue 
page to get to the consent page has been added.
Reviewer 13 
(expert)
Long list of questions was off-putting. Was 1 supposed to read them all, or just click on the ones 
of interest, or ignore and continue?
The layout of this page has been improved.
The subjects should have to work through each question to get to the next page- at least the 
then the content is in front of them if only for a few seconds. If people are sufficiently interested 
to go on the site, they should be sufficiently interested to read information sheet.
The layout of this page has been improved.
Reviewer 14 
(expert)
‘Would be helpful to have some links here.
-What do 1 need to do now -  maybe a link to take you straight to the consent screen?
-what if you have other concerns -  clickable email link to Prof Elwyn, or a link to the Contact 
details screen.
Wording has been amended instructing users to 
click on the continue button to go to the consent 
page.
The email on the contact details doesn’t work. This has been amended.
Reviewer 15 
(expert)
List at beginning very long and a bit intimidating -  is this necessary- it almost made me turn off. The layout of this page has been improved.
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Reviewer Com m ent Action taken
R e v i e w e r  16 
( e x p e r t )
’What will happen if 1 don't want to carry on with the study? You can withdraw from the study at 
any point by closing the web browser.' Is this really what you want to happen? There are various 
reasons why a web browser can close without implying intention to withdraw - crashes, 
navigating away and not being able to get back, being called away and the kids then start using 
the computer etc. Better for the system to require deliberate withdrawal, and allow return after 
interruption -
though detect if they never return within a specified time frame and count that as a withdrawal.
Due to the nature of the website being constructed 
in Adobe Flash, users cannot return to the page in 
which they exited previously.
R e v i e w e r  17 
( e x p e r t )
There is a risk that people might be mislead regarding the source of this website, which is Cardiff 
University and not Br Heart Foundation
The participant information page clearly states that 
Cardiff University is the source.
Grammatical amendments needed on participant information. See email. This has been amended.
R e v i e w e r  18 
( e x p e r t )
Change ‘Why have 1 been chosen? To ‘Why am 1 eligible’
Change what if something goes wrong to ‘What If 1 have concerns/ What if 1 become worried?’
This has been amended. 
This has been amended.
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Disclaimer, consent and eligibility assessment pages
Reviewers commenting on the disclaimer, consent and eligibility assessment pages 
(Table 6.2) said they would like a back button on the browser in case users wanted to 
view the participant information pages again before consenting, or in case they 
changed their minds about participating. As the website was created in Adobe 
Acrobat Flash software, it was not possible to implement this into the website. 
Comments that were able to be addressed resulted in adding a title heading to the 
consent page and providing a reference to the published algorithm used by the 
website, e.g. the Personal Heart Score (Mainous et al. 2007).
Baseline and pre-intervention questionnaires
Three comments were made regarding the baseline and pre-intervention questions 
given to those in the first control group (Table 6.3). Two of these were personal 
opinions about wording of one of the scales used in the questionnaires, PANAS-SF 
(Thompson 2007). As this is a published scale that has been validated, and the 
opinions were not reflected by the group of reviewers as a whole, these comments 
were not addressed and no action was taken.
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Table 6.2 Comments regarding disclaimer, consent and eligibility assessment pages.
Reviewer 13 
(expert)
Language is a bit high brow (published prediction tool, self-reported information) This is a personal opinion. No action 
was taken.
Reviewer 14 
(expert)
Consent -  a ‘back’ button would be helpful in case the person wants to review the participant options 
again before consenting.
This is a feature of the website being 
constructed in Adobe Flash, it cannot 
be changed.
We are sorry you do not wish to take part -  a ‘back’ button might be helpful as well in case the person 
decides to change their mind. A ‘quit’ button to confirm their decision and take them out of the website.
It was not possible to do this.
Disclaimer -  this mentions a published prediction tool. It would be nice if this were referenced, or if 
there was a link to it, for anyone who wants further info.
This has been done.
Reviewer 17 
(expert)
Once on the consent page, 1 don’t think 1 actually saw it labelled as a ‘consent page’. Possible to give it 
that heading?
It has been made sure that the consent 
page is labelled.
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Table 6.3 Comments regarding the baseline affect/worry and pre-intervention questionnaires.
Reviewer 9 1 didn’t like being asked if 1 was ashamed or nervous (1 assume that was for personality type) it 
(expert) seemed irrelevant and intrusive.
Reviewer 13 Q16 suddenly has numbers -3,-2,-1,0,1,2,3 rather than previous 1,2,3,4,5,6,7 which was a bit 
(expert) confusing. Also, the minus end was sometimes associated with the most positive response 
(easy/rewarding).
Reviewer 16 Page 'Before we calculate your risk': are we asking how worried they feel, or how concerned? 
(expert) I'm concerned re my heart disease risk - but not worried. 1 realise that this is my most likely
pathway of death. 1 am taking reasonable steps to minimise my risk. 1 have plenty else of more 
immediate concern.
This is a personal opinion; these questions 
form part of the PANAS (a published and 
validated scale).
The questionnaire format is recommended 
by published guidelines on constructing 
TPB questionnaires. No action was taken.
This is personal opinion, not a website 
issue. No action was taken.
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Risk assessment pages
Table 6.4 demonstrates the comments made by the reviewers about the risk 
assessment pages of the website. The ‘expert’ reviewers commented on the 
questions asking whether users had ever been told by their GP that they had 
high cholesterol, one expected a definition of what constitutes high, another 
would have liked to have seen the option to request more information. 
Furthermore, the definition of family history (e.g. first degree relative 
diagnosed under the age of 50) surprised one reviewer, as they reported that 
other algorithms use 60 years of age. However, no action was taken to 
address these comments as they related to the risk factors used by the 
published algorithm not with the functionality of the website. The sensitivity of 
the weight scales and height ruler were reduced after two reviewers 
commented that it was still very sensitive and difficult to get the arrow to their 
exact weight and height. A computer glitch was sorted out after a reviewer 
reported that they had proceeded to the next webpage without answering 
some of the risk assessment questions. Lastly, one reviewer thought that 
aesthetically, the line joining the response options boxes on the smoking 
question should be removed, therefore, this was done.
Risk output results
Five reviewers commented on the risk output results page (Table 6.5). The 
hyperlinks were amended so that the text did not disappear when highlighted 
and the definition of a coronary heart disease event was improved in
233
response to comments from two reviewers. One reviewer reported that they 
did not understand the purpose of the thumbnails given in the metonym 
format (See Figures 6.17 to 6.19). However, no action was taken to address 
this as it was felt that the thumbnails provided context, as they showed how 
the metonym was used to represent a user’s risk category compared to the 
metonyms used to represent other risk categories. If these were removed, the 
metonym image on its own would not be easily interpreted or understood. 
Additionally, one reviewer commented on the lack of anonymity when 
requesting a copy of the risk output result by entering contact details for a 
copy to be emailed to you. As described previously, it was not possible to 
provide a function that enabled a printout straight from the website. This 
limitation is acknowledged and will be discussed in Chapter 9.
Post-intervention questionnaires
A statement clarifying why the post-intervention questionnaire pages ask 
about a user’s intentions to stop smoking, lose weight and exercise more was 
added to this page, in response to the comments from two reviewers: one 
who suggested that the questions had no real introduction and an unclear 
purpose, and another who said that they thought these questions were asked 
because of the responses they gave on the risk assessment pages, i.e. that 
the website was recommending that they should exercise more or lose 
weight.
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Five reviewers commented on the different numerical values on the response 
sets, suggesting that they should be kept the same because the scales are 
confusing and caused hesitation in how to interpret the sudden switch to the 
answer format, which numerically challenged users’ may find ‘off-putting’. 
However, no action was taken to amend this because the post-intervention 
questionnaire was constructed using the published guidelines on constructing 
Theory of Planned Behaviour Questionnaires (Francis et al. 2004). According 
to Francis et al (2004) it is suggested that bipolar items with an evaluative 
component (where the respondent is required to make a judgement about the 
probability that the item is true) should have positive and negative values, 
such as -3 to +3. This determines the direction of the opinion, e.g. a negative 
score represents an opinion that is against the behaviour in question, a 
positive score represents an opinion that is favourable towards the behaviour 
and zero score represents a neutral opinion.
Additionally, two reviewers commented on the items that were reversed 
scored, suggesting they seemed to be intuitively the wrong way round and 
asked whether the numerical values were meant to be showing, where there 
were negative scores for positive items and positive scores for negative items. 
No action was taken to address these comments as the reversal of some 
items was deliberately done to reduce the possibility of response set bias; as 
recommended when constructing questionnaires and surveys (Oppenheim 
2001).
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It was also suggested that the response options should comprise all the same 
response option anchors such as ‘strongly agree to strongly disagree’. 
However, no action was taken in response to this comment, as the 
questionnaire was designed to have a variation in response option anchors to 
reduce the possibility of response set bias (Oppenheim 2001), and this was a 
comment suggested by one reviewer only.
Lastly, one reviewer felt the questionnaire was repetitive. However, no action 
was taken as the number of items was kept to an absolute minimum so not to 
cognitively overload the respondents and thus reducing drop-out /attrition 
rates.
End of study and contact details pages
Four reviewers provided comments about the end of study and contact details 
pages (Table 6.7). Two commented that the progress bar had not gone all the 
way to the end when the study was complete and users were on the last 
webpage. This was amended. Additionally, one reviewer reported that they 
would have liked to have clicked on a ‘close’ button when leaving the site, 
rather than just closing the web browser. This was not able to be addressed 
due to the software used to develop the website (e.g. Abode Acrobat Flash).
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Table 6.4 Comments regarding risk assessment pages.
Reviewers 1 & 2 
(non-experts)
The only problem we both encountered was setting our weight on the gauge. We had to leave it as close 
as, as it was very sensitive to movement.
The sensitivity of the height ruler and 
weighing scales has been reduced.
Reviewer 6 
(expert)
Dials with moving needles -  could perhaps be bigger. This has been done.
Reviewer 8 
(expert)
Do you smoke?- if this question is missed and ‘click to continue’ clicked, the ‘please answer all 
questions’ message is displayed. If smoking is answered and ‘click to continue’ clicked, the survey goes 
to the next page, even if the other 3 qs (exercise, height and weight) are missed. 1 had a very good 
result, presumably because it thought 1 was 130cm high and weighed 25kg! 1 have not checked all 
combinations on all pages.
This has been amended.
Reviewer 9 
(expert)
Would have liked to see stones and pounds rather than kilos There are already both imperial and 
metric measurements on display.
Reviewer 10 
(expert)
Question about high cholesterol -1  don’t think that is very clear. How high does it have to be to be 
counted as high? Does the total have to be 5.5? 6? 7? What about the ratio of low hdl to high? I ’m not 
sure that will get clear answers. And clearly the risk does depend on whether it is 6 or 10?
This comment relates to the responses 
options of the algorithm that is used in 
the risk assessment. It is not a website 
issue.
Reviewer 13 
(expert)
The line joining 3 boxes for do you smoke and exercise questions suggested a visual analogue scale. 
Why have it? The boxes alone would be clearer.
This has been amended.
Reviewer 14 
(expert)
Weight adjustable pointer is very sensitive and a bit fiddly. The sensitivity of the height ruler and 
weighing scales has been reduced.
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Reviewer Comment Action taken
Reviewer 15 Family history -  you have risk as being event below 50 -  most other assessment make it 60. These comments relate to the algorithm
(expert) that is used in the risk assessment. It is
1 was a bit surprised that although 1 ticked box for raised cholesterol there was no further details 
requested here - 1  came out as low risk but surely if my cholesterol was high this would not be accurate.
not a website issue.
Reviewer 18 The questions on exercise or play sport; Shouldn't you define what is exercise? Is regular walking or The definitions came from the Personal
(expert) cycling, e.g. to work, exercise? Heart Score paper by Mainous et al.
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Table 6.5 Comments regarding the risk output results pages.
Reviewer 6 (expert) 1 wonder whether there should be some comparators to the risk statistic- perhaps the 
difference from average, or the percentage of improvement if lifestyle is changed. Something 
to improve the understanding of the message.
This is beyond the scope of the study. No 
action was taken.
Reviewer 7 (expert) 1 don’t understand the purpose of the two buttons marked ‘moderate risk’ and ‘high risk’ This comment refers to the small thumbnails 
on the metonym format designed for users to 
see where their category fits in along the risk 
category scale of low, moderate and high. 
Displaying only the relevant risk category will 
not allow users to put the metonym 
representing their risk into context. No action 
was taken.
Reviewer 8 (expert) Blue link text on the basic calculated display disappears when highlighted. This has been amended.
Reviewer 10 (expert) Explanation of CHD event -  don’t think Ml or cardiac procedure were as helpful to a 
layperson as it could be.
This has been amended.
Reviewer 14 (expert) Would be nice to be able to print off your risk profile at the end, not just request it by email -  it 
would also preserve your anonymity.
Although, this is preferable, it was beyond the 
scope of the web-developers to achieve this. 
No action was taken.
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Table 6.6 Comments regarding the post-intervention questionnaires.
Reviewers 1 & 
2 (non-experts)
The only bit 1 wasn’t sure of was the section at the end about exercise and weight. 1 wondered if this 
had been calculated from the information that I ’d given and it was recommended that 1 exercise more 
and lose weight.
This has been addressed by adding wording 
at the start of the post-intervention 
questionnaire that address why the study 
asks about intentions to stop smoking, losing 
weight and exercising more.
Reviewers 3 & 
4 (non-experts)
Questionnaire was a bit repetitive. This is a personal opinion. No action was 
taken.
Reviewer 6 
(expert)
1 don’t think 1 understood some of the option about fear and exercise fully, so may have flipped 
through without giving them enough attention, so perhaps reducing their value.
This is personal opinion, no a website issue. 
No action was taken.
Reviewer 7 
(expert)
In Qs 51-54 the numbers attributed to each level of difficulty. Etc. seem intuitively to be the wrong 
way around. 1 would expect to select -3 for difficult for example rather than +3. Ditto for 66-69.
The questionnaire format has different 
response endpoints to reduce the possibility 
of response bias. No action was taken.
Q60 asks if 1 am prepared to lose weight. Is it asking me if 1 am ready to try losing weight or if 1 am 
willing to try losing weight, which are not the same thing.
More than one item measuring each 
component of the TPB was used to assess 
the internal reliability/ consistency of user’s 
responses. No action was taken.
Reviewer 8 
(expert)
If question 56 is missed it is highlighted. If it is subsequently filled in but something else is missed, it 
is still highlighted.
This has been amended.
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Reviewer Comment Action taken
Reviewer 10 
(expert)
Wasn’t clear why we had to go through the first set of questions again, about being angry, anxious 
etc. -  some explanation might help. It was tempting to just give the same answers as before without 
thought.
Wording has been added to this page to 
address this point.
Q 69 was hard to answer -  forgot to write it down.
This is personal opinion. Not a website issue.
Reviewer 11 
(expert)
Q 48-51 -  isn’t entirely clear what you are supposed to read here -  it may be that patients might be 
confused and think the question has been missed off.
This has been amended.
Also, the scale on Qs 51-54 is confusing given what has gone before, why not just use 1-7 as 
above?? Same with other questions using this scale.
The questionnaire format is recommended by 
published guidelines on constructing TPB 
questionnaires. No action was taken.
Page with Q60-65 -  programme got stuck after complete all qs and 1 couldn’t move on. It is not possible to determine the cause of 
this, as only one reviewer has mentioned it, to 
action has been taken and the cause 
attributed to a computer glitch.
Reviewer 13 
(expert)
1 don’t consider 1 need to lose weight and so all the losing weight section seemed irrelevant and a bit 
irritating. Is it not better to exclude this if BMI below 24?
The appropriateness of responses regarding 
intention to lose weight and actual BMI will be 
assessed.
Reviewer 14 
(expert)
Weight reduction -  q69. ‘difficult’ is mis-spelt. This has been amended.
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Reviewer Comment Action taken
Reviewer 15 
(expert)
Reviewer 16 
(expert)
Reviewer 17 
(expert)
Reviewer 18 
(expert)
The questions at the end here have no real introduction -  so their purpose is not clear -  I think a few 
introductory words ‘Now we’d like to check out your views on taking more exercise and losing 
weight...’ or similar.
Click to continue after questions 31-33 didn't work, first, but then it jumped to questions 47-54. Maybe 
I clicked twice, thinking the first click didn't register. Though one isn't allowed to move forward from 
other pages that require responses -???
Questions 51-54 are appropriately scored as -3 to +3 for analysis - but this might be off-putting to 
numerically challenged respondents - why switch from using 1 to 7? Ditto 66-69.
Are questions 60-65 appropriate to ask of someone for whom there would be no great advantage to 
losing weight? I don't like my trousers being tight around my waist, but I don't feel inclined to actively 
lose weight for health reasons - 1 don't think you do either.
Q33 -  didn’t know what to answer here, my indicated risk was very low but of course ‘do as much as 
you can’ is the only answer possible even when you’re at low risk.
Similar for Q60: of course I am prepared to lose weight but how does this fit in with weight not being 
an issue in some cases? Guess the problem is that I don’t quite see what these answers would tell 
you.
Q51: hesitated a long time here as to how to interpret the sudden switch to the -3,-2,-1,0.1,2,3 
answer format..numbers are not my strong point and even now I ’m not quite sure if I gave the 
answers I intended to give.
I was confused by the difference in answering scales. It was all 7-point, which is fine. But sometimes 
the scale was -3, to +3 (e.g. in questions 51-54) instead of 1 to 7 .1 would opt for the latter format 
only.    ___________ .___________________________
Wording has been added to this page to 
address this point.
It is not possible to determine the cause of 
this, as only one reviewer has mentioned it, to 
action has been taken and the cause 
attributed to a computer glitch.
The questionnaire format is recommended by 
published guidelines on constructing TPB 
questionnaires. No action was taken.
The appropriateness of responses regarding 
intention to lose weight and actual BMI will be 
assessed.
The question is designed to measure 
instances like this.
The appropriateness of responses regarding 
intention to lose weight and actual BMI will be 
assessed.
The questionnaire format is recommended by 
published guidelines on constructing TPB 
questionnaires. No action was taken.
The questionnaire format is recommended by 
published guidelines on constructing TPB 
questionnaires. No action was taken._______
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Reviewer 19 
(expert)
Why don’t you change all questions to strongly agree- strongly disagree? 
Some of the questions do not make sense.
The questionnaire format has different 
response endpoints to reduce the possibility 
of response bias, where users do not read all 
of the questions properly. No action was 
taken.
This is personal opinion, the questions were 
piloted previously. As only one reviewer 
mentioned this, no action was taken.
Table 6.7 Comments regarding the end of study and contact details pages.
Reviewers 1 & 
2(non-experts)
We both wanted to check 2 boxes on education. The question asks for the highest level of 
education attained. No action is taken.
Reviewer 9 
(expert)
Progress bar still had a way to go once I ’d finished. This has been amended.
Reviewer 13 
(expert)
Last page told me 1 could close the browser, yet progress line was only 90% complete. This has been amended.
Reviewer 17 
(expert)
1 would have loved a ‘close’ button of some kind on the very last page instead of just the advice to 
close the browser. A psychological thing, 1 guess, 1 want to know I ’ve rounded off something, 
completed something. Closing the browser just means I ’m moving on to something else and leaving 
something ‘open’ behind me. It’s all in the mind, 1 know, but it does make a difference, 1 think.
A message informing users that they may 
close the web-browser has been added.
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General comments
Two reviewers commented on the lack of a functional back button and one reviewer 
reported that they had to zoom out (decrease the size of the webpage) to view all of 
the webpage. However, due to the Adobe Acrobat Flash software it was not possible 
to address these comments. It was suggested that an indication should be given at 
the beginning of the website about how long it is likely to take to complete the study. 
This was added to the participant information page. One reviewer commented on the 
fact that the wording throughout the website appeared in different sized fonts which 
could be distracting to users. Therefore, this was amended so that the important 
information of the page appeared in the biggest font with information of less 
importance in a smaller font.
Functionality of data storage
The data storage of the server was also assessed. No problems were found with the 
database of respondent’s answers or the web-logs of the times each web page was 
visited.
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Table 6.8 General comments made about the website.
Reviewer 5 (non­
expert)
‘No back button, couldn’t see if I ’d filled in the last question on a page and there was no way to 
go back and see’.
This is a feature of the website being constructed 
in Adobe Flash, it cannot be changed.
Reviewer 8 
(expert)
‘At whom is this aimed? The language used appears to be above 9 -year-old/sun reader 
literacy level’.
This is a personal opinion, The author does not 
agree with this comment.
Reviewer 13 
(expert)
‘Font sizes differed and the information in largest font did not always seem most important. 
This seemed a bit of a distraction -  maybe better all the same size?’
The font for all web-pages was assessed to make 
sure important info appeared in bigger font.
Reviewer 16 
(expert)
‘The back button on the browser doesn't work with this site - is this deliberate? Desirable? 1 
would have liked to go back, if only to see the pages 1 missed. Obviously 
we don't want people to be able to alter what they responded before seeing their risk - but I'm 
not sure that, after this stage, it is appropriate to prevent them doing so. ’
This is a feature of the website being constructed 
in Adobe Flash, it cannot be changed.
Reviewer 18 
(expert)
‘Should give info about responding time (about 10 mins) at the beginning. ’
‘There was no escape during the process. Does this mean that you will only generate data on 
participants who have gone through all pages? Will you not file non- or incomplete 
responders?’
This has been added.
Every visit to the website will be logged.
7 had to zoom out to view the complete home page’. This is due to the size of the website pages and 
cannot be changed.
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Internal reliability of the Theory of Planned Behaviour questionnaire
It is best practice to assess the internal reliability of a newly developed questionnaire 
at the piloting stage (Oppenheim 2001), so that inconsistent items can be identified 
and addressed, e.g. items not meeting the reliability requirements can be eliminated 
from the final questionnaire. However, due to the small sample size of the second 
phase of the pilot testing, it was not possible to assess the internal reliability of the 
Theory of Planned Behaviour questionnaire at this stage. An assessment of 
Cronbach’s Alpha Coefficient was made in the analysis of the main trial data. 
Appendix 39 shows screenshots of the final versions of the web pages to be used in 
the main trial.
6.3 Summary
To summarise, this chapter has described the development of the website to be 
used in the web-based RCT; and the results of the two phase pragmatic pilot study 
that assessed the layout, usability and functionality of the website.
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Chapter 7. Primary results of a web-based randomised controlled 
trial of cardiovascular risk representation formats.
7.1 Introduction
This chapter describes the primary results of the web-based randomised controlled 
trial of cardiovascular risk representation formats. The chapter is divided into 
sections according to the research objectives and/or hypotheses. This chapter also 
presents the data screening procedures, assumption testing, sample characteristics 
and summary statistics of the outcome measures.
The main statistical analyses are presented in the appendices. The syntax and full 
SPSS outputs are presented in an on-line Google document, accessible by using the 
following link:
https://docs.google.com/viewer?a=v&pid=explorer&chrome=true&srcid=OBOZzQPPd
5mfKZTQ0MjliMDgtMjE3MS00MGVILWIyMmltMTQzZjMwZGIyMzlk&hl=en_GB.
The primary objectives described in this chapter are outlined below:
• Assessment of the effects of the cardiovascular risk representation formats to 
assess which format leads to the greatest intention to change behaviour, best
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facilitates understanding of risk information and alters positive and negative 
affect and worry about future heart disease.
• Multiple regression analysis to determine which variables predict intention to 
change behaviour.
• Assessment of within group changes in positive and negative affect and worry 
about future risk of heart disease after viewing cardiovascular risk.
• Analysing the correlational validity between intention to change behaviour, 
and understanding of risk information, to find out if understanding results in 
more appropriate intentions to change behaviour to reduce cardiovascular 
risk.
• Examination of the level of worry about future risk of heart disease that 
increases intention to change behaviour.
• Determining whether responses are mediated by a respondent’s risk 
category, by conducting sub-group analyses on responses.
7.2. Data screening
This section explains the initial data screening preceding the main analyses, 
including how a violation in the condition allocation randomisation was rectified. The 
trial commenced on 11th February 2010 and ended on 7th June 2010. The flow of 
participants through each stage of the recruitment process is also described.
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7.2.1 Randomisation violation
The distribution of respondents allocated to each condition made by the website’s 
randomiser was examined when just over 100 respondents had been recruited to the 
study. It was evident that the original algorithm was biased towards two of the four 
conditions (Conditions 2 and 3). The reason behind this is demonstrated in Appendix 
40. Unfortunately, due to the small sample this issue was not identified in the pilot 
study. An alternative algorithm was suggested (Appendix 41). Before incorporating 
the alternative algorithm into the site a demonstration file (demo.swf) created a 
dummy run to look at the distribution of random numbers generated over time. 
Screenshots of the dummy runs using both algorithms are presented in Appendix 42.
Two goodness of fit Chi-square tests were conducted to ensure that the alternative 
algorithm was working correctly, and producing an equal chance of the four 
conditions being selected (Appendix 43). With 90 randomisations, the expected chi- 
square would be 10, corresponding to a power of just under 90% (i.e. a 10% risk that 
there would be a failure in detecting that the new algorithm was still wrong). The first 
goodness of fit Chi-square test looked at whether there were any consistent 
differences between the numbers allocated to the four conditions, which were all 
treated on an equal footing. Therefore, the resulting Chi-square statistic was 
interpreted as having 3 degrees of freedom. There was a significant difference 
between the total number of times each condition was selected in the randomisation 
using the original algorithm (Chi square = 94.83, df=3, p=.000). Conversely, when 
the alternative algorithm was assessed, there were no significant differences
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between the conditions in terms of the number of times they were selected for 
randomisation (Chi square = 4.21, df=3, p=.240).
The second goodness of fit Chi-square test compared the total number in conditions 
1 and 4 with the total number in conditions 2 and 3. Again, a significant difference 
between conditions was found for the original algorithm (Chi square = 94.39, df=1, 
p=.000) and no significant differences were found for the alternative algorithm (Chi 
square = 2.20, df=1, p=.138). Therefore, as both types of analyses agreed, it was 
concluded that the original algorithm produced a clear discrepancy well beyond the 
limits of chance variation, whereas, the differences between the group frequencies 
with the alternative algorithm were within chance variation.
The alternative algorithm was installed into the site and a clear distinction between 
the respondents randomised using the original algorithm and those randomised 
using the alternative algorithm was made.
A number of options could have been employed to rectify the randomisation 
violation. Firstly, all the responses that were randomised according to the original 
algorithm could have been discarded. This option was not optimal, as a large sample 
size was needed for the trial. Second, it could have been ensured that the next 120 
respondents got allocated to the four conditions in the ratio of 40: 20: 20: 40, and 
equally thereafter as this does not ‘waste’ any respondents’ data. However, this 
option was rejected due to the confounding between group allocation and position in 
the recruitment sequence. Lastly, a random half of the data from conditions 2 and 3
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could be discarded, which had the risk of decreasing the sample size and hence 
reducing the power. This was thought to be more favourable compared to group 
allocation confounding. Therefore, the latter option was chosen and a random half of 
the responses from conditions 2 and 3 in the first phase were discarded from the first 
100 recruits. A simple coin toss determined whether responses 1, 3, 5 etc. were 
excluded over 2, 4, 6 etc. In accordance with the Consolidated Standards of 
Reporting Trials (CONSORT) guidelines (Schulz et al. 2010), the trial flowchart 
(Figure 7.1) demonstrates this protocol violation. 53 cases were excluded in total.
7.2.2 Cleaning of database
An SQL database stored the responses of visitors to the website. This database was 
queried and exported via comma separated variables (CSV), into an Excel 
spreadsheet. Partially completed responses were excluded, as were entries made by 
spy bots and crawlers (i.e. non-human activity). Non-human activity was identified by 
analysing the database for instances where a webpage had been completed, but no 
randomisation had occurred, meaning that the homepage had not been visited and 
no consent given.
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Flow of participants through the trial
The CONSORT diagram (Figure 7.1) demonstrates the flow of participants through 
each stage of the trial. There were 2463 visits to the homepage in total; 342 
respondents did not meet the inclusion criteria of being between 45 to 64 years of 
age and not having existing heart disease. 31 did not consent, so did not proceed 
with the study. However, this figure is only an approximation as it cannot be 
determined how many respondents were not eligible or did not consent, and exited 
the website by closing the web browser instead of checking the appropriate boxes on 
the eligibility assessment and consent pages.
There were 144 incomplete responses and 18 cases that contained some missing 
data. As the website required all responses to be completed before proceeding to 
the next page, it is likely that this was due to a technical glitch involving the storing of 
data by the host Server. Cases that were not fully completed were excluded.
Because there were only a small number of affected cases and the missing values 
were randomly distributed through the data, a listwise deletion (where an entire 
record is excluded from the analysis if any single value is missing) was chosen, as 
opposed to a pairwise deletion (which excludes missing data cases only from the 
calculations that involve variables with missing data) (Allison 2001; StatSoft 2010).
The fully completed responses were imported into SPSS version 16. Cleaning the 
dataset revealed three duplicate responses, thought to be due to a database bug. 
The duplicates were excluded, leaving a total of 908 completed responses.
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JFigure 7.1 CONSORT diagram of flow of participants through each stage of the
Randomised Controlled Trial.
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Values were screened for plausibility. When the ‘Weight’ variable was analysed, 5 
cases were identified where respondents reported they weighed 25kg (3 stone 13 
lbs). As this is highly unlikely in an adult, it was assumed that these respondents did 
not move the arrow on the weighing scales. These cases were excluded by filtering 
out low instances of BMI less than 15, as it could not be ascertained that the rest of 
the questionnaire was answered correctly. After excluding respondents with very low 
BMI socres, the total number of respondents in the analyses was 903.
Distribution of responses across trial conditions
There appeared to be an even distribution of respondents allocated to the four 
conditions (arms of the trial) (See Figure 7.1 and Table 7.1). For example, 23.5% 
(n=212) were randomised to control group 1 (bar graph with pre intervention 
questionnaire), 26.7% (n=241) were randomised to the second control group (bar 
graph without pre-intervention questionnaire), 24.6% (n=222) to intervention group 1 
(pictogram format), and 25.2% (n=228) to the second intervention group (metonym 
format). A goodness of fit Chi-square test (Appendix 44) revealed an even 
distribution of respondents randomised across the conditions. There were no 
significant differences between the number of respondents allocated to the four 
conditions (Chi square = 1.965, df = 3, p=.580).
254
Table 7.1 Distribution of responses across trial conditions.
Frequency(n) 212 241 222 228
Percentage
(%)
23.5 26.7 24.6 25.5
7.2.3 Summary
This section has explained the process of the initial data screening and cleaning. 
This led to a total of 903 completed responses included for analysis. It also 
described a violation in the randomisation of respondents to the trial conditions and 
how this was rectified.
7.3 Characteristics of the sample
This section describes the characteristics of the sample who participated in the trial. 
Frequencies of the sex, age, level of education and risk factor information are 
reported.
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7.3.1 Sex and Age of respondents
Of the 903 fully completed responses included in the analysis, 61.7% (n=557) were 
female. Table 7.2 presents the frequencies of the characteristics of the sample. 
34.9% (n=315) were between 45 and 49 years and 19.8% (n=179) were between 60- 
64 years. The frequencies of individual ages were analysed (Figure 7.2), the mean 
age was 53 (SD 6.06) years (Appendix 45). An over representation of 45-year olds 
was found (n=119, 13.2%), the most plausible explanation is that respondents who 
were too young to participate wanted an assessment of future cardiovascular risk 
projected at age 45, and therefore indicated that they were within the eligible age 
range. However, this cannot be determined for certain. It was decided to include 
these respondents as this was unlikely to impact on the main aim of the study, which 
was to investigate the effects of cardiovascular risk representation formats.
Exclusion would have reduced the power of the sample to detect differences 
between the formats.
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Age
Figure 7.2 Age of respondents.
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Table 7.2 Characteristics of sample.
Sex
Male 82 (38.7) 101 (41.9) 79 (35.6) 84 (36.8) 346 (38.3)
Female 130 (61.3) 140 (58.1) 143 (64.4) 144 (63.2) 557 (61.7)
Age
45-49 76 (35.8) 92 (38.2) 86 (38.7) 61 (26.8) 315(34.9)
50-54 42(19.8) 64 (26.6) 55 (24.8) 66 (28.9) 227 (25.1)
55-60 48 (22.6) 45(18.7) 38(17.1) 51 (22.4) 182 (20.2)
60-64 46 (21.7) 40(16 .6) 43(19.4) 50 (21.9) 179(19.8)
Highest level of Education
Left school before age 16 (no 
formal qualifications)
10(4.7) 8 (3.3) 6 (2 .7 ) 16(7) 40 (4.4)
Left school at 16 (GCSE, CSE, 
O level or equivalent)
19(9) 22 (9.1) 32(14.4) 32(14) 105(11.6)
Left school at 18 (A levels or 
equivalent)
14(6.6) 13(5.4) 12(5.4) 3 (1 .3) 42 (4.7)
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Risk factors
Family history of heart disease 37(17.5) 38(15.8) 47 (21.2) 39(17.1) 161 (17.8)
Hypertension 31 (14.6) 45(18.7) 45 (20.3) 35(15.4) 156(17.3)
Hypercholesterolemia 41 (19.3) 58 (24.1) 39(17.6) 48 (21.1) 186 (20.6)
Diabetes 8 (3.8) 9 (3.7) 8 (3.6) 9 (3.9) 34 (3.8)
BMI <30 159 (75) 184 (76.3) 177 (79.7) 175 (76.8) 695 (77)
BMI >30 53 (25) 57 (23.7) 45 (20.3) 53 (23.2) 208 (23)
Smoking status
Current 19(9) 20 (8.3) 26(11.7) 16(7) 81 (9)
Former 66 (31.1) 90 (37.3) 71 (32.0) 82 (36) 309 (34.2)
Never 127 (59.9) 131 (54.4) 125 (56.3) 130 (57) 513(56.8)
Level of physical activity
Seldom/ never 60 (28.3) 72 (29.9) 58 (26.1) 54 (23.7) 244 (27)
Sometimes 80 (37.7) 82 (34) 80 (36) 94 (41.2) 336 (37.2)
Often/ very often 72 (34) 87 (36.1) 84 (37.8) 80 (35.1) 323 (35.8)
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7.3.2 Level of education
Respondents were asked to indicate their highest level of education attained. 40 
(4.4%) left school before the age of 16; 105 (11.6%) were educated to GCSE level, 
and 42 (4.7%) were educated to A level. Over half the sample (53%, n=479) were 
educated to university degree level or higher (Table 7.2). This is higher than the 
estimated 20 per cent of the adult population who are educated to university degree 
level or higher in the UK, according to Census data (Office for National Statistics 
2001). 13% (n=117) of respondents in the sample did not wish to disclose 
information on their level of education, perhaps this was due to privacy fears. A Chi- 
square test (Appendix 46) revealed no significant differences in the level of 
education of respondents across conditions (Chi square = 24.544, df = 18, p=.138).
7.3.3 Risk factor information
To predict the risk of a future coronary heart disease event, respondents were asked 
questions about their risk factors. This information comprised age, sex, family history 
of heart disease, diagnosis of hypertension, hypercholesterolemia or diabetes, 
smoking status, level of physical activity and BMI (Mainous et al. 2007).
Family history of heart disease was reported by 17.8% (n=161) of respondents. This
was defined as a parent who was under the age of 50 when told by a clinician that
they had heart disease. 17.3% (n=156) stated that a clinician had diagnosed them
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with high blood pressure, and 20.6% (n=186) stated they had been diagnosed with 
high cholesterol. 34 respondents (3.8%) reported they had diabetes. Of these, 3.1% 
of the sample were female and 4.9% were male. This is similar to the estimated 
overall prevalence rate of diabetes in England in 2006 in people aged 45 to 54 years 
of age, which was 3.6% for women, but lower than the 6% prevalence rate in men 
(Diabetes UK 2010).
Respondents were asked to input their height and weight to calculate their BMI 
score. The mean BMI score was 27 (SD 5.76). 23% of respondents (n=208) reported 
a BMI of 30 and over which is considered as being obese/ morbidly obese (Appendix 
45). This is the same as the estimated percentage of adults in the UK classed as 
overweight/obese in 2009 (The NHS Information Centre for Health and Social Care 
2009).
When asking about smoking status, there were three response categories for 
respondents to chose from: current smoker, former smoker (i.e. smoked in the past 
but no longer) and never smoked. 81 respondents (9%) reported that they were 
current smokers and 309 (34.2%) were former smokers. This is lower than the 
national average of current smokers reported to be 21% in 2008 (Robinson and 
Bugler 2010). Additionally, respondents were asked to report their level of physical 
activity. Response options were: seldom or never, occasionally and often or very 
often. 35.8% (n= 323) exercised or played sport often or very often, 27% (n=244) 
reported that they seldom or never exercised or played sport (Table 7.2).
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7.3.4 Risk category
Once the risk factor information had been obtained, the cardiovascular risk calculator 
provided respondents with their risk category. The calculator provides a 
predetermined classification of the risk of having a coronary heart disease event in 
the next 10 years (i.e. low, moderate and high). It uses conventions of under 10% to 
define low risk, 10-20% to define moderate risk and over 20% to define high risk.
This trial adopts these conventions as used in the Personal Heart Score (Mainous et 
al. 2007). However, it is acknowledged that there is discussion in the literature 
regarding risk category thresholds (Graham 2007; Joint British Societies 2005). The 
majority of respondents fell into the low risk category (82.8%, n=748). 127 (14.1%) 
were at moderate risk and 28 (3.1%) were categorised as high risk. The number of 
respondents at moderate and high risk was lower than expected, when considering 
that CVD is the main cause of death in the UK (Scarborough et al. 2010).
7.3.5 Requesting copy of risk assessment results
At the end of the study, respondents indicated whether or not they wanted a copy of 
their risk output. Respondents wanting a copy of their output left their contact details, 
for their results were emailed to them. 143 respondents (15.8%) in total requested a 
copy of their risk output.
2 6 2
The Bar graph condition had the highest proportion of respondents requesting a 
copy of their risk output (n=40) and the Metonym condition had the lowest proportion 
of respondents requesting a copy of their risk output (n=31). A Chi-square (Appendix 
47) revealed no significant differences across conditions between those who 
requested a copy of their risk output and those that did not (Chi square = 2.163, df = 
3, p=.539).
Table 7.3 Frequencies of respondents who request a copy of their risk output 
results for each of the trial conditions.
Frequency (n) 39 40 33 31 143
Percentage (%) 18.4 16.6 14.9 13.6 15.8
7.3.6 Summary
This section has reported the characteristics of the sample who participated in the 
trial. To summarise, the sample recruited was different to the expected cohort of 
respondents participating in this trial in this age group. Over half of the sample were 
female, there was an over representation of 45 year olds (the lower end of the age
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range for study inclusion), and the sample was highly educated. They smoked less, 
but reported similar BMI scores those of the general population. However, there was 
an even spread of respondents across physical activity levels. The majority of 
respondents were categorised as low risk, and there were fewer moderate and high 
risk respondents than expected.
7.4 Variables measured
This section describes the primary and secondary outcome measures that were 
used in this trial. It also provides summary statistics of each outcome measure.
7.4.1 Primary and Secondary Outcome Measures
The primary and secondary outcome measures are described in Table 7.4. The 
primary outcome measure comprised intention to change behaviour (e.g. exercising 
more, losing weight and stopping smoking). The secondary outcome measures 
comprised understanding of risk information (comprising level of understanding and 
confidence in understanding), affect (positive and negative) and worry about future 
risk of heart disease.
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Table 7.4 Description o f p rim ary and secondary outcome measures.
O u t c o m e  M e a s u r e
Intention to change 
behaviour
Understanding of 
risk information
Affect
Positive and 
Negative Affect 
Schedule- Short 
Form (PANAS-SF) 
(Thompson 2007)
Worry about future 
heart disease
Components E x a m p l e  o f  i t e m S c o r i n g
Intention to 
exercise more
Intention to lose 
weight
Intention to stop 
smoking
Absolute
probability
perception
Subjective 
understanding of 
the risk 
information
I intend to exercise more.
How likely are you to lose 
weight?
To what extent are you 
prepared to stop 
smoking?
7-point Likert scales 
indicating higher scores 
indicate greater 
intentions
What are your chances of 3 pre-defined response
having heart disease in 
the next 10 years?
options:
Low
moderate
high
What should someone in 3 pre-defined response
your risk category do to 
reduce their risk of heart 
disease?
options:
Do nothing to 
reduce risk 
Try and do a little bit 
to reduce risk 
Do as much as you 
can to reduce risk
Confidence in 
understanding
Positive affect
Negative affect
How confident are you 
that you have understood 
the risk information given 
to you?
Thinking about yourself 
right now at this present 
to what extent do you feel 
inspired?
At this present moment to 
what extent do you feel 
upset?
After viewing your results, 
how worried do you feel 
about developing heart 
disease in the future?
7-point Likert Scale 
indicating degree of 
confidence in 
understanding
5-point Likert response 
scale anchored ‘not at 
all’ to ‘extremely’
5-point Likert response 
scale anchored ‘not at 
all’ to ‘extremely’
7-point Likert response 
scale from very worried’ 
to ‘not at all worried’
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Intention to change behaviour
Items measuring intention to change behaviour (e.g. exercising more, losing weight 
and stopping smoking) were summed and a mean intention to change behaviour 
score was calculated. Higher scores represented greater intentions to change 
behaviour.
Understanding of risk information
Understanding of risk information was measured using level of understanding and 
confidence in understanding components. Level of understanding assessed the 
appropriateness of absolute probability perception (i.e. recalling the risk category) 
and subjective understanding (i.e. what a person with the same risk category should 
do about their cardiovascular risk) responses. Absolute probability perception and 
subjective understanding responses were assessed for accuracy. Respondents who 
correctly answered both of these items scored two and were said to have complete 
understanding. Those answering one item correctly scored one and were said to 
have partial understanding. Those with no correct items scored zero and were 
deemed to have no understanding. These aggregate scores represented the variable 
level of understanding. Confidence in understanding was measured by asking 
respondents how confident they were that they had understood the risk information.
A 7-point Likert Scale indicated the degree of confidence in understanding.
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Affect
Affect was measured at baseline as well as post-intervention, in order to assess 
changes after viewing the different representations of cardiovascular risk. Scores 
from the positive and negative affect items were summed separately, giving total 
scores out of 25. Higher scores indicated a greater degree of positive or negative 
affect.
Worry about future risk of heart disease
Worry about future risk of heart disease was measured at baseline and post­
intervention to assess within-group changes after viewing the different 
representations of cardiovascular risk. Higher scores indicated a greater level of 
worry about the future risk of heart disease.
Summary statistics
Table 7.5 provides baseline and post-intervention summary statistics for the primary 
and secondary outcome measures. Mean intention to change behaviour scores were 
above the mid-point of the scales, indicating high intentions to exercise more (M=5 
SD=1.22), lose weight (M=4.65, SD=1.6) and stop smoking (M=4.06, SD=1.61).
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Mean level of understanding was 1.09 (SD=.41) which represents partial 
understanding of the risk information presented. This means they either answered 
the absolute probability item correctly (suggesting they accurately recalled their risk 
category) or the subjective probability item correctly (suggesting they understood the 
appropriate degree of action that needed to be taken by someone of the same risk 
category). A high degree of confidence in understanding (M= 6.07, SD=1.24) was 
demonstrated by the respondents.
At baseline, respondents had greater positive affect (M=18.11, SD=2.99) than 
negative affect (10.68, SD=2.78). These both decreased post-intervention (i.e. after 
viewing cardiovascular risk), positive affect decreased to 17.64 (SD=3.86) and 
negative affect decreased to 7.59 (SD=3.35). Worry about future risk of heart 
disease had a mean of 2.8 (SD=1.04) at baseline and 2.15 (SD=0.98) post­
intervention, indicating that respondents generally possessed low levels of worry 
about the future risk of heart disease, which further reduced after viewing 
cardiovascular risk. Statistical analysis on within-group changes are described in 
section 7.8 of this chapter.
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Table 7.5 Baseline and post-intervention summary statistics fo r the prim ary and secondary outcome measures.
Intention
to
Exercise
More
Intention 
to Lose 
Weight
Intention 
to Stop 
Smoking
Baseline
Positive
affect
Post­
intervention
Positive
affect
Baseline
Negative
affect
Post­
intervention
Negative
affect
Baseline
Worry
Post­
intervention
Worry
Level of 
understanding
Confidence in 
understanding
n 903 903 81 903 903 903 903 903 903 903 903
Mean 5 4.65 4.06 18.11 17.64 10.68 7.59 2.8 2.15 1.09 6.07
SD 1.22 1.6 1.61 2.99 3.86 2.78 3.35 1.04 0.98 0.41 1.24
Median 5 5 4 18 18 10 6 3 2 1 6
Mode 5 5 4 19 20 10 5 3 2 1 7
Min 1 1 1 5 5 5 5 1 1 0 1
Max 7 7 7 25 25 23 25 5 5 2 7
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7.4.2 Tertiary Outcome Measures
The tertiary outcome measures (Table 7.6) included the sub-components of the 
Theory of Planned Behaviour (Ajzen 1991), measuring the three risk reducing 
options (exercise more, lose weight and stop smoking). The mean scores were 
determined by summing the items and dividing by the number of items measuring 
each sub-component.
Attitudes
Attitudes comprise evaluative (e.g. evaluation using bipolar opposites), instrumental 
(e.g. whether the behaviour achieves something) and experiential (e.g. how it feels 
to perform the behaviour) items. A higher attitude score indicated a more positive 
attitude to perform the behaviour.
Perceived behavioural control
Perceived behavioural control represents self-efficacy about performing the 
behaviour and the degree that the respondents feel control over performing the 
behaviour. Higher scores indicate greater self-efficacy and controllability over the 
behaviour.
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Table 7.6 Description o f te rtia ry  outcome measures.
Attitudes Evaluative For me stopping 7-point Likert scale 
smoking would be...
Bad/ Good.
Instrumental -  For me losing weight 
would be...
the wrong thing to do / 
the right thing to do.
Experiential For me exercising 
more would be... 
Unenjoyable / 
Enjoyable.
Perceived behavioural Self-efficacy 1 am confident that 1 7-point Likert scale
control can exercise more.
Controllability of Whether 1 lose weight
the behaviour or not is entirely up to 
me.
Subjective norms 1 feel under social 7-point Likert scale
pressure to lose
weight.
Indirect measure of - Measured by examining whether respondents
intention to change 
behaviour
requested a copy of their risk output results.
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Subjective norms
Subjective norms relate to the perceptions of significant others’ preferences about 
whether one should or should not engage in a specific behaviour. A higher score 
indicates a greater influence of subjective norms.
Indirect measure of intention to change behaviour
Lastly, an indirect measure of intention to change behaviour to reduce 
cardiovascular risk was measured by whether respondents requested a copy of their 
risk output results, which it was suggested that they could take it to their GP.
Summary statistics
Table 7.7 shows the baseline and post-intervention summary statistics for the tertiary 
outcome measures. Mean attitude scores ranged from 1.45 (SD= 1.21) to 1.79 
(SD=1.14) indicating a low positive attitude towards exercising more, losing weight 
and stopping smoking. The influence of subjective norms was less for losing weight 
(M=3.38, SD=1.62) than it was for exercising more (M=5.63, SD=1.06) and stopping 
smoking (M=5.19, SD=1.33). Lastly, mean perceived behavioural control for all 
behaviours ranged from 4.62 (SD=1.08) to 5.22 (SD=1.09), indicating respondents
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felt a high degree of self-efficacy and control over exercising more, losing weight and 
stopping smoking.
7.4.3 Summary
This section has summarised the primary, secondary and tertiary outcomes of this 
trial. The summary statistics across all trial conditions for each outcome measure 
have been reported. Intentions to exercise more, lose weight and stop smoking, 
positive affect and confidence in understanding after viewing cardiovascular risk 
were all reasonably high. This was despite the majority of respondents 
demonstrating only a partial level of understanding of their risk information. 
Conversely, worry about future risk of heart disease was low at baseline, and further 
decreased after viewing cardiovascular risk. Positive affect was higher than negative 
affect at baseline, both decreased post-intervention.
The tertiary outcome measures (sub-components of the TPB), attitudes, subjective 
norms and perceived behavioural control were similar across the three behaviours 
(exercising more, losing weight and stopping smoking).
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Table 7.7 Summary statistics for the post-intervention tertiary outcome measures and pre-intervention questionnaire given to
control group 1.
Pre-intervention Questionnaire Attitudes Subjective norms Perceived behavioural
items given to Control group 1. control
Intention to 
reduce risk 
of heart 
disease
Attitudes 
towards 
reducing 
risk of 
HD
Subjective 
norms to 
reducing 
risk of HD
PBC over 
reducing 
risk of 
heart 
disease
Exercise
more
Lose
weight
Stop
smoking
Exercise
more
Lose
weight
Stop
smoking
Exercise
more
Lose
weight
Stop
smoking
n 211 211 211 211 903 903 81 903 903 81 903 903 81
Mean 6.25 2.21 5.15 5.14 1.78 1.52 1.41 5.63 3.37 5.16 5.22 5.06 4.59
SD 1.26 0.92 1.89 1.17 1.14 1.71 1.21 1.06 1.62 1.33 1.092 1.041 1.067
Median 7 2.33 6 5.50 2 2 1.33 5.67 3.33 5.34 5.25 5.25 4.50
Mode 7 3 7 5.50 3 3 3 6 2 6.33 6 6 4.25
Min 1 -1 1 1 -3 -3 -2 2 1 2 1 1 2
Max 7 3 7 7 3 3 3 7 7 7 7 7 7
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7.5 Assumption testing
This section reports the assumptions that needed to be tested before the data were 
analysed to examine the hypotheses proposed. This included the assessment of 
normal distributions suitable for parametric tests and identification of univariate 
outliers.
7.5.1 Normality testing
To assess normality of the variables, the distributions on histograms and normal 
probability plots were examined (Appendix 48). An alternative way of assessing 
normal distribution is to look at the Kolmogorov-Smirnov statistic, where normality is 
assumed if this statistic is significant. However, it is not suitable for use in this trial, 
as it is common for this statistic to be significant in large samples (Tabachnick and 
Fidell 2001).
There was deviation from the Gaussian distributional form for two variables (post­
intervention negative affect and confidence in Understanding). Post negative affect 
had extreme positive skewness. It was decided to apply a logarithmic transformation 
to alter the distribution and remove outliers, making it acceptable to apply parametric 
statistical tests (Tabachnick and Fidell 2001). It was also necessary to do the same 
transformation to the data from the variable Baseline negative affect, as these data 
were related to the post negative affect variable.
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Confidence in understanding was negatively skewed; therefore, scores needed to 
undergo a process known as ‘reflection’, to make them positively skewed before they 
could be transformed. Reflection is done by identifying the highest score in the 
distribution and adding 1, this creates the ‘constant’. Scores are then subtracted from 
this constant (Tabachnick and Fidell 2001). As the maximum score in the distribution 
was 7, the constant became 8. A log transformation was performed on the reflected 
scores. When interpreting a reflected variable, the direction of the interpretation 
needs to be reversed, or the log transformations can be reflected back keeping the 
interpretation of the results in the original direction (Tabachnick and Fidell 2001). In 
this instance, the scores were reflected back. The transformed variables were 
checked for normality (Appendix 49). The transformed distributions were considered 
to be normal, and therefore suitable for parametric analysis.
7.5.2 Identification of univariate outliers
The variables were assessed for the presence of univariate outliers. This was done 
by examining the box plots for each of these variables (Appendix 50). Seven of the 
variables had outliers (baseline positive affect, baseline negative affect, baseline 
worry about future risk of heart disease, post positive affect, confidence in 
understanding, level of understanding and intention to exercise). The values of these 
variables were checked for plausibility (assessing whether they were within the 
range of possible scores and not an error in the dataset). The means of these
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variables were compared to the 5% trimmed means (e.g. mean with the top and 
bottom 5% of cases omitted) before deciding whether to exclude the outliers from 
subsequent analyses. The 5% trimmed means were almost identical to the means 
(Table 7.8) and therefore, outlier scores did not need to be omitted from the analysis.
Table 7.8 Means and 5% trim m ed means of the variables with univariate outliers.
Mean 18.11 1.01 2.80 17.63 8.21 1.09 5.01
Trimmed
5%
mean
18.19 1.06 2.78 17.76 8.20 1.09 5.04
7.5.3 Ratio of cases to independent variables
There are statistical recommendations that relate to the ratio of cases to the number 
of independent variables measured. To examine this assumption, the number of 
cases and independent variables in this study was compared with the recommended 
minimum number of cases per variable needed to satisfy the assumption. This study 
had a sample of 903 with seven independent variables, giving a ratio of 129 cases
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per independent variable. This exceeded the minimum requirement of 111 for testing 
individual predictors (calculated by the formula =104 + # of independent variables), 
and 106 for testing multiple correlations (calculated by the formula = N> 50 + 8* # of 
independent variables) (Tabachnick and Fidell 2001). However, this assumption 
was violated for the intention to stop smoking variable, as only 81 respondents 
reported that they smoked and answered items relating to smoking cessation. It was 
decided to proceed with the analyses using this variable but to interpret the results 
with caution.
7.5.4 Internal reliability of the Theory of Planned Behaviour
questionnaire
The internal reliability of items measuring the components of the Theory of Planned 
Behaviour (TPB) was examined. It was not possible to assess this in the pilot study 
due to the small sample size. Firstly, the appropriate items were re-coded and/or 
reverse scored in the SPSS database (Appendix 25). Then, Cronbach’s Alpha 
coefficient was calculated to assess the internal reliability of the TPB components: 
attitudes, perceived behavioural control and subjective norms (Appendix 51). For 
items to possess satisfactory internal reliability, the alpha level should exceed 0.7 
(Tabachnick and Fidell 2001). The Cronbach’s alpha for the components for each of 
the three behaviours (exercising more, losing weight and stopping smoking) were 
assessed separately (see Table 7.9).
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Table 7.9 Cronbach's alpha for the components of Theory of Planned Behaviour.
I n t e n t i o n n / a 0 . 5 4 0 . 9 0 0.88
Improved to: " 0 . 9 0
if item Q54 is 
removed
- -
A t t i t u d e s 0 . 5 6 0 . 7 4 0 . 9 6 0 . 5 8
Improved to: 0 . 7 6
if item Q17 is 
removed
- - 0 . 6 3
if item Q39 is 
removed
S u b j e c t i v e  n o r m s n / a 0 . 4 2 0 . 8 2 0 . 9 4
Improved to: - cannot be 
improved
- -
P e r c e i v e d
b e h a v i o u r a l  c o n t r o l
0 . 8 1 0 . 5 3 0 . 5 2 8 0 . 5 6
Improved to: 0 . 6 5
if item Q55 is 
removed
0 . 5 6
if item Q68 is 
removed
0 . 6 2
if item Q42 is 
removed
There were seven instances where the alpha level was less than 0.7, meaning the
items measuring the components of the TPB were not internally reliable. For two of
the components (pre-intervention attitudes and intention to exercise more) a
satisfactory alpha level could be achieved by the removal of an item. However,
multicollinearity would be caused if this was done for the intention to exercise more
component, where the other items correlate too highly with each other making one of
the items superfluous. Internal consistency is only one aspect of validity; therefore, it
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was decided to include all items, with acknowledgment of the lower than ideal alpha 
level when interpreting results.
It is thought that the poor internal reliability of the components of the TPB may be 
due to the direct measure of the TPB components (e.g. assessing intention by using 
three generalised intention items and three predictor variables) as recommended by 
a manual for constructing TPB questionnaires (Francis et al. 2004). A direct measure 
of the TPB was chosen as it keeps the number of items to a minimum, thus reducing 
the cognitive demand on respondents and avoiding attrition. The items appeared to 
have face validity, where it could clearly be seen which component they were 
supposed to be measuring. It was decided to proceed with the data analysis without 
removing any of the items, but to interpret the findings with caution.
7.5.5 Internal reliability of the PANAS questionnaire
Cronbach’s alpha coefficient was calculated to assess the internal reliability of the 
PANAS scale (Thompson 2007). Internal reliability checks were made to PANAS 
presented at baseline and after respondents had received their results (post­
intervention). Positive and negative items were assessed separately (Appendix 52). 
The alpha levels were satisfactory for the components measuring positive and 
negative affect at baseline (baseline positive affect a = 0.78, baseline negative affect 
a = 0.73), and post-intervention (post-intervention positive affect a = 0.85, post­
intervention negative affect a = 0.88). This means that the components measuring
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both baseline and post-intervention positive and negative affect were all internally 
reliable and all items could be included.
7.5.6 Summary
This section has described the assumptions that were tested to assess the suitability 
of the data for parametric analysis. Variables that were not normally distributed were 
log transformed and univariate outliers were identified. These did not have any 
significant impact on the overall means and were not omitted. There were fewer 
cases in the intention to stop smoking variable than the required ratio of cases per 
independent variable, due to having a small sample of current smokers. It was 
decided to proceed and interpret the results with caution. Internal reliability of the 
TPB was not reached in seven out of fourteen instances. However, this was not 
rectified due to the limited number of items in the questionnaire and to prevent 
multicollinearity. This will be acknowledged when interpreting results. Conversely, 
the internal reliability of the PANAS was measured, and acceptable Cronbach’s 
alpha levels were reached for the positive and negative items that were presented 
both at baseline and post-intervention.
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7.6 The effect of cardiovascular risk representation formats
This section reports the analysis conducted to assess the effects of cardiovascular 
risk representation formats on the primary and secondary outcome measures. This 
was to determine which format led to the greatest intention to change behaviour; 
best facilitated understanding of risk information and appropriately 
increased/decreased affect and worry about future heart disease. All cardiovascular 
risk representation formats were compared on an equal footing first for each of the 
primary and secondary outcome measures separately (i.e. intention to change 
behaviour, understanding of risk information, affect and worry about future risk of 
heart disease).
Planned comparisons were conducted using three pairwise contrasts (Bar graph with 
pre-intervention questionnaire versus Bar graph’, Bar graph versus Pictogram; Bar 
graph versus Metonym). The analyses were split by risk category, where risk was 
dichotomised into two categories: (a) low risk and (b) moderate or high risk. This was 
to determine whether a person’s calculated risk category had any influence on their 
responses.
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7.6.1 Comparing cardiovascular risk representation formats on an equal 
footing
Analyses of variance (ANOVA) were conducted to explore the impact of 
cardiovascular risk representation formats on intention to change behaviour, level of 
understanding, positive and negative affect and worry about future risk of heart 
disease. The four conditions were first compared on an equal footing using one-way 
ANOVAs (e.g. the four risk representation formats: bar graph with pre-intervention 
questionnaire, bar graph, pictogram and metonym). An advantage of the ANOVA is 
that it is robust when parametric test assumptions are not entirely met, providing that 
the cell sizes are equal (Brace et al. 2006). Table 7.10 summaries the ANOVA 
results for these variables.
The subsequent four tables (Tables 7.11 -  7.14) show the summary statistics for 
each of the primary outcomes (intention to change behaviour, understanding of risk 
information, affect and worry about future risk of heart disease) across the conditions 
respectively.
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Table 7.10 Results of ANOVAs examining the effects of risk representation 
formats on intention to change behaviour, understanding of risk information, 
affect and worry about future risk of heart disease.
mm
Intention to exercise more 3 0.655 0.580 0.002
Intention to lose weight 3 0.710 0.546 0.002
Intention to stop smoking 3 1.436 0.239 0.053
Level of understanding 3 0.944 0.419 0.003
Confidence in understanding 3 1.108 0.345 0.004
Positive affect 3 1.595 0.189 0.005
Negative affect 3 0.776 0.507 0.003
Worry about future risk of heart disease 3 0.021 0.996 0.000
Intention to change behaviour to reduce cardiovascular risk
Table 7.11 demonstrates the summary statistics for intention to exercise more, lose 
weight and stop smoking across the four conditions. The results were not displayed 
in bar graphs as these are not helpful when displaying small amounts of variation. 
Intentions to stop smoking were lower across all the conditions than intentions to 
exercise more and lose weight.
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Table 7.11 Summary statistics fo r intention to change behaviour by condition.
C o n d i t i o n
n
M e a n
SD
M e d i a n
M o d e
M i n
M a x
B a r  g r a p h  w i t h  p r e -  B a r  g r a p h  P i c t o g r a m  M e t o n y m
i n t e r v e n t i o n  
q u e s t i o n n a i r e
(C ontro l group 1) (C ontro l group 2) (Intervention group 1) (Intervention group 2)
Exercise
more
Intention to.. 
Lose 
weight
Stop
smoking
Exercise
more
Intention to... 
Lose 
weight
Stop
smoking
Exercise
more
Intention to... 
Lose 
weight
Stop
smoking
Exercise
more
Intention to.. 
Lose 
weight
Stop
smoking
212 212 19 241 241 20 222 222 26 228 228 16
5 . 0 6 4 . 7 5 4 . 2 8 5 . 0 2 4 . 6 5 4 . 5 6 5 . 0 3 4 . 6 8 3 . 6 4 4 . 9 1 4 . 5 3 3 . 8 5
1.20 1.56 1.64 1.21 1.61 1.45 1.18 1.62 1.83 1.27 1.61 1.27
5 5 4 5 5 4.50 5 5 3.50 5 4.67 3.83
5 5 4 5.33 5 4 5 5 2.33 4.33 4 3.67
1 1 1.33 1 1 1.67 1 1 1 1 1 1
7 7 7 7 7 7 7 7 7 7 7 6.33
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One-way ANOVAs were performed on the difference between the conditions in the 
means of the post-intervention intention to exercise more, intention to lose weight 
and intention to stop smoking scores(see Table 7.10). The variances were equal 
across groups as the Levene’s test of homogeneity of variance was not significant 
(Appendix 53).
Scores did not significantly differ across the conditions for intention to exercise more 
(F(3,899) =.655, p=.580, partial q2= 002). The estimated effect size indicates that 
.02% of the overall variance in intention to exercise more was accounted for by 
cardiovascular risk representation. Furthermore, scores did not significantly differ for 
intention to lose weight (F(3,899) =.710, p= .546, partial r|2=.002) and intention to 
stop smoking (F(3,77) = 1.436, p=.239, partial r|2=.053). This means that there was 
no statistically significant main effect of risk representation format on intention to 
change behaviour.
Understanding of risk information
As described previously, level of understanding was determined by the correctness 
of the absolute probability perception and subjective understanding items. 
Respondents who answered both items correctly were said to have complete 
understanding. One correct answer was determined to be partial understanding. If 
both items were answered incorrectly, this was taken as having no understanding of 
the risk information. Confidence in understanding was also measured.
286
Table 7.12 shows the mean level of understanding scores and confidence in 
understanding for each of the four groups representing the different cardiovascular 
risk representation formats. There was little difference in level of understanding 
across all conditions. The mean scores indicated a partial level of understanding. 
Confidence in understanding was reasonably high regardless of which cardiovascular 
risk representation formats was presented, however it was lower in the metonym 
condition (M=5.98, SD=1.27).
One-way between-groups ANOVA (Table 7.10) found no statistically significant effect 
of cardiovascular risk representation format on level of understanding (F(3,899)
=.944, p=.419, partial r|2=.003). Nor was there a statistically significant effect of 
representation format on how confident respondents felt that they understood their 
risk information (F(3,899) =1.108, p=.345, partial r|2=.004) (Appendix 54).
Affect
The mean post-intervention positive and negative affect scores are shown in Table 
7.12. Positive affect scores were consistently higher than the negative affect scores 
across the conditions. General linear models were used with baseline positive and 
negative affect set as covariates (Table 7.10). There was no significant main effect of 
cardiovascular risk representation format on positive affect (F(3,898) =1.595, p=.189, 
partial q2=.005) or negative affect (F(3,898) =.776, p=.507, partial r|2=.003) (Appendix 
55).
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Worry about future risk of heart disease
There was little variation in worry about future risk of heart disease across the four 
conditions demonstrated in Table 7.14. A general linear model, with baseline worry 
about future risk of heart disease scores set as a covariate (Table 7.10), revealed no 
significant main effect of cardiovascular risk representation format on respondents’ 
worry about future risk of heart disease (F(3,898)=.021, p=.996, partial r|2=.000) 
(Appendix 56).
Sub group analysis split by risk category
Responses were split and analysed separately according to risk category 
(Appendices 57-60). This was to determine whether responses differed according to 
the cardiovascular risk level of respondents. Due to an uneven distribution of 
respondents in each of the low, moderate and high categories, the moderate and 
high risk categories were combined and compared against the low risk category.
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Table 7.12 Summary statistics fo r understanding by condition.
Condition Bar graph with pre- Bar graph Pictogram Metonym
intervention
questionnaire
(Control group 1) (Control group 2) (Intervention group 1) (Intervention group 2)
Understanding... Understanding... Understanding... Understanding...
Level Confidence ‘Confidence Level Confidence ‘ Confidence Level Confidence ‘ Confidence Level Confidence ‘Confidence
n 212 212 212 241 241 241 222 222 222 228 228 228
Mean 1.06 6.13 8.20 1.09 6.10 8.20 1.09 6.08 8.22 1.12 5.98 8.24
SD .39 1.26 .24 .42 1.28 .24 .42 1.16 0.23 .42 1.27 0.24
Median 1 7 8 1 7 8 1 6 8.30 1 6 8.30
Mode 1 7 8 1 7 8 1 7 8 1 7 8
Min 0 1 8 0 1 8 0 2 8 0 1 8
Max 2 7 8.85 2 7 8.85 2 7 8.78 2 7 8.85
* Confidence in understanding log transformed and reflected back
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Table 7.13 Summary statistics for affect by condition.
Condition Bar graph with pre- Bar graph Pictogram Metonym
intervention 
questionnaire
(Control group 1) (Control group 2) (Intervention group 1) (Intervention group 2)
Positive
affect
Affect
Negative
affect
‘ Negative
affect
Positive
affect
Affect
Negative
affect
‘ Negative
affect
Positive
affect
Affect
Negative
affect
‘ Negative
affect
Positive
affect
Affect
Negative
affect
‘ Negative
affect
n 212 212 212 241 241 241 222 222 222 228 228 228
Mean 17.49 7.53 0.84 17.86 7.53 0.85 17.36 7.51 0.84 17.82 7.65 0.85
SD 3.68 3.46 0.17 3.72 3.46 0.16 3.95 3.18 0.16 4.06 3.47 0.17
Median 18 6 0.78 18 6 0.78 18 6 0.78 18 6 0.78
Mode 20 5 0.70 18 5 0.70 20 5 0.70 20 5 0.70
Min 5 5 0.70 5 5 0.70 6 5 0.70 5 5 0.70
Max 25 20 1.30 25 20 1.40 25 23 1.36 25 20 1.30
* Negative affect log transformed
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Table 7.14 Summary statistics fo r w orry  about future risk  of heart disease by condition.
Worry about future risk of heart Worry about future risk of heart Worry about future risk of heart Worry about future risk of heart
disease disease disease disease
n 212 241 222 228
Mean 2.17 2.14 2.17 2.12
SD 0.99 1.01 0.90 1.03
Median 2 2 2 2
Mode 2 2 2 2
Min 1 1 1 1
Max 5 5 5 5
291
There were no significant differences across the conditions for intention to change 
behaviour (i.e. exercise more, lose weight and stop smoking), understanding of risk 
information (i.e. level of understanding and confidence in understanding), positive 
and negative affect or worry about future risk of heart disease for those of low 
cardiovascular risk or those of moderate/high risk. The p-values and estimated effect 
sizes for the ANOVAs split by risk category are summarised in Table 7.15.
7.6.2 Planned comparisons between conditions
Planned comparisons were carried out as they are more sensitive to detecting 
differences and the overall main effect does not have to be significant to test specific 
differences. Three pairwise contrasts were conducted: Bar graph versus Pictogram\ 
Bar graph versus Metonym and Bar graph versus Bar graph with pre-intervention 
Questionnaire.
As more than one planned comparison was performed on the same set of data, it 
needed to be checked that the comparisons were orthogonal, meaning they were 
independent of one another and not over-lapping (Brace et al. 2006). This was done 
by ensuring that the products of the coefficients assigned to each level for each pair 
of comparisons sum to zero. The conditions were assigned the appropriate 
coefficients (weights) so that the sum of the weights equalled zero (Table 7.16).
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Table 7.15 Results of ANOVAs examining the effects of risk  representation formats 
on intention to change behaviour, understanding of risk information, affect and 
w orry about future risk of heart disease split by risk category.
In tention to exercise m ore Low risk 3 1.095 0.350 0.004
Moderate / High risk 3 0.596 0.618 0.012
In tention to lose w eight Low risk 3 1.178 0.317 0.005
Moderate / High risk 3 1.314 0.272 0.025
In tention to stop sm oking Low risk 3 0.752 0.527 0.048
Moderate / High risk 3 2.047 0.130 0.180
Level o f understanding Low risk 3 1.022 0.382 0.004
Moderate / High risk 3 1.743 0.161 0.033
Confidence in Low risk 3 1.359 0.254 0.005
understanding Moderate / High risk 3 1.229 0.301 0.024
Positive affect Low risk 3 1.503 0.231 0.006
Moderate / High risk 3 1.569 0.199 0.030
Negative affect Low risk 3 0.866 0.458 0.003
Moderate / High risk 3 0.005 1.000 0.000
W orry ab o u t fu ture risk  o f Low risk 3 0.117 0.950 0.000
heart d isease Moderate / High risk 3 0.999 0.395 0.000
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The planned comparisons tested the hypotheses that the Pictogram would lead to 
greater intentions to change behaviour and be better understood compared to the 
Bar graph format; the Metonym would lead to greater intentions compared to the Bar 
graph, and the Bar graph with pre-intervention questionnaire would lead to greater 
intentions compared to the bar graph only format, as a result of thinking about 
cardiovascular risk before viewing actual risk.
Table 7.16 Coefficients assigned to conditions for the planned comparisons.
Comparison 1
Bar graph vs. Pictogram 0 1 -1 0 0
Comparison 2
Bar graph vs. Metonym 0 1 0 -1 0
Comparison 3
Bar graph vs. Bar graph +
preQ 1 -1 0 0 0
Bar graph versus Pictogram
Planned comparisons between the Bar Graph and Pictogram conditions (Appendix 
61) revealed that respondents who received their risk in the pictogram format did not 
significantly differ in intention to exercise more (t=-.110, df=899, p=.913); intention to
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lose weight (t=.856, df=899, p=.856); intention to stop smoking (t=1.915, df=77, 
p=.59); level of understanding (t=.040, df=899, p=.968); confidence in understanding 
(t=-.735, df=899, p=.462); positive affect ( t -1.402, df=899, p=.161); negative affect 
(t=.463, df=899, p=.644) and worry about future risk of heart disease (t=-.324, 
df=899, p=.746) compared to those who received the bar graph format.
Bar graph versus Pictogram split by risk category
Subgroup analyses of risk categorised into low or moderate / high were conducted 
(Appendix 62). Respondents in the low risk category who received the pictogram 
format did not differ in terms of: intention to exercise more (t=.015, df=744, p=.988); 
Intention to lose weight (t=-.150, df=744, p=.881); intention to stop smoking (t=.361, 
df=45, p=.720); level of understanding (t=1.372, df=744, p=.171); confidence in 
understanding (t=-1.547, df=744, p=.122); positive affect (t=-1.817 df=744, p=.070); 
negative affect (t=.465, df=744, p=.642) and worry about future risk of heart disease 
(t=-1.080, df=744, p=.273) than those who received the bar graph format.
Likewise, no significant differences were found between the Bar graph and Pictogram 
conditions in the moderate/high risk category in terms of: intention to exercise more 
(t=-.219, df=151, p=.827); intention to lose weight (t=-.039, df=81.475, p=.969 equal 
variances not assumed); intention to stop smoking (t=2.018, df=28, p=.053); level of 
understanding (t=-1.651, df=151, p=.101); confidence in understanding (t=1.297, 
df=83.426, p=.198 equal variances not assumed); positive affect (t=-.400, df=151,
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p=.690); negative affect (t=-.096, df=151, p=.923) and worry about future risk of heart 
disease (t=.951, df=71.676, p=.345 equal variances not assumed).
Bar graph versus Metonym
No significant differences were found in the planned comparisons for the Bar graph 
and Metonym conditions (Appendix 63). Those who received their risk in the 
metonym format did not significantly differ in intention to exercise more (t=1.003, 
df=899, p=.316); intention to lose weight ({=.807, df=899, p=.420); intention to stop 
smoking (t=1.300, df=77, p=.197); level of understanding (t=-.932 df=899, p=.352); 
confidence in understanding (t=-1.522, df=899, p=.128); positive affect (t=.109, 
df=899, p=.913); negative affect (t=.185, df=899, p=.853); worry about future risk of 
heart disease (t=.203, df=899, p=.839) compared to those who received the bar 
graph format.
Bar graph versus Metonym split by risk category
A subgroup analysis of risk categorised into low or moderate / high were conducted 
(Appendix 64). For the low risk category, respondents who received the bar graph 
format did not differ compared to those who received the pictogram format in terms 
of: intention to exercise more (t=1.549, df=744, p=.122); intention to lose weight 
(t=1.473, df=744, p=.141); intention to stop smoking (t=-.142, df=45, p=.887); level of
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understanding (t=.267, df=744, p=.789); confidence in understanding (t=-1.691, 
df=744, p=.091); positive affect (t=-.921, df=744, p=.357); negative affect (t=.015, 
df=744, p=.988) and worry about future risk of heart disease (t=-.390, df=744, 
p=697).
No significant differences were found between the groups for the moderate/high risk 
category. For example: intention to exercise (t=-.980, df=151, p=.329), intention to 
lose weight (t=-1.361, df=80.334, p=.177 equal variances not assumed), intention to 
stop smoking (t=1.781, df=28, p=.086), level of understanding (t= -2.002, df = 151, 
p=.047), confidence in understanding (t= -.408, df=79.938, p=.684 equal variances 
not assumed), positive affect (t= -1.528, df=151, p=.129), negative affect (t= -.060, 
df=151, p=.952) and worry about future risk of heart disease (t= .338, df=57.498, 
p=.737 equal variances not assumed).
Bar graph versus Bar graph with pre-intervention questionnaire
Planned comparisons revealed no significant differences between the Bar graph and 
Bar graph with pre-intervention questionnaire conditions. Respondents who received 
the bar graph format did not differ from those who completed a pre-intervention 
questionnaire before viewing the bar graph format. The scores of the two groups did 
not significantly differ in intention to exercise more (t=-.301, df=899, p=.764); 
intention to lose weight (t=.651, df=899, p=.515); intention to stop smoking (t=-.527,
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df=77, p=.600); level of understanding (t=-.782 df=899, p=.434); confidence in 
understanding (t=-.112, df=899, p=.911); positive affect (t=-1.015, df=899, p=.311); 
negative affect (t=-.732, df=899, p=.464) and worry about future risk of heart disease 
(t=.354, df=899, p=.723). This suggests that the questionnaire did not seem to have 
had an intervention effect (Appendix 65). This will be explored more in Chapter 8 
when determining the existence of a Hawthorne effect (Adair 1984).
Bar graph versus Bar graph with pre-intervention questionnaire by risk 
category
A subgroup analyses of risk categorised into low or moderate / high were conducted 
(Appendix 66). For the low risk category respondents who received the bar graph 
format did not differ compared to those who received the bar graph with pre­
intervention questionnaire in terms of: intention to exercise more (t=-.196, df=744, 
p=.854); intention to lose weight (t=.055, df=744, p=.956); intention to stop smoking 
(t=.891, df=45, p=.378); level of understanding (t=-1.340, df=744, p=.181); 
confidence in understanding (t=.446, df=744, p=.656); positive affect (t=-1.094, 
df=744, p=.275); negative affect (t=-.933, df=744, p=.351) and worry about future risk 
of heart disease (t=.669, df=744, p=.504).
For the moderate/high risk category no significant differences were found between
those who received the bar graph format and those who received the bar graph
format with pre-intervention questionnaire in terms of: intention to exercise more
(t=1.108, df= 151, p=.270); intention to lose weight (t=1.691-, df=76.116, p=.095 equal
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variances not assumed); intention to stop smoking (t=-1.752, df=28, p=.091); level of 
understanding (t=.470, df=151, p=.639); confidence in understanding (t=-.904, 
df=77.999, p=.369 equal variances not assumed); positive affect (t=-.595, df=151, 
p=.553); negative affect (t=.723, df=151, p=.471) and worry about future risk of heart 
disease (t=.528, df=58.589, p=.599 equal variances not assumed).
7.6.3 Summary
This section has described the analyses conducted to examine the effects of 
cardiovascular risk representation formats on intention to change behaviour, 
understanding of risk information, affect and worry about future risk of heart disease. 
Firstly, all conditions were compared on an equal footing using one-way ANOVAs. 
Secondly, planned comparisons using three pairwise contrasts (Bar graph versus 
Pictogram; Bar graph versus Metonym and Bar graph versus Bar graph with pre­
intervention questionnaire) were conducted. No significant differences were found in 
the scores across the conditions (even when responses were dichotomised into low 
or moderate/high risk), meaning there were no main effects of cardiovascular risk 
representation formats on intention to exercise more, intention to lose weight, 
intention to stop smoking, level of understanding, confidence in understanding, 
positive affect, negative affect and worry about future risk of heart disease.
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7.7 Predicting intention to change behaviour
This section describes the multivariate analyses determining which variables predict 
intention to change behaviour. Firstly, assumptions were tested to assess the 
suitability of the data for multivariate analyses. Then, multiple regression models for 
intention to exercise more, intention to lose weight and intention to stop smoking 
were conducted. These models indicate which variables influence intention to change 
behaviour by assessing how much variance in the intention to change behaviour 
scores are attributed to understanding, affect, worry about future risk of heart disease 
or the risk category of respondents.
7.7.1 Assumption Testing for Multivariate Analyses
A number of assumptions were checked before proceeding with the multiple 
regression models. Some of the necessary assumptions checks were assessed 
previously, e.g. the ratio of cases to independent variables, normality and presence 
of univariate outliers (Appendices 48-50). However, further checks needed to be 
conducted to ensure the suitability of the data for multivariate analyses. The 
assumptions that were tested are reported below.
Linearity and homoscedasticity of residuals
The assumptions of normality, linearity and homoscedasticity between predicted 
dependent variable scores and errors of prediction are assessed by a residual
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scatterplot. This checks whether the residuals are normally distributed about the 
predicted dependent variable scores, that the residuals have a straight-line 
relationship with the predicted dependent variable scores, and that the variance of 
the residuals about predicted dependent variable scores is the same for all predicted 
scores (Tabachnick and Fidell 2001).
Scatterplots of residuals against predicted values were assessed for the dependent 
variables of intention to exercise more, lose weight and stop smoking. For normality, 
linearity and homoscedasticity assumptions to be satisfied, the residual in the 
scatterplots should resemble a rectangular shape distribution with a concentration of 
scores around the centre along the zero point. This is demonstrated in Figures 7.3 to 
7.5. Therefore, these assumptions were not violated.
The scatterplots can also be used to identify outliers. A standardised residual of less 
than -3.3 or more than 3.3 is considered to be an outlier (Tabachnick and Fidell 
2001). As seen in the scatterplot for intention to lose weight (Figure 7.5) there 
appeared to be residuals with a standardised predicted value of around -4 and 4. 
However, before the decision was made whether to take action, the presence of 
outliers was investigated further.
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Figure 7.3 Scatterplot of the residuals against predicted values for Intention to
exercise more.
Regression Standardized Predicted Value
Figure 7.4 Scatterplot of the residuals against predicted values for Intention to
lose weight.
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Figure 7.5 Scatterplot of the residuals against predicted values for intention to
stop smoking.
Multivariate outliers
Mahalanobis distance (i.e. distance of a case from the means of the predictor 
variables) was calculated to identify multivariate outliers. A critical chi square table 
was consulted to obtain the critical chi square value at a= 0.001, where the number 
of independent variables equals the degrees of freedom (Tabachnick and Fidell 
2001). In this instance, the degrees of freedom equalled 7 and the critical value was 
24.32 at p<0.001. One multivariate outlier (case 28) was found among the 
independent variables as its value was greater or equal to the critical chi square 
value. However, it is suggested that a few multivariate outliers are not unusual in
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large samples, and one case should not cause concern (Pallant 2006). Therefore, it 
was felt that no action needed to be taken to omit this from the regression model.
Additionally, the Cook’s distance was calculated. Cook’s distance is the change in 
regression coefficients when a case is deleted to measure its influence on the other 
cases. Influence scores greater than 1 are suspected of being outliers (Tabachnick 
and Fidell 2001). As the maximum value in this instance was 0.164, this assumption 
was not violated.
Multicollinearity and Singularity
The correlation matrix between variables was assessed for multicollinearity 
(Appendix 67). This assumption looks at correlations between the independent 
variables, as presence of high or perfect correlations (over 0.7) between the 
independent variables make it difficult to interpret the relationships between them 
and attribute variance in the dependent variables to one of independent variables. 
None of the variables correlated above 0.7. The highest correlation was 0.43 
(between negative affect and worry about future risk of heart disease). Therefore, the 
assumption of multicollinearity was not violated.
The coefficients tables (Appendix 68) were consulted to look for possible problems 
with multicollinearity that may not be evident in the correlation matrix. The tolerance 
value (calculated using the formula 1-R2 for each variable) is an indication of how 
much of the variability of the specified independent variable is not explained by the
304
other independent variables in the model. Values less than 0.10 are considered to be 
of concern. Additionally, the VIF (Variance inflation factor) values, which are the 
inverse of the tolerance values, of above 10 would be of concern indicating 
mulitcollineary (Pallant 2006). As the tolerance values are all above 0.10 and the 
VIF values are all less than 10 for the three independent variables (intention to 
exercise more, lose weight and stop smoking), the multicollinearity assumption was 
not violated. Furthermore, as there was no perfect linear relationship between any of 
the independent variables, the assumption of singularity was not violated.
7.7.2 Multiple Regression Models to predict intention to change
behaviour
Three multiple regression models were conducted, where the dependent variables 
were represented by each of the behavioural intentions (exercising more, losing 
weight and stopping smoking). A simultaneous method was chosen which specifies 
the set of predictor variables that make up the model (Brace et al. 2006). The 
success of the model in predicting the criterion variable (i.e. intention to exercise 
more, lose weight and stop smoking) was assessed. The predictor variables 
comprised level of understanding, positive affect, negative affect, worry about future 
risk of heart disease and the risk category of respondents
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Intention to exercise more
Multiple regression analysis examined intention to exercise more (Appendix 69). A 
significant model emerged: F(5,897)= 24.851, p=.000. The model explained 11.7% 
of the variance in intention to exercise more scores (Adjusted R2 = .117). Figure 7.6 
provides information for the predictor variables entered into the model and shows the 
standardised beta coefficients.
Four independent variables made the largest statistically significant contribution in 
explaining the variance in intention to exercise more; positive affect accounted for 
32.9%, negative affect accounted for 8.2%, the risk category of the respondent 
accounted for 6.9% and level of understanding accounted for 6.5%. The 
standardised beta coefficients measure the contribution of each variable to the 
model in terms of standard deviations. Beta is the predicted change in standard 
deviation of the criterion variable, for a change in 1 standard deviation in the 
predictor whilst controlling for the other predictors (Brace et al. 2006).
Therefore, the model suggests that in order to increase intention to exercise more by 
1 SD, positive affect needs to be increased by 0.329 SD. Whilst negative affect 
needs to be decreased by -0.082 and level of understanding needs to be decreased 
by - 0.065 SD.
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p= .329 **
|3=-.0821
p= .0691
R2 = .117
p= .004
Understanding
Positive Affect
Negative Affect
Risk category 
(dichotomised)
Worry about 
futu re risk of 
heart disease
Intention to 
exercise more
* S ignificant correlation atp<0.05 
** S ignificant correlation atp<0.001
Figure 7.6 Standardised beta coefficients for Intention to exercise more.
Intention to lose weight
Multiple regression analysis examined intention to lose weight (Appendix 70). Using 
the enter method, a significant model emerged: F(5,897)= 8.175, p=.000. The model 
explained 3.8% of the variance in intention to lose weight scores (Adjusted R2 =
.038). Figure 7.7 provides information for the predictor variables entered into the
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model and shows the standardised beta coefficients. Two independent variables 
made the largest statistically significant contribution in explaining the variance in 
intention to lose weight, positive affect accounted for 18.8% and level o f 
understanding accounted for 8.4%. When assessing the standardised beta 
coefficients it is predicted that to increase intention to lose weight by 1 SD, positive 
affect needs to increase by 0.188 SD, whilst level o f understanding needs to 
decrease by -0.084 SD.
Positive Affect
Intention to 
lose weight
p=-.011
Negative Affect ^
* Significant correlation atp<0.05 
** Significant correlation atp<0.001
Figure 7.7 Standardised beta coefficients for Intention to lose weight.
R2 = .038 >
Understanding
Worry about 
futu re risk of 
heart disease
Risk category 
(dichotomised)
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Intention to stop smoking
Multiple regression analysis examined intention to stop smoking (Appendix 71). 
Using the enter method, a model emerged that was not significant: F(5,75)= 1.469, 
p=.210. The model explained 2.8% of the variance in intention to stop smoking 
scores (Adjusted R2 = .028). Figure 7.8 provides information for the predictor 
variables entered into the model and shows the standardised beta coefficients. 
Positive affect was the only independent variable that made a statistically significant 
contribution in explaining the variance in intention to stop smoking, accounting for 
2.8%. However, as the ratio of cases to independent variables was lower than is 
recommended the results should be interpreted with caution. The standardised beta 
coefficients predict that increasing intention to stop smoking by 1 SD, positive affect 
should increase by 0.261 SD.
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P= .261
R2 = .028
p= .026
Understanding
Positive Affect
Negative Affect
Risk category 
(dichotomised)
Worry about 
future risk of 
heart disease
Intention to 
stop smokim
Significant correlation atp<0.05
Figure 7.8 Standardised beta coefficients for Intention to stop smoking.
7.7.3 Summary
This section reports the multivariate analyses conducted to determine which 
variables predict intention to change behaviour. The appropriate assumption testing 
preceding the multivariate analyses were described. Three multiple regression 
models were conducted for intention to exercise more, intention to lose weight and 
intention to stop smoking. The intention to exercise more and intention to lose weight 
models were statistically significant, and explained 11.7% and 3.8% of the variance
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in intention scores respectively. It is concluded that the small sample size of those 
who completed the items on smoking cessation resulted in the non-significant 
multiple regression model for intention to stop smoking.
Intention to exercise more was significantly predicted by positive affect, negative 
affect, level of understanding and risk category of respondents. This suggests that 
increasing physical activity and exercise levels can be achieved by increasing 
positive emotions, decreasing negative emotions and the level of understanding a 
person has regarding their cardiovascular risk. Also, exercising is partly dependent 
on the risk magnitude of the individual.
Intention to lose weight was significantly predicted by positive affect and level of 
understanding. Although, the intention to stop smoking model was not significant 
overall, positive affect significantly predicted intention to stop smoking.
Positive affect was the only variable to significantly predict all three behavioural 
intentions (exercise more, lose weight and stop smoking) and was consistently the 
largest contributor to the variance in intention scores. This suggests that positive 
emotions have an influence on decisions to change behaviour. Therefore, 
developers of health interventions should focus on increasing a person’s positive 
emotions to effectively increase health protective behaviours.
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7.8 Changes in affect and worry about future risk of heart disease after viewing
cardiovascular risk.
This section will report the analysis conducted to assess changes to affect and worry 
about future risk of heart disease resulting from viewing cardiovascular risk. Paired 
analysis using paired t-tests were conducted to compare baseline and post­
intervention scores for positive and negative affect and worry about future risk of 
heart disease (Appendix 72), to examine whether they decreased or increased after 
viewing cardiovascular risk. Additionally, subgroup analyses splitting responses into 
low or moderate/high risk were conducted to see if there were differences between 
scores depending on the risk category of respondents (Appendix 73). Subgroup 
analysis of the four conditions of the trial was also carried out to determine whether 
the changes in baseline and post-intervention scores differed according to the 
cardiovascular risk representation formats viewed by respondents (Appendix 74).
7.8.1 Paired analysis of baseline and post-intervention positive affect
Figure 7.9 shows the baseline and post-intervention positive affect. A decrease in 
positive affect scores can be seen. The mean score at baseline was 18.11 
(SD=2.99) and 17.64 (SD=3.86) post-intervention. The mean difference between 
baseline and post-intervention scores was 0.47 (95% Cl=0.03-0.64). Paired t-tests 
showed that this decrease in positive affect scores after viewing cardiovascular risk
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was significant (f=5.313, df=902, p=.000). This suggests that when people find out 
their risk of CVD, a decrease in their positive emotion results.
Subgroup analysis by risk category
The subgroup analysis split responses into low or moderate/high risk. For the low 
risk category, positive affect reduced by 0.4 (95% CI=0.22-0.59) after viewing 
cardiovascular risk (baseline M= 18.27, SD=2.96 compared to post-intervention M=
17.87, SD=3.86). Paired t-tests showed that this difference was significant (f=4.279, 
df=747, p=.000).
For the moderate/ high risk category, positive affect was reduced by 0.78 (95% 
0=0.34-1.26) after viewing cardiovascular risk (baseline M= 17.32, SD= 2.99 
compared to post-intervention M= 16.54, SD=3.63). Paired t-tests showed that this 
difference was significant (t=3.288, df=154, p=.001).The greater reduction in positive 
emotions found in those of moderate and high risk respondents compared to those 
of low risk is logical and in the direction that would be expected, because someone 
finding out that they are of elevated risk of CVD is likely to be less reassuring and 
cause more concern, than finding out that they are at low cardiovascular risk.
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Figure 7.9 Error bar plots of mean and 95% confidence intervals of baseline and
post-intervention positive affect.
7.8.2 Paired analysis of baseline and post-intervention negative affect
As shown in Figure 7.10, negative affect decreased after viewing cardiovascular risk 
(baseline M= 1.10, SD=0.11 compared to post-intervention M= 0.85, SD=0.16, log 
transformed). The mean difference between conditions was 0.17 (95% Cl=0.16- 
0.18). Paired t-tests showed that this decrease was significant (f=34.449, df=902,
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p=.000). This suggests that when people find out their risk of CVD, their negative 
emotions decrease. However, this finding is likely to be due to the majority of 
respondents being of low cardiovascular risk and thus, they did not need to be overly 
concerned about their risk result.
Subgroup analysis by risk category
A subgroup analysis dichotomised responses into low or moderate/ high risk. For the 
low risk category, the baseline mean negative affect score was 10.70 (SD= 2.74) 
compared to post-intervention mean 7.27 (SD=3.11) log transformed. Negative affect 
reduced by 3.43 (95% Cl= 3.22-3.63) after viewing cardiovascular risk. Paired t-tests 
showed that this difference was significant (#=32.718, df=747, p=.000).
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Figure 7.10 Error bar plots of mean and 95% confidence intervals of baseline and 
post-intervention negative affect (log transformed).
For the moderate/high risk category, the mean baseline negative affect score was 
10.63 (SD= 2.93) compared to post-intervention mean of 9.17 (SD=3.98) log 
transformed. Negative affect reduced by 1.46 (95% Cl=0.96-1.97) after viewing 
cardiovascular risk. Paired t-tests showed that this difference was significant 
(f=5.746, df=154, p=.000).
The decrease in negative emotions was greatest in those who were of low risk than 
in those of moderate/high risk. This is a logical and expected finding, suggesting that
people who find out that they are of low risk do not need to feel negative emotion, 
and can be reassured by their risk category.
7.8.3 Paired analysis of baseline and post-intervention worry about 
future risk of heart disease
The mean baseline worry about future risk of heart disease score was 2.80 
(SD=1.04) and the mean post-intervention score was 2.15 (SD=0.98), demonstrated 
in Figure 7.11. The mean difference was 0.66 (95% Cl= 0.60-0.71). Paired t-tests 
showed that this difference was significant (#=22.494, df=902, p=.000).
Subgroup analysis by risk category
A subgroup analysis split responses into low or moderate/ high risk. For the low risk 
category, the mean baseline worry about future risk of heart disease score was 2.73 
(SD= 1.04) compared to 2.00 (SD=0.90) post-intervention. Worry about future risk of 
heart disease reduced by 0.73 (95% Cl =0.67-0.79) after viewing cardiovascular risk. 
The paired t-tests showed that this difference was significant (#=22.997, df=747,
p=.000).
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Figure 7.11 Error bar plots of mean and 95% confidence intervals of baseline and 
post-intervention worry about future risk of heart disease.
For the moderate/high risk category, the mean baseline worry about future risk of 
heart disease was 3.16 (SD=1.0) compared to 2.87(SD=1.04) post-intervention. 
Worry about future risk of heart disease reduced by 0.29 (95% Cl=0.16-0.49). Paired 
t-tests showed that this difference was significant (f=4.443, df=154, p=.000).
The greatest reduction was seen in these of low cardiovascular risk. As with negative 
affect, this is in the expected direction and suggests that finding out that you are of 
low risk, reduces negative emotions including worry about future risk of heart 
disease.
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7.8.4 Positive affect, negative affect and worry about future risk of heart
disease split by condition
A further subgroup analysis split responses by three trial conditions (e.g. Bar graph, 
Pictogram and Metonym). This assessed whether the changes in baseline and post­
intervention scores differed according to the different risk representation formats.
Positive affect was significantly reduced in the pictogram condition (t=4.386, df=221, 
p=.000). This format led to the greatest reduction across the conditions (mean 
difference= 0.74, 95% Cl= 0.41-1.08). The bar graph format reduced positive affect 
the least (Mean difference= 0.29, 95% Cl= -0.53-0.63).
Negative affect was significantly reduced across all the conditions e.g. bar graph 
(t=17.08, df=240, p=.000), pictogram (t=16.912, df=221, p=.000) and metonym 
(t=17.340, df=227, p=.000). However, only small reductions were seen. The 
pictogram led to the greatest reduction (M=0.17, 95% Cl=0.14-0.18). The bar graph 
format lead to the least reduction in negative affect across the groups (M =0.16, 95% 
Cl =0.14-0.18).
Across all formats, a significant decrease in worry about future risk of heart disease 
was observed, e.g. bar graph (t=11.125, df=240, p=.000); pictogram (t=12.531, 
df=221, p=.000); metonym (t=12.309, df=227, p=.000). The pictogram format led to 
the greatest reduction in worry about future risk of heart disease (Mean difference =
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0.67, 95% Cl= 0.57-0.78) and the bar graph format led to the least reduction (Mean 
difference =.64, 95% CI=0.53-0.76).
Pictograms were responsible for the greatest reductions in positive affect, negative 
affect and worry about future risk of heart disease. Conversely, bar graphs altered 
affect and worry about future risk of heart disease the least. This suggests that 
pictograms make more of an impact when used to visually represent cardiovascular 
risk, compared to bar graphs which have the least influence over how a person feels 
about their risk.
7.8.5 Summary
This section described paired analyses conducted to assess changes to affect and 
worry about future risk of heart disease after respondents viewed their 
cardiovascular risk in this trial. Positive affect, negative affect and worry about future 
risk of heart disease all significantly decreased after viewing cardiovascular risk. 
When responses were split by risk category, the greatest reduction in positive affect 
was seen in those categorised as moderate/high risk. This is an expected finding as 
having elevated risk of CVD reduces feelings of reassurance and can cause 
concern.
Conversely, the greatest reduction in negative affect and worry about future risk of 
heart disease was seen for those at low risk. Again, this is an expected finding as
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being of low risk can reduce previous negative emotions, worries and anxieties about 
CVD risk and can provide reassurance.
Responses were also split by the condition respondents were assigned to. Negative 
affect and worry about future risk of heart disease were significantly reduced across 
all conditions, whereas positive affect was significantly reduced by the pictogram 
format. The pictogram format consistently led to the great reductions in affect and 
worry about future risk of heart disease and the bar graph format consistently led to 
the least reductions in affect and worry about future risk of heart disease. This 
suggests that pictograms make more of an impact when used to present 
cardiovascular risk, compared to bar graphs which have the least influence over how 
a person feels about their risk.
7.9 Examination of understanding of risk information items
This section describes the examination of items used to assess understanding of risk 
information. Absolute probability perception (e.g. recalling risk category), subjective 
understanding (e.g. stating what someone in the same risk category should do about 
their cardiovascular risk) and confidence in understanding (e.g. how confident 
respondents were that they had understood their risk correctly) were used to 
measure understanding of risk information. The level of understanding respondents 
had was determined by assessing the accuracy of the responses to the absolute 
probability perception and subjective understanding items. Analysis of level of
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understanding is described in this section, along with an assessment of the 
relationship between level of understanding and confidence in understanding, to 
determine whether those who report being highly confident that they have 
understood the risk information actually do understand their risk correctly.
7.9.1 Assessing level of understanding
121 respondents (13.4%) demonstrated complete understanding, as they answered 
both absolute probability perception and subjective understanding items correctly. 41 
(4.5%) had no understanding and answered both items incorrectly. Of the 741 (82%) 
who had partial understanding, 17 (1.9%) correctly answered the subjective 
understanding item, but incorrectly answered the absolute probability perception 
item. 724 (80.2%) correctly answered the absolute probability perception item, but 
gave an inappropriate subjective understanding response (Figure 7.12). This 
suggests that the majority of respondents could accurately recall their risk category, 
but most did not understand the degree of action that needed to be taken because of 
their risk. Leading to the conclusion that either subjective understanding is not a 
suitable measure of understanding, or the respondents in this trial were overly 
prepared to take (or were already taking) actions to reduce their risk even though 
this was not necessary.
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incorrect perception and (correct perception but (appropriate subjective (both correct perception 
inappropriate subjective inappropriate subjective response but incorrect and appropriate 
response) response) perception) subjective response)
Level of understanding and appropriateness of responses
Figure 7.12 Frequencies for level of understanding and appropriateness of 
responses measuring understanding.
7.9.2 Relationship between level of understanding and confidence in 
understanding
A correlational analysis (Appendix 75) was conducted between confidence in 
understanding and level o f understanding (see section 7.4 for a detailed description 
of these variables), to assess the hypothesis that people with a greater level o f 
understanding would have higher confidence in understanding. Therefore, it was
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expected that those with complete understanding would have higher confidence in 
their understanding. The mean confidence in understanding scores were calculated 
for each of the three levels of understanding; complete understanding, partial 
understanding and no understanding (Table 7.17,).
Table 7.17 Means and standard deviations of confidence in understanding scores
according to level of understanding.
M SD
Complete understanding 6.08 1.41
Partial understanding 6.13 1.16
No understanding 5.02 1.70
It can be seen in Figure 7.13, that those with complete understanding did have 
higher confidence in understanding (M=6.08, SD=1.41) compared to those with no 
understanding (M=5.02, SD=1.70), consistent with the proposed hypothesis. 
However, respondents with partial understanding (i.e. correctly answering one out of 
the two understanding items) displayed the highest confidence in their understanding 
o f the risk information overall (M=6.13, SD=1.16).
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Figure 7.13 Mean confidence in understanding scores for each level of
understanding.
A significant negative correlation between level of understanding and confidence in 
understanding was found (r= -.107, N=903, p=.001 two-tailed), suggesting that level 
of understanding decreases with high confidence in understanding. However, the 
relationship is weak as only 1% of the variance is explained (Appendix 75).
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7.9.3 Subgroup analysis of the relationship between level of 
understanding and confidence in understanding split by risk category
Responses were split by risk category (dichotomised into low or moderate/high) to 
see if results varied according to the level risk of the respondents (Appendix 76). For 
the low risk category, there was a significant negative correlation between level of 
understanding and confidence in understanding (r= -.173, N=748, p=.000 two-tailed; 
rs= -.172, N=748, p=.000 two-tailed). However, this correlation was not seen for the 
moderate/high risk category (r=-.013, ISM 55, p=.875 two-tailed).
7.9.4 Summary
This section reported the correlational analyses conducted to examine the 
relationship between level of understanding and confidence in understanding. It was 
hypothesised that those with a high level of understanding would have high 
confidence that they had understood the risk information. A plot of the mean 
confidence in understanding scores for each level of understanding (i.e. no 
understanding, partial understanding and complete understanding) revealed a trend 
consistent with the hypothesis, where higher confidence in understanding was seen 
in those who possessed complete understanding as opposed to those with no 
understanding. However, a significant negative relationship was found suggesting 
that understanding decreases with increasing confidence. This may an artefact 
resulting from the large proportion of respondents (82%) who displayed partial
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understanding and also possessed the highest confidence in understanding scores 
of the groups.
Furthermore, the negative correlation found between level of understanding and 
confidence in understanding could be explained by subjective understanding (e.g. 
stating what someone in the same risk category should do about their cardiovascular 
risk) not being a suitable measure when assessing whether risk information has 
been understood. This is because those with partial understanding (who mainly 
answered the subjective understanding item incorrectly) may have actually 
understood the risk information correctly and be highly confident that they have done 
so, but are just overly prepared to take (or already engaged in) actions to reduce 
their risk even when it is not necessary.
7.10 Correlational validity between level of understanding and intention to 
change behaviour
This section will describe the analysis conducted to assess the correlational validity 
between intention to change behaviour and level of understanding of risk 
information. The concept of correlational validity (Ubel 2008) hypothesises that those 
with understanding of their risk should have a greater intention to change their 
behaviour in order to reduce their cardiovascular risk. A correlational analysis was 
conducted to determine whether understanding results in more appropriate 
intentions to change behaviour.
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7.10.1 Correlational analysis between level of understanding and
intention to change behaviour
Correlations between level of understanding and intentions to exercise more, lose 
weight and stop smoking were conducted (Appendix 77). It was hypothesised that 
higher level of understanding would result in a greater intention to change behaviour.
Intention to exercise more summary statistics for each level of understanding (e.g. 
complete understanding, partial understanding and no understanding) are presented 
in Figure 7.14. The greatest mean intention to exercise more score was seen for 
those with partial understanding (M=5.04, SD=1.19). Those with complete 
understanding had the lowest mean intention to exercise more scores (M=4.82,
SD=1.35). The mean intention to exercise more score for those with no 
understanding was 4.9 (SD=1.25). This did not follow the hypothesised direction.
The correlational analysis found no significant relationship between level of 
understanding and intention to exercise more (r=-.041, N=903, p=.108).
328
6 .00“
5.00“
M 4 .0 0 -
3 .00"
2.00"
1.00-
o.oo-
No understanding Partial understanding
Level of understanding
Complete understanding
Figure 7.14 Mean intention to exercise more scores for each level of
understanding.
Figure 7.15 demonstrates the intention to lose weight summary statistics for each of 
the three levels of understanding. The highest mean intention to lose weight score 
was seen in those with partial understanding (M=4.72, SD=1.56). Those with 
complete understanding had the lowest intention to lose weight (M=4.24, SD=1.81), 
counter to the hypothesis. The mean score for those with no understanding was 4.63 
(SD=1.55).
The correlational analysis found a significant correlation between level of 
understanding and intention to lose weight (r=-.081, N=903, p=.008). This was a
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negative correlation, where those possessing a high level of understanding had 
lower intentions to lose weight. However, the relationship was weak as 8% of the 
variance in scores was explained.
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Figure 7.15 Mean intention to lose weight scores for each level of understanding.
Those with no understanding had the greatest intention to stop smoking (M= 4.24, 
SD=1.93). Those with partial understanding had the lowest intention to stop smoking 
(M= 4.04, SD=1.66). However, as seen in Figure 7.16, the differences are small. The 
mean score for those with complete understanding was 4.07 (SD=1.06). The
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correlational analyses revealed no significant relationship between level of 
understanding and Intention to stop smoking (r=-.019, N=81, p=.432).
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Figure 7.16 Mean intention to stop smoking scores for each level of
understanding.
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7.10.2 Subgroup analysis split by risk category
Analyses were split by the risk category of the respondents (Appendix 78). For those 
in the low risk category, a significant negative correlation between level of 
understanding and intention to lose weight was found, where intention to lose weight 
decreased with an increased level of understanding (r= -.104, N=748, p=.002). 
However, the relationship was weak as only 1 % of the variance was explained. 
Conversely, no significant relationship was found between level of understanding 
and intention to exercise more (r= -.026, N=748, p=.240) or intention to stop smoking 
(r= -.111, N=49, p=.225).
For those in the moderate/ high risk category, level of understanding did not 
significantly correlate with intention to exercise more (r= -.090, ISM 55, p=.133), 
intention to lose weight (r= -.043, ISM 55, p=.300) or intention to stop smoking 
(r=.018, N=49, p=.461).
7.10.3 Summary
This section has described the correlational analyses of intention to change 
behaviour and level of understanding. This was conducted to examine the 
hypothesis that a higher level of understanding would result in a greater intention to 
change behaviour. A significant negative correlation was found between intention to 
lose weight and understanding, although not in the direction expected. Intentions to
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lose weight decreased with increased level of understanding. This may be explained 
by the disproportionate number of respondents who were at low risk and correctly 
understood their risk category. They were reassured that they did not need to take 
any action (such as losing weight) to reduce their cardiovascular risk, and therefore 
had low intentions to change behaviour. No significant relationships were found 
between level of understanding and intention to exercise more or stop smoking. The 
subgroup analyses found no significant relationships between level of understanding 
and intention to change behaviour for those categorised as moderate/high risk. The 
relationship in the low risk category echoes what was found in the main analysis, 
where intentions to lose weight decreased with a high level of understanding. This 
strengthens the above explanation put forward to account for the unexpected 
direction of the relationship.
7.11 Relationship between worry about future risk of heart disease and 
intention to change behaviour
This section described the analysis conducted to assess the relationship between 
worry about future risk of heart disease and intention to change behaviour. An 
inverted-U/ curvilinear relationship was hypothesised, where lower intentions to 
change behaviour would result with very low and high levels of worry about future 
risk of heart disease. The analysis examined the existence of an inverted-U/ 
curvilinear relationship.
3 3 3
Firstly, the mean intention to exercise more, lose weight and stop smoking scores for 
each point on the worry about future risk of heart disease 5-point Likert scale were 
calculated to identify any visible trends in the data (Table 7.18).
Table 7.18 Means and standard deviations of intention to change behaviour 
scores for each point on the worry about future risk of heart disease scale.
M SD M SD M SD
1 (not at all worried) 5.12 1.34 4.63 1.76 4.08 1.75
2 4.10 1.12 4.54 1.61 3.97 1.71
3 4.90 1.20 4.75 1.43 4.35 1.63
4 4.94 1.28 4.89 1.38 3.72 1.43
5 (very worried) 4.96 1.13 5.10 1.48 3.67 0.88
Then, one-way ANOVAs were conducted to examine the relationship between each 
of the intention to change behaviour scores (exercise more, lose weight and stop 
smoking) and worry about future risk of heart disease (Appendix 79). A 2nd degree 
polynomial (quadratic) model was fitted to the data (i.e. curve with one bend), to 
assess whether there is evidence of a curvilinear relationship between intention to 
change behaviour and worry about future risk of heart disease. The polynomial 
contrasts were examined to see how well the data fitted the model, i.e. to what 
extent a curvilinear relationship existed.
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7.11.1 Intention to exercise more
Figure 7.17 depicts the mean intention to exercise more scores for each point on the 
Likert Scale measuring worry about future risk of heart disease. The mean intention 
to exercise more scores at the extremes of the scale were greater than the mean 
score on the mid-point on the scale (M=5.12, SD=1.34 and M=4.96, SD=1.13 
compared to M=4.90, SD=1.20). This indicates intention to exercise more is greater 
when respondents are not at all worried about the future risk of heart disease or very 
worried. This is the reverse of what would be expected in the hypothesised 
curvilinear relationship between the two variables.
A one-way ANOVA (sum of squares with 4 degrees of freedom) with a second 
degree polynomial model was conducted. There were no statistically significant 
differences between intention to exercise more and worry about future risk of heart 
disease (F(4,898) =1.004, p=.404). However, this is not sensitive at detecting any 
meaningful first order trends (i.e. linear) or second order trends (including U shaped 
and inverted-U shaped). Therefore, these trends were examined using a quadratic 
term (sensitive to a curvilinear / U-shape or inverted-U shape between two 
variables). Again, no statistically significant trends were found in the data 
(F(1,898)=.861, p=.354). Although there was some evidence of a linear trend 
between the variables, where lower intentions to exercise more were associated with 
higher levels of worry about future risk of heart disease, this did not quite reach 
significance (F(1,898) =3.034, p=.082).
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Figure 7.17 Mean intention to exercise more scores for each point on the worry
about future risk of heart disease scale.
7.11.2 Intention to lose weight
The mean intention to lose weight scores increase with increased worry about future 
risk of heart disease (Figure 7.18). For example, the mean score was 4.63 (SD=
1.76) for respondents who reported that they were not at all worried about the future
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risk of heart disease and 5.10 (SD=1.48) for those who were very worried. However, 
there was one exception to this, the second point of the Likert scale (M=4.54,
SD=1.61).
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Figure 7.18 Mean intention to lose weight scores for each point on the worry 
about future risk of heart disease scale.
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The one-way ANOVA did not find any significant difference between intention to lose 
weight and worry about future risk of heart disease scores (F(3,898) =1.359, 
p=.246). There was no evidence of a quadratic/ curvilinear trend between the 
variables (F(1,898) =1.697, p=.193), nor a linear trend (F( 1,898) =2.922, p=.088).
7.11.3 Intention to stop smoking
The mean intention to stop smoking scores for each of the points on the worry about 
future risk of heart disease scale are displayed on Figure 7.19. No pattern in the data 
is observed. This is confirmed by a one-way ANOVA that found no significant 
differences between intention to stop smoking and worry about future risk of heart 
disease (F(3,76) =.396, p=.811).
The linear term did not reveal any linear trends in the data (F(1,76) =.084, p=.773), 
and the quadratic term did not reveal any curvilinear trends in the data (F(1,76) 
=.440, p=.509). However, it must be acknowledged that the intention to stop smoking 
sample is reduced and comprises less than 10% of the respondents who completed 
the study as a whole.
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Figure 7.19 Mean intention to stop smoking scores for each point on the worry 
about future risk of heart disease scale.
7.11.4 Subgroup analysis split by risk category
Table 7.19 demonstrates the means and standard deviations for intention to exercise 
more, lose weight and stop smoking for each of the points on the worry about future 
risk of heart disease scale, when responses were split by risk category.
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Table 7.19 Means and standard deviations of intention to change behaviour for 
each point of the worry about future risk of heart disease scale dichotomised by
low or m oderate/high risk category.
Intention to Intention Intention to Intention to Intention to Intention tc
exercise
more
to lose 
weight
stop
smoking
exercise
more
lose weight stop
smoking
M SD M SD M SD M SD M SD M SD
1 (not at 
all
worried)
5.09 1.34 4.67 1.71 4.00 1.88 5.46 1.23 4.17 2.42 4.50 1.18
2 5.03 1.11 4.56 1.62 4.13 1.92 4.77 1.23 4.34 1.46 3.67 1.26
3 4.88 1.23 4.80 1.42 3.74 1.66 4.94 1.15 4.63 1.47 4.95 1.47
4 4.75 1.27 4.63 1.51 3.61 1.29 5.18 1.28 5.23 1.13 3.83 1.67
5 (very 
worried)
4.90 0.98 3.86 1.09 4.17 0.24 5.00 1.29 6.07 0.89 2.67 0.00
For the low risk category, there was a trend in intention to exercise more scores, 
where intention to exercise more decreased as worry about future risk of heart 
disease increased. Conversely, there did not seem to be any distinct pattern in 
intention to lose weigtht or intention to stop smoking scores.
For the moderate/high risk category, no visible trend was seen for intention to
exercise more scores. But intention to lose weight scores increased with increasing
worry about future risk of heart disease (M=4.17, SD=2.42 for those who were not at
all worried about the future risk of heart disease and M=6.07, SD=.89 for those who
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reported being very worried). Where intention to stop smoking was concerned, there 
was one respondent who reported being very worried about their future risk of heart 
disease, although they had the lowest intention to stop smoking (M=2.67).
One way ANOVAs were conducted for the low risk and moderate/high risk 
categories separately (Appendix 80). For the low risk category, there was no 
significant difference between intention to exercise more (F(4,743) =1.182, p=.317), 
intention to lose weight (F(4,743) =.955, p=.431) or intention to stop smoking 
(F(4,44)=.157, p=.959) for each of the points on the worry about future risk of heart 
disease scale. There was no evidence to support the hypothesis of a curvilinear 
relationship between the intention to exercise more (F( 1,743) =.001, p=.918), 
intention to lose weight (F(1,743) =.173, p=.678) or intention to stop smoking 
(F( 1,44)=.017, p=.896) and worry about future risk of heart disease. Furthermore, no 
evidence of a linear relationship was seen for intention to lose weight (F (1,743)
=.000, p=.922), or intention to stop smoking (F(1,44)=. 189, p=.666) and worry about 
future heart disease. However, a significant linear trend was found for intention to 
exercise more (F(1,743) =4.295, p=.039), where intention to exercise more 
decreased with increased worry about future risk of heart disease.
For the moderate/high risk category, there were no significant differences between 
the intention to exercise more (F(4,150) =1.104, p=.357) or intention to stop smoking 
scores (F(4,27)=1.679, p=.184) for each point of the worry about future heart disease 
scale. However, there was a significant difference in intention to lose weight scores 
across each level of worry about future risk of heart disease (F(4,150) =3.851,
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p=.005). This was a statistically significant linear trend (F(1,150)= 13.654, p=.000), 
where intention to lose weight increased as worry about future risk of heart disease 
increased. There was no evidence of a linear relationship between intention to 
exercise more (F( 1,150) =.001, p=.973) or intention to stop smoking (F( 1,27)=.015, 
p=.904) and worry about future heart disease scale. Inconsistent with the hypothesis, 
no significant curvilinear relationship was found for intention to exercise more 
(F( 1,150) =1.598, p=.208), intention to lose weight (7^1,150) =1.713, p=.193), or 
intention to stop smoking (F( 1,27)=2.101, p=.159) and worry about future risk of 
heart disease.
7.11.5 Summary
This section described the analysis conducted to examine a relationship between 
intention to change behaviour and worry about future risk of heart disease. It was 
hypothesised that there would be a curvilinear relationship where lower intentions 
to change behaviour would be found in those who were either not at all worried or 
very worried about the future risk of heart disease. One-way ANOVAS were 
conducted and a polynomial (quadratic) model was fitted to the data. For intention 
to exercise more and intention to lose weight a linear pattern was observed, 
where intentions increased with worry about future risk of heart disease. However, 
these trends were not statistically significant. No coherent pattern was identified 
for intention to stop smoking. There was no significant evidence of the 
hypothesised curvilinear direction. This is likely to be due to the variation in
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intention to change behaviour scores among respondents at any given level of 
worry about future risk of heart disease that obscures any suggestion of a 
meaningful trend in the data. When responses were dichotomised by risk 
category, significant linear relationship were found between worry about future risk 
of heart disease and intention to exercise more for the low risk category; and 
intention to lose weight for the moderate/high risk category. Intention to lose 
weight increased with greater worry about future risk of heart disease, which is a 
logical finding, where it would be expected that those who are concerned about 
their future risk of heart disease would want to try and take action (such as losing 
weight) in order to reduce their risk. However, intention to exercise more 
decreased with greater worry about future risk of heart disease, which is not in the 
expected direction and is difficult to explain.
7.12 Summary of all results
To summarise, this trial found no statistically significant main effects of 
cardiovascular risk presentation format on intention to change behaviour (e.g. 
exercise more, lose weight or stop smoking), level of understanding, confidence in 
understanding, positive and negative affect or worry about future risk of heart 
disease.
Multiple regression analysis assessed which variables predicted intention to change 
behaviour. Significant models for intention to exercise and intention to lose weight
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were found, where 11.7% and 3.8% of the variance in intention scores was 
explained respectively.
Intention to exercise more was significantly predicted by positive affect, negative 
affect, level of understanding and risk category of respondents. This suggests that 
with increasing risk of CVD, increasing positive emotions and decreasing negative 
emotions will lead to greater intentions to exercise more. However, decreasing level 
of understanding was also found to improve intentions, which is not in the direction 
that would be expected.
Intention to lose weight was significantly predicted by positive affect and level of 
understanding. This suggests that increasing positive emotions and decreasing level 
of understanding will improve intentions to lose weight; whereas, a person’s level of 
cardiovascular risk and negative emotions (including worry about future risk of heart 
disease) play no part in decisions about losing weight.
Positive affect was the only variable to significantly predict all three behavioural 
intentions (exercise more, lose weight and stop smoking), it was consistently the 
largest contributor to the variance in intention scores. This suggests that developers 
of interventions aimed at increasing health protective behaviours should focus on 
increasing positive emotions to improve the effectiveness of the intervention.
Changes in affect and worry about future risk of heart disease after viewing 
cardiovascular risk were examined. There was a significant decrease in positive
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affect, negative affect and worry about future risk of heart disease after viewing 
cardiovascular risk. These decreases were upheld when responses were split by risk 
category. Positive affect was reduced most in the moderate/ high risk category. This 
is an expected finding as realising that you have an elevated risk of CVD reduces 
feelings of reassurance and can cause concern. Negative affect and worry about 
future risk of heart disease was reduced most in the low risk category. Again, this is 
an expected finding as being of low risk can reduce previous negative emotions, 
worries and anxieties about risk of CVD risk, and can provide reassurance. The 
pictogram format consistently led to the greatest reductions in affect and worry about 
future risk of heart disease, and the bar graph format consistently led to the least 
reductions in affect and worry about future risk of heart disease. This suggests that 
pictograms make more of an impact when used to present cardiovascular risk, 
compared to bar graphs which have the least influence over how a person feels 
about their risk.
Further analyses revealed a significant negative correlation between level of 
understanding and intention to lose weight, where intention to lose weight decreases 
as understanding increases. This is inconsistent with the correlational validity 
hypothesis (Ubel 2008), suggesting intentions are greater with increased 
understanding. An explanation for this may be the disproportionate number of 
respondents who were at low risk and correctly understood their risk category, but 
were reassured that they did not need to take any action (such as losing weight) to 
reduce their CVD risk. No significant correlations were found between level of 
understanding and intention to exercise more or intention to lose weight.
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Additionally, a significant negative correlation was found between level of 
understanding and confidence in understanding, where confidence decreases as 
level of understanding increases. It is likely that this finding is attributable to the 
inappropriate subjective understanding responses (which indicates what people think 
someone of the same risk category should do to reduce their risk, e.g. nothing, a 
little or a lot). This suggests that either the subjective understanding item is not a 
suitable measure of whether respondents have understood the risk information 
presented to them, or that the respondents in this trial were just overly prepared to 
take action to reduce their risk of CVD even though this was not necessary.
Lastly, it was hypothesised that low and high levels of worry about future risk of heart 
disease would lead to reduced intention to change behaviour. However, there was 
no evidence of a curvilinear relationship between intention to change behaviour and 
worry about future risk of heart disease. When responses were dichotomised by risk 
category, significant linear relationships were found between worry about future risk 
of heart disease and intention to exercise more for the low risk category; and 
intention to lose weight for the moderate/high risk category. Intention to lose weight 
increased with greater worry about future risk of heart disease, which is a logical 
finding, but intention to exercise more decreased with greater worry about future risk 
of heart disease. A plausible explanation cannot be suggested for the direction of 
this finding.
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Chapter 8. Secondary results of a web-based randomised
controlled trial of cardiovascular risk representation formats.
8.1 Introduction
This chapter describes the results of the secondary objectives of the web-based 
randomised controlled trial on cardiovascular risk representation formats. This 
chapter is divided into sections; the research objectives and/or hypotheses are 
presented at the start, the results are reported and summarised at the end of each 
section.
As with the data analysis of the primary objectives, the main outputs are presented in 
the appendices. Syntax and full SPSS outputs are accessible using the following link 
to an on-line Google document:
https://docs.google.com/viewer?a=v&pid=explorer&chrome=true&srcid=OBOZzQPPd
5mfKZTQ0MjliMDgtMjE3MS00MGVILWIyMmltMTQzZjMwZGIyMzlk&hl=en_GB.
The secondary objectives are outlined below:
• Examination of the existence of the Hawthorne effect by comparing the 
responses of the two control groups.
• Analysis of within-group changes between pre and post-intervention 
responses in the group who completed both questionnaires.
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• Examining the appropriateness of intention to change behaviour when 
requesting copy of risk output, including assessment of direct and indirect 
intentions to change behaviour.
• Assessment of the Theory of Planned Behaviour’s efficacy to predict intention 
to change behaviour to reduce future heart risk.
• An evaluation of the use of the internet-provided risk formatter (process 
evaluation), including analysis of web-logs.
8.2 Existence of a Hawthorne effect
This section describes the examination of a possible Hawthrone effect (Adair 1984) 
of an outcome questionnaire about cardiovascular risk. This was done using two 
control groups: the first control group was given a pre-intervention questionnaire 
asking respondents about their cardiovascular risk perceptions and intentions to 
reduce future cardiovascular risk. The second control group was not given the pre­
intervention questionnaire but received the same graphical risk representation format 
as the first control group (e.g. bar graph). It was hypothesised that respondents who 
received the pre-intervention questionnaire would have higher intentions to change 
behaviour to reduce risk, than those who did not receive the pre-intervention 
questionnaire.
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8.2.1 Comparison of the two control groups
Figure 8.1 demonstrates the Error bar plots of 95% confidence intervals for mean 
intention to exercise more, lose weight and stop smoking scores for control group 1 
(who completed the pre-intervention questionnaire) and control group 2 (who were 
not offered the pre-intervention questionnaire).
Control Group 1 Control Group 2
Bar graph with pre-Q Bar graph only
4-
Mean intention to Mean intention to lose Mean intention to
exercise more scores weight scores stop smoking scores exercise more scores weight scores stop smoking scores
Figure 8.1 Error bar plots of 95% confidence intervals for mean post-intention to 
exercise more, lose weight and stopping smoking scores for control group 1 and
control group 2.
Those who received the pre-intervention questionnaire (control group 1) had slightly 
higher intentions to exercise more (M=5.06, SD=1.2) and lose weight (M=4.75,
SD=1.56) than those who did not receive the pre-intervention questionnaire (control 
group 2) (M=5.02, SD= 1.21 and M=4.65, SD= 1.61, respectively). This was in the 
hypothesised direction. However, intention to stop smoking was highest in the group 
who did not receive the pre-intervention questionnaire (M=4.55, SD=1.45) compared 
to those who did (M=4.28, SD =1.64), which was contrary to the hypothesis.
The planned comparisons reported in Chapter 7 (Section 7.6.2) revealed no 
significant differences between the Bar graph and Bar graph with pre-intervention 
questionnaire conditions (Appendix 64). Respondents who received the bar graph 
format did not differ from those who completed a pre-intervention questionnaire. The 
scores of the two groups did not significantly differ in terms of: intention to exercise 
more (t=-.301, df=899, p=.764); intention to lose weight (t=.651, df=899, p=.515); 
intention to stop smoking (t=-.527, df=77, p=.600); level of understanding (t=-.782 
df=899, p=.434); confidence in understanding (t=-.112, df=899, p=.911); positive 
affect (t=-1.015, df=899, p=.311); negative affect (t=-.732, df=899, p=.464) and worry 
about future risk of heart disease (t=.354, df=899, p=.723). This suggests that 
questionnaire did not have an intervention effect.
Therefore, it is concluded that there was no Hawthorne effect of thinking about
cardiovascular risk on intentions to change behaviour in order to reduce risk.
Demonstrating that answering questions about personalised risk of future
cardiovascular disease before viewing actual risk does not lead to increased
intentions to changing your behaviour to reduce risk (such as and exercising more,
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losing weight and stopping smoking), neither does it affect level of understanding of 
risk information, or alter positive and negative emotions, including worry about future 
risk of heart disease.
8.2.2 Subgroup analysis by risk category
Responses were split by either low or moderate and high risk categories (Appendix 
65). Again, there were no significant differences between those who received the 
pre-intervention questionnaire and those who did not for low risk or moderate/high 
risk respondents (all p values >0.5).
8.2.3 Summary
This section has described the comparison of the two control groups to look for the 
existence of a Hawthorne effect of an outcome questionnaire about cardiovascular 
risk. There were no significant differences between the control group who received 
the pre-intervention questionnaire and the control group who did not. When 
responses were split by risk category (low or moderate/high) still no Hawthorne 
effect was evident. This demonstrates that answering questions about your risk of 
future cardiovascular disease before viewing your actual risk does not lead to 
increased intentions to changing your behaviour (such as exercising more, losing 
weight and stopping smoking), neither does it affect your level of understanding of 
your risk information, or alter your positive and negative emotions, including worry 
about your future risk of heart disease.
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8.3 Analysis of pre and post-intervention intention to change behaviour to 
reduce cardiovascular risk
This section will describe the analysis of the responses from control group 1 who 
received a pre-intervention questionnaire before viewing their cardiovascular risk and 
also completed the post-intervention questionnaire. This is to see whether intentions 
to reduce cardiovascular risk by behaviour change (e.g. exercising more, losing 
weight and stopping smoking) are increased or decreased after viewing personally 
calculated cardiovascular risk.
8.3.1 Within-group changes in intention to exercise more, lose weight 
and stop smoking
Serial within-group changes of intention to change behaviour between the pre and 
post-intervention questionnaires of the first control group were assessed. The pre­
intervention intention to reduce risk of heart disease score was compared to post­
intervention scores for intention to exercise more, iose weight and stop smoking. 
Assessment of these changes gives an indication of the behaviours likely to be 
chosen by respondents who originally intended to reduce their risk of heart disease; 
and determines whether viewing cardiovascular risk result actually increases or 
decreases the original intention to reduce cardiovascular risk.
Figure 8.2 demonstrates the mean intention scores with 95% confidence intervals for
pre-intervention intention to reduce risk of heart disease and post-intervention mean
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intention to exercise more, lose weight and stopping smoking for control group 1 
scores.
Re intention to reduce 
heart disease risk
Post intention to exercise 
more
Post intention to lose 
weight
Post intention to stop 
smoking
Figure 8.2 Error bar plots of mean intention scores with 95%  confidence intervals 
for pre-intention to reduce risk of heart disease and post-intention to exercise 
more, lose weight and smoking cessation for control group 1.
Pre-intervention intention to reduce cardiovascular risk was higher (M=6.26,
SD=1.27) than the post-intervention intention to exercise more (M=5.06, SD=1.20), 
lose weight (M=4.75, SD= 1.56) and stop smoking (M=4.28, SD=1.638).
3 5 3
There was a statistically significant effect of viewing the cardiovascular risk, although 
it was not in the expected direction (Appendix 81). There was a significant decrease 
in intention to reduce cardiovascular risk by exercising more after viewing 
cardiovascular risk (t(211)=9.915, p=.000). However the eta squared statistic (.318) 
indicated a small effect size (calculated from equation given by Pallant 2006) (Pallant 
2006, p.212). Furthermore, there was a statistically significant decrease in intention 
to reduce cardiovascular risk by losing weight after viewing cardiovascular risk 
(t(211 )=11.641, p=.000). Again, the eta statistic (.391) indicated a small effect size. 
Lastly, the same was seen for intention to stop smoking, where intention to reduce 
cardiovascular risk by stopping smoking scores significantly decreased after viewing 
cardiovascular risk results (t(18)=4.496, p=.000). The eta squared statistic (.529) 
indicated a small to moderate effect size.
It was expected that intentions to change behaviours would increase after viewing 
cardiovascular risk, and respondents would have greater intentions to exercise more, 
lose weight and stop smoking that their initial pre-intervention intention to reduce 
their risk of heart disease. The results are contrary to this, and may be because 
intention to reduce heart disease risk is more theoretical than the specific lifestyle 
changes: exercising more, losing weight and stopping smoking, which are more 
practical options, and hence they may be viewed differently. Alternatively, 
respondents may have expected their cardiovascular risk to be higher, and therefore 
may have been reassured by their risk result, which led to reduced intentions to 
change behaviour in order to reduce risk.
354
8.3.2 Within-group changes in intention to exercise more, lose weight 
and stop smoking subgroup analysis split by risk category
As risk magnitude may have had an influence on the intention scores, paired t-tests 
were recalculated with the respondent’s risk category as a subgroup (Appendix 82). 
Figure 8.3 demonstrates the mean intention scores for pre-intervention intention to 
reduce heart disease risk and mean post-intervention intention to exercise more, 
lose weight and stop smoking for control group 1, dichotomised by the risk category 
of respondents.
Again, pre-intervention intention to reduce cardiovascular risk (M=6.27, SD=1.24) 
was greater than post-intervention intention to exercise more (M=5.04, SD=1.22), 
lose weight (M=4.70, SD=1.63) and stop smoking (M=4.53, SD=1.74) for 
respondents categorised as low risk.
The same was seen for those at moderate/high risk, where the pre-intervention 
intention to reduce cardiovascular risk (M=6.18, SD=1.45) was greater than the post­
intervention intentions to exercise more (M=5.17, SD=1.11), lose weight (M=5.02 , 
SD= 1.04) and stop smoking (M=3.86, SD=1.48).
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Figure 8.3 Error bar plots of mean intention score with 95% confidence intervals 
for pre-intention to reduce risk of heart disease and post-intention to exercise 
more, lose weight and stopping smoking scores for control group 1 dichotomised
by risk category.
Low risk category
For respondents at low risk, there was a significant decrease in intention to reduce 
cardiovascular risk by exercising more (t(178)=9.235, p=.000), losing weight
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(t(178)=11.01, p=.000) and stopping smoking (t(11 )=3.548, p=.005) after viewing
cardiovascular risk.
Moderate/high risk category
A significant decrease in intention to reduce cardiovascular risk by exercising more 
(t(32)=3.584, p=.001), losing weight (t(32)=3.843, p=.001) and stopping smoking 
(t(6)=2.564, p=.043) after viewing cardiovascular risk was also found for respondents 
in the moderate/high risk category. However, the intention to stop smoking results 
should be interpreted with caution due to small cell sizes (n=7).
8.3.3 Summary
This section has described the analysis of serial within-group changes of 
respondents allocated to control group 1 who completed the pre and post­
intervention questionnaires. This was to determine whether intention to reduce 
cardiovascular risk by changing behaviour (exercising more, losing weight and 
stopping smoking) increased or decreased after viewing actual cardiovascular risk. 
Significant differences in intention scores were found, although this was not in the 
direction that was expected. There was a significant decrease in intention to reduce 
cardiovascular risk by exercising more, losing weight and stopping smoking after 
viewing risk. This may have been due to the large proportion of respondents who 
were categorised as low risk, who realised that they did not need to reduce their 
cardiovascular risk. Perhaps they were expecting to have a higher risk result, and
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therefore felt reassured by their lower risk category. Although, this does not explain 
the significant decrease was still evident in the respondents who were categorised 
as moderate/high risk in the sub-group analysis.
Alternatively, there may be a limitation when comparing the results directly, as 
asking respondents about their intentions to reduce their risk of heart disease is 
more theoretical than asking about their intentions to perform specific lifestyle 
changes, such as exercising more, losing weight and stopping smoking. Therefore, 
the two may be viewed differently, leading to the differences that were found before 
and after respondents viewed their cardiovascular risk.
8.4 Intention to reduce cardiovascular risk when requesting a copy of risk 
output
This section describes the examination of intention to change behaviour between
those who request a copy of their risk output and those who do not. At the end of the
study respondents were given the option to leave their contact details if they wanted
a copy of their risk results to be sent to them. It was suggested that they could take
these results to their GP. The analysis of the groups who requested a copy of their
results and those who did not determined whether those who wanted a copy of their
risk output had greater intentions to reduce their cardiovascular risk, by exercising
more, losing weight and stopping smoking, than those who did not.
As already described in Chapter 7, 143 respondents requested a copy of their risk
output result. The bar graph condition (Control group 2) had the highest proportion
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of respondents requesting a copy of their risk output (n=40) and the metonym format 
(Intervention group 2) had the lowest proportion of respondents requesting a copy of 
their risk output (n=31) (Table 7.3). No significant differences were found across 
conditions between those who requested a copy of their risk output results and those 
that did not (Chi square = 2.163, df = 3, p=.539) (Appendix 47).
Independent samples t-tests were conducted to compare the intention to exercise 
more, lose weight and stop smoking scores for those who requested a copy of their 
risk output results and those that did not (Appendix 83). These are described below.
8.4.1 Intention to exercise more
Box plots (Figure 8.4) demonstrate the mean intention to exercise more scores for 
respondents who requested a copy of their risk output and those that did not. The 
mean was higher for those who requested their risk output results (M=5.13, SD 1.12) 
than for those who did not request their results (M=4.98, SD 1.23).
Independent t-tests revealed no significant differences in the intention to exercise 
more scores between the two groups (#(901 )= -1.348, p=.178 (equal variances 
assumed as the Levene’s test was not significant, p=.218)), indicating that those who 
requested a copy of their risk output did not possess greater intentions to reduce 
their cardiovascular risk by exercising more than those who did not request a copy of 
their risk output.
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No (n=760) Yes (n=143)
C o p y  o f  r i s k  o u t p u t  r e q u e s t e d ?
Figure 8.4 Comparison of mean intention to exercise more scores for respondents 
who requested a copy of their risk output and those who did not.
Subgroup analysis by risk category
A subgroup analysis of risk category was conducted, where respondents were 
dichotomised into those at low risk or moderate/high risk (Appendix 84). In the low 
risk category, those who requested a copy of their risk output results had a greater 
intention to exercise more than those who did not request a copy (M=5.17, SD= 1.13 
compared to M=4.98, SD=1.23). However, the difference was not significant; t(746)= 
-1.513, p=.131 (equal variances assumed as the Levene’s test was not significant, 
p=.431).
In the moderate/high risk category, again, intention to exercise more was higher for 
those who requested their results than for those who did not (M=5.02, SD= 1.115 
compared M=5.00, SD=1.253), but again this difference did not reach significance 
(f(153)= -.108, p=.914 equal variances assumed).
8.4.2 Intention to lose weight
Figure 8.5 shows the mean intention to lose weight scores for respondents who 
requested a copy of their risk output and those that did not. Intention to lose weight 
was higher in those who requested a copy of their risk output (M=4.88, SD=1.41) 
compared to who did not request a copy of their risk output (M=4.60, SD=1.63). The 
difference was significant (t(220.331)= -2.080, p=.039 (equal variances not assumed 
as Levene’s test was significant, p=.037)), indicating that those who requested a
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copy of their risk output had greater intentions to lose weight than those who did not 
request a copy of their risk output.
No(n=760) Yes (n=143)
Copy of risk output requested?
Figure 8.5 Comparison of mean intention to lose weight scores for respondents 
who requested a copy of their risk output and those who did not.
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Subgroup analysis by risk category
A subgroup analysis of risk category dichotomising respondents into low or 
moderate/high risk was conducted (Appendix 84). For the low risk category, those 
who requested a copy of their risk output results had a higher intention to lose weight 
than those who did not request a copy (M=4.80, SD=1.46 compared to M= 4.61, 
SD=1.63). However, this difference was not significant (t(746)=-1.086, p=.278 equal 
variances assumed).
In the moderate/high risk category, those who requested a copy of their risk output 
also had a higher intention to lose weight than those who did not (M=5.08, SD=1.27 
compared to M=4.58, SD=1.64), but again, this difference was not significant 
(f(153)= -1.765, p=.080 equal variances assumed).
8.4.3 Intention to stop smoking
As demonstrated in Figure 8.6, those who did not request a copy of their risk output 
had a higher intention to stop smoking than those who did request a copy (M =4.17, 
SD= 1.61 compared to M=3.60, SD= 1.56). This was the not in the expected 
direction. However, Independent t-tests found that this difference was not significant 
(/(79)=1.263, p=.210 (equal variances assumed as the Levene’s test was not 
significant, p=.458)). This suggests that those requesting a copy of their risk output 
did not possess more appropriate intentions to reduce their cardiovascular risk by 
stopping smoking than those who did not request a copy of their risk output.
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However, results should be interepeted with caution as only 16 of the current 
smokers requested a copy of their risk output.
No (n=65) Y es (n=16)
C o p y  o f  r i s k  o u t p u t  r e q u e s t e d ?
Figure 8.6 Comparison of mean intention to stop smoking scores for respondents 
who request a copy of their risk output and those who did not.
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Subgroup analysis by risk category
When risk was dichotomised (Appendix 84), those in the low risk category who did 
not request a copy of their risk output had higher intentions to stop smoking (M=3.99, 
SD= 1.742) than those that did (M= 3.76, SD=1.585). This demonstrates that those 
who requested a copy of their risk output were less likely to want to stop smoking 
than those who requested a copy of their risk results. However, the trend was not 
significant (f(47)=.399, p=.692 equal variances assumed).
Again, higher intentions to stop smoking were found for those who did not request a 
copy of their risk output (M=4.42, SD=1.407) compared to those who did (M=3.27, 
SD=1.606) in the moderate/high risk category. However, this difference was not 
significant t(30)=1.650, p=.109 equal variances assumed as Levene’s test was not 
significant, p=.984). It should be acknowledged that limited number of smokers who 
participated in this study led to small cell sizes (11 low risk and 5 moderate/high risk 
respondents requested a copy of their risk output). Therefore, the results should be 
interpreted with caution.
8.4.4 Summary
This section describes the comparison of intentions to reduce cardiovascular risk by 
exercising more, losing weight and stopping smoking in respondents who requested 
a copy of their risk output and those who did not. It was hypothesised that higher
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intentions to reduce cardiovascular risk would result in those who wanted a copy of 
their risk output to retain for future use. However, the only significant difference 
between groups was seen for intention to lose weight, where those who requested a 
copy of their risk output had higher intentions to lose weight that those who did not. 
This indicates that people with greater intentions to reduce cardiovascular risk by 
losing weight are more likely to want a copy of their risk output, maybe so that they 
can take it to their GP to start a discussion regarding reducing their cardiovascular 
risk.
8.5 Comparing direct and indirect measures of intention to change behaviour
This section describes the assessment of direct and indirect intentions to change 
behaviour, to see whether those who request a copy of their risk output actually 
indicate that they intend reduce cardiovascular risk by exercising more, losing weight 
or stopping smoking. It was hypothesised that there would be a positive relationship 
between respondents requesting a copy of risk output results and intentions to 
reduce cardiovascular risk by exercising more, losing weight and stop smoking. 
Pearson product-moment correlation coefficients were used to examine the 
relationship between direct and indirect measures of intention (Appendix 85).
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8.5.1 Intentions to exercise more, lose weight and stop smoking
Overall, weak relationships were found between direct and indirect measures of 
intention to reduce cardiovascular risk by exercising more, losing weight and 
stopping smoking. There was no significant correlation between intention to exercise 
more (r=.45, n=903, p=.178), intention to lose weight (r=.63, n=903, p=.060) or 
intention to stop smoking (r= -.141, n=81, p=.210) and requesting a copy of risk 
output results.
8.5.2 Subgroup analysis by risk category
Responses were split by risk category dichotomised into low or moderate/high and 
analysed separately (Appendix 86). Again, no relationships were found between the 
direct and indirect measures of intention. For those in the low risk category, there 
was no significant correlation between intention to exercise more (r=.055 n=748, 
p=.131), intention to lose weight (r=.040, n=748, p=.278) or intention to stop smoking 
(r=-.058 n=49, p=.692) and requesting copy of risk output results.
Neither was a relationship evident for those in the moderate/high risk category. No 
significant relationship was found between intention to exercise more (r=.009 n=155, 
p=.914), intention to lose weight (r=. 141, n=155, p=.080) or intention to stop smoking 
(r=-.289 n=32, p=.109) and requesting copy of risk output results.
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8.5.3 Summary
Overall, there were no significant relationships between the direct and indirect 
measures of intention to reduce cardiovascular risk by exercising more, losing weight 
and stopping smoking. This shows that those who requested a copy of their risk 
output results do not have greater intentions to reduce their cardiovascular risk by 
exercising more, losing weight and stopping smoking. This could imply that those 
who request a copy of their risk output results are not doing so for the purposes of 
wanting to reduce their cardiovascular risk and taking it to their GP to discuss 
cardiovascular risk reduction.
8.6 The efficacy of the Theory of Planned Behaviour in predicting intention to 
change behaviour
This section describes the assessment of the subcomponents of the Theory of 
Planned Behaviour (attitudes, subjective norms and perceived behavioural control). 
Multiple regression models were conducted to see how well the subcomponents 
predict intention to change behaviour in order to reduce cardiovascular risk, by 
explaining the variance in intention to exercise more, lose weight and stop smoking 
scores.
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8.6.1 Assumption testing
Multivariate assumptions were examined before conducting the regression analysis. 
Firstly, the assumptions of multicolinearity and singularity were assessed by 
correlation matrices (Appendix 87). For the dependent variables of intention to 
exercise more and intention to lose weight, there were two instances where 
correlations were above 0.7. However, as these were correlations between the 
independent variables with the dependent variables, no action needed to be taken. A 
violation would have occurred if an independent variable correlated with other 
independent variables, and in these instances it is recommended that these are 
removed (Tabachnick and Fidell 2001). Additionally, the coefficients table was 
consulted and the tolerance values were above the minimum value of .10, whereas 
the VIF (variance inflation factor) values were all less than 10, indicating no violation. 
Assumptions of linearity, homoscedasticity of residuals and existence of multivariate 
outliers were assessed previously and were found not be violated (see Chapter 7).
8.6.2 Intention to exercise more
Multiple regression analysis examined intention to exercise more (Appendix 88). 
Using the enter method, a significant model emerged: F(4,898)= 267.731, p=.000. 
The model explained 54.2% of the variance in intention to exercise more scores 
(Adjusted R2 = .542).
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Figure 8.7 provides information for the predictor variables entered into the model and 
shows the standardised beta coefficients for the independent variable of intention to 
exercise more. Two components made the largest statistically significant contribution 
in explaining the variance in intention to exercise more. Perceived behavioural 
control accounted for 59.7% and attitudes accounted for 24%. Demonstrating that 
intention to exercise more is increased with greater perceived control and more 
positive attitudes towards exercising more. This suggests that exercising is 
dependent on personal motivation, such as own perceived control about being able 
to exercise and attitude towards exercising. It is not influenced by the views of others 
(i.e. subjective norms) or your personal cardiovascular risk.
P=.240
p=.042
Attitudes
Subjective norms
Risk category 
(dichotomised)
Perceived
Behavioural
Control
R2 = .542 >
Intention to 
exercise more
•Significant correlation atp<0.001
Figure 8.7 Standardised beta coefficients for Intention to exercise more in a 
Multiple Regression Model assessing the subcomponents of the TPB
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8.6.3 Intention to lose weight
Multiple regression analysis examined intention to lose weight (Appendix 89). Using 
the enter method, a significant model emerged: F(4,898)= 429.469, p=.000. The 
model explained 65.5% of the variance in intention to exercise more scores 
(Adjusted R2 = .655).
Figure 8.8 provides information for the predictor variables entered into the model and 
shows the standardised beta coefficients for intention to lose weight. The three 
subcomponents of the TPB made a statistically significant contribution in explaining 
the variance in intention to lose weight. Attitudes accounted for 70.3%, perceived 
behavioural control accounted for 28.6% and subjective norms predicted 6.1%. This 
indicates that intention to lose weight can be increased with more positive attitudes 
towards losing weight, greater perceived control and greater influence of subjective 
norms (i.e. the views of significant others). Losing weight is more dependent on 
personal motivation, such as your attitude towards losing weight and your own 
perceived control about being able to lose weight; however, the views of others do 
have small influence on intentions to lose weight. Conversely, actual cardiovascular 
risk does not play a role in decisions to lose weight.
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Figure 8.8 Standardised beta coefficients for Intention to lose weight in a Multiple 
Regression Model assessing the subcomponents of the TPB.
8.6.4 Intention to stop smoking
Multiple regression analysis examined intention to stop smoking (Appendix 90). 
Using the enter method, a significant model emerged: F(4,76)= 17.119, p=.000. The
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model explained 44.6% of the variance in intention to stop smoking scores (Adjusted 
R2 = .446).
Figure 8.9 provides information for the predictor variables entered into the model and 
shows the standardised beta coefficients for intention to stop smoking. Again, all the 
subcomponents of TPB made a statistically significant contribution in explaining the 
variance in intention to stop smoking. Attitudes accounted for 40.6%, perceived 
behavioural control accounted for 34.5%% and subjective norms predicted 20.3%.
This suggests that intention to stop smoking can be increased by more positive 
attitudes towards stopping smoking, greater perceived behavioural control and with 
greater subjective norms. Stopping smoking is dependent on personal motivation 
such as attitudes towards smoking and perceived control over being able to stop 
smoking, as well as the influence of other people. As seen with intentions to exercise 
more and lose weight, personal risk of having a future coronary heart disease event 
does not influence intentions to stop smoking. However, caution should be taken 
when interpreting these results, due to the smaller cell sizes and the low internal 
consistency of some of the components.
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* Significant correlation atp<0.05  
* *  Significant correlation atp<0.001
Figure 8.9 Standardised beta coefficients for Intention to stop smoking in a 
Multiple Regression Model assessing the subcomponents of the TPB.
8.6.5 Summary
This section described the assessment of the efficacy of the Theory of Planned 
Behaviour at predicting intentions to perform the three cardiovascular risk reducing 
behaviours of: exercising more, losing weight and stopping smoking. Multiple 
regression models were conducted and the subcomponents of the Theory of 
Planned Behaviour were entered as independent variables. Significant models 
emerged, indicating that the subcomponents of the TPB do significantly predict
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intention exercise more, lose weight and stop smoking. Attitudes and perceived 
behavioural control consistently predicted the intentions for all behaviours (exercising 
more, losing weight and stopping smoking). Subjective norms significantly predicted 
intention to lose weight and stop smoking. This suggests that higher scores on these 
components lead to greater intentions.
The findings suggest that personal motivation, such as your perceived control about 
performing the behaviour and your attitude towards the behaviour, is more influential 
than the views of others (i.e. subjective norms). Conversely, the risk category of 
respondents did not significantly predict intentions, suggesting that behaviour 
change is not dependent on personal risk of having a future coronary heart disease 
event. The weak contribution made by cardiovascular risk when deciding whether to 
change behaviour may be due to a lack of interest in one’s cardiovascular risk or that 
the risk is not properly understood. However, as described previously, caution must 
be taken when interpreting these findings, as some of the components of the TPB 
failed to reach internal consistency.
8.7 Process Evaluation
This section describes a number of analyses conducted to evaluate the process of
participating in the web-based RCT. This is to gain further information about the
visitors who accessed the website and/or participated in the study, such as the time
respondents spent on the website. Website analytics software was installed (e.g.
Goolge Analytics and AW  Stats). This generates statistics about the total number of
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visits to the website, the country of origin of visitors and information regarding 
external websites that were visited comprising the myHeartRisk website hyperlink. 
Examples of the reports that were generated by the website analytics software are 
given in Appendices 91 and 92.
Google Analytics was installed at the start of the recruitment period (11th February 
2010); however, due to a software conflict it had to be removed on 23rd February 
2010 and replaced with AW  stats. Therefore, the process evaluation analyses using 
the web analytic software combines the results from both Google Analytics and AW  
stats. It must be acknowledged that the statistics reported by these web analytic 
services are based on all traffic to the website, including those who visited the 
homepage only, partial completers, full completers, and non-human activity (such as 
spiders, bots, metacrawlers etc.). It may not accurately reflect the numbers of actual 
human traffic. Additionally, these two web analytic software systems use different 
visitor collection metrics and are not directly comparable. Therefore, the results 
generated from collating the information from these two different web analytic 
systems (Google Analytics and AW  Stats) should be interpreted with caution.
8.7.1 Time spent on website
This section describes the procedure used to calculate the mean time respondents 
spent on the myHeartRisk website. The SQL database was queried to retrieve the 
time that each page of the website was accessed by all visitors. This information was 
exported into a spreadsheet, where fully completed responses were separated from
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incomplete ones. The times spent on the website pages by the respondents who 
successfully completed the study were imported into a SPSS database. The time 
visited on the ‘homepage’ was subtracted from the time visited on the ‘thank you 
page’ (the last page before respondents have the option to input their contact details 
to request a copy of their risk output), this gave the total number of minutes/ seconds 
that the respondents spent on the website in total. There were two incidences where 
it was indicated that the total time spent was zero minutes/seconds, as this was 
obviously a glitch in the web-log database, it was felt necessary to exclude these 
when conducting the descriptive analyses for the total time spent on the website. 
Therefore, a filter was devised to exclude all cases where the time spent on the 
website was stated as zero.
The mean total time spent on the website by respondents who fully completed the 
study was 16.42 minutes (SD= 64.50). The shortest time spent was 2.03 mins and 
the longest time spent was 1271.41 mins (21.19 hours). 20 respondents took over 1 
hour to complete the study. Two of these were on the website for over 20 hours. 
However, it was concluded that this was just artefact where the user had not closed 
the website browser after use.
8.7.2 Analysis of drop-outs
The risk category of the respondents who partially completed the study but dropped 
out before completing the post-intervention questionnaire was analysed. This was to 
examine whether there were actually more respondents categorised as moderate
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and high risk who were motivated enough to visit the website and have their risk 
assessed (but dropped out before the end), than the proportion moderate and high 
risk people who completed the study.
Of the 144 respondents who partially completed the study, 112 completed the risk 
assessment but dropped out before completing the post-intervention questionnaire. 
The risk categories of these partial completers were analysed. As seen in those who 
fully completed the study, there was a disproportionately large number of low risk 
respondents (n= 78, 69.64%), 22 were categorised as moderate risk (19.64%) and 
11 (9.82%) were high risk. This demonstrates that more low risk respondents were 
motivated to take part in the study and have their risk assessed than those at 
moderate and high risk. Therefore, it cannot be concluded that a reason for the 
dropout after the risk assessment was distress from finding out that they were at a 
higher risk category.
8.7.3 Number of visits obtained across the recruitment period
As shown in Figure 8.10, there were 3684 visits (hits) to the website throughout the
recruitment period according to the SQL database. Nearly half of these visits
(n=1675, 45.5%) were made during the first month of recruitment (February 2010).
The number of hits decreases with continuing duration of the recruitment period. The
website achieved 345 hits (9.4%) in the last whole month of recruitment (May 2010),
and 3% (n= 111) was achieved in the last week of recruitment (1-7th June 2010).
This is consistent with the employment of the recruitment strategies, as more effort
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was made at advertising the study at the start of the recruitment period than towards 
the end. This demonstrates that increased exposure of the study increases traffic to 
the website, and therefore increases the likelihood of obtaining respondents who 
complete the study.
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Figure 8.10 Number of hits obtained across the recruitment period according to
the SQL database.
8.7.4 Country of origin of respondents
As web-based studies are accessible globally, information about the country of origin 
of the website visitors is of interest. The web analytic services use information from
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the visitor’s Internet Protocol (IP) addresses to determine this information. According 
to the web analytic services, visitors to myHeartRisk website were recorded from 46 
different countries. The three countries with the highest number of visitors were: UK 
(n=10512), Australia (n=187) and USA (n=169). However, the web analytic services 
categorised some users into categories without an identifiable country. These were: 
Commercial, classified by suffix .com (n=12823); Network, classified by suffix .net 
(n=1288); and Unknown (n=10260). The visits from Network IP addresses are likely 
to be worldwide; however, those from Commercial IP addresses are likely to be from 
USA. The number of visits reported by the web analytic services is greater than the 
number of visits recorded by the host server. This is because the web analytic 
services record all visits to the website including visits from all non-human sources, 
whereas the host sever captured only some of the non-human activity.
8.7.5 Recruitment methods
A number of methods (predominiently electronic and internet-based) were employed 
during the recruitment period. Information about which methods were most 
successful was obtained from the self-reporting of respondents and also statistics 
from the web analystic software. Each will be described in turn.
Self-reported recruitment methods
At the end of the study, respondents were asked to indicate where they heard about 
the study and the myHeartRisk website. Figure 8.11 demonstrates where
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respondents reported that they had been recruited to take part in the study. The 
most successful recruitment method appears to be email invitation as 31.6% (n=285) 
of respondents indicated that they heard about the study by this method. Social 
networking sites (including Facebook, Twitter and over 50s forums) were the second 
most successful recruitment method, as 22.3% of respondents (n=201) were 
recruited by this method. Newspaper articles recruited the fewest respondents 
(n=47, 5.2%) and 112 (12.4%) of respondents did not disclose information about 
where they heard about the study/ website. However, it must be noted that this 
information is self-reported, therefore it cannot be concluded that these frequencies 
are entirely accurate.
Analysis of recruitment methods and sources used to access the myHeartRisk 
hyperlink using web analytic software
The visitor information obtained from the web analytics service gives an indication of 
where all traffic to the website has come from. Figure 8.12 demonstrates the number 
of visits produced by each method of recruitment. For example, social networking 
sites seemed to produce the most traffic (n=919). When these were analysed further, 
Twitter was found to produce 634 visits. Forums (including Sagazone and Over50s) 
produced 165 visits, social bookmarking sites (e.g. delicious, reddit, stumble upon) 
produced 90 visits and Facebook produced 30 visits.
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University electronic noticeboards and staff intranet was the second most popluar 
method used to access the myHeartRisk website (n=672). Of these, Cardiff 
University produced 468 visits, University of Glamorgan produced 117 visits and 
University of Wales, Newport produced 70 visits.
335 vistors to the website came from Search engines. Google (including suffixes: 
.com, .co.uk, .au, and .be) produced 214 visits, Yahoo produced 55 and Microsoft 
live/Bing produced 58 visits. A hyperlink on the Cardiff Council intranet / staff email 
produced 49 visits. Additionally, there were 41 miscillaneous websites with 
hyperlinks that people used to visit the myHeartRisk website. The most popular of
these was http://www.decisionlaboratory.com, which produced 27 visits. However, 
there were 460 direct visits to the myHeartRisk website where no hyperlink was 
used.
1000
Recruitment method.
Figure 8.12 Number of visits produced by each type of recruitment method.
The top 10 most successful sources used to access the myHeartRisk hyperlink are 
represented in Figure 8.13. The Cardiff University electronic noticeboard produced 
the most traffic (n=468), followed by direct visits to the myHeartRisk website (n=460) 
and Twitter (social networking site) produced 351 hits to the myHeatRisk website.
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When information about recruitment methods from respondents self-reporting and 
the amount of traffic according to the web analytic software was combined, it can be 
seen that social networking sites (in particular twitter.com) appear to be the most 
successful method of recruitment (apart from email invitations), as it generated the 
most traffic to the myHeartRisk website and led to the highest number of 
respondents who completed the study.
Posting on University noticeboards (in particular Cardiff University) was the second 
most successful recruitment method. This demonstrates that for web-based studies, 
web-based recruitment methods appear to work best. This is likely to be because 
potential respondents can easily and immediately click on the hyperlink that takes 
them to the study website, rather than having to enter the website address manually 
into the computer’s web-browser the next time they are sitting at a computer, as 
would be the case with non web-based methods of recruitment.
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hyperlink.
8.7.6 Summary of process evaluation
This section described the process evaluation conducted to gain further information 
about the visitors to the website and/or participants of the study. This included the 
time respondents spent on the website, number of visits throughout the recruitment 
period, the country of origin of visitors and which recruitment methods were most 
successful. Respondents completed the study in a reasonable amount of time 
(Mean= 16.42 minutes). There were more visits to the website at the start of the
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recruitment period than at the end, which is consistent with when most of the 
recruitment strategies were employed. Although a web-based study has the potential 
to reach any country around the world, the UK, Australia and United States of 
America produced the most traffic to the myHeartRisk website. According to self- 
reporting of respondents, the most successful recruitment methods were email 
invitation and social networking sites. When information from the web analytic 
software about the where traffic to the website had come from, and which sources 
were used to access the myHeartRisk website hyperlink was analysed, it was found 
social networking sites (in particular twitter.com) and posting on University electronic 
notice boards generated the most traffic and participants to the study. This 
demonstrates that the self-reporting of respondents about where they heard about 
the study produces trustworthy information about the recruitment methods employed.
8.8 Summary of all results
The results from the secondary objectives of the study were described in this 
chapter. The findings are summarised below:
Comparison of the two control groups provided no evidence of a Hawthorne effect, 
demonstrating that thinking about your future risk of cardiovascular disease before 
viewing your actual risk does not lead to an increased intention to change behaviour 
to reduce cardiovascular risk. Analysis of responses from the first control group, who 
completed the pre and post-intervention questionnaires, showed that intention to 
reduce cardiovascular risk by changing behaviour (e.g. exercising more, losing
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weight and stopping smoking) significantly decreased after viewing actual 
cardiovascular risk, converse to what was expected. This will be discussed more in 
the evaluation of the trial (Chapter 9).
Whether respondents requested a copy of their risk output results (which was 
suggested could be taken to their GP to discuss cardiovascular risk reduction) was 
thought to be an indirect measure of intention to reduce cardiovascular risk. It was 
hypothesised that there would be a positive relationship between requesting a copy 
of risk output results and intention to reduce cardiovascular risk by exercising more, 
losing weight and stopping smoking; and that those who requested a copy of their 
risk output results would have greater intentions than those who did not request a 
copy of their risk output results. However, there was no evidence of a significant 
relationship between the direct and indirect measures of intention to reduce 
cardiovascular risk, showing that those who requested a copy of their risk output 
results were not significantly more likely to have greater intentions to reduce their 
cardiovascular risk by exercising more, losing weight and stopping smoking.
Conversely, those who requested a copy of their risk output results possessed 
greater intentions to lose weight than those who did not request a copy of their risk 
output. However, it cannot be determined whether the reason respondents 
requested a copy of their risk output was actually for them to take it to their GP, even 
though it was suggested that they could do this. Perhaps a copy of their risk output 
results was requested for reasons other than assisting with discussions about 
cardiovascular risk reduction with a GP. This indicates that requesting a copy of your
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risk output results is not an adequate indirect measure of intention to change 
behaviour.
The efficacy of the Theory of Planned Behaviour (TPB) at predicting the intention to 
reduce cardiovascular risk was examined using multiple regression models. The 
subcomponents of the TPB significantly predicted intention to exercise more, lose 
weight and stop smoking. Attitudes and perceived behavioural control were the main 
components that predicted intentions for all behaviours (exercising more, losing 
weight and stopping smoking). Subjective norms significantly predicted intention to 
lose weight and stop smoking. This suggests that higher scores on these 
components lead to greater intentions. Therefore, an intervention aimed at 
increasing intentions to change these behaviours, should focus on installing positive 
attitudes and increasing perceived behavioural control over the behaviour. However, 
some of the subcomponents failed to reach internal consistency and therefore, these 
findings should be interpreted with caution.
Lastly, a process evaluation was conducted in order to gain further information about 
the visitors to the website and/or participants of the study. The mean time spent on 
the website was just under 17 minutes. There were more visitors to the website at 
the start of the recruitment period when most of the recruitment strategies were 
employed. Most traffic to the myHeartRisk website came from the UK, Australia and 
USA.
Self-reporting from respondents about where they heard about the study, and the 
statistics generated by web analytic software, indicated that the most successful
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recruitment methods were electronic (internet-based) strategies. The top three 
methods that generated the most traffic and participants to the study appeared to be 
email invitations, social networking sites (in particular twitter.com) and posting on 
University electronic notice boards.
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Chapter 9. Evaluation of the web-based randomised controlled trial 
of cardiovascular risk representation formats.
9.1 Introduction
This chapter will provide an evaluation and critique of the RCT conducted on the 
effects of cardiovascular risk representation formats on intention to change 
behaviour, understanding of risk information, positive and negative affect and worry 
about future risk of heart disease. This chapter will summarise the main findings of 
the trial, compare them to previous literature and consider the strengths and 
weaknesses of the trial.
9.2 Summary of main findings
This section summarises the main findings of the trial. Possible reasons behind the 
unexpected results that did not support the hypotheses are given.
9.2.1 Effects of cardiovascular risk representation formats
This trial found no significant main effects of graphical cardiovascular risk 
representation format on intentions to change behaviour, understanding of risk
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information, affect or worry about future risk of heart disease. This finding suggests 
that the type of format used to present risk to individuals has little effect in motivating 
individuals to making risk-reducing changes to their behaviour, does not influence 
emotions (including worry about future risk of heart disease); and that no one format 
is more helpful in facilitating understanding of risk information than another. This 
leads to the conclusion that intentions to change behaviour in order to reduce 
cardiovascular risk, are not influenced by the risk representation format used in the 
risk communication, but are dependent on other factors. Therefore, developers of 
risk communication interventions need to use clear representation formats in their 
tools, but may not need to be concerned with the subtle differences in formats. It 
may be more beneficial for them to focus more on the motivational issues regarding 
risk reducing behaviour change. However, it is possible that the lack of effect found 
in this study is due to a type II error resulting from the biased, unrepresentative 
sample. This will be discussed in more detail in Chapter 10.
9.2.2 Predicting intention to change behaviour
Multiple regression models found that a moderate amount of variance in intention to 
exercise more and intention to lose weight scores was explained by the independent 
variables measured in this trial (11.7% and 3.8% respectively). Intention to stop 
smoking was not significantly predicted by the independent variables. This is likely to 
be due to the lack of current smokers in the study (n=81, 9%) resulting in an 
inadequately powered model.
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Intention to exercise more was significantly predicted by affect (positive and 
negative), risk category of respondents (as described above) and understanding of 
risk information. Whereas, intention to lose weight was significantly predicted by 
positive affect and understanding. This is an important finding to the developers of 
interventions aimed at increasing health-protective behaviours, as it suggests that 
increasing positive emotions will facilitate greater intentions to adopt behaviours, 
such as increasing level of physical activity and losing weight.
Understanding of risk information also made a significant contribution; however the 
beta coefficients were negative, indicating that in an intervention aiming to increase 
intention to exercise more or lose weight, understanding of risk information should be 
reduced. This should not be taken as evidence that motivating behaviour change 
results from limiting an individual’s understanding of the risk information, which could 
be argued to be unethical. A more plausible explanation is that this is an artefact 
resulting from the high proportion of respondents who possessed complete or partial 
understanding of the risk information presented to them, and the high proportion of 
respondents who were categorised as low cardiovascular risk but still possessed 
high intentions to change behaviour.
9.2.3 Changes in affect
This trial found that viewing cardiovascular risk alters emotions by significantly 
reducing positive and negative affect and worry about future risk of heart disease.
The extent that these were reduced depended on the person’s risk category. For
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example, those of moderate or high cardiovascular risk had greatest reductions in 
positive affect, whilst those at low cardiovascular risk had greatest reductions in 
negative affect and worry about future risk of heart disease. This demonstrates that 
risk magnitude plays an important role in how people feel about their risk, which in 
turn may influence subsequent behaviours. However, this is only partially supported 
by the multiple regression models that found that the risk magnitude only significantly 
predicted intention to exercise more, and not intentions to lose weight or stop 
smoking.
The lack of influence of risk magnitude on intentions to lose weight and stop smoking 
may be due to the over-representative sample of people at low risk who did not 
actually need to lose weight or stop smoking, and therefore had low intentions to 
perform these behaviours. This would decrease the ability to detect meaningful 
trends in the data. Alternatively, it could be that people perceive increasing the 
amount of exercise that they do as more effective in reducing cardiovascular risk 
than losing weight or stopping smoking. Therefore, exercising more would be the 
favoured risk reduction option, resulting in greater intentions to perform this 
behaviour when informed of personal cardiovascular risk.
9.2.4 Correlational validity hypothesis between understanding and
intention to change behaviour
This trial found no support for the correlational validity hypothesis (Ubel 2008) that 
suggests intentions to change behaviour are greater with increased understanding of
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risk information. No significant correlations were found between the level of 
understanding and intention to exercise more or intention to lose weight The reverse 
was found for intention to lose weight, where intention significantly decreased with 
increased understanding (in those of low cardiovascular risk). A reason for this is 
finding is likely to be due to the over-representative sample of respondents 
categorised as low cardiovascular risk and a small number of respondents 
categorised as moderate or high risk (n=155, 17.2%). Furthermore, the majority of 
respondents possessed partial to full understanding of the risk information presented 
to them. The uneven cell sizes result in an under-powered analysis and reduces the 
statistical ability to identify any significant differences between intentions to change 
behaviour (i.e. exercising more, losing weight and stopping smoking) and 
understanding of risk information. Therefore, the correlational validity hypothesis 
cannot be confirmed or rebutted by the results of this trial. Further research is 
needed before any conclusions are made regarding the true relationship between 
understanding of risk information and intention to change behaviour.
9.2.5 Curvilinear relationship between intention to change behaviour and
worry about future risk of heart disease
Previous literature supports the existence of a curvilinear (inverted-U) relationship 
between worry and intention to change behaviour hypothesised that the extremes of 
worry about future risk of heart disease (i.e. low and high) lead to the reduced 
intention to change behaviour (Consedine et al. 2004; Witte 1998). The results from 
this trial did not support this hypothesis as there was no evidence of a curvilinear
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relationship between intention to change behaviour and worry about future risk of 
heart disease. Significant positive relationships were found when responses were 
dichotomised by risk category. However, these relationships were linear. For 
example, intention to lose weight for those categorised as moderate risk, increased 
with greater worry about future risk of heart disease. This relationship is logical, as 
those of moderate or high risk may in fact be worried about their risk of having a 
future coronary heart disease, and feel that losing weight would help reduce their 
cardiovascular risk. However, for those categorised as low risk, increased worry 
about future risk of heart disease led to decreased intention to exercise more.
A possible explanation for this finding is that respondents were worried about their 
future risk of heart disease, but felt that increasing exercise levels was not an 
effective method to reduce cardiovascular risk. However, it is more likely that this 
finding is an artefact from having a over-representative sample of low risk 
respondents who did not need to reduce their cardiovascular risk. This makes it 
difficult to detect true differences in the data. Furthermore, the results were skewed 
by the ‘worried well’ who possessed high intentions to change behaviour even 
though they were informed of their low cardiovascular risk. Perhaps these 
respondents were reassured by their low risk result, but were still anxious about their 
future risk of heart disease, and therefore still intended to maintain a healthy lifestyle 
so not to elevate their cardiovascular risk in the future by modifiable risk factors.
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9.2.6 Hawthorne effect
Comparison of the two control groups, in which one group received a pre­
intervention questionnaire on perceptions of and intentions to reduce cardiovascular 
risk provided no evidence of a Hawthorne effect. This demonstrates that thinking 
about your future risk of cardiovascular disease before viewing your actual risk does 
not lead to an increased intention to change behaviour. Converse to what was 
expected, the analysis of responses from the first control group who completed the 
pre and post-intervention questionnaires, showed that intention to reduce 
cardiovascular risk by changing behaviour (exercising more, losing weight and 
stopping smoking) significantly decreased after viewing actual cardiovascular risk.
Again, this finding is likely to be due to the over-representation of respondents 
categorised as low cardiovascular risk, and the ‘worried well’ who were concerned 
about their risk. Perhaps they initially thought their risk was higher than that 
predicted by the risk calculator (i.e. were incorrectly pessimistic about their risk), and 
therefore reported a high intention to reduce their risk of heart disease at pre­
intervention. This intention may have decreased after they were informed of their low 
risk result.
9.2.7 Theory of Planned Behaviour
The efficacy of the Theory of Planned Behaviour at predicting the intention to reduce 
cardiovascular risk through exercising more, losing weight and stopping smoking was
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examined using multiple regression models. The subcomponents of the TPB 
significantly predicted intention to exercise more, lose weight and stop smoking. 
Attitudes and perceived behavioural control were the main components that predicted 
intentions for all behaviours (exercising more, losing weight and stopping smoking), 
subjective norms significantly predicted intention to lose weight and stop smoking.
This finding suggests that greater intentions to change behaviour in order to reduce 
cardiovascular risk can be achieved by promoting more positive attitudes towards the 
behaviours, increasing perceived behavioural control (i.e. sense of control over heart 
disease and the self-efficacy that the desired behaviour can be achieved), and for 
losing weight and stopping smoking only, increasing the perceived influence of 
significant others.
However, these findings should be interpreted with caution, as although the items 
measuring the components appeared to have face validity, some items failed to reach 
internal consistency (i.e. they did not correlate with each other to a satisfactory level 
as expected in psychological scales).
9.2.8 Direct and indirect measures of intention to change behaviour
An indirect measure of intention to reduce cardiovascular risk was whether 
respondents requested a copy of their risk output results that could be taken to their 
GP to discuss cardiovascular risk reduction. It was hypothesised that there would be a 
positive relationship between requesting a copy of risk output results and intentions to
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exercise more, lose weight and stop smoking; those who requested a copy of their risk 
output results would have greater intentions than those who did not request a copy of 
their risk output results. However, there was no evidence of a significant relationship 
between the direct and indirect measures of intention to change behaviour, showing 
that those who requested a copy of their risk output results were not more likely to 
have greater intentions to exercising more, losing weight and stopping smoking than 
those who did not.
This study shows that requesting a copy of cardiovascular risk output results is not an 
adequate measure of intention to reduce cardiovascular risk. It cannot be certain that 
respondents who requested a copy of their risk output actually intended to take it to 
their GP to facilitate discussions about cardiovascular risk reduction. Perhaps a copy 
of their risk output results was requested for other reasons, such as a reminder of their 
risk printed for reassurance, a token for taking part in the study, or curiosity as to what 
the output would look like or whether information about risk reduction would be 
provided. As intention to change behaviour is only a proxy measure of actual 
behaviour change, this finding shows that in circumstances where actual behaviour 
change cannot be measured, a more appropriate measure is needed than indirect 
measures that are merely suggestive of behaviour change.
9.2.9 Measures of understanding of risk information
This trial attempted to address the limitations of previous research that has measured 
understanding by asking respondents to report the risk that was presented to them.
398
This measures recall ability and not whether respondents have actually understood 
the risk information. Additionally, proxy measures of respondent’s self reported 
confidence in their understanding are often used in other studies. Again, this does not 
address whether individuals are accurate in their interpretation of the risk information.
This trial attempted to address these issues by using a measure of subjective 
understanding. This asked respondents what someone in the same risk category as 
them should do about their cardiovascular risk. The pre-defined options were: do a lot 
to reduce risk; do a little to reduce risk or do nothing to reduce risk. This measure 
allowed the assessment of whether respondents understood the implications of their 
risk category. For example, a correct response for someone categorised as high risk 
would be the acknowledgment that someone in that risk category should be doing a 
lot in order to reduce their cardiovascular risk. This was measured along with 
probability perception (i.e. recall of the assigned risk category) and confidence in 
understanding (i.e. how confident respondents are that they have understood the risk 
information presented to them). Comparing the responses for the probability 
perception and subjective understanding items allowed a judgement to be made on 
the level of understanding of the respondents. Those who answered both items 
correctly were regarded as having complete understanding of their risk, those who 
answered one of the two items correctly had partial understanding, and those who 
answered both items incorrectly were said to have no understanding.
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Level of understanding and confidence in understanding
Level of understanding was compared to confidence in understanding to see whether 
respondents who reported being confident that they understood the risk information 
presented to them had actually interpreted the information correctly. This allowed for 
conclusions to be made about the adequateness of confidence in understanding as a 
proxy for measuring whether respondents understood the risk information.
The findings of this trial found a significant negative correlation between level of 
understanding and confidence in understanding, where confidence decreased as level 
of understanding increased. This suggests that those who report being confident that 
they have understood their risk were more likely to have interpreted their risk 
incorrectly. This provides evidence against the use of confidence in understanding as 
a proxy measure. As the analysis combined the responses across the four trial 
conditions, a reason for these findings could be that respondents in the second 
intervention group were unfamiliar with the metonym format, as this trial was the first 
to use this representation format to communicate cardiovascular risk. Perhaps 
respondents felt unsure about the images used to represent the different risk 
categories for future coronary heart disease risk, and were therefore unconfident in 
their interpretation of their risk category.
An additional explanation for the findings could be the over-representation of 
respondents who possessed a partial or high level of understanding which may have 
resulted from the biased sample of highly educated respondents (educated to degree 
level or equivalent), who were likely to have above average numeracy skills.
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Inappropriate subjective understanding
The majority of respondents had only a partial level of understanding, as most 
incorrectly answered the subjective understanding item. Low risk individuals felt that 
someone of their risk category should be ‘doing a lot’ to reduce their cardiovascular 
risk, thus leading to the conclusion that they possessed an inappropriate subjective 
understanding of their cardiovascular risk. A more fitting response for someone 
categorised as low risk would be that they did not need to do anything further in 
order to reduce their cardiovascular risk.
One explanation for the lack of subjective understanding was that the responses 
came from the ‘worried well’. The ‘worried well’ are anxious and over-pessimistic in 
their risk perceptions about developing cardiovascular disease in the future, and feel 
that it is best to live a healthy lifestyle and do everything they can to prevent the 
occurrence of future disease.
However, another possible explanation could be that respondents who took part in 
this trial did not trust the risk prediction given to them. The Personal Heart Score 
(Mainous et al. 2007) predicts cardiovascular risk based on self-reported information, 
in absence of physiological measurements. This may have provided a conservative 
result leading to an under-estimation of risk. Respondents may not have trusted the 
result that was presented to them. This will be discussed further with regards to the 
internal validity of the intervention of this trial.
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9.2.10 Summary
This section has described the main findings of the RCT of cardiovascular risk 
representation formats. The most plausible explanation given for the lack of effect or 
findings contrary to the hypotheses was the over-representative sample of 
respondents at low cardiovascular risk, and the possible ‘worried well’ who reported 
inappropriate intentions to change behaviour to reduce cardiovascular risk. This 
skewed the majority of the findings because intention to change behaviour was the 
primary outcome measure and was used in most of the analyses.
9.3 Comparison with previous literature
This section will present previous research that supports or contradicts the findings 
from this trial. Differences in risk representation formats, positive emotions and 
health, the impact of risk magnitude on intention to change behaviour, risk 
perceptions, and the psychological effect of screening and risk prediction will be 
considered.
9.3.1 Evidence of different effects of risk representation formats
This trial did not find any significant differences in the graphical risk representation 
formats, in terms of intention to change behaviour, understanding of risk information, 
positive and negative affect and worry about future risk of heart disease. This finding
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suggests that the representation format used when communicating risk is of little 
importance. No one format is better than another at influencing a patient’s motivation 
to reduce cardiovascular risk, enhancing understanding of the risk information or 
altering emotions. This is consistent with a previous web-based RCT that examined 
the effects and preferences for different risk formats in people with diabetes 
(Edwards et al. 2006b). The trial comprised four intervention groups: (1) detailed 
numerical information (absolute/relative risk; numbers needed to treat); (2) anchoring 
information (i.e. matching it to everyday or familiar risks/descriptions); (3) graphical 
presentation (bar graphs, thermometer scales; population/ crowd diagrams; and (4) 
all three combined. No significant effects of the interventions were found on 
decisional conflict (e.g. patients’ confidence or uncertainty about whether they feel 
their treatment choice is the best for them personally) or satisfaction with the 
information. However, natural frequencies were the most preferred numerical format, 
and bar graphs were the most preferred graphical format, these were viewed as 
more helpful than pictograms or thermometer formats (Edwards et al. 2006b).
More recently, a trial of cancer and arthritis patients in Singapore examined the 
effects of risk representation formats on agreement to participate in a hypothetical 
clinical trial of a pain relief medication. Patients received information about the risk of 
side effects in one of three formats (frequency, percentage and verbal descriptor).
No differences were found in the willingness to participate in the hypothetical trial, or 
on the likelihood of changing one's decision. However, the frequency format was 
strongly preferred by most patients (Cheung et al. 2010).
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Furthermore, differences in risk perceptions, emotional reactions and screening 
intentions resulting from different formats for presenting risk of colorectal cancer was 
been assessed by Lipkus et al (1999). Participants were presented with absolute 
lifetime risk of getting colorectal cancer either with or without comparative risk, 
compared to other cancers and related risk factors (e.g. age and polyps). No 
differences were found between the formats in how worried, anxious and fearful 
participants felt about getting colorectal cancer or their intentions to be screened for 
colorectal cancer (Lipkus et al. 1999).
Evidence that risk presented in different formats has little impact on the treatment of 
patients by health professionals comes from a trial by Fahey et al (2001), who 
evaluated the effect of framing of cardiovascular risk as two formats in clinical 
practice guidelines for controlling blood pressure. No significant differences were 
seen when risk was presented in the clinical guidelines as absolute risk or as 
numbers needed to treat in blood pressure control, cardiovascular risk reduction or 
intensity of prescribing of blood pressure lowering drugs at 12 month follow-up 
(Fahey et al. 2001).
Some research evidence contradicts the lack of effect of different cardiovascular risk
representation formats found in this trial. For example, Timmermans et al (2008)
presented participants with hypothetical health scenarios (including hereditary
hypercholesterolemia, hereditary breast cancer and prenatal testing for Down
syndrome) where risk information was presented in different formats (percentages,
natural frequencies and pictogram/ population diagrams). A correlation was found
between affective evaluation and perceived chance of the risk occurring. There were
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significant differences between the formats (p<.05). Population diagrams had the 
highest affective impact, i.e. risks were regarded as the most frightening, worrisome 
and serious compared to risks presented as percentages and frequencies. There is 
debate whether this is a desirable effect. It is suggested that a problem of using a 
more ‘affective’ format may be that evaluation of the probability is influenced and 
distorted by the value of the outcome of the risk (i.e. value induced bias) leading to 
inaccurate risk perceptions. Furthermore, the risk representation formats influenced 
treatment decisions, as significantly more respondents receiving the pictogram 
formats favoured preventive surgery over screening, than respondents who received 
risks as frequencies or percentages (p=.05), perhaps this was due to the heightened 
affective evaluation and greater perceived chance of risks occurring when this format 
was presented. Conversely, no significant differences were found between the 
formats for cognitive evaluation e.g. how complex, difficult to understand and how 
hard it was to imagine the formats (Timmermans et al. 2008).
An on-line randomised trial by Soureti et al (2010) compared percentage format with 
cardiovascular age equivalent or Heart-Age analogy format. The 204 participants 
who received the Heart-Age format, had more realistic risk perceptions that were 
more in-line with their actual risk, but were significantly more worried (p=.005) and 
were more likely to view the risk result as a ‘wake-up’ call (p=.004), than the 209 
respondents who received the percentage format (particularly in younger individuals 
at higher CVD risk). The Heart-Age format also lead to significantly greater 
percentage of respondents (84.3%) reporting that they intended to eat more healthily 
and increase their level of physical activity (82.4%), compared to 79.9% and 76.6%
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of respondents who received the percentage format expressing 10-year risk of 
cardiovascular disease (Soureti et al. 2010).
Another web-based randomised trial compared four graphical displays of the benefits 
of antibiotics for people with sore throat who were deciding whether to seek 
treatment (Carling et al. 2009a). Participants were asked to imagine they had a sore 
throat and were deciding whether or not to seek medical treatment. Information 
about the benefits of antibiotic treatment were presented in four formats although 
only two of these displayed equivalent information (e.g. a pictogram of happy/sad 
face icons and a bar graph showing the proportion of people with symptoms on day 
three with and without treatment). There were significant differences in the 
participants’ ability to understand the information presented by the formats and 
participants showed preferences for one format over another. For example, a bar 
graph (showing the duration of symptoms) was reported to be the easiest to 
understand (37%) and was the most preferred format (38%), whereas the pictogram 
of faces was the least easiest to understand and was preferred the least out of all the 
formats. There were also significant differences in the decisions to seek medical 
treatment across the graphical formats, but not for the two formats that presented 
equivocal information. These two formats had the highest proportion of respondents 
reporting they would seek medical treatment (34.6% and 34.4% respectively) with no 
significant difference between them (Carling et al. 2009a).
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Furthermore, Carling et al (2009) report the findings a web-based randomised trial 
comparing summary statistics for communicating the effects of statins on the risk of 
coronary heart disease (Carling et al. 2009b). Information was presented in six 
formats (relative risk reduction, absolute risk reduction, number needed to treat, 
event rates, tablets needed to take and natural frequencies). The relative risk 
reduction format (known to be most persuasive) motivated behaviour change 
through treatment choices, as it resulted in a 21% higher probability of choosing to 
take statins, compared to the other formats. Furthermore, natural frequencies were 
reported to be best understood, as 86% of participants reported they understood 
them well or very well (Carling et al. 2009b). However, as understanding was 
measured by self-report, it cannot be determined whether any of the formats led to a 
more accurate understanding of the risk information and not just perceived 
understanding.
Lastly, an analogue study comprising hypothetical risk profiles examined the impact 
of graphical risk representation formats on motivation to quit smoking. It was 
hypothesised intentions to quit smoking would differ in participants who viewed 
pictograms comprising grouped icon displays compared to dispersed icon displays. 
180 smokers were randomly allocated to vignettes about the genetic risk of Crohn’s 
disease, varying in terms of the graphical display (e.g. icon arrays of grouped or 
dispersed icons). Grouped icon displays were more motivating than the dispersed 
icons, as participants receiving risk information in the form of grouped icons reported 
a greater intention to quit smoking than those who received the dispersed icon array 
(Wright et al. 2008).
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The inconsistent research into the effects of risk representation formats is likely to be 
partly due to previous research that has focused on different formats, using different 
outcome measures to assess their effects. However, the contradictory results do 
also suggest that there are individual differences in how people respond to risk 
representation formats (perhaps based on a variety of factors that have not been 
controlled for in the previous trials), and it may never be determined with format is 
the most effective in terms of motivating behaviour change, facilitating understanding 
and altering inappropriate emotions, as there is simply no ‘magic bullet’ for 
communicating risk to everybody.
This view is supported by findings from a focus groups of health consumers and GPs 
(Hill et al. 2010). Sixteen risk representation formats were presented including 
statements, icon arrays / population diagrams, graphical formats (such as bar graph, 
thermometer, line graph) alone or in combination. Participants were asked about 
their understanding of risk and how they thought risk tools might be discussed in a 
doctor-patient encounter. For each format, consumers were asked whether the 
format was clear and how it made them feel (e.g. scared, concerned, reassured, do 
not care); GPs were asked whether they thought their patients would understand and 
how they thought they would react. Formats were considered to be the most 
preferred if they were most easily understood and the most effective in convincing 
consumers that 16% was a high risk for CVD over 5 years. There was evidence that 
no one format is suitable for all patients, as some formats were rated as clear and 
effective by some, but rated as unclear and confusing by others. For example, many 
participants viewed the icon arrays/ population diagrams and line graphs as unclear,
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confusing or potentially misleading, but graphical formats in general were perceived 
as helpful for representing risk. The most preferred formats were vertical bar graph, 
thermometer scale (presenting risk as percentages and using colour to indicate risk 
levels ( as a traffic light system). Two formats that were preferred provided 
comparative risk information to help indicate degree of risk, this included risk 
statement presenting risk as a percentage and comparison with an average older 
person. Concern was raised over the use of green to indicate low risk (i.e. the traffic 
light system), with fears that this could be interpreted as safety rather than neutrality 
(Hill et al. 2010). An additional focus group regarding diabetes risk information 
reported similar findings, such as preferences for simple visual formats, with logical 
use of colour and comparative cues (Price et al. 2009).
To conclude, this trial did not find any differences in the effects of graphical risk 
representation formats on intentions to change behaviour, understanding of risk 
information and emotions. It still remains unclear whether this trial failed to identify 
true differing effects resulting from the risk representation formats, or whether the 
portrayal of risk has little influence on patients’ behaviours, cognitions and emotions. 
It could also be true that there is no ‘magic bullet’ suitable for communicating risk to 
everyone, which if this is the case, creates considerable challenges for GPs when 
conveying risk information to patients. More research is needed before any 
conclusions can be drawn as to the importance of representation formats in risk 
communication.
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9.3.2 Positive emotions and health
Positive affect was the largest contributor to the variance in intention to change 
behaviour scores. It was the only variable that was significantly associated with all 
three behavioural intentions (exercise more, lose weight and stop smoking). Positive 
emotions accounted for 32.9% of the variance in intention to exercise more scores, 
18.8% of the variance in intention to lose weight scores, and 28% of the variance in 
intention to stop smoking scores. This suggests that positive emotions have an 
influence on decisions to change behaviour.
This finding supports previous research on ‘positivity’ that suggests that positive 
emotions, such as appreciation, hope, gratitude and joy, contribute to psychological 
and physical well-being via more effective coping (Tugade et al. 2004). Positive 
emotions open the mind by broadening a person’s outlook, allowing for the discovery 
and building of new skills, new knowledge and new ways of being (Fredrickson 
2009). Positivity has long-term effects, as positive emotions help to build-up 
resources. These include physical resources, such as a better night’s sleep, as well 
as psychological resources, such as increased optimism and resilience (Fredrickson 
2009).
More specifically, the broaden-and-build theory of positive emotions (Fredrickson
2001) postulates that positive emotions ‘broaden’ people’s ideas about possible
actions in contrast to negative emotions that narrow ideas. This leads to increased
awareness to a wider range of thoughts, actions and acceptable behavioural options,
making the person more creative and receptive to information, meaning a person in
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a positive frame of mind will be more accepting and willing to make behavioural 
changes in order to reduce health risks.
When relating the findings of this trial to this theory, it can be suggested that 
positivity and positive emotions lead to ‘a richer appreciation of life’ (Tugade et al. 
2004, p.1166). This results in a desire for longevity and wanting to be at your best by 
looking after your health. Positivity and positive emotions means people will be more 
likely to look after themselves, be open to new knowledge and suggestions about 
how to stay healthy, and be more likely to adopt health protective behaviours. 
Additionally, Fredrickson suggests that positivity can help build psychological 
strength which can facilitate changing ‘bad’ habits into good ones (Fredrickson 
2009). The evidence that positive emotions lead to better coping strategies by 
increasing psychological resilience, means that positive emotions may reduce the 
need for people to rely on behavioural practices that are considered harmful to their 
health, as a way of coping with life-events and stressful situations, such as smoking, 
eating unhealthy food, excessive alcohol consumption etc. Therefore, developers of 
health interventions should focus on increasing a person’s positive emotions to 
effectively increase health protective behaviours.
9.3.3 Risk perceptions
This trial found evidence of inappropriate risk perceptions, as the item measuring 
subjective understanding (i.e. what someone in the same risk category should do to 
reduce their risk) indicated that individuals at low risk intended to ‘do a lot’ to reduce
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their risk of future heart disease. These could be labelled as the ‘worried well’, who 
are informed about their low risk but are still anxious to monitor their risk and may 
feel the urge to ask for diagnostic or therapeutic interventions (van Steenkiste et al. 
2004b).
Risk perceptions can be inaccurate in two ways: firstly, as demonstrated above, low- 
risk patients overestimate their risk or are overly anxious about their risk of CVD 
(termed as incorrect pessimism or pessimistic bias); and secondly, high-risk patients 
underestimate the probability of CVD or are not anxious about being of elevated risk 
(termed incorrect optimism or optimistic bias). It is surmised that the inappropriate 
intentions to change behaviour displayed by the low-risk respondents in this trial are 
suggestive of an overestimation of cardiovascular risk and pessimistic bias.
Studies comparing actual and perceived risk of CVD, have found that inappropriate 
risk perceptions are common among patients in primary care settings. For example 
incorrect pessimism was seen in 1 in 5 low risk patients visiting the GP for a 
consultation about their cardiovascular risk (van der Weijden et al. 2007). 
Additionally, incorrect perceptions and overestimations of risk have been seen in 
between 42 to 48% of participants in other studies (Alwan et al. 2009; Frijling et al. 
2004).
Evidence for underestimation of risk (i.e. optimistic bias) has also been found. For
example, the study described above by van der Weijden et al (2007) found that
nearly 4 in 5 high risk patients were incorrectly optimistic about their risk (van der
Weijden et al. 2007). In another study, patients were asked to compare their risk of
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CHD or Ml with an average person of the same and sex. More than one-third of high- 
risk patients reported their risk of Ml as lower than the average person (equating to 
nearly half of women and more than one half of men reporting optimistic bias) (Aalto 
et al. 2007). Furthermore, when assessing patients’ perceptions of their risk of heart 
attack and stroke, 45% displayed optimistic bias. This was higher than the 
percentage of people overestimating their risk of cancer or risk of a motor vehicle 
crash (16% and 11% respectively) (Kreuter and Strecher 1995).
Biases in risk perception have also been seen in doctors as well as patients (Lloyd 
2001). A review into the risk perceptions of patients facing treatment risks sought to 
identify the accuracy of the risk perceptions, the factors that affect these risk 
perceptions and explanations for the reasons why risk perceptions are not always 
accurate. The findings suggested that both patients and doctors exhibit some form of 
biases in risk perception and decision making, where many patients have poor 
comprehension and recall of risk information (Lloyd 2001).
Interventions aimed at correcting patients’ risk perceptions have had varying
success. For example, in a study Paterson et al 2002, where nearly all participants
overestimated their risk, a Heartcheck workbook displaying 10-year risk of having a
coronary event (e.g. angina pectoris, Ml or coronary death) in percentages, and
relative risk presented in a table format, along with information about major
contributing risk factors, successfully corrected risk misconceptions. This was seen
even in participants under 40 years of age and those of low numeracy skills
(Paterson et al. 2002). Moreover, Kreuter and Strecher (1995) found a risk feedback
intervention, comprising graphic and numerical presentation of 10-year mortality risk
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of Ml and a table of treatment options and goals for achieving and maintaining 
desirable risk level, significantly improved accuracy of risk perceptions in those who 
were optimistically biased. This was maintained at 6 month follow-up (Kreuter and 
Strecher 1995).
However, some interventions have been found not to successfully alter inaccurate 
risk perceptions. For example, a web-based risk calculator for predicting diabetes 
risk for those who were over 45 years of age, failed to correct inaccurate risk 
perceptions after using the website. Reasons for this finding were proposed, 
including participants not paying attention to the information provided, having 
numeracy difficulties or limited understanding of the risk estimates, and the 
information viewed as being non-credible and not persuasive (Harle et al. 2008).
Correction of risk perceptions may only be successful in the short-term. For example, 
a study by Christian et al (2005) found that most women in their sample, who were of 
low risk, overestimated their risk; whereas most women at moderate/high risk 
underestimated their risk. A brief educational intervention aimed at improving 
knowledge of personal risk improved accuracy of risk perceptions immediately after 
the intervention, but after one month follow-up, only half the participants maintained 
their accurate perceptions (Christian et al. 2005). This could be taken as evidence to 
support the findings from patient interviews by van Steenkiste et al (2004) that found 
risk perceptions are rarely based on facts, and are more often based on familiarity 
with the disease, and how it relates to experiences with family, close friends or 
colleagues who have suffered from CVD (van Steenkiste et al. 2004b).
414
Risk perceptions have been found to have an effect on emotions. For example, 
higher perceived risk has been associated with a less positive and more negative 
mood (measured by PANAS). Providing patients, who were originally incorrectly 
pessimistic about their risk of CHD and stroke as a consequence of diabetes, with an 
accurate risk estimate of their CHD/stroke risk improved their mood, by decreasing 
negative emotions and increasing positive emotions. Mood improved with increasing 
correction of the difference between actual and perceive risk, i.e. biggest 
improvements in mood were seen for those who had the greatest inaccuracies of 
their perceived risk compared to their actual risk (Asimakopoulou et al. 2008b).
Furthermore, in the study by van der Weijden et al (2007), anxiety correlated 
moderately well with absolute probability perception, suggesting that correcting 
inappropriate risk perceptions might be a successful vehicle to reduce inappropriate 
anxiety (van der Weijden et al. 2007).
Risk perceptions also have the potential to influence health-related intentions and 
behaviours (Ali 2002). A study into the Health Belief Model revealed that perceived 
susceptibility to CHD explained 76% of the variance in CHD preventive behaviours 
such as ‘engaging in physical activity for at least 30 minutes 3-5 days a week’ and 
‘when eating out, selecting low fat, low cholesterol foods’ (Ali 2002).
In contrast, evidence against a relationship between risk perceptions and intention to
change behaviour has also been found (Hivert et al. 2009). The perception of
diabetes risk was measured in non-diabetic patients using a validated risk perception
survey. Those who had a higher perceived risk did not display greater intentions to
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adopt a healthier lifestyle than those who had lower perceived risk (p=0.69). 
However, true differences between the groups may not have been detected due to 
the biased sample willing to take part in the study. Participants in this sample were 
possibly more health conscious than non-participants, as there was a high reporting 
of behaviour changes that were made recently before participating in the study. 
Additionally, the sample comprised middle-aged, Caucasian and well educated 
participants, which further limits that generalisability of the results (Hivert et al. 2009).
To conclude, this trial has provided evidence that people have difficulty in accurately 
estimating their risk. This is consistent with other research that has found that 
patients commonly overestimate their risk. Research shows that risk perceptions 
influence emotions and subsequent intentions and behaviour. It is important for 
patients to have accurate risk estimates, as inaccurate risk estimation can have 
implications in primary care. For example, high risk patients who do not perceive 
themselves to be at risk and are prescribed medication for lowering cholesterol may 
be poorly motivated to adhere to the medication. Conversely, low risk individual’s 
who overestimate their risk and worry about their health may request treatment and 
be over-treated or over-investigated (van der Weijden et al. 2008).
9.3.4 Psychological effects of screening and risk prediction
This trial found that viewing cardiovascular risk significantly decreased negative 
affect and worry about future risk of heart disease. The greatest reductions were
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seen for those categorised as low risk. This supports the findings by Pijl et al (2009) 
that presenting a patient’s actual risk of diabetes (in a graphical bar graph, 
accompanied by information about diabetes and prevention), increased positive 
affect and decreased negative affect and worry about the chances of getting 
diabetes at three month follow-up (although differences were not statistically 
significant) (Pijl et al. 2009). In a cardiovascular screening context, a randomised trial 
into a population-based intervention programme aiming to reduce risk of CVD found 
no evidence to suggest that participation on the programme led to an increase in 
anxiety or concern about health. However, this may have been due to the 
intervention being nurse-led and therefore, any adverse effects may have been 
dispelled (Marteau et al. 1996).
This trial also found a decrease in positive affect for all respondents, including those 
of low cardiovascular risk. This was unexpected as a low risk outcome could be 
associated with providing reassurance to the individual and therefore, positive 
emotions should increase, particularly in the ‘worried well’. Previous studies have 
found a lack of reassurance from favourable (i.e. negative) test results, and proposes 
that this stems from a disparity between expectations of being at increased personal 
risk and the negative or low risk result, which may lead to distrust of the risk 
assessment tool and its result (Michie et al. 2003; Michie et al. 2002). This suggests 
that upholding the original (incorrect) risk perception by mistrusting the new risk 
information is favoured over updating or readjusting initial estimations of own risk.
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The decrease in positive emotions seen in this trial is likely to be short-term 
consequence only. A review into the psychological effects of screening that included 
54 risk assessment studies (21 involving cardiovascular risk), examined the 
psychological effects of predicting individuals’ risk of illness. It was found that 
adverse psychological effects (such as depression, anxiety, poorer perceptions of 
health and psychological distress) were common as an immediate consequence of 
having a positive test result. Anxiety and depression were significantly higher in 
those with a positive result compared with those who tested negative in the short­
term (up to four weeks after testing). However, these effects dissipated over time, 
and there was no evidence of any long-term adverse effects (Shaw et al. 1999).
It is argued that the variation in the responses to risk assessment arises from the 
differences in how risk is assessed, and in how participants respond to threatening 
information. It is suggested by Shaw et al (1999) that providing detailed information 
about the meaning of test results and methods of coping with the distress generated 
by positive test results are important components to include in risk assessment 
programmes, to minimise the occurrence of adverse psychological distress (Shaw et 
al. 1999). In contrast, it is important to ensure that people who are found not to be at 
increased risk do not develop a false sense of reassurance or feel invulnerable to 
any adverse effects resulting from their risky behaviour. Additionally, there is a need 
for these people to understand that they have a residual (albeit lower) risk of 
developing the condition and should be encouraged to engage in risk reducing 
behaviours relevant for the general population (Marteau and Lerman 2001).
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To conclude, this trial found that viewing cardiovascular risk decreased negative 
emotions and worry about future risk of heart disease. This lends support to previous 
research that has found risk screening does not have adverse psychological effects 
in this kind of population. Positive emotion was also reduced, although this was likely 
to be only a short-term consequence. A beneficial use of cardiovascular risk 
prediction tools may be to provide reassurance to the ‘worried well’ who are over 
pessimistic about their future risk of developing CVD. However, the low risk 
respondents in this trial did not display reassurance from their risk result (suggested 
by an increase in positive emotion). A reason for this may be because of a mismatch 
between prior risk perceptions and the actual results, which led to a mistrust of the 
risk information presented to them.
9.3.5 Predicting intention to change behaviour
This trial assessed the efficacy of the Theory of Planned Behaviour (TPB) (Ajzen 
1991) to predict intention to change behaviour to reduce risk of future heart disease. 
The subcomponents of the TPB (attitudes, perceived behavioural control and 
subjective norms) were entered into multiple regression models, to see how well they 
predicted intention to change behaviour by explaining the variance in intention to 
exercise more, lose weight and stop smoking scores. The TPB components made a 
significant contribution to explaining the variance in intention to exercise more, 
intention to lose weight and intention to stop smoking. For intention to exercise more, 
54.2% of the variance in scores was significantly predicted by the TPB components. 
For intention to lose weight, 65.5% of the variance in scores was significantly
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predicted, and for intention to stop smoking 44.6%. This is slightly higher than what 
has been found in previous literature reviews on studies that have utilised the TPB.
For example, a meta-analysis of the relationships among variables in the Theory of 
reasoned action and the TPB found between 40-50%  of the variance in intention was 
explained by the TPB components (Sutton 1998). Furthermore, Armitage and 
Conner (2001) included 185 independent studies in a review and found 39% of the 
variance was explained (Armitage and Conner 2001). However, the percentages 
reported by these reviews are derived from studies into different types of health 
behaviour from screening through to addictive behaviours. Additionally, ‘file-drawer’ 
problem or publication bias may have arisen, where only studies showing significant 
findings have been submitted for publication (Armitage and Conner 2001).
Therefore, it is difficult to make direct comparisons with the findings of this trial.
In the context of cardiovascular risk prevention, a recent randomised trial into a 
decision aid for reducing cardiovascular risk, measured intention to adhere to the 
decision made during a consultation with a GP regarding cardiovascular risk 
prevention. 44% of the variance in intention to adhere to the decision was explained 
by the TPB components (Krones et al. 2010), which is lower than the variance in 
intention to exercise more and lose weight scores explained in this trial. However, 
the lack of internal reliability of some of the components in this trial must be 
remembered.
This trial demonstrated that attitudes and perceived behavioural control significantly 
predicted intentions to change behaviour (24 -70% for attitudes and (29-60%  for
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perceived behavioural control). The subjective norms component was the weakest 
contributor accounting for between 6% and 20% of the variance in intention to lose 
weight and intention to stop smoking, and did not significantly predict intention to 
exercise more. This supports previous research, as subjective norms have been 
found to account for the least variance of the components (between 1-12%) 
(Armitage and Conner 2001; Krones et al. 2010). An explanation for this may be that 
people do not attend to the views of their significant others because they are known, 
constant, in the background and do not change.
Conversely, perceived behavioural control has most often been the variable making 
the strongest contribution with the highest explanatory value, as much as 34%  
(Conner and Sparks 2005; Godin and Kok 1996; Krones et al. 2010). It has added 
another 6% of the prediction of intention independently, over and above attitudes 
and subjective norms components, which suggests perceived behavioural control 
influences behaviours directly and indirectly, independently of the other TPB 
components in this context (Armitage and Conner 2001).
Intention as a measure of behaviour change
This trial was not able to assess whether the risk representation formats had any
motivating effects on respondent’s actual lifestyle. Instead, intention to change
behaviour was measured. Intentions are associated with an increased likelihood of
changing actual behaviour, and therefore are considered an adequate proxy
measure for predicting behaviour. However, previous reviews reported that intention
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only explains between 27-34% of the variance in behavioural change. The likely 
explanation for this is that people have good intentions but fail to act on them (Godin 
and Kok 1996; Orbell and Sheeran 1998; Sutton 1998).
It remains unclear whether high intentions will lead to actual changes in behaviour. 
Evidence against the use of intentions to predict behaviour comes from Silagy et al 
(1993). A postal questionnaire followed by a health check by nurses found that most 
smokers were aware of the risk posed to their health, and 91% expressed a desire to 
stop smoking. However, only 39% claimed to have seriously tried to stop smoking 
during the 12 month follow-up. Additionally, in the 188 participants with high fat diets 
who regarded a high-fat diet as harmful, 91% wanted to reduce the fat in their diet, 
but only 61% had attempted to do this. Lastly, in 289 obese participants who 
regarded their diet as harmful, 98% wanted to change their diets, but only 76% had 
actually changed their diet at follow-up (Silagy et al. 1993).
It was not possible to determine in this trial whether respondents who indicated high 
intentions to exercise more, lose weight or stop smoking actually executed these and 
made the changes to their behaviour. However, as indicated by previous research, 
intentions may only have a small influence over behaviours. Therefore, future trials 
of risk representation formats should measure actual behaviour change, to 
determine whether they have any impact. Additionally, future trials should combine 
risk communication with other behaviour change strategies to increase their 
effectiveness.
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To conclude, this trial supports the TPB’s ability to predict intention to change 
behaviour through the components of attitudes, subjective norms and perceived 
behavioural control. More variance was explained by the components on this trial 
than has been demonstrated previously. Consistent with other research, subjective 
norms made the least contribution; whereas perceived behavioural control and 
attitudes components made the greatest contribution in explaining the overall 
variance in intention to change behaviour. This suggests that behavioural change 
interventions should focus on increasing perceived behavioural control and positive 
attitudes. Assessing actual behaviour change as opposed to intentions should also 
be considered. However, more studies into lifestyle behaviour change, using the 
TPB with reliable scales are needed before any real conclusions can be made.
9.3.6 Risk magnitude and intention to change behaviour
This trial entered the risk category of respondents (i.e. low risk or moderate/high risk)
into multiple regression models to see whether risk magnitude predicted
respondents’ intentions to change behaviour. Risk magnitude significantly predicted
intention to exercise more, by explaining 6.9% of the variance in scores. The beta
coefficient indicates a positive relationship between the two variables, suggesting
that the higher the risk magnitude, the greater the intention to exercise more. The
effect of risk magnitude on intentions is consistent with previous work involving
vignette studies (Frosch et al. 2008; Sanderson and Michie 2007; Wright et al. 2006;
Wright et al. 2008). For example, Wright et al 2008 used an analogue design and
examined the impact of risk magnitude (as well as graphical risk format described
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previously) on motivation to quit smoking. It was hypothesised that higher 
magnitudes of risk would generate greater intentions to stop smoking. 180 smokers 
were randomly allocated to receive vignettes about the genetic risk of Crohn’s 
disease that differed in the risk magnitude that was presented (e.g. 3%, 6% or 50%). 
The greater the magnitude of risk, the stronger the participants’ intentions to adopt 
risk-reducing behaviour. Pain/vise comparisons showed that those who received the 
highest risk magnitude (e.g. 50%) had significantly higher intentions to quit smoking 
than those receiving the lowest magnitude (e.g. 3% ) (Wright et al. 2008).
If higher risk estimates motivate behaviour change, it follows that lower risk 
estimates would decrease motivation to engage in health behaviours. However, this 
was not found in this trial or by previous research. A study by Grant et al (2009) 
surveyed a nationally representative sample of physicians and patients in the US, 
asking for views regarding genetic testing for diabetes risk prediction. Both patients 
and physicians reported high expectations that genetic testing would increase patient 
motivation to adopt the necessary behaviours to control or prevent type 2 diabetes. 
71% of patients indicated that receiving a ‘high risk’ result would be very likely to 
improve motivation to adopt preventative lifestyle changes. 78% reported that 
genetic testing would make them much more motivated to adhere to medications, 
and only two patients reported that receiving a low risk result would make them 
‘much less motivated’ (Grant et al. 2009). This is what would be expected by the 
‘worried well’ population, who despite being told of their low risk, are still cautious, 
likely to perform risk reducing behaviour and monitor their risk (van Steenkiste et al. 
2004b).
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To conclude, risk magnitude significantly predicted intention to exercise more, where 
a higher risk estimate was associated with greater intention. This supports previous 
research conducted using analogue designs with hypothetical risk profiles. However, 
it is questionable whether low risk estimates decrease motivation to engage in risk 
reducing behaviours.
9.3.7 Summary
This section has compared the findings of notable interest in this trial with previous 
literature. This trial did not find any significant differences in the graphical risk 
representation formats, in terms of intention to change behaviour, understanding of 
risk information, positive and negative affect and worry about future risk of heart 
disease. However, it remains unclear whether the portrayal of risk does have little 
influence on patient’s behaviours, cognitions and emotions, or whether this trial failed 
to identify true differing effects resulting from the risk representation formats. The 
contradictory evidence also points towards there being no ‘magic bullet’ that is 
suitable for communicating risk to everyone. Therefore, more research is needed 
before any conclusions can be drawn as to the importance of representation formats 
in risk communication.
This trial provided evidence that individuals’ have difficulty in accurately 
understanding their risk. This supports the previous research, which has also 
demonstrated that risk perceptions influence emotions and subsequent intentions
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and behaviour. This has implications in primary care, as accurate risk perceptions 
reduce time wasting, superfluous prescribing and frustration in both patients and 
physicians. Furthermore, this trial found viewing cardiovascular risk decreased 
negative emotion and worry about future risk of heart disease. This lends support to 
previous research that has found risk screening does not lead to adverse 
psychological effects. The lack of reassurance (i.e. no increase in positive emotion) 
may have occurred because of a mismatch between prior risk perceptions and the 
actual results, leading to a mistrust of the risk information presented.
This trial used the TPB as the theoretical model underpinning the primary outcome 
measure (intention to change behaviour), it assessed the ability of the TPB to predict 
intention to change behaviour through the components of attitudes, subjective norms 
and perceived behavioural control. The TPB significantly predicted intention to 
exercise more and intention to lose weight. More variance was explained by the 
components on this trial than demonstrated by previous studies. However, in-line 
with other research, subjective norms made the least contribution, whereas 
perceived behavioural control and attitudes components made the greatest 
contribution to explaining the overall variance in intention to change behaviour.
Lastly, this trial partially supports previous evidence suggesting that risk magnitude 
plays a role in predicting individuals’ intentions and behaviour, where a higher risk 
estimate was associated with greater intention to exercise more. This demonstrates 
that a number of factors contribute a person’s decision to reduce cardiovascular risk 
and adopt lifestyle changes and risk reducing behaviours.
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9.4 Strengths of the Randomised Controlled Trial
This section summaries the strengths of the randomised controlled trial, which has 
been conducted and reported according to the Consolidated Standards of Reporting 
Trials (CONSORT) statement guidelines (Schulz et al. 2010). A critique of the trial 
will be made looking at aspects deemed important for assessing internal validity (e.g. 
extent that systematic error or bias is minimised) and external validity (e.g. the 
generalisability of the results of a trial to a wider population), such as recruitment, 
randomisation, intervention, outcome measurement and analysis, in accordance with 
the MRC framework for developing and evaluating complex interventions (Medical 
Research Council 2000; Medical Research Council 2008).
9.4.1 Recruitment
A number of recruitment methods were implemented. These included both internet- 
based (such as invitation on staff intranet electronic notice boards of the local 
Council and Universities, posting on social networking websites and forums, and the 
‘snowballing’ technique of emailing personal contacts); as well as non internet-based 
methods (such as a press release in local newspapers, a radio interview and 
advertisements via posters and cards). These diverse methods enabled a wide 
audience to be reached, which maximises potential participation in the study, 
increasing data collection. Internet-based methods appeared to be the most 
successful. It is thought this was because respondents are already at their computer 
and if interested in participating in the study, would just have to click on the hyperlink
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to take them to the study website. However, balanced risk stratification was not 
achieved by doing this. The SQL database recorded 2463 visits to the website, of 
which, 908 completed the study (before data cleaning). Therefore it can be estimated 
that there was a 63% (n=1555) drop-out rate.
Research has identified features of web-based surveys that may influence drop-out 
rates. For example, open-ended questions, questions arranged in tables, ‘fancy’ slow 
to load graphics (thought to increase the download time for each webpage), unclear 
instructions on how to complete, and absence of navigational aids have been found 
to increase the likelihood of dropouts (Bosnjak and Tuten 2001). For this study, drop­
out rates due to the design of the website were minimised, as the website was 
designed with the target population in mind, (i.e. 45-64 year olds). Ease of use was 
an important consideration, where all text was displayed in an adequate font size 
and instructions were clearly visible. There was simple navigation throughout the 
web pages by use of a ‘click to continue’ button, and sliding scales were used for 
recording age, height and weight of respondents. It was also piloted on a small 
sample of lay people who fitted the inclusion criteria, as well as academics with 
experience of undertaking research in a healthcare setting. Furthermore, an 
incentive was provided for respondents, as it was stated that a £1 donation would be 
given to the British Heart Foundation for every person who took part and completed 
the study. It has been shown that incentives can maximise data collection by 
increasing the numbers of people who are willing to participate, and improve the 
retention rates of those who finish the study (Goritz 2006). Therefore, the high drop-
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out rates are likely to be due to reasons other than the design/usability of the website 
and lack of incentive.
9.4.2 Randomisation
The use of a computer generated randomiser has the advantage of concealing 
allocation of respondents to the trial conditions and thus minimising selection bias, 
which in turn enhances the internal validity of the trial. Table 7.2 in Chapter 7 (results 
of primary objectives) shows the characteristics of the sample for each of the 
conditions, the even distribution demonstrates the success of the randomisation.
9.4.3 Intervention
The intervention of this study comprised a web-based risk formatter tool that 
predicted an individual’s 10-year risk of having a future coronary heart disease event 
(e.g. Ml, angina pectoris or coronary death).
Real cardiovascular risk assessment
This is one of the first web-based four armed RCTs on the effects of different 
cardiovascular risk presentation formats that has used actual risk assessment, rather 
than analogue design with hypothetical patient risk profiles. The risk formatter tool
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was specifically designed for this study and went through an extensive piloting 
procedure assessing usability and internal logic.
Web delivery
The web-based risk formatter tool for predicting future cardiovascular risk used the 
Personal Heart Score algorithm (Mainous et al. 2007). This departs from traditional 
methods for assessing cardiovascular risk, which involve risk assessment in a 
clinical setting and use physiological assessments, such as cholesterol and blood 
pressure measurements. The Personal Heart Score (Mainous et al. 2007) enables a 
rudimentary assessment of the future risk of having a coronary heart disease event 
by using non-laboratory self-reported information. This maximises the data collection 
as participants do not need to know their cholesterol or blood pressure 
measurements, which may involve visiting their GP for a clinical assessment. The 
Personal Heart Score (Mainous et al. 2007) provides an adequate starting point for 
individuals who have not thought about their risk of heart disease before and 
therefore, are not aware that they may be at risk. Normally, an individual would have 
their risk assessed in a clinical setting in a consultation with their GP. In contrast, 
respondents in this trial completed a risk assessment remotely in a setting of their 
choice, usually in their homes or work place. The researcher is absent, thus reducing 
researcher bias.
The Personal Heart Score (Mainous et al. 2007) categories risk into low, moderate 
and high. This is advantageous to some individuals who are thought to translate
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numeric risks into categories when interpreting and using the information (Wertz et 
al. 1989).
9.4.4 Outcome measurement
The primary and secondary outcome measures in this trial were clearly defined a 
priori and assessed by self-completion on-line questionnaires. A self-completion 
approach can result in more truthful responses due to anonymity. This minimises 
social desirability bias (the tendency for respondents to reply in a manner that will be 
viewed favourably by others) (Oppenheim 2001).
The primary outcome measure was intention to change behaviour (e.g. exercising 
more, losing weight and stopping smoking) in order to reduce cardiovascular risk. 
This was chosen because intention is a good proxy measure, in instances where it is 
not possible to measure actual behaviour change. Additionally, it has been used as 
the main outcome in many previously published trials (Marteau et al. 2010; Price et 
al. 2008; Watts et al. 2003). Other outcomes measured in this trial comprised 
understanding of risk information, affect, worry about future risk of heart disease and 
the subcomponents of the Theory of Planned Behaviour (TPB) (attitudes, subjective 
norms, perceived behavioural control). Justification for the assessment of these 
outcome measures is presented in Chapter 5.
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Two outcomes measured in this study used existing well-validated scales or adapted 
items from existing scales. For example, positive and negative affect was measured 
using the Positive and Negative Affect Schedule- Short Form (PANAS-SF) 
(Thompson 2007). This has been validated, demonstrating construct validity and has 
been used extensively in previous research (Watson et al. 1988). The one-item scale 
measuring worry about future risk of heart disease was developed by adapting 
previously validated scales relating to other health conditions such the Lerman 
Breast Cancer Worry Scale (Lerman et al. 1991).
Alternatively, some of the outcomes were measured using items developed 
specifically for the purpose of this study. This included understanding of risk 
information (i.e. absolute probability perception, subjective understanding and 
confidence in understanding items), intention to change behaviour (i.e. exercise 
more, lose weight and stop smoking) and the subcomponents of the TPB (attitudes, 
subjective norms and perceived behaviour control) (Ajzen 1991). All questionnaire 
items went through a piloting procedure before the trial commencement, and in the 
case of the TPB components, items were developed using guidance from published 
guidelines on constructing TPB questionnaires from the University of Newcastle 
(Francis et al. 2004). This manual integrates advice from previous literature on the 
TPB, has been widely used in previous research that has required TPB 
questionnaire development (Frosch et al. 2008; Giles et al. 2007; Tavousi et al.
2009). It has gone through a process of extensive reviewing and trialling.
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9.4 5 Analysis
The plan of analysis was finalised during the development of the protocol for the trial 
(Appendix 20). This was done with advice from a statistical expert. The sample size 
calculation was based on a previously published trial (Wright et al. 2008) that used 
Likert scales for the same primary outcome measure as this trial (i.e. intention to 
change behaviour). The sample size calculation stipulated that a fully powered study, 
sufficient to attain a power 90% for the primary outcome measure of intention to 
change behaviour, would need approximately 200 subjects in each condition, 
equalling 800 subjects needed in total. This was exceeded, as the total sample size 
for the final analysis was 903.
Data analyses were conducted according to the analysis plan developed a priori. A 
slight amendment to the proposed risk category subgroup analyses was made due 
to the disproportionate cell sizes of the low risk category, compared to the moderate 
and high risk categories. Instead of analysing the three categories separately, 
respondents were dichotomised into either low or moderate/high risk. The 
conventional statistical tests were performed and p values and 95% confidence 
intervals were calculated where appropriate.
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9.4.6 Summary
This section has highlighted the strengths of this randomised controlled trial, paying 
attention to the recruitment, randomisation, intervention, outcome measurement and 
analysis. To summarise, this study is one of the first to use a four-armed randomised 
controlled trial to assess the effects of different graphical cardiovascular risk 
representation formats using actual risk assessment (and not hypothetical risk 
profiles). The web-based design placed no time or location constraints on 
participants. It used self-reported, non-physiological measurements in the 
assessment of cardiovascular risk, which maximised data collection by enabling 
those who had not thought about their risk, and not previously visited a GP for a 
clinical assessment to participate. Where possible, validated scales were used to 
measure the outcomes of interest, and extensive piloting was undertaken in 
instances where a new scale had to be developed for the purposes of the study. 
Lastly, a plan of analysis was developed and sample size calculation was performed 
before the commencement of the trial, in accordance with the CONSORT guidelines 
for randomised controlled trials (Schulz et al. 2010).
9.5 Weaknesses of the Randomised Controlled Trial
In the same way as the strengths of the randomised controlled trial, the weaknesses 
will also be considered in accordance with the CONSORT statement guidelines
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(Schulz et al. 2010). Again, particular attention has been paid to the factors 
influencing the external and internal and validity of the trial, in accordance with the 
MRC framework (Medical Research Council 2000; Medical Research Council 2008).
9.5.1 External validity
There are a number of factors that limit the external validity of the findings of this 
RCT. This concerns the extent that the results can be generalised to a wider 
population.
9.5.2 Recruitment
Weaknesses of the trial that affect external validity mostly arise from the way 
respondents were recruited. For example, the methods of recruitment that were 
used, the incentive to participate and the opt-in nature of the study will be discussed 
in turn, with reference to the potential biases that result.
Recruitment methods
The recruitment of a trial is an important aspect to consider when assessing external
validity. Firstly, the trial was web-based and therefore limited participation to those
who had access to a computer with the internet, and possessed adequate computer
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literacy skills. In a recent survey on internet access by the Office of National 
Statistics (Office of National Statistics 2010), it was estimated that 60% of all adults 
in the UK (30.1 million) have access to the internet, with 9.2 million adults reporting 
that they have never used the internet.
Recruitment for this trial used a number of methods, mainly web-based. Some 
methods were more successful than others, leading to greater recruitment rates (i.e. 
internet-based methods), whereas others were less successful, leading to lower 
recruiting rates (i.e. posters and card advertisements). This affects the external 
validity of the trial’s results. The top three methods that generated the most traffic 
and participants to the study were email invitations, social networking sites (in 
particular Twitter.com, Facebook, Over 50 forums) and posting on University 
electronic notice boards. Four Universities agreed to post a link on their staff 
electronic notice boards, which led to an over-representation of respondents who 
were highly educated to degree level or equivalent. This meant the sample were 
likely to possess high numeracy and literacy skills, leading to an increased likelihood 
that they understood the risk information presented to them regardless of its 
representation format. This may have reduced the ability to detect true differing 
effects of the risk representation formats on understanding of risk information.
Incentive to participate
The incentive of a £1 donation made to the British Heart Foundation for every 
respondent who participated and completed the study, may have resulted in an
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altruistic motivation to take part in the study to support the charity, rather than a 
desire to have their future risk of cardiovascular disease assessed.
Opt-in nature of study
The opt-in nature of the study leads to volunteer bias, as internet users volunteered 
to have their future risk of cardiovascular disease assessed, as opposed to 
respondents recruited through alternative methods (such as general practice). The 
respondents who took part in this study may have possessed different characteristics 
to those of the general population. For example, they may have an interest in their 
health and cardiovascular risk, making them curious or worried about their health, 
and therefore, more motivated to reduce their cardiovascular risk, than other 
populations such as smokers who are less concerned about their health.
Furthermore, the opt-in nature of the recruitment results in a self-selecting sample.
This makes collection of data on the external validity of respondents difficult. The
web-based delivery means it was not possible to determine a meaningful response
rate and gather information on the number or characteristics of those who did not
want to participate. Only an estimation of the number of those who did not consent to
the study was collected from those who indicated on the ‘Consent’ webpage that
they did not wish to participate in the trial (n=31). However, this figure is likely to be
underestimated, as it is possible that those who did not want to participate (a) did not
visit the homepage in the first place, or (b) visited the website but left without ticking
the appropriate box on the consent page that indicated they did not wish to take part
in the study. Therefore, it is possible that there were significant differences between
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those who wished to participate and those who did not on variables that were 
unmeasured. The external validity of the findings is limited in this respect.
9.5.3 Biased Sample
The trial comprised a sample that was biased for a number of reasons including the 
age, level of education level and cardiovascular risk category. This limits the 
generalisability of the results.
Age and level of education
The sample achieved by this trial predominantly comprised those who were at the 
lower end of the age range criteria (i.e. 45 year olds) and educated to degree level or 
equivalent. This reflects the demographics of internet users reported by the Office of 
National Statistics. For example, 97% of adults educated to degree level use the 
internet, compared to only 45% of those without formal qualifications; and the 
younger the adult, the more likely they are to use the internet. As 99% of 16 to 25 
year olds access the internet compared to 40% of over 65 year olds (Office of 
National Statistics 2010).
Internet Users
The web-based nature of the study resulted in a sample that was large (n=903), but 
not representative of those without internet access. Additionally, the study
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participation was limited to those with adequate computer literacy skills. However, 
the goal of the study was not to achieve representative sampling, but rather to 
compare the impact of different cardiovascular graphical risk representation formats.
Low cardiovascular risk
The sample predominantly comprised respondents who were categorised as being 
of low cardiovascular risk. The number of respondents who were categorised at 
moderate and high cardiovascular risk was lower than expected (n=155, 17.2%). The 
disproportionate numbers of respondents in the risk categories meant a lack of 
power for the statistical tests to detect true differences between the groups. This was 
due to the small cell sizes for those of moderate and high risk, despite dichotomising 
risk into two groups: low and moderate/high combined. This also limits the 
generalisability of the results. However, the lower proportion of respondents with 
elevated risk is consistent with previous trials, such as the IMPALA (IMproving 
Patient Adherence to Lifestyle Advice) study that reported only 30% of the sample 
was at high cardiovascular risk (Koelewijn-van Loon et al. 2010); and a cross- 
sectional study into the risk perceptions of patients who had discussed their 
cardiovascular risk during a consultation with their GP, that found that only 17% of 
the sample were at high cardiovascular risk (van der Weijden et al. 2007).
A reason for the lower numbers of respondents at elevated cardiovascular risk could 
be due to the component of the trial that required the assessment of actual 
cardiovascular risk. Some people may have been reluctant to participate due to the 
fear of the unknown and the risk of potentially finding out something they did not
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want to, such as being at higher cardiovascular risk than they originally thought.
This may have meant that the people at higher cardiovascular risk, who are aware 
that they have unhealthy lifestyles, might not have been motivated to participate in 
these types of health appraisal studies, preferring to take a coping style for health 
threats that would represent low monitoring (i.e. ignoring threat-relevant information) 
and high blunting (i.e. distracting oneself from the health threat) (Miller et al. 1988; 
Williams-Piehota et al. 2005), as opposed to the ‘worried well’ who participated in the 
trial, who would be regarded as having a high monitoring and low blunting coping 
style.
9.5.4 Internal validity
This section will assess the internal validity of the RCT, which concerns the extent 
that systematic error (or bias) is minimised. The randomisation, intervention, 
outcome measures and analysis will be considered.
9.5.5 Randomisation
The internal validity of the trial was originally jeopardised at the start of the trial due
to selection bias (e.g. bias in the allocation of respondents to the intervention and
control groups). This study used computer-generated randomisation, where an
algorithm was programmed into the computer which randomised respondents to one
of the four conditions when they visited the homepage. However, after the first 100
respondents had been recruited, it became evident that allocation was not entirely
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random. This was because the original algorithm was disproportionately allocating 
respondents to the conditions. Twice as many respondents were allocated to 
conditions two and three, than to conditions one and four. This was soon rectified by 
replacing the algorithm and discarding a random half of the data from conditions two 
and three. This resulted in the loss of 42 completed responses (see Chapter 7 for 
more detailed explanation).
9.5.6 Intervention
The intervention of this trial involved respondents having their risk of future coronary 
heart disease calculated by the risk formatter from information they provided 
regarding their personal characteristics (sex, age, BMI, family history of 
cardiovascular disease) and health and lifestyle status (GP diagnosis of 
hypertension, hypercholesterolemia or diabetes, smoking status, level of physical 
activity); then viewing their risk in one of the three graphical risk representation 
formats (bar graph, pictogram, metonym). Risk was categorised into low (under 
10%), moderate (between 10-20%) or high (over 20%).
The risk categories had wide confidence intervals with a high level of uncertainty. 
More precise risk estimations, such as those provided by Framingham, SCORE or 
QRISK2 (Conroy et al. 2003; D'Agostino et al. 2008; Hippisley-Cox et al. 2008) were 
not possible, due to the absence of physiological measurements including 
cholesterol and blood pressure levels. The personal heart score is likely to have 
provided a conservative result leading to a possible underestimation of risk. This
441
becomes problematic if respondents did not trust or believe the result presented to 
them.
To consent to taking part in the trial, respondents would have had an interest in their 
own cardiovascular risk strong enough to motivate them to take part in this study. 
Perhaps this motivation to monitor their cardiovascular risk existed before this trial, 
leading them to have already obtained a more accurate risk assessment from their 
GP or health professional. If their previous risk assessment contradicted the results 
from the Personal Heart Score, it is possible that they were thinking about this 
previous result when answering the post-intervention questionnaire, rather than the 
category that was presented to them by the risk formatter in this trial.
Additionally, a disclaimer statement was presented on the beginning pages of the 
risk formatter website. This highlighted that the risk prediction of this study was only 
an indication of risk and users were advised to visit their GP for a more clinical 
assessment.
Taking these two points into consideration, it is possible that the main aim of the trial 
was hindered by reducing the impact of the risk message communicated to users via 
the different risk representation formats. Thus, any true effects resulting from the 
different cardiovascular risk representation formats would be obscured.
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9.5.7 Outcomes measures
There are weaknesses in the outcome measures used in this trial. For example, use 
of Likert scales, the direct measurement of the TPB components, lack of internal 
reliability in the TPB questionnaire, modification to the wording of the PANAS scale 
and omission of a baseline measure of perceived risk. These will be discussed in 
turn.
Likert scale measurement
The outcomes of this trial were measured using Likert scales. These were chosen as 
they are commonly used in research questionnaires and are recommended by the 
Manual for constructing TPB questionnaires (Francis et al. 2004). They have the 
advantages of providing information of the degree of agreement and disagreement of 
statements representing the variable of interest, and are easy to construct 
(Oppenheim 2001). On the other hand, they have been criticised for the lack of 
reproducibility, where the same score may be achieved in different ways, where it 
has entirely different meanings, making it difficult to interpret. Additionally, a Likert 
scale does not offer metric or interval measures and does not have a clear neutral 
point. Therefore, it cannot be determined whether a score in the middle ranges are 
due to lukewarm responses (from lack of attitude, lack of knowledge etc.), uncertain 
responses, or are slightly positive or negative in their direction. These different 
possibilities make identification and interpretation of these scores difficult 
(Oppenheim 2001).
In this trial, attempt was made at reducing the possibility of response set bias 
(tendency to answer a series of questions in a certain direction regardless of the 
content). This involved reversing the direction of some items to increase the attention 
that needs to be paid when reading the items (and then reversing the direction of the 
scoring). Furthermore, in accordance with recommendations from the manual for 
contrasting TPB questionnaires (Francis et al. 2004), items measuring these 
components comprised a 7-point Likert scale; whereas the validated scale for 
measuring positive and negative affect e.g. PANAS-SF (Thompson 2007) comprised 
a 5-point Likert Scale.
These two inconsistencies in the questionnaire presentation may have aggrieved 
some respondents who did not like the change in item direction or number of points 
on the scale, or confused respondents unfamiliar with this type of questionnaire 
measurement. This may have lead to an increased possibility of respondents 
dropping out before completing the study. On the other hand, drop-outs could have 
occurred by the repetitive nature of the scale items, especially as items measuring 
intention to change behaviour (i.e. exercising more, losing weight and stopping 
smoking) were similar. Therefore, personal preference is one of the determining 
factors in whether respondents complete the study, and although attrition can be 
minimised, it cannot be controlled for completely.
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Internal reliability of TPB questionnaire
As already described, items measuring the outcomes of interest were either from 
previously validated scales or were developed specifically for the purposes of this 
trial, such as the items measuring intention to change behaviour (exercising more, 
losing weight and stop smoking) and the subcomponents of the TPB (attitudes, 
subjective norms and perceived behavioural control). Reliability checks were not 
possible at the piloting stage due to the small sample size. Therefore, the internal 
reliability was assessed after the main data had been collected, using Cronbach’s 
alpha correlation coefficient.
Out of the 14 components measuring variables for exercising more, losing weight 
and stopping smoking, 7 failed to reach a satisfactory level of internal consistency as 
the items did not possess a Cronbach’s alpha correlation coefficient of 0.7 or above. 
The alpha level could have been improved with the removal of one item in two 
instances (pre-intervention attitudes towards reducing risk of heart disease and 
intention to exercise more). However, this would have caused multicollinearity, 
where items become superfluous if they correlate too highly with each other. 
Therefore, a decision was made not to remove any items. This means that the 
findings using the components without adequate internal reliability should be 
interpreted with caution. Although, all items had face validity as the components they 
were measuring could be clearly identified. Further reliability and validity checks, in 
particular construct validity should be used on this questionnaire if it is used in future 
research.
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Direct measure of TPB components
A possible reason for the inadequate internal consistency of the TPB components 
may be attributable to the direct measure that was used. This comprised items to 
assess the components of attitudes, subjective norms and perceived behavioural 
control. This direct approach was taken to keep the number of items in the 
questionnaire to a minimum, thus reducing cognitive demand of the participants and 
the possibility of attrition.
An alternative, indirect approach that could have been chosen that considers beliefs 
contributing to the predictor variables. The indirect approach measures behavioural 
beliefs and outcome evaluations for the attitude component; normative beliefs and 
motivation to comply for the subjective norms component; control beliefs and 
influence of control beliefs for the perceived behavioural control component. This 
approach consists of using more items to measure the components. It may have 
increased the internal reliability of the TPB questionnaire in this trial, and may have 
led to an increased efficacy of the TPB model in predicting intention to change 
behaviour to reduce cardiovascular risk (e.g. exercise more, lose weight and stop 
smoking). However, recent research has demonstrated no differences between 
direct and indirect measures of the TPB at predicting behaviour (Jeong 2011).
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Modification to the wording of the PANAS Scale
It should be acknowledged that there is a weakness in the outcome measures of this 
study, as slight amendments were made to the wording of the PANAS scale 
(Thompson 2007). This comprised changing the instructions presented at post­
intervention to enable a more logical assessment of positive and negative affect after 
viewing cardiovascular risk. For example, the instructions presented at baseline were 
‘ Thinking about yourself and how you normally feel, to what extent do you feel...?’, 
whilst the instructions presented at post-intervention were ‘At this present moment to 
what extent do you feel...?’. Making amendments to the wording of published and 
validated scales should be avoided if possible, as this can limit the reliability of the 
results. However, it must be noted in this instance that both baseline and post­
intervention scales were internally reliable and possessed acceptable Cronbach’s 
Alpha levels.
Omission of baseline measure of perceived risk
This study is also limited as it did not measure perceived risk at baseline. This 
decision was made in order to keep the number of items in the pre-intervention 
questionnaire to a minimum, reducing the possibility of attrition (drop out). However, 
this meant that it was not possible to determine whether the risk representation 
formats modified risk perceptions, or whether a respondent’s preconceived 
perception of their cardiovascular risk prevailed after risk was assessed and 
displayed in one of the selected formats of the study. Therefore, it is important for
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future research to take into account a person’s preconceived perception of their risk, 
to see whether this has an influence on the effectiveness of the risk communication 
intervention.
9.5.8 Analysis
There are weaknesses in the analysis of the trial results. These include deviation 
from the planned subgroup analysis; analysis on intentions to stop smoking using a 
small sample of smokers; and the appropriateness of intention to lose weight item.
Subgroup analysis deviation
It was originally stipulated in the analysis plan that a subgroup analysis of each of 
the risk categories would be conducted to examine whether risk magnitude had any 
influence over the effects of the graphical risk representation formats. However, due 
to the disproportionate number of respondents assigned to the low risk category 
(82.8%, n=748), the analysis deviated from the original plan and risk was 
dichotomised into low (under 10%), or moderate and high (10% and over). This 
decision was made to increase the statistical power and increase the likelihood of 
differences being detected between the risk category groups.
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Intention to stop smoking
The sample comprised a smaller than anticipated number of current smokers. This 
meant one of the assumptions used to assess suitability of the data for the 
appropriate statistical analyses was violated. The required ratio of cases to 
independent variables was calculated at between 106-111. However, for the 
intention to stop smoking variable there was only 81 cases. Therefore, the findings 
regarding respondents’ intentions to stop smoking should be interpreted with caution 
due to the small cell sizes.
Appropriateness of intention to lose weight
The intention to lose weight component was given to all respondents regardless of 
their BMI, and whether they actually needed to lose weight. The sample 
characteristics showed that only 23% of the sample had a BMI of over 30, which is 
classified as being overweight/ obese, and thus needing to lose weight. However, 
the mean intention to lose weight was above the mid-point at 4.65 (SD=1.6), 
suggesting that participants had inappropriate intentions to lose weight (i.e. they had 
high intentions to lose weight even though they did not need to). This is further 
evidence of the sample comprising the ‘worried well’ and may contribute to the lack 
of differences across the risk representation formats.
Ideally, the intention to lose weight items should only have been given to those who
needed to lose weight, in the same way that the intention to stop smoking items were
only given to those who were current smokers. However, there are reasons against
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this. Firstly, the BMI classification system for obesity may not be the best method for 
assessing whether respondents need to lose weight. There are a number of 
circumstances where the current thresholds provide misleading information about a 
person’s body fat content. For example, athletes have a higher muscle density with 
lower body fat content because the greater muscle mass elevates their BMI, 
classifying them as obese. Conversely, as a person ages, muscle density reduces 
and body fat increases, which means that body weight and BMI can stay the same 
despite the increase in body fat. Additionally, there are racial differences in total body 
fat, which demonstrate a need for differing cut-off points for classification of being 
overweight and obese (Prentice and Jebb 2001). Therefore, more accurate 
assessment of obesity is needed before judgements can be made regarding a 
person’s need to lose weight. Furthermore, it has also been suggested that 
cardiovascular risk is associated more with the proportion of saturated fat in the diet, 
as opposed to the degree of obesity (Keys et al. 1986).
Secondly, if the suitability of items given in the post-intervention questionnaire is 
assessed on the basis of the risk factor information, then intention to exercise more 
should be assessed in the same way. Items regarding intention to exercise more 
should only be given to respondents who reported seldom or never exercising or 
playing sport in their spare time (e.g. the item in the risk assessment that assessed 
level of physical activity). This would lead to smaller numbers of respondents 
answering the intention to change behaviour questions, where some respondents 
possessing optimal risk factors might not answer any questions regarding their 
intentions to change behaviour. This means a much larger sample would be required
to ensure that there are adequate numbers of cases to assess each of the variables.
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9.5.9 Summary
This section has described the limitations of the trial in terms of internal and external 
validity, paying particular attention to the randomisation, intervention, outcome 
measures and analysis. It is concluded that the generalisability of the results 
(external validity) is limited due to the biased sample, partly resulting from the 
recruitment methods that were used. Additionally, it was debated whether the 
internal validity was affected by the algorithm used in the trial that produced results 
that perhaps were not trusted or believed because of the absence of physiological 
measurements and precise numerical risk estimates, and also the lack of internal 
reliability of some of the variables.
If this trial was conducted again, a number of changes could be made to improve the 
internal and external validity of the findings. For example, generalisability of the 
findings could be improved by minimising the risk of a biased sample. This could be 
done by making more of an attempt to target respondents of moderate and high 
cardiovascular risk, rather than the low risk ‘worried well’. This could be achieved by 
recruiting through general practitioner records or approaching higher risk 
populations, such as smokers in designated outdoor smoking areas. Additionally, 
less reliance on certain web-based methods, such as University staff electronic 
notice boards would result in respondents from differing educational levels that are 
more representative of the general population, rather than the large proportion of 
respondents who were educated to degree level, resulting from this trial being 
advertised across four Universities.
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The internal validity (reduction of systematic bias) could be increased by using a 
more precise algorithm that provides an estimation of risk with smaller confidence 
intervals (such as an exact probability estimate rather than a risk category).
However, it is likely that this would require physiological measurements such as 
cholesterol and blood pressure, and therefore respondents would be required to 
attain these measurements before taking part in the trial. This would reduce the 
benefits of the web-based ‘arm-chair’ risk assessment conducted in people’s own 
homes, without GP involvement. Furthermore, a bigger sample at the piloting stage 
would enable more reliability checks to be conducted on the items before 
commencement of the trial, making sure they reach an adequate level of internal 
reliability and actually measure the construct they have been designed to measure. 
Lastly, alternative survey methods, as opposed to the Likert Scale could be 
considered.
9.6 Implications for policy and practice
This study has shown that online cardiovascular risk prediction tools are successful 
in reducing negative affect and worry about the future risk of heart disease, and thus 
providing reassurance to those individuals at low cardiovascular risk. These users 
could be described as the ‘worried well’ and possess inappropriately high intentions 
to change their behaviour to reduce their cardiovascular risk even though they do not 
need to. The trial’s failure to recruit individuals at moderate and high risk suggest 
that more needs to be done to encourage these unaware ‘at risk’ people to use on­
line risk prediction tools to assess their risk of cardiovascular risk. This is so that they
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can be informed of their risk and make the appropriate decisions about how best to 
reduce their risk, by making lifestyle changes and/or adhering to 
treatment/medication.
This trial did not find any significant differences between the graphical risk 
representation formats, suggesting that there is no one method that is more effective 
than another; as the way risk is communicated to patients has no influence on 
behaviours (i.e. changing behaviour to reduce risk), cognitions (in terms of 
understanding) or emotions. This informs developers of cardiovascular risk 
prediction tools and risk reduction interventions that getting the message across is 
the most important aspect of the risk communication, not what format the message is 
presented in.
9.7 Summary I Conclusion
This chapter has given an evaluation of the RCT of the effects of different 
cardiovascular risk representation formats. It has compared the primary findings with 
previous research in the area, critically evaluated the trial by acknowledging its 
strengths and weaknesses, and has suggested future modifications that could be 
made to improve the internal and external validity. Also, implications of the trial’s 
main findings for policy and practice have been highlighted.
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Chapter 10. Discussion and Conclusions of thesis.
10.1 Introduction
This chapter will summarise the main findings of the studies that comprise this 
thesis. The primary focus of this thesis was to assess which risk representation 
formats are currently being used to communicate cardiovascular risk, and design 
and conduct a trial examining the effects of different cardiovascular risk 
representation formats on patient-related outcomes. The thesis comprised (1) a 
critical appraisal of existing web-based cardiovascular risk calculators; (2) a 
systematic review on ways of presenting cardiovascular risk information to patients; 
and (3) a randomised controlled trial of the effects of different graphical 
cardiovascular risk representation formats.
This chapter draws together the findings from each stage of the thesis. The findings 
will be presented in the context of previous, existing research relevant to the field of 
cardiovascular risk communication. A critique of the strengths and weaknesses of 
the thesis as a whole will be summarised. Lastly, implications for practice and policy 
will be presented, along with possible future directions for research and areas that 
warrant further research and discussion.
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10.2 Aims and summary of thesis findings
The aims of this thesis were firstly to identify what tools are available for the public to 
use when searching for cardiovascular risk assessment at home, and examine how 
well these tools present cardiovascular risk and to what extent risk reduction is 
encouraged; secondly, to review past literature to determine which risk 
representation formats are most effective in communicating cardiovascular risk to 
patients; and lastly, to design, conduct and evaluate a web-based RCT to assess the 
effects of different cardiovascular risk representation formats on patient-based 
outcomes.
10.2.1 Summary of results from Critical Appraisal of cardiovascular risk
prediction tools
The thesis described a critical appraisal of cardiovascular risk prediction tools 
retrieved when searching for risk assessment tools on-line. The 10 highest ranked 
cardiovascular risk prediction tools most likely to be found on Google were included. 
A standardised critical appraisal template, designed by adapting existing guidelines 
and evaluation tools was used. Hypothetical patient profiles were inputted into the 
risk prediction tools to create a risk output. The quality of the risk communication in 
the prediction tools was assessed, such as the type of risk representation format and 
the timeframe/s used. The extent that the tools encouraged risk reduction by 
providing information about behaviour change and/or treatment options was also
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appraised, such as reporting the main contributing risk factors or providing treatment 
goals.
When the quality of the risk communication was appraised it was found that nearly 
all tools presented absolute risk, and just over one third presented alternative types 
of risk (such as comparative or relative risk, which gives context for users to evaluate 
their risk). The most commonly used numerical risk representation format was 
percentages, with natural frequencies second. The majority of tools provided more 
than one way of expressing probability of cardiovascular risk. Under half of the tools 
provided graphical risk representation. In general, graphical formats used were 
congruous with the numerical probability estimates presented in the risk outputs (e.g. 
bar graphs displaying percentages and pictograms displaying natural frequencies). 
One tool allowed users to choose one of four graphical formats for viewing results. 
The majority of tools provided risk in a 10-year timeframe only. Two tools 
demonstrated short-term risk less than 10 years, and one tool projected longer term 
risk by illustrating 10-year risk if the user added 10, 20 or 30 years to their current 
age. Three tools had the facility of displaying risk in more than one timeframe option 
(such as 1, 5 or 10-years).
When the tools were appraised for how and to what extent they facilitated risk 
reduction, all tools processed at least one characteristic that focused on 
cardiovascular risk reduction. The most common features included the option to print 
out the results, and direction to further information sources about cardiovascular 
disease and risk reduction. However, the American Heart Association tool focused 
on cardiovascular risk reduction the most and provided all the features deemed
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helpful when considering risk reduction, which were compiled in the standardised 
critical appraisal template designed by adapting existing guidelines and evaluation 
tools.
To conclude, the critical appraisal of the web-based cardiovascular risk prediction 
tools found variation in the quality of the risk communication of the cardiovascular 
risk prediction tools available on the internet. Some tools focused on risk reduction 
more than others by providing functions that facilitated decisions regarding behaviour 
change and treatment options. The most common features were the option to print 
out results and direction to further information regarding cardiovascular risk.
However, it was concluded that the tools could incorporate more of the ‘best 
practices’ suggested by the research evidence in risk communication, and include 
more features to facilitate risk reduction; for example, using the option for an 
individual to revisit their risk profile and record progress as they attempt to reduce 
their cardiovascular risk.
10.2.2 Summary of results from Systematic Review on ways of
presenting cardiovascular risk to patients
The systematic review into effective ways of communicating cardiovascular risk to 
patients, found that not much research has been conducted to date into how to 
communicate risk estimates that motivate people to modify their risk of developing 
heart disease. The review comprised broad inclusion criteria, but only found 15 
studies. Only 4 studies dealt with the presentation of patients’ real risk, as the
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remaining 11 were analogue studies using hypothetical risk profiles. The 
methodological quality of the studies varied, only two were deemed to be of high 
methodological quality according to the Downs and Black checklist (Downs and 
Black 1998). There were two RCTs, 9 were observational designs and 4 were quasi- 
experimental. There was heterogeneity in the conceptualisation, formats and framing 
of cardiovascular risk probabilities. This meant only a few meaningful subgroups 
could be formulated for comparison purposes, such as real versus hypothesised risk 
and the type of cardiovascular risk manipulation.
Results were summarised in a narrative synthesis, but given the evidence few 
conclusions could be drawn from the individual studies. These are tentative and 
need further exploration. For example, (1) making patients aware of their risk can 
encourage risk reduction action to be taken, especially if this risk is high; (2) 
numerical presentation of risk as opposed to simple risk categories leads to more 
accurate risk perceptions and can influence treatment decisions; (3) relative risk 
reduction format ‘encourages’ acceptance of treatment the most, and number 
needed to treat format leads to the least acceptance of treatment; (4) the 
presentation of absolute and comparative risk, both graphically and numerically, 
affects risk perceptions and emotions and can lead to reduction in patient risk 
factors, however, the impact of comparison risk depends on the level of personal 
risk, e.g. comparative risk is attended to less when personal risk is high; lastly, (5) 
shorter timeframes (i.e. less than 10 years) lead to more accurate risk perceptions 
and increased intention to change behaviour, than timeframes longer than 10 years.
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Studies were identified that had two different aims when communicating 
cardiovascular risk. The studies either used risk communication to influence patient 
awareness and correct inappropriate risk perception to facilitate the decision to 
reduce risk or not to reduce risk; or the studies aimed to assess the impact of 
different risk reduction strategies in facilitating decisions on how to reduce the risk.
To conclude, the review demonstrated a lack of well-designed studies in 
cardiovascular risk communication. This was due to a combination of diverse 
methodological quality, heterogeneity of study characteristics (such as the design, 
sample and type of cardiovascular risk presented), inconsistency in the risk 
representation formats used, a wide range of outcomes that have been measured; 
and contradictory results. It was suggested that compared to the intensive and 
ongoing investment in the calculation of cardiovascular risk estimates, there is a 
poverty of research on how to convey these risk estimates in a meaningful way, and 
further research is needed before drawing any firm conclusions.
10.2.3 Summary of results from RCT
The last main section of this thesis describes the design, piloting, primary and 
secondary results, and evaluation of a web-based RCT into the effects of 
cardiovascular risk representation formats on intention to change behaviour to 
reduce cardiovascular risk, understanding of risk information, positive and negative 
affect and worry about future risk of heart disease. A website comprising a risk 
calculation based on the Personal Heart Score (Mainous et al. 2007) and risk
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formatter, which randomised users to one of four conditions to receive their results in 
one of three risk representation formats (bar graph, pictogram or metonym) was 
used in the trial.
This trial found no significant main effects of graphical representation formats, 
suggesting that the type of format used to present risk to people has no influence on 
motivating individuals to making risk-reducing changes to their behaviour. No 
particular format is more helpful than another in facilitating understanding of risk 
information, and the formats did not appear to influence affect and worry about future 
risk of heart disease. This leads to the conclusion that decisions to reduce 
cardiovascular risk are not significantly influenced by the way risk is communicated, 
but are dependent on other criteria. Therefore, developers of risk communication 
interventions need to use clear representation formats in their tools, but may not 
need to be concerned with subtle differences in formats; furthermore, it may be more 
beneficial for them to focus more on behaviour change interventions. However, it 
was noted that this finding is likely to be due to a type II error resulting from a biased 
and unrepresentative sample.
Furthermore, the trial found that viewing personalised cardiovascular risk alters 
emotions. Positive and negative affect and worry about future risk of heart disease 
were significantly reduced after respondents received their risk output results. The 
extent of the decrease in emotions depended on the individual’s risk magnitude. For 
example, those told they were of moderate to high cardiovascular risk had greatest 
reductions in positive emotions, whilst those of low cardiovascular risk had greatest
reductions in negative emotions (including worry about future risk of heart disease).
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This is in the direction that would be expected when people find out their risk of 
developing a disease in the future; i.e. low risk individuals feeling less worried and 
fearful about their future risk, and moderate/high risk individuals feeling less assured 
about their risk and realising that it is elevated and needs to be reduced. This finding 
demonstrates the important role that risk magnitude plays in how people feel about 
their risk, which in turn may influence subsequent behaviours.
A moderate amount of variance in intention to exercise more and intention to lose 
weight scores was explained by the variables measured in this trial (11.7% and 3.8% 
respectively). Intention to exercise more and intention to lose weight was significantly 
predicted by positive affect, suggesting that increasing positive emotions will 
facilitate people to adopt protective health behaviours. Level of exercise can also be 
increased by reducing negative emotions and taking into account the risk magnitude 
of the individual. Understanding of risk information also made a significant 
contribution to intentions. However, the negative beta coefficients indicated that 
intentions decrease with increased understanding. It is highly likely that this is an 
artefact resulting from the high proportion of respondents who possessed complete 
or partial understanding of the risk information. Therefore, it should not be taken as 
evidence that motivating behaviour change results from limiting an individual’s 
understanding of their risk information.
The trial evaluation concluded that the most plausible explanation for the lack of 
effect and findings contrary to the hypotheses was the biased sample, comprising an 
over-representation of respondents at low cardiovascular risk, and the possible 
‘worried well’ who reported inappropriate intentions to reduce their cardiovascular
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risk, even though it was low and did not need to be reduced. This meant a skew in 
the majority of the findings, particularly the primary outcome measure used in most 
of the analyses (intention to change behaviour).
10.3 Strengths and limitations of thesis
The strengths and weaknesses of this thesis will be discussed separately in relation 
to the three components: the critical appraisal of publicly available cardiovascular 
risk prediction tools, the systematic review on the effectiveness of cardiovascular risk 
representation formats and the web-based RCT.
10.3.1 Strengths of thesis
This thesis contributes to the research into the communication of cardiovascular risk, 
and furthers knowledge of the effects of risk representation. It has investigated how 
well publicly available web-based cardiovascular risk prediction tools present 
cardiovascular risk, identifying that internet users searching for on-line 
cardiovascular risk assessment are likely to find tools varying in the quality of the risk 
communication and extent that risk reduction is facilitated and encouraged. It has 
also systematically reviewed and synthesised past research into cardiovascular risk 
representation formats, highlighting the need for more methodologically sound 
studies into the effectiveness of risk representation formats (particularly graphical 
risk representation formats). It has addressed this issue by designing and conducting 
a RCT using the MRC framework for developing and evaluating complex
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interventions (Medical Research Council. 2000; Medical Research Council 2008) as 
guidance.
The RCT has also addressed the lack of research into cardiovascular risk 
communication that uses patient’s actual risk, rather than analogue designs using 
hypothetical scenarios asking them to imagine they are have a particular risk profile. 
This strengthens the validity of the findings as it is known that real patients differ in 
their responses to participants of hypothetical studies (Lloyd 2001). Furthermore, the 
primary outcome (intention to change behaviour) was theoretically underpinned by a 
well established model of behaviour/ behaviour change (Ajzen 1991), and a 
questionnaire was developed for the purposes of the trial, using already existing 
validated scales (Thompson 2007) where possible; or constructing new items using 
published guidelines (Francis et al. 2004). Lastly, it also sought to address the 
limitations of other studies when measuring understanding by assessing ‘subjective 
understanding’, which determines whether respondents had interpreted their risk 
correctly and know the extent that they should be reducing their risk.
The RCT involved a web-based risk formatter tool comprising an in-built risk 
calculator predicting 10-year cardiovascular risk, with three possible graphical 
formats presenting the results. The risk formatter was specifically designed for this 
trial and went through an extensive piloting procedure assessing usability and 
internal logic. Data collection was maximised by using a number of different 
recruitment strategies, both internet-based (such as posting on social networking 
websites and forums) and non internet-based (such as posters and cards). These
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diverse methods enabled a wide audience to be reached, which maximised potential 
participation in the trial.
10.3.2 Limitations of thesis
This section will describe the weaknesses of this thesis that need to be 
acknowledged in the interpretation and broader application of the findings.
The critical appraisal of publicly available cardiovascular risk prediction tools 
assessed the top 10 ranked tools most likely to be retrieved using Google search 
engine. The transient nature of the internet and the secrecy surrounding how Google 
determines which websites appear first on a page according to their SERP rankings, 
means that it is quite possible that the tools that were appraised in this thesis are no 
longer the ones that are most likely to be retrieved by users, or worse, no longer 
available for people to use on-line. Alternatively, new tools may become available 
that were not found in the tool search. This makes some of the findings of the 
appraisal ‘out-of-date’ or redundant. However, it is envisaged that some conclusions, 
such as the wide variation in the quality of the risk communication found in the tools, 
and the varying degrees of focus on risk reduction, will hold true due to the 
unregulated nature of the internet, in terms of what websites are available 
(particularly regarding health information), and the lack of engagement of the 
developers of risk prediction tools with the research evidence on risk communication.
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A limitation with the systematic review on the effectiveness of cardiovascular risk 
communication is one that is applicable to all reviews. Literature searches are unable 
to retrieve all papers that would meet the inclusion criteria of the review. This is due 
to the way journals index the papers using different subject headings and keywords. 
Therefore, despite best efforts to maximise study retrieval (by opting for high recall/ 
low precision), it is likely that some studies eligible for inclusion were not found by 
the searches and therefore were not included in the review. Furthermore, the review 
was conducted at the beginning of the PhD, and searches included studies 
published up to November 2008. Newer relevant studies have been published since, 
that have not been incorporated into the narrative synthesis. However, throughout 
the duration of the PhD, attempts have been made to keep up-to-date with the 
research into cardiovascular risk communication, and relevant studies have been 
identified and described in this thesis where appropriate.
There are a number of weaknesses with the RCT into the effects of cardiovascular 
risk representation formats, including the unrepresentative sample leading to a 
possible type II error of the results, and the selection of the risk representation 
formats used in the trial, these will be discussed separately.
Unrepresentative sample
The generalisability of the results is limited due to the unrepresentative sample,
comprising a highly educated sample (e.g. educated to degree level or equivalent)
and those predominantly of low cardiovascular risk (17.2% of the sample being of
moderate or high risk). The target audience was not reached, as those with elevated
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risk, who would have benefited the most from having a cardiovascular risk 
assessment, were not motivated to participate in this trial. It was suggested that this 
may have been because they were aware of their elevated risk, due to an unhealthy 
lifestyle, but chose not to do anything about it.
Another possible reason may have been due to the web-based nature of the study, 
which limited participation to those with adequate computer literacy and access to a 
computer with the internet. This is a concept known as the digital health divide, 
where the internet is less accessible to certain groups (such as those of low income, 
low literacy, ethnic minority, disabled or elderly people) (Eng et al. 1998). It relates to 
the ‘inverse information law’ suggesting that those in the greatest need of information 
about preventable or treatable conditions, are least likely to have access to the 
necessary technologies, which can lead to poorer health outcomes (Eng et al. 1998; 
Ziebland 2004).
Type II error
After the results of the trial indicated that there were no significant main effects of the 
cardiovascular risk representation formats, the null hypothesis was accepted. 
However, based on the previous literature on risk communication (described in 
Chapter 4) it is surmised that different risk representation formats do have differing 
effects. Therefore, the null hypothesis may have been falsely retained, when it 
should have been rejected, and the alternative hypothesis retained. This leads to a
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false negative result and a type II (or beta) error (Biau et al. 2010) and indicates that 
the trial was not sensitive enough to detect such differences between the risk 
representation formats.
The biased and unrepresentative sample may have contributed to the possible type 
II error, as the low risk, ‘worried well’ sample did not need to reduce their 
cardiovascular risk, but had inappropriate intentions to change their behaviour to 
decrease their risk. They possessed an adequate understanding of the risk 
information presented to them regardless of the formats that were used, their mean 
positive affect was reasonably high before viewing risk, negative affect was 
moderate, and worry about future risk of heart disease was reported as being low. 
However, respondents must have been slightly concerned about their risk of heart 
disease otherwise they would not have wanted to participate in the study. Perhaps 
the ‘worried well’ had already been to the GP to have their risk assessed and were 
already adopting behaviours to protect them from heart disease, such as taking 
statins and cholesterol lowering medications, and therefore were not worried about 
their future risk of heart disease at the time of study. This would explain the lack of 
high motivation to exercising more or losing weight, but the subjective understanding 
responses that suggested that respondents thought that someone of low risk should 
be ‘doing a lot’ to reduce their risk of CVD.
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Selection and development of the risk representation formats
A novel way of communicating risk was assessed in this trial. This was the metonym 
format which depicted the seriousness of having a myocardial infarction as an 
image, rather than graphically representing a numerical risk estimate (as with the bar 
graph and pictogram formats). The metonym was thought to be particularly helpful to 
those of lower numeracy/ literacy skills as it provided some context and enabled the 
individual to see what their risk category actually meant. As this format has not been 
used in risk communication research before, it would have been useful to conduct 
some qualitative work beforehand, such as focus groups with patients and the 
general public, to gauge their opinions and reactions towards the metonym format. 
This would have ensured that the metonyms representing the different risk 
categories were understood correctly and communicated the severity of the risk in 
the appropriate way. However, no unreasonable adverse effects were seen in those 
who received this format, and therefore, this trial can be regarded as providing a 
starting point for developing the concept of using metaphors (metonyms in particular) 
in the communication of personalised risk.
10.3.3 Summary
The strengths and weaknesses of the thesis were discussed in this section, focusing
on the critical appraisal of publicly available cardiovascular risk prediction tools, the
systematic review on the effectiveness of cardiovascular risk representation formats
and the web-based RCT. Strengths of the thesis included identifying the variation in
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the quality of the risk communication of on-line cardiovascular risk prediction tools; 
systematically reviewing and synthesising past research into cardiovascular risk 
representation formats, highlighting the need for more methodologically sound 
studies into the effectiveness of risk representation formats; and addressing this 
issue by designing and conducting a RCT involving actual risk assessment.
Weaknesses of the critical appraisal stemmed from the transient nature of the 
internet, which changes the tools most likely to be found by users searching for on­
line risk assessment, and therefore making some of the findings redundant. The 
systematic review was not able to be updated to include newer studies published 
after November 2008. Additionally, it is impossible to retrieve every study eligible for 
inclusion in literature reviews. Lastly, the RCT comprised an unrepresentative and 
biased sample, leading to a possible type II error, and there was a lack of preliminary 
work on the novel metonym format.
10.4 Findings in context of previous research
The findings of this thesis will be compared and contrasted with previous relevant 
research in this section. Again, the three components of the thesis (critical appraisal, 
systematic review and RCT) will be discussed separately.
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10.4.1 Previous research relating to Critical Appraisal of web-based
cardiovascular risk prediction tools
Previous findings relating to the critical appraisal of publicly available web-based 
cardiovascular risk prediction tools will be discussed in relation to the guidelines and 
research evidence into the communication of risk, and also previous research into 
web-based risk prediction tools.
Comparison with guidelines and research evidence
The formats used by the cardiovascular risk prediction tools will be discussed in 
relation to guidelines and research evidence to determine how well these tools are 
portraying risk in-line with best practice and recommendations.
1) It has been widely accepted that graphical accompaniments to risk
information can help with understanding (Lipkus 2007). However, still nearly 
half of the risk prediction tools included in the critical appraisal failed to 
provide any graphical representation with their numerical formats.
Additionally, a tool by the University of Edinburgh was the only one to let users 
choose between four graphical formats to view the risk output. This should be 
acknowledged as a desirable criterion for publicly available risk prediction tools, 
because people will have individual preferences for one format over another.
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2) Natural frequencies are the natural way people think about risk probabilities 
and are effective in correcting inappropriate risk perceptions (Cuitie et al. 
2008; Gigerenzer and Hoffrage 1995; van der Weijden et al. 2008). Five tools 
in the critical appraisal gave a probability estimate in the form of a natural 
frequency. Three tools also used pictograms of smiley faces to demonstrate 
this; however one did not provide the numerical explanation in 
accompaniment, and another only provided a graphical format for high-risk 
patients.
3) Age is the single strongest risk factor for future cardiovascular events (Ridker 
and Cook 2005). Two tools attempted to illustrate this by showing how risk 
exponentially increases with the risk score using a line graph; and offering the 
projection of risk if the user was 10,20 30 years older, demonstrating how risk 
increases if you do not improve your modifiable risk factors.
4) An alternate method for addressing the timeframe issue in cardiovascular risk 
communication is by using the cardiovascular age equivalent format (‘Heart 
Age’). This has been shown to be more memorable, emotionally impactful and 
motivating in making lifestyle changes than more conventional methods such 
as percentages (Goldman et al. 2006; Soureti et al. 2010). Only one of the 
cardiovascular risk prediction tools in this critical appraisal provided this as a 
format for presenting risk (QRISK2).
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5) The majority of risk prediction tools in this study used 10-year timeframes and 
three used timeframes less than 10 years. This is in-line with the findings from 
the systematic review (Chapter 3) that found shorter timeframes (less than 10 
years) lead to more accurate risk perceptions and increased intention to 
change behaviour, than timeframes longer than 10 years (Asimakopoulou et 
al. 2008a; Frileux et al. 2004).
6) Communication about risk reduction: In the critical appraisal, just under half of 
the tools reported the possible options to reduce risk. Some tools did provide 
means to compare the risk achievable from modifying risk factors (such as the 
comparison thermometer by University of Edinburgh tool). However, provision 
of material to help with the decision making of changing behaviour and 
treatment options was scarce; only one tool (American Heart Association) had 
the option of an ‘action plan’. This does not follow current insights such as 
IPDAS, that provides criteria for good practice in facilitating decision making 
(IPDAS 2005). Criteria include starting possible treatment options, the 
comparison of different outcome probabilities, and the provision of tools to 
enable discussion with others (such as a health professional).
Comparison with previous research into web-based cardiovascular risk 
prediction tools
Studies into web-based cardiovascular risk prediction tools have found variation in 
the numbers of tools that readily provided the information needed to assess the
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quality and suitability of these tools (Gillois et al. 1999; Quaglini et al. 2005). This 
was also found in the critical appraisal. For example, different tools had different 
target populations, measured different risk factors and predicted different endpoints. 
Some tools did not provide reference to the algorithm used, did not specify exactly 
what they were predicting (e.g. cardiac risk only or cardiac plus cerebral risk); and 
did not give advice about the eligible population.
The variation of risk representation formats used by the web-based cardiovascular 
risk prediction tools found in this critical appraisal is consistent what has been found 
by pervious research into web-based cancer risk prediction tools (Waters et al. 
2009).
To summarise, the cardiovascular risk prediction tools included in this critical 
appraisal varied in how they communicated risk consistent with the research 
evidence and best practice guidelines. Some tools provided more features deemed 
beneficial and helpful in facilitating risk communication than others, and no tool 
addressed all the issues surrounding cardiovascular risk communication. The 
variation in quality of the risk communication and the extent that risk reduction is 
encouraged may lead to confusion in internet users at home, seeking on-line risk 
assessment independent of their GP. This may contribute to inaccurate risk 
perceptions. This variation is mirrored across the web-based assessment tools in 
other contexts, such as cancer risk prediction.
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10.4.2 Previous research relating to Systematic Review
The principal findings of the systematic review conducted to assess the effectiveness 
of cardiovascular risk representation formats confirm previous research in risk 
communication indicating that:
1) Visual displays have desirable properties that are helpful for representing risk, 
enhance understanding of risk and are favourably evaluated by patients (Hill 
et al. 2010; Lipkus and Hollands 1999; Price et al. 2009).
2) Cardiovascular age equivalent formats (i.e. Heart -Age) are clear, memorable 
and considered an ‘eye-opener’ or ‘wake-up call’, and have the potential to 
motivate people to make beneficial health-related behaviour change. This is in 
contrast to the more traditional statistical probability formats for 
communicating risks that were viewed as being confusing and uninspiring 
(Goldman et al. 2006).
3) Frequencies are the natural way people think about risk probabilities, and are 
effective in correcting inappropriate risk perceptions (Cuitie et al. 2008; 
Gigerenzer and Hoffrage 1995; van der Weijden et al. 2008).
Additionally, the results from a randomised trial published after this review was 
conducted, confirm the positive evaluation of frequencies. When summary statistics 
for communicating the effects of statins on the risk of coronary heart disease were 
presented in different formats, natural frequencies were best understood (86% of
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participants reported they understood them well or very well) and participants were 
most satisfied with this information, compared to other the formats, such as absolute 
risk reduction and number needed to treat (Carling et al. 2009b).
4) The relative risk format is more favourably evaluated than other formats (such 
as absolute risk or number needed to treat) (Covey 2007; Cranney and 
Walley 1996).
To summarise, studies into the communication of cardiovascular risk included in the 
review generally report similar findings to what has already been found by previous 
studies in risk communication, with the exception of some contradictory findings 
which are likely to be the result of the variation in methodological quality of the 
studies and differences in outcomes measured etc.
10.4.3 Previous research relating to Randomised Controlled Trial
The RCT on the effects of cardiovascular risk representation formats will be 
discussed in relation to previous research that either supports or contradicts the 
findings. It will focus on the effects of risk representation formats, positive emotions 
and health, risk perceptions and the psychological effect of screening and risk 
prediction.
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Risk representation formats
This trial did not find any significant differences in the graphical risk representation 
formats, in terms of intention to change behaviour, understanding of risk information, 
positive and negative affect and worry about future risk of heart disease. This finding 
suggests that the representation format used when communicating risk is of little 
importance (providing reasonable attempts of accuracy are made and no overt 
framing is used); and no format is better than another at influencing a patient’s 
motivation to reduce cardiovascular risk, enhance understanding of the risk 
information or altering emotions. This is consistent with some of the previous 
research into the effects and preferences for different risk formats (Cheung et al. 
2010; Edwards et al. 2006b; Fahey et al. 2001; Lipkus et al. 1999).
However, some research evidence has shown differing effects of risk representation 
formats. For example, risks presented as population diagrams were regarded as the 
most frightening, worrisome and serious compared to risks presented as 
percentages and frequencies. The formats also influenced treatment decisions, but 
not cognitive evaluations, such as how hard the risks were to understand 
(Timmermans et al. 2008).
Furthermore, those receiving the Heart-Age format (e.g. cardiovascular age
equivalent analogy) had more realistic risk perceptions, that were more in-line with
their actual risk, but were significantly more worried than those who received the
percentage format. The Heart-Age format also led to greater intentions to eat more
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healthily and increase level of physical activity those who received the percentage 
format (Soureti et al. 2010).
When communicating the effects of statins on the risk of coronary heart disease, the 
relative risk reduction format motivated decisions to choose statins, and natural 
frequencies were best understood (Carling et al. 2009b).
Lastly, differences in risk representation formats have also been seen for the genetic 
risk of crohn’s disease (Wright et al. 2008), and graphical displays of the benefits of 
antibiotics for people with sore throat who are deciding whether to seek treatment 
(Carling et al. 2009a).
It was concluded that the inconsistent research into the effects of risk representation 
formats is likely to be partly due to previous research comparing different formats, 
and the different outcomes used to measure their effects. However, the contradictory 
results do also suggest that there are individual differences in how people respond to 
risk representation formats (perhaps based on a variety of factors that have not been 
controlled for in the previous trials). Furthermore, it may never be determined which 
format is the most effective in terms of motivating behaviour change, facilitating 
understanding and altering inappropriate emotions, as there is simply no ‘magic 
bullet’ for communicating risk to everybody.
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Positive emotions and health
Positive affect was the largest contributor to the variance in intention to change 
behaviour scores. It was the only variable to significantly predict all three behavioural 
intentions (exercise more, lose weight and stop smoking). Positive emotions 
accounted for 32.9% of the variance in intention to exercise more scores, 18.8% of 
the variance in intention to lose weight scores, and 28% of the variance in intention 
to stop smoking scores. This suggests that positive emotions have an influence on 
decisions to change behaviour.
This supports previous research on ‘positivity’ that suggests that positive emotions, 
such as appreciation, hope, gratitude and joy contribute to psychological and 
physical well-being via more effective coping (Tugade et al. 2004). More specifically, 
the broaden-and-build theory of positive emotions postulates that positive emotions 
open the mind and ‘broaden’ people’s ideas about possible actions, in contrast to 
negative emotions that narrow ideas. This allows for the discovery and building of 
new skills, new knowledge and new ways of being (Fredrickson 2009), which 
increases awareness to a wider range of thoughts and actions and acceptable 
behavioural options, making the person more creative and receptive to information. 
Meaning a person in a positive frame of mind will be more accepting and willing to 
make behavioural changes in order to reduce health risks (Fredrickson 2001).
When relating this trial’s findings to this theory, it can be suggested that positivity and
positive emotions lead to ‘a richer appreciation of life’ (Tugade et al. 2004, p.1166).
This results in a desire for longevity and wanting to be at your best by looking after
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your health. Positivity and positive emotions mean people will be more likely to look 
after themselves, be open to new knowledge and suggestions about how to stay 
healthy, and be more likely to adopt health protective behaviours.
Additionally, Fredrickson suggests that positivity can help build psychological 
strength which can facilitate changing ‘bad habits into good ones (Fredrickson 2009). 
The evidence that positive emotions lead to better coping strategies by increasing 
psychological resilience, means that positive emotions may reduce the need for 
people rely on behavioural practices that are considered harmful to their health, as a 
way of coping with life-events and stressful situations, such as smoking, eating 
unhealthy food, excessive alcohol consumption etc. Therefore, developers of health 
interventions should focus on increasing a person’s positive emotions to effectively 
increase health protective behaviours.
However, Cameron and Chan 2008 suggest that more research needs to be done 
into health communications that arouse positive emotions (Cameron and Chan 
2008). They suggest that developers of health interventions should consider the goal 
of the health communication, the affective experience that it will generate and how 
the emotions aroused by health communications may promote or interfere with the 
aims of the communication. For example, if the aim is to motivate individuals to take 
action on a health risk already familiar to them, the message contents should be 
constructed to induce a positive emotional arousal and a sense of self-efficacy; 
whereas, if the aim of the communication is to make individuals aware of a health 
threat and install a sense of risk, then message contents arousing other (less 
positive) emotions may best promote the aim (Cameron and Chan 2008).
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Risk perceptions
This trial provided evidence that people have difficulty in accurately perceiving their 
risk and found evidence of inappropriate risk perceptions in ‘worried well’, who are 
informed about their low risk, but are still anxious to monitor their risk and may feel 
the urge to ask for diagnostic or therapeutic interventions (van Steenkiste et al. 
2004b). Inappropriate risk perceptions, mainly incorrect pessimism, where people 
overestimate their risk, have been seen in previous research (Alwan et al. 2009; 
Frijling et al. 2004; van der Weijden et al. 2007). Incorrect optimism, where risk is 
underestimated has also been found (Aalto et al. 2007). Improving the accuracy of 
risk perceptions is important as they have been shown to influence emotions 
(Asimakopoulou et al. 2008b) and behaviours (Ali 2002).
Interventions aimed at correcting patients’ risk perceptions have had varying 
success (Harle et al. 2008; Kreuter and Strecher 1995; Paterson et al. 2002), and 
may only have short-term effects (Christian et al. 2005). This could be taken as 
evidence to support findings by van Steenkiste et al (2004) that risk perceptions are 
rarely based on an understanding of the probable risks at the level of the individual, 
and are more often based on familiarity with the disease, and how it relates to 
experiences with family, close friends or colleagues who have suffered from CVD  
(van Steenkiste et al. 2004b).
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Psychological effects of screening and risk prediction
This trial found that viewing cardiovascular risk significantly decreased negative 
affect and worry about future risk of heart disease. The greatest reductions were 
seen for those categorised as low risk. This lends support to previous research that 
has found risk screening does not lead to adverse psychological effects (Marteau et 
al. 1996; Pijl et al. 2009). This trial also found a decrease in positive affect for all 
respondents, including those of low cardiovascular risk. This was unexpected, as a 
low risk outcome could be associated with providing reassurance to the individual, 
and therefore increase positive emotion, particularly in the ‘worried well’. Previous 
studies have also found a lack of reassurance from favourable (i.e. negative) test 
results, and suggest that this stems from a disparity between prior risk perceptions 
and expectations and the actual negative or low risk results, leading them to mistrust 
the risk information that has been presented to them (Michie et al. 2003; Michie et al. 
2002). The decrease in positive affect seen in this trial is likely to be a short-term 
consequence only, as previous research has shown that negative effects dissipate 
over time, and there is no evidence of any long-term adverse effects (Shaw et al. 
1999).
Summary
To summarise, this trial did not find any significant differences in the graphical risk 
representation formats, in terms of intention to change behaviour, understanding of 
risk information, positive and negative affect and worry about future risk of heart
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disease. However, the evidence is contradictory and it remains unclear whether the 
portrayal of risk does have little influence on patient’s behaviours, cognitions and 
emotions, or whether this trial failed to identify true differing effects resulting from the 
risk representation formats. Therefore, more research is needed before any 
conclusions can be drawn. This trial supports the body of evidence that individual’s 
have difficulty in accurately perceiving their risk, and demonstrated that risk 
perceptions influence emotions and subsequent intentions and behaviour. Lastly, 
viewing cardiovascular risk was found to decrease negative affect and worry about 
future risk of heart disease, this lends support to previous research that has found 
risk screening does not cause adverse psychological effects.
10.4.4 Summary
This section has compared the findings of notable interest in this thesis with previous 
literature. The critical appraisal of web-based cardiovascular risk prediction tools 
found that publicly available tools most likely to be retrieved by Google varied in how 
they communicated risk consistent with the research evidence and best practice 
guidelines. Some tools provided more features deemed beneficial and helpful in 
facilitating risk communication than others, and no tool addressed all the issues 
surrounding cardiovascular risk communication. The variation is mirrored across the 
web-based assessment tools in other contexts, such as cancer risk prediction.
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The systematic review on the effectiveness of cardiovascular risk representation 
formats found that studies into the communication of cardiovascular risk generally 
support the findings from past risk communication research. However, contradictory 
findings do exist, which are likely to be the result of the variation in methodological 
quality of the studies and differences in outcomes measured etc.
The RCT into graphical cardiovascular risk representation formats supports the body 
of evidence that individual’s have difficulty in accurately perceiving their risk. It lends 
support to previous research that has found risk screening does not cause adverse 
psychological effects, as viewing cardiovascular risk was found to decrease negative 
emotions (including worry about future risk of heart disease). However, the trial 
found no significant main effects of the cardiovascular risk representation formats, 
but the past evidence is inconsistent with regards whether risk representation 
formats do influence people’s perceptions, cognitions, emotions or behaviours. 
Therefore, more research is needed before any firm conclusions can be made.
10.5 Implications for Practice and Policy
This section will discuss important aspects that have been highlighted during the 
research for this thesis that have implications on practice and policy. These include 
the identification of differing aims of risk communications, and engaging those who 
may be of unaware of their elevated cardiovascular risk to have a risk assessment. 
Wider implications such as the way society has contributed to the difficulties people
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have in adopting healthier lifestyles, and the preference of medication to reduce risk 
over lifestyle change will also be discussed.
10.5.1 Research into cardiovascular risk communication
The critical appraisal into web-based cardiovascular risk prediction tools and the 
systematic review into cardiovascular risk representation formats highlighted that 
determining how best to present cardiovascular risk information to patients strongly 
depends on the intended aims of the communication. The complexity surrounding 
the area of research could be reduced if the communicators of risk were clearer 
about their intended aims of the communication. Two purposes of risk 
communication became apparent: (1) raising awareness and improving 
understanding; and (2) persuading those at risk to adopt new behaviours to reduce 
risk. If communication informs patients that their risk is higher than average due to 
increased but modifiable risk factors, it seems important to ensure that balanced 
information about how to change lifestyle and/or add drug treatment, should be 
provided.
Synthesis of the previous research conducted into the effects of different risk 
representation formats enable guidelines for the ‘gold standard’ of communication of 
health risks to be developed and used during consultations between health 
professionals and patients, and also for the developers of risk prediction tools 
available on the World Wide Web.
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10.5.2 Risk awareness
The failure in the RCT to recruit more people of moderate and high risk suggest that 
more needs to be done so that people at high risk are appropriately identified and 
helped to consider their risk, by methods such as interactive counselling using on­
line risk prediction tools. This is so they can make informed decisions regarding how 
best to reduce their risk through making lifestyle changes and/or adhering to 
treatment/medication.
This trial did not find any significant differences between the graphical risk 
representation formats, suggesting that there is no method that is more effective 
than another; as the way risk is communicated to patients has no influence on 
behaviours (i.e. changing behaviour to reduce risk), cognitions (in terms of 
understanding) or emotions. This informs developers of cardiovascular risk 
prediction tools and risk reduction interventions that getting the message across is 
the most important aspect of the risk communication, not what format the message is 
presented in.
10.5.3 Failure to motivate behaviour change
This thesis has found that cardiovascular risk prediction tools do not support efforts 
to achieve behaviour change. The focus has been on the accuracy of the risk 
prediction and increasing people’s awareness of their risk. The tools present 
cardiovascular risk in a variety of ways, but it is questionable whether this alone, can
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encourage people with elevated risk to do something about it and attempt to reduce 
it.
The trial conducted as part of this thesis found that when people were shown their 
risk category; this had little or no influence in motivating behaviour change. This is 
supported by a recent RCT by Price et al (2011), which aimed to determine if 
personalised 10-year cardiovascular risk estimates could increase risk reduction 
behaviours. 194 high risk adults (i.e. over 20%) from four general practices, were 
randomised to the intervention group (receiving personalized 10-year CVD risk 
estimate based on the UK Prospective Diabetes Study Risk Engine), or the control 
(told they had elevated risk factors according to guidelines). At one month follow-up 
there was no increase in physical activity or significant change in estimated 10-year 
CVD risk in those receiving personalised CVD risk estimates. Furthermore, there 
were no within or between-group differences in anxiety, quality of life, self-regulation, 
worry about future risk of heart attacks, or intention to increase physical activity. This 
shows that the risk estimates had no effect in comparison to being informed of 
elevated risk factors. However, the sample has been criticised as being 
unrepresentative of the general population, as those who participated in the study as 
could have been more motivated and interested in reducing cardiovascular disease 
risk than those who did not; they were also more physically active at baseline than 
was expected (Price et al. 2011).
This is supported by risk prediction tools designed for use in GP consultations. 
Montgomery et al (2000) developed a computer-based clinical decision support 
system with cardiovascular risk chart (presenting 5-year absolute risk of a fatal or
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non-fatal cardiovascular event based on the New Zealand guidelines for the 
management of hypertension. The risk chart and computer-based clinical decision 
support system were no better than usual care at reducing absolute cardiovascular 
risk, in those with a risk higher than 10%, nor conferred any benefit in blood pressure 
control at 12 month follow-up (Montgomery et al. 2000).
10.5.4 Medication versus lifestyle change
A reason for the failure of cardiovascular risk prediction tools to motivate lifestyle 
behaviour change could be due to difficulty people have in changing their lifestyle. It 
is estimated that adherence to lifestyle advice and medication varies between 20 and 
90%, with most estimates averaging in the region of 50% (Ashenden et al. 1997; 
Burke et al. 1997; Koelewijn-van Loon 2010; World Health Organisation 2003). A 
meta-analysis found that interventions comprising educational and behavioural 
components can be effective in improving adherence (Roter et al. 1998). However, 
intervention programs have been successful in promoting short-term adherence to 
physical activity and dietary regimes for promoting health (Wylie-Rosett et al 1994; 
Svendsen et al 1994; Stevens et al 2002). Few have long-term success (Burke et al. 
1997; Orleans 2000) as most people who succeed in making changes revert back to 
their previous more unhealthy behaviour within 6-12 months (Orleans 2000).
The trial by Price et al (2011) described above, gives support to the notion that 
people prefer medication over lifestyle changes. Receiving personalised 10-year 
cardiovascular risk estimate was associated with a clinically significant reduction in
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lipids and an increase in the number of cardiovascular disease risk-reduction 
therapies prescribed but no increase in physical activity (Price et al. 2011).
Furthermore, a focus group study exploring how individuals respond to global CHD  
risk and use it in combination with treatment information to make decisions regarding 
initiating and maintaining risk reducing strategies, found that most participants would 
accept medication under certain circumstances, such as when the medication was 
safe, the easier option, a bridge to lifestyle changes. When evaluating decisional 
factors that influence risk reduction, participants expressed a preference for risk- 
reducing options that did not interfere with their enjoyment of life. They also wanted 
risk reducing options that had quick and tangible results, that had been extensively 
researched by trusted sources (Sheridan et al. 2009).
The variable success of lifestyle interventions and the increasing incidence of obesity 
suggests that people find it difficult to make changes to their health-behaviours and 
habits, i.e. social determinants are more powerful than individual choices. However, 
the steady decrease in the incidence of CVD, confirmed by the 40% decrease in 
death rates from CVD in people under 75 in the last decade (Allender et al. 2008), 
indicates some degree of societal shift in disease prevalence. The British Heart 
Foundation statistics report that prescriptions for the prevention and treatment of 
CVD have increased steadily since 1980. In 2008, 266 million prescriptions were 
issued, this was nearly 5 times as many prescriptions than issued in 1986, and 6%  
more than in 2007 (Scarborough et al. 2010). More specifically, the number of 
prescriptions issued for antihypertensive therapy was 21,075 in 2000 and increased
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to 57,823 in 2008. Additionally, 10,331 prescriptions for lipid-lowering drugs were 
issued in 2000, and rose to 52,190 in 2008 (Office of National Statistics 2009).
These statistics show that more and more people are opting for medication to reduce 
their risk of CVD, or that this is the most commonly used strategy in CVD prevention. 
A reason for this could be the Inverse Benefit Law (Brody and Light 2011). This law 
proposes that the ratio of benefits and harms among patients taking new drugs 
varies inversely with how extensively the drugs are marketed (Brody and Light 2011, 
p.399). The marketing works because it is believed that heavily marketed drugs are 
more efficacious and safer than older, less marketed drugs.
The Inverse Benefit Law assumes that low and high risk populations receive different 
degrees of benefit and harm from administration of a drug. Patients at the highest 
risk or with most severe symptoms have the greatest chance of benefiting from the 
drug (represented as a low NNT). However, this means that only a small percentage 
of the population are eligible to receive the drug and therefore, there is a low yield of 
sales. Marketing increases drug use by extending the use of the drug beyond the 
proper evidence-based threshold for beginning the drug therapy, and less at-risk or 
less severely affected patients are given the drug. This means many more patients 
need to be treated for one patient to benefit (increasing the NNT). The benefit-to- 
harm ratio worsens as more adverse reactions occur due to more people being 
exposed to the drug.
Furthermore, guidelines for risk factors such as cholesterol, recommend drug 
therapy for groups with progressively lower low-density lipoprotein levels, despite
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very high NNTs and lack of evidence of benefit of drug therapy as primary 
prevention. The writers of these guidelines often have conflicts of interest (Brody and 
Light 2011). Therefore, risk assessment may be a marketing ploy for pharmaceutical 
companies, generating a ‘risk society’ as a tool for marketing exercises.
The prognostic models used to predict CVD may be redundant and no longer used 
to estimate outcome risk and to influence patient management, due to the 
suggestion to give everyone over the age of 55 the ‘polypill’ (e.g. combinations of 
statins such as atorvastatin or simvastatin, blood pressure lowering drugs such as 
thiazide, a beta blocker, and an angiotensin converting enzyme inhibitor, folic acid 
and aspirin) to reduce cardiovascular risk (for example, ischaemic heart disease by 
88% and stroke by 80%) (Moons et al. 2009; Wald and Law 2003).
10.5.5 Society contributing to lifestyle choices and health outcomes
Societal norms make a significant contribution how we live our lives. It is an 
accepted paradigm in developed countries that individuals of lower socio-economic 
status (SES) tend to have poorer health than those of higher SES. For example, 
lower SES groups have a higher incidence of CVD and some forms of cancer and a 
higher prevalence of risk factors for CVD and type 2 diabetes (Kuhle and Veugelers 
2008). This is known as the ‘social gradient’ and is thought to reflect the fact that 
‘lower SES is associated with barriers in access to quality health care; environmental 
exposures; and limitations in knowledge, time and opportunity for making healthy 
lifestyle choices’ (Kuhle and Veugelers 2008, p.7).
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However, the extent of this paradigm is less obvious in obesity. The lack of variation 
in rates of obesity across the social-economic gradients is demonstrated in a report 
by the British Heart Foundation (Allender et al. 2008). In 2006, 65% of men in the 
lowest household income quintile were classified as overweight/obese (BMI >25 
kg/m2) compared to 68% of men in the highest household income quintile; and 50% 
of women in the highest quintile compared to 64% in the lowest quintile (Allender et 
al. 2008). Further evidence against the social gradient for obesity is demonstrated by 
Kuhle and Veugelers (2008) who found a negative association between SES and 
overweight/obesity for women and an inconsistent relationship for men (Kuhle and 
Veugelers 2008). This supports previous research from a number of industrialised 
countries (Ball et al. 2002; Robert and Reither 2004; Wardle et al. 2002; Wolff et al. 
2006; Zhang and Wang 2004).
Food consumption patterns have been suggested as a contributing factor to the 
obesity rates across all social gradients. For example, those of higher SES are more 
likely to eat outside of the home compared to lower SES groups (Kuhle and 
Veugelers 2008). The limited success of risk factor interventions using counselling or 
educational methods leads to the conclusion that different approaches to promoting 
health protective behaviours, such as better access to recreational and sporting 
facilities and availability of healthier foods, may be more successful than advice from 
health professionals (Ebrahim et al. 2006). Additionally, public health campaigns 
should address lifestyle choices at an earlier age, so healthy behaviour patterns 
become habitual, as it is very difficult for people to change their bad habits after they 
have had them for years.
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10.5.6 Summary
To summarise, this section has discussed the research conducted for this thesis in 
relation to the implications it has on practice and policy. It has described important 
issues such as the conflicting aims of risk communication and the lack of 
engagement of ‘at risk’ groups to participate in cardiovascular risk assessment. The 
limited success of lifestyle interventions to reduce risk were described, and possible 
reasons were put forward. These included the fact that people find lifestyle changes 
hard to achieve, sometimes reverting back to their old habits after a few months; and 
the preference for medication over lifestyle change, which is partially due to 
aggressive pharmaceutical marketing and the lowering of treatment thresholds. It 
was concluded that public health campaigns may need to look at the bigger picture 
and make changes on a societal level, facilitating the adoption of lifestyles that lead 
to a decreased risk of CVD.
10.6 Directions for future research
This section identifies areas where further work would be of value, building on the 
current research. It also describes research that is already being conducted into 
cardiovascular risk prediction that addresses some of the issues relating to the 
problems in communicating cardiovascular risk to patients.
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10.6.1 General consideration for the improvement of future research
To further expand on the work into the effects of risk representation formats, more 
methodologically sound studies (such as RCTs) need to be conducted that measure 
patient-related outcomes. Past research in risk communication has over-relied on 
hypothetical risk profiles. Therefore, it would be useful if future studies assessed 
patient outcomes resulting from the presentation of their actual risk. If future 
research in risk communication aims to improve the consistency in terms of study 
design, sample, type of risk predicted and outcomes measured, this will allow 
reviews of the literature comprising a more in-depth synthesis of results, than was 
achieved by the systematic review conducted for this thesis. Thus enabling a 
consensus as to which formats are most effective for communicating risk, and will 
provide a basis for compiling risk communication guidelines based on the research 
evidence.
The systematic review found that further investigation is needed into the framing of 
information regarding the benefits and harms of treatment and the provision of 
comparative risk information (e.g. risk compared with the average person of the 
same age and sex), that shows baseline risk and puts personal risk into context.
More attention needs to be paid to the quality of the risk communication that is being
presented in on-line risk assessment tools. Poor quality information has the potential
to mislead and confuse by providing an inaccurate and unbalanced picture. This
leads to inappropriate risk perceptions, such as incorrect pessimism or optimistic
bias. It is even more important that this is avoided if these tools are designed for use
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outside of the healthcare setting, without guidance from a GP or health professional. 
The value of web-based risk prediction tools intended to be used outside of 
consultations with health practitioners is reduced if users do not fully understand or 
appreciate the reasons behind their risk result. Although some tools included in the 
critical appraisal did attempt to define and explain the risk result, more tools should 
consider doing this. Also, the tools need to have consensus in the endpoints they 
predict, so that results are more consistent across tools. Users of more than one tool 
will have their risk result validated and will have more faith in the results.
The creators of these risk prediction tools need to incorporate more of the ‘best 
practice’ criteria found by the research evidence in the communication of 
cardiovascular risk. Tools could also be improved by incorporating important 
features that help with the decision making process of cardiovascular risk reduction, 
such as the option to revisit the tools and record progress as attempt is made at 
reducing cardiovascular risk. This will enable the development of a fully 
comprehensive risk prediction tool that could be considered the ‘gold standard’ for 
cardiovascular risk communication.
10.6.2 New directions for future research into cardiovascular risk 
communication
There are a number of issues that need to be addressed with regards the
conventional methods of communicating cardiovascular risk. These include: (1) the
presentation of abstract numerical risk estimates, rather than more salient outcomes
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that provide context and meaning to the risk; and (2) the 10-year timeframe over 
which cardiovascular risk is predicted, which due to the nature of cardiovascular risk, 
predicts absolute risk of a younger person with modifiable risk factors as ‘low’ due to 
the protection of age. Each will be discussed separately below, and will highlight 
relevant research that has just started to address these issues.
Presenting risk as more salient outcomes
People have difficulty in forecasting their future risk, and more meaningful 
projections should be used instead of presenting risk in an abstract 10-year horizon. 
This could be in the form of more salient outcomes and forecasts of loss in the 
future, such as not being able to achieve important milestones, birth of grandchildren 
or similar. The RCT conducted for this thesis assessed the effect of presenting risk 
as a salient outcome, by using a metonym image depicting the seriousness of having 
a myocardial infarction. This deviates away from the more conventional methods 
involving representations of numerical risk estimates and provides context for 
interpreting the risk information. Although, the trial did not find that this format 
differed in its effectiveness of communicating risk compared to the more traditional 
methods (i.e. percentage bar graphs and natural frequency pictograms/ icon arrays), 
it should not be ruled out as a possible way of presenting cardiovascular risk (or any 
other risk), as people (particularly those of lower numeracy and literacy skills) may 
find this format easier to understand than the numerical risk estimates currently 
being favoured for the communication of risk.
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Support for presenting risk as more salient outcomes comes from a RCT described 
earlier (Soureti et al. 2010), which examined the effects of presenting patients with 
their ‘Heart-Age’ (an analogy also known as cardiovascular age equivalent). This 
was calculated using the equivalent risk of a person who has no modifiable risk 
factors. Those who received the Heart-Age format had more accurate risk 
perceptions in-line with their actual risk, than those who received the percentage 
format. The Heart-Age format was more emotionally impactful in younger individuals 
at higher CVD risk, as they were significantly more worried and were more likely to 
view it as a ‘wake-up’ call (Soureti et al. 2010).
Further evidence of the effects of showing patients how their lifestyle has affected 
their health in a salient way comes from a RCT into smoking cessation (Parkes et al. 
2008). Spirometry (which assesses lung function, detects obstructive lung damage 
and premature ageing) was used to calculate ‘lung age’ by comparing an individual’s 
results, to work out the age of a healthy individual who would perform similar to them 
on spirometry. The impact of this salient message on smoking cessation was 
determined by salivary cotinine testing at 12 month follow-up. 561 participants, over 
the age of 35, who had smoked for the past 12 months were randomised to either 
the intervention group to receive their ‘lung age’, or the control group where they 
were advised that they would be tested again in 12 months to see if there had been 
any change in their lung function. Those shown their ‘lung age’ were significantly 
more likely to quit smoking than those who were not. 13.6% of patients in the 
intervention group had quit smoking within 12 months, compared to 6.4%  of the 
control group (difference 7.2%. p=.005, 95% Cl 2.2% -12.1% ) (Parkes et al. 2008).
Additional support of presenting risk in more salient outcomes comes from a recent 
randomised trial aimed to determine the motivating effects of web-based animation 
technology depicting a three-dimensional heart (Lee et al. 2011). Images showed the 
condition of the heart over time if a healthy diet and regular exercise was maintained, 
contrasted with an ‘unhealthy’ heart in the future, resulting from a lack of exercise 
and a poor diet (e.g. increased heart rate, damage to heart wall, enlarged chambers, 
plaque build-up, few capillaries). Sedentary university students and staff, under 35 
years of age were randomised to receive either: imagery and descriptive text, image 
only, text only or control (no imagery or text). Understanding of risk, worry, intentions 
and behaviours towards physical activity and healthy diet were assessed at baseline, 
2 days, 2 weeks and 4 weeks post-intervention. The heart imagery increased 
understanding, worry and intentions to improve physical activity and diet. However, 
only understanding and worry were sustained at 4 week follow-up (Lee et al. 2011). 
This work should be extended further by using a sample older than 35 years of age 
and providing detail about a person’s own major risk factor levels.
In a study investigating the framing effects of presenting the consequences of health- 
related behaviour (Galesic and Garcia-Retamero 2011), numerical information about 
the relationship between CVD risk and exercise and weight was presented as risk 
estimates (e.g. ‘people who are overweight have a 36 percent risk of heart failure-18 
percent higher than an average person.’ and ‘people who exercise regularly have a 
21 percent risk of cardiovascular disease-13 percent lower than an average person’) 
or life-expectancy (e.g. ‘people who are overweight have a life expectancy of 73
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years- 60 months shorter than an average person’ and ‘people who exercise 
regularly have a life expectancy of 81 years- 36 months longer than the average 
person’). Respondents of high and low numeracy, who received the information 
framed as life-expectancy, recalled the information significantly better than the risk 
estimates, both immediately after and later at three week follow up (Galesic and 
Garcia-Retamero 2011).
It was suggested that effectiveness of salient outcomes may be attributable to 
imaginability (e.g. imagining life expectancy), where people are better able to 
connect the risk representation to their everyday life. According to Paivio’s dual­
coding hypothesis, imaginability of the information is based on cognitive processes 
where concrete portrayals invoke mental images more readily than abstract 
portrayals. Greater imaginability leads to better encoding and a richer memory trace, 
enabling both verbal and visual encoding in memory and enhance recall of 
information (Paivio 1969). Additionally, the undesirability of the risk (e.g. perception 
of risk of the undesired event) may also be attributable. This is an emotional process, 
where more emotion is evoked (negative emotion in particular) with increasing 
distinctiveness of the event in memory and subsequently improves its recall (Galesic 
and Garcia-Retamero 2011).
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Time orientation
The interpretation of a person’s cardiovascular risk is likely to be affected by their 
‘time orientation’. This is a psychological characteristic that describes the different 
preferences people have for certain timeframes which influence their information 
processing, and evaluation of actions and the possible outcomes of those actions 
(Crockett et al. 2008). The two most common of these are ‘future’ and ‘present’ 
orientation. Those with a high ‘present’ orientation think about immediate 
consequences of their behaviour, and take a fatalistic approach with a limited sense 
of control over life events. They are also more likely to engage in practices that have 
immediate gains, such as substance abuse. In contrast, people with high ‘future’ 
orientation think more about the future and have an awareness of current actions on 
future outcomes. They are likely to engage in practices that have an immediate cost 
for a future gain, such as physical activity and healthy eating (Crockett et al. 2008; 
Keough et al. 1999; Rothspan and Read 1996).
Support for the differences in time orientation comes from a focus group study into 
the attitudes about CVD (Gabhainn et al. 1999). This revealed that despite good 
knowledge about risk factors for heart disease, participants had a low motivation to 
change lifestyle behaviour. One of the reasons suggested for this was that age was 
seen to be an important motivating factor for change. Older participants (especially 
men) thought it was too late to make lifestyle changes to reduce their future risk, and 
younger participants thought it was too soon and therefore not necessary to change 
(Gabhainn et al. 1999). Research has identified additional factors that may affect a
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person’s time orientation. For example, work on screening for diabetes found that 
socially disadvantaged groups are more ‘present’ rather than ‘future’ oriented 
(Crockett et al. 2008).
This work suggests that the presentation of future risk of developing CVD is likely to 
have a differential impact on those with different time orientations; being more 
effective for those with a high ‘future’ orientation. Alternative methods need to be 
devised for those with a high ‘present’ orientation, particularly younger people, such 
as projecting short-term risk over longer time horizons.
Projection of short-term risk over longer time horizons
Current cardiovascular risk prediction algorithms usually predict future risk over a 10- 
year timeframe. However, this makes managing younger patients with multiple 
cardiovascular risk factors a challenge. For example, according to these 
cardiovascular risk calculators, a 40 year old male smoker, who is overweight and 
has high HDL cholesterol and blood pressure, has a 5% risk of having a heart attack 
or stroke in the next 10 years. Therefore, has not reached the threshold considered 
for initiating risk reduction. This is because these calculators are strongly dependent 
on age and do not capture the importance of younger patients longer term risk and 
what the future holds. A solution to this problem is forecasting short-term risk 
throughout the lifespan (Jackson 2010).
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This has been attempted by the QRISK lifetime risk calculator (Hippisley-Cox et al. 
2010), comprising graphs representing a continuous prediction of patients’ 
cumulative cardiovascular risk throughout their lifetime, based on both current risk 
profiles and if their risk profiles improve. Time (which is the most important risk 
factor) is incorporated into the graph and the predicted risk for any time period can 
be read (see Figure 10.1).
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Figure 10.1 Example of the QRISK® cardiovascular lifetim e risk calculator output
with cumulative graph.
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A similar concept has been adopted by a risk calculator developed by the New 
Zealand Heart Foundation and the University of Auckland called the ‘Heart Age 
Forecast tool’ (Wells et al. 2010).
This tool incorporates both short-term and long-term risk in one display, which has 
advantages over separate 10-year and lifetime cardiovascular risk calculators (such 
as the QRISK lifetime risk calculator). It also has the added dimension of ‘arterial 
age’ (heart age), with long-term risk demonstrating how the arterial age is 
determined. Treatment thresholds and scenarios for lifestyle and modifiable risk 
factor changes are also given.
It is designed to be used during a consultation between a physician and patient 
forecasting short-term risk at all ages from 35 to 75 years. It has an interactive 
graphical application that conveys several cardiovascular risk communication 
messages individualised for each patient in a stepwise fashion (See Figure 10.2). It 
is not dependent on a patient’s health literacy and supports cardiovascular risk 
communication and shared decision making (Wells et al. 2010).
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Figure 10.2 Example of Heart Age forecast tool output.
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The first page (top screenshot in Figure 10.2) illustrates a patient’s 5-year absolute 
CVD risk, the second page illustrates the 5-year absolute risk trajectory of a person 
who is the same age and gender as the patient but who has ‘ideal’ levels of 
modifiable risk factors (blue arrowed line in middle screenshot in Figure 10.2), the 
third page (middle screenshot in Figure 10.2) displays the arterial (heart) age 
demonstrating the impact of the patient’s modifiable risk factors on their arteries. The 
next page (bottom screenshot in Figure 10.2) forecasts the patients 5-year risk as 
they age, assuming they do not change any of the current risk factors. The 
subsequent pages show the guidelines and recommendations for starting drug 
treatment and ‘what if scenarios generate new forecasts based on changes to the 
risk profile (Wells et al. 2010).
10.6.3 Summary
Two main issues with current cardiovascular risk prediction have been highlighted:
(1) the presentation of abstract numerical risk estimates, rather than more salient 
outcomes that can provide context and meaning; and (2) the 10-year timeframe for 
predicting cardiovascular risk, in which a younger person’s absolute risk will be low 
regardless of any elevated modifiable risk factors, due to the protective nature of 
age. Recent research has shown the benefits of communicating risk using more 
salient outcomes (Galesic and Garcia-Retamero 2011).
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However, the RCT conducted as part of this thesis did not find any differences in 
presenting an alternative format (i.e. metonym) to the more traditional formats based 
on numerical risk estimates. Therefore, more methodologically sound trials are 
needed in this area.
The second issue has been addressed by projecting short-term risk over longer time 
horizons, which incorporates the benefits of relative risk and long term risk 
measures. Two recently developed cardiovascular risk prediction tools have 
achieved this (Hippisley-Cox et al. 2010; Wells et al. 2010). The latter incorporating 
the ‘Heart-Age’ (or cardiovascular age equivalent) format, which has had promising 
results so far (Goldman et al. 2006; Grover et al. 2007; Soureti et al. 2010) and also 
addresses the first issue of presenting risk using more salient outcomes.
10.7 Conclusions
Cardiovascular risk prediction tools are becoming increasing available on the web for 
people to use at home, outside of a clinical setting. However, research on the most 
effective ways of communicating cardiovascular risk has been scarce and patchy, 
leading to inconsistent conclusions. This thesis aimed to examine how well publicly 
available cardiovascular risk prediction tools present cardiovascular risk and 
encourage risk reduction; review past literature to determine which risk 
representation formats are most effective in communicating cardiovascular risk to 
patients; and lastly to design, conduct and evaluate a web-based RCT assessing the
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effects of different cardiovascular risk representation formats on patient-based 
outcomes.
The thesis found that the publicly available web-based cardiovascular risk prediction 
tools vary in the quality of their risk communication and the extent that they 
encourage risk reduction by incorporating features that facilitate decisions to be 
made to regarding lifestyle change and treatment. This was considered to be an 
issue for the users of these tools, who carry out risk assessments at home without 
the support of GPs or health professionals. The conflicting and poor quality 
information can lead to inaccurate risk perceptions, such as incorrect pessimism or 
false optimism. This has been shown to influence health behaviour and treatment 
decisions, leading to dissatisfaction in a consultation with the GP, when perceived 
risk is not consistent with actual risk.
Review of the literature on cardiovascular risk representation formats highlighted the 
need for more methodologically sound studies into the effectiveness of risk 
representation formats, particularly using actual risk assessment, rather than 
analogue studies that rely on hypothetical risk scenarios. This issue was addressed 
by the RCT into the effects of different graphical cardiovascular risk representation 
formats.
The RCT found that viewing cardiovascular risk significantly reduces negative 
emotions and worry about future heart disease in the ‘worried weir, thus helping to
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correct inaccurate risk perceptions. There were no main effects of graphical risk 
representation formats, suggesting that the way cardiovascular risk is presented 
does not make a difference in motivating behaviour change, facilitating 
understanding of risk information, or altering emotions (including worry about future 
heart disease). However, a possible type II error occurred, as the sample was 
unrepresentative and biased towards those of low cardiovascular risk and those who 
were highly educated. Further research is needed to reach target audiences and 
engage those who would benefit the most to participate in risk assessments.
This thesis discussed the findings in relation to policy and practice. It was concluded 
that it is difficult to reach ‘at risk’ groups and motivate them to adopt healthier 
lifestyles. This is because people find it hard to change their behaviour, and cease 
their bad habits. Therefore, public health campaigns may need to look at the bigger 
picture, and make changes on a societal level when developing strategies to prevent 
future CVD.
Limitations with current methods used for presenting future cardiovascular risk were 
also described in this thesis. These included the use of abstract numerical risk 
estimates and the 10-year timeframe. It was suggested that more salient outcomes 
should be used that can provide context and meaning. Recent research has shown 
the benefits of communicating risk in this way. Additionally, projecting short-term risk 
over longer time horizons addresses the problem with the 10-year timeframe in 
younger people, where absolute risk will be low regardless of any elevated
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modifiable risk factors, due to the protective nature of age. This incorporates the 
benefits of relative risk and long term risk measures, and has already been 
incorporated into two popular web-based cardiovascular risk prediction tools. The 
deviation from conventional risk presentation is promising and may change the way 
cardiovascular risk is communicated to patients. This will potentially lead to better 
understanding of risk and increased motivation to change lifestyle in order to prevent 
future cardiovascular disease.
508
References
Aalto, A. et al. 2007. Sociodemographic differences in myocardial infarction risk 
perceptions among people with coronary heart disease. Journal of Health 
Psychology 12, pp. 316-329.
Adair, G. 1984. The Hawthorne Effect: A reconsideration of the methodological 
artifact. Journal of Applied Psychology 69(2), pp. 334-345.
Ades, P. et al. 1997. Cost-effectiveness of cardiac rehabilitation after myocardial 
infarction. Journal of Cardiopulmonary rehabilitation 17, pp. 222-231.
Ajzen, I. no date. Constructing a TpB Questionnaire: Conceptual and Methodological 
Considerations [Online]. Available at:
http://www.unix.oit.umass.edu/~aizen/pdf/tpb.measurement.pdf [Accessed: 
11.01.2011
Ajzen, I. 1991. The Theory of Planned Behaviour. Organizational Behaviour and 
Human Decision Processes 50, pp. 179-211.
Ajzen, I. and Fishbein, M. 1980. Understanding attitudes and predicting social 
behaviour. New Jersey: Prentice-Hall.
Akl, E. et al. 2011. Using alternative statistical formats for presenting risks and risk 
reductions (Review). The Cochrane Database of Systematic Reviews 3.
Alexa. 2009. Google.com [Online]. Available at: 
http://www.alexa.com/siteinfo/google.com [Accessed: 17.09.2009].
Alexa. 2010. About the Alexa Traffic Rankings [Online]. Available at: 
http://www.alexa.com/help/traffic-learn-more [Accessed: 14.04.2010].
Ali, N. 2002. Prediction of Coronary Heart Disease Prevnetive Behaviours in 
Women: A Test of the Health Belief Model. Women and Health 35, pp. 83-96.
Allender, S. et al. 2008. Coronary Heart Disease Statistics. [Online]. Available at: 
www.heartstats.org [Accessed: 20.06.2011].
Allison, P. ed. 2001. Missing Data, Sage Univeristy Paper Series on Quantitative 
Applications in the Social Sciences. CA: Thousand Oaks, pp. 7-136.
Alwan, H. et al. 2009. Perception of cardiovascular risk and comparison with actual 
cardiovascular risk. European Journal of Cardiovascular Prevention and 
Rehabilitation 16, pp. 556-561.
American Heart Association. Heart Attack Risk Assessement [Online]. Available at: 
http://www.americanheart.org/presenter.jhtml?identifier=3003499 [Accessed:
17.7.2010].
509
Anderson, K. et al. 1990. Cardiovascular disease risk profiles. American Heart 
Journal 121, pp. 293-298.
Angus, J. et al. 2005. Sneaky disease’: the body and health knowledge for people a 
risk of coronary heart disease in Ontario, Canada. Social Science and Medicine 60, 
pp. 2117-2128.
Armitage, C. and Conner, M. 2001. Efficacy of the theory of planned behaviour: a 
meta-analytic review. British Journal of Social Psychology 40, pp. 471-499.
Armstrong, K. et al. 2002. Effect of framing as gain versus loss on understanding 
and hypothetical treatment choices: survival and mortality curves. Medical Decision 
Making 22, pp. 76-83.
Ashenden, R. et al. 1997. A systematic review of the effectiveness of promoting 
lifestyle change in general practice. Family Practice 14, pp. 160-176.
Asimakopoulou, K. et al. 2008a. The impact of different time frames of risk 
communication on Type 2 diabetes patients' understanding and memory for risk of 
coronary heart disease and stroke. Diabetic Medicine 25, pp. 811-817.
Asimakopoulou, K. et al. 2008b. Unrealistic pessimism about risk of coronary heart 
disease and stroke in patients with type 2 diabetes. Patient Education and 
Counseling 71, pp. 95-101.
Assmann, G. 2005. Calculating global risk: the key to intervnetion. European Heart 
Journal 7 (Suppl F), pp. F9-F14.
Ball, K. et al. 2002. Which aspects of socioeconomic status are related to obesity 
among men and women? . International Journal of Obesity and Related Metabolic 
Disorders 26, pp. 559-565.
Ballantyne, C. et al. 2005. Lipids and CVD management: towards a global 
consensus. European Heart Journal 26, pp. 2224-2231.
BBC.co.uk. 2010. Science Cafe, 21st February 2010 [Online]. Available at: 
http://www.bbc.co.uk/wales/radiowales/sites/sciencecafe/updates/20100221.shtml 
[Accessed: 16.06.2010].
Bedell, S. et al. 2004. A systematic critique of diabetes on the World Wide Web for 
patients and their physicians. International Journal of Medical Informatics 73, pp. 
687-694.
Benner, J. et al. 2008. A novel programme to evaluate and communicate 10-year 
risk of CHD reduces predicted risk and improves patients' modifiable risk factor 
profile. International Journal of Clinical Practice 62, pp. 1484-1498.
510
Biau, D. et al. 2010. P value and the theory of hypothesis testing: an explanation for 
new researchers. Clinical Orthopaedics and Related Research 468, pp. 885-892.
Bosnjak, M. and Tuten, T. 2001. Classifying Response Behaviors in Web-based 
Surveys Journal of computer mediated communication 6, no page numbers.
Brace, N. et al. 2006. SPSS for Psychologists: A Guide to Data Analysis using SPSS 
for Windows. 3rd ed. Hampshire: Palgrave Macmillan.
Brewer, N. et al. 2007. Meta-analysis of the relationship between risk perception and 
health behavior: the example of vaccination. Health Psychology 26, pp. 136-145.
Brindle, P. et al. 2006. Accuracy and impact of risk assessment in the primary 
prevention of cardiovascular disease: a systematic review. Heart 92, pp. 1752-1759.
British Heart Foundation. 2009. Heart and circulatory disease is the UK's biggest 
killer [Online]. Available at: http://www.heartstats.org.uk/datapage.asp?id=39 
[Accessed: 28.4.2011].
British Hypertension Society. Cardiovascular Risk Charts and Calculators [Online]. 
Available at:
http://www.bhsoc.org/Cardiovascular_Risk_Charts_and_Calculators.stm [Accessed:
17.7.2010].
British Hypertension Society. Proposed Joint British Societies Cardiovascular 
Disease New Risk Assessment Charts 2009 [Online]. Available at: 
http://www.bhsoc.org/Cardiovascular_Risk_Prediction_Chart.stm [Accessed:
17.7.2010].
Brody, H. and Light, D. 2011. The inverse benefit law: how drug marketing 
undermines patient safety and public health. American Journal of Public Health 101, 
pp. 399-404.
Brown, S. et al. 2011. Health literacy, numeracy, and interpretation of graphical 
breast cancer risk estimates. Patient education and counselling 83, pp. 92-98.
Buehler, R. et al. 2007. Motiviated prediction of future feelings: effects of negative 
mood and mood orientation on affective forecasts. Personality and Social 
Psychology Bulletin 33, pp. 1265-1278.
Burke, L. et al. 1997. Compliance with cardiovascular disease prevention strategies: 
a review of the research. Annals of Behavioral Medicine 19, pp. 239-263.
Cameron, L. and Chan, C. 2008. Designing health communications: harnessing the 
power of affect, imagery and self-regulation. Social and Personality compass 2/1, pp. 
262-282.
511
Cardiff University. 2010. Web-based calculator to help predict heart disease [Online]. 
Available at:
http://www.cardiff.ac.uk/news/mediacentre/mediareleases/Feb10/webbased- 
calculator-to-help-predict-heart-disease.html [Accessed: 16.06.2010].
Carling, C. et al. 2009a. The effect of alternative graphical displays used to present 
the benefits of antibiotics for sore throat on decisions about whether to seek 
treatment: a randomized trial. PLoS Med 6, p. e1000140.
Carling, C. et al. 2009b. The effect of alternative summary statistics for 
communicating risk reduction on decisions about taking statins: A randomized trial. . 
PLoS ONE 6 p. e1000134.
Charlson, M. E. et al. 2008. Changing health behaviours to improve health outcomes 
after angioplasty: a randomized trial of net present value versus future value risk 
communication. Health Education Research 23, pp. 826-839.
Cheung, Y. et al. 2010. Risk communication in clinical trials: a cognitive experiment 
and a survey. BMC Medical Informatics and Decision Making 10, p. 55.
Christian, A. H. et al. 2005. Coronary Heart Disease in Ethnically Diverse Women: 
Risk Perception and Communication. Mayo Clinic Proceedings 80(12), pp. 1593- 
1599.
Collins, G. and Altman, D. 2010. An independent and external validation of QRISK2 
cardiovascular risk disease score: a prospective open cohort study. British Medical 
Journal 340, p. 1231.
Connelly, N. and Knuth, B. 1998. Evaluating risk communication: Examining target 
audience perceptions about four presentation formats for fish consumption health 
advisory information. Risk Analysis 18, pp. 649-659.
Conner, M. and Sparks, P. eds. 2005. Theory of Planned Behaviour and Health 
Behaviour. 2nd ed. Berkshire: Open University Press, pp. 170-222.
Conroy, R. et al. 2003. Estimation of ten-year risk of fatal cardiovascular disease in 
Europe: the SCORE project. European Heart Journal 24, pp. 987-1003.
Consedine, N. et al. 2004. Fear, Anxiety, Worry, and Breast Cancer Screening 
Behavior: A Critical Review. Cancer Epidemiology Biomarkers and Prevention 13, 
pp. 501-510.
Constans, J. 2001. Worry, propensity and the perception of risk. Behaviour Research 
and Therapy 39, pp. 721-729.
Covey, J. 2007. A Meta-analysis of the Effects of Presenting Treatment Benefits in 
Different Formats. Medical Decision Making 27, pp. 638-654.
512
Craig, P. et al. 2008. Developing and evaluating complex interventions: the new 
Medical Research Council guidance. British Medical Journal. 337, a1655.
Cranney, M. and Walley, T. 1996. Same information, different decisions: the 
influence of evidence on the management of hypertension in the elderly. British 
Journal of General Practice. 46, pp. 661 -663.
Crockett, R. et al. 2008. Social Patterning of screening uptake and the impact of 
facilitating informed choices: Psychological and ethical analyses. Health Care 
Analysis 16, pp. 17-30.
Cuitie, C. et al. 2008. A Test of Numeric Formats for Communicating Risk 
Probabilities Medical Decision Making 28, pp. 377-384.
D'Agostino, R. et al. 2008. General Cardiovascular Risk Profile for Use in Primary 
Care: The Framingham Heart Study. Circulation 117, pp. 743-753.
Dahl, R. et al. 2007. Can postponement of an adverse outcome be used to present 
risk reductions to a lay audience? A population survey. BMC Medical Informatics and 
Decision Making 7, p. 8.
Davies, M. et al. 2008. The Handbook for Vascular Risk Assessment, Risk 
Reduction and Risk Management. London:
delicious.com. 2010. My Heart Risk [Online]. Available at: 
http://www.delicious.com/url/ac96af17e00c6c7c50757b31f6ffc529?show=all). 
[Accessed: 08.04.2010].
Detsky and Goldman calculators, untitled [Online]. Available at: 
http://www.vasgbi.com/riskdetsky.htm [Accessed: 17.7.2010].
DeWalt, D. et al. 2004. Literacy and Health Outcomes: A Systematic Review of the 
Literature. Journal of General Internal Medicine 19, pp. 1228-1239.
Diabetes UK. 2010. Diabetes in the UK 2010: Key Statistics on Diabetes [Online]. 
Available at:
http://www.diabetes.org.uk/Documents/Reports/Diabetes_in_the_UK_2010.pdf 
[Accessed: 16.01.2011].
Diaz, J. et al. 2002. Patients’ use of the Internet for Medical Information. Journal of 
General Internal Medicine 17, pp. 180-185.
Downs, S. and Black, N. 1998. The feasibility of creating a checklist for the 
assessment of the methodological quality both of randomised and non-randomised 
studies of health care interventions. Journal of Epidemiology and Community Health 
52, pp. 377-384.
513
Dudley, N. 2001. Importance of risk communication and decision making in 
cardiovascular conditions in older patients: a discussion paper. Quality in Healthcare 
10((suppl I ) ), pp. i19-i22.
Durrington, P. 2009. How to estimate cardiovascular risk in practice. Primary Care 
Cardiovascular Journal 2, pp. 175-180.
e-tools Age. Heart Attack Risk Calculator [Online]. Available at: 
http://www.etoolsage.com/Calculator%5CHeart_Attack_Risk_Calculator.asp7toolsort 
=1500 [Accessed: 17.7.2010].
Ebrahim, S. et al. 2006. Multiple risk factor interventions for primary prevention of 
coronary heart disease. Cochrane Database of Systematic Reviews 4.
Edwards, A. and Bastian, H. eds. 2001. Risk communication - making evidence part 
of patient choices. Oxford: Oxford University Press, pp. 144-160.
Edwards, A. and Elwyn, G. 1999. How Should Effectiveness of Risk Communication 
to Aid Patients' Decisions Be Judged? A Review of the Literature. Medical Decision 
Making 19, pp. 428-434.
Edwards, A. and Elwyn, G. 2001. Understanding risk and lessons for clinical risk 
communication about treatment preferences. Quality in Health Care 10((suppl I)), pp. 
i9-i13.
Edwards, A. et al. 2001. Presenting risk information- a review of the effects of 
“framing” and other manipulations on patient outcomes. Journal of Health 
Communication 6, pp. 61-82.
Edwards, A. et al. 2002. Explaining risks: turning numerical data into meaningful 
pictures. British Medical Journal 324, pp. 827-830.
Edwards, A. et al. 2006a. Personalised risk communication for informed decision 
making about taking screening tests (Review). The Cochrane Database of 
Systematic Reviews 4.
Edwards, A. and Prior, L. 1997. Communication about risk -  dilemmas for general 
practitioners. British Journal of General Practice 47, pp. 739-742.
Edwards, A. et al. 2006b. Presenting risk information to people with diabetes: 
Evaluating effects and preferences for different formats by a web-based randomised 
controlled trial. Patient Education and Counseling 63, pp. 336-349.
Elwyn, G. et al. 1999. Shared Decision Making in Primary Care: the neglected 
second half of the consultation. British Journal of General Practice 49, pp. 477-482.
Emslie, C. et al. 2001. ‘I’d rather go with a heart attack than drag on’: lay images of 
heart disease and the problems they present for primary and secondary prevention. 
Coronary Health Care 5(1), pp. 25-32.
514
Eng, T. et al. 1998. Access to health information and support: A public highway or 
private road. Journal of American Medical Association 280, pp. 1371-1375.
Epping-Jordan, J. E. et al. 2005. Preventing chronic diseases: taking stepwise 
action. The Lancet 366, pp. 1667-1671.
Epstein, R. et al. 2004. Communicating evidence for participatory decision making. 
Journal of the American Medical Association 291 pp. 2359-2366.
Erhardt, L. and Hobbs, F. 2002. Public perceptions of cardiovascular risk in five 
European countries: the REACT survey. International Journal of Clinical Practice 56, 
pp. 638-644.
EuroScore. European System for Cardiac Operative Risk Evaluation [Online]. 
Available at: http://www.euroscore.org/ [Accessed: 17.7.2010].
Eysenbach, G. and Kohler, C. 2002. How do consumers search for and appraise 
health information on the world wide web? Qualitative study using focus groups, 
usability tests, and in-depth interviews. British Medical Journal 324, pp. 573-577.
Fagerlin, A. et al. 2007a. Making Numbers Matter: Present and Future Research in 
Risk Communication. American Journal of Health Behavior. 31(suppl 1), pp. S47- 
S56.
Fagerlin, A. et al. 2007b. If I’m better than average, then I’m ok?”: Comparative 
information influences beliefs about risk and benefits. Patient Education and 
Counseling 69, pp. 140-144.
Fahey, T. et al. 2001. Randomized trial evaluating the framing of cardiovascular risk 
and its impact on blood pressure control. BMC Health Services Research 1, p. 10.
Fair, A. K. et al. 2008. Using Hypothetical Data to Assess the Effect of Numerical 
Format and Context on the Perception of Coronary Heart Disease Risk. American 
Journal of Health Promotion 22, pp. 291-296.
Feldman-Stewart, D. et al. 2000. Perception of quantitative information for treatment 
decisions. Medical Decision Making 20, pp. 228-238.
Fox, S. 2009. Patient Choice in Health Information Technology 16 Sept 2009 
[Online]. Available at: http://www.pewinternet.org/Presentations/2009/32--Patient- 
Choice-in-Health-lnformation-Technology.aspx [Accessed: 17 September 2009].
Framingham Heart Study. Risk Score Profiles [Online]. Available at: 
http://www.framinghamheartstudy.org/risk/index.html [Accessed: 17.7.2010].
Francis, J. et al. 2004. Constructing Questionnaires Based on The Theory of 
Planned Behaviour: A Manual for Health Services Researchers. Newcastle upon 
Tyne: Centre for Health Services Research, Univeristy of Newcastle.
Franco, O. et al. 2007. Primary prevention of cardiovascular disease: Cost- 
effectiveness comparison. International Journal of Technology Assessment in Health 
Care 23, pp. 71-79.
Fredrickson, B. 2001. The role of positive emotions in positive psychology: the 
broaden-and-build theory of positive emotions. American Psychologist: Special Issue 
(56), pp. 218-226.
Fredrickson, B. 2009. Positivity. Oxford: Oneworld publications.
French, D. P. et al. 2004. The Impact of Personal and Social Comparison 
Information about Health Risk. British Journal of Health Psychology 9, pp. 197-200.
Frijling, B. et al. 2004. Perceptions of cardiovascular risk among patients with 
hypertension or diabetes. Patient Education and Counseling 52, pp. 47-53.
Frileux, S. et al. 2004. The Impact of a Preventative Medical Message on Intention to 
Change Behaviour. Patient Education and Counseling 52, pp. 79-88.
Frosch, D. et al. 2008. Using decision aids in community-based primary care: A 
theory-driven evaluation with ethnically diverse patients. Patient Education and 
Counseling 73, pp. 490-496.
Gabhainn, S. et al. 1999. Socio-demographic variations in perspectives on 
cardiovascular disease and associated risk factors. Health Education Research 14, 
pp. 619-628.
Galesic, M. and Garcia-Retamero, R. 2011. Communicating consequences of risky 
behaviors: Life expectancy versus risk of disease. Patient Education and Counseling 
82, pp. 30-35.
Gigerenzer, G. 2002. Reckoning with risk: Learning to live with uncertainty. Allen 
Lane: The Penguin Press.
Gigerenzer, G. 2003. Why Does Framing Influence Judgment? Journal of General 
Internal Medicine 18, pp. 960-961.
Gigerenzer, G. and Edwards, A. 2003. Simple tools for understanding risks: from 
innumeracy to insight. British Medical Journal 327, pp. 741-744.
Gigerenzer, G. and Hoffrage, U. 1995. Howto improve Bayesian reasoning without 
instruction: frequency formats. Psychological Review 102, pp. 684-704.
Giles, M. et al. 2007. Measuring young people’s attitudes to breastfeeding using the 
Theory of Planned Behaviour. Journal of Public Health 29, pp. 17-26.
516
Gillois, P. et al. 1999. A critical appraisal of the use of Internet for calculating 
cardiovascular risk. Proceedings of American Medical Informatics Association 
Annual Symposium, pp. 775-779.
Godin, G. and Kok, G. 1996. The theory of planned behaviour: a review of its 
applications to health-related behaviours. American Journal of Health Promotion 11, 
pp. 87-98.
Goldman, R. et al. 2006. Patients’ Perceptions of Cholesterol, Cardiovascular 
Disease Risk, and Risk Communication Strategies. Annals of Family Medicine 4, pp. 
205-371.
Goodyear-Smith, F. et al. 2008. Patients Prefer Pictures to Numbers to Express 
Cardiovascular Benefit From Treatment. Annuals of Family Medicine 6, pp. 213-217.
Google. 2010. Webmaster guidelines [Online]. Available at: 
http://www.google.com/suppo rt/webmasters/bin/answer.py?answer=35769#1 
[Accessed: 16th April 2010].
Goritz, A. 2006. Incentives in Web Studies: Methodological Issues and a Review 
International Journal of Internet Science 1, pp. 58-70.
Graham, I. 2007. European guidelines on cardiovascular disease prevention in 
clinical practice: executive summary. European Heart Journal 28, pp. 2375-2414.
Grant, R. et al. 2009. The clinical application of genetic testing in type 2 diabetes: a 
patient and physician survey. Diabetologia 52, pp. 2299-2305.
Gray, J. 2006. Diabetes, Heart Disease and Stroke Prevention Project Advisory 
Group: Vascular Disease Control Programme. London:
Grover, S. A. et al. 2007. Patient Knowledge of Coronary Risk Profile Improves the 
Effectiveness of Dyslipidemia Therapy. Archives of Internal Medicine 167, pp. 2296- 
2303.
Grundy, S. et al. 1999. Assessment of cardiovascular risk by use of multiple-risk 
factor assessment equations: a statement for healthcare professionals from the 
American Heart Association and the American College of Cardiology. Circulation 
100, pp. 1481-1492.
Gurmankin, A. et al. 2004. The effect of numerical statements of risk on trust and 
comfort with hypothetical physician risk communication. Medical Decision Making 24, 
pp. 265-271.
Gurmankin Levy, A. et al. 2008. Making Sense of Cancer Risk Calculators on the 
Web. Journal of General Internal Medicine 23(3), pp. 229-235.
517
Halpern, J. and Arnold, R. 2008. Affective Forecasting: an unrecognized challenge in 
making serious health decisions. Journal of General Internal Medicine 23, pp. 1708- 
1712.
Hansen, D. et al. 2003. Adolescents searching for health information on the internet: 
An observational study. Journal of Medical Internet Research 5(4), p. e25.
Harle, C. et al. 2008. The impact of web-base diabetes risk calculators on 
information processing and risk perceptions. American Medical Informatics 
Association Symposium Proceedings, pp. 283-287.
Harris, P. and Smith, V. 2005. When the risks are low: the impact of absolute and 
comparative information on disturbance and understanding in US and UK samples. 
Psychology and Health 20, pp. 319-330.
Hawley, S. et al. 2008. The impact of the format of graphical presentation on health- 
related knowledge and treatment choices. Patient Education and Counseling 73, pp. 
448-455.
Hay, J. et al. 2006. Does worry about breast cancer predict screening behaviors? A 
meta-analysis of the prospective evidence. Preventive Medicine 42, pp. 401-408.
Healthline. Coronary Heart Disease: Tools [Online]. Available at: 
http://www.healthline.com/channel/coronary-heart-disease_tools [Accessed:
17.7.2010].
Healthwise. Interactive Tool Are You At Risk For A Heart Attack? [Online]. Available 
at: http://www.aolhealth.com/health-concern/interactive-tool-are-you-at-risk-for-a- 
heart-attack [Accessed: 17.7.2010].
Healthy. 2010. What's your Heart Risk? [Online]. Available at: http://www.healthy- 
magazine.co.uk/blog/whats-your-heart-risk [Accessed: 16.06.2010].
Higgins, J. and Green, S. eds. 2009. Cochrane Handbook for Systematic Reviews of 
Interventions. Version 5.0.2. The Cochrane Collaboration 2009.
Hill, S. et al. 2010. Absolute risk representation in cardiovascular disease prevention: 
comprehension and preferences of health care consumers and general practitioners 
involved in a focus group. BMC Public Health 10, p. 108.
Hippisley-Cox, J. et al. 2010. Derivation, validation, and evaluation of a newQRISK  
model to estimate lifetime risk of cardiovascular disease: cohort study using 
QResearch database. British Medical Journal 341, p. c6624.
Hippisley-Cox, J. et al. 2007. Derivation and validation of QRISK, a new 
cardiovascular disease risk score for the United Kingdom: prospective open cohort 
study. British Medical Journal 335, pp. 136-141.
518
Hippisley-Cox, J. et al. 2008. Predicting cardiovascular risk in England and Wales: 
prospective derivation and validation of QRISK2. British Medical Journal 336, pp. 
1475-1482
Hivert, M. et al. 2009. Diabetes risk perception and intention to adopt healthy 
lifestyles among primary care patients. Diabetes Care 32, pp. 1820-1822.
Hoffrage, U. et al. 2000. Communicating Statistical Information. Science 290, pp. 
2261-2262.
Houts, P. et al. 2006. The role of pictures in improving health communication: A 
review of research on attention, comprehension, recall, and adherence. Patient 
Education and Counseling 61, pp. 173-190.
Hux, J. E. and Naylor, D. C. 1995. Communicating the Benefits of Chronic 
Preventive Therapy: Does the Format of Efficacy Data Determine Patients' 
Acceptance of Treatment? Medical Decision Making 15, pp. 152-157.
I PDAS. 2005.1PDAS 2005: Criteria forjudging the Quality of Patient Decision Aids. 
[Online]. Available at: http://ipdas.ohri.ca/IPDAS_checklist.pdf [Accessed:
18.09.2009].
Isen, A. ed. 1984. Toward understanding the role of affect in cognition. 3 ed. New 
Jersey: Erlbaum, pp. 179-236.
Jackson, R. 2010. Is estimating lifetime cardiovascular risk useful? British Medical 
Journal 341, p. c7379.
Jeong, M. ed. 2011. Efficiency of Direct and Indirect Measures: Theory of Planned 
Behavior (Abstract). AAHPERD (Alliance for Health, Physical Education, Recreation 
and Dance) National Convention and Exposition. San Diego, 29 March -2 April.
Joint British Societies. 2005. JBS2: Joint British Societies’ Guidelines on Prevention 
of Cardiovascular Disease in Clinical Practice. [Online] 91 (Suppl V). Available at: 
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1876394/pdf/v091 p000v1 .pdf. 
[Accessed: 17.7.2011].
Jolliffe, J. et al. 2001. Exercise-based rehabilitation for coronary heart disease. 
Cochrane Database Systematic Review 1, p. CD001800.
Kassam, K. et al. 2008. Future anhedonia and time discounting. Journal of 
Experimental Social Psychology 44, pp. 1533-1537.
Keller, C. and Siegrist, M. 2009. Effect of risk communication formats on risk 
perceptions depending on numeracy. Medical Decision Making 29, pp. 483-490.
Keough, K. et al. 1999. Who's smoking, drinking, and using drugs? Time perspective 
as a predictor of substance use. Basic and Applied Social Psychology 21, pp. 149- 
164.
519
Keys, A. et al. 1986. The diet and 15 year death rate in the seven countries study. 
American Journal of Epidemiology 124, pp. 903-915.
Knowles, M. and Moon, R. 2006. Introducing Metaphor. Oxon: Routledge.
Koelewijn-van Loon, M. 2010. Involving patients in cardiovascular risk management 
in general practice: Evaluation of a nurse-led intervention. Maastricht University.
Koelewijn-van Loon, M. et al. 2010. Improving lifestyle and risk perception through 
patient involvement in nurse-led cardiovascular risk management: A cluster- 
randomized controlled trial in primary care. Preventive Medicine 50, pp. 35-44.
Kreuter, M. 1999. Understanding how people process health information: a 
comparison of tailored and non-tailored weight loss materials. Health Psychology 18, 
pp.487-494.
Kreuter, M. and Strecher, V. 1995. Changing inaccurate perceptions of health risk: 
Results from a randomized trial. Health Psychology 14, pp. 56-63.
Kristiansen, I. et al. 2002. Number needed to treat: easily understood and intuitively 
meaninful? Theoretical considerations and a randomized trial. Journal of Clinical 
Epidemiology 55, pp. 888-892.
Krones, T. et al. 2010. The theroy of planned behaviour in a randomized trial of a 
decision aid on cardiovascular risk prediction. Patient Education and Counseling 78, 
pp. 169-176.
Krones, T. et al. 2008. Absolute Cardiovascular Disease Risk and Shared Decision 
Making in Primary Care: A Randomized Controlled Trial Annals of Family Medicine 
6, pp. 218-227.
Kuhle, S. and Veugelers, P. 2008. Why does the social gradient in health not apply 
to overweight? . Health Reports 19, pp. 7-14.
Lakoff, G. and Johnson, M. 2003. Metaphors we live by. Chicago: University of 
Chicago Press.
Lalonde, L. et al. 2006. Evaluation of a decision aid and a personal risk profile in 
community pharmacy for patients considering options to improve cardiovascular 
health: the OPTIONS pilot study. International Journal of Pharmacy Practice 14, pp. 
51-62.
Lee, T. et al. 2011. A randomized trial of computer-based communications using 
imagery and text information to alter representations of heart disease risk and 
motivate protective behaviour. British Journal of Health Psychology 16, pp. 72-91.
Lerman, C. et al. 1991. Psychological side effects of breast cancer screening. Health 
Psychology 10, pp. 259-267.
Lichtenstein, S. and Slovic, P. 2006. The Construction of Preference. New York: 
Cambridge.
Lipkus, I. 2007. Numeric, Verbal, and Visual Formats of Conveying Health Risks: 
Suggested Best Practices and Future Recommendations. Medical Decision Making 
27, pp. 696-713.
Lipkus, I. et al. 1999. Testing different formats for communicating colorectal cancer 
risk. Journal of Health Communication 4, pp. 311-324.
Lipkus, I. M. and Hollands, J. G. 1999. The Visual Communication of Risk. Journal of 
the National Cancer Institute Monographs 25, pp. 149-163.
Lloyd, A. 2001. The extent of patients’ understanding of the risk of treatments.
Quality in Health Care 10, pp. i14-i18.
Lobb, E. et al. 2003. Women’s preferences and consultants’ communication of risk in 
consultations about familial breast cancer: impact of patient outcomes. . Journal of 
Medical Genetics 40, p. e56.
Loewenstein, G. et al. 2001. Risk as feelings. Psychological Bulletin 127, pp. 267- 
286.
London School of Health and Tropical Medicine. A Risk Score for Cardiovascular 
Disease [Online]. Available at: http://riskscore.lshtm.ac.uk/ [Accessed: 17.7.2010].
Luengo-Fernandez, R. et al. 2006. Cost of cardiovascular disease in the United 
Kingdom. Heart 92, pp. 1384-1389.
Magnan, R. et al. 2009. The Effects of Warning Smokers on Perceived Risk, Worry, 
and Motivation to Quit. Annals of Behavioral Medicine 37, pp. 46-57.
Mainous, A. et al. 2007. A Coronary Heart Disease Risk Score Based on Patient- 
Reported Information. American Journal of Cardiology 99, pp. 1236-1241.
Malenka, D. et al. 1993. The framing effect of relative and absolute risk. Journal of 
General Internal Medicine 8, pp. 543-548.
Man-Son-Hing, M. et al. 1999. A Patient Decision Aid Regarding Antithrombotic 
Therapy for Stroke Prevention in Atrial Fibrillation. Journal of American Medical 
Association 282(8), pp. 737-743.
Man-Son-Hing, M. et al. 2002. The effect of qualitative vs. quantitative presentation 
of probability estimates on patient decision-making: a randomised trial. Health 
Expectations 5, pp. 246-255.
Marshall, T. et al. 2006. Predictors of patients' preferences for treatments to prevent 
heart disease. Heart 92, pp. 1651-1655.
521
Marteau, T. et al. 1996. The psychological impact of cardiovascular screening and 
intervention in primary care: a problem of false reassurance? British Family Heart 
Study Group. British Journal of General Practice 46, pp. 577-582.
Marteau, T. and Lerman, C. 2001. Genetic risk and behavioural change. British 
Medical Journal 322, pp. 1056-1059.
Marteau, T. et al. 2010. Impact of an informed choice invitation on uptake of 
screening for diabetes in primary care (DICISION): randomised trial. British Medical 
Journal 340, p. c2138.
Mason, D. et al. 2008. Perceptions of Absolute Versus Relative Differences Between 
Personal and Comparison Health Risk. Health Psychology 27(1), pp. 87-92.
Mayo Clinic. Heart disease risk calculator [Online]. Available at: 
http://www.mayoclinic.com/health/heart-disease-risk/hb00047 [Accessed:
17.7.2010].
McCaul, K. and Goetz, P. Worry [Online]. National Cancer Institute. Available at: 
http://cancercontrol.cancer.gov/brp/constructs/index.html [Accessed: 05.08 2009].
McCaul, K. et al. 2007. The motivational effects of thinking and worrying about the 
effects of smoking cigarettes. Cognition and Emotion 21, pp. 1780-1798.
McGill, H. et al. 2008. Preventing Heart Disease in the 21st Century: Implications of 
the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Study. 
Circulation 117, pp. 1216-1227.
md+calc. TIMI Risk Score for UA/NSTEMI [Online]. Available at: 
http://www.mdcalc.com/timi-risk-score-for-uanstemi [Accessed: 17.7.2010].
Medical Research Council. 2000. A framework for the development and evaluation of 
RCTs for complex interventions to improve health. London: MRC.
Medical Research Council. 2008. Developing and evaluating complex interventions: 
new guidance [Online]. Available at: www.mrc.ac.uk/complexinterventionsguidance 
[Accessed 17.11.2011].
Michie, S. et al. 2003. Predictive genetic testing: Understanding why negative test 
results sometimes fail to reassure. American Journal of Medical Genetics 119A, pp. 
340-347.
Michie, S. et al. 2002. Predictive genetic testing: High risk expectations in the face of 
low risk information. Journal of Behavioural Medicine 25, pp. 33-50.
Miller, S. et al. 1988. Styles of Coping With Threat: Implications for Health. Journal of 
Personality and Social Psychology 54, pp. 142-148.
522
Misselbrook, D. and Armstrong, D. 2001. Patients' responses to risk information 
about the benefits of treating hypertension. British Journal of General Practice 51, 
pp. 276-279.
Mokad, A. et al. 2004. Actual causes of death on the United States, 2000. Journal of 
American Medical Association 291, pp. 1238-1245.
Montgomery, A. et al. 2000. Evaluation of computer based clinical decision support 
system and risk chart for management of hypertension in primary care: randomised 
controlled trial. British Medical Journal 320, pp. 686-690.
Moons, K. et al. 2009. Prognosis and prognostic research: application and impact of 
prognostic models in clinical practice British Medical Journal 338, p. b606.
MyOptumHealth.com. Heart Attack Risk Calculator [Online]. Available at: 
http://www.myoptumhealth.com/portal/ManageMyHealth/Heart+Attack [Accessed:
17.7.2010].
National Cholesterol Education Program (prof). Risk Assessment Tool for Estimating 
10-year Risk of Developing Hard CHD (Myocardial Infarction and Coronary Death) 
[Online]. Available at: http://hp2010.nhlbihin.net/atpiii/calculator.asp?usertype=prof 
[Accessed: 17.7.2010].
National Cholesterol Education Program (public). Risk Assessment Tool for 
Estimating Your 10-year Risk of Having a Heart Attack [Online]. Available at: 
http://hp2010.nhlbihin.net/atpiii/calculator.asp [Accessed: 17.7.2010].
National Prescribing Service Limited. Cardiovascular risk calculator [Online]. 
Available at:
http://www.nps.org.au/health_professionals/tools/cardiovascular_risk_calculator 
[Accessed: 17.7.2010].
Natter, H. and Berry, D. 2005. Effects of presenting the baseline risk when 
communicating absolute and relative risk reductions. Psychology, Health and 
Medicine 10, pp. 326-334.
Nelson, W. et al. 2008. Clinical Implications of Numeracy: Theory and Practice. 
Annals of Behavioral Medicine 35, pp. 261-274.
Nexoe, J. et al. 2005. Influence of number needed to treat, costs and outcome on 
preferences for a preventive drug. Family Practice 22, pp. 126-131.
NHS Choices. Personal health check [Online]. Available at: 
http://www.nhs.uk/healthprofile/Pages/HeartDiseaseCalculator.aspx [Accessed:
17.7.2010].
Nielsen. 2009. Nielsen Announces July U.S. Search Share Rankings; Total 
Searches Increase 5 Percent Month-Over-Month August 2009 [Online]. Available at: 
http://en-
523
us.nielsen.com/main/news/news_releases/2009/august/Nielsen_Announces_July_U 
_S Seach_Rankings [Accessed: 17.09.2009].
O'Keefe, D. and Jensen, J. 2009. The relative persusasiveness of gain-framed and 
loss-framed messages for encouraging disease detection behaviors: A meta­
analysis review. Journal of Communication 59, pp. 296-316.
Office of National Statistics 2009. Prescription cost analysis 2008. Leeds: The 
information centre.
Office of National Statistics. 2010. Internet Access. [Online]. Available at: 
http://www.statistics.gov.uk/cci/nugget.asp?id=8 [Accessed: 25.03.2011].
Oppenheim, A. 2001. Questionnaire Design, Interviewing and Attitude Measurement 
London: Continuum.
Orbell, S. and Sheeran, P. 1998. “Inclined abstainers”: a problem for predicting 
health related behaviour. British Journal of Social Psychology 37, pp. 151-165.
Orleans, C. 2000. Promoting the maintenance of health behaviour change: 
Recommendations for the next generation of research and practice. Health 
Psychology 19(suppl 1), p. 76.
Paivio, A. 1969. Mental imagery in associative learning and memory. Psychological 
Review 76, pp. 241-263.
Pallant, J. 2006. SPSS survival manual. 2nd ed. Berkshire: Open University Press.
Parkes, G. et al. 2008. Effect on smoking quit rate of telling patients their lung age: 
the Step2quit randomised controlled trial. British Medical Journal 336, pp. 598-600.
Paterson, J. et al. 2002. Using disease risk estimates to guide risk factor 
interventions: field test of a patient workbook for self-assessing coronary risk. Health 
Expectations 5, pp. 3-15.
Patient UK. Primary Cardiovascular Risk Calculator [Online]. Available at: 
http://www.patient.co.uk/doctor/Primary-Cardiovascular-Risk-Calculator.htm 
[Accessed: 17.7.2010].
Pauling, J. 2003. Strategies to help patients understand risks. British Medical Journal 
327, pp. 745-748.
Peters, E. et al. 2007. Numeracy Skill And The Communication, Comprehension,
And Use Of Risk-Benefit Information. Health Affairs 26, pp. 741-748.
Physical Health Assessments. Slow Heart Attack Assessment [Online]. Available at: 
http://physicalhealth.bizcalcs.com/Calculator.asp?Calc=Slow-Heart-Attack 
[Accessed: 17.7.2010].
524
Pijl, M. et al. 2009. Impact of communicating familial risk of diabetes on illness 
perceptions and self-reported behavioural outcomes: a randomised controlled trial. 
Diabetes Care 32, pp. 597-599.
Politi, M. 2007. Communicating the Uncertainty of harms and Benefits of Medical 
Interventions. Medical Decision Making 27, pp. 681-695.
Prentice, A. and Jebb, S. 2001. Beyond body mass index. Obesity Review 2, pp. 
141-147.
PreventDisease.com. untitled [Online]. Available at: 
http://preventdisease.eom/healthtools/tools.html# [Accessed: 17.7.2010].
Price, H. et al. 2009. Use of focus groups to develop methods to communicate 
cardiovascular disease risk and potential for risk reduction to people with type 2 
diabetes. Family Practice 26, pp. 351-358.
Price, H. et al. 2011. Impact of personalized cardiovascular disease risk estimates 
on physical activity— a randomized controlled trial. Diabetic Medicine 28, pp. 363- 
372.
Price, H. et al. 2008. The impact of individualised cardiovascular disease (CVD) risk 
estimates and lifestyle advice on physical activity in individuals at high risk of CVD: a 
pilot 2 x 2  factorial understanding risk trial. Cardiovascular Diabetology 7, p. 21.
QRISK2. Welcome to the QRISK®2 cardiovascular disease risk calculator [Online]. 
Available at: http://www.qrisk.org/ [Accessed: 17.7.2010].
Quaglini, S. et al. 2005. Cardiovascular risk calculators: understanding differences 
and realising economic implications. International Journal of Medical Informatics 74, 
pp. 191-199.
Reyna, V. 2008. A Theory of Medical Decision Making and Health: Fuzzy Trace 
Theory. Med Decis Making 28, pp. 850-865.
Reyna, V. and Brainerd, C. eds. 1994. The origins of probability judgement: a review 
of data and theories. West Sussex: John Wiley and Sons, pp. 239-272.
Reyna, V. and Brainerd, C. 2007. The importance of mathematics in health and 
human judgment: Numeracy, risk communication, and medical decision making. 
Learning and Individual Differences 17, pp. 147-159.
Reynolds Risk Score. Calculating Heart and Stroke Risk for Women and Men 
[Online]. Available at: http://www.reynoldsriskscore.org/IAccessed: 17.7.2010].
Ridker, P. et al. 2007. Development and validation of improved algorithms for the 
assessment of global cardiovascular risk in women. Journal of the American Medical 
Association 297, pp. 611-619.
525
Ridker, P. and Cook, N. 2005. Should Age and Time Be Eliminated From 
Cardiovascular Risk Prediction Models? Circulation 111, pp. 657-658.
Robert, S. and Reither, E. 2004. A multilevel analysis of race, community 
disadvantage, and body mass index among adults in the US. Social Science and 
Medicine 59, pp. 2421-2434.
Roberts, E. et al. 2007. "First-hit" heart attack risk calculators on the world wide web: 
Implications for laypersons and healthcare practioners. International Journal of 
Medical Informatics 77, pp. 405-412.
Robinson, S. and Bugler, C. 2010. Smoking and drinking among adults 2008.
Roter, D. et al. 1998. Effectiveness of Interventions to Improve Patient Compliance: 
A Meta-Analysis. Medical Care 36, pp. 1138-1161.
Rothman, A. et al. 1993. The influence of message framing on intentions to perform 
health behaviours. Journal of Experimental Social Psychology 29, pp. 408-433.
Rothspan, S. and Read, S. 1996. Present versus future rime perspective and HIV 
risk among heterosexual college students. Health Psychology 15, pp. 131-134.
Rush University Medical Center. Am I at Increased Risk for a Heart Disease? 
[Online]. Available at: http://www.rush.edu/rumc/page-1099918806283.html 
[Accessed: 17.7.2010].
Safeer, R. et al. 2006. The impact of health literacy on cardiovascular disease. 
Vascular Health and Risk Management 2, pp. 457-464.
Sanderson, S. and Michie, S. 2007. Genetic testing for heart disease susceptibility: 
potential impact on motivation to quit smoking. Clinical Genetics 71, pp. 501-510.
Scarborough, P. et al. 2010. Coronary heart disease statistics. London:
Schapira, M. et al. 2001. Frequency or Probability? A Qualitative Study of Risk 
Communication Formats Used in Health Care. Medical Decision Making, pp. 459- 
467.
Schmiege, S. et al. 2009. Distinctions between worry and perceived risk in the 
context of the theory of planned behavior. Journal of Applied Social Psychology 39, 
pp. 95-119.
Schulz, K. et al. 2010. CONSORT Statement: updated guidelines for reporting 
parallel group randomised trials. BMC Medicine 9, p. 18.
Scott, L. B. and Curbow, B. 2006. The Effect of Message Frames and CVD risk 
factors on Behavioural Outcomes. American Journal of Health Behaviour 30(6), pp. 
582-597.
526
Search Engine Watch. 2009. Global Search Market Share, July 2009 vs. July 2008 
[Online]. Available at: http://searchenginewatch.com/3634922 [Accessed:
16.09.2009].
Shaw, C. et al. 1999. Psychological impact of predicting individuals' risks of illness: a 
systematic review. Social Science and Medicine 49, pp. 1571-1598.
Sheridan, S. et al. 2009. Individuals’ responses to global CHD risk: A focus group 
study. Patient Education and Counseling 76, pp. 233-239.
Sheridan, S. et al. 2003. A Randomized Comparison of Patients’ Understanding of 
Number Needed to Treat and Other Common Risk Reduction Formats. Journal of 
General Internal Medicine 18, pp. 884-892.
Sheridan, S. et al. 2006. The impact of a decision aid about heart disease prevention 
on patients' discussions with their doctor and their plans for prevention: a pilot 
randomized trial. BMC Health Services Research 6, p. 121.
Sheridan, S. et al. 2010. The Effect of Giving Global Coronary Risk Information to 
Adults. A Systematic Review. Archives of Internal Medicine 170, pp. 230-239.
Silagy, C. et al. 1993. Cardiovascular risk and attitudes to lifestlye: what do patients 
think? British Medical Journal 306, pp. 1657-1660.
Siteman Cancer Center. Heart Disease [Online]. Available at: 
http://www.yourdiseaserisk.wustl.edu/hccpquiz.pl?lang=english&func=home&quiz=h 
eart [Accessed: 17.7.2010].
Slovic, P. et al. 2004. Risk as Analysis and Risk as Feelings: Some Thoughts about 
Affect, Reason, Risk and Rationality. Risk Analysis 24, pp. 311-321.
Slovic, P. et al. 2005. Affect, Risk and Decision Making. Health Psychology 
24(Suppl.), pp. S35-S40.
Smerecnick, C. et al. 2010. Understanding the positive effects of graphical risk 
information on comprehension: measuring attention directed to written, tabular, and 
graphical risk information. Risk Analysis 30, pp. 1387-1398.
Sorensen, L. et al. 2008. Laypersons' understanding of relative risk reductions: 
Randomised cross-sectional study. BMC Medical Informatics and Decision Making 
8(31).
Soureti, A. et al. 2010. Evaluation of a cardiovascular disease risk assessment tool 
for the promotion of healthier lifestyles. European Journal of Cardiovascular 
prevention and rehabilitation 17, pp. 519-523.
South East Public Health Observatory. 2010. Cardiovascular Disease Profiles 
[Online]. Available at: http://www.sepho.org.uk/CVDprofiles.aspx [Accessed:
28.4.2011].
527
StatSoft. 2010. Electronic statistics textbook [Online]. Available at: 
http://www.statsoft.eom/textbook/statistics-glossary/p/button/p/ [Accessed:
16.01.2011].
Stevens, J. et al. 2002. Fitness and fatness as predictors of mortality from all causes 
and from cardiovascular disease in men and women in the lipid research clinics 
study. American Journal of Epidemiology 156, pp.832-841.
Stone, E. et al. 1997. Effects of numerical and graphical displays on professed risk- 
taking behaviour. Journal of Experimental Psychology: Applied 3, pp. 243-256.
Stovring, H. et al. 2008. Communicating effectiveness of intervention for chronic 
diseases: what single format can replace comprehensive information? BMC Medical 
Informatics and Decision Making 8(25).
Straus, S. 2002. Individualising Treatment Decisions: The Likelihood of Being 
Helped or Harmed. Evaluation and the Health Professions 25, pp. 210-223.
Strecher, V. et al. 1995. Do cigarette smokers have unrealsitic perceptions of thier 
heart attack, cancer, and stroke risks? Journal of Behavioural Medicine 18, pp. 45- 
54.
Sutton, S. 1998. Predicting and Explaining Intentions and Behavior: How well are we 
doing? Journal of Applied Social Psychology 28, pp. 1317-1338.
Svendsen, O. et al. 1994. Six months’ follow-up on exercise added to a short-term 
diet in overweight postmenopausal women: Effects on body composition, resting 
metabolic rate, cardiovascular risk factors, and bone. International Journal of Obesity 
18, pp.692.
Tabachnick, B. and Fidell, L. 2001. Using Multivariate Statistics. 4th ed. Needham 
Height, MA: Allyn and Bacon.
Tallis, F. and Eysenck, M. 1994. Worry: Mechanisms and modulating Influences. 
Behavioural and Cognitive Psychotherapy 22, pp. 37-56.
Tavousi, M. et al. 2009. Are Perceived Behavioral Control and Self-Efficacy Distinct 
Constructs? European Journal of Scientific Research 30, pp. 146-152.
The NHS Information Centre for Health and Social Care 2009. Health Survey of 
England.
Thomesen, T. et al. 2001. A new method for CHD prediction and prevention based 
on regional risk scores and randomized clinical trials; PRECARD and the 
Copenhagen Risk Score. Journal of Cardiovascular risk 8, pp. 291-297.
528
Thompson, E. 2007. Development and Validation of an Internationally Reliable 
Short-Form of the Positive and Negative Affect Schedule (PANAS). Journal of Cross- 
Cultural Psychology 38, pp. 227-242.
Timmermans, D. et al. 2008. Presenting health risk information in different formats: 
the effect on participants’ cognitive and emotional evaluation and decisions. Patient 
Education and Counseling 73, pp. 443-447.
Toth, P. 2007. Making a Case for Quantitative Assessment of Cardiovascular Risk. 
Journal of Clinical Lipidology 1, pp. 234-241.
Townsend, E. 2006. Affective influences on risk perceptions of, and attitudes toward 
genetically modified food. Journal of Risk Research 9, pp. 125-139.
Tugade, M. et al. 2004. Pyschological resilience and positive emotional granularity: 
examining the benefits of positive emotions on coping and health. Journal of 
Personality 72(6), pp. 1161 -1190.
Ubel, P. ed. 2008. Beyond knowledge: Figuring out how to help people make “good” 
decisions. Princeton: Princeton University and Russell Sage Foundation Presses.
University of Edinburgh. Cardiovascular risk calculator [Online]. Available at: 
http://cvrisk.mvm.ed.ac.uk/calculator/calc.asp [Accessed: 17.07.2010].
van der Weijden, T. et al. 2008. Primary care patients’ recognition of their own risk 
for cardiovascular disease: implications for risk communication in practice. Current 
Opinion in Cardiology 23, pp. 471-476.
van der Weijden, T. et al. 2007. Primary prevention of cardiovascular diseases in 
general practice: Mismatch between cardiovascular risk and patients’ risk 
perceptions. Medical Decision Making 27, pp. 754-761.
van Steekiste, B. et al. 2007. Improving cardiovascular risk management: a 
randomized, comtrolled trial on the effect of a decision support tool for patients and 
physicians. European Journal of Cardiovascular Prevention and Rehabilitation 14, 
pp. 44-50.
van Steenkiste, B. et al. 2004a. Barriers to implementing cardiovascular risk tables in 
routine practice. Scandinavian Journal of Primary Health Care 22, pp. 32-37.
van Steenkiste, B. et al. 2004b. Patients’ ideas, fears and expectations of their 
coronary risk: barriers for primary prevention. Patient Education and Counseling 55, 
pp. 301-307.
Vasan, R. and D'Agostino, R. 2005. Age and Time Need Not and Should Not be 
Eliminated From the Coronary Risk Prediction Models. Circulation 111, pp. 542-545.
Wald, N. and Law, M. 2003. A strategy to reduce cardiovascular disease by more 
than 80%. British Medical Journal 326, p. 1419.
Waldron, C. et al. 2010. The effect of different cardiovascular risk presentation 
formats on intentions, understanding and emotional affect: a randomised controlled 
trial using a web-based risk formatter (protocol). BMC Medical Informatics and 
Decision Making 10, p. 41.
Waldron, C. et al. 2011. What are effective strategies to communicate cardiovascular 
risk information to patients? A systematic review. Patient Education and Counseling 
82, pp. 169-181.
Wales online.co.uk. 2010. Website can help calculate heart risk [Online]. Available 
at: http://www.walesonline.co.uk/news/cardiff-news/2010/02/13/website-can-help- 
calculate-heart-risk-91466-25824829/ [Accessed: 18.11.2010].
Wardle, J. et al. 2002. Sex differences in the association of socioeconomic status 
with obesity. American Journal of Public Health 92, pp. 1299-1304.
Waters, E. 2008. Feeling good, feeling bad, and feeling at-risk: a review of incidental 
affect’s influence on likelihood estimates of health hazards and life events. Journal of 
Risk Research 11, pp. 569-595.
Waters, E. et al. 2009. What Is My Cancer Risk? How Internet-Based Cancer Risk 
Assessemnt Tools Communicate Individualized Risk Estimates to the Public:
Content Analysis. Journal of Medical Internet Research 11(3), p. e33.
Waters, E. et al. 2006. Formats for improving risk communication in medical tradeoff 
decisions. Journal of Health Communication 11, pp. 167-182.
Watson, D. et al. 1988. Development and validation of brief measures of positive and 
negative affect: the PANAS scales. Journal of Personality and Social Psychology 54, 
pp. 1063-1070.
Watts, B. et al. 2003. Intention to be Screened Over Time for Colorectal Cancer in 
Male Automotive Workers. Cancer Epidemiology Biomarkers and Prevention 12, p. 
339.
Weinstein, N. 1999. What Does It Mean to Understand a Risk? Evaluating Risk 
Comprehension. Journal of the National Cancer Institute Monographs 25, pp. 15-20.
Wells, S. et al. 2010. ‘Your Heart Forecast’: a new approach for describing and 
communicating cardiovascular risk? Heart 96, pp. 708-713.
Wertz, D. et al. 1989. Clients’ interpretation of risks provided in genetic counselling. 
American Journal of Human Genetics 39, pp. 253-264.
Williams-Piehota, P. et al. 2005. Matching Health Messages to Monitor-Blunter 
Coping Styles to Motivate Screening Mammography. Health Psychology 24, pp. 5 8 -  
67.
530
Wills, C. and Holmes-Rovner 2003. Patient comprehension of information for shared 
treatment decision making: state of the art and future directions. Patient Education 
and Counseling 50, pp. 285-290.
Wilson, D. et al. 1988. Compliance to health recommendations: A theoretical 
overview of message framing. Health Education Research: Theory and Practice 3, 
pp. 161-171.
Wilson, P. 2002. How to find the good and avoid the bad or ugly: a short guide to 
tools for rating quality of health information on the internet. British Medical Journal 
324, pp. 598-602.
Wilson, P. et al. 1998. Prediction of Coronary Heart Disease Using Risk Factor 
Categories. Circulation 97, pp. 1837-1847.
Wilson, T. and Gilbert, D. 2005. Affective Forecasting: Knowing what to want. 
Current Directions in Psychological Science 14, pp. 131-134.
Witte, K. ed. 1998. Fear as motivator, fear as inhibitor: using the extended parallel 
process model to explain fear appeal successes and failures. New York: Academic 
Press, pp. 423-449.
Wolff, H. et al. 2006. Converging prevalences of obesity across educational groups 
in Switzerland. Obesity (Silver Spring) 14, pp. 2080-2088.
Woloshin, S. and Schwartz, L. 2011. Communicating data about the benefits and 
harms of treatment: a randomized trial. Annals of Internal Medicine 155, pp. 87-96.
Woloshin, S. et al. 2003. Making sense of risk information on the web. Don’t forget 
the basics. British Medical Journal 327, pp. 695-696.
Woman’s Heart Foundation. Women's Heart Disease Risk Quiz [Online]. Available 
at: http://www.womensheart.org/content/HeartDisease/heart_disease_risk_quiz.asp 
[Accessed: 17.7.2010].
Woodward, M. et al. 2007. Adding social deprivation and family history to 
cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health 
Extended Cohort (SHHEC). Heart 93, pp. 172-176.
World Health Organisation 1998. Obesity: Preventing and Managing the global 
epidemic. Geneva:
World Health Organisation 2002. The World Health Report: Reducing risks, 
promoting healthy lifestyle. Geneva: World Health Organisation.
World Health Organisation 2003. Adherence to long-term therapies. Evidence for 
action. Geneva: WHO.
531
Wright, A. et al. 2006. Can genetic risk information enhance motivation for smoking 
cessation? An analogue study. Health Psychology 25, pp. 740-752.
Wright, A. et al. 2008. The impact of genetic testing for Crohn’s disease, risk 
magnitude and graphical format on motivation to stop smoking: an experimental 
analogue study. Clinical Genetics 73, pp. 306-314.
Wylie-Rosett, J. et al. 1994. Weight reduction intervention that optimizes use of 
practitioner's time, lowers glucose level, and reaises HDL cholesterol level in older 
adults. Journal of the American Dietetic Association 94, pp.37-42.
Zhang, Q. and Wang, Y. 2004. Trends in the association between obesity and 
socioeconomic status in U.S. adults: 1971 to 2000. Obesity Research 12, pp. 1622- 
1632.
Ziebland, S. 2004. The importance of being expert: The quest for cancer information 
on the internet. Social Science and Medicine 59, pp. 1783-1793.
Zikmund-Fisher, B. J. et al. 2005. What’s Time Got to Do with It? Inattention to 
Duration in Interpretation of Survival Graphs. Risk Analysis 25(3), gp. 589-595.
532
Appendix 1. Email invitation sent to respondents in search term elicitation survey.
£ *  Id *  Htfoey iootonrts Ieoh t& >  Belated Unto
O t  C j S f l S I  https:.''w*bmaAcf.ac.u»:gw.'v*«bacc?act>on=I*ff
a  Repv ” ^  ^  Read Later J  (0
Mail Properties
From: Cherry-Arm Waldron
<cherryannwaldron@googlemall.com>
To: <Soott.bishop20btlntemet.com>, <waldronc@oardlff.ac.i*> 
Subject: Fwd: Search term survey
Thursday - April 29,2010 11:06 AM
Attachm ents Mkne.822 (5754 bytes) [View] [Save As]
Hello,
If you have 5 minutes to spare, please could you help me with a mini survey I'm conducting as part o f my PhD?
I am trying to find out what search terms people would use if hey were going to look on the internet to find out what their risk o f heart disease was. 
If you can help, please click on the link which will take you to a one question survey. Once completed please press submit.
Your answers will be confidential and completely anonymous.
Many rhank-s in advance.
Cherry-Ann 
Cherry-Ann Waldron
Department of Primary Care and Public Health
Clinical Epidemiology Interdisciplinary Research Group
Cardiff University
2nd Floor, N'euadd Meirionnydd
Heath Part
Cardiff CF14 4YS
T: -44(0)29 2068 7193
E: waldronctficardifT.ac.uk
I've invited you to fill out the form Search term sarvey To fill it out, visit: 
A-iewfonn?fonnkev=dGdRZi 13OEJzd2NNREJuU0ZaViRJWHc6MO
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Appendix 2. Example of survey page when respondents click on link to participate in the
search term elicitation survey.
• C ' I '  , http. jpwd*Mts.gocgi«-coni Vi«w#onn?Tomifcc^dG^2il30CJzd2NF#EJ\AX)2qVjRMHc6MQ • - |
O f  &  ■ '  I * “ ' *  • *1 • S3 Mrt - p  * nw«J - r>»"9 • §  W Mob* IS- Sign in
g  Swrch term survey
Search term survey
Please imagine you are interested in finding what your risk of heart disease is.
You are going to look on the internet to see if there are any tools out there that wil help you do this
•Required
What search terms would you enter Into Google or other search engines? (please Hst) *
Submit
Powered by Gooole Docs
Report Abuse- Terms of Service - ArMrtigrW Terms
£* E<* rtfWy looton«ta 1* 0* loon ttt> gewdlrta
O f  • <2 ■ '  ■ l |  - $ 3 l * i  • Q * n a « n  - <  Oabn^ ■ §  V M ob* Sp iin
• ■'I' f i  ©  * *  fcj
1 “ -
Thanks!
Your response will now appear in my spreadsheet.
Go Back to the form | Create your own form
Goc )gle docs
p  ©  - >
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Appendix 3. Results from search term elicitation survey.
Respondent no. Response to Question: What search terms would you 
enter into Google or other search engines? (please list).
Respondent 1 My risk of heart attack
Heart failure risk
Heart attack risk
Chance of heart attack
Heart disease risk
Risk factors for heart disease
How can I find out my risk of heart disease?
What is my risk of heart attack?
Respondent 2 Risks leading to heart disease
Respondent 3 Causes of heart disease 
Heart disease risk calculator 
Am I at risk if heart disease?
Respondent 4 Heart disease risk
Respondent 5 Heart disease 
Heart disease info 
Have I got heart disease?
Respondent 6 Heart disease 
Cardiac failure
Respondent 7 Heart disease risk factors 
Causes of heart disease
Respondent 8 Heart disease risk
Respondent 9 Myocardial infarction 
Cardiac arrest
Respondent 10 Heart disease risk assessment
Respondent 11 Risk of heart disease
Respondent 12 Heart risk advice
Respondent 13 Risk heart
Respondent 14 Heart attack 
Cardiac arrest 
Heart disease
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Respondent 15 Cardiovascular risk calculator 
Cardiovascular risk score 
Heart risk calculator 
Heart risk score
Heart disease risk management 
Cardiac risk score
Respondent 16 Calculate my risk of heart disease 
Identify my risk of heart disease 
Work out my risks of heart disease 
Risk of heart disease
Respondent 17 My risk of heart disease 
Risk factors and heart disease
Respondent 18 Heart disease risk 
Heart disease risk factor 
Heart disease risk assessment
Respondent 19 Heart disease risk 
Cardiac disease risk 
Heart attack risk
Respondent 20 Heart disease risk
What is my risk of heart disease?
Calculate heart disease
Respondent 21 Risk heart attack 
Risk cardiac 
Heart disease
Risk factors cardiac condition 
Risk tool heart condition 
Questionnaire risk factors heart disease 
Am I at risk of heart disease?
Respondent 22 Heart disease risk 
Heart risk
Risk of heart disease 
Heart disease risk 
Risk factors heart 
Developing heart disease
Respondent 23 Heart disease risk
What is my risk of heart disease?
Calculate heart disease
Respondent 24 Heart risk 
Heart disease 
Heart attack
What is my risk of heart disease?
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Appendix 4. Frequency of search terms generated by the search term elicitation survey.
Search term
Heart disease risk
Heart disease
Risk of heart disease
What is my risk of heart disease?
Am I at risk of heart disease?
Calculate heart disease 
Heart attack risk 
Heart disease risk assessment 
Heart disease risk calculator 
Heart disease risk factors 
Heart risk
Calculate my risk of heart disease 
Cardiac arrest 
Cardiac disease risk 
Cardiac failure 
Cardiac risk score 
Cardiovascular risk calculator 
Cardiovascular risk score 
Chance of heart attack 
Causes of heart disease 
Developing heart disease 
Have I got heart disease?
Heart attack
Heart disease info
Heart risk advice
Heart disease risk management
Heart failure risk
Heart risk calculator
Heart risk score
How can I find out my risk of heart disease?
Identify my risk of heart disease
My risk of heart attack
My risk of heart disease
Myocardial infarction
Questionnaire risk factors heart disease
Risk cardiac
Risk factors cardiac condition 
Risk factors for heart disease 
Risk factors heart 
Risk factors and heart disease 
Risk heart 
Risk heart attack 
Risks leading to heart disease 
Risk tool heart condition 
What is my risk of heart attack?
Work out my risk of heart disease_________
n
11
4
3
3
2
2
2
2
2
2
2
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Appendix 5. Results from the pilot testing of the search term word stems for the tailored 
search specific to cardiovascular risk prediction tools.
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bv BL Cadwell - 2007 - Cited bv 2 - Related articles
A Bayesian approach to assess heart disease mortality among persons with diabetes in the 
presence of missing data Betsy L Cadwell & James P Boyle ...
www spnngeriink com/index/V50Q28160723680P pdf
Standardized tests encouraged to aaaeaa children's arteries fo r ... O
3 Sep 2009 ... Standardized tests encouraged to assess childrens arteries for heart disease
Statement highlights The American Heart Association has ...
amenc an heart mediaroom com/index php?s=43&item - Cached - Similar
Boston Scientific Close The Gap : Aaaeaa Your Risk O
Does anyone in your immediate family have a history of heart disease or... American Heart 
Association Heart Disease and Stroke Statistics 2007 Update ...
www bostonscientific com > Close the Gap - Cached ■ Similar
Searches related to assess heart d isease
diabetes heart disease coronary artery heart disease heart disease stroke Ml Choietteroi heart disease
heart attack disease high blood cholesterol heart disease coronary heart disease cardiovascular disease hftl .heart .disease
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Appendix 6. List of search terms used in the tailored search specific to cardiovascular
risk prediction tools.
1 Heart risk calculator
2 Heart risk prediction
3 Heart risk assessment
4 Heart risk tool
5 Heart disease calculator
6 Heart disease prediction
7 Heart disease assessment
8 Heart disease tool
9 Heart attack calculator
1 0 Heart attack prediction
1 1 Heart attack assessment
1 2 Heart attack tool
13 Heart attack risk tool
14 Calculate heart risk
15 Calculate heart disease
16 Calculate heart attack
17 Predict heart risk
18 Predict heart disease
19 Predict heart attack
2 0 Assess heart risk
2 1 Assess heart disease
2 2 Assess heart attack
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Appendix 7. Template of questions used in Critical Appraisal.
Name of web-based prediction tool: j
|
Web address:
Notes:
Characteristics of risk prediction tool.
1.1 W hat is the risk prediction tool? 
e.g. algorithm, chart, questionnaire etc.
1 .2 Is the algorithm used in the prediction tool 
reported?
-if so, what?
1.3 W hat risk factors are measured?
1.4 Are details given on the development and 
validation of the prediction tool?
- if so, what?
- is the context reported? (E.g. university, 
general practice)
1.5 Is there reference to academic papers 
relating to the prediction tool?
-  if so, what and how is this evidence 
accessed (pdf, link etc)
1 .6 Are authors qualifications/ credentials 
reported?
- if so, what are they?
1.7 Is any affiliation/ funding reported? 
- if so, what is it?
1 .8 Is any conflict of interest declared? 
-  if so, what is it?
1.9 Are commercial advertisements present?
- if so, how many?
- what are they for?
1 .1 0 Does the site say when it was last updated?
1 .1 1 Does the user have to register as a member
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before accessing the prediction tool?
1 . 1 2 Is security provided when users enter their 
personal information?
1.13 Is the target audience identified? 
If so, who?
1.14 Does the site state who the prediction tool is 
not suitable for?
If so, who?
1.15 Is plain language used that can be easily 
understood by the majority of the target 
audience?
1.16 Are external links to additional useful 
information given?
If so, what are these for?
If so, Is it easy for the user to return to the 
site after visiting the external links?
1.17 Is there option to contact the authors for 
additional help or information?
If so, how can this be done?
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Risk C om m unication questions
2 . 1 W hat type of cardiovascular risk is predicted?
2 . 2 Is this type of risk defined?
2.3 W hat is the main time frame that is used?
2.3 Is there more than one timeframe option? 
If  so, what are they?
2.4 W hat is the main format used to express the 
risk output?
2.5 Is there more than one way that the risk is 
presented?
I f  so, what are they?
2 . 6 Can the user choose their preferred method 
of presentation?
2.7 How is the risk framed? (Absolute, relative 
etc)
2 . 8 Is there a comparison with peer risk?
2.9 Is the risk graphically summarised? 
I f  so, how?
2 . 1 0 Is there an option for printing out the results?
2 . 1 1 Can you save the risk output and return at a 
later date?
2 . 1 2 Can the risk output be re-calculated by 
modifying the risk profile?
2.13 Is there mention of the uncertainty regarding 
the risk estimate presented?
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Focus on behaviour change/ treatm ent questions
3.1 Does the output report the main contributing 
factors to the risk?
3.2 Are possible options to reduce risk reported?
3.3 Is the user directed to further information 
sources about reducing risk?
If so, in what form? (external links, online 
pamphlets etc.)
Who are they by?
3.4 Is contacting a Healthcare Practitioner 
recommended /  advised ?
3.5 Is the risk reduction achieved by behaviour 
change/ treatment options reported?
If so, what format is it given in?
How is it framed (positive/negative/both)?
3.6 Are the different risks displayed together to 
enable comparison?
3.7 Are treatment goals provided? 
If so, how?
3.8 Is there the option to record progress as user 
attempts to reduce their risk?
3.9 Are tools (e.g. worksheets, question lists) 
provided that enable the user to make notes 
and discuss options with others.
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Appendix 8. Ranking scores for the eligible web-based cardiovascular risk prediction tools retrieved by all search terms tailored to
cardiovascular risk prediction tools.
Search term Risk prediction tool
Day 1 
Position Rank
Day 2 
Position Rank
Position on 1st page of SERP 
Day 3 Day 4 
Position Rank Position Rank
Day 5 
Position Rank
Overall rankings
Assess heart attack American Heart 
Association
2nd
1 1
2nd 9 3rd 8 3rd 8 3rd 8 44/5 = 8 . 8 9
Healthwise MSN 5th 8 5th 8 5th 8 6 th 7 5th 8 39/5= 7.8 8
Assess heart disease American Heart 
Association
2nd
1 1 3rd 1 0 3rd 1 0 5th 8 2nd 1 1 50/5 = 10 1 0
Healthwise MSN - 0 1 0 th 3 1 0 th 3 g t h 4 1 0 th 3 13/5 =2.6 3
Assess heart risk American Heart 
Association
l St 1 2 1 st 1 2 1 st 1 2 l St 1 2 1 st 1 2 60/5 =12 1 2
NCEP professional use 2nd 1 1 2nd 1 1 2nd 1 1 2nd 1 1 2nd 1 1 55/5 =11 1 1
London School of 
Hygiene and Tropical 
Medicine
3rd 1 0 3rd 1 0 3rd 1 0 3rd 1 0 3rd 1 0 50/5 =10 1 0
Healthwise MSN g t h 4 9th 4 g t h 4 1 0 th 3 1 0 th 3 18/5 = 3.6 4
Calculate heart 
attack
e-Tools Age l St 1 2 1 st 1 2 2nd 1 1 2nd 1 1 2nd 1 1 57/5 = 11.4 1 1
NCEP public use 2nd 1 1 2nd 1 1 3rd 1 0 4th 9 3rd 1 0 51/5 =10.2 1 0
My Optum Health 3rd 1 0 3rd 1 0 4th 9 3rd 1 0 4th 9 48/5 =9.6 1 0
Reynolds risk score 4th 9 4th 9 5th 8 5th 8 6 th 7 41/5 =8.2 8
Prevent disease.com 8 th 5 8 th 5 8 th 5 8 th 5 g t h 4 24/5 =4.8 5
American Heart 
Association
“ 0 9th 4 g t h 4 g t h 4 8 th 5 17/5 =3.4 3
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Calculate heart 
disease
NCEP public use 1 st 1 2 1 st
Reynolds risk score 2nd 1 1 2nd
e-Tools Age 3rd 1 0 3rd
My Optum Health 4th 9 4th
London School of 
Hygiene and Tropical 
Medicine
g t h 4 g t h
Calculate heart risk London School of 
Hygiene and Tropical 
Medicine
l St 1 2 l St
NCEP professional use 2nd 1 1 2nd
NCEP public use 3rd 1 0 3rd
My Optum Health 6 th 7 6 th
American Heart 
Association
g t h 5 g t h
The University of 
Edinburgh (calculator 
info page)
g t h 4 g t h
Heart attack 
assessment
American Heart 
Association
l St 1 2 3rd
NCEP public use 2nd 1 1 1 st
NCEP professional use 3rd 1 0 2nd
Healthwise MSN g t h 4 g t h
CardioSmart (American 
College of Cardiology)
1 0 th 3 “
Heart attack NCEP public use 1 st 1 2 l St
calculator
12
11
10
9
4
12
11
10
7
4
5
10
12
11
4
0
12
l St 1 2 1 st 1 2 1 st 1 2 60/5 =12 1 2
2 nd
1 1
2 nd
1 1
2 nd
1 1 55/5= 11 1 1
4th 9 5th 8 5th 8 45/5= 9 9
5th 8 5th 8 4th 9 43/5= 8 . 6 9
- 0 - 0 - 0 8/5=1 . 6 2
1 st 1 2 1 st 1 2 1 st 1 2 60/5 =12 1 2
2 nd
1 1
2 nd
1 1
2 nd
1 1 55/5 =11 1 1
3rd 1 0 3rd 1 0 3rd 1 0 50/5 =10 1 0
6 th 7 6 th 7 6 th 7 35/5 =7 7
g t h 4 1 0 th 3 1 0 th 3 19/5 =3.8 4
8 th 5 g t h 4 g t h 4 22/5 =4.4 4
1s    3rd
ccpcc p t ccnri tin
10 1 st 12 1 st 12 56/5 =11.2 1 1
CI9969911ICI lv rAdwvvlOllvll
 2 nd    1 st 12 2 nd 11 2 nd 11 57/5 =11.4 1 1
   2 nd  2 nd 11 3rd 10 - 0 42/5 =8.4 8
 9th  9th  8 th 5 gth 5 7th 6 24/5 =4.8 5
  -  10th 3 - 0 1 0 th 3 9/5 =1.8 2
     1 s  1 st 12 1 st 12 2 nd 11 59/5 =11.8 1 2
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Heart attack 
prediction
My Optum Health 2 n d 1 1 2 n d 1 1
American Heart 
Association
4 th 9 6 th 7
Everyday Health 5 th 8 4 th 9
Med India 6 th 7 5 th 8
QRisk 2 8 th 5 8 th 5
Mayo Clinic 9 th 4 9 th 4
NCEP professional use 5 th 8 5 th 8
Heart Attack Risk 
Tool
Heart attack tool
NCEP public use 1 st 1 2 1 st 1 2
NCEP professional use 2 n d 1 1 2 n d 1 1
Healthwise AOL 3 rd 1 0 3 rd 1 0
American Heart 4 th 9 4 th 9
Association
Healthwise Yahoo health 5 th 8 5 th 8
Mayo Clinic 8 t h 5 g t h 5
Cleveland Clinic 1 0 th 3 1 0 th 3
Myheartrisk.net - 0 - 0
Prolipid - 0 - 0
NCEP public use 1 st 1 2 1 st 1 2
NCEP professional use 2 n d 1 1 2 n d 1 1
Healthwise Yahoo health 5 th 8 5 th 8
Mayo Clinic 6 th 7 6 th 7
American Heart 7th 6 7th 6
Association 
Healthwise MSN g t h 4 g t h 4
Cleveland Clinic - 0 - 0
2 nd
1 1
2 n d
1 1 1 s t 1 2 5 6 / 5  = 1 1 . 2 1 1
6 th 7 6 th 7 6 th 7 3 7 / 5  = 7 . 4 7
4 th 9 4 th 9 4 th 9 4 4 / 5 =  8 . 8 9
5 th
8 5 th 8 5 th 8 3 9 / 5  = 7 . 8 8
8 th 5
g t h
5
8 th
5 2 5 / 5  = 5 5
g t h 4 g t h 4 9 th 4 2 0 / 5  = 4 4
5 th 8 5 th 8 5 th 8 4 0 / 5  = 8 8
1 s t 1 2
2 n d
1 1
2 n d
1 1 5 8 / 5  = 1 1 . 6 1 2
2 n d
1 1 3 rd 1 0 3 rd 1 0 5 3 / 5  = 1 0 . 6 1 1
3 rd 1 0 5 th 8 5 th 8 4 6 / 5  = 9 . 2 9
4 th
9
4 th
9
4 th
9 4 5 / 5  = 9 9
5 th 8 6 th 7 6 th 7 3 8 / 5  = 7 . 6 8
g t h
5 9 th 4 g t h 4 2 3 / 5 =  4 . 6 5
1 0 th 3 1 0 th 3 1 0 th 3 1 5 / 5  = 3 3
- 0 1 s t 1 0 1 s t 1 0 2 0 / 5  = 4 4
- 0 1 1 th 2 1 1 th 2 4 / 5  =  0 . 8 1
1 s t 1 2 1 s t 1 2 1 s t 1 2 6 0 / 5  = 1 2 1 2
- 0
2 n d
1 1
2 n d
1 1 4 4 / 5  = 8 . 8 9
4 th
9 3 rd 1 0
4 th
9 4 4 / 5  = 8 . 8 9
5 th 8 5 th 8 5 th 8 3 8 / 5  = 7 . 6 8
g t h
7 6 th 7 6 th 7 3 3 / 5  = 6 . 6 7
g t h
5
g t h
5 8 th 5 2 3 / 5  = 4 . 6 5
- 0 1 0 3 - 0 3 / 5 = 0 . 6 1
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Heart Disease 
Assessment
American Heart 
Association
3 rd 1 0
g t h 7 6 th
NCEP public use 5 th 8 4 th 9 4 th
NCEP professional use 6 th 7 5 th 8 5 th
Siteman Cancer Center 
(Washington University) 
Homepage
7 th 6 7 th 6 7 th
CardioSmart (American 
College of Cardiology)
1 0 t h 3 1 0 th 3 1 0 th
Heart Disease 
Calculator
My Optum Health 2 n d 1 1 2 " d 1 1 2 n d
Patient UK 3 rd 1 0 3 rd 1 0 3 rd
London School of 
Hygiene and Tropical 
Medicine
4 th 9 4 th 9 4 th
Ethrisk (Framingham) 5 th 6 5 th 6 5 th
The University of 
Edinburgh (calculator 
info page)
6 th 7 6 th 7 6 th
NCEP public use 7 th 6 7 th 6 7 th
QRisk 2 8 th 5 8 th 5 8 th
American Heart 
Association
g t h 4 - 0 -
Mayo Clinic - 0 1 0 t h 3 1 0 th
Heart disease tool Mayo Clinic l St 1 2 1 s t 1 2 1 s t
NCEP public use 2 n d 1 1 2 n d 1 1 2 n d
Weight loss advisory.com 6 th 7 y t h 6 6 th
Healthwise Yahoo health 7 th 6 g t h 5 7 th
Open Clinical g t h 5 g t h 4 g t h
American Heart 
Association
1 0 th 3 ■ 0 -
7 g t h 7 4 th 9 4 0 / 5  = 8 8
9 4 th 9 6 th 7 4 2 / 5  = 8 . 4 8
8 5 th 8 - 0 3 1 / 5  = 6 . 2 6
6 7 th 6 5 th 8 3 2 / 5  = 6 . 4 6
3 1 0 th 3 g t h 4 1 6 / 5  =  3 . 2 3
1 1
2 n d
1 1
2 n d
1 1 5 5 / 5  = 1 1 1 1
1 0 3 rd 1 0 3 rd 1 0 5 0 / 5 = 1 0 1 0
9 4 th 9 4 th 9 4 5 / 5 = 9 9
6 5 th 6 5 th 6 3 0 / 5  = 6 6
7 6 th 7 6 th 7 3 5 / 5  = 7 7
6 7 th 6 7 th 6 3 0 / 5  =  6 6
5 8 t h 5 8 th 5 2 5 / 5  =  5 5
0 - 0 g t h 4 8 / 5  = 1 . 6 2
3 1 0 th 3 1 0 th 3 1 2 / 5  = 2 . 4 2
1 2 1 s t 1 2 1 s t 1 2 6 0 / 5  = 1 2 1 2
1 1
2 n d
1 1
3rd
1 0 5 4 / 5  = 1 0 . 8 1 1
7 6 t h 7 7 th 6 3 3 / 5  = 6 . 6 7
6 7 th 6 8 th 5 2 8 / 5 =  5 . 6 6
5 g t h 5 g t h 4 2 3 / 5  = 4 . 6 5
0
g t h 4 1 0 t h 3 1 0 / 5 =  2 2
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Heart risk
assessment
Heart risk calculator
Heart risk tool
Patient UK 2nd 1 1 2nd 1 1
American Heart 
Association
3rd 1 0 8 th 5
Heart Institute of the 
Cascades
5th 8 5th 8
NCEP professional use 7th 6 6 th 7
Assign 9th 4 1 0 3
Ethos Heart Aware - 0 - 0
Patient UK 1 st 1 2 1 st 1 2
The University of 
Edinburgh (calculator 
info page)
4th 9 4th 9
QRisk 2 5th 8 5th 8
London School of 
Hygiene and Tropical 
Medicine
y t h
6 6 th 7
American Heart 
Association
9th 4 9th 4
NCEP professional use 1 0 th 3 1 0 th 3
NCEP professional use 1 st 1 2 1 st 1 2
NCEP public use 2nd 1 1 2nd 1 1
American Heart 
Association
3rd 1 0 3rd 1 0
Mayo Clinic 6 th 7 6 th 7
Healthwise MSN 1 0 th 3 1 0 th 3
Open Clinical - 0 - 0
2 n d
1 1
2 n d
1 1
2 n d
1 1 5 5 / 5  = 1 1 1 1
8 th 5 8 th 5
g t h 4 2 9 / 5  = 5 . 8 6
g t h 7 6 th 7 g t h 7 3 7 / 5  = 7 . 4 7
7 th 6 7 th 6 7 th 6 3 1 / 5 =  6 . 2 6
1 0 3 9 4 1 0 3 1 7 / 5 =  3 . 4 3
- 0 1 0 3 - 0 3 / 5  = 0 . 6 1
1 s t 1 2 1 s t 1 2 1 s t 1 2 6 0 / 5  =  1 2 1 2
4 th 9 4 th 9 4 th 9 4 5 / 5 =  9 9
5 th 8 5 th 8 5 th 8 4 0 / 5  = 8 8
6 th 7 6 th 7 6 th 7 3 4 / 5 =  6 . 8 7
g t h 4 g t h 4 - 0 1 6 / 5 =  3 . 2 3
1 0 th 3 - 0 - 0 9 / 5  =  1 . 8 2
1 st 1 2 l St 1 2 1 s t 1 2 6 0 / 5 = 1 2 1 2
2 n d
1 1
2 n d
1 1
2 n d
1 1 5 5 / 5  = 1 1 1 1
3 rd 1 0 3 rd 1 0 3 rd 1 0 5 0 / 5  = 1 0 1 0
5 th 8 5 th 8 5 th 8 3 8 / 5  =  7 . 6 8
1 0 th 3 g t h 4 g t h 4 1 7 / 5  = 3 . 4 3
g t h 4 - 0 - 0 4 / 5  = 0 . 8 1
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Appendix 9. Ranking scores for the eligible web-based cardiovascular risk prediction tools retrieved by the general layman search terms.
Search term Risk prediction tool
Day 1 
Position Rank
Day 2 
Position Rank
Position on 1st page of SERP 
Day 3 Day 4 
Position Rank Position Rank
Day 5 
Position Rank
Overall rankings
Am 1 at risk of heart 
disease?
American Heart 
Association
2 nd
1 1 “ 0 - 0 - 0 - 0 11/5 = 2.2 2
My Optum Health - 0 - 0 9th 4 - 0 - 0 4/5= 0.8 1
Calculate heart NCEP public use l St 1 2 1 st 1 2 1 st 1 2 1 st 1 2 2 nd 1 1 59/5 = 11.8 1 2
disease
Reynolds risk score 2 nd 1 1 2 nd 1 1 2 nd 1 1 2 nd 1 1 1 st 1 2 56/5 = 11.2 1 1
e-Tools Age 3rd 1 0 3rd 1 0 4th 9 5th 8 5th 8 45/5 = 9 9
My Optum Health 4th 9 4th 9 5th 8 4th 9 4th 9 44/5 = 8 . 8 9
London School of 
Hygiene and Tropical 
Medicine
9th 4 1 0 th 3 0 0 0 7/5 = 1.4 1
Calculate my risk of NCEP public use 1 st 1 2 1 st 1 2 1 st 1 2 1 st 1 2 1 st 1 2 60/5= 12 1 2
heart disease
Siteman Cancer Center 
(Washington University) 
Homepage
2 n d
1 1
2 n d
1 1
2 n d
1 1
2 n d
1 1
2 n d
1 1 55/5 =11 1 1
American Heart 
Association
3rd 1 0 3rd 1 0 3rd 1 0 3rd 1 0 3rd 1 0 50/5 =10 1 0
Revolution Health 4th 9 4 th 9 4th 9 4 th 9 4th 9 45/5 =9 9
My Optum Health 6 th 7 6 th 7 6 th 7 6 th 7 6 th 7 35/5 =7 7
Heart Healthy Women 
Org
8 th 5 g t h 5 g t h 5 g t h 5 g t h 5 25/5 =5 5
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Cardiac Disease risk London School of 
Hygiene and Tropical 
Medicine
6 th 7 6 th 7
University of Maryland 
Health Center
1 0 th 3 1 0 th 3
Medical college of 
Winconsin
1 2 th 1 - 0
Cardiac risk score Md + Calc 1 st 1 2 1 st 1 2
NCEP professional use 3rd 1 0 3rd 1 0
London School of 
Hygiene and Tropical 
Medicine
4th 9 4th 9
American Heart 
Association
7th 6 7th 6
Cardiovascular risk 
calculator
The University of 
Edinburgh (calculator 
info page)
1 st 1 2 1 st 1 2
The University of 
Edinburgh (calculator 
page)
2nd
1 1
2nd
1 1
Patient UK 3rd 1 0 3rd 1 0
QRisk 2 5th 8 5th 8
UCL Hospital 6 th 7 6 th 7
GP training.net 7th 6 7th 6
London School of 
Hygiene and Tropical 
Medicine
g t h 4 g t h 4
The Filey Surgery /Black 1 0 th 3 1 0 th 3
Heath Medical Centre
5th 8  6 th 7
g t h 4 12th 1
- 0 - 0
l St 1 2 1st 1 2
3rd 1 0 3rd 1 0
4th 9 4th 9
5th 8 5th 8
1st 1 2 1st 1 2
2nd
1 1
2nd
1 1
3rd 1 0 3rd 1 0
5th 8 5th 8
6th 7 g t h 7
7th 6 7th 6
g t h 4 g t h 4
10th 3 10th 3
6 th 7 36/5=7.2 7
1 1 th 2 13/5=2.6 3
- 0 l/5=0.2 0
1 st 1 2 60/5 =12 1 2
3rd 1 0 50/5=10 1 0
4th 9 45/5 =9 9
5th 8 36/5 =7.2 7
1 st 1 2 60/5 =12 1 2
2 nd
1 1 55/5 =11 1 1
3rd 1 0 50/5 = 10 1 0
5th 8 40/5 = 8 8
6 th 7 35/5 =7 7
7th 6 30/5 = 6 6
g t h 4 20/5 = 4 4
1 0 th 3 15/5 = 3 3
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Cardiovascular risk 
score
London School of 
Hygiene and Tropical 
Medicine
3rd 1 0 4th 9
Assign 6 th 7 7th 6
NCEP professional use 7th 6 g t h 5
Patient UK 8 th 5 3rd 1 0
NCEP public use 1 0 th 3 9th 4
Chance of heart NCEP public use 3rd 1 0 - 0
attack
My Optum Health 7th 6 7th 6
Allina Hospitals and 
Clinics
1 0
2nd
1 1
Heart attack risk NCEP public use 1 st 1 2 l St 1 2
My Optum Health 5th 8 4th 9
American Heart 
Association
7th 6 0
Heart disease risk London School of 
Hygiene and Tropical 
Medicine
2nd
1 1
2nd
1 1
American Heart 
Association
4th 9 4th 9
Medical college of 
Winconsin
7th 6 7th 6
University of Maryland 
Health Center
9th 4 g t h 4
Heart Disease Risk NCEP public use 1 st 1 2 l St 1 2
Assessment
American Heart 
Association
3rd 1 0 - 0
4th 9 5th 8 5th 8 44/5 =8 . 8 9
7th 6 7th 6 6 th 7 32/5= 6.4 6
g t h 5 g t h 5 7th 6 27/5 =5.4 5
3rd 1 0 3rd 1 0 3rd 1 0 45/5 =9 9
g t h 4 g t h 4 8 th 5 20/5 =4 4
3rd 1 0 3rd 1 0 3rd 1 0 40/5= 8 8
7th 6 7th 6 7th 6 30/5 = 6 6
1 0 “ 0 “ 0 11/5= 2.2 2
1 st 1 2 1 st 1 2 1 st 1 2 60/5=12 1 2
5th 8 2 nd 1 1 2 nd 1 1 47/5=9.4 9
" 0 7th 6 - 0 12/5=2.4 2
2 nd
1 1 6 th 1 1 6 th 1 1 55/5=11 1 ]
4th 9 3rd 1 0 3rd 1 0 47/5=9.4 9
- 0 7th 6 7th 6 24/5=4.8 5
9th 4 9th 4 g t h 4 20/5=4 4
1 st 1 2 2 nd 1 1 2 nd 1 1 58/5=11.6 12
- 0 1 0 th 3 1 0 th 3 16/5=3.2 3
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Siteman Cancer Center 
(Washington University) 
Homepage
5th 8 3rd 1 0
CardioSmart (American 
College of Cardiology)
0 0
Heart disease risk 
calculator
Mayo Clinic 2 nd 1 1 2 nd 1 1
Patient UK 3rd 1 0 3rd 1 0
The University of 
Edinburgh (calculator 
info page)
5th 8 5th 8
QRisk 2 6 th 7 6 th 7
London School of 
Hygiene and Tropical 
Medicine
7th 6 7th 6
NCEP public use 8 th 5 g t h 5
My Optum Health g t h 4 g t h 4
University of Maryland 
Health Center
1 0 th 3 1 0 th 3
Heart Disease Risk 
Management
American Heart 
Association
3rd 1 0 3rd 1 0
Heart risk American Heart 
Association
3rd 1 0 5th 8
NCEP professional use 7th 6 g t h 4
University of Maryland 
Health Center
- 0 - 0
Heart risk calculator Patient UK 12 12
3rd 1 0 3rd 1 0 3rd 1 0 48/5=9.6 1C
g t h 4 - 0 - 0 4/5=0.8 1
2 nd
1 1
2 nd
1 1
2 nd
1 1 55/5 =11 13
3rd 1 0 3rd 1 0 3rd 1 0 50/5 =10 1C
5th 8 5th 8 5th 8 40/5 = 8 8
6 th 7 6 th 7 6 th 7 35/5 =7 7
7th 6 7th 6 7th 6 30/5 = 6 6
g t h 5 g t h 4 g t h 4 23/5 =4.6 5
g t h 4 g t h 5 g t h 5 22/5 =4.4 4
1 0 th 3 1 0 th 3 1 0 th 3 15/5 =3 3
3rd 1 0 3rd 1 0 3rd 1 0 50/5=10 1C
- 0 1 0 th 3 - 0 21/5=4.2 4
4 th 9 g t h 5 4 t h 9 33/5=6.6 7
- 0 7th 6 - 0 6/5=1.2 1
1 st 1 2 1 st 1 2 1 st 1 2 60/5 = 12 i :
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The University of 
Edinburgh (calculator 
info page)
4th 9 4th 9
QRisk 2 5th 8 5th 8
London School of 
Hygiene and Tropical 
Medicine
7th 6 g t h 7
American Heart 
Association
g t h 4 g t h 4
NCEP professional use 1 0 th B 1 0 th 3
Heart Risk Score London School of 
Hygiene and Tropical 
Medicine
2 nd
1 1
2 nd
1 1
NCEP professional use 3rd 1 0 3rd 1 0
Patient UK 6 th 7 6 th 7
Md + Calc 7th 6 7th 6
American Heart 
Association
g t h 5 g t h 4
Reynolds risk score 1 0 th 3 1 0 th 3
The University of 
Edinburgh (calculator 
info page)
0 0
How can 1 find out Healthwise Yahoo health 6 th 7 7th 6
my risk of heart 
disease
My Optum Health g t h 4 - 0
My risk of heart NCEP public use 3rd 1 0 3rd 1 0
attack
Healthwise Yahoo health 4th 9 5th 8
4th 9 4th 9 4th 9 45/5 =9 9
5th 8 5th 8 5th 8 40/5 = 8 8
6 th 7 6 th 7 6 th 7 34/5 =6 . 8 7
g t h 4 9th 4 g t h 4 20/5 = 4 4
1 0 th 3 - 0 - 0 9/5 =1.8 2
6 th 7 2 nd 1 1 2 nd 1 1 51/5= 10.2 1 0
2 nd
1 1 4th 9 4th 9 49/5 =9.8 1 0
g t h 4 6 th 7 7th 6 31/5 = 6.2 6
5th 8 6 th 7 7th 6 33/5= 6 . 6 7
g t h 5 g t h 4 g t h 4 22/5 =4.4 4
- 0 - 0 - 0 6/5=1.2 1
1 0 th 1 0 0 1/5= 0.2 0
6 th 7 7th 6 g t h 7 33/5=6.6 7
- 0 - 0 - 0 4/5=0.8 1
3rd 1 0 2 nd 1 1 3rd 1 0 51/5= 10.2 1 0
4th 9 3rd 1 0 5th 8 44/5= 8 . 8 9
556
American Heart 6 th 7 -
Association 
My Optum Health g t h 5 g t h
My risk of heart NCEP public use 3rd 1 0 3rd
disease
My Optum Health 5th 8 g t h
American Heart g t h 5 -
Association
Healthwise Yahoo health 6 th 7 7th
Risk cardiac NCEP professional use 5th 8 5th
CVHealth (university of 7th 6 7th
Risk Heart
Edinburgh) 
American Heart 5th 8 g t h
Association
NCEP professional use g t h 5 7th
Risk Heart attack American Heart 2 nd 1 1 5th
Association 
NCEP public use g t h 5 7th
My Optum Health 9th 4 8 th
Risk of heart disease London School of 3rd 1 0 3rd
Hygiene and Tropical 
Medicine
0
5
10
7
0
6
8
6
4
6
8
6
5
10
Risks leading to London School of 6 th 7
heart disease Hygiene and Tropical
Medicine
0
- 0
g t h 7 - 0 14/5= 2.8 3
7 th
6
g t h 5 g t h 5 26/5= 5.2 5
3rd 1 0 3rd 1 0 5th 8 48/5=9.6 1 0
5th 8 6 th 7 6 th 7 37/5=7.4 7
- 0 g t h 5 - 0 10/5=2 2
6 th 7 7th 6 7th 6 32/5=6.4 6
5th 8 4th 9 4th 9 42/5=8.4 8
7th 6 7th 6 7th 6 30/5=6 6
g t h 4 2 nd 1 1 - 0 27/5=5.4 5
7th 6 6 th 7 6 th 7 31/5=6.2 6
6 th 7 g t h 7 6 th 7 40/5=8 8
g t h 5 g t h 5 g t h 5 26/5=5.2 5
g t h 4 g t h 4 g t h 4 21/5=4.2 4
3rd 1 0 1 0 th 3 6 th 7 40/5=8 8
0 0 0 7/5=1.4 1
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Risk tool heart 
condition
American Heart 
Association
1 st 1 2 2 n d 1 1
Mayo Clinic 2 n d 1 1 l St 1 2
Siteman Cancer Center 
(Washington University) 
Homepage
3rd 1 0 3rd 1 0
NCEP public use 5th 8 5th 8
Disease risk index 
(Harvard school of public 
health)
7th 6 7th 6
CardioSmart (American 
College of Cardiology)
9th 4 1 0 th 3
Open Clinical (link to 
NCEP professional use)
1 0 th 3 " 0
Healthwise MSN 1 1 th 2 - 0
Health Risk Assessors 
EBSCO
0 9th 4
Questionnaire risk 
factors heart disease
Siteman Cancer Center 
(risk calculator page)
8 th 5 8 th 5
What is my risk of NCEP public use 1 st 1 2 1 st 1 2
heart attack?
Healthwise Yahoo health 2 n d 1 1 2 n d 1 1
My Optum Health 5th 8 5th 8
American Heart 
Association
6 th 7 1 0 th 3
What is my risk of NCEP public use 3rd 1 0 3rd 1 0
heart disease?
Healthwise Yahoo health 4 th 9 5th 8
American Heart 
Association
6 th 7 - 0
5 th 8 5 th 8 5 th 8 4 7 / 5 = 9 . 4 9
1 s t 1 2 1 s t 1 2 1 s t 1 2 5 9 / 5 = 1 1 . 8 1 2
2 n d
1 1
2 n d
1 1
2 n d
1 1 5 3 / 5 = 1 0 . 6 1 1
3 rd 1 0 3 rd 1 0 3 rd 1 0 4 6 / 5 = 9 . 2 9
6 th 7 6 t h 7 7 th 6 3 2 / 5 = 6 . 4 6
g t h
4
g t h
4 - 0 1 5 / 5 = 3 3
1 0 t h 3 1 0 th 3 - 0 9 / 5 = 1 . 8 2
- 0 - 0 - 0 2 / 5 = 0 . 4 0
” 0 “ 0 0 4 / 5 = 0 . 8 1
8 t h 5 8 th 5
g t h
5 2 5 / 5  = 5 5
1 s t 1 2 1 s t 1 2 3 rd 1 0 5 8 / 5  =  1 1 . 6 1 2
2 n d
1 1
2 n d
1 1 6 th 7 5 1 / 5  = 1 0 . 2 1 C
4 th 9 3 rd 1 0 5 th 8 4 3 / 5  =  8 . 6 9
g t h
4 7 th 6 7 th 6 2 6 / 5  = 5 . 2 5
3 rd 1 0
2 n d
1 1 3 rd 1 0 5 1 / 5  = 1 0 . 2 1 C
4 th 9 3 rd 1 0 5 th 8 4 4 / 5  =  8 . 8 9
- 0 6 th 7 - 0 1 4 / 5  =  2 . 8 3
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My Optum Health 5 5
Work out my risk of NCEP public use 
heart disease
My Optum Health 
American Heart 
Association 
Reynolds risk score 
Siteman Cancer Center 
(Washington University) 
Homepage
1s t 12 1s t 12
2n d 11 2n d 11
3 rd 10 - 0
_ 0 4 th 7
- 0 10th 3
7 th 6 8th 5 8th 5 2 6 / 5  = 5 . 2 5
1s t 12 1s t 12 3 rd 10 5 8 / 5 =  1 1 . 6 12
2n d 11 2n d 11 4 th 9 5 3 / 5 =  1 0 . 6 11
3 rd 10 3 rd 10 5 th 8 3 8 / 5  = 7 . 6 8
4 th 7 4 th 7 8th 3 2 4 / 5  = 4 . 8 5
- 0 - 0 - 0 3 / 5  = 0 . 6 1
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Appendix 10. Mean rankings for all web-based cardiovascular risk prediction tools retrieved by the tailored cardiovascular risk
prediction tools search terms.
Search term 12 11 10 9 8
Rank 
7 6 5 4 3 2 1 0
Assess heart 
attack.
- - - AHA Healthwise
MSN
- - - - - - -
Assess heart 
disease.
- - AHA - - - - - Healthwise
MSN
- - -
Assess heart 
risk.
AHA NCEP prof LSHTM - - - Healthwise
MSN
- - - -
Calculate heart 
attack.
e-Tools Age NCEP public
My Optum  
Health
Reynolds 
risk score
Prevent
disease.
com
AHA
Calculate heart 
disease.
NCEP public Reynolds 
risk score
e-Tools
Age
My Optum  
Health
LSHTM
Calculate heart 
risk.
LSHTM NCEP prof NCEP public My Optum  
Health
University
of
Edinburgh 
(calculator 
info page) 
AHA
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Search term 12 11 10 9
Heart attack - NCEP public
assessment.
AHA
Heart disease . . .
assessment.
Heart risk Patient UK
assessment.
Heart attack NCEP public My Optum - Everyday
calculator. Health Health
Heart disease - My Optum Patient UK LSHTM
calculator. Health
Heart risk Patient UK - - University
calculator. of
Edinburgh 
(calculator 
info page)
8
NCEP prof
NCEP
public
AHA
Med India
QRisk 2
Health - - Cardio
wise Smart
MSN
Siteman - - Cardio
Cancer Smart
Center 
Homepage
NCEP prof
Heart 
Institute of 
the 
Cascades
NCEP prof
AHA
Assign Ethos
Heart
Aware
AHA QRisk 2 Mayo Clinic
University
of
Edinburgh 
(calculator 
info page)
Ethrisk QRisk 2
NCEP
public
Mayo
Clinic
AHA
LSHTM AHA NCEP
prof
561
Search term  12 11 10 9
Heart attack 
prediction.
Heart attack NCEP public 
tool.
NCEP prof
Healthwise
Yahoo
health
Heart attack NCEP public NCEP prof - AHA
risk tool.
Healthwise
AOL
Heart disease Mayo Clinic NCEP public 
tool.
8
NCEP prof
Mayo
Clinic
Healthwise
Yahoo
health
Heart risk tool. NCEP prof NCEP public AHA Mayo
Clinic
7
AHA
Weight
loss
advisory.
com
6 5 4 3 2 1
Health - - - Cleveland
wise Clinic
MSN
Mayo My Cleveland - Prolipid
Clinic heartrisk. Clinic
net
Health Open - - AHA
wise Clinical 
Yahoo 
health
Healthwise - Open
MSN Clinical
562
Appendix 11. Mean rankings for all web-based cardiovascular risk prediction tools retrieved by the general layman search terms.
Rank
Search term 12 11 10 9 8 7 6 5 4 3 2 1 0
Am 1 at risk of 
heart disease?
- - - - - - - - - AHA My
Optum
Health
-
Calculate heart 
disease.
NCEP public Reynolds 
risk score
e-Tools 
Age 
M y Optum  
Health
LSHTM
Calculate my risk 
of heart disease.
NCEP public Siteman
Cancer
Center
Homepage
AHA Revolution
Health
- My Optum  
Health
Heart
Healthy
Women
Org
“ “ “ “
Cardiac disease 
risk.
LSHTM University
of
Maryland
Health
Center
Medical 
college of 
Winconsin
Cardiac risk 
score.
Md + Calc - NCEP prof LSHTM - AHA - - - - - -
Cardiovascular 
risk calculator.
University of 
Edinburgh 
(calculator 
info page)
University of 
Edinburgh 
(calculator 
page)
Patient UK " QRisk 2 UCL GP 
Hospital training.net
- LSHTM The Filey 
Surgery
-
Cardiovascular 
risk score.
Patient UK 
LSHTM
Assign NCEP prof NCEP
public
563
Search term  12 11 10 9
Chance o f heart . . . .
attack.
Heart attack risk. NCEP public - - My Optum
Health
Heart disease - LSHTM - AHA
risk.
Heart disease risk NCEP public - Siteman
assessment. Cancer
Center
Homepage
Heart disease risk - Mayo Clinic Patient UK
calculator.
Heart disease risk AHA
management.
8
NCEP
public
University
of
Edinburgh 
(calculator 
info page)
Heart risk.
QRisk 2
NCEP prof
6 5 4 3 2
My Optum - - - Allina
Health
AHA
Medical University
college of of
Winconsin Maryland
Health 
Center
AHA
LSHTM NCEP M y University
public Optum of
Health Maryland 
Health 
Center
AHA
Cardio
Smart
University
of
Maryland
Health
Center
564
Search term 12 11 10 9
Heart risk Patient UK - - The
calculator. University
of
Edinburgh 
(calculator 
info page)
Heart risk score. - - NCEP prof
LSHTM
How can I find 
out my risk of 
heart disease?
M y risk of heart 
attack.
M y risk of heart 
disease.
NCEP public
NCEP public
Healthwise
Yahoo
health
8
QRisk 2
Risk cardiac. 
Risk heart.
NCEP
prof
7
LSHTM
Md + Calc
Healthwise
Yahoo
health
My Optum  
Health
6 5 4 3 2 1 0
AHA - NCEP
prof
Patient UK AHA Reynolds 
risk score
The
University
of
Edinburgh 
(calculator 
info page)
NHS
Choices
My
Optum
Health
My Optum  
Health
AHA
Healthwise - - - AHA
Yahoo 
health
CVHealth . . . .
NCEP prof AHA
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Search term 12 11 10 9
Risk heart attack.
Risk of heart . . . .
disease.
Risks leading to  . . . .
heart disease.
Risk tool heart Mayo clinic Siteman - AHA
condition. Cancer
Center NCEP
Homepage public
Questionnaire . . . .
risk factors heart
disease.
W hat is my risk 
of heart attack?
NCEP public Healthwise
Yahoo
health
My Optum  
Health
W hat is my risk 
of heart disease?
NCEP public Healthwise
Yahoo
health
W ork out my risk 
of heart disease.
NCEP public My Optum  
Health
8
AHA
LSHTM
AHA
Disease 
risk index 
(Harvard)
NCEP My
public Optum
Health
LSHTM
Cardio Open Health
Smart Clinical Risk
Assessors
EBSCO
Siteman . . . .
Cancer 
Center (risk 
calculator 
page)
AHA . . . .
M y Optum - AHA
Health
Reynolds - - - Siteman
risk score Cancer
Center
Homepage
Healthwise
MSN
566
Appendix 12. Aggregated mean ranking scores for web-based cardiovascular risk prediction tools retrieved by the search tailored to
cardiovascular risk prediction tools.
Risk prediction tool W ebpage retrieved Aggregated rankings Total
ranking
score
1st NCEP public http://hp2010.nhlbihin.net/atD iii/calculator.asD 1 0 ,1 2 ,1 0 ,1 1 ,  8 ,1 2 , 6 ,1 2 , 
1 2 ,1 1 ,1 1
115
2 n d AHA http://w w w .am ericanheart.org /presenter.ihtm l? identifier=3003499 9, 12, 10, 4, 3, 11, 8, 6, 7, 2, 
3, 7, 2 ,1 0
94
3 rd NCEP prof httD://hp2010.nhlbihin.net/atDiii/calculator.asD?usertvDe=prof (homepage) 
http://www.ODencrmical.org/aPD nhlbiCHDrisk.htm (open clinical page)
1 1 ,1 1 , 8, 6, 6, 2, 8, 9 ,1 1 ,1 2  
5 ,1
90
4 th Healthwise http://w w w .aolhealth .com /health-concern/in teractive-tool-are-vou-at-risk-for-a-heart-attack
httD://health.msn.com/health-tODics/cholesterol/articlepage.asDX?CD-documentid=100105399
http://health.vahoo.com /heart-causes/interactive-tool-are-vou-at-risk-for-a-heart-
attack/healthw ise--te7950.htm l
9
8, 3, 4, 5, 5 ,3
9, 8 ,6
60
5th M y Optum Health http://w w w .m voD tum health .com /porta l/M anageM vH ealth /H eart+A ttack 10, 9, 7 ,1 1 ,1 1 48
6th LSHTM http://riskscore.lshtm .ac.uk/ 10, 2 ,1 2 , 9, 7 40
7th M ayo Clinic h ttp://w w w .m avoclin ic.com /health /heart-d isease-risk/hb00047 4, 2, 8 ,1 2 , 5, 8 39
8th Patient UK http://www.patient.co.uk/doctor/Prim arv-Cardiovascular-Risk-Calculator.htm 1 1 ,1 2 , 10 33
Joint e-Tools Age http://w w w.etoolsage.com /Calculator% 5CHeart Attack Risk Calculator.asp?toolsort=1500 1 1 ,9
g th University of 
Edinburgh
http://cvrisk.m vm .ed.ac.uk/calculator.htm  (calculator info page) 4, 7 ,9 20
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10th Reynolds risk score h tto ://w w w . revnoldsriskscore.org/ 8 ,1 1 19
11th QRisk 2 htto.V /w w w . arisk.org/ 5, 5 ,8 18
12th Everyday Health h tto : / /w w w .evervdavhealth.com /oublicsite/ha calculator.asox 9 9
13th M ed  India h tto : / /w w w .m edindia.net/oatients/calculators/cardiacrisk.aso 8 8
Joint
14th
Heart Institute of the  
Cascades
h tto : / /w w w .vourheart.org /Vour Heart Risk Assessment/ 7
W eight loss 
advisory.com
h tto : / /w ww .weightlossadvisorv.com /heart disease tool.htm 7 7
Joint Ethrisk h tto : / /w w w .eoi.bris.ac.uk/CVDethrisk/CHD CVD form .htm l 6
15th Siteman Cancer 
Center
h tto : / /www.vourdiseaserisk.wustl.edu/ (hom eoage) 6 6
Joint Cardio Smart h ttD ://w ww .cardiosm art.org/CardioSm art/Default.aspx?id=298 2 ,3
16th Prevent disease.com htto://o reventd isease.com /healthtools /heart attack risk.html 5
5
Joint Cleveland Clinic h ttD ://m v .clevelandclinic.org/heart/Drevention/fram ingham .asDx 1 ,3 4
17th M yheartrisk.net h ttD ://m vh eartrisk .n et/ 4
18th Assign htto ://assign-score.com / 3 3
Joint Ethos Heart Aware h ttD s://w w w .healthaw areservices.com /nahrs/index.htm ?hosDlD=108&m oduleNam e=heartAw are 1 1
19th Prolipid h ttD ://w ww .DroliD id.com /tiDS-and-tools/heart-attack-risk-calculator.htm l 1
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Appendix 13. Aggregated mean ranking scores for web-based cardiovascular risk prediction tools retrieved by the general layman search
terms.
Risk prediction tool W ebpage retrieved Aggregated rankings Total
ranking
score
1st NCEP public httD://hD2010.nhlbihin.net/atD iii/calculator.asp 1 2 ,1 2 , 4, 8, 1 2 ,1 2 , 5 ,1 0 , 10, 5, 9 ,1 2 ,  
1 0 ,1 2
133
2nd AHA http://w w w .am ericanheart.org /presenter.ih tm l? identifier=3003499 2 ,1 0 , 7, 2, 9, 3 ,1 0 , 4, 4, 4, 3, 2, 5, 8, 9, 
5, 3 ,8
98
3rd LSHTM httD://riskscore.lshtm. ac.uk/ 1, 7, 9, 4, 9 ,1 1 , 6, 7 ,1 0 , 8 ,1 73
4 t h M y Optum  Health h ttD ://w w w .m voD tum health .com /porta l/M anageM vH ealth /H eart+A ttack 9 ,1 ,  7, 6, 9, 4 ,1 ,  5, 4, 9, 5 ,1 1 71
5th NCEP prof httD://ho2010.nhlbihin.net/atDiii/calculator.asD?usertVDe=Drof (homepage) 
http://w w w .openclin ical.org/apD  nhlbiCHDrisk.htm (open clinical page)
10, 5, 7, 2 ,1 0 , 8, 6, 
2
50
6th Patient UK http://w w w.patient.co.uk/doctor/Prim arv-Cardiovascular-Risk-Calculator.htm 10, 9 ,1 0 ,1 2 ,  6 47
7th Healthwise http://health.vahoo.com /heart-causes/in teractive-tool-are-vou-at-risk-for-a-heart-
attack/healthw ise--te7950.htm l
7, 9, 6 ,1 0 , 9
41
8th University of 
Edinburgh
http://cvrisk.m vm .ed.ac.uk/calculator.htm  (calculator info page) 
http://cvrisk.m vm .ed.ac.uk/calculator/calc.asp (calculator page)
12, 8, 9, 0  
11
40
g t h Siteman Cancer http://w w w .vourdiseaserisk.w ustl.edu/ (hom e page) 1 1 ,1 0 ,1 1 ,1
Center h ttD ://www.vourdiseaserisk.wustl.edu/hccpquiz.pl?lang=english&func=home&auiz=  
heart (calculator page)
5 38
Joint M ayo Clinic http://w w w .m avocrm ic.com /health /heart-d isease-risk/hb00047 1 1 ,1 2 23
10th QRisk 2 h ttp ://w w w .arisk .o rg / 8, 7 ,8
569
11th M d + Calc h tto : / /w w w .m dcalc.com/fram ingham-cardiac-risk-score 1 2 ,7 19
12th Reynolds risk score h tto ://w w w . revnoldsriskscore.org/ U ,  1, 5 17
13th University of 
M aryland Health 
Center
h tto : / /w w w .healthcalculators.org/calculators/heart disease risk.aso 3, 4, 3 ,1
11
Joint Revolution Health h tto ://w w w . revolutionhealth .com /calculators/heart-attack-risk 9 Q
14th e-Tools Age h tto : / /w w w .etoolsage.com /Calculator% 5CHeart Attack Risk Calculator.aso?toolsor 
t=1500
9
15th UCL Hospital h t to : / /w w w .mvcvrisk.co.uk/ 7 7
Joint
16th
Disease risk index 
(Harvard)
h tto : / /w w w .diseaseriskindex.harvard.edu/uodate/ 6
Assign htto://assign-score.com / 6 6
GP training.net h tto : / /w w w .go -tra in ing .ne t/doctors/u tilities /fram /fram .h tm 6
CVHealth (University 
of Edinburgh)
h tto : / /w w w .cvhealth .ed.ac.uk/ 6
Joint
17th
Heart Healthy  
W om en Org
h tto : / /w w w .hearthealthvw om en.org /index.DhD?view =article& id=382& ltem id=l& O D  
tion=com  content
5
M edical college of 
Winconsin
h tto : / /w ww .m cw .edu/disDlav/router.aso?docid=3131 0 ,5 5
18th Cardio Smart h tto : / /w w w .cardiosm art.org/CardioSm art/Default.asox?id=298 1 ,3 4
19th The Filey Surgery h tto : / /w ww .filevsurgerv.com /coronarv risk calculator.htm 3 3
20th Allina Hospitals and 
Clinics
h tto : / /w w w .allina.com /ahs/healthw ellness.nsf/oage/heart assess 2
2
570
21st Health Risk httD://calculators.eDnet.com /?docid=healthcalculators/chd/Drecalcdoc&token=59ff 1
Assessors EBSCO c286-2897-478f-9 f5f- 1
f40d3249a5a9&DelivervContext=coe& CollectionllD=347&fram e=ail
571
Appendix 14. Homepages of top 10 ranked web-based cardiovascular risk calculators 
included in Critical Appraisal.
NCEP (public) - Risk assessment 
tool for estimating your 10 year 
risk of having a heart attack.
American Heart Association -  
Heart attack, coronary heart 
disease, metabolic syndrome risk 
assessment.
NCEP (prof) - Risk assessment 
tool for estimating 10 year risk of 
developing Hard coronary heart 
disease (myocardial infarction 
and coronary death).
*  High Blood C hotoM rol Hi Adults ( A M  T ie e m n t  P m l  II:
Risk Assessment Tool for Estimating Your 10-year Risk of Having a Heart 
Attack
The nsk assessment tool below uses information from the Framingham Heart Study 
to predict a person's chance of having a heart attack in the next 10 years This tool is 
designed for adults aged 20 and older who do not have heart disease or diabetes 
To find your risk score, enter your information in the calculator below 
Age □ y e a r s
Gender r  Female r  Male
I |mg/dL 
□  mg/dL 
No Yes 
| |mnVHg
Are you currently on any medication to treat high r  no r  Yes
blood pressure
Calculate Your 10-Yaar Risk
Bright blue buttons end undrckned m in ts  a n  be clicked
HEART ATTACK
R I S K  C A L C U L A T O R
Use this assessment to find out about your risk of heart attack 
r dying from coronary heart disease and what you can do about It.
gfMMWM ISftM ltiM il
r tio rm acsuH o t a w A n w  w ith
GoogleThe Pharmeceuecal Roundtable is a 
proud sponsor of this risk calculator.
f i r  Adults
Risk Assessment Tool for Estimating 10-year Risk of Developing Hard CHD 
(Myocardial Infarction and Coronary Death)
The risk assessment tool below uses recent data from the Framingham Heart Study 
to estimate 10-year risk for "hard* coronary heart disease outcomes (myocardial 
infarction and coronary death) This tool is designed to estimate risk in adults aged 
20 and older who do not have heart disease or diabetes Use the calculator below to 
estimate 10-year risk
Age: I I years
Gender <* Female Mate
HDL Cholesterol | |mgML
Smoker r  No r  Yes
Systolic Blood Pressure: | |mrrWHg
treat high blood r
| C a lc a iaN  10-Yeer Ridfc |
Currently on any medication to  i  l   No r  Yes 
pressure
«>»* Total cholesterol - Total cholesterol values should be the average of 
at least two measurements obtained from lipoprotein analysis
572
Healthwise -  Interactive Health, 
heart attack risk.
My Optum Health -  Heart attack 
risk calculator.
London School of Health and 
Tropical Medicine -  A risk score 
for cardiovascular disease.
msnV  Health *  Fitness
H eart attack risk
healthwise-
FH In / w  values and then cUck to calculate
To use ties calculator you wW need to know your systolic blood 
pressure, your HDL and yota total cholesterol values
Gander: Smoker? V *  * o a :|sa.av.v«e« M
Tha nformaoon was adapted from the National Cholesterol Educaton Program and National Heart, Lung, and Blood Institute, a part of the National 
Institutes of Health and the U.S. Department of Health and Human Services. (2004). Risk Assessment tool for estimating your 10-year risk of having 
a heart attack. Avaftabie ordne http://fp2010.rt*i«njiet/atpA/c^cviator.asp
y » y > jt > p tu m H e a k h  com
Heart Attack Risk Calculator
; *  B  » » < •« -HeoBhCl'CVS.
.
A Risk Score for Cardiovascular Disease
Click here to colttilott your risk score
Pc- pet«n*c Stafek Aegtna *
r f M  rf dymp within t  years frtm  t
T* calculate the nefc score yn. need is kne» ike fettemnp
previews heart attack/wyocor dial infarction?
P a W )r..s llb s » .h « h n *k fa d e ry < if* r )a r«
Okr yeW is 10 c a po^-» on* t W  phy* ^ **  *  eases* t W  evaraiI n *  of cardiovaocal^  disease- TW* «,ll ksip m mok rq pmc- -cat judgement* or -hot ♦* dc ob* 
car d r >aandar health a.h*d«n paecibli nssdk far h»e-ety«e change* or »yg treatment  of parhadar risk factory ewek os raiaod Mead p ro cr*
Pvll ena-W of ike nek ecare and he. *  nee domed 01  publ ished •  ike § r* *k  Jm rm ! of 14 Jwly 2001 TWt article antiHad ‘ 4 Scars far Pred'ctmg fl
Daaik m Adult* - i t  fievdod Weed Presses* « by Stead Pececk Water* McCenaech Prance* •wsyff*r Plerent Seat** ftebart Pagord and Joan-Pierre le<se*i 
♦a 01 I t  can be fawnd He •
The eoars a derived fraa data an 47 000 aken and aomer 
A a nape f ells . up aae avar 5 yaare and 00J0 patient* d*ed ef car^»ta>e>dar (keaaaa (1031 c 
elevated bleed preeaura ike nek ecers chewtd be af ida^rm rf see m health * trse*ng net nc
< af *wg *resi*"c*t far lugh Wood praaars *  Straps at 
371 ftraka and 237 ether) Though fkaea tnal pari
nkf motivated by high blood praactrs
n la predKtMf nek Aye sen anakvty eyctol* Wood praaar s and tehTks coJect*n af nek factory *  based an **»♦ n*fce* a kpMy *>ga*f *cant independent c 
knew* to be lapariawf Alee d*6*tt* and left ventncwier hypertrophy a* r eacs nek as dace a preview* etrok* or keen attack Re»*ed ereotvwne sad chert rt©t\r« an  
fader* bv ft* cubd aw».al body af e*>dance far » W  .apcrtancs copper** awr mcWa* *f f t * .  .  fhe n*fc scars He never .f 
your nek Incdentally dc*t*lx Wood praaars das* not help to pradid ymr risk a c n  ones rydoi.c prasmr* ■* taken mt* accawit and kanoa yew d**tol.« pracare
\  »—o M u  11* Dwnodb* lilAUe
^  ,------------------- -  — T||if | W„ f  MW
U * W . » *  13* Jana 2444
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TR AVEL YOUR OWN W AY W l 
TH E  NEW  M IC H E LIN  GREEN Gt
Patient UK -  primary 
cardiovascular using algorithm.
Mayo clinic -  Heart disease risk 
calculator.
#  Patient UK
Co**v*nef>eairn: r > **urrnaf*P^ 
as prvmdnf 0? GH smt nunes to 
p*tfentf Ourtng carmAMton*
Search Pn»-ent UK o
You k« hm Hm» * Pmmw+Ws * taA <«h«AHer
Horn Irrfarmetmn far Petwnts Care ft Support Profess**W Reference Pharmacy ft M nftu i Equevm
£  M e  • • ■ ^  OM O M k ^  f t  Ci
fJ iT hb H a PattontPfcn K ttdr. PatteatPfc* artteles are written for doctors and so the language can be 
tecta teat, however tome people find d»at they add depth to the pattern Information leaflets rou may 
fled the abbrevtettem record hetpfol.
Primary Cardiovascular Risk Calculator
( a d tw K i lM  ftafc Cafcwteeer for Piowei y to w e fte a
Sea
Systolic BP 
Dtastottc BP 
Tetri Cholesterol 
HOL Cholesterol
Total /HOI Ratio 
Serum TG mmol/i
Smoking Status | Non Smoker
Glucose | Normal
LVH (n o LVM - )
Central Obesity P53
South Asian Origin [ S 3
FamBy History of CM) | n o i=h
Cftcd— |
caoMw. wnw S i  see*
CtoarFwMs
UsiogSystoHe BP prediction, the to year risk :• | JBS CVD Rrek^J •$ f 
The equivalent risk cetajlatten wfth diastolic 9 *  f ft
I 6rter eearxh here
Have ' utteeeesanooendtem i Hw!hs»
Heart disease
*'* Ljocumc Heart disease risk calculator
Hearth Manager ByMayoCfimcstaff
r  ^ ttce 
I-  <d«wi cwa^vrtg
r t  uwng »wh cancer
U  RSS Feeds
Heart disease risk calculator
Calculate your heart disease risk score
Us« On tool to f M  out your m* of twingiliMrt attack or 
dying o* Dean dUease nflkifl «>* o a t 10 p i
*r»
Set owe reow
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needs further exploration.
Conclusion: Better quality trials are needed that compare different risk presentation formats, before 
conclusions can be drawn as to the most effective ways to communicate cardiovascular risk to patients 
Practice implications: Instead of directing attention to the accuracy of cardiovascular risk prediction, 
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1. Introduction
Although it is possible to quantitatively predict the risk of heart 
disease with increasing precision, such as Framingham. SCORE and 
QR1SK2 (1-3), much less is known about how to make use of the 
risk prediction and how to portray and communicate the risk, in 
ways which motivate people to reduce their risk by modifiable 
factors. This paper reports a systematic review of studies which 
have compared different ways of communicating cardiovascular 
risk to patients.
There are various ways statistical risk information can be 
communicated to patients. Numerical expressions include per­
centages. natural frequencies and numbers needed to treat (4.5). 
Graphical representations can also be used. These include bar 
graphs and pictograms or icon arrays [6|. The effects of risk 
presentation on patients' have been described previously (7-10).
* Corresponding author at: Department of Primary Care and Public Health. CardifT 
University. Neuadd Meirionnydd. Heath Park. Cardiff. CF14 4YS. United Kingdom. 
Tel.: +44 29 20 68 71 39: fax: +44 29 20 68 72 19
E-mail address: vvaldronc9cardiffac.uk (CA Waldron).
0738-3991/$ -  see front matter C 2010 Elsevier Ireland Ltd. All rights reserved, 
doi: 10.1016/j.pec.2010.04.014
For example, understanding, perceptions and behaviour are 
sensitive to the way the risk information is formatted and framed 
(11-14). There is a call for this risk information to be presented in a 
simple and balanced way. Also, there is an emerging consensus 
that it is important to communicate risk appropriately and 
effectively, as poor representation of statistical information may 
result in sub-optimal choices and treatment (4.5,11). We are not 
aware of any literature reviews that have focused on the effect of 
presentation formats for communicating cardiovascular risk to 
patients.
The communication of cardiovascular risk is particularly 
complex for a number of reasons. Firstly, there are multiple 
factors, such as age. cholesterol levels and smoking status that 
contribute to cardiovascular disease (CVD); with at least 80% of 
CVD, stroke and type 2 diabetes attributable to the existence of 
modifiable risk factors such as a poor diet, lack of physical activity 
and tobacco use (15).
Secondly, extended time horizons need to be considered. Heart 
disease is an insidious process and reducing its risk is work that has 
to be carried out over many decades, including multiple changes to 
lifestyle (16). The optimum time to reduce risk is when aged in the 
early 20 s and certainly in the 30 s (17). However, most risk
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calculations are done much later and the methods almost always 
assume that the issue of risk is addressed in later life. For example. 
CVD risk calculations usually present anticipated risk over the 
coming 10 years and are highly dependent on age as a variable. Age 
is the single strongest risk factor for future cardiovascular events, 
but by emphasising the impact of ageing in risk prediction models, 
modifiable risk factors, such as blood pressure are underempha­
sised (18).
Lastly, patients find CVD an abstract concept, they have 
difficulty interpreting personal candidacy for it and consider it a 
'sneaky disease' (19). Patients' understanding of how CVD risk is 
made up is generally poor and insufficient; the risk presented in 
prediction tools is often misunderstood, which can lead to 
unrealistic perceptions (20]. Misperceptions occur when the 
perceived risk does not correspond with actual risk; this can be an 
under-estimation (incorrect optimism or optimistic bias) or over- 
estimation (incorrect pessimism) (21,22]. In aggregate, then. CVD 
risk communication strategies need to help individuals better 
understand the multiplicity of risk factors and the contribution of 
ageing to future risk; as well as being able to promote perceptions 
of risk, in order to motivate behaviour change and for informed 
decisions to be made regarding cardiovascular health. A previous 
systematic review (23] on the effects of presenting coronary risk 
information has recently been conducted. It concluded that 
coronary risk information can improve accuracy of risk percep­
tions and increase intention to initiate prevention strategies. 
However, it did not focus on the differing forms that risk 
information can take.
The aim of this review was to compare the effectiveness 
of different interventions used to communicate cardiovascular 
risk and assess the impact of the formats used in these 
interventions, on patient related outcomes such as understand­
ing. affect, intention to modify behaviour and reduction in actual 
risk.
2. Methods
2.1. Data sources and search strategy
Systematic searches of six electronic databases: ASSIA. EMBASE, 
MEDLINE. C1NAHL PsydNFO and Science Citation Index Expanded 
were conducted from January 1980 up to November 2008. 
Comprehensive search strategies (aiming for high recall, low 
predsion) were adapted from Cochrane Heart Filter mesh terms. 
The search strategy included subject heading and keyword 
searching. Terms (such as cardiovascular disease; heart disease; 
risk communication; risk assessment) were combined. Searches 
were adapted to each of the databases used (available on request). 
Citations of retrieved papers were hand searched to identify 
further relevant studies.
22. Study inclusion and selection
Studies were eligible for inclusion if they: (1) were published in 
peer-reviewed journals written in English; (2) involved adult 
population (over 18 years old) (3) were of any quantitative design, 
such as randomised controlled trials (RCT) or observational; (4) 
compared risk communication interventions (of any format) for 
individualised cardiovascular risk assessment in primaiy or 
secondary care, against other interventions, with a control or 
usual care. Non peer-reviewed, unpublished or non-English 
language papers, qualitative designs, and those solely reporting 
the preferences patients had for risk presentation formats were 
excluded.
CAW conducted a title and abstract screen to select relevant 
studies, the selection was validated by CE and TvdW. who each
checked half of the abstracts. Disagreement was resolved by 
discussion. Full text papers were obtained for included studies.
2.3. Data extraction and analysis plan
Data extraction was undertaken using a 64-item template 
(available on request), comprising population characteristics, risk 
communication strategies, outcome measures and results. Meth­
odological quality was assessed using a checklist for both 
randomised and non-randomised studies (24]. This has been 
identified as a useful tool for assessing risk of bias (25]. It was 
chosen due to the broad inclusion criteria in the design of the 
studies.
CAW extracted data, and as validation, two other authors 
(TvdW and SL) each extracted data from a random half of the 
studies. Meta-analysis was not feasible due to the heterogeneity in 
study outcomes and therefore a narrative synthesis of findings was 
conducted. Studies were categorised into those that assessed 
individuals’ actual risk and analogue studies that used hypothetical 
risk profiles.
3. Results
3.1. Included studies
Fig. 1 summarises the study selection and extraction process. 56 
full papers were retrieved for further assessment and 29 were 
excluded. Of the 27 studies included for detailed data extraction, 
four were subsequently excluded because they only varied the 
degree of risk rather than the presentation or communication of risk 
formats [26-29], Another five were excluded because the risk 
communication elements were embedded in a decision aid that 
had other components, and therefore, the outcomes could not be 
attributed to the risk communication strategy alone [30-34]. 
Lastly, three were excluded because they were not comparative 
studies of risk formats or did not report their comparison group 
[35-37]. No additional studies were found in the hand searching of 
the included studies' citations. In summary, fifteen studies were 
included. Only four studies assessed individual’s actual risk, as the 
majority (n -  1 1 ) were analogue studies asking individuals to 
imagine a hypothetical risk profile. Table 1 provides a detailed 
description of each study in terms of design, sample, risk 
communication intervention, outcomes and main findings.
32. Quality of studies
Methodological quality of studies was assessed using the 
Downs and Black checklist (24]. Two studies were determined to 
be of good quality [3839]. The other studies were deemed to be of 
medium quality (40-52).
Of the four studies where individuals’ actual risk was calculated 
[38-41], two were RCTs [3839] and two were observational 
(40,41). The RCTs were of good quality: both were adequately 
powered and compared groups to identify possible confounders. in 
one trial the outcome assessor was blinded to the randomisation 
groups [38]. However, in the other trial, contamination of the 
control group may have occurred due to the randomisation at a 
patient and not physician level (39). The two observational studies 
achieved lower quality scores.
Eleven analogue studies asked individuals to imagine a 
hypothetical risk profile. They were predominantly observational 
studies with a factorial design. Six studies randomised groups 
(43.47.4830-52); six attempted to identify principal confounders 
by comparing groups (42,45.4730-52) and two blinded partici­
pants to the manipulations (47,49). However, six studies did not 
report power calculations for sample sizes (42-45,48,49]; one was
579
CA Waldron et al./Patient Education and Counseling 82 (2011) 169-181 1711
15 studies included.
27 studies selected for data extraction.
389 studies excluded.
29 studies exduded.56 full papers retrieved for further 
assessment
12,806 studies excluded.
4,005 duplicates.
445 studies independently reviewed by 
CAW and GE or TvdW or basis of title 
and abstract.
Disagreaments resolved by discussion.
4 studfos excluded where varying risk 
levels are assessed only.
5 studies excluded where risk 
communication formed pvt of 
interventions such as decision aids.
3 non-comparative studtes excluded.
ASS1A.. .1052
CINAHL...................... ................ .2808
EMBASE....................................... 3684
MEDUNE................................. .... 6436
PsyclNFO ............   1849
Science Citation Index Expanded..1427
17,256 Studies Identified from electronic 
searches for title and abstract 
assessment).
Fig-1. Study selection and extraction process flowchart.
underpowered (52) and one reported concerns about the reliability 
of the findings because participants failed to follow questionnaire 
instructions [50]. There was variation of included studies in terms 
of risk presentation formats, type of cardiovascular risk, timeframe 
and outcomes measured (see Table 2).
3.3. Summary of findings
3.3.1. Numerical formats
One study assessing patients' actual risk (41) and seven 
analogue studies [42,43,45.46,493132] compared a number of 
different numerical risk presentation formats with each other. 
Additionally, one actual risk study used a combination of two 
numerical formats in an intervention and compared it with usual 
care [39], and one analogue study compared a numerical format 
with risk categories [47].
Two analogue studies were concerned with whether percep­
tions of risk and emotional responses were sensitive to numerical 
risk presentation [42.43]. Fair and colleagues [42] examined the 
effect of two formats (percentages and frequencies) on responses 
to messages regarding the risk of coronary heart disease (CHD). 
Risk perceptions, emotions and behavioural intentions were 
sensitive to the format used. Frequencies led to higher perceived 
risk (OR-2.471 (95* Cl; 1.692-3.609). p< 0.001), more worry 
(p < 0 .0 0 1 ), more disturbance (p < 0 .0 0 1 ), and increased intention 
to make lifestyle changes (p < 0.05), than did percentages. 
Conversely, French et al. [43] used vignettes that presented risk 
of having a cardiac event in either percentage or frequency formats,
and found no differing effect on risk perception, emotion or 
understanding.
One study assessing actual risk [41] and five analogue studies 
[45.46,493132] were mainly concerned with presenting treat­
ment effectiveness in differing numerical formats. These studies 
evaluated how different formats lead to differing acceptance rates 
of medication. Straus (41) compared formats for presenting the 
ratio of the benefits and costs of taking warfarin medication, and 
measured patients' intention to take warfarin. The highest 
percentage of patients (76.4%, n-13) chose to warfarin when 
they were presented with the likelihood of being helped or harmed 
ratio. Conversely, the absolute risk reduction versus absolute risk 
increase ratio had the lowest percentage of patients choosing to 
take warfarin (17.6%, n -  3). It is not reported whether differences 
were significant and no confidence intervals are given. This study 
had a small sample (n - 17) and needs to be interpreted with 
caution.
In a cross-sectional study by Coodyear-smith [45], respondents 
with existing CVD were presented with descriptions of the benefit 
of a hypothetical medication to reduce the risk of a future heart 
attack. The same information was expressed in different formats. 
Their willingness to accept the medication was measured. The 
presentation of negatively framed 5-year absolute risk (expressed 
as percentages) encouraged acceptance the most, with 89% (n -  89) 
consenting to take medication when this format was presented. 
The numbers needed to treat (NNT) format encouraged acceptance 
of treatment the least compared to the other formats (67%, n « 67). 
This finding was also seen in a similar study by Hux and Naylor
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Table 1
Design characteristics and principal results of included studies by type of risk assessment.
Author, year, 
country
Sample, context Design, aim. 
methodological 
quality score
Type of
cardiovascular risk
Variables of 
the risk
communication
Main outcome 
measure(s)
Main conclusions
Actual risk assessment In patients 
Asimakopoulou 95 patients with
et al. 2006, 
UK J40|
Chari son et al., 
2008. USA (38]
Grover et al.,
2007. Canada [39]
Straus, 2002, 
UK and 
Canada |41)
Type 2 diabetes and 
without existing 
cardiovascular 
disease (CVD), 
Diabetic Clinics and 
General Practitioner 
Surgeries.
660 patients 
undergoing coronary 
artery
catheterization.
Hospital.
3053 men and 
women aged 30-70 
years with diabetes 
or CVD; or men (aged 
45-70) and women 
(aged 55-70) 
without CVD who 
had a 10-year 
coronary risk of at 
least 10% based on 
Framingham 
equations. Primary 
care.
17 patients admitted 
for nonvalvular atrial 
fibrillation. Hospital
Observational-factorial 
design. To examine the 
impact of communicating 
risk of coronary heart disease 
(CHD) and stroke, using 3 
timeframes, on patients’ 
perception, understanding of 
risk of CHD/stroke and their 
subsequent recall/memory 
for these risks. t3.
Randomised controlled trial. 
To test whether an innovative 
approach of framing risk, 
based on ‘net present value’ 
economic theory (what 
patients can gain now), 
would be more effective in 
behavioural intervention 
than the standard future 
value approach' in reducing 
cardiovascular morbidity and 
mortality following 
angioplasty. 22.
Randomised controlled trial. 
To determine whether 
showing physicians and 
patient’s the patient’s 
calculated coronary risk can 
improve the effectiveness of 
treating dyslipidemia in a 
primary care setting. 22
Observatkmal-pre-post 
design. To test a patient- 
centred measure of the 
likelihood of being helped or 
harmed by an intervention, 13.
Absolute 1.5 or 10- 
year risk of 
developing CHD/ 
stroke as a result of 
having diabetes, 
using the UKPDS Risk 
Engine v2.0.
Relative potential to 
improve current 
health status and 
quality of life, when 
modifying risk 
factors in the 
intervention group; 
and value of 
preventing future 
health problems in 
the control group.
Absolute and 
comparative 8-year 
cardiovascular risk, 
evidenced by 
increased
cardiovascular age in 
intervention group; 
usual care in the 
control group.
Ratios of being 
helped or harmed by 
warfarin medication 
(e.g. decreased risk of 
stroke and increased 
risk of haemorrhage).
Numerical and graphical 
presentation: percentage 
of risk In given timeframe 
(1 .5 .10  years). Bar charts, 
with 10-slice pie chart and 
pktogram of 100 smiley 
faces used as 
supplements.
Numerical presentation: 
Net present value 
approach (biologic age 
reduction one could 
achieve. If each risk factor 
was changed). Future risk 
approach, (risk reduction 
framed as the value of 
preventing future health 
problems).
Numerical and graphical 
presentation: Percentages 
and cardiovascular age. 
Comparative risk 
graphically summarised 
by population risk tertiles. 
so patient could see his/ 
her absolute risk 
compared with that of 
peers. Vertical bar graphs 
showing risk change after 
each lipid profile was 
taken.
Numerical presentation.
•  Absolute risk reduction/ 
absolute risk increase 
(ARR/ARI).
•  Relative risk reduction/ 
relative risk increase 
(RRR/RR1).
•  Number needed to treat/ 
numbers needed to harm 
(NNT/NNH).
•  Likelihood of being 
helped or harmed) (LHH).
Risk perception, 
understanding and 
memory.
Freedom from death, 
myocardial 
infarction (M l) 
stroke, angina or 
severe asymptomatic 
ischemia at 2 years, 
discrete stage of 
change and 
behaviour specific 
self-efficacy.
Changes in blood 
lipid levels and non­
lipid risk factors, 
percentage of 
patients reaching 
lipid targets and 
global 10-year risk.
Patients' choice to 
take medication.
The 10-year timeframe produced consistently higher perceived, 
understood and recalled CHD risk estimates compared with both 
1-year (mean difference-14.52. p < 0.001) and 5-year groups 
(mean difference- 1034. p < 0.01). This was also seen for stroke 
risk. The 10-year time frame produced consistently inflated 
understood and recalled risk estimates compared with both the 1 - 
year (mean difference-9.22, p < 0.001) and 5-year (mean 
difference-627, p < 0.05) groups. Originally inflated risk 
perceptions of CHD were successfully corrected with the help of 
the graphical tools (F1M -73.01; p < 0.001 X as was inflated stroke 
risk (Ft.«i -119.05; p < 0.001). but 10-year risk group was the most 
resistant to correction for both CHD and stroke, as they were the 
only group who recalled much higher risk at 6 week follow-up 
than they understood at the consultation (F4176«4.73; p < 0.001). 
No significant differences were found between groups for the rates 
of death, stroke. Ml. class II—IV angina or severe ischemia between 
the net present value group and future value group (p-non  
significant); or stage of change and self-efficacy (p-non  
significant). Over the 2-year follow-up, patients in both groups 
reached action on 1.5 risk factors.
Over the 12-month follow-up the intervention (i.e. coronary risk 
profile) led to greater cholesterol reductions (OR - 1.26 (95% C); 
1.07-1.48, p value not reported). After adjustment for baseline 
difference between groups, the intervention group was more 
likely to reach the recommended lipid targets (O R -1.26 (95% Cl; 
1.04-1.53. p value not reported). There was a significant 
interaction effect between the risk profile and cardiovascular age. 
in that the higher a patient’s risk (evidenced by increased 
cardiovascular age) the greater the impact associated with the risk 
profile (O R -1.69 (95* Cl; 1.21-2.36; p<0.05).
LLH had the highest percentage of patients choosing warfarin 
(76.4%, n -1 3 ). 70.4% (n -1 2 ) accepted treatment when presented 
with the ARR/ARI format. 47.1% (n -8 ) accepted treatment when 
presented with NNT/NNH. ARR/ARI had the lowest percentage of 
patients choosing warfarin (17.6%, n -3 ). Whether differences 
were significant was not repotted.
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Analogue studies 
Fair et al..
2008, UK (421
French et al* 
2004. UK (431
Frileux et al*
2004, France (44)
740 respondents 
from general 
population who had 
not previously 
suffered horn a 
medically diagnosed 
heart condition 
(heart attack or 
angina). Location not 
stated.
Quasi-experi mental- 
factorial design. To test the 
hypothesis that responses to 
CHD risk estimates are 
heightened by use of ratio 
formats, peer group risk 
information, and long 
timeframes, 16.
970 adults aged 40- 
60 with no history of 
heart disease, 
Location not stated.
150 respondents 
from a convenience 
sample without 
established heart 
disease. Location not 
stated.
Absolute and 
comparative 10 or 30 
risk of CHD. based on 
risk tables published 
by the Framingham 
Heart Study.
Observational-factorial 
design. To examine the 
emotional and cognitive 
impact of personal and soda) 
comparison information 
about health risk and to 
examine the effect of 
presenting this risk 
information using different 
probability formats, and the 
presence or absence of 
format-congruent visual 
representations. 13.
Observational-factorial 
design. To explore the impact 
of the preventive medical 
message on intention to 
change behaviour, to explore 
the impact of the severity of 
the threatened disease 
manifestation, its likelihood, 
the time frame of the risk, the 
effectiveness of a preventive 
behaviour, and the nature of 
this behaviour on people’s 
intention to engage in action 
to prevent the disease. 10
Absolute and 
comparative 10-year 
risk of having a 
cardiac event (heart 
attack, angina, heart 
failureX
5.10,15.20-year risk 
of coronary artery 
disease (CAD) 
presented as 2 
severities: angina 
pectoris or heart 
attack.
Numerical presentation: 
Natural frequencies and 
percentages, either with 
or without comparative/ 
peer group risk.
Risk perception, 
emotional response 
to risk information 
and intention to 
make lifestyle 
changes.
Numerical and graphical 
presentation: Vignettes 
describing the risk of 
having a cardiac event, 
with four factors 
manipulated: format 
(percentage or natural 
frequency); format- 
congruent visual 
representation, eg. bar 
chart for percentages, 
pictogram for natural 
frequencies (presence or 
absence); level of social 
comparison risk 
(favourable or 
unfavourable) and level of 
personal risk (low or high). 
Numerical presentation: 
percentages. Four 
different components of a 
message about preventing 
CAD were manipulated: 
severity (angina pectoris 
and heart attack); 
probability occurrence (5. 
10,15,20X); time horizon 
(5 .10 .15.20  years); level 
of controllability (entirely 
under your control or not 
much you can do to 
reduce it).
Ratings of 
disturbance/worry, 
ratings of 
reassurance, 
likelihood of having a 
cardiac event, 
comparison of own 
risk compared to 
others and 
confidence in 
understanding of 
information given.
Intention to adopt a 
specific behaviour.
No main effect of timeframe on risk perception was observed. A 
significantly higher proportion of respondents perceived their risk 
to be higher when risk was presented in frequency formats 
(OR-2.471 (95XG; 1.692-3.609). p< 0.001). or if  those risks were 
supplemented with peer group risk information (OR - 1.578 (95X 
O; 1.144- 2.177), p< 0.01). Respondents presented with risks in 
the form of a frequencies reported feeling more worried 
(p < 0.001) and disturbed (p < 0.001) than those presented with 
percentages. Respondents who saw both personal and peer group 
risk information said they felt more worried (p < 0.01 j and 
disturbed (p < 0.01) and less reassured (p < 0.05) than those who 
were presented with risk over a 10-year period. There was a 
significant interaction between age group and numerical 
expression of risk; when risk was expressed as a frequency, 
younger age groups (30-49 years) felt more worried (p < 0.01) and 
more disturbed (p <0.05) than the older groups (50-70 years). 
There was also a significant interaction between age group and 
peer group risk, in which the younger age groups felt more 
worried (p < 0.001 \  more disturbed (p < 0.05) and less reassured 
(p < 0.05). Presentation of frequencies also increased intention to 
make lifestyle changes (p < 0.05). Peer group risk information 
failed to have an impact on intention to change (p-non  
significant). There was a significant interaction between peer 
group risk and age group on intention to change lifestyle. The 30- 
39 year old age group had a higher stated intention to change their 
lifestyle than the older age groups (when presented with peer 
group risk as well as personal risk (p < 0.05).
There were no main effects of frequency versus percentage format 
(p-non significant). Respondents who received a visual 
presentation gave lower ratings of being disturbed/worried 
(M -  9.37) than those who did not received a visual representation 
(M -10.98) (F ( 1,313-8.74; p < 0.01). This main effect was not 
found for the ratings of being reassured. Favourable social 
comparison Information led to significantly less disturbance/ 
worry, more reassurance and lower personal susceptibility ratings 
than unfavourable information (p < 0.05) Unfavourable social 
comparison information had no discernible impact relative to not 
providing any social comparison information. No difference in the 
comparison of own risk compared to others, between those who 
received unfavourable, favourable or no social comparison 
information. Personal risk had more of an impact on reassurance 
(i>*-0.08) than social comparison risk (q2«0.06) This was also 
seen for disturbance/worry (q2 -0 .09 vs. q2-0 .05) and perceived 
risk (q2 -  0.07 vs. r f -O M ) .
All 4 main factors had a significant effect on the intention to adopt 
a preventive behaviour. Greater severity (heart attack) produced 
greater intentions than lower severity (angina pea oris)
(p < 0.001) The higher the probability the higher the estimated 
level of intention (effort stronger at low probabilities than at 
higher probabilities) (p < 03)0001) The shorter the time horizon 
the higher the intention (FM u  -229.33; p < 0.001) The lower the 
controllability, the lower the estimated level of intention to 
change behaviour, (p < 0.00001) Respondents intended to change 
behaviour even when told this would be of little use. There was an 
interaction between age and timeframe, where intention to adopt 
a preventive behaviour was greater for older participants (aged 
between 60 and 80 years) when shorter timeframes were used, 
and for younger participants (aged between TO and SO years)
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TaMe 1 (Continued)
Author, year, 
country
Sample, context Design, aim, 
methodological 
quality score
Type of
cardiovascular risk
Variables of 
the risk
communication
Main outcome 
measurefj)
Main conclusions
Goodyear-Smith 
et al.. 2008,
New Zealand (45]
Hux and Naylor. 
1995. USA [46)
Man-Son-Hing 
et al„ 2002, 
Canada |47|
100 patients with 
existing heart 
disease (M l. angina 
or both), taking 
statins and who had 
experience with 
taking medications 
and making 
decisions regarding 
medications. Family 
Practice.
100 outpatients of 
family practice, 
hypertension and 
cardiology centres. 
Private setting.
Qua si •experimental, 
explorative study. To 
determine which methods of 
expressing a preventive 
medication’s benefit 
encourage patients with 
known cardiovascular 
disease to decide to take the 
medication 13.
Quasi-experimental-cross- 
sectional design. To assess 
how three different formats 
of the same data affected the 
willingness to take what were 
implied to be different lipid- 
lowering drugs, 12.
198 Volunteers aged 
60-80 years without 
atrial fibrillation. 
Recruitment from 
outpatient geriatric 
and medical clinics.
Observational-factorial 
design. To compare the 
Impact of quantitative vs. 
qualitative descriptions of 
probability risk estimates in 
decision aids on the clinical 
decision-making process, 
regarding stroke prevention 
in atrial fibrillation. 18.
5-Year risk of a heart 
attack with and 
without medication 
(16* with and 23* 
without medication).
Data on effectiveness 
of a drug to prevent 
myocardial 
infarction and heart 
disease.
Absolute 2-year 
probabilities of 
stroke and major 
haemorrhage with 
no antithrombotic 
therapy. Set at low 
(3 *) or moderate 
(8%) risk.
Numerical and graphical 
presentation:
• Relative and absolute 
risk (positive and negative 
framing) -  percentages.
•  Detailed and simplified 
natural frequencies.
•  NNT.
•  Odds ratios.
•  Vertical bar graphs- 
natural frequencies of 
those who have and do 
not have a heart attack 
with and without 
medication.
Numerical presentation:
•  RRR and ARR 
percentages.
•  Positively and negatively 
framed NNT -  number of 
people treated for 5 years 
to prevent one myocardial 
infarctioa
•  Average gain on disease- 
free years -  number of 
extra weeks free of heart 
disease.
•  Stratified gain in 
disease-free survival -  
percentages, e.g. SXhadan 
extra 2 to 6 yean free from 
heart disease.
Numerical and graphical 
presentation: natural 
frequencies and 
pktogram of 100 faces in 
the quantitative 
(numerical) condition; 
Category phrases 
describing the risk of 
stroke and bleeding (e.g. 
low, moderate, etc.) in the 
qualitative condition.
Acceptance of 
treatment.
Acceptance of 
treatment
81* were willing to take medication regardless of the way the 
benefit of medication was expressed. Absolute risk (negative 
framing) encouraged acceptance of treatment the most with 89X 
of respondents accepting treatment NNT least encouraged 
acceptance of treatment with 67* of respondents accepting 
treatment. Natural frequency bar graph produced a higher 
acceptance rate (86X) compared to its numerical equivalent (7SX). 
it is not reported whether this was significant (p-not reported).
Relative risk reduction format had highest proportion accepting 
treatment (88*. n -  88). NNT had the lowest acceptance rate (31*. 
n«31). Average gain in disease-free years had a 40* (n -4 0 ) 
acceptance rate and stratified gain in disease-free survival had a 
56* (n -5 6 ) acceptance rate. A significantly higher percentage of 
patients accepted treatment on the basis of RRR (88X) than 
absolute risk reduction (42*) and NNT(31X) (p< 0.001).
Choice of 
antithrombotic 
therapy, rank-order 
of stroke risk and 
realistic expectations 
of outcomes.
No significant difference between treatment choices for the low 
risk arm (p-non significant). In the moderate risk arm, 
respondents in the qualitative group were more likely to choose 
therapy at the extremes of effectiveness (warfarin or not therapy) 
(p -0 .01). Also, more persons in the qualitative group chose the 
options of aspirin and were 'unsure' than those in the quantitative 
group. The use of qualitative or quantitative decision aid made no 
significant difference in respondents' ability to rank-order their 
stroke risk in a quantitative or qualitative manner (all comparison 
p values >0.10). The quantitative (numerical) decision aid resulted 
in a significantly higher percentage of respondents having realistic 
estimates of the numerical probabilities for all outcomes 
compared to the qualitative decision aid (all values p < 0.01) e.g. 
when estimating the chance of stroke while taking warfarin, 76 
and 32* of the quantitative and qualitative groups gave correct 
answers, respectively. Linear regression showed that female 
gender was significantly associated with an increased choice to 
take warfarin medication (p<0.05).
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Mason et al., 
2008. USA (48|
Misselbrook and 
Armstrong, 2001, 
UK|4»|
Scott and Cutbow, 
2006. USA (90|
Sorensen et al., 2008, 
Denmark (51]
L/l
00•I*
683 respondents 
from a reactive 
sample of people 
who were not 
teachers or 
researchers. Internet 
survey completed 
remotely.
Observational-factorial 
design. To determine 
whether people focus 
primarily on information 
about their own risk status or 
on a comparison with others. 12.
274 hypertensive 
patients and age/sex 
matched non- 
hypertensive 
patients. General 
Practice.
395 College/ 
University women. 
University 
classrooms.
Absolute and 
comparative 10-year 
risk of having a 
cardiac event (heart 
attack, angina, heart 
failure),
Qua* i-experi mental-cross- 
sectional design. To examine 
patients’ choice about 
treatment in response to 
different forms of risk 
presentation of the benefits 
of treating mild 
hypertension, 13.
Observational study- 
factorial design, To examine 
the interactive effects of 
message frames and CVD risk 
factors on women's 
knowledge, beliefs, efficacy 
and behavioural intentions, 
15.
Benefit of treatment 
in reducing stroke.
1519 non- 
institutionalised 
Danes over 40 years 
randomly drawn 
from a national 
database at Statistics 
Denmark. Location 
not stated.
Observational-cross- 
sectional design. To explore attack within 3 years,
whether lay people can 
discriminate between 
preventive interventions 
when effectiveness is 
presented in terms of relative 
risk reduction, and whether 
such discrimination is 
influenced by presentation of 
baseline risk. 18.
Numerical presentation: 
Percentages, absolute risk 
and 4 levels of increasing 
comparison risk 
difference.
No individualised 
risk estimates, 
generalised 
descriptive 
statements regarding 
the prevention of 
heart disease.
Death of a heart
Negative affect 
responses to the risk 
information 
(disturbed and 
worried) and 
seriousness of a 
cardiac event in a 
person of the same 
age and sex.
Numerical presentation:
•  RRR and personal 
probability of benefit from 
treatment model -  
percentages.
•  NNT.
•  AM  -  natural 
frequencies.
4 messages comprising 
either the probable 
benefits/gains of engaging 
in healthy behaviours or 
the probable costs/losses 
of not doing so. in either 
the short-term or long­
term future, e.g.
•  Gain x Present
•  Gain x Future
•  Loss x Present
•  Loss x Future 
Numerical presentation: 
percentages and natural 
frequencies (for baseline 
risk of heart attack). RRR 
achieved by a 
hypothetical drug 
treatment to prevent 
heart attacks presented as 
10,20,30,40.50 or 60X In 
order to test whether 
baseline risk had an effect 
on acceptance of 
treatment. Baseline 
numeric risk information 
was either present or not.
Acceptance of 
treatment.
Susceptibility, self- 
efficacy to prevent 
heart disease, 
perceived efficacy of 
behavioural 
interventions and 
behavioural intent.
Acceptance of 
treatment and 
perceived difficulty 
of understanding the 
size of the treatment 
effect.
When maintaining constant relative differences between personal 
risk and comparison risk, negative affect was higher at high 
personal risk (20X) than at low personal risk ( 10X) (p < 0.01). Also, 
respondents responded to the magnitude of the difference 
between personal and comparison risk, such that, as the difference 
increased (in which personal risk was higher than comparison 
risk), so did negative affect, independently of personal risk 
(Fijjo-9.10, p< 0.01, rj* m 0.044). When maintaining constant 
absolute differences between personal risk and comparison risk, 
there was no significant main effect of level of personal risk 
(p-non significant). Affective responses to comparison difference 
were sensitive to relative difference between personal and 
comparison risk. Relative differences correlated negatively with 
personal risk (FWJ0-  8.19. p < 0.01. rj* = 0044). it could be 
argued that at higher levels of personal risk, the role of comparison 
information becomes less. Judgements of the severity and 
prevalence of cardiac events was not affected by personal risk and 
comparison difference whether controlling for relative or absolute 
differences (p-non significant).
For RRR most patients would accept treatment (92X Cl; 89-96, 
n-255). For absolute risk reduction 75X (95X a ; 70-80, n -208) 
would accept treatment. For NNT 68X (95X Cl; 63-74, n - 188) 
would accept treatment.
Personal probability of benefit had least patients accepting 
treatment (44X, 95X Cl; 38-50, n -121) with the narrow majority 
declining treatment Also, Hypertensive patients were 
significantly more willing than non-hypertensive patients to cake 
treatment when presented with relative risk reduction 
Information (Mann-Whitney U -6688. p < 0.001).
There were no main or interactive effects of time orientation on 
any outcomes (p-non significant). Those who read a gain-framed 
message showed a significantly greater mean increase in self- 
efficacy to prevent heart disease compared to those who read a 
loss-framed message(Ft.Mi-8 .2 1 ,p < 0 .05 . effect size-0.02). 
There was a significant interactive effect of message frame and 
parental history of high blood pressure for intention to check 
blood pressure (F - 5.13, p < 0.05. effect size-0.01). Intention was 
significantly increased only in those with a family history exposed 
to the loss-framed message. Conversely, only the gain-framed 
message significantly increased intention in those without a 
family history. No other significant main or interactive effects of 
message and health history variables on any other outcomes.
No significant difference in acceptance rates across respondents 
who were and were not presented with baseline risk information 
(p -  non significant). 76X of respondents reported that RRR was not 
difficult to understand. There was no difference in reported 
understanding of RRR across respondents who were or were not 
presented with baseline risk information (p-non significant). 
Respondents who reported no difficulties understanding the 
concept, were more likely to accept the hypothetical treatment 
irrespective of RM-level and whether baseline risk had been 
presented (p < 0.05).
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{46). where NNT resulted in only 31% (n«31) of respondents 
willing to take the medication. Additionally, the relative risk 
reduction (RRR) format (expressed as percentages) elicited the 
highest proportion of respondents accepting treatment (8 8 %, 
n = 8 8 ). When Misselbrook and Armstrong (49) presented the 
benefits of reducing the risk of stroke, the personal probability of 
benefit format led to the lowest percentage of respondents 
accepting treatment (44%, 95% G; 38-50, n -  121) compared to 
the other formats. Again, the highest percentage of respondents 
accepted treatment on the basis of the RRR format (92% Cl; 89-96, 
n -  255).
Stovring et al. (52) examined the concordance of the decision to 
accept treatment (e.g. whether the decision was upheld), when 
treatment effectiveness was presented as a single numerical 
format, and then as a more comprehensive, collective presentation 
of formats including absolute risk reduction (ARR), RRR and NNT. 
Decisions tended not to change with presentation of the 
comprehensive additional information. Furthermore, Sorensen 
et al. [51 ] examined acceptance rates of treatment to reduce risk of 
fatal heart attack. Acceptance did not change when the RRR format 
was supplemented with baseline risk information (expressed as 
natural frequencies), which would enable a calculation to 
determine perspective.
In the study that compared a numerical intervention with usual 
care, Grover et al. (39) gave patients a copy of their coronary risk 
profile. This comprised 8 -year absolute cardiovascular risk 
presented as increased cardiovascular age, comparative risk 
(expressed as percentages) and bar graphs (to demonstrate the 
changes in patients’ lipid levels over time). At 12-month follow-up, 
patients receiving their risk profile were more likely to reach lipid 
targets (OR -  1.26 (95% G; 1.04-1.53, p value not reported) and 
achieve greater cholesterol reductions (OR -  1.26 (95% G; 1.07- 
1.48, p value not reported).
Man-Son-Hing et al. (47) compared two versions of a 
decision aid that differed in the way they presented risk, using 
a factorial design. The purpose of the decision aid was to help 
with choices regarding antithrombotic therapy to prevent 
stroke; the risk information was presented in either quantitative 
numerical formats (natural frequencies) with graphical repre­
sentations (pictograms with smiley faces); or in a more 
qualitative way (high to low risk categories). When the risk 
of stroke without antithrombotic therapy was presented as 
‘moderate’ (8 %), participants receiving the numerical informa­
tion were significantly more likely to choose the therapy with 
the extremes of effectiveness (e.g. warfarin or no therapy) 
(p < 0 .0 1 ); and those receiving the risk category information 
were more likely to choose aspirin (middle of the range 
effectiveness) and be more uncertain about their choice. This 
difference was not seen when a low (3%) risk of having a stroke 
with no therapy was presented. Additionally, those receiving the 
numerical decision aid were significantly more likely to have 
realistic risk perceptions, by giving correct estimates of the 
numerical probabilities for the outcomes achievable from 
therapy, than those who received the alternative risk categoty 
version (p < 0 .0 1 ).
To summarise, studies looking at numerical risk presentation 
formats have found that making patients aware of their risk can 
encourage risk reduction action to be taken, especially if this risk is 
high. There is conflicting evidence regarding whether numerical 
presentation formats can effect patients’ perceptions or emotions. 
However, numerical presentation of risk as opposed to simple risk 
categories (e.g. high, moderate, low) appears to lead to more 
accurate risk perceptions. Additionally, treatment decisions are 
sensitive to the way a treatment’s effectiveness is presented. The 
RRR format appears to ‘encourage* treatment the most and the NNT 
format leads to the least acceptance.
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Table 2
Summary of cardiovascular risk manipulation of included studies by type of risk assessment.
Study Numerical formats Graphical formats Risk
Percentages Natural frequencies Ratios NNT Other (state) Rar graph Pktogram Other (state) Absolute Comparative Relative Risk reduction
Actual risk assessment in patients
Asimakopoulou et a l, 2006 (40) • - - - - a a a* a - -
Charison et aL. 2006 [36] - - - - - - - •  • •
Grover et a]„ 2007|39) • - - - a - — a •  — •
Straus 2002141) - - • - - - - - -  • •
Analogue studies
Fair et al.. 2006142| • • - - - - - a •  — _
Flench et al„ 2004 (43| • • - - - a a a •  -
Frileux et aL, 2004144| • - - - - - a - _
Goodyear-Smith et a l. 200$ |45| • • • • - a - a -  • •
Hux and Naylor. 1995 |46| • - • - - a — • •
Man-son-Hing et a l. 2002 [471 - • - - A - a a - _
Mason et a l. 2006 (4$) • - - - - - a • - -
Misselbrook and Armstrong. 2001 [49] • • - • - - - a — • •
Scott and Curbow, 2006 (SO) - - - - - - -
Sorensen et i l  2006 [S I] • • - - - - - -  • •
StovingetaL. 2006 [52| • - - • a a • — • •
Study Timeframe Outcomes
<10 >10 Risk Emotional Understanding Intention to Change in risk Acceptance of treatment/ Other (state)
perception response change behaviour factors, Overall risk Medication choice
Actual risk assessment In patients
Asimakopoulou et a l, 2008 (40) • - • - • - - - J
Charison et al„ 2006136| • - - - - - • -
Grover et al- 2007139) • - - - - - • - -
Straus 2002 (41) - - - - - - - • -
Analogue studies
Fair e ta l, 2006[42| • • • • - a - - -
French etaL. 2004 (43| • - • • • _ - _
Frileux et a l. 2004 (44| • • - - - a _ - *
Goodyear-Smith et a l. 2006 (45) • - - - - - _ • -
Hux and Naylor. 1995146| - - - - - - - • -
Man-son-Hing et a l. 2002 (47) • - - - - - - • 6**
Mason et al.. 2006 (46) • - • • - - _ -a -
Misselbrook and Armstrong. 2001 (40) - - - - - - _ • -
Scott and Curbow, 2006 [S0| - - • _ _ a _ -
Sorensen et aL. 2006 (511 • - - _ • _ _ • -
Stoving et a l, 2006 (52) - - - - a - - •
* Pie chart.
h Net present value approach (biologic age reduction). 
c Future value approach. 
d Cardiovascular age.
* Average gain in disease-free years.
' Stratified gain in disease-free survival.
* Categories.
h Descriptive statements.
1 Stage of change.
1 Memory/recall.
* Self-efficacy.
1 Outcome expectation. 
m Rank order of stroke risk.
" Outcome expectation.
° Sclf-cfflcacy.
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3.32. Graphical formats
Six studies in this review used graphical representations, 
mainly bar graphs and pictograms. Two used actual risk assess­
ment [39,40] and four were analogue studies (43,45,47.52). No 
study compared different graphical formats with each other. 
Two studies compared a graphical format against its numerical 
equivalent (43,45). Four studies used numerical and graphical 
formats collectively (39.40.4732): two of which used more than 
one graphical representation and reported the effect resulting from 
a combination of the graphical formats (4032).
Four studies incorporated both graphical and numerical 
formats into their interventions. Asimakopoulou et al. (40) 
presented 1.5 and 10-year absolute risk of developing CHD or 
stroke to patients with diabetes, using percentages in conjunction 
with bar graphs, pictograms of smiley faces and pie charts. 
Patients' perceived risk was grossly inflated compared to their 
actual risk. The graphical tools helped to correct these inflated risk 
perceptions of CHD risk (F,.9 2 - 73.01: p< 0.001), as well as 
inflated stroke risk (Ft.9, * 119.05; p < 0.001). Additionally, Grover 
et al. (39) presented patients with a risk profile comprising bar 
graphs to demonstrate the changes in patients' lipid levels over 
time. This was more successful in reducing cholesterol (OR -  1.26 
(95% G; 1.07-1.48. p value not reported) and meeting lipid targets 
(OR - 1.26 (95% Cl; 1.04-1.53, p value not reported) than usual 
care.
Man-Son-Hing et al. [47] found that when the risk of a stroke 
without antithrombotic medication was moderate and presented 
as a pictogram of natural frequencies, as opposed to risk categories, 
more realistic risk perceptions resulted (p < 0 .0 1 ) and therapy 
with extremes of effectiveness (e.g. warfarin or no therapy) was 
more likely to be chosen. Stovring et al. (52) presented 
comprehensive information about the effectiveness of a pharma­
ceutical drug, using a combination of four numerical formats and a 
pictogram showing numbers affected with and without treatment 
Initial decisions to accept treatment made when one numerical 
format was presented first did not change after subsequent 
presentation of the more comprehensive risk information. This 
finding is contradicted by Goodyear-Smith and colleagues (45) 
who found that acceptance of medication to reduce the risk of a 
heart attack increased by 11 % (from 75% to 8 6 %) when bar graphs 
(showing the number of people who do and do not have a heart 
attack when taking the medication, compared to those who do not 
taking it) were presented, as opposed to when the same 
information was expressed only numerically as natural frequen­
cies. However, it is not reported whether this was significant
Lastly, the effect of the presence or absence of graphical 
presentation was compared by French et al. (43). When the risk of 
having a cardiac event was accompanied with visual representa­
tion (e.g. bar graphs for the percentage format pictograms for the 
natural frequency format) significantly less disturbance and worry 
resulted, compared to those who did not receive visual repre­
sentations (Fun -  8.74: p < 0.01). However, greater feelings of 
reassurance were not reported, which would intuitively be 
expected, and perceptions and behavioural intentions remained 
unaffected.
To summarise, studies that have used graphical presentation 
in their interventions have shown that presenting risk both 
graphically and numerically can lead to more accurate risk 
perceptions, to favourable changes in risk factors and can help 
reduce negative emotions. However, whether treatment decisions 
are sensitive to numerical or graphical formats used in the 
presentation of medication effectiveness is not clear.
3.3.3. Presentation of comparative risk
Comparative or peer group risk can be used to demonstrate how 
an individual's risk compares to that of the average person of the
same age and sex. The effects of presenting comparative risk 
information were examined by four studies. Three were analogue 
(42,43,48). Two of these compared the presentation of both 
personal and comparative risk against presentation of personal risk 
only (42,43). One of these also examined the effect of presenting 
comparative risk higher or lower than personal risk (43). One study 
examined the effects of relative differences between personal and 
comparison risk (48). Assessment of actual risk was used in one 
study, which incorporated comparative risk into an intervention 
comprising numerical and graphical presentations (39).
Of the two studies that compared the presentation of personal 
and comparative risk against personal risk only. Fair et al. (42) 
found that risk perceptions and emotions were sensitive to the 
presence of comparative risk information. When messages about 
CHD contained information about both personal and comparative 
risk, respondents perceived their risk to be significantly higher 
(OR- 1.578 (95% G: 1.144-2.177), p <0.01), and reported more 
worry (p < 0 .0 1 ), more disturbance (p < 0 .0 1 ), and less reassurance 
(p < 0 .0 1 ), than presentation of personal risk information only. 
However, behaviour intentions did not differ significantly. The 
other study by French et al. (43) assessed respondents’ perceptions 
and emotions. Personal risk had more of an impact on reassurance 
(»72 -  0.08) than social comparison risk (r)2 m 0.06). This was also 
seen for disturbance and worry (r)2 -0.09 vs. t)2 -  0.05) and 
perceived risk (p2«0.07 vs. 172 -  0.03). This study also distin­
guished between the presentation of favourable and unfavourable 
comparative risk information, and compared this against not 
providing any comparative risk information. Those presented with 
favourable comparison information (e.g. average or below average 
risk) reported being significantly more reassured, less disturbed 
and worried and thought they were less likely to have a cardiac 
event than those who received unfavourable information (e.g. 
above average risk) (p < 0.05). However, unfavourable comparison 
information had no discernible impact on risk perceptions or 
emotions, relative to not providing any comparison information.
Mason et al (48) examined whether people attend mainly to 
information regarding personal risk or comparative risk. They 
presented hypothetical scenarios about the risk erf' a cardiac event 
Levels of personal and comparison risk varied in these scenarios. As 
the difference between personal risk and comparison risk 
increased (in which personal risk was higher than comparison 
risk), so did worry and disturbance. (F|.5 3O- 9 .1 0 , p<0.01, 
r)2 = 0.044). Furthermore, responses to the varying relative 
differences between personal risk and comparison risk correlated 
negatively with personal risk (F3 3 3 0  -  8.19. p < 0.01, n2p = 0.044). 
suggesting that at higher levels of personal risk, the role of 
comparison information becomes less.
The study by Grover et al. (39) showed how an individual's risk 
compares to the average person by using the concept of 
cardiovascular age equivalent This is calculated using the 
equivalent risk of a person who has no modifiable risk factors. 
In cases where an individual has modifiable risk factors, their risk 
will be higher than a person of the same age and sex without those 
factors; therefore their risk will be equivalent to someone older. 
When a risk profile was given to patients that presented 
comparative 8 -year cardiovascular risk as cardiovascular age 
equivalent and percentages, patients had greater cholesterol 
reductions (OR -  1.26 (95% G; 1.07-1.48, p value not reported) 
and were more likely to reach lipid targets (OR -  1.26 (95% G; 
1.04-1.53, p value not reported) over the 12-month follow-up, 
than those who did not receive their risk profile. In particular, an 
interaction effect was found where the higher the patient's risk 
(evidenced by increased cardiovascular age), the greater the 
impact of the risk profile (OR -  1.69 (95% G; 1.21-2.36), p < 0.05).
To summarise, using comparative risk together with personal 
risk effects risk perceptions and emotions, and can reduce risk
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factors. However, the impact of comparison risk depends on the 
level of personal risk; when personal risk is high, negative 
emotions are heightened and comparative risk is attended to less.
3.3.4. Framing of risk information
One analogue study investigated the impact of risk message 
framing (50]. Scott and Curbow (50) evaluated framing of messages 
regarding the probable benefits or costs of engaging in or not 
engaging in healthy behaviours relating to heart disease. These were 
presented as 'gain-framed' (e.g. benefits of engaging in healthy 
behaviours) or 'loss-framed' (e.g. costs of not engaging in healthy 
behaviours). Cain-framed messages led to a significant increase in 
self-efficacy to prevent heart disease as opposed to loss-framed 
messages (F,^ 9, -  8.21.p < 0.05, effect size -  0.02). Moreover, there 
was a significant interactive effect of message frame and parental 
history of high blood pressure for intention to check blood pressure 
(F- 5.13, p<0.05. effect size -  0.01). Intention was significantly 
increased only in those with a family history exposed to the loss­
framed message. Conversely, only the gain-framed message 
significantly increased intention in those without a family history.
3.3.5. Timeframe manipulations
The timeframe used when presenting cardiovascular risk 
information was manipulated in one study assessing actual risk 
(38) and four analogue studies (40,42,4430). Specific timeframes 
were not used in two studies, only present vs. future (38) and 
short-term vs. long-term (50). One study examined time horizons 
less than 10 years (40). Two studies (42.43) considered the 
presentation of risk over longer time horizons, greater than 10 
years.
Charison et al. (38) presented information about the reduction 
of cardiovascular morbidity risk achievable by modifying risk 
factors, using the ‘net present value’ approach (biologic age 
reduction one could achieve either in 3 months or 2 years, e.g. 
respondents told that changing behaviour would decrease their 
biological age) or the ‘future value' approach (risk reduction 
framed as the value of preventing future health problems, e.g. 
respondents told changing behaviour would increase lifespan). 
However, at 2-year follow-up no differences between the two 
groups were found in rates of death, stroke, myocardial infarction, 
angina or severe ischemia, stages of change or self-efficacy. Also, 
Scott and Curbow (501 framed information about the costs and 
benefits of engaging in or not engaging in healthy behaviours, in 
relation to heart disease, in the short or long-term. The timeframe 
of the messages did not have an effect on behavioural intentions, 
self-efficacy or perceived susceptibility. It is argued that this may 
have been due to the young sample used and the future-oriented 
nature of heart disease.
Asimakopoulou et al (40) presented the risk of developing CHD 
or stroke as a result of having diabetes in 1. 5 or 10 years, using 
percentages with graphical accompaniments. Originally inflated 
risk perceptions of CHD were successfully corrected with the help 
of the graphical tools (FtS2 ” 73.01; p < 0.001), as was inflated 
stroke risk (Fli9i -119.05; p< 0.001). However, those who 
received risk information in the 10-year timeframe were most 
resistant to correction and recalled a much higher risk at 6 week 
follow-up than they understood at the initial consultation 
( £ * .1 7 6  " 4.73; p < 0.001), possibly suggesting they did not under­
stand the concept of accrual of risk over time.
Frileux et al. (44) found that when individuals indicated their 
intention to adopt a specific behaviour for a number of scenarios 
that varied in the timeframe presented (either short 5 or 10 years, 
or long 15 or 20 years), shorter timeframes led to greater intention 
to change behaviour (Ft.ua “ 29.66; p < 0.001). In fact, the shorter 
the timeframe, the greater the intention to change behaviour 
(£3 .4 1 4 -  22933; p < 0.001 ). Furthermore, an interaction between
age and timeframe was found, where intention to adopt 
preventive behaviour was greater for older participants (age 
between 60 and 80) when shorter timeframes were used, and fc 
younger participants (aged between 20 and 30) when longc 
timeframes were used. Conversely, Fairet al. (42) found no effect c 
timeframe manipulation on perceptions, emotion or behaviour, 
intentions, when 10 or 30-year timeframes were used in message 
regarding CHD risk.
To summarise, patients remain insensitive to the framing of ri s 
information merely in the short-term or long-term. The presenta 
tion of specific timeframes does have an effect; shorter timeframe 
(less than 1 0  years) may lead to more accurate risk perceptions an 
increased intention to change behaviour, than 1 0 -year risk c 
longer, especially for older patients.
4. Discussion and conclusion
4.1. Discussion
This review demonstrates that compared to the intensive an 
ongoing investment in the calculation of cardiovascular ris 
estimates, there is a poverty of research on how to convey thes 
estimates in a meaningful way. so as to motivate people to modif 
their risk of developing heart disease. We had broad inclusio 
criteria, yet only found 15 studies. 11 of which were analogu 
studies and only 4 studies which dealt with the presentation c 
actual risk to patients. The methodological quality of studie 
varied, the majority had observational designs and were hetero 
geneous with respect to the conceptualisation, formats am 
framing of cardiovascular risk probabilities. Therefore, only 
few meaningful subgroups could be formulated (real or hypothe 
sised risk, type of cardiovascular risk manipulation, etc.).
The conclusions we draw from these few studies are tentativ 
and need further exploration. Nevertheless, we summarise th 
results from individual studies. Making patients aware of their ris 
can encourage risk reduction action to be taken, especially if this ris 
is high. Numerical presentation of risk as opposed to simple ris 
categories leads to more accurate risk perceptions and can influenc 
treatment derisions. Relative risk reduction format ‘encourage! 
acceptance of treatment the most and numbers needed to trea 
format encourages the least The presentation of absolute am 
comparative risk, both graphically and numerically, effects ris 
perceptions and emotions and can lead to reduction in patient ris 
factors. However, the impact of comparison risk depends on the I eve 
of personal risk; comparative risk is attended to less when persona 
risk is high. Lastly, shorter timeframes (less than 10 years) lead ti 
more accurate risk perceptions and increased intention to chang< 
behaviour, than timeframes longer than 1 0  years.
A strength of this review is that it comprised a comprehensiv 
systematic literature search that aimed for high recall. Stud; 
inclusion and data extraction were agreed and validated by at lea s 
two reviewers throughout the reviewing process. Weaknesse 
include possible selection bias from the exclusion of unpublished 
literature and non-English language studies; and the fact that dat. 
extraction was not independent, but involved a validatioi 
procedure (however, consensus between reviewers was verj 
high). Caution needs to be taken when interpreting this review' 
findings as it incorporated studies that used actual risk assessmen 
and analogue studies. Real patients* differ from participants ir 
hypothetical studies (12). Additionally, multiple types of CVD risl 
were included (such as those for primary CHD prevention 
secondary prevention, and stroke prevention in Atrial Fibrillation) 
Therefore, there may be an interaction of format effect by type o 
CVD risk, in which investigation is beyond die scope of this review
The principal findings of this review confirm previous researc! 
indicating that visual displays have desirable properties tha
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enhance understanding of risk (6); cardiovascular age equivalent 
formats are clear, memorable and considered an 'eye-opener* or 
‘wake-up call* (53); natural frequencies are the natural way people 
think about risk probabilities and are effective in correcting 
inappropriate risk perceptions [8.22.54]; and the relative risk 
format is more favourably evaluated than other formats (such as 
absolute risk or numbers needed to treat) [7.55].
Studies in this review provided inconclusive evidence of the 
effect of presenting patients with comparative risk information. 
They demonstrated that individuals attend to risk information 
based on the magnitude of personal risk and their risk in 
comparison to others. These appear to be independent and 
additive, as comparing individual risk with the 'average' may be 
less important when ones' personal risk is high; possibly because 
the salience of the personal risk overrides the comparative 
information in these circumstances (48). However, the exact 
nature of the effect on behavioural intentions, perceptions and 
emotion is arguable. This format is potentially important as it puts 
individualised risk into context and is a way demonstrating the risk 
attributable to non-modifiable risk factors, such as age. Previous 
studies have shown it to influence treatment decisions [56].
Furthermore, the cardiovascular age equivalent format should 
be an effective motivator in reducing risk [53], because in cases 
where an individual has multiple risk factors, their ‘heart age’ will 
be higher than their biological age. In this review, this format was 
assessed by one RCT [39]. An effect on the reduction of risk factors 
was found, especially when cardiovascular age was high; but this 
was only compared against not providing risk information to 
patients, not against alternative formats.
The inconsistency found in this review regarding the effect of 
longer timeframes (such as 15, 20 and 30 years), could be 
attributed to the fact that individuals are poorly attuned to how 
risk accumulates over time, are not good at forecasting the future, 
fail to take account of the timeframes used to represent risk and do 
not adjust their risk perceptions to account for the longer time 
spans [10.56-58].
The few studies that measured understanding did so by recall 
immediately after presentation, self reported confidence or 
perceived difficulty in understanding [40.43.S1.52]. A question 
has to be asked as to whether these methods really do measure a 
patient's understanding of their risk, or mere recall of information. 
If this is the case, is there a more suitable way to measure 
understanding? Furthermore, only a small number of studies in 
this review used graphical representations, these being mainly bar 
graphs and pictograms; and no study compared graphical formats 
with each other (only graphics used collectively with numeric 
presentation).
This review highlights the tension between providing patients 
with neutral and unbiased risk information whilst presenting risk 
in a way that encourages behaviour change and risk reduction. 
During analysis, a distinction between two types of studies 
emerged; studies that seemed to use risk communication to 
achieve risk reduction by modifying lifestyle or taking medication, 
and those that did not Two studies assessing real patients’ risk, 
communicated risk in order to explicitly 'persuade' and reduce 
risk. They measured changes in risk factors or overall reduction of 
risk 138,39). Three analogue studies had a persuasive motive as 
well, as they measured intention to change behaviour [42.44.50]. 
Seven studies (six analogue [45-47.49.51,52] and one real [41]) 
also persuaded to a lesser extent and measured the acceptance of 
treatment to reduce cardiovascular risk. This raises debate as to 
how legitimate it is to persuade people to make decisions 
regarding their health, such as changing their behaviour or taking 
medication. In contrast three studies (one real [40] and two 
analogue [43,48]) were concerned only with the emotional and 
cognitive aspects of the risk communication, such as what people
thought about the risk presentation not how they acted upon it. 
The difference in outcomes measured by risk communication 
studies has been highlighted previously [59].
5. Conclusion
This review demonstrates a lack of well-designed studies in 
cardiovascular risk communication. This has been due to a 
combination of diverse methodological quality and contradictory 
results. It is likely that the heterogeneity of study characteristics, 
such as the design, sample and type of cardiovascular risk 
presented have contributed to this. A wide range of outcomes 
have been measured and there has been little consistency in risk 
presentation formats used, therefore, it is difficult to draw firm 
conclusions. Two different aims were identified in the communi­
cation of cardiovascular risk; first, risk communication to influence 
patient awareness and correct inappropriate risk perception to 
facilitate the decision to reduce risk; and second, the impact of 
different risk reduction strategies to facilitate the decision on how 
to reduce the risk.
5.1. Practice implications
There is a need for more research into the communication of 
actual risk to real patients. RCTs comparing different risk 
presentation formats are needed to examine whether peoples' 
intentions, perceptions and understanding of risk vary by graphical 
format Projecting risk over longer time horizons to show increase 
in risk as the patient ages was attempted in the studies included in 
this review, but failed to have any desirable impact. It needs to be 
accepted that patients have difficulty in forecasting their future 
risk, and more meaningful projections should be used instead of 
presenting risk in an abstract 10-year horizon. This could be in the 
form of more salient outcomes and forecasts of loss in the future, 
such as not being able to achieve important milestones, birth of 
grandchildren or similar.
Determining how best to present cardiovascular risk informa­
tion to patients strongly depends on the intended aims of the 
communication. Is the purpose to raise awareness and improve 
understanding, or to persuade those at risk to adopt new 
behaviours to reduce risk? Being dear about the communication 
aims would help clarify research in this complex area.
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Appendix 16. Search strategies for electronic databases.
Medline search strategy
Database: M EDLINE (1 9 9 6 - February W e e k  3 20 08 )
Search Strategy:
1 . *  C a r d i o v a s c u l a r  D i s e a s e s /
2 .  *  H e a r t  d i s e a s e s /
3 .  *  C o r o n a r y  D i s e a s e /
4 .  C o r o n a r y  h e a r t  d i s e a s e $  .m p
5. H I1-4
6 . *  R is k /
7 .  *  R is k  f a c t o r s /
8 . r e la t iv e  r is k  .m p
9 .  a b s o l u t e  r is k  .m p
10. risk adj assess$ .mp
11. risk adj predicts .mp
12. risk adj estimat$ .mp
13. risk adj perception .mp
14. risk adj analys$ .mp
15. risk adj calculat$ .mp
16. risk adj apprais$ .mp
17. risk adj approximat$ .mp
18. risk adj evaluation .mp
19. risk adj format .mp
20. risk adj score .mp
21. risk adj information .mp
22. risk adj display .mp
23. risk adj presentation .mp
24. risk adj Communication .mp
25. HI 6- 24
26.5 and 25
27. Limit to English language and human studies
Embase search strategy
Database: EMBASE (1 9 9 6 - 2 0 0 8  W e e k  09 )
Search S trategy:
1 . *  C a r d i o v a s c u l a r  D i s e a s e /
2 .  *  H e a r t  D i s e a s e /
3 .  *  H E A R T  I N F A R C T I O N  P R E V E N T I O N /
4. N/1-3
5 .  *  R is k  A s s e s s m e n t /
6 . *  R I S K  F A C T O R /
7 .  r e la t i v e  r is k  .m p
8 . a b s o l u t e  r is k  .m p
9. risk adj assess$ .mp
10. risk adj predicts .mp
11. risk adj estimat$ .mp
12. risk adj perception .mp
13. risk adj analys$ .mp
14. risk adj calculat$ .mp
15. risk adj apprais$ .mp
16. risk adj approximat$ .mp
17. risk adj evaluation .mp
18. risk adj format .mp
19. risk adj score .mp
20. risk adj information .mp
21. risk adj display .mp
22. risk adj presentation .mp
23. risk adj Communication .mp
24. N15-23
25. 4 and 24
26.* CARDIOVASCULAR RISK/
27.* CORONARY RISK/
28. 26 or 27
29. presentation .mp
30. communication .mp
31. 29 or 30
32. 28 and 31
33. 25 or 32
34. Limit to English language and human studies
CINAHL search strategy
Database: Cinahl (1 9 8 2 -F e b ru a ry  W e e k  3 2 0 0 8 )  
Search Strategy:
1. CARDIOVASCULAR DISEASES/
2. Coronary Disease/
3. *Heart Diseases/
4. Coronary heart disease$ .mp
5. /N  1-4
6. *RISK FACTORS/
7. *RELATIVE RISK/
8. *RISK ASSESSMENT/
9. absolute risk .mp
10. risk adj assess$ .mp
11. risk adj predict$ .mp
12. risk adj estimat$ .mp
13. risk adj perception .mp
14. risk adj analys$ .mp
15. risk adj calculat$ .mp
16. risk adj apprais$ .mp
17. risk adj approximat$ .mp
18. risk adj evaluation .mp
19. risk adj format .mp
20. risk adj score .mp
21. risk adj information .mp
22. risk adj display .mp
23. risk adj presentation .mp
24. risk adj Communication .mp
25. N/ 6-24
26.5 and 25
27. CARDIOVASCULAR RISK FACTORS/
28. Presentation .mp
29. Communication .mp 
30.28 or 29
31.27 and 30 
32.26 or 31
33. Limit to English Language
PsyclNFO search strategy
D atabase: PsyclNFO (February W e e k  4  2 0 0 8 )
Search Strategy:
1. Exp Heart Disorders/
2. Exp Cardiovascular Disorders/
3. Exp Heart/
4. Cardiovascular disease$ .mp
5. Coronary heart disease$ .mp
6. Coronary disease$ .mp
7. Heart disease$ .mp
8. /N 1-7
9. Exp Risk Factors/
10. Exp Risk Assessment/
11. Exp Risk Perception/
12. relative risk .mp
13. absolute risk .mp
14. risk adj assess$ .mp
15. risk adj predicts .mp
16. risk adj estimat$ .mp
17. risk adj perception .mp
18. risk adj analys$ .mp
19. risk adj calculat$ .mp
20. risk adj apprais$ .mp
21. risk adj approximat$ .mp
22. risk adj evaluation .mp
23. risk adj format .mp
24. risk adj score .mp
25. risk adj information .mp
26. risk adj display .mp
27. risk adj presentation .mp
28. risk adj Communication .mp
29. HI 9 -28 
30.8 and 29
31. Limit to English language and human studies
A SS IA  search strategy
r  r
AND OR 
Combine
Search History
r  #23
Search Q uery  #23  ((risk co m m unication) or (risk presentation) or (risk display) or 
(risk in fo rm atio n ) o r (risk score) or (risk fo rm at) or (risk evaluation ) or (risk 
a p p ro x im a t*) o r (risk ap p ra is *) o r (risk ca lcu la t*) or (risk analys*) or (risk 
perception ) or (risk e s tim a t* ) o r (risk p re d ic t*) or (risk factors) or (risk 
assessment) or (risk)) and ((coronary h eart disease) or (h eart disease) or 
(cardiovascular disease)) (Coov Q uerv)
1023 results found in M u ltip le  Databases
1509 results found in COS Scholar Universe: Social Science
2 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  Current
Limited to: Published W orks Only; English Only
F  #22
Search Q uery  #22 (risk com m unication) or (risk p resen tatio n) or (risk display) or 
(risk in fo rm atio n ) or (risk score) or (risk fo rm a t) o r (risk eva luation ) or (risk 
a p p ro x im a t*) o r (risk ap p ra is *) or (risk ca lcu la t*) or (risk an alys*) or (risk 
p erception ) or (risk e s tim a t* ) o r (risk p re d ic t*) or (risk factors) or (risk 
assessment) or (risk) (Coov Querv)
28051 results found in M u ltip le  Databases
15359 results found in COS Scholar Universe: Social Science
42 0  results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  Current
Limited to: Published W orks Only; English Only
r~
r  #21
Search Q uerv  #21  risk com m unication  (Coov Querv)
91 results found in M u ltip le  Databases
3648 results found in COS Scholar Universe: Social Science
1 result found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
. . . .  . . .  
r  #20
Search O uerv  #2 0  risk presentation  (Coov Querv)
2 results found in M u ltip le  Databases
5425 results found in COS Scholar Universe: Social Science
0 results found in W eb  Resources Related to  the Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r
#19
Search O uerv  #19  risk displav (Codv Querv)
1 result found in M u ltip le  Databases
1262 results found in COS Scholar Universe: Social Science
0 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r  #18
Search Q uerv  #18  risk in fo rm ation  (Codv Querv)
69 results found in M u ltip le  Databases
10042 results found in COS Scholar Universe: Social Science
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2 results found in W eb Resources Related to  the Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
I '
p
1 #17
Search Q uerv #17 risk score (Codv Querv)
40  results found in M u ltip le  Databases
30 30  results found in COS Scholar Universe: Social Science
0 results found in W eb Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r  #16
Search Q uerv #16 risk fo rm a t (Codv Querv)
1 result found in M ultip le  Databases
1493 results found in COS Scholar Universe: Social Science
0 results found in W eb  Resources Related to  the Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r  #15
Search Q uerv #15 risk eva lu ation  (Codv Querv)
13 results found in M u ltip le  Databases
6376  results found in COS Scholar Universe: Social Science
1 result found in W eb  Resources Related to  the Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
P  #14
Search Q uerv #14  risk ao D ro x im at* (Codv Querv)
1 result found in M u ltip le  Databases
3167 results found in COS Scholar Universe: Social Science
0 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r  #13
Search Q uerv #13 risk ao o ra is * (Codv Querv)
72 results found in M u ltip le  Databases
1294 results found in COS Scholar Universe: Social Science
0 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r  #12
Search Q uerv #12 risk ca lcu la t* (Codv Querv)
9 results found in M u ltip le  Databases
2285 results found in COS Scholar Universe: Social Science
0 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r  #11
Search Q uerv #11  risk analvs* (Codv Querv)
4 0  results found in M u ltip le  Databases
11868 results found in COS Scholar Universe: Social Science
1 result found in W eb  Resources Related to  the Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r  #1 0
Search Q uerv  #10  risk percep tion  (Codv Querv)
45 9  results found in M u ltip le  Databases
44 8 0  results found in COS Scholar Universe: Social Science
1 result found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r  #9
Search Q uerv  #9 risk e s tim a t*  (Codv Q uerv)
77 results found in M u ltip le  Databases
5784  results found in COS Scholar Universe: Social Science
0 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Lim ited to: Published W orks Only; English Only
00
L
Search Q uerv  #8  risk p red ic t* (Codv Querv)
72 results found in M u ltip le  Databases
73 78  results found in COS Scholar Universe: Social Science
0  results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
D ate Range: Earliest to  2008
Lim ited to: Published W orks Only; English Only
r  #7
Search Q uerv  #7 risk factors (Codv Querv)
69 26  results found in M u ltip le  Databases
9162  results found in COS Scholar Universe: Social Science
19 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
D ate Range: Earliest to  2008
Lim ited to: Published W orks Only; English Only,
F  #6
Search Q uerv  #6  risk assessment (Codv Querv)
1645 results found in M u ltip le  Databases
6963 results found in COS Scholar Universe: Social Science
96  results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Lim ited to: Published W orks Only; English Only
"  
r  #5
Search Q uerv  #5 risk (Codv Querv)
28051  results found in M u ltip le  Databases
15359 results found in COS Scholar Universe: Social Science
4 2 0  results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Lim ited to: Published W orks Only; English Only
r  #4
Search Q uery  #4  (coronary h eart disease) or (h eart disease) or (cardiovascular 
disease) (Codv Q uerv)
2108  results found in M ultip le  Databases
2101  results found in COS Scholar Universe: Social Science
17 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  Current
Limited to: Published W orks Only; English Only
«
r  #3
Search O uerv  #3 coronarv h eart disease (Codv Querv)
801  results found in M u ltip le  Databases
4 8 9  results found in COS Scholar Universe: Social Science
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4 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
'
r  #2
Search Q uerv ft2 h eart disease (Codv Querv)
1524 results found in M u ltip le  Databases
1636 results found in COS Scholar Universe: Social Science
14 results found in W eb  Resources Related to th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
r  #1
Search Q uerv #1 cardiovascular disease (Codv Querv)
700 results found in M u ltip le  Databases
1181 results found in COS Scholar Universe: Social Science
3 results found in W eb  Resources Related to  th e  Social Sciences/Hum anities
Date Range: Earliest to  2008
Limited to: Published W orks Only; English Only
Science C itation  Index Expanded search strategy
Search History
Set Results
# 9 1,288
# 8 16.540
# 7 9 ,409
# 6 4 ,5 90
# 5 2 ,054
# 4 764
# 3 > 100 .000
# 2 >100 .000
# 1 77 .591
Save H istory /  C rea te  A le rt O pe
#8 AND #3
Databases=SCI-EXPANDED Tim espan=AII Years 
#7 OR #6  OR #5 OR #4
Databases=SCI-EXPANDED Tim espan=AII Years 
TS=risk presentation AND Language=(English) 
Databases=SCI-EXPANDED Tim espan=AII Years 
TS= risk com m unication AND Language=(English) 
Databases=SCI-EXPANDED Tim espan=AII Years 
TS=risk display AND Language=(English) 
Databases=SCI-EXPANDED Tim espan=AII Years 
TS=risk fo rm at AND Language=(English) 
Databases=SCI-EXPANDED Tim espan=AII Years 
#2  OR #1
Databases=SCI-EXPANDED Tim espan=AII Years 
TS=heart disease AND Language=(English) 
Databases=SCI-EXPANDED Tim espan=AII Years 
TS=cardiovascular disease AND Language=(English) 
Databases=SCI-EXPANDED Tim espan=AII Years
Appendix 17. Data Extraction Template used in Systematic Review.
Study ID:
Section 1:
1.1 Author(s)
1.2 Title
1.3 Y ear
1.4 Source
Methods
Section 2: Details of study
2:1 Aim of intervention
2:2 Tim e when study took place (not year of publication)
2:3 Study design
2:4 Methods of recruitment of participants
2:5 Inclusion/exclusion criteria for participation in study
2:6 Informed consent obtained? Y es/N o /U nclear
2:7 Ethical approval Y es/N o /U nclear
2:8 Funding and source
2:9 Incentive? Y es/N o /U nclear
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Section 3 Assessment of study quality
3:1 Randomisation Y es/N o /U nclear
3:2 Method of generating randomisation schedule for 
RCTs
3:3 Method of concealm ent of allocation
3:4  Blinding
•  Participants
•  Providers
•  Outcom e as se ss o rs )
Y es /N o /U nc lear
Y es /N o /U nc lear
Y es /N o /U nc lear
3:5 Baseline comparability of intervention and control 
groups
Y es /N o /U nc lear
3:6 Statistical methods and their appropriateness (if 
relevant)
3:7 Power calculation Y es /N o /U n c lear
3:8 Patient involvement
•  In design of study and/or intervention
•  In delivery of intervention
•  In evaluation of intervention
•  In interpretation of study findings
Y es /N o /U n c lear
Y es /N o /U n c lear
Y es /N o /U nc lear
Y es /N o /U nc lear
3:9 Advantages of study
3:10 Limitations of study
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Section 4: Participants
4:1 Description
4:2 Geographic location
4:3 Setting
Num ber
4:4 Eligible
4:5 Excluded
4:6 Refused to take part
4:7 Randomised to intervention
4:8 Randomised to control
4:9 Excluded post randomisation
4:10 Withdrawn
4:11 Lost to follow-up
4:12 Died
4:13 Included in analysis
4:14 Included for each outcome
4:15 Age: range, mean
4:16 G ender
4:17 Ethnicity
4:18 Health status/problem/diagnosis
4:19 O ther health problem (s)
4:20 Stage of problem/illness
4:21 C V D  related treatm ent received/receiving
4:22 O ther social/demographic details
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Section 5: Information on the nature of the CVS risk and formats used in the study
In te rve n tio n  A In terven tio n  B control
5:1 C h arac teris tics  o f in te rve n tio n
(e.g. what the risk communication is 
embedded in/ general format of 
intervention)
5:2 Type o f C V D  risk p resen ted  (e.g. 
CHD event/CVD death)
5:3 M ode o f risk p o rtraya l used (e.g. 
percentages/odds ratio/ natural 
frequencies)
5:4 Form at o f risk p resen ta tio n
(Specify)
•  Narrative/verbal (e.g. categories)
•  Numerical
•  Graphical (e.g. bar graph, 
pictogram, pie chart)
•  Metaphorical
5:5 M ode o f d e liv ery  (e.g. table/score 
sheet/ calculator)
5:6 M edium  (e.g. Paper/computer/face 
to face consultation)
5:7 In terac tive?
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Section 6: Outcomes
6:1 Principal outcome measures
6:2 Secondary outcome measures
6:3 Validated m easurem ent tools for each outcome
6:4 Methods of assessing outcom e m easures
6:5 Methods of follow-up for non-respondents
Timing of outcome assessment
•  6:6 Frequency
• 6:7 Length of follow-up
6:8 Adverse events
Section 7: Results
8. Study’s 
conclusion
Section 9: Miscellaneous
9:1 Changes in trial protocol Y es /N o /U nc lear
9:2 W as study translated from a language other than 
English?
Y es /N o /U nc lear
9:3 W as the study a duplicate publication? Y es /N o /U nc lear
9:4 Contact with author Yes/No
Section 10: Notes:
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Appendix 18. Downs and Black Checklist for measuring study quality.
Reporting Yes No
1 Is the hypothesis/aim/objective of the study clearly described? 1 0
2 Are the main outcomes to be measured clearly described in the 1 0
Introduction or Methods section?
If the main outcomes are first mentioned in the Results section, the question 
should be answered no.
3 Are the characteristics of the patients included in the study clearly 1 0
described?
In cohort studies and trials, inclusion and/or exclusion criteria should be 
given. In case-control studies, a case-definition and the source for controls 
should be given.
4 Are the interventions of interest clearly described? 1 0
Treatments and placebo (where relevant) that are to be compared should be 
clearly described.
Yes Partially
5 Are the distributions of principal confounders in each group of 2 1
subjects to be compared clearly described?
A list of principal confounders is provided.
Yes No
6 Are the main findings of the study clearly described? 1 0
Simple outcome data (including denominators and numerators) should be 
reported for all major findings so that the reader can check the major 
analyses and conclusions. (This question does not cover statistical tests 
which are considered below).
7 Does the study provide estimates of the random variability in the data 1 0
for the main outcomes?
In non normally distributed data the inter-quartile range of results should be 
reported. In normally distributed data the standard error, standard deviation 
or confidence intervals should be reported. If the distribution of the data is 
not described, it must be assumed that the estimates used were appropriate 
and the question should be answered yes.
8 Have all important adverse events that may be a consequence of the 1 0
intervention been reported?
This should be answered yes if the study demonstrates that there was a 
comprehensive attempt to measure adverse events. (A list of possible 
adverse events is provided).
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9 Have the characteristics of patients lost to follow-up been described? 1 0
This should be answered yes where there were no losses to follow-up or 
where losses to follow-up were so small that findings would be unaffected 
by their inclusion. This should be answered no where a study does not 
report the number of patients lost to follow-up.
10 Have actual p robab ility  values been reported(e.g . 0.035 ra ther than 1 0
<0.05) fo r the m ain  outcom es except w here the probab ility  value is
less than 0.001?
E xterna l valid ity
All the following criteria attempt to address the representativeness of the findings of the study and 
whether they may be generalised to the population from which the study subjects were derived.
Yes No Unable to 
determ ine
11 Were the subjects asked  to partic ipate  in the s tudy  representative o f  1 0  0
the entire population from  w hich they w ere recru ited?
The study must identify the source population for patients and describe how 
the patients were selected. Patients would be representative if they 
comprised the entire source population, an unselected sample of 
consecutive patients, or a random sample. Random sampling is only 
feasible where a list of all members of the relevant population exists. Where 
a study does not report the proportion of the source population from which 
the patients are derived, the question should be answered as unable to 
determine.
12 W ere those subjects w ho w ere p repared  to  partic ipate  representative  1 0  0
o f the entire population from  w hich they w ere recru ited?
The proportion of those asked who agreed should be stated. Validation that 
the sample was representative would include demonstrating that the 
distribution of the main confounding factors was the same in the study 
sample and the source population.
13 W ere the staff, p laces, an d  facilities  w here the patients  w ere treated, 1 0  0
representative o f  the treatm ent the m ajo rity  o f  patients receive?
For the question to be answered yes the study should demonstrate that the 
intervention was representative of that in use in the source population. The 
question should be answered no if, for example, the intervention was 
undertaken in a specialist centre unrepresentative of the hospitals most of 
the source population would attend.
In ternal valid ity  - bias
14 Was an attem pt m ade to b lin d  study subjects to the in tervention they  1 0  0
have received?
For studies where the patients would have no way of knowing which 
intervention they received, this should be answered yes.
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15 Was an attempt made to blind those measuring the main outcomes of 1 0  0
the intervention?
16 If any of the results of the study were based on “data dredging", was 1 0  0
this made clear?
Any analyses that had not been planned at the outset of the study should be 
clearly indicated. If no retrospective unplanned subgroup analyses were 
reported, then answer yes.
17 In trials and cohort studies, do the analyses adjust for different lengths 1 0  0
of follow-up of patients, or in case-control studies, is the time period
between the intervention and outcome the same for cases and 
controls?
Where follow-up was the same for all study patients the answer should yes.
If different lengths of follow-up were adjusted for by, for example, survival 
analysis the answer should be yes. Studies where differences in follow-up 
are ignored should be answered no.
18 Were the statistical tests used to assess the main outcomes 1 0  0
appropriate?
The statistical techniques used must be appropriate to the data. For 
example nonparametric methods should be used for small sample sizes.
Where little statistical analysis has been undertaken but where there is no 
evidence of bias, the question should be answered yes. If the distribution of 
the data (normal or not) is not described it must be assumed that the 
estimates used were appropriate and the question should be answered yes.
19 Was compliance with the intervention/s reliable? 1 0  0
Where there was non compliance with the allocated treatment or where
there was contamination of one group, the question should be answered no.
For studies where the effect of any misclassification was likely to bias any 
association to the null, the question should be answered yes.
20 Were the main outcome measures used accurate (valid and reliable)? 1 0  0
For studies where the outcome measures are clearly described, the 
question should be answered yes. For studies which refer to other work or 
that demonstrates the outcome measures are accurate, the question should 
be answered as yes.
Internal validity - confounding (selection bias)
21 Were the patients in different intervention groups (trials and cohort 1 0
studies) or were the cases and controls (case-control studies)
recruited from the same population?
For example, patients for all comparison groups should be selected from the 
same hospital. The question should be answered unable to determine for 
cohort and case control studies where there is no information concerning 
the source of patients included in the study.
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22 Were s tudy subjects  in d ifferent in tervention groups (trials and  cohort 1 0 0
studies) o r  w ere the cases an d  contro ls (case-contro l studies) 
recru ited o ver the sam e p e rio d  o f  tim e?
For a study which does not specify the time period over which patients were 
recruited, the question should be answered as unable to determine.
23 Were study subjects  random ised  to in tervention groups?  1 0 0
Studies which state that subjects were randomised should be answered yes 
except where method of randomisation would not ensure random allocation.
For example alternate allocation would score no because it is predictable.
24 Was the random ised  in tervention assignm ent concealed  from  both  1 0 0
patients and  health  care s ta ff un til recru itm ent w as com plete and
irrevocable?
All non-randomised studies should be answered no. If assignment was 
concealed from patients but not from staff, it should be answered no.
25 Was there adequate ad justm ent fo r confounding  in the analyses from  1 0 0
which the m ain findings w ere draw n?
This question should be answered no for trials if: the main conclusions of 
the study were based on analyses of treatment rather than intention to treat; 
the distribution of known confounders in the different treatment 
groups was not described; or the distribution of known confounders differed 
between the treatment groups but was not taken into account in the 
analyses. In nonrandomised studies if the effect of the main confounders 
was not investigated or confounding was demonstrated but no adjustment 
was made in the final analyses the question should be answered as no.
26 W ere losses o f  patients  to fo llow -up taken into account?  1 0 0
If the numbers of patients lost to follow-up are not reported, the question 
should be answered as unable to determine. If the proportion lost to follow- 
up was too small to affect the main findings, the question should be 
answered yes.
Pow er
27 D id  the study have suffic ien t p o w er to detect a c lin ically  im portan t S ize o f sm allest
effect where the probab ility  value fo r a d ifference being  due to chance  intervention group  
is  less than 5% ?
Sample sizes have been calculated to detect a difference of x% and y%.
A. <n1 = 0
B. n1-n2 = 1
C. n3-n4 = 2
D. n5-n6 = 3
E. n7-n8 = 4
F. n8+ = 5
Taken from: Downs S, Black N. The feasibility of creating a checklist for the assessment of the 
methodological quality both of randomised and non-randomised studies of health care interventions. 
J Epidemiol Community Health 1998; 52 pp.377-84
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Appendix 19. Scores of included studies on the Downs and Black Checklist for measuring study quality.
Checklist 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 TOTAL
no.
Actual risk assessment In patients
Asimakopoul 
ou et al 2008
Y
1
Y
1
Y
1
Y
1
P
1
Y
1
N
0
N
0
N
0
N
0
N
0
N
0
Charlson et Y Y Y Y Y Y Y Y Y N Y N
al 2008 1 1 1 1 2 1 1 1 1 0 1 0
Y Y Y Y Y Y Y Y Y N Y Ytrover zuu/ 1 1 1 1 2 1 1 1 1 0 1 1
Straus 2002 Y Y Y Y N Y Y N N N N N
1 1 1 1 0 1 1 0 0 0 0 0
Analogue studies
Fair et al Y Y Y Y P Y Y N N Y Y Y
2008 1 1 1 1 1 1 1 0 0 1 1 1
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The effect of different cardiovascular risk 
presentation formats on intentions, understanding 
and emotional affect: a randomised controlled 
trial using a web-based risk formatter (protocol)
Cherry-Ann Waldron1*, John Gallacher1, Trudy van der Weijden2, Robert Newcombe1, Glyn Elwyn1
Abstract
Background: The future risk of heart disease can be predicted with increasing precision. However, more research 
is needed into how this risk is conveyed and presented. The aim of this study is to compare the effects of 
presenting cardiovascular risk in different formats on individuals' intention to change behaviour to reduce risk, 
understanding of risk information and emotional affect.
Methods/design: A randomised controlled trial comprising four arms, with a between subjects design will be 
performed. There will be two intervention groups and two control groups. The first control comprises a pre­
intervention questionnaire and presents risk in a bar graph format The second control presents risk in a bar graph 
format without pre-intervention questionnaire. These two control groups are to account for the potential 
Hawthorne effect of thinking about cardiovascular risk before viewing actual risk. The two intervention groups 
comprise presenting risk in either a pictogram or metonym format (image depicting seriousness of having a 
myocardial infarction). 800 individuals' aged between 45 and 64 years, who have not been previously diagnosed 
with heart disease and have access to a computer with internet, will be given a link to a website comprising a risk 
calculator and electronic questionnaires. 10-year risk of having a coronary heart disease event will be assessed and 
presented in one of the three formats. A post-intervention questionnaire will be completed after viewing the risk 
format. Main outcome measures are 0) intention to change behaviour, (ii) understanding of risk information, (iii) 
emotional affect and (iv) worry about future heart disease. Secondary outcomes are the sub-components of the 
theory of planned behaviour: attitudes, perceived behavioural control and subjective norms.
Discussion: Having reviewed the literature, we are not aware of any other studies which have used the 
assessment of actual risk, in a trial to compare different graphical cardiovascular risk presentation formats. This trial 
will provide data about which graphical cardiovascular risk presentation format is most effective in encouraging 
behaviour change to reduce cardiovascular risk.
Trial registration: Current Controlled Trials ISRCTN91319318
Background
The ride of heart disease can be predicted with increas­
ing with precision, with the development of algorithms 
such as Framingham, SCORE and QR1SK2 [1-3], Less is 
known about how to portray and communicate cardio­
vascular risk in ways that motivate people to modify
* Correspondence: WaldronCecardiff.ac.uk
’Department of Primary Care and Pubte Health. School of Medicine. Cardiff 
University. Cardiff, UK
B M U m I  Central
their lifestyle to reduce this risk. However, recent 
research on the effects of presenting coronary risk infor­
mation found that the presentation of global coronary 
heart disease (CHD) risk estimates can improve the 
accuracy of risk perceptions and increase intention to 
initiate prevention strategies [4]. A systematic review on 
the effects of different interventions used to communi­
cate cardiovascular risk [5], found that studies compar­
ing interventions for cardiovascular risk presentation
O 2010 Waldron et al. licensee BioMed Central Ltd This is an Open Access article distributed under the terms of the Creative 
Commons Attribution License (http//creativecommons.org4icenses/by/2.0). whKh permits unrestricted use. distribution, ana 
reproduction m any medium, provided the original work is properly cited
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have been heterogeneous in design, and that many have 
been of low methodological quality. Very few studies 
assessed patients' actual risk. The majority were analo­
gue studies where individuals were asked to imagine a 
hypothetical risk. There was no consistency in which 
presentation formats were used (percentages and natural 
frequencies were the most commonly assessed), and 
only a small number of studies used graphical represen­
tations (mainly bar graphs and pictograms). A wide 
range of outcome measures were assessed, including 
changes in risk and risk factors, intention to change 
behaviour and acceptance rates of treatment The lack 
of coherent research, and need for methodologically 
sound trials provides the basis for this proposed trial. 
The purpose of this trial is to assess cardiovascular risk 
communication strategies and their impact on preventa­
tive behavioural intentions.
At least 80 percent of heart disease, stroke and type 2 
diabetes are thought to be attributed to the modifiable 
risk factors of poor diet, lack of physical activity and 
tobacco use [6]. Therefore, lifestyle and behaviour 
change is important in order to reduce the impact of 
these factors and decrease the incidence rate of heart 
disease in the population. Informing patients of their 
future risk is the first step in helping them make deci­
sions about reducing their risk. However, the way this 
risk information is formatted and framed can influence 
understanding, perceptions and behaviours [7-10]. Diffi­
culties in communicating cardiovascular risk arise due 
to the interaction of many variables. Most research has 
focused on epidemiological precision rather than on 
how to motivate behaviour change. It has also over­
looked the major contribution to risk arising from age 
(an unmodifiable risk variable) and the difficulty people 
have in considering risk over long time horizons, such 
as 10 years spans [11].
Although previous research has compared different 
graphical risk presentation formats relating to conditions 
such as diabetes and hereditary breast cancer [12-15]; 
studies have yet to compare graphical cardiovascular 
risk presentation formats with each other, especially 
when assessing and presenting patients' actual risk [5].
There are numerous, commonly used theoretical 
approaches to health behaviour and behaviour change 
[16-19]. However, of particular interest is the Theory of 
Planned Behaviour (TPB) [20]. This theory postulates 
that behaviour is determined by a small number of fac­
tors, namely attitudes, subjective norms and perceived 
behavioural control It has empirical support for predict­
ing a wide range of behaviours [21,22]. It predicts inten­
tion, which is generally regarded as a strong predictor of 
behaviour, as people tend to engage in behaviours that 
they plan to perform [23]. In instances where it is not
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feasible to measure actual behaviours, intention can be 
an adequate proxy.
Models are unable to account for every factor that 
influences behaviour. Most health behaviour theories fail 
to consider emotion or affect in the form of ‘feelings’ as 
opposed to ‘affective judgements’ [24]. Emotions are 
important when considering behaviour relating to the 
reduction of cardiovascular risk, as they have been 
shown to influence perceptions of risk [25,26] which in 
turn, can affect health-related behaviour [27]. In our sys­
tematic review on cardiovascular risk communication 
[5], emotional responses to cardiovascular risk were 
only addressed in analogue studies requiring individuals 
to imagine a hypothetical risk profile. There is currently 
little information on the impact of emotions when peo­
ple are asked to consider their actual cardiovascular risk.
’Worry’ is extremely relevant when thinking about 
one’s future risk of heart disease. It has been associated 
with risk perception and is referred to as cognition 
‘coloured by affect’ [28,29]. Some suggest that worry 
contains an appraisal of risk elements (such as likeli­
hood and loss) [30] and is not necessarily maladaptive. 
Specifically, previous research has found that worry 
positively predicts behavioural intentions [31]. When at 
high levels, worry can lead to the uptake of screening 
behaviour [32] and has found to be the strongest predic­
tor of contemplation to quit smoking [33]. However, 
evidence has also been found for an inverted-U or curvi­
linear relationship between worry and consequent beha­
viour [34]. Too much worry can lead to the activation 
of defensive mechanisms, where incoming information 
is ignored or distorted [35]. When communicating car­
diovascular risk, we do not know how much worry is 
beneficial and would lead to increasing an individual’s 
motivation to reduce risk versus denial. At what level 
does worry induce a positive intention to reduce risk, 
and is there an optimum level before the risk communi­
cation process becomes inhibitory?
Patients’ understanding of their own cardiovascular 
risk is generally poor to the point of being non-existent. 
In addition, there is evidence to show that the data pre­
sented in cardiovascular risk prediction tools is often 
misunderstood [26,36]. This can inhibit people from 
making informed decisions regarding their health and 
behaviour. There is as yet no consensus as to which for­
mat is most effective in terms of facilitating patient 
understanding of their risk information [37]; and also, 
what the most appropriate way to measure understand­
ing actually is. It is argued that current attempts used in 
the communication of cardiovascular risk, such as recall, 
self-reported confidence in understanding and perceived 
difficulty in understanding are not suitable methods; as 
repetition and personal judgements do not indicate that
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individuals' have derived the correct meaning and pos­
sess a true understanding [5].
A prerequisite of understanding health related risk 
information is adequate numeracy and literacy skills. 
These are poor in many adults, leading to difficulty with 
simple decimal places and ratio concepts (including 
fractions, proportions and probabilities) [38]. It has been 
documented that smokers with lower literacy skills, are 
less likely to understand their risk of heart disease and 
stroke [39]. This may be because interpreting risk infor­
mation involves a hierarchy of skills ranging from calcu­
lation, inferences and interpreting tables and charts, 
which is problematic for those with lower levels of 
numeracy [40]. Therefore, an important question is: can 
understanding of risk information be improved? Are 
there alternative ways of presenting cardiovascular risk 
to individuals' that are not numerically-based, precise 
estimates, but more qualitative, gist representations? 
These are arguably what are most required, as they are 
used when ‘interpreting’ the given risk information [41].
One contender for representing gist information is the 
concept of a metonym. This is a type of metaphor and 
involves part and whole relations and associations. It is 
a word for a part of something, used to refer to the 
whole entity; or the whole is referred to in terms of 
something associated with it [42]. An example would be 
representing heart disease by using the concept of a 
myocardial infarction. Metonyms are important to 
everyday life as their concepts structure thoughts, atti­
tudes and actions, as well as language [43]. Using a 
metonym to present future risk of a disease could be a 
way of improving affective forecasting, as people are not 
good at predicting die future [44]. It is a striking symbo- 
lisation what the disease encompasses, rather than an 
abstract numerical value. As for as we are aware, there 
are no existing studies that have used the metonym con­
cept to present risk information.
The concept defined as correlational validity by Ubel 
[45], can be used to test whether individuals are apply­
ing their knowledge and understanding rationally. For 
example, men and women at high risk of heart disease 
should be more willing to take statins or blood pressure 
lowering drugs, than those at moderate or low risk. 
Therefore, it follows that if high risk individuals under­
stand the risk information presented to them, they 
should be more likely to have greater intentions to 
change behaviour to reduce risk and vice versa.
Aims and Objectives
The overall aim of this trial is to compare the effects of 
different graphical cardiovascular risk presentation for­
mats on individuals' intention to reduce risk, understand­
ing of risk information, emotional affect and worry about 
future heart disease, using a web-based risk calculator.
The primary objectives of this study are:
• To assess which format leads to the greatest inten­
tion to change behaviour.
• To determine which format best facilitates under­
standing of risk information.
• To analyse which format alters emotional affect
• To assess which format induces worry about future 
heart disease the most
• To examine the correlational validity between 
intention to change behaviour, understanding of risk 
and worry about future heart risk. To find out if 
understanding results in more appropriate intentions 
regarding cardiovascular risk and what level of worry 
increases intention to change behaviour.
• To determine whether intention to change beha­
viour, understanding of risk, and emotional affect 
are mediated by a person’s risk category.
The secondary objectives of this study are:
• To examine the existence of the Hawthorne effect 
using two control groups.
• To analyse within group changes between pre and 
post-intervention responses in the group who com­
pleted both questionnaires.
• To evaluate the use of the internet-provided risk 
formatter (process evaluation), including analysis of 
web-logs.
• To assess the TPB’s efficacy to predict intention to 
change behaviour to reduce future heart risk.
Mithodi/Parign
0 Design
A randomised controlled trial (RCT), with a between- 
subjects design, will be used to compare the effect of 
each presentation format on the specified outcomes. 
There will be four conditions in total, comprising two 
intervention groups and two control groups. This is to 
address the possibility of the Hawthorne effect [46] of 
the four groups and the effect of thinking about cardio­
vascular risk before viewing actual risk.
N) Setting
The trial will be conducted remotely from any location 
with access to a computer and the internet This places 
no time or locality constraints on the respondents, as 
they can participate at their convenience.
HQ Participants
Respondents are eligible for inclusion in die trial if aged 
between 45 and 64, and have not been previously diag­
nosed with cardiovascular disease. This is because the 
risk calculator algorithm is unsuitable for use in a
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population of those with existing heart disease due to an 
underestimation of risk. However, those with hyperten­
sion, hypercholesterolemia and diabetes are still eligible. 
Respondents must also have access to a computer with 
the internet, have adequate IT skills and be able to read 
English.
iv) Recruitment
Respondents will be invited to take part in the study 
using a number of methods. In order of implementation 
and preference, these methods are: emails to educational 
institutions, co-operation with large organisations where 
the workforce has access to a computer, social network­
ing websites (such as Facebook) and advertisements in 
local newspapers. The study will also be advertised on 
posters and pocket sized cards.
v) Intervention end comparisons
A website comprising a cardiovascular risk formatter 
and questionnaires has been developed. The purpose of 
this tool is to enable the different risk presentation for­
mats to be randomly assigned to respondents, creating a 
platform to measure the outcomes of interest. It uses 
the Personal Heart Score [47] which assesses 10-year 
risk of having a coronary heart disease (CHD) event 
(myocardial infarction, fatal CHD, or cardiac procedure). 
It uses self-reported, non-laboratory measurements such 
as age, gender, previous diagnosis of hypertension, 
hypercholesterolemia or diabetes, smoking status, family 
history of premature CHD (e.g. a parent who was under 
the age of 50 when they were told by their GP/Physician 
that they had a heart attack), level of physical activity (e. 
g. exercising or playing sport in leisure time) and body 
mass index. A point scoring system categorises risk into 
three groups (low risk < 10%; intermediate risk 10-20%; 
high risk > 20%). It is recognised that other algorithms 
such as Framingham Risk Score, SCORE or QRISK2 
[1-3], provide a more precise risk estimation, especially 
if they include physiological measurements such as 
blood pressure. However, it is believed that the Personal 
Heart Score is most appropriate for the purpose of this 
study as it provides an estimation of risk level, which 
can easily be presented in different formats to enable a 
head-to-head comparison. More importantly, it enables 
assessment of individuals who have not thought about 
their cardiovascular risk before and are unaware that 
they may be at high risk; most of whom are unlikely to 
have visited a health professional to undergo formal 
clinical assessment The website recommends that con­
cerned respondents visit their GP for more formal clini­
cal investigation and before under taking lifestyle 
changes, links to useful websites such as the British 
Heart Foundation will also be provided.
Before respondents can proceed, they will be given 
brief details about the study, asked to indicate their 
informed consent electronically and will be assessed for 
eligibility. The computer will then randomise the 
respondent into one of the four arms, ensuring alloca­
tion concealment (see Figure 1). These comprise a bar 
graph with pre-intervention questionnaire (control 
group 1), bar graph only (control group 2), pictogram 
(intervention group 1) or metonym (intervention group 
2). Following the risk assessment, all respondents will be 
given their risk category (low, moderate or high) and 
the corresponding percentage figure (< 10%, 10-20% or 
> 20%). The main comparators will be the accompany­
ing graphical risk presentation formats (bar graph, picto­
gram and metonym).
The bar graph format to be used in the two control 
groups consists of vertical bar graph depicting percen­
tages. This will be animated (growing upwards) to 
demonstrate the wide confidence intervals of the risk 
categories in the Personal Risk Score [47]. A bar graph 
has been chosen as it is the standard presentation for­
mat commonly used in current risk prediction tools. A 
pictogram of 100 hearts depicting natural frequencies 
will be used in intervention group 1. Research shows 
that these formats are better understood by patients, 
natural frequencies intuitively offer more insight than 
other formats [9,10] and pictograms help the viewer see 
the risk in context and facilitate accurate judgements of 
probability [48,49]. Again, this format will be animated, 
highlighting each affected heart in turn, to account for 
the range of numbers affected in the risk category. A 
metonym format will be used in intervention group 2.
Aecruiled
(iv«00)
Figure 1 Flowchart of the RCT with intervention and control 
groups
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This will depict the seriousness of an emergency admis­
sion for a myocardial infarction. This has been chosen 
as heart disease is generally associated with having a 
myocardial infarction [50]. An image demonstrating 
healthy longevity will be shown to those in the low risk 
category; those at moderate risk will be shown an ambu­
lance traveling towards a person's house, and a person 
being defibrillated will be shown to the high risk 
category.
To assess changes in emotional affect and worry, all 
respondents will have these measured at baseline during 
the risk assessment. Those in the bar graph and pre­
intervention questionnaire group (control group 1) will 
also complete a partially parallel version of the post­
intervention questionnaire. This is to address the 
Hawthorne effect of the four groups, and compare those 
who are asked to think about their cardiovascular risk 
and their prior intentions to reduce this, against those 
who are not. However, to keep the total number of 
items to a minimum, the focus is on reducing overall 
cardiovascular risk, instead of specific behaviours that 
lead to risk reduction. All respondents will view the risk 
in the format that they have been randomly assigned to 
and complete die post-intervention questionnaire.
There will be two main comparisons:
1. (a) Bar graph only v. Pictogram
(b) Bar graph only v. Metonym.
This will enable a head-to-head comparison of the 
outcomes resulting from the different risk presentation 
formats.
2. Bar graph and pre-intervention questionnaire v. 
Bar graph only. Responses from viewing the bar 
graph and completing the baseline questionnaire will 
be compared with those from viewing the bar graph 
only. Additionally, within group changes between 
baseline and post-intervention questionnaires will be 
analysed in the group who completed both question­
naires (control group 1).
vi) Outcome Assessment
Outcomes will be assessed by means of a self-complete 
on-line questionnaire integrated into the web-based for­
matter. Reliability measures, such as Cronbach’s alpha for 
internal reliability, will be carried out on the questionnaire 
items at the piloting stage of this trial. Items not meeting 
the reliability requirements will be eliminated from the 
final questionnaire. To address possible response bias 
occurring from fatigue, items measuring the different out­
comes and components of the TPB will be mixed up in 
the questionnaire (as recommended by Ajzen [51]).
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The primary outcome measures are:
(i) Intention to change behaviour- Items relating to 
cardiovascular risk reduction were developed using 
guidance from a manual for constructing question­
naires based on the TPB [52]. This manual was cho­
sen as it has been widely used in previous research 
that has required TPB questionnaire development 
[53-55]. It also provides a way of measuring the TPB 
contrasts directly, reducing the number of items and 
thus, keeping the cognitive demand of respondents 
to a minimum. The questionnaire items comprise 
three risk reducing options of: smoking cessation, 
exercising more and losing weight. These are the 
three modifiable risk factors assessed by die Personal 
Heart Score. The relevance of these risk reducing 
options will be assessed. Questions relating to smok­
ing will only be asked to those who reported that 
they are current smokers; adjustment will be made 
for this during analysis. Responses for intention to 
lose weight will be assessed for appropriateness (e.g. 
whether those who do not report this intention actu­
ally need to lose weight). Scale items such as 7 
in tend  to exercise m ore ' with a 7-point Likert 
response options will be used. An indirect measure 
of intention to change behaviour will be also 
assessed, by examining whether individuals take the 
opportunity to obtain a copy of their risk output to 
take to their GP.
( ii)  Understanding  - Items specific to the under­
standing of cardiovascular risk information have 
been developed and will be piloted, as no suitable 
validated scale currently exists. These comprise 
absolute probability perception e.g. ’W hat are your 
chances o f having heart disease in  die next 10 years V 
with three pre-defined response options (low, mod­
erate, high,); subjective understanding of the risk 
information e.g. 'W hat should someone in  your risk  
category do to reduce th e ir risk  o f heart disease?’ 
with 3 pre-defined response options (do nothing to 
reduce their risk, try and do a little bit to reduce 
their risk, do as much as they can to reduce their 
risk); and confidence in understanding e.g. 'How con­
fid e n t are you th a t you have understood the risk  
inform ation given to you?’ with a 7 point Likert Scale 
to indicate level of confidence in understanding.
( iii)  Emotional affect a fte r viewing cardiovascular risk 
- The Positive and Negative Affect Schedule- Short 
Form (PANAS-SF) will be used [56]. This is a 10- 
item truncated version of the PANAS, which has 
been well validated and cited in over 2,000 scholarly 
papers [57]. It was felt that the original 20-items 
would be too time-consuming and cognitively 
demanding for respondents, possibly leading to high
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drop out rates. As this study is interested in respon­
dents’ changes of affect after viewing their risk out­
put, a slight adaptation to the wording of the 
instructions and anchors/pole labels was made to 
the post-intervention scale, to make it more logical. 
An example of one item is: ‘Thinking about yourself 
right now at this present moment, to what extent do 
you feel upset?' with a 5-point Likert response scale 
anchored ‘not at all' to 'extremely'.
(iv) Worry about future heart disease - one item will 
be used to measure this construct, in order to keep 
the total time needed to complete the questionnaires 
to a minimum. No previously developed and vali­
dated scale regarding worry about future risk of 
heart disease currently exists. Therefore, the item 
was developed using previously validated scales relat­
ing to other health conditions, such the Lerman 
Breast Cancer Worry Scale [58] as a guide. This 
item is ‘After viewing your results, how worried do 
you feel about developing heart disease in the future? 
with ‘very worried’ to 'not at all worried’ anchored 
on a 7-point Likert response scale.
The following secondary outcomes will also be 
assessed; these comprise the sub-components of the 
TPB [20]: attitudes, perceived behavioural control and 
subjective norms. Items were developed to measure the 
components directly according to the manual by Francis 
et al [52]. They will measure the three risk reducing 
options (smoking cessation, exercising more, losing 
weight). Again, relevance of the risk reducing options 
will be assessed, and those not applicable will be 
omitted from the post-intervention questionnaire.
•  Attitudes - This comprises evaluative (evaluation 
using bipolar opposites), instrumental (whether the 
behaviour achieves something) and experiential (how 
it feels to perform the behaviour) items. An example
is 'For me, stopping smoking would b e  ' with a 7-
point Likert scale anchored 'pleasant to 'unpleasant.
•  Perceived Behavioural Control - Items relate to 
either self-efficacy or the controllability of the beha­
viour. An example of a controllability item is 
'Whether /  lose weight or not is entirely up to me’ 
with a 7-point Likert scale to indicate the extent to 
which the respondent agrees with the statement An 
example of a self-efficacy item is 7 am confident that 
1 can exercise more’ with ‘very confident to ‘not at 
all confident anchored on a 7-point Likert scale.
•  Subjective Norms - These relate to the perceptions 
of significant others' preferences about whether one 
should or should not engage in a specific behaviour. 
An example is 7  feel under social pressure to lose 
weight' with a 7-point Likert scale to indicate the
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extent to which the respondent agrees with the 
statement
Other data collection comprises:
•  Respondents characteristics (risk category, gender, 
age, family history of heart disease, diagnosis of 
hypertension, hypercholesterolemia, diabetes, smok­
ing status, physical activity status, height and weight 
for BMI calculation and whether the respondent 
requests an electronic copy of their risk output for 
their GP).
♦ Web logs examining how long respondents take to 
complete the study and how long they spend on 
each page.
vii) Sample size calculation
For simplicity, the sample size calculation is based on a 
comparison of means, though die analysis will recognise 
the ordinal nature of the data. It is hard to speculate on 
the difference between the groups and so the sample 
size is based on comparing 2 groups on the primary 
outcome measure which is intention to change beha­
viour, this will give a group size which will be used for 
all the groups. Recruitment will continue until 800 
respondents (200 in each group) have completed the 
trial. The likely uptake rate is unknown and a number 
of the suggested recruitment methods may be needed. 
Based on a study that used a similar Likert Scale scoring 
system for a different risk context [59], the scores on 
intention to change behaviour within a group should 
have an SD of about 1.5. The total sample size in each 
group of 200 would then be sufficient to detect a differ­
ence of 0.5 point between two groups, with 90% power 
and significance value of or = 0.05.
vtti) Analysis
The results will stored on a SQL database and fed back 
to the researcher via the server that hosts the website. 
The data will be stored on the shared drive which will 
be password protected and only accessible to the 
researcher. Data will be retrieved, coded and inputted 
into computer software. Microsoft Office Excel 2007 
will be used for data manipulation and SPSS version 16 
for the main data analyses.
The usual descriptive statistics will be presented to 
summarise baseline characteristics of the study sample. 
Continuous variables such as age and level of cardio­
vascular risk will be summarised using mean and SD 
and/or median and quartiles. Binary variables such as 
gender and whether the respondent requests an elec­
tronic copy of their risk output for their GP will be 
summarised by counts and proportions. Summary
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statistics will be obtained for the study population as a 
whole, and for the four randomised groups, without 
formal testing of statistical significance of any differ­
ences between them.
The main analyses of efficacy will relate to the primary 
outcome measures: intention to change behaviour, 
understanding of risk information, emotional affect and 
worry about future heart disease. Summary statistics for 
the four groups will be presented, as above. The four 
groups will first be compared on an equal footing using 
one-way ANOVA. The three selected pairwise contrasts 
between the specified groups, will then be constructed 
(e.g. bar graph only v. pictogram; bar graph only v. 
metonym; and bar graph and preintervention question­
naire v. bar graph only).
Several secondary analyses will be performed. For the 
bar graph and preintervention questionnaire group (con­
trol group 1), paired analyses will be used to assess 
serial changes in outcome measures between pre- and 
postintervention questionnaires.
A multiple regression model will be used in a sub­
group analysis to look for correlations between risk 
category on intention to change behaviour, understand­
ing of risk and post worry about future heart disease 
outcomes, to see if responses are mediated by risk cate­
gory. It will also be used to assess the correlational 
validity between intention to change behaviour, worry 
about future heart disease and understanding of risk 
information; to determine what level of worry increases 
intention to change behaviour and whether understand­
ing also results in appropriate intentions. The subcom­
ponents of the TPB (attitudes, perceived behavioural 
control and subjective norms) will also be examined, to 
see if they sufficiently predict intention to change beha­
viour (in order to test the efficacy of the model in pre­
dicting cardiovascular-related behaviour change).
The direct and indirect measures of intention to 
change behaviour will be correlated, to see whether 
those who report that they intend to change their beha­
viour actually take the opportunity to print out their 
risk output to take to their GP. Furthermore, a correla­
tion between accurate understanding of risk information 
and confidence in understanding will be conducted. 
Lastly, Independent T-tests will compare baseline and 
post-intervention emotional affect and worry about 
future heart disease scores, to determine whether scores 
generally decrease after viewing a particular risk presen­
tation format, or increase, demonstrating a possible 
negative impact
For all analyses, point and interval estimates will be 
obtained, as well as p-values. In the event of substantial 
departure from Gaussian distributional form, transfor­
mation of scale and/or analogous non-parametric meth­
ods will be considered.
Discussion
This protocol provides a detailed description of a RCT 
designed to compare different graphical cardiovascular 
risk presentation formats and evaluate their effects on 
patient-related outcomes. The findings will inform 
developers of cardiovascular risk prediction tools and 
risk reduction interventions, providing insight into 
which format is most effective in encouraging behaviour 
change to reduce cardiovascular risk.
As far as we are aware, this will be the first RCT to 
assess different cardiovascular risk graphical presenta­
tion formats using actual risk assessment, rather than 
relying on hypothetical risk scenarios. However, a couple 
of limitations should be acknowledged. Firstly, a mean­
ingful response rate will not be able to be calculated, 
but web-logs will give information on response trends 
(such as those who do not complete the study). Sec­
ondly, there is sample bias, as this study uses a self- 
selecting sample and is restricted to computer literature 
individuals. Further possible biases will be explored in 
the event that no difference between the risk presenta­
tion formats occurs; this is to avoid under-estimation of 
their effects.
Lastly, we are only able to provide respondents with a 
rudimentary estimation of their future 10-year risk of 
having a CHD event, and present them with a risk cate­
gory that has wide confidence intervals and a high level 
of uncertainty. This is due to the use of an algorithm 
that uses non laboratory, self-reported information [47]; 
which has been chosen to increase the feasibly of data 
collection. Nonetheless, this will be an adequate starting 
point for individuals who have not thought about visit­
ing their GP for a clinical assessment before and may 
not know that they are at risk.
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Appendix 23. The original algortihm used by the website for randomisation.
The website was made using Adobe flash. There is an inbuilt flash function called 
Math.random that generates a random number between 0 and 1.
Adobe Flash gets a random value between 0 and 1 by calling the built in flash 
function Math.random. This value is inputted into the following equation:
Pathway = Math.round ( 3 x Math.random() )  +1
For example,
Random value = 0.74
1) Pathway = Math.round (3 x 0.74) + 1
2) Pathway = Math.round (2.22) +1
3) Pathway = 2 + 1
4 ) Pathway = 3
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Appendix 24. Participant Information Sheet.
myHeartRisk
Cardiff
UNIVERSITY
PRIFYSGOL
CaeRDv,§)
Glyn Elwyn BA MB BCh MSc FRCGP PhD 
Research Professor 
Department of Primary Care and Public Health 
School of Medicine 
Cardiff University 
Neuadd Meirionnydd 
Heath Park CF14 4XN 
Visiting Chair Centre for Quality of Care Research 
Radboud University Nijmegen Netherlands
ElwynG@cardiff.ac.uk 
00 44 29 20 68 71 94 tel 
00 44 29 20 68 72 19 fax
M yHeartR isk Study  
A study into public perceptions of heart d isease risk
Participant Information Sheet 
Please read this information carefully
Introduction
You are being invited to take part in a research study by Cardiff University. Before you make 
a decision about whether to take part, it is important for you to understand why the research 
is being done and what it will involve. Please read the following information carefully and 
discuss with others if you wish. Take time to decide whether or not you wish to take part.
You are welcome to contact us if you have any questions or require further information.
What is the purpose o f this study?
Heart disease is the biggest killer in the UK and lots of people are unaware they are at risk 
from it. Heart disease risk can be reduced by making changes to lifestyle, such as adopting 
healthier behaviours or taking medication.
This study is being conducted to examine people’s perceptions towards heart disease risk.
In order to do so, the research team at Cardiff University have developed a web-based heart
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disease risk estimator (www.myheartrisk.co.uk). This uses a developed prediction tool1 to 
assess an individual’s future risk of developing heart disease, by using information about 
their health and lifestyle. There is also an electronic questionnaire which asks people’s 
opinions about their risk.
The overall aim of this study is to provide insight into what people think about their risk when 
it is presented to them in a certain way. Specifically, we wish to look at issues such as 
understanding, intentions and emotion. From these results we hope to consider the wider 
implications for healthcare providers, such as General Practitioners. This study is envisaged 
to last for 6 months.
Am I eligible?
W e are asking around 800 people to participate in the study and have their risk of heart 
disease calculated. In order to take part you will need to be between 45  and 64 years of age, 
not have been previously diagnosed with heart disease, not have had a heart attack, other 
cardiac event (e.g. angina) or had a stroke. You must also have access to the internet, either 
at home or in another location, and be able to use a computer.
Do I have to take part?
No. Participation is entirely voluntary and it is up to you to decide if you want to take part in 
this research. You will be free to withdraw from the study, by exiting the web browser at any 
point and without giving a reason. If you do decide to take part, you will be asked to read the 
rest of this information page, and indicate your consent by checking the relevant boxes on 
the consent page.
What w ill happen to me i f  I decide to take part?
If you decide to take part in the study you will be asked to spare around 20-30  minutes of 
your time and navigate through the myheartrisk website. You will be asked to answer 
questions regarding your health and lifestyle, in order for your future risk of heart disease to
1 Mainous et al. 2007. A Coronary Heart Disease Risk Score Based on Patient-Reported Information. American 
Journal of Cardiology 99, pp. 1236-1241.
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be calculated. W e will also ask you to complete an online questionnaire on your feelings 
about how your risk has been presented to you.
This study is a randomised trial. W e  would like to find out more about how people’s 
perceptions differ when their risk is presented in different ways. In order to do this, we need 
to make comparisons and will put people into groups. Each group will be given a different 
format for presenting their risk. To ensure the groups are the same to start with, each 
participant is put into a group by chance (randomly). The results are then compared.
All the data from the study will be stored on computer. Only the research team will access 
the data. It will be securely protected by using passwords. The same research team that 
collected the data will perform the analysis of the information.
What do I have to do?
You will be required to navigate through the myheartrisk website, input information regarding 
your health and lifestyle, view your estimated future risk of heart disease and complete a 
short questionnaire.
Will m y taking part in the study be kept confidential?
Yes. All information about your participation in this study will be kept strictly confidential and 
only made available to the research team. Participation is entirely anonymous and we 
cannot trace your answers back to you. W e do not ask you to provide your contact details, 
unless you would like us to contact you regarding further information about the study. The 
results of the questionnaire will be kept securely and then destroyed after an agreed period 
in keeping with recommended research guidelines.
What are the disadvantages o r risks o f taking part?
W e recognise that viewing your risk of heart disease may be a difficult task. It is possible that 
the results may be unexpected, make you slightly worried or cause distress. W e will, in fact, 
ask you about any worries that you feel in the questionnaire.
If you do become worried or distressed about your risk of heart disease, we urge you 
to visit your GP for a formal clinical assessment, especially before undertaking any 
major changes to your lifestyle and health. W e will also provide a link to the British 
Heart Foundation website that provides information about heart disease.
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What are the possible benefits of taking part?
You will receive a personalised estimation of your future risk of heart disease.
The results of this study will provide us with a better understanding of the effect of presenting 
risk information in different ways. W e will then be able to inform healthcare professionals and 
the developers of risk prediction tools, to improve risk communication. The study does not 
aim to modify treatment or medication.
What w ill happen i f  I don’t  want to carry on with the study?
You can withdraw from the study at any point by closing the web browser.
What i f  I become concerned?
W e recognise that it is possible that personalised risk information may cause you worry or 
distress. If you wish to discuss any issues raised during the research, we urge you to visit 
your GP.
If you wish to complain, or have any concerns about any aspect of the way you have been 
treated during the course of this study, you should contact:
Professor Glyn Elwyn, Department of Primary Care and Public Health, School of Medicine, 
Cardiff University, Neuadd Meirionnydd, Heath Park, Cardiff, CF14 4XN , (Tel: (0)29 20 68 71 
94, ElwynG@cardiff.ac.uk).
What w ill happen to the results o f the research study?
The information from the study will be presented in a report and may also be published in 
appropriate journals. The information used in the publications will be anonymous; it will not 
be possible to identify you.
If you would like more information about the study and your participation in it, or would like a 
copy of the published results once they become available, there is a page on the website 
where you can leave your contact details. A  member of the research team  will then get back 
to you.
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Who is organising and funding this research?
The study is organised by Professor Glyn Elwyn of the Department and Primary 
Care at Cardiff University. It is funded by the School of Medicine at Cardiff 
University.
Who has reviewed this study?
The study plan has been peer-reviewed by the Medical and Dental School Research 
Ethics Committee at Cardiff University.
What do I need to do now?
If you do wish to take part in this study, please navigate to the consent page by clicking the 
‘continue’ button at the bottom of this page. You will then be able to start filling out the 
questionnaire and have your future risk of heart disease estimated.
What i f f  have other concerns?
If after reading this information sheet you decide not to take part in the study, but feel you 
would like to discuss any of the issues we have raised, or have other questions about this 
study, please contact the Principal Investigator, Professor Glyn Elwyn.
Who should I contact fo r further information?
Professor Glyn Elwyn
Department of Primary Care and Public Health
School of Medicine
Neuadd Meirionydd
Cardiff University
Heath Park
Cardiff
CF14 4XN
Email: ElwynG@cardiff.ac.uk 
Tel: 029 2068 7194
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Appendix 25. Coding docum ent fo r on-line questionnaires.
No missing data
Identification information for each respondent:
Variable Description Values
Participant number ID of respondents
Session ID Unique Session ID to log respondents time on 
website
*
Date and Time Date and time respondent entered the 
website
“
Risk output request Whether respondents requested to have a 
copy of their risk output result emailed to 
them.
0 = No 
1= Yes
Condition allocation The condition respondents were randomised 
to.
1= Bargraph with pre­
intervention questionnaire 
2 = Bargraph 
3= Pictogram 
4 = Metonym
Baseline Questionnaire given to everyone:
No missing data
Variable Description Values
Q 1 Pre PANAS -  To what extent do you feel... 
Upset
Scale = 1 (never) to 7 (always)
Q2 Pre PANAS -  To what extent do you feel... 
Hostile
Scale = 1 (never) to 7 (always)
Q3 Pre PANAS -  To what extent do you feel... 
Alert
Scale = 1 (never) to 7 (always)
Q4 Pre PANAS -  To what extent do you feel... 
Ashamed
Scale = 1 (never) to 7 (always)
Q5 Pre PANAS -  To what extent do you feel... 
Inspired
Scale = 1 (never) to 7 (always)
Q6 Pre PANAS -  To what extent do you feel... 
Nervous
Scale = 1 (never) to 7 (always)
Q7 Pre PANAS -  To what extent do you feel... 
Determined
Scale = 1 (never) to 7 (always)
Q8 Pre PANAS -  To what extent do you feel... 
Attentive
Scale = 1 (never) to 7 (always)
Q9 Pre PANAS -  To what extent do you feel... 
Afraid
Scale = 1 (never) to 7 (always)
Q10 Pre PANAS -  To what extent do you feel... 
Active
Scale = 1 (never) to 7 (always)
Total_Pre_Positive_affect Total scores for positive items from pre PANAS 
(e.g 03 ,05 ,07 ,08 ,010 )
Total score between 7-49
T ota l_Pre_N egative_affe ct Total scores for Negative items from pre 
PANAS (e.g 01 ,02 ,04 ,06 ,09 )
Total score between 7-49
Q l l Pre worry -  How worried do you feel about 
developing heart disease in the future?
Scale = 1 (not at all worried) to 
5 (very worried)
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Questions given to those in condition 1 only (Bar graph with pre intervention questionnaire)
9 for missing data -  i.e. those who were not randomised to this condition.
Variable Description Values
Q12 Pre risk perception probability-/ think my risk 
o f heart disease in the next 10 years is..
1 = low 
2= moderate 
3= High
Q13 Pre intention to reduce heart disease -  1 want 
to reduce my risk of heart disease.
Scale= 1 (strongly agree) to 7 
(strongly disagree)
Q13_reversed Q13 scores reversed so higher score means 
greater intention.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q15 Pre subjective norm -  People who are 
important to me want me to reduce my risk of 
heart disease.
Scale= 1 (strongly agree) to 7 
(strongly disagree)
Q15_re versed Q15 scores reversed so higher score means 
greater influence of subjective norms.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q14 Pre Perceived Behavioural Control 
(controllability) -  The decision to reduce my risk 
of heart disease is mostly up to me.
Scale= 1 (strongly agree) to 7 
(strongly disagree)
Q14_reversed Q14 scores reversed so higher score means 
greater PBC.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q16 Pre PBC (self-efficacy) -  Reducing my risk of 
heart disease would be Easy /  Difficult.
Scale = -3 (easy) to +3 (difficult)
Q16_converted_only Converting Q16 scores from -3 to +3 into 1 to 7 Scale: 1 =-3 (easy) to 7 = +3 
(difficult)
Q16_converted_
reversed
Q16 converted scores reversed so higher score 
means greater PBC.
Scale= 1 (difficult) to 7 (easy)
Mean_pre_PBC_score Mean total pre PBC score (sum of 
Q14_reversed,Q16_converted_reversed /  2)
Higher score means greater 
perceived behavioural control.
Q17 Pre attitudes - Reducing my risk o f heart disease 
would be Rewarding/Unrewarding.
Scale = -3 (rewarding) to +3 
(unrewarding)
Q17_reversed Q17 scores reversed so higher score means 
more positive attitude.
Scale = -3 (unrewarding) to +3 
(rewarding)
Q18 Pre attitudes - Reducing my risk o f heart disease 
would be Undesirable /  Desirable.
Scale = -3 (undesirable) to +3 
(desirable)
Q19 Q19 pre attitudes - Reducing my risk o f heart 
disease would be Worthless /  Worthwhile.
Scale = -3 (worthless) to +3 
(worthwhile)
Mean_pre_attidude_
Score
Mean total pre attitude score (sum of 
Q17_reversed,Q18,Q19 /  3)
Higher score means more positive 
attitude towards reducing heart 
disease.
Post intervention questionnaire given to everyone.
No missing data
Variable Description Values
Q20 Post PANAS -  At this present moment to 
what extent do you feel... Upset
Scale = 1 (not at all) to 7 
(extremely)
Q21 Post PANAS -  At this present moment to 
what extent do you feel... Hostile
Scale = 1 (not at all) to 7 
(extremely)
Q22 Post PANAS -  At this present moment to 
what extent do you feel... Alert
Scale = 1 (not at all) to 7 
(extremely)
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Q23 Post PANAS - A t  this present moment to 
what extent do you feel... Ashamed
Scale = 1 (not at all) to 7 
(extremely)
Q24 Post PANAS -  At this present moment to 
what extent do you feel... Inspired
Scale = 1 (not at all) to 7 
(extremely)
Q25 Post PANAS -  At this present moment to 
what extent do you feel... Nervous
Scale = 1 (not at all) to 7 
(extremely)
Q26 Post PANAS -  At this present moment to 
what extent do you feel... Determined
Scale = 1 (not at all) to 7 
(extremely)
Q27 Post PANAS -  At this present moment to 
what extent do you feel... Attentive
Scale = 1 (not at all) to 7 
(extremely)
Q28 Post PANAS -  At this present moment to 
what extent do you feel... Afraid
Scale = 1 (not at all) to 7 
(extremely)
Q29 Post PANAS - A t  this present moment to 
what extent do you feel... Active
Scale = 1 (not at all) to 7 
(extremely)
T ota l_post_Positive_affe ct Total scores for positive items from post 
PANAS (e.g Q3,Q5,Q7,Q8,Q10)
Total score between 7-49
T ota l_post_Negati ve_affe ct Total scores for Negative items from post 
PANAS (e.g 0 1 ,02 ,0 4 ,06 ,09 )
Total score between 7-49
Q30 Post worry -A fte r  viewing your results how 
worried do you feel about developing heart 
disease in the future?
Scale = 1 (not at all worried) to 
5 (very worried)
Q31 Understanding - probability perception -  
What are your chances o f having a coronary 
heart disease event in the next 10 years?
1= 1 am at low risk 
2= 1 am at moderate risk 
3 = 1 am at high risk
Q32 Understanding -  confidence -  How confident 
are you that you have understood the risk 
information given to you?
Scale = 1 (not at all confident) to 
7 (very confident
Q33 Understanding - subjective understanding -  
What should someone in your risk category 
do to change their risk o f heart disease?
1= Do nothing
2 = Try and do a little
3 = Do as much as they can
Level_of_understanding Respondent said to have understanding if 
the appropriate responses are given to 031  
and 033 according to their risk category.
0 = No understanding -  incorrect 
responses.
1= Partial understanding (Q31 
correct but Q33 incorrect).
2= Partial understanding (Q31 
incorrect but Q33 correct).
3 = complete understanding -  
correct responses.
Level_of_understanding_as 
_ scale
Level of understanding turned into a three 
point scale but recoding 0=0,1  or 2 = 1, 3=2.
0 = no understanding
1 = partial understanding
2 = complete understanding
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Questionnaire about intention to stop smoking -  given to current smokers only
9 for missing data (i.e. those who do not smoke)
Variable Description Values
Q34 Smoking -  intention -  To what extent are you 
prepared to stop smoking?
Scale =1 (completely unprepared) 
to 7 (completely prepared).
Q35 Smoking -  intention -  How likely are you to 
stop smoking?
Scale= 1 (very unlikely) to 7 (very 
likely).
Q41 Smoking -  intention -  1 intend to stop 
smoking.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Mean_smoking_intention 
_ score
Mean total smoking intention score (sum of 
Q 34,Q35,Q 41/3)
Higher score means greater 
intention to stop smoking
Q37 Smoking -  attitude -  For me stopping smoking 
would be... Bad/Good.
Scale= -3 (bad) to +3 (good)
Q38 Smoking -  attitude -  For me stopping smoking 
would be... Harmful/  Beneficial.
Scale= -3 (harmful) to +3 
(beneficial)
Q39 Smoking -  attitude -  For me stopping smoking 
would be... Unpleasant/  Pleasant.
Scale= -3 (Unpleasant) to +3 
(Pleasant)
Mean_smoking_attitude_
score
Mean total smoking attitude score (sum of 
Q 37,Q 38,Q 39/3)
Higher score means more positive 
attitude towards stopping 
smoking.
Q40 Smoking -  PBC (self-efficacy) -  For me 
stopping smoking would be... D ifficu lt/ Easy.
Scale= -3 (Difficult) to +3 (Easy)
Q40_con verted Q40 scores converted Scale: 1 =-3 (Difficult) to 7 = +3 
(Easy)
Q45 Smoking - PBC (self-efficacy)- 1 am confident 
that 1 can stop smoking.
Scale = 1 (strongly disagree) to 7 
(strongly agree)
Q42 Smoking - PBC (controlability) -  Whether 1 
stop smoking or not is entirely up to me.
Scale = 1 (strongly disagree) to 7 
(strongly agree)
Q44 Smoking - PBC (controlability) -  The decision 
to stop smoking is beyond my control.
Scale = 1 (strongly disagree) to 7 
(strongly agree)
Q44 reversed Q44 scores reversed so a higher score means greater PBC
Mean_smoking_PBC_
Score
Mean total smoking PBC score (sum of Q40- 
converted,Q45/Q42/Q44_reversed /  4)
Higher score means greater PBC 
over stopping smoking.
Q36 Smoking - subjective norm -  Most people who 
are important to me think that /... should not 
stop smoking /should stop smoking.
Scale= -3 (should not) to +3 
(should)
Q36_converted Converted Q36 scores from -3 to +3 into 1 to 7 Scale: 1 =-3 (should not) to 7 = +3 
(should)
Q43 Smoking - subjective norm - 1 feel under social 
pressure to stop smoking.
Scale = 1 (strongly disagree) to 7 
(strongly agree)
Q46 Smoking - subjective norm -  It is expected of 
me to stop smoking.
Scale = 1 (strongly disagree) to 7 
(strongly agree)
Mean_smoking_subjective 
_ norm_score
Mean total smoking subjective norm score 
(sum of Q36_converted,Q43,Q46 /  3)
Higher score means greater 
influence of subjective norms.
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No missing data
Questionnaire about exercising more - given to everyone
Variable Description Values
Q47 Exercise -  intention -  To what extent are you 
prepared to exercise more?
! Scale =1 (completely unprepared) 
| to 7 (completely prepared).
Q48 Exercise -  intention -  How likely are you to 
exercise more?
Scale= 1 (very unlikely) to 7 (very 
likely).
Q54 Exercise -  intention -  1 intend to exercise 
more.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Mean_exercise_intention_
score
Mean total exercise more intention score 
(sum of Q47,Q48,Q54 /  3)
Higher score means greater 
intention to exercise more.
Q50 Exercise -  attitudes -  For me exercising more 
would be... a negative thing to do /  a positive 
thing to do.
Scale= -3 (negative) to +3 
(positive)
Q51 Exercise -  attitudes - For me exercising more 
would be... Unenjoyable /  Enjoyable.
Scale= -3 (unenjoyable) to +3 
(enjoyable)
Q53 Exercise -  attitudes - For me exercising more 
would be... Useless /  Useful.
Scale= -3 (useless) to +3 (useful)
Mean_exercise_attitude_
score
Mean total exercise more attitude score (sum 
of 0 5 0 ,0 5 1 ,0 5 3 /3 )
Higher score means more positive 
attitude towards exercising more.
Q52 Exercise - PBC (self-efficacy) - For me 
exercising more would be... Difficult /  Easy.
Scale= -3 (Difficult) to +3 (Easy)
Q52_con verted Converted Q52 scores from -3 to +3 into 1 to 7 Scale: 1 =-3 (easy) to 7 = +3 
(difficult)
Q58 Exercise - PBC (self-efficacy) -  1 am confident 
that 1 can exercise more.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q55 Exercise - PBC (controlability)- Whether! 
exercise more or not is entirely up to me.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q57 Exercise - PBC (controlability)- The decision to 
exercise more is beyond my control.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q57_re versed 044 scores reversed so a higher score means 
greater PBC.
Scale= 1 (strongly agree) to 7 
(strongly disagree)
Mean_exercise_PBC_score Mean total exercise more PBC score (sum of 
Q52_converted,058,055, Q57_reversed /  4)
Higher score means greater PBC 
over exercising more.
Q49 Exercise - subjective norm -M ost people who 
are important to me think that /... should 
exercise more/should not exercise more.
Scale= -3 (should not) to +3 
(should)
Q49_converted Converted Q49 scores from -3 to +3 into 1 to 7 Scale: 1 =-3 (should not) to 7 = +3 
(should)
Q56 Exercise - subjective norm - 1 feel under social 
pressure to exercise more.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q59 Exercise - subjective norm -  It is expected of 
me to exercise more.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Mean_exercise_subjective 
_ norm_score
Mean total exercise more subjective norm 
score (sum of Q49_converted,Q56,059 /  3)
Higher score means greater 
influence of subjective norms.
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No missing data
Questionnaire about losing weight - given to everyone
Variable Description Values
Q60 Lose weight -  intention -  To what extent are you 
prepared to stop smoking?
Scale =1 (completely unprepared) 
to 7 (completely prepared).
Q61 Lose weight- intention -  How likely are you to 
lose weight?
Scale= 1 (very unlikely) to 7 (very 
likely).
Q67 Lose weight- intention -  1 intend to lose weight. Scale= 1 (strongly disagree) to 7 
(strongly agree)
Mean_loseweight_
intention_score
Mean total lose weight intention score (sum of 
Q60,Q61,Q67 /  3)
Higher score means greater 
intention to lose weight.
Q63 Lose weight -  attitudes -  For me losing weight 
would be... the wrong thing to do /  the right thing 
to do.
Scale= -3 (wrong thing) to +3 
(right thing)
Q64 lose weight -  attitudes - For me losing weight 
would be... unsatisfying /  Satisfying.
Scale= -3 (Unsatisfying) to +3 
(Satisfying)
Q65 Lose weight -  attitudes - For me losing weight 
would be... Unhelpful /  Helpful.
Scale= -3 (Unhelpful) to +3 
(Helpful)
Mea n J  ose we ight_ 
attitude_ score
Mean total exercise more attitude score (sum of 
Q63,Q64,Q65 /  3)
Higher score means more positive 
attitude towards losing weight.
Q66 Lose weight -  PBC (self-efficacy)- For me losing 
weight would be... Difficult /  Easy.
Scale= -3 (Difficult) to +3 (Easy)
Q66_converted Converted Q66 scores from -3 to +3 into 1 to 7 Scale: 1 =-3 (Unhelpful) to 7 = +3 
(Helpful)
Q71 Lose weight - PBC (self-efficacy) -  1 am confident 
that 1 can lose weight.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q68 Lose weight - PBC (controlability)- Whether 1 lose 
weight or not is entirely up to me.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q70 Lose weight - PBC (controlability) -  The decision 
to lose weight is beyond my control.
Scale = 1 (strongly disagree) to 7 
(strongly agree)
Q70_re versed Q70 scores reversed so a higher score means 
greater PBC.
Scale= 1 (strongly agree) to 7 
(strongly disagree)
Mean_loseweight_PBC
_score
Mean total lose weight PBC score (sum of 
Q66_converted,Q71,Q68, Q70_reversed /4 )
Higher score means greater PBC 
over losing weight.
Q62 Lose weight - subjective norm -  Most people who 
are important to me think that /... Should not lose 
weight /  Should lose weight.
Scale= -3 (should not) to +3 
(should
Q62_converted Converted Q62 scores from -3 to +3 into 1 to 7 Scale: 1 =-3 (should not) to 7 = +3 
(should)
Q69 Lose weight - subjective norms -  Ifeel under 
social pressure to lose weight.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Q72 Lose weight - subjective norm -  It is expected o f 
me to lose weight.
Scale= 1 (strongly disagree) to 7 
(strongly agree)
Mean_losewieght_
subjective_norm_score
Mean total exercise more subjective norm score 
(sum of Q62_converted,Q69/Q72 /  3)
Higher score means greater 
influence of subjective norms.
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9 for missing data
Questionnaire given to everyone
Variable | Description Values
Q73_level_of_education What is your level of education? 1 1 = Left school before 16 (no formal 
Qualifications)
2 = Left school at 16 (GCSEs, CSE, 0  
level or equivalent)
3 = Left School at 18 (A levels or 
equivalent)
4 = College certificate or diploma
5 = University degree or higher
6 = other
7 do not wish to disclose
Q74_recruitment_methods Where did you find out about this 
website?
1 = Email invitation at workplace
2 = Found link on the internet
3 = Social networking sites
4 = from personal contacts
5 = poster or card advertisements
6 = Newspaper
7 = Other
8 = undisclosed
No missing data.
Risk Assessment questions.
Variable Description Values
Sex Are you male or female? 1 = male 
2= female
Age What is your age? Between 45-64
Age_Categorised Ages put into categories 1= 45-49
2 = 50-54
3 = 55- 59
4 = 60-64
FamilyHistory Does your family have a history of 
heart disease?
0=No 
1= Yes
Hypertension Has your Doctor diagnosed you with 
high blood pressure?
0=No
l=Yes
Hypercholesterolemia Has your Doctor diagnosed you with 
high cholesterol?
0=No 
1= Yes
Diabetes Has your Doctor diagnosed you with 
diabetes?
Smoking_status Do you smoke? 0=Never 
1= former 
2= current
Exercise_status Do you exercise or play sport in your 
leisure time?
0 = seldom /  Never 
1= sometimes 
2 = often /  very often
Height Drag the marker to show your correct 
height.
cm
Weight Drag the arrow to show your correct Kg
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weight.
BMI BMI calculated
BMI_recoded BMI coded into below 30 or 30 and 
above
1= under 30 
2= 30 and above
Risk_output Risk output (respondents result) 1= low 
2= moderate 
3= High
Risk_output_
dichotomised
The risk output results dichotomised 
into low and moderate/high due to 
small cells. For subgroup analysis.
l=Low
2= Moderate /  High
filter_BMI Filter to eliminate those who failed to 
move the arrow to indicate weight 
and specified they were 3 stonel3lbs
Filter on for all analyses.
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Appendix 26. Example of risk output results send to respondents on request.
myHeartRisk
Cardiff
UNIVERSITY
PRIFYSG O L
C a eRDY[§>
Glyn Elwyn BA MB BCh MSc FRCGP PhD
Research Professor
Department of Primary Care and Public Health
School of Medicine 
Cardiff University
Neuadd Meirionnydd 
Heath Park CF14 4YS
Visiting Chair Centre for Quality of Care Research 
Radboud University Nijmegen Netherlands
00 44 29 20 68 71 95 tel 
00 44 29 20 68 72 19 fax
M yHeartR isk Study
A study into public perceptions of heart d isease risk
This page has been produced as you kindly took part in a study by Cardiff University looking 
into people’s perceptions of heart disease risk and requested a copy of the results from your 
heart disease risk assessment.
The assessment was carried out using a developed prediction tool1 that calculates an 
individual’s future risk of developing heart disease, by using information about health and 
lifestyle. This includes age, family history of heart disease, diagnosis of high blood pressure, 
high cholesterol or diabetes, smoking status, level of physical activity and body mass index.
Please find below, your personalised risk calculated from the information you gave us. This 
is an estimation of your future risk of heart disease and is not a medical diagnosis.
1 Mainous et al. 2007. A Coronary Heart Disease Risk Score Based on Patient-Reported Information. American 
Journal of Cardiology 99, pp. 1236-1241.
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Your calculated risk of having a coronary heart disease event in the  
next 10 years is:
High (over 20%)
A coronary heart disease event is defined as:
Myocardial infarction (heart attack)
Fatal coronary heart disease (death from coronary heart disease) 
or cardiac procedure (a medical procedure involving the heart)
For further inform ation about Heart health please visit:
The British Heart Foundation: http://www.bhf.org.uk/
British Heart Foundation main telephone number: 020 7554 0000  
Heart Helpline: 0300 330 3311 (open Monday to Friday 9am to 6pm)
For further inform ation about this study please contact:
Cherry-Ann Waldron: W aldronC@ cardiff.ac.uk
Professor Glyn Elwyn: ElwvnG@ cardiff.ac.uk
W e would like to take the opportunity to thank you once again for your participation in this 
study.
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Appendix 27. Press release issued to Local Newspapers.
EXPLORE CARDIFF UNIVERSITY HOME ABOUT EDUCATION RESEARCH NEWS EVENTS A-Z
CARPIFTUMIVf^ fTV
r t t r v s c o cQtRP®
News Centre
News from Cardiff University
. n : .< /
Recent News 
Research News 
Staff and Student News 
Archive
Download Newsletter 
Media Centre
► Directory of Expertise
► Media Releases
► October 2010
► September 2010
► August 2010
► July 2010
► June 2010
► May 2010
► April 2010
► March 2010
» February 2010
► January 2010
► December 2009
► November 2009
► October 2009
► September 2009
► August 2009
► July 2009 
» June 2009
► May 2009
► April 2009
► March 2009
► February 2009
► January 2009
► Cardiff University in the 
News
► Media Statements
► Public Relations Contacts
► Public Relations Services
W e b -b a s e d  c a lc u la to r  to  h e lp  p re d ic t  h e a r t  d is e a s e
For im m ediate release:
Friday 12th February, 2009
Internet users can assess their future risk of having heart disease by visiting a new website 
developed by Cardiff University experts.
myHeartRisk.co.uk is a new website that assesses risk of developing heart disease in the future, by 
using information about health status and lifestyle. There is also an electronic questionnaire which 
asks people's opinions about their nsk.
Heart disease is the biggest killer in the UK and lots of people do not know they are at nsk from it. 
Heart disease risk can be reduced by making small changes to lifestyle, such as adopting healthier 
behaviours or taking medication. Therefore, it is important to have an assessment to know if you are
at risk.
The website has been developed as part of a research study by Pnnople Investigator Professor Glyn 
Elwyn and Cherry-Ann Waldron from Cardiff University's Department of Primary Care and Public 
Health and supported by Professor Julian Halcox of the Wales Heart Research Institute.
The aim of the research study is to examine perceptions and attitudes towards heart disease, and 
provide insight into what people think about their risk when it is presented to them in a certain way.
Professor Glyn Elwyn who leads Cardiff University's School of Medicine's Decision Laboratory 
research group said: 'myHeartRisk is a quick and 'easy- tc-use' website that provides an estimation 
to those who may not have thought about their nsk of heart disease before.'
The study is looking for volunteers to visit the website, who are aged between 45 and 64 years of 
age, have not been previously diagnosed with heart disease, had a cardiac event (such as a heart 
attack or angina) or had a stroke.
£1 will be donated to the British Heart Foundation for every person who takes part and completes the 
study with the University hoping to raise over £1,000.
-Ends-
Notes:
1. Further in form ation o r to  arrange a m edia in terview , please contact:
Angela Watkins
Tel: 029 206 87190
E-mail: watkmsa6#Cardiff.ac.uk
Cherry-Ann Waldron 
029 206 87193
E-mail WaldronC0cardiff.ac.uk
2. Cardiff School o f Medicine
Cardiff University's School of Medicine is a significant contnbutor to healthcare in Wales, a major 
provider of professional staff for the National Health Service and an international centre of excellence 
for research delivering substantial health benefits locally end internationally. The school's 800 staff 
indude 500 research and academic staff who teach more than 2,000 students, induding 1,110 
postgraduate students.
The School is based at the Heath Park Campus, a site it shares the University Hospital of Wales, the 
third largest university hospital in the UK. The School has an all-Wales role, contributing greatly to 
promoting, enhancing and protecting the nation's health. A key partner in this role is the National 
Health Service (NHS) in Wales, with which the School is linked at all levels. This mutual dependency is 
illustrated by the teaching of medical undergraduates in more than 150 hospitals located in all of 
Wales' health authorities. The medical curriculum followed at the School enables students to acquire 
and apply knowledge, skills, judgement and attitudes appropnate to delivering a high standard of 
professional care.
Around 300 new doctors currently graduate from the School every year and the Welsh Assembly 
Government has invested substantially in new teaching facilities to increase this number further.
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Appendix 28. Healthy on-line magazine blog entitled: What's your Heart Risk?
Healthy
Your natural health expert
Tuesday, OS Match 2016 ■STM
h - i - l . ■ I B
Missed o u t 0*1  a defcoous 
recipe in  H ea lth y  m agazine 
Use o u r recipe search  engine  
to  fin d  th e  one yo u  w ant
R td M ;
m  Back to Blog
What’s your heart risk?
Take pert <n a neartcksease study ana ra*e money tor the Bntisn Heart foundation
Internet users can assess tien future nsk of having heart disease by visiting www myHeartRisk CO uk 
Its a new website developed by Card* University eipetts to assess »ie nskot developing heart 
disease »i me Mure. o. using mformabon aoout health status and lifestyle There is also an eledrome 
questionnaire which asks people s opinions aoout their nsk. Heart disease is me biggest killer m me 
UK and lots of people do not know they are at nsktrom l out dean be reduced by making smal 
changes to your lifestyle. such as adopting healthier behaviours or taking me&cabon
Therefore it is important to have an assessment to know if you are at nsk. The aim of the research 
study is to esamme perceptions and attitudes towards heart disease and provide insight into what 
people mink about their nsk when it is presented to them m a certain way
Professor Glyn Elwyn Irom C a r** universitys School of Uetkane said •myHeartRisk is a Q uick and 
easy to-use website mat provides an estimator to those who may not have thought about meir nsk of 
heart disease before ’
The study is tooting tor volunteers to visit me website who are aged between 45 and 64 years of age 
nave not been previously diagnosed wdh heart disease had a cardiac event (such as a heart attack or 
angina) or had a stroke Best thing at at? They'll donate £ 1 to me British Heart Foundation lor every 
person who takes part and completes me study The University is hoping to raise over £1.000 so cSck 
here to take part
No com m erits
Nobody has posted a comment yet why not be m * ItrsP
y  Leave a com ment
HememeuMtf)
I an eye on Deve 
IT  w  ape Oy Dr Jotm Cuppa"
Hfft -  Prayed To ttwae Women's Health issues I e image tzjmoafl
Kris freem en. Closing Thoughts on Vancouver 701* 
23 n  p e t ,  Am, r
we Put TTve - Round* In Roundup 
Ptoaae
•  day* ago H  CTT>ir t arur
Now if*e men par attention to  me again* ttyt agrRr Shawm
Pumpkin Pecan Butler
Hertoai and Alte rnative M edicine 
*36 a>y» ago by ad— i
Win a romantic break to Antigua
I OlltIWi* COiW tOtt .I
Offers & Giveaways
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Appendix 29. A5 sized posters and pocket-sized cards.
myHeartRisk
Would you like to find out your 
future risk of heart disease?
Please visit:
www.myheartrisk.co.uk
m yHeartR isk is a web-based calculator that predicts your 
future risk of heart disease.
It was developed for a research study into people's 
perceptions of heart disease.
W e w ill do nate  £1 to  th e  British H eart Foundation , 
fo r every  person w h o  takes part and c o m p le tes th e  
study. W e aim  to  raise over £1 ,000 .
Please tell your friends and family who may be interested in
taking part.
For further information contact:
myHeartRisk
Would you like to find out your 
future risk of heart disease?
Please visit:
www.myheartrisk.co.uk
CARDIFF
UNIVERSITY
P R IFVSG O l
CAERDn§>
myHeartRisk is a web based calculator that predicts your 
future risk of heart disease.
It was developed for a research study into people's 
perceptions of heart disease.
We will donate £1 to the British Heart Foundation, 
for every person who takes part and completes the 
study. We aim to raise over £1,000.
Please tell your friends and family who may be interested *n 
taking part.
cxpar
For Iwlfw tnformotion contact
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Appendix 30. Storyboard of web pages given to web developer.
Homepage
uk
Welcome to 'myheartrisk.co.uk'
A web-based tool that calculates your risk of heart disease
Cardiff
UNIVERSITY
PR IFYSG O L
C a eRDY[§>
A study Into public perceptions of heart disease risk
Click to 
continue..
version 3 -13 /3 /09
A study into public perceptions of heart disease risk 
Participant Information page 
P lease read this carefully
Introduction
What is the purpose of this study?
Why have I been chosen?
Do I have to take part?
Whatwill happen to me if I decide to take part?
What do I have to do?
Will my taking part in the study be kept confidential?
What are the disadvantages or risks of taking part?
What are the possible benefits of taking part?
Whatwill happen if I don’t want to carry on with the study?
What If something goes wrong?
Whatwill happen to the results of the research study?
Who Is organising and funding this research?
Who has reviewed this study?
Whatdol need to do now?
What If I have other concerns?
Who should I contact for further information?
Thank you for taking the time to read this information page. _________________
Please print a copy for future reference.
version 3 -1 3 /5 /0 9  I  P rogrtgBar I
►
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Disclaimer page g .
IP -
D isc la im er
• You will be presented with an estimation of your future risk of 
heart disease calculated from the information you give us.
• This study uses a published prediction tool that assesses risk 
using patient self-reported information.
• This estimation is an indication of risk and is not to act as a 
medical diagnosis.
• We are not able to enter into personal discussions about your 
cardiovascular risk, you must visit your doctor for this.
ProgressBar Click to 
continue.. ►
version 3 -1 3 /3 /0 9
ELECTRONIC CONSENT FORM
A study into public perceptions of heart disease risk
Please check the appropriate boxes
1. I confirmthatl have read andunderstoodtheinformation page
dated...................for the above study and have been informed of the
opportunity to ask questions and how to do this
2 I understand that my participation isvoluntary andthat I am free to with draw at 
anytime, by exitingfrom theweb browser with out giving any reason
3. I have read the disclaimer and understood thatthis study provides an
estimation of my risk of h eart disease, an d I am to visit my GP if I am interested 
in having a more formal clinical assessment.
4 I agree to take part in the above study
5. I do not wish to take part in the above study
FrogregBar |
version 3 -13 /3 /09  4
■ 'a
m
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End page for those not con sen ting to participate
We are sorry you do not wish to take part In this study.... myhoaitfisk.co.uk
Many thanks for taking time to visit this website.
Please tell your friends and family who may be interested 
in taking part in this study.
| For further information about the study please contact:
3 The Research Team at Cardiff University
Cherry-Ann Waldron waldronc@cardiff.ac.uk 
Professor Glyn Elwyn Elwyng@cardiff.ac.uk
Forfurther information about heart health please contact: 
The British Heart Foundation n ttp ://www.bhf.org.uk/
version 3 -1 3 /3 /0 9
Eligibility page
Progr«ssBar
Are you eligible to take part? myh«aiHi$k.co.uk
Please indicate whether you agree with the below statements, 
by checking the box that best describes you.
I am between the ages of 45 and 64 years of age.
I have never been previously diagnosed with 
cardiovasculardisease, had a heart attack, other 
cardiac event, or had a stroke.
ve rs io n 3 -1 3 /3 /0 9
Click to 
continue..
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End page for illegible respondents
Sorry.................
This calculator is unsuitable for you to use as it cannot give you as an 
accurate estimation as possible.
Many thanks for visiting this website and please tell your friends and family 
who may be interested in this site and taking part in this study.
For further information about the study please contact:
The Research Team at Cardiff University
Cherry-Ann Waldron waldronc@cardiff.ac.uk 
Professor Glyn Elwyn Elwyng@cardiff.ac.uk
For further information about heart health please contact: 
The British Heart Foundation http://www.bhf.org.uk/
•ers ion  3 - 1 3 /3 /0 9
Pre intervention questionnaire measuring nsk perception -  example questions only
Before we calculate your risk.......
Please read the statements below and check the box on the scale 
that most applies to you:
EXAMPLE: I like going on holiday
A re you worried about developing a heart disease in the future ?
Can you indicate on a scale of 1 to 7 how worried you are?'
(with 1 = not at all worried and 7 = extremely worried)
Click to 
continue..
ersion 3 -13/3 /09
lron® *  * r e e  Ne*»er agree S ro r^ r
or disagree oisogree
■
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Risk profile questions 1
In order for us to calculate your risk profile.....
Please check the box that most applies to you
Are you male or female?
Age
(Move curser over scale to 
your age and click once)
f  f
D: □ □ □
50 60 |
Does your family have a history of heart disease?
Has your doctor diagnosed you with any of the following?.
High blood pressure 
(Hypertension)
High cholesterol
(Hypercholesterolemia)
Diabetes
version 3 -13 /3 /0?
myheaiHisk.co.uk
Click to 
continue..
Risk profile qu estion s 2
Just a couple more questions.
Please check the box that most applies to you
Do you smoke?
Do you exercise?
o.uk
Drag arrow to show your height 
and click once.
175.26 cm 
or 
5 f t 9 "
ProgressBa
Drag arrow to show your weight 
and click once.
version 3 -13/3/09
stone Click here for 
calculation
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l i t uk
P lease w a it a few  m om ents  w h ile  yo u r risk is ca lcu la ted .
Progr<ssBa>
version 3 -13/1/09
Risk format page (printable page)
Your calculated risk of having a coronary heart disease (CHD) event 
in the next 10 years is 9%
uk
40
30
RISK
% 20
10
10 year risk
10 years
If you would like to print a copy of this to show your doctor click here
uliiiu
version 3 -13/3 /09 12
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Arrow a ppea rs to gu ide to addition a I in fo pa ge
Your calculated risk of having a coronary heart disease (CHD) event m 
in the next 10 years is 9% y?
40
10 year risk
30
RISK
20
10 years UllUll
If you would like to print a copy of this to show your doctor click here
Pf0{r8!!e» |
version 3 -1 3 /3 /0 9
k.co.uk
13
A Coronary Heart Disease event has been defined as:
Myocardial Infarction (heart attack)
Fatal CHD (death from coronary heart disease)
Or Cardiac Procedure (medical procedure involving the heart)
For more information about any of these, please visit the BHF website 
using the link at the end of this study.
Click to returnProgress Bar
version 3 -13/3/09
649
Print out page for GP- Details of study and respondents personalised risk estimate 
Dear Doctor.
Cardiff
U N tV tR S ITY
P RIFYSG O LCAfRDY0
o.ufc
This printouthas been produced as your patient has taken partin a study by Cardiff University looking into 
peoples' attitudes and perceptions of heart disease risk.
A rudimentary assessment of risk was carried out using a published prediction tool that uses self-reported 
data. It categories 10 year risk of a coronary heart disease event (M I. fatal CHD or cardiac procedure) into 
high (over 20%). medium (10-20%) and Low (under 10%). Respondents in this study either had their 10 year 
risk or longer-term (30 year) risk projected to them.
Please find below, your patients personalised risk according to this prediction tool. All respondents were 
advisedto discuss their risk with their doctor before making any necessary changes to reduce their risk.
For further information please contact:
Cherry-Ann Waldron ald io ixard iff ac.uk 
Professor Glyn Elwyn f I ng.w.u diff.ac.uk
40
RISK 3C
%
2C
1C
version 3 - 1 3 /3 /0 $ 10 years is
Post intervention questionnaire -  example questions onfy
Please read the statements below and
check the box on the scale that most applies to you:
Ne»>er agree 
or disagree
EXAMPLE: I like going on holiday
Please indicate your response on the scales
definitely do Q  definitely do
.......................intend to stop smoking
After viewing your results how worried/disturbed do you feel?
(1= not worried at all. 7= vety worried)
version 3 -13/3/09
650
End of study page
Many thanks for taking part in this study m
For further information about the study please contact:
o.uk
Cardiff
U N IV I R SlTY
P R I F Y S G O LC^RDyjV
The Research Team at Cardiff University
Cherry-Ann Waldron rldron cyai(tiff ac.uk 
Professor Glyn Elwyn El.yng ' cardiff.ac.uk
For further Information about heart health please contact:
The British Heart Foundation 
http ://www. bhf.org.uk/
British Heart Foundation main telephone number: 020 7554 0000 
Heart Help Line: 0300 330 3311 (open Monday to Friday 9am-6pm)
If you would like further information about this study and your participation in it, 
or would like a copy of the results once they have been published
Please click here:
version 3 -13/3 /09 17
Forfurtfi er information
Please enter your contact details
Name:
Email:
Telephone:
Address:
enter
enter
enter
Enter
Preferred method of contact: Email:
Telephone: |  
Letter
Nature of enquiry: More details of study
Details about your participation 
Copy of published results 
Other: (please specify)
Free text box
■■■■
version 3 -1 3 /3 /0 9
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Last page
i | L
Thank you
Your details have been submitted.
A member of the research team  will contact you shortly
version 3 -1  Ji'3/09
Flowchart of web pages
Consent?
Non consent 
End page
Home page
Patient Electronic
- information
page
-  ' Disclaimer -  » consent
form Yl
NoteNgfole 
End page
EKgfciKty
page
O fib ie?
Randomisation
Randomised to
I ' 1 Control condition?
YES
Coronary heart 
disease 
definition pace
Pre-
intervention
questionnaire
Printout
page Coronary heart disease 
definition?\  YES -----------
Print out? Risk presentation 
page 
(See flowchart 2)
NO Risk profile 
questionnaire
YES
Please wait page <-
NO
More information i YES
Post-
intervention
questionnaire
Thank you 
end page
End of 
study page
NO
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Appendix 31. Hypothetical risk profiles created for phase 1 of pilot testing.
Hypothetical risk profiles
Risk factors
1 2 3 4 5 6 7 8 9 10 11
Sex Male Female Male Female Male Female Male Female Male Female Female
Age 62 50 52 56 50 48 52 46 59 47 45
Family History Yes No Yes No No No No No No No Yes
High blood 
pressure
No Yes No Yes No No No No Yes No Yes
High cholesterol No Yes Yes Yes No No No No No No Yes
Diabetes Yes Yes No No No Yes No No No No Yes
Smoking status Current Former Never Current Former Current Never Current Never Former Current
Exercising
status
Sometimes Seldom/
Never
Often/ 
very often
Sometimes Often/ 
very often
Never Sometimes Sometimes Sometimes Often/ 
very often
Never
Height 165cm 5ft 6” 186cm 5ft 2” 170cm 5ft 4” 180cm 185cm 5ft 2” 187cm 5ft 8”
Weight 199kg 13st 10lbs 70kg 8st 7lbs 87 kg 9st 6lbs 80kg 78 kg 11st 9lbs 68kg 10st
6lbs
Risk category High High Moderate Moderate Low Moderate Low Low Moderate Low High
Appendix 32. Em ail circulated to re c ru it review ers fo r phase 1 o f p ilo t testing.
Subject: help with my heart risk website
Dear Decision Lab,
In  the meeting on 9th December I  was asking for volunteers to  pilot test 
the website for my trial. The web-site is now ready and I  am looking for 
people to try it out.
I f  you can spare around 10 minutes of your tim e in the next day or so, 
please let me know and I  will give you sheet with questions and a 
hypothetical risk profile to input into the website.
Your help will be much appreciated.
Many thanks,
Cherry-Ann
Cherry-Ann Waldron 
PhD student
Departm ent of Primary Care and Public Health
Clinical Epidemiology Interdisciplinary Research Group
Cardiff University
2nd Floor, Neuadd Meirionnydd
Heath Park
Cardiff CF14 4YS
T: + 4 4 (0 )2 9  2068  7193
E: waldronc@ cardiff.ac.uk
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Appendix 33. Instruction sheet with one of the hypothetical risk profiles for phase
1 of pilot testing.
P i l o t  s t u d y  p h a s e  1 .
For the purposes of this pilot study, please imagine you are the person described 
below.
Please visit www.myheartrisk.co.uk/pilot.html
Work your way through the site, entering the information from the hypothetical risk 
profile and complete the questionnaires.
As you navigate through the website, please make a note of which risk category you 
were given, and any problems and glitches etc. that you experienced.
Also, please state which web-browser you use on your computer.
Many thanks for your help.
H y p o t h e t i c a l  r i s k  p r o f i l e  1
S e x Male
A g e 62
F a m i l y  H i s t o r y Yes
H i g h  b l o o d  p r e s s u r e No
H i g h  c h o l e s t e r o l No
D i a b e t e s Yes
S m o k i n g  s t a t u s Current
E x e r c i s i n g  s t a t u s Sometimes
H e i g h t 165cm
W e i g h t 199kg
R i s k  c a t e g o r y  (e.g. high, moderate, low)_________________
W e b - B r o w e r  u s e d
(e.g. Firefox version 3.0.15 / Internet Explorer 8)___________
F e e d b a c k  ( p r o b l e m s ,  g l i t c h e s  e t c )
Appendix 34. Responses from reviewers in phase 1 of the pilot testing.
Reviewer
1
2
F u n c t i o n a l i t y  o f  w e b s i t e
Can’t go back.
Doctor printout said low when I was high.
Progress bar not to end on the thank you screen
Not clear if it is ok to log out of you don’t want to leave 
details.
End of study page - progress bar doesn’t go to the 
end.
Difficult to select exact weight.
Tried to print page that had risk represented as hearts, 
but took me to next page.
Tried to print that page an site froze -  then switched 
risk category to low when I got back to page
Print page didn’t work.
Accidently clicked on the back button on browser 
during process and took me to homepage -  started 
again.(Don’t know whether this is actually a problem or 
not though).
L a y o u t R i s k  p r e s e n t a t i o n  f o r m a t s M i s c .
Also, one thing I thought about the arrow Don’t understand the point of the 
to show weight -  seemed question marks on the risk graph,
counterintuitive to decrease rather than 
increase weight.
Freezes on male/female/age page (tried twice).
Also, cannot unclick a section.
If you’re aged 45 you have to move the marker across 
and back for the page to move. You should start at 40 
so people can move marker and not get stuck.
On the risk page it initially jumped then 2 
static.
,nd click was
I originally ticked former smoker -  all 
smoking questions 34-41 were about 
smoking -  N/A (also, cannot turn page 
unless answered questions).
Family history of heart disease -  not 
known.
Fleight in cm -  older people use feet and 
inches.
Question marks on bar graph 
unclear - 1 think block of colour 
and number would be better.
Q what are the possible 
benefits o f taking part? -  
participant may expect the 
1st time to be ‘ you will 
receive a personalised, 
approximated 
measurement of your risk 
of heart disease -  future 
risk of heart disease 
estimated.
Who is funding this 
research?- not BFIF? 
Worth mentioning?
Further info -  should your 
name + details be provided 
also?)
I went to the more info section right at the end and 
then changed my mind so clicked ‘back’ and it just 
went back to the home page so I couldn’t go back and 
print the results.
Questions 60 to 65 on Likert scale it 
states negative response items only on 
either side of the scale.
Didn’t spot too many glitches, but 
when it came to the part where it 
calculated my risk profile I got a 
row of hearts with question marks. 
I don’t know what that’s supposed 
to mean, but I found this a bit 
puzzling.
Everything else was clear 
and worked very well. I 
liked the progress bar at 
the bottom.
Wasn’t sure whether the click to continue button would 
take me through all of the info at the beginning.
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The weighing scales were a little difficult to get the 
exact weight as they’re very sensitive. Could you 
maybe have an alternative box to enter numbers?
8  Dragging the marker for height was tricky -  it didn’t 
work until I clicked over it a number of times, then 
worked ok.
When I clicked through to entering contact details and 
changed my mind, the back button doesn’t work.
When I clicked submit when the details were empty, it 
confirmed details have been submitted -  maybe a 
message could be added saying ‘please enter details’ 
before the user is allowed to click ‘submit’ and 
progress to next page.
Maybe because I am using a Mac, each section took 
two clicks on the mouse rather than 1.
Pre Q -  all questions all of the time?
Q 6 0 - 6 5  -  2  x  strongly disagree etc (2 
negative anchors).
I like the layout and design of the site -  
simple and eye catching.
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/ thought it was easy to follow and very professional! There is an issue with qns 60-65, both 
ends of the scales are labelled the same 
on these questions.
The only other thing is that I 
was unsure how to interpret 
‘how do you normally 
feel/feel now’ questions in 
some cases e.g. upset 
because of external factors, 
or just finding self upset?
Or alert- in a positive way 
or because stressed and 
concerned? I probably 
would answer these with 
different interpretations of 
the meanings pre and post 
survey.
10 Option to print show worry scale results.
When I clicked on CHD for the definition and I clicked 
continue, my calculated risk changed from moderate to 
low.
Back doesn’t work.
When I filled in the question (sex, age etc) a 2nd time a 
different result has been given (hearts instead of bar 
charts).
Why do the ticked boxes turn red?
Colours beige are clickable but not on 
the last page -  blue and underlined 
everyone recognises as a hyperlink.
Why change the answer categories in 
51, 52,53,54 (to right was positive, but 
now to the left and answers are with -, 
while it’s positive.
Different font questions 66-72 and again 
positive thing to do is left now and -3 
etc. and different within the same page.
It could be me, but I find the heats 
with ? in them a bit confusing 
(same with bat chart). The two 
lines (10 hearts) looks very 
different, maybe you could explain 
why there is a difference.
The red hearts look definite, 
(maybe a definite statement to go 
with it?) and pink with ? look like 
you don’t know (maybe a not so 
definite statement here?)
9
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On risk page ‘coronary heart disease’ disappears when 
highlighted -  clicking on this moves up the progress 
bar and continuing take me to a ‘low’ risk page.
Back button on browser doesn’t work as expected.
All info pages are longer than my 
screen, even of very little text on them.
Losing weight Qs have some options for 
high and low numbers.
Items 6 8 - 6 9  a r e  offset to the left.
So people can relate to that, 
because your attention is being 
drawn to the diagrams/ figures it 
might be easier to relate to the 
diagram by using in your 
explanation.
Appendix 35. Email circulated to recruit reviewers in phase 2 of pilot testing.
S u b j e c t :  H e l p  w i t h  p i l o t i n g  a  w e b - b a s e d  t r i a l  o n  c a r d i o v a s c u l a r  r i s k  
c o m m u n i c a t i o n
Dear Clinical Epidemiology IRG members,
I am looking for volunteers to  participate in a piloting phase of a web-based tria l 
on cardiovascular risk communication.
The aim of this pilot is to ensure there are no glitches in the website and that 
everything is user-friendly and easily understood.
I am looking for between 10 and 15 people aged between 45 and 64 (w ithout 
established heart disease) to navigate through the web-site. This will involve 
answering questions to assess your future risk of heart disease, viewing the 
result, and completing a post-intervention questionnaire.
I f  you have 10 m inutes to spare and are able to help, please contact me and I will 
send you the link to  the website. I will be extrem ely grateful.
Many thanks in advance,
Cherry-Ann
Cherry-Ann Waldron 
PhD student
Department o f Primary Care and Public Health
Clinical Epidemiology Interdisciplinary Research Group
Cardiff University
2nd Floor, Neuadd Meirionnydd
Heath Park
Cardiff CF14 4YS
T: +44(0)29 2068 7193
E: waldronc@cardiff.ac.uk
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Appendix 36. Email circulated to those who agreed to participate in phase 2 of
pilot testing.
Subject: Many thanks for agreeing to help with piloting a web-based trial 
on cardiovascular risk communication
D e a r  C l in ic a l  E p i d e m i o l o g y  I R G  m e m b e r ,
M a n y  t h a n k s  f o r  a g r e e i n g  t o  t a k e  p a r t  in  t h e  p i l o t i n g  p h a s e  o f  t h i s  w e b - b a s e d  t r i a l  
o n  c a r d i o v a s c u l a r  r i s k  c o m m u n i c a t i o n .
T h e  w e b s i t e  a d d r e s s  is  w w w . m v h e a r t r i s k . c o . u k
P le a s e  w o r k  y o u r  w a y  t h r o u g h  t h e  w e b s i t e ,  a n s w e r i n g  t h e  q u e s t i o n s  a s  t r u t h f u l l y  
a s  p o s s i b le  ( d o n ' t  w o r r y  i t  is  c o m p l e t e l y  a n o n y m o u s  a n d  y o u  c a n n o t  b e  
i d e n t i f i e d ! ) .
P le a s e  m a k e  a  n o t e  a n d  l e t  m e  k n o w  o f  a n y  g l i t c h e s  o r  p r o b l e m s  y o u  e n c o u n t e r ,  
o r  a n y t h i n g  t h a t  is  c o n f u s in g  a n d  d o e s  n o t  m a k e  s e n s e .
Y o u r  p a r t i c i p a t i o n  is  v e r y  m u c h  a p p r e c i a t e d .
M a n y  t h a n k s  a g a i n ,
C h e r r y - A n n
C h e r r y - A n n  W a l d r o n  
P h D  s t u d e n t
D e p a r t m e n t  o f  P r i m a r y  C a r e  a n d  P u b l ic  H e a l t h
C l in ic a l  E p i d e m i o l o g y  I n t e r d i s c i p l i n a r y  R e s e a r c h  G r o u p
C a r d i f f  U n i v e r s i t y
2 n d  F l o o r ,  N e u a d d  M e i r i o n n y d d
H e a t h  P a r k
C a r d i f f  C F 1 4  4 Y S
T :  + 4 4 ( 0 ) 2 9  2 0 6 8  7 1 9 3
E : w a l d r o n c @ c a r d i f f . a c . u k
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Appendix 37. Phase 2 of pilot testing - Reviewers comments of a positive nature.
Reviewer General comments about the 
site
Participant
information
Disclaimer,
Consent,
Eligibility
Baseline 
affect/worry 
and Pre­
intervention 
questionnaire
Risk assessment 
questions
Risk output Post­
interventions
questionnaires
End of
study
and
Contact
details
page
Reviewer 1 
n-ex
Reviewer 2 
n-ex
We found it very easy to follow and 
the information given was clear.
It's certainly an excellent eye
opener for those who need to 
improve their lifestyle. Well done 
I’m very impressed.
Reviewer 3 
n-ex
Reviewer 4 
n-ex
It looked good.
Reviewer 5 
n-ex
Reviewer 6 
n-ex
The website is easy to follow, 
bright and inviting!
Very clear and concise. I found the 
site both user friendly and friendly.
Reviewer 9 
ex
Generally, I was impressed and 
found it quite easy to navigate etc.
- - - - No problems 
answering any of the 
predictor questions.
- -
Reviewer 10 
ex
Scrolling to see progress bar ok in 
Opera and chrome in kiosk mode.
The black on 
white, sans serif 
typeface is clear 
for the individual 
pages.
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Reviewer 11
ex
Reviewer 12 
ex
Reviewer 13 
ex
Reviewer 14 
ex
Reviewer 15 
ex
Reviewer 16 
ex
Reviewer 17 
ex
I liked it!
Great colour and graphics.
Seems basically fine
Nice website.
Clearly laid out.
Links seemed to work.
Very nice and slick web-site, I 
actually found it very useful, easy 
to navigate and couldn’t find any 
glitches, wording was fine also.
Looks attractive, no significant 
problems at all.
It works very nicely and the 
graphics are great.
Generally easy to use, clear 
straightforward etc.
Reviewer 18 
ex
I liked the 
interactive tools, 
e.g. the weighing 
scales.
I particularly liked 
the adjustable 
pointers for age, 
height and weight.
The system displayed 
my risk pictorially as 9 
men out of 100 - this 
looked OK.
Reviewer 19
ex
Reviewer 20 
ex
Brilliant site. Very easy to navigate 
and great graphic design. 
Appealing and convincing. My 
compliments!
I enjoyed the experience and 
happy to know I’m not about to 
keel over any time soon.
I like the idea of the one pound 
incentive for the Br Heart 
Foundation.
Reviewer 21 
ex
I liked this dragging The bar chart looks The TPB questions 
options. fine. do not seem to take
too much time.
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Appendix 38. Phase 2 of pilot testing - Reviewers comments of a negative nature.
Reviewer General 
comments 
about the site
Participant information Disclaimer,
Consent,
Eligibility
Baseline 
affect/worry and 
Pre-intervention 
questionnaire
Risk assessment 
questions
Risk output Post-intervention
questionnaires
End of 
study and 
Contact 
details page
Reviewer 1 
n-ex 
Reviewer 2 
n-ex
The only problem we 
both encountered 
was setting our 
weight on the gauge. 
We had to leave it as 
close as, as it was 
very sensitive to 
movement.
The only bit I wasn’t sure 
of was the section at the 
end about exercise and 
weight. I wondered if this 
had been calculated from 
the information that I’d 
given and it was 
recommended that I 
exercise more and lose 
weight.
We both 
wanted to 
check 2 
boxes on 
education.
Reviewer 3 
n-ex 
Reviewer 4 
n-ex
When I was reading through 
each of the information items 
from the list at the start, each 
time I closed a particular item 
it took me back towards the 
top of the list, not on the item I 
had just been on so I could 
move on to the next one.
Questionnaire was a bit 
repetitive.
Reviewer 5 
n-ex
No back 
button, 
couldn’t see if 
I’d filled in the
last question 
on a page and 
there was no 
way to go 
back and see.
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Reviewer 6 - The introduction list, I seemed
n-ex to have to step back and
select each item, rather than 
flick forward through it, each 
one seemed clear and short, 
so I would have preferred that.
Reviewer 7 - ‘What is the purpose of this
Ex study’ you give the url of the
website but it is not the same 
as the URL that displays in the 
browser status bar.
‘will my taking part be kept 
confidential’ you say ‘..at an 
agreed period’ rather than 
‘..after an agreed period.
‘what do I need to do now?’ 
you instruct to navigate to the 
electronic consent page, yet 
the only button available is a 
‘continue’ button. It would be 
better to say press continue 
button which will take you to 
the consent page.
Dials with moving 
needles -  could 
perhaps be bigger.
I wonder whether 
there should be 
some comparators to 
the risk statistic- 
perhaps the 
difference from 
average, or the 
percentage of 
improvement if 
lifestyle is changed. 
Something to 
improve the 
understanding of the 
message.
I don’t understand 
the purpose of the 
two buttons marked 
‘moderate risk’ and 
‘high risk’
I don’t think I understood 
some of the option about 
fear and exercise fully, so 
may have flipped through 
without giving them 
enough attention, so 
perhaps reducing their 
value.
In Qs 51-54 the numbers 
attributed to each level of 
difficulty. Etc. seem 
intuitively to be the wrong 
way around. I would 
expect to select -3 for 
difficult for example rather 
than +3. Ditto for 66-69.
Q60 asks if I am prepared 
to lose weight. Is it asking 
me if I am ready to try 
losing weight or if I am 
willing to try losing weight, 
which are not the same 
thing.
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Reviewer 8 
Ex
Reviewer 9 
Ex
At whom is Scrolling is still a pain,
this aimed?
The language This really needs to retain and
used appears indicate where the participant
to be above 9 has visited, otherwise they
-year-old/sun won’t know where they have
reader literacy been. A ‘next’ option would be 
level. handy, but there is a lot to
wade through.
What are the disadvantages 
or risks of taking part? Typo: 
‘we recognise that viewing you 
risk...’
What if something goes 
wrong? -  professor Glyn 
Elwyn, line break
I didn’t like being 
asked if I was 
ashamed or 
nervous (I assume 
that was for 
personality type) it 
seemed irrelevant 
and intrusive.
Do you smoke? -  if 
this question is 
missed and ‘click to 
continue’ clicked, the 
'please answer all 
questions’ message 
is displayed. If 
smoking is answered 
and ‘click to continue’ 
clicked, the survey 
goes to the next 
page, even if the 
other 3 qs (exercise, 
height and weight) 
are missed. I had a 
very good result, 
presumably because 
it thought I was 
130cm high and 
weighed 25kg! I have 
not checked all 
combinations on all 
pages.
Would have liked to 
see stones and 
pounds rather than 
kilos
Blue link text on the 
basic calculated 
display disappears 
when highlighted.
If question 56 is missed it 
is highlighted. If it is 
subsequently filled in but 
something else is missed, 
it is still highlighted.
Do you intend to have the 
values for answers 
showing, especially for qs 
51-54, 66-69, etc. 
(negative scores for 
positives, positive scores 
for negatives).
Progress bar 
still had a 
way to go 
once I’d 
finished.
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Reviewer 10
ex
Under disadvantages, in line 1 
it should be your, not you.
In the what if something goes 
wrong, the formatting of Glyn 
is a bit odd.
In the what will happen to the 
results, the punctuation is a bit 
odd in the second paragraph.
In what do I need to do now,., 
the questionnaire.
Reviewer 11 
ex
Question about high 
cholesterol - 1 don’t 
think that is very 
clear. How high does 
it have to be to be 
counted as high? 
Does the total have to 
be 5.5? 6? 7? What 
about the ratio of low 
hdl to high? I’m not 
sure that will get clear 
answers. And clearly 
the risk does depend 
on whether it is 6 or 
10?
Explanation of CHD 
event -  don’t think Ml 
or cardiac procedure 
were as helpful to a 
layperson as it could 
be.
Wasn’t clear why we had 
to go through the first set 
of questions again, about 
being angry, anxious etc. 
-  some explanation might 
help. It was tempting to 
just give the same 
answers as before without 
thought.
Q 69 was hard to answer 
-  forgot to write it down.
Q 48-51 -  isn’t entirely 
clear what you are 
supposed to read here -  it 
may be that patients 
might be confused and 
think the question has 
been missed off.
Also, the scale on Qs 51- 
54 is confusing given 
what has gone before, 
why not just use 1-7 as 
above?? Same with other 
questions using this 
scale.
Page with Q60-65 -  
programme got stuck 
after complete all qs and I 
couldn’t move on.
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Reviewer 12
ex
Reviewer 13 
ex
Reviewer 14 
ex
Font sizes Long list of questions was off- Language is a
differed and putting. Was I supposed to bit high brow
the information read them all, or just click on (published
in largest font the ones of interest, or ignore prediction tool,
did not always and continue? self-reported
seem most information)
important. This The subjects should have to
seemed a bit work through each question to
of a distraction get to the next page- at least
-  maybe the then the content is in front
better all the of them if only for a few
same size? seconds. If people are 
sufficiently interested to go on 
the site, they should be 
sufficiently interested to read 
information sheet.
- Would be helpful to have Consent -  a
some links here. ‘back’ button
-What do I need to do now - would be helpful
maybe a link to take you in case the
straight to the consent screen. person wants to
-what if you have other review the
concerns -  clickable email link participant
to Prof Elwyn, or a link to the options again
Contact details screen before
-The email on the contact 
details doesn’t work.
consenting.
Q16 suddenly has 
numbers -3,-2,- 
1,0,1,2,3 rather 
than previous 
1,2,3,4,5,6,7 
which was a bit 
confusing. Also, 
the minus end 
was sometimes 
associated with 
the most positive 
response 
(easy/rewarding).
The line joining 3 
boxes for do you 
smoke and exercise 
questions suggested 
a visual analogue 
scale. Why have it? 
The boxes alone 
would be clearer.
I don’t consider I need to 
lose weight and so all the 
losing weight section 
seemed irrelevant and a 
bit irritating. Is it not better 
to exclude this if BMI 
below 24?
Weight adjustable 
pointer is very 
sensitive and a bit 
fiddly.
Would be nice to be 
able to print off your 
risk profile at the end, 
not just request it by 
email -  it would also 
preserve your 
anonymity.
Weight reduction -  q69. 
‘difficult is mis-spelt.
Last page 
told me I 
could close 
the browser, 
yet progress 
line was only 
90% 
complete.
We are sorry 
you do not wish 
to take part -  a 
‘back’ button 
might be helpful 
as well in case 
the person 
decides to 
change their 
mind.
A ‘quit’ button to 
confirm their 
decision and 
take them out of 
the website.
Disclaimer -  
this mentions a 
published 
prediction tool. 
It would be nice 
if this were 
referenced, or if 
there was a link 
to it, for anyone 
who wants 
further info.
Reviewer 15 
ex
List at beginning very long and 
a bit intimidating -  is this 
necessary- it almost made me 
turn off.
Family history -  you 
have risk as being 
event below 50 -  
most other 
assessment make it 
60.
I was a bit surprised
The questions at the end 
here have no real 
introduction -  so their 
purpose is not clear - 1 
think a few introductory 
words ‘Now we’d like to 
check out your views on 
taking more exercise and 
losing weight...’ or similar.
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Reviewer 16 
ex
The back What will happen if I don't - Page 'Before we
button on the want to carry on with the calculate your
browser study? You can withdraw from risk': are we
doesn't work the study at asking how
with this site - any point by closing the web worried they feel,
is this browser.' Is this really what or how
deliberate? you want to happen? There concerned? I'm
Desirable? I are various concerned re my
would have reasons why a web browser heart disease risk
liked to go can close without implying - but not worried. I
back, if only to intention to withdraw - realise that this is
see the pages crashes, navigating my most likely
I missed. away and not being able to pathway
Obviously get back, being called away of death. I am
we don't want and the kids then start using taking reasonable
people to be the computer, steps to minimise
able to alter etc. Better for the system to my risk. I have
what they require deliberate withdrawal, plenty else of
responded and allow return after more immediate
before seeing interruption - concern.
their risk - though detect if they never
but I'm not return within a specified time
sure that, after frame and count that as a
this stage, it is withdrawal.
appropriate to 
prevent them 
doing so.
that although I ticked 
box for raised 
cholesterol there was 
no further details 
requested here - 1 
came out as low risk 
but surely if my 
cholesterol was high 
this would not be 
accurate.
Click to continue after 
questions 31-33 didn't 
work, first, but then it 
jumped to questions 47- 
54.
Maybe I clicked twice, 
thinking the first click 
didn't register. Though 
one isn't allowed to move 
forward from other pages 
that require responses - 
???
Questions 51-54 are 
appropriately scored as -3 
to +3 for analysis - but 
this might be off-putting to 
numerically challenged 
respondents - why switch 
from using 1 to 7? Ditto 
66-69.
Are questions 60-65
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Reviewer 17 
ex
Grammatical 
amendments 
needed on 
participant 
information, 
see email.
Once on the 
consent page, I 
don’t think I 
actually saw it 
labelled as a 
‘consent page’. 
Possible to give 
it that heading?
appropriate to ask of 
someone for whom there 
would be no great 
advantage to losing 
weight? I don't like my 
trousers being tight 
around my waist, but I 
don't feel inclined to 
actively lose weight for 
health reasons - 1 don't 
think you do either. Do 
the questions I missed 
seeing ask about smoking 
cessation intentions, or 
are such questions only 
asked to respondents 
who say they smoke?
I would have 
loved a 
‘close’ button 
of some kind 
on the very 
last page 
instead of 
just the 
advice to 
close the 
browser. A 
psychologica 
I thing, I 
guess, I 
want to know 
I’ve rounded 
off
something, 
completed 
something.
Q51: hesitated a long Closing the
Q33 -  didn’t know what to 
answer here, my 
indicated risk was very 
low but of course ‘do as 
much as you can’ is the 
only answer possible 
even when you’re at low 
risk.
Similar for Q60: of course 
I am prepared to lose 
weight but how does this 
fit in with weight not being 
an issue in some cases? 
Guess the problem is that 
I don’t quite see what 
these answers would tell 
you.
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Reviewer 18 
ex
Should give 
info about 
responding 
time (about 10 
mins) at the 
beginning.
There was no 
escape during 
the process.
Does this 
mean that you 
will only 
generate data 
on participants 
who have 
gone through 
all pages? Will 
you not file 
non- or 
incomplete 
responders?
I had to zoom
there is a risk that people 
might be mislead regarding 
the source of this website, 
which is Cardiff University and 
not Br Heart Foundation
The questions on 
exercise or play sport; 
Shouldn't you define 
what is exercise? Is 
regular walking or 
cycling, e.g. to work, 
exercise?
time here as to how to 
interpret the sudden 
switch to the -3,-2,- 
1,0.1,2,3 answer 
format..numbers are not 
my strong point and even 
now I’m not quite sure if I 
gave the answers I 
intended to give.
I was confused by the 
difference in answering 
scales. It was all 7-point, 
which is fine. But 
sometimes the scale was 
-3, to +3 (e.g. in questions 
51-54) instead of 1 to 7 .1 
would opt for the latter 
format only.
browser just 
means I’m 
moving on to 
something 
else and 
leaving 
something 
‘open’ 
behind me. 
It’s all in the 
mind, I 
know, but it 
does make a 
difference, I 
think.
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out to view the 
complete 
home page.
Reviewer 19 
ex
Change what if something 
goes wrong to “What If I have 
concerns/ What if I become 
worried?’
Change ‘Why have I been 
chosen? To ‘Why am I eligible’
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Appendix 39. Final version of the website used in the RCT.
myHeartRisk n f l
W elcome to myHeartRisk.co.uk
A web tool that predicts your future 
risk of heart disease
We will donate £1 to the British Heart Foundation, for 
every person who takes part and completes the study. 
We aim to raise over £1,000
myHeartRisk.co.uk
Pioqiess
A stidv rtfo pnbi< perceptions of heart disease risk
myHeartRisk
Participant Information Sheet
Please read this information carefully.
Click on the arrows to move down the page and dick 'continue' when you 
are ready to proceed.
Introduction
You are being invited to take part in a research study by Cardiff University. 
Before you make a decision about whether to take part it is important for you 
to understand why the research is being done and what it will involve. Please 
read the following information carefully and discuss with others if you wish. 
Take time to decide whether or not you wish to take part You are welcome to 
contact us if you have any questions or require further information.
What is the purpose of this study?
Heart disease is the biggest killer in the UK and lots of people are unaware they 
are at risk from it. Heart disease risk can be reduced by making changes to 
lifestyle, such as adopting healthier behaviours or taking medication.
6 7 6
Progress m  _______________________ _  owpuf
A study into pubU perceptions ot heart disease risk
myHeartRisk
Disclaimer
You will be presented with an estimation of your future risk of heart disease 
calculated from the information you give us.
This estimation is an indication of risk and is not a medical diagnosis.
We are not able to enter into personal discussions about your heart disease risk; 
you must visit your doctor for this.
3 1
myHeartRisk
Consent Page
Please read the following statements and check the appropriate box
1 I confirm I have read the information about this study.
2 I understand my participation is voluntary and I am free to withdraw from the 
study at any time.
: I have read the disclaimer and understand that this study provides an 
estimation of my future risk of heart disease, and I am to visit my GP if I am 
interested in having a more formal clinical assessment
4 I agree to take part in the study.
■  I agree with the above statements
■  I disagree with the above statements
t'ontmup
Progress 8 S 2 S
* A st trty into publc \ errephons of host nsk C»KPW
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myHeartRisk 31
Are you eligible to take part?
Please read the following statements and check the appropriate box.
I am between 45 and 64 years of age.
I have never been previously diagnosed with heart disease, had a heart attack, 
other cardiac event (e.g. angina) or had a stroke.
■  I agree with the above statements
■  l disagree with the above statements
Progress
A st idy into pubic perceptions of head disease nsk
myHeartRisk
3 1
Before we calculate your risk, we would like to find out about 
how you generally feel.
Please read the following statements/ questions and check the number 
that best corresponds to you.
Thinking about yourself and how you normally feet 
to what extent do you feel:
l. Upset Never | ] E □ □ E  Always
2. Hostile Never | | B B □ E  Always
3. Alert Never Q B □ □ E  Always
4. Ashamed Never ( ] B B D E  Always
5. inspired Never Q B □ □ E  Always
6. Nervous Never | | B D □ E  Always
7. Determined Never Q B □ □ E  Always
8. Attentive Never [ ] B B □ E  Always
9. Afraid Never Q B □ □ E  Always
10. Active Never | ] B □ □ E  Always
11. How worried do you feel about developing heart disease in the future?
Not at all worried D  B  D  D  B  Very worried
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A st idy into pubic perceptions of heart disease nsk
myHeartRisk Ml
Please read the following questions/statements and check the boxes that best 
corresponds to you.
12.1 think my risk of heart disease in the next 10 
years is_
High
13.1 want to reduce my risk of heart 
disease
14. The decision to reduce my risk of 
heart disease is mostly up to me.
1 S. People who are important to me 
want me to reduce my risk of heart 
disease.
“22 ■ B B D B □ ■ £ £
Strongly
B  B  D  D D  D  D Disagree
D  O  O  O  D  0 ^ 2 2
Reducing my risk of heart risk would be...
16. Easy E  E  B  □  f l  B  B  Difficult
17. Rewarding E  E  B  □  D  □  □  Unrewarding
18. Undesirable E  E  B  □  D  B  B  Desirable
19. Worthless E  E  B  D  D  B  B  Worthwhile
Progress
A study into public perceptions of hosd diseise nsk
myHeartRisk
In order for us to calculate your risk profile, 
please answer the following questions.
Ml
Are you male or female?
(Please dick on the appropriate box)
What is your age?
(Drag the marker over the scale to 
show your correct age) 50 55 60 64
Does your family have a history of heart disease?
(By family history we mean <kd you have a parent who was under the age of 50, 
when they were told by their GP/Physician that they had a heart attack. If this is 
unknown please answer ho' J
Has your doctor diagnosed you w ith any of the 
following?
High Blood pressure (Hypertension)
High cholesterol (Hypercholesterolemia)
Diabetes
mmO
m ■
uao
■ ■
B■
■ ■
— — J jg S !
■ K i£ ij3
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myHeartRisk
Just a couple more questions...
Please check the box that most applies to you. 
Do you smoke?
No, I have never 
smoked
I have smoked in the  
past but no longer
Yes. I smoke regularly 
or I have smoked 
within the last year
Ml
Do you exercise or play sport in your leisure time?
Often or Very Often Sometimes Seldom or Never
Drag the marker to 
show your correct 
height
Drag the arrow to 
show your correct 
weight.
0  ISO 160 170 180 190 200 210
25 Kg
3 Stone 13 I s
A study into pubic perceptions of hea t^cSsease rtsk
myHeartRisk
Your calculated risk of having a coronary heart disease event 
in the next 10 years is Low (under 10%)
1 0 0  -i
90 - 
80 - 
70 - 
60 - 
50 - 
40 
30 - 
20 -  
10 -  
0
Risk %
~y Risk = Low
(Somewhere under 10%)
10 years
M l
Click on the blue link to view the definition of a coronary heart disease event.
Progress
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myHeartRisk M
Your calculated risk of having a coronary heart disease event 
in the next 10 years is Moderate (between 10 and 20%)
100
Risk%
Risk = Moderate
(Somewhere between 10% and 20%)
10 years
Click on the blue link to view the definition of a coronary heart disease event.
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A study into public perceptions of heart disease risk
myHeartRisk
Your calculated risk of having a coronary heart disease event 
in the next 10 years is High (over 20%)
100 -  
90 - j 
80 
70 - 
60 
50 - 
40 - 
30 
20 
10 
0
MI
Risk% - Risk = High 
(Somewhere over 20%)
10 years
Click on the blue link to view the definition of a coronary heart disease event.
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myHeartRisk w t l
Your calculated risk of having a coronary heart disease event
in the next 10 years is Low (under 10%)
This means that less than 10 people in every 100 like you will have a coronary 
heart disease event in the next 10 years.
N / X / V ' N / V ' X / S / X / N / people like you who may 
have a coronary heart 
disease event.
Click on the blue link to view the definition of a coronary heart disease event.
myHeartRisk f it  I
Your calculated risk of having a coronary heart disease event 
in the next 10 years is Moderate (between 10 and 20%)
This means that somewhere between 10 and 20 people in every 100 like you will 
have a coronary heart disease event in the next 10 years.
\ / S / S / S / V ' v ^ S / ' s / V ' ' v /
w w w w w v
▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼
people like you who wiH 
definitely have a coronary 
heart disease event.
people like you who may 
have a coronary heart 
disease event
▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼ ▼
Click on the blue link to view the definition of a coronary heart disease event.
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myHeartRisk fit I
Your calculated risk of having a coronary heart disease event
in the next 10 years is High (over 20% )
This means that more than 20 people in every 100 like you will have a coronary 
heart disease event in the next 10 years.
people like you who will 
definitely have a coronary 
heart disease event.
people like you who may 
have a coronary heart 
disease event.
Click on the blue link to view the definition of a coronary heart disease event.
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Ml
moderate risk
high risk
myHeartRisk
Click on the blue link to view the definition of a coronary heart disease event.
Continue
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Your calculated risk of having a coronary heart disease event 
in the next 10 years is Low (under 10%)
.jIuEMS
............I
myHeartRisk ftt I
Your calculated risk of having a coronary heart disease event 
in the next 10 years is Moderate (between 10 and 20%)
tM9hmk
Click on the blue link to view the definition of a coronary heart disease event.
A study into public perceptions of heart disease risk
myHeartRisk
Your calculated risk of having a coronary heart disease event 
in the next 10 years is High (over 20%)
ntl
Click on the blue link to view the definition of a coronary heart disease event.
■ ■ ■ ■  I
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myHeartRisk
i t l
A Coronary Heart Disease event is defined as:
Myocardial infarction (heart attack)
Fatal CHD (death from coronary heart disease)
or Cardiac Procedure (medical procedure involving the heart)
For more information about any of these, 
please visit the BHF website using the link 
at the end o f this study.
Continue
lOPP’ff
A s tu d y  in to  p ub lic  p e rce p tio n s  o f  h e a rt d isease risk
S I
Now you have seen your risk, we would like to see if your feelings 
have changed.
Please read the following questions/statements and check the number that best 
corresponds to you.
myHeartRisk
Thinking about yourself right now at this present moment to what extent do 
you feel:
20. Upset Not at ail D B □ □ B Extremely
21. Hostile NotataD D B □ D B Extremely
22. Alert Not at all D B □ D B Extremely
23. Ashamed Not at all D B □ □ B Extremely
24. Inspired NotataD D B □ D B Extremely
25. Nervous Not at all D B B □ B Extremely
26. Determined Not at all D B □ □ B Extremely
27. Attentive Not at all D B □ □ B Extremely
28. Afraid Not at all D B □ □ B Extremely
29. Active NotataD D B □ D B Extremely
30. After viewing your results, how worried do you feel about developing heart disease in 
the future? Not at all worried O B □ □ E3 Veryworried
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Please read the following questions and check the option that best 
corresponds to you.
31. What art your chances of having a coronary heart disease event in the next to years?
■  I am at low risk of having a coronary heart disease event in the next 10 years
■  I am at moderate risk of having a coronary heart disease event in the next 10 years. 
|  I am at high risk of having a coronary heart disease event in the next 10 years.
32. How confident are you that you have understood the risk information given to you?
£ £  D  D  B  D  E  D  °  confident
33. What should someone in your risk category do to change their risk of heart disease?
■  Do nothing to reduce their risk.
■  Try and do a little bit to reduce their risk.
■  Do as much as they can to reduce their risk.
■■■■■III
myHeartRisk Ml
We would now like to ask your views on some of the ways that could help reduce the risk of 
heart disease.
The following questions and statements are about smoking.
Please check the number that best corresponds to your views on this.
34. To what extent are you 
prepared to stop smoking?
35. How likely are you to stop 
smoking?
36. Most people who are important 
to me think that L -
Compieteiy _ _ _ _ _ _ _  Completely
unprepared D □ □ □  B □  □ prepared
unfifeh D D B D B D O ^
Should not _ _ _ _ _ _ _  Should slopE C E C D D DHop smoking unofcing
For me. stopping smoking would be.
37. Bad E E B B D B B  Good
38. Harmful E E B D D B B Beneficial
39. Unpleasant E E B □ D B B Pleasant
40. Difficult E E B □ D B □ I
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myHeartRisk MI
The following statements are about smoking.
Please check the number that best corresponds to your views on this.
41.1 intend to stop smoking Strongly
42. Whether I stop smoking or not 
is entirely up to me.
43. I feel under social pressure to 
stop smoking.
44. The decision to stop smoking is 
beyond my control.
45. I am confident that I can stop 
smoking.
Disagree
Strongly
D □ E3 D E C D
Disagree B □ B D B B B
D D D O G D OStronglyDisagree
££  B B B D E D B
Strongly B B B O B □ B
Disagree
Strongly
Agree
Strongly
Agree
Strongly
Agree
Strongly
Agree
Strongly
Agree
46. It is expected of me to stop 
smoking.
B □ B □ B B B StronglyAgree
A st .idy nto public perceptions of heart dtsease risk
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We would now like to ask your views on some o f the ways that could reduce your risk of 
heart disease.
The following questions and statements are about exerdsing.
Please check the number that best corresponds to your views on this.
47. To what extent are you conpieteiy 
prepared to exercise more? unprepared
48 How lately are you to 
exercise more?
Very
unlikely
B B □ □  B □  B
D □  □ D B B □
Completely
prepared
Very
likely
MI
49. Most people who are
important to me think that L.
Should not Should
exercise B E B D B B B 
more more
For me, exercising more 
would be_
50.
51.
52.
53.
A negative thing to do E E B □  D B B Apo”®v*
thing to do
UnenjoyaWe E E B G D B B Enjoyable
Difficult b  E B □ B B B
useless E E B □ B B B Useful
PlogitSi ........................1 ■" 1 ■■■........................  . gssff
retrace*
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myHeartRisk 31
The following questions and statements are about exercising.
Please check the number that best corresponds to your views on this.
5 4 . I intend to exercise more. Strongly
Disagree D D D D B Q D
■
Strongly
Agree
Whether I exercise more or strongly
s5- not is entirely op to me.
I feel under sociai 
56- pressure to exercise 
more.
Disagree D □ B B E3 B D
B □ B B B B B
The decision to  exercise Strongly
more is beyond my control. ftsagree
I am confident that I can 
exercise more.
D □ B D B □ B
Stro™,ty D B B B B □ BDisagree
Strongly
Agree
Strongly
Agree
Strongly
Agree
Strongly
Agree
M  it is expected of me to 
exercise more. £ £ n o n n u n n
—
3 1
myHeartRisk
We would now Bke to ask your views on some o f the ways that could reduce your risk o f 
heart disease.
The following questions and statements are about losing w eight
Please check the number that best corresponds to your views on this.
60. To what extent are you 
prepared to lose weight?
Completely | |  Q  Q  Q  Q  Q  Q  Complete* 
Unprepared Prepared
61. How likely are you to 
lose weight?
Very
Unlikely D B B □ B □ B VeryUke*
62. Most people who are 
important to me think 
that I..
£ £ 2  B B B D O O O £ “ *,
For me losing weight would be._
63.
64.
65.
66.
The wrong thing to do E E D D B O D The r ig h t thngtodo
Unsatisfying E fi D B B B B Satisfying
Unhelpful E E D □ B B B
Difficult B B B D B B B [45y
• ' | __  '
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The following statements are about losing weight.
Please check the number that best corresponds to your views on this.
67. 1 intend to lose 
weight
Strongly
Disagree
D B B B B □ B Strongly
Agree
68. Whether I lose weight or not is 
entirely 14) to me.
Strongly
Disagree D B □ □  □ □ □
Strongly
Agree
69. 1 feel under social 
pressure to lose weight
Strongly
Disagree D B □
□□ B B
Strongly
Agree
70. The decision to lose 
weight is beyond my 
control.
Strongly
Disagree D B □
□□
D □ StronglyAgree
71. 1 am confident that 1 can 
lose weight.
Strongly
Disagree D B B B B □ B
Strongly
Agree
72. It is expected of me to 
lose weight.
Strongly
Disagree D □ □
□□a
□
Strongly
Agree
myHeartRisk
In order to find out more about the people who have used this site, we 
would be grateful if you could provide the following information.
73. What is your level of education?
(Please check the box corresponding to the highest level attained)
■  Left school before age 16 (no formal qualifications)
■  Left school at 16 (G C StCStO  level or equivalent)
■  Left school at 18 (A levels or equivalent)
■  CoHege certificate or diploma
■  University degree or higher
■  Other (please state) |
■  Do not wish to disclose
74. Where did you And out about this website?
■  Email invitation at workplace (please state workplace)
■  Found link on the internet (please state website)
■  Social networking sites
■  From personal contacts
■  Poster or card advertisements
■  Advertisement in local newspaper
■  Other (please state)
Piogiess
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myHeartRisk
End of Study
Many thanks for taking part in this study
If you would like us to send you an electronic copy of your risk 
output to take to your doctor, or would like further information 
about the study, please dkk here.
If not you may now dose the web browser.
ttfl
For further information about the study please contact:
JggjQj Research Team at Cardiff University
Cherry-Ann Waldron WaldronC**card iff.ac.uk 
Professor Glyn Elwyn 0wynGtdcardrff.ac.uk
For further information about heart health please contact
The British Heart Foundation 
httpy/www.bhf.org.uk/
British Heart Foundation main telephone number: 020 7554 0000 
Heart Helpline: 0300 330 3311 (open Monday to Friday 9am-6pm)
Progress
A study mfo puhl r  perceptions of heart disease nsk
myHeartRisk
Please enter your contact details
Name:
Email:
Telephone:
Address:
Preferred method of contact: 
Nature erf enquiry
Email ■  Telephone ■  Letter
If you w ould like us to  send you an electronic copy o f your risk ou tp u t please 
check the box and remember to  leave your em ail address.
A study into puhl/: perceptions of heart disease nsk
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myHeartRisk
Thank you
Your details have been submitted.
A member of the research team will contact you shortly
You can now close the web browser.
J jp g g i
■ ■ ■ ^ ■ i
Appendix 40. Why the original algorithm was biased towards two conditions.
Adobe Flash gets a random value between 0 and 1 by calling the built in flash 
function Math.random. This value is inputted into the following equation.
Flash calls the Math.random function to generate the number to be inputted into the 
following algorithm.
Algorithm: Pathway = Math.round ( 3 x Math.random() )  +1
For example,
Random value = 0.74
1) Pathway = Math.round (3 x 0.74) + 1
2) Pathway = Math.round (2.22) +1
3) Pathway = 2+1
4) Pathway = 3
Taking the +1 into account (to compensate for the random number starting 
from 0 and going up to 3), the following applies:
To end up with 1 = the random number needs to be in the range 0 to 0.49999.
To end up with 2 = the random number needs to be in the range 0.50 to 1.4999.
To end up with 3 = the random number needs to be in the range 1.50 to 2.4999.
To end up with 4 = the random number needs to be in the range 2.50 to 3.
Due to the nature of the Adobe Flash function math.round rounding up or down to the 
nearest integer, the number 2 or 3 has double the chances of being created.
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Appendix 41. The alternative algorithm used by the website for randomisation.
Adobe Flash gets a random value between 0 and 1 by calling the built in flash 
function Math.random. This value is inputted into the following equation.
Flash calls the Math.random function to generate the number to be inputted into the 
following algorithm.
A lg o rith m :
H igh  = 4  
L o w  = 1
Pathway = M a th .f lo o r  (M a th  ra n d o m ()* (1 + H ig h -lo w ))  + L o w
Pathway = remove any numbers following the decimal place from (random number 
generated by Math.random between 0 and 1 x (1+(4-1)) + 1
Pathway= remove any numbers following the decimal place from ( Random number 
between 0 and 1 x (1 + (4-1)) + 1
For example:
Random value = 0.7
1) Pathway = remove any numbers following the decimal place from ( 0.7 x (1 + 
(4-1))+1
2) Pathway = remove any numbers following the decimal place from ( 0.7 x 4) + 1
3) Pathway = remove any numbers following the decimal place from 2.8 + 1
4) Pathway = remove any numbers following the decimal place from 3.8
5) Pathway = 3
Appendix 42. Screenshot of the dummy runs of the random pathways using original and
alternative algorithms.
0  C'>U*nVChmy *«iNAe»0«tt\teaAT«mp\dBnej<d„lDmi*-l*' Mndmn Ctpkxtf
 ^±  C :\U tm f.a*rrr-IM \AftD tU M oar.lm f\dm a_oH h * \ * t  a ! > - -
^  * Q - •  * ***>- Tm»i * # •
P a th w a y  to ta ls
1. 165
2. 321
3. 328
4. 178
»  C o^Mto I h a m  Mode cm
9  C niM O xyM iM M i SMy< link. # .
Pathway totals
1. 257
2. 214
3. 243
4. 246
1 - «,M0\ -
Top left screen = original algorithm. 
Bottom right screen= new algorithm.
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Appendix 43. Goodness of fit Chi-square tests on the dummy runs of the original and
alternative algorithms.
A B C D E
1
Check random isation  
results from  
screenshots 2/16/10
2
3 Algorithm Old Old New New
4 Run 1 2 1 2
5 |
6 |Numbers in 4 groups
7 |Group 1 165 71 257 114
8 [Group 2 321 137 214 90
9 |Group 3 328 146 243 90
10 [Group 4 178 71 246 99
11 j
12 Total 992 425 960 393
13
14 jchisq (3 df) 94.83 47.16 4.21 3.92
15 |p-value 0 0.0 0.240 0.271
is ]-
17 |Groups 1 & 4 together 343 142 503 213
18 Groups 2 & 3 together 649 283 457 180
19
20 Chisq (1 df) 94.39 46.78 2.20 2.77
21 p-value 0 0.0 0.138 0.096
22 .
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Appendix 44. Goodness of fit Chi-square test to assess distributions of respondents to the 
four conditions.
Test Statistics
Condition_al location
Chi-Square 1.965a
df 3
Asymp. Sig. .580
a. 0 cells (.0%) have expected frequencies less than 5. 
The minimum expected cell frequency is 227.0.
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Appendix 45. Descriptive statistics of continuous variables assessed in the RCT.
Statistics
Total Pre 
Positive 
Affect score
Total Pre 
Negative 
Affect score
Total post 
Positive 
Affect 
score
Total post 
Negative 
Affect 
score
Pre
Worry
Post
Worry
Understanding 
-  confidence
Level of 
understanding
Total
exercise
intention
score
Total lose 
weight 
intention 
score
Total
smoking
intention
score Age BMI
N Valid 903 903 903 903 903 903 903 903 903 903 81 903 903
Missing 0 0 0 0 0 0 0 0 0 0 882 0 0
Mean 18.11 10.68 17.64 7.59 2.80 2.15 6.07 1.09 5.00 4.65 4.06 53.12 27.0069
Median 18.00 10.00 18.00 6.00 3.00 2.00 6.00 1.00 5.00 5.00 4.00 52.00 25.7725
Mode 19 10 20 5 3 2 7 1 5 5 4 45 24.80
Std. Deviation 2.988 2.776 3.856 3.348 1.043 .984 1.241 .414 1.217 1.600 1.609 6.058 5.76006
Skewness -.493 .666 -.528 1.503 .024 .660 -1.585 .596 -.429 -.594 -.024 .266 1.653
Kurtosis .637 .726 .423 2.207 -.506 -.066 2.290 2.329 -.148 -.249 -.737 -1.179 4.546
Minimum 5 5 5 5 1 1 1 0 1 1 1 45 17.31
Maximum 25 23 25 25 5 5 7 2 7 7 7 64 62.00
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Appendix 46. Chi-square test of the level of education of respondents across conditions.
Chi-Square Tests
Value df
Asymp. Sig. (2- 
sided)
Pearson Chi-Square 24.544a 18 .138
Likelihood Ratio 27.834 18 .065
Linear-by-Linear 1.402 1 .236
Association
N of Valid Cases 903
a. 4 cells (14.3%) have expected count less than 5. The minimum 
expected count is .94.
Appendix 47. Chi-square test of those who requested copy of risk output results and those who did not 
across conditions.
Chi-Square Tests
Value df
Asymp. Sig. (2- 
sided)
Pearson Chi-Square 2.163a 3 .539
Likelihood Ratio 2.157 3 .540
Linear-by-Linear 2.147 1 .143
Association
N of Valid Cases 903
a. 0 cells (.0%) have expected count less than 5. The minimum 
expected count is 33.57.
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Appendix 48. Normality testing of continuous variables.
Normal Q-Q Plot of Total Pre Positive Affect
Histogram
Mean = 18.11 
Std. Dev. = 2.988 
N = 903
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Appendix 49. Normality testing after log tranformation.
Histogram
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Appendix 50. Indentifying univariate outliers.
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Appendix 51. Cronbach's Alpha to assess internal reliability of the components of the Theory of Planned
Behaviour.
Intention to exericse more
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha Based on Standardized Items N of Items
.535 .593 3
Item-Total Statistics
Scale Mean 
if Item 
Deleted
Scale Variance if 
Item Deleted
Corrected Item- 
Total Correlation
Squared Multiple 
Correlation
Cronbach's Alpha 
if Item Deleted
Q47 exercise - intention 9.98 6.740 .543 .679 .139
Q48 exercise - intention 10.40 6.755 .540 .679 .144
Q54 exercise - intention 9.65 8.404 .083 .007 .903
Intention to lose weight
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha Based on Standardized Items N of Items
.897 .897 3
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q60 lose weight - intention 9.00 10.601 .818 .671 .835
Q61 lose weight - intention 9.68 11.483 .769 .592 .877
Q67 lose weight - intention 9.22 10.234 .807 .658 .845
Intention to stop smoking.
Reliability Statistics
Cronbach's
Alpha
Cronbach’s Alpha Based on 
Standardized Items N of Items
.882 .882 3
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q34 smoking - intention 8.35 10.279 .794 .634 .812
Q35 smoking - intention 8.26 11.194 .748 .559 .853
Q41 smoking - intention 7.74 11.419 .775 .606 .831
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Attitudes - Pre Q for control group 1. 
Reliability Statistics____________________
Cronbach's Alpha Cronbach's Alpha Based on Standardized Items N of Items
.557 .589 3
Item-Total Statistics
Scale Mean 
if Item 
Deleted
Scale 
Variance if 
Item Deleted
Corrected
Item-Total
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if 
Item 
Deleted
Q17 pre attitudes_ reverse scored 4.85 4.316 .197 .039 .762
Q18 pre attitudes 4.21 4.045 .491 .386 .280
Q19 pre attitudes 4.19 4.072 .471 .381 .307
Attitudes to exercise more.
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha Based on Standardized Items N of Items
.735 .756 3
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q50 exercise - attitudes 3.26 6.135 .669 .469 .547
Q51 exercise - attitudes 4.13 4.976 .507 .280 .759
Q53 exercise - attitudes 3.32 6.472 .553 .382 .662
Attitudes to lose weight.
Reliability Statistics
Cronbach’s Alpha Cronbach's Alpha Based on Standardized Items N of Items
.958 .958 3
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q63 lose weight - attitudes 3.09 11.814 .906 .834 .942
Q64 lose weight - attitudes 2.97 12.285 .892 .805 .952
Q65 lose weight - attitudes 3.06 11.563 .935 .875 .920
Attitudes to stop smoking.
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha Based on Standardized Items N of Items
.581 .634 3
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q37 smoking - attitude 2.19 7.028 .494 .292 .339
Q38 smoking - attitude 1.80 9.210 .414 .235 .510
Q39 smoking - attitude 4.48 4.903 .370 .143 .625
Subjective norms -  exercise more.
Reliability Statistics
Cronbach’s Alpha Cronbach's Alpha Based on Standardized Items N of Items
.417 .396 3
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q49 exercise - subjective 
norm converted
12.07 5.547 .364 .194 .118
Q46 exercise - subjective 
norm
8.27 7.914 .060 .004 .599
Q59 exercise - subjective 
norm
13.45 4.006 .363 .196 .061
Subjective norms -  lose weight.
Reliability Statistics
Cronbach’s Alpha Cronbach's Alpha Based on Standardized Items N of Items
.820 .821 3
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q62 lose weight - subjective 
norm converted
5.92 12.110 .608 .399 .818
Q69 lose weight - subjective 
norms
7.15 11.521 .657 .486 .770
Q72 lose weight - subjective 
norm
7.12 10.694 .763 .587 .660
71
Subjective norms -  stop smoking.
Reliability Statistics
Cronbach's Alpha Cronbach's Alpha Based on Standardized Items N of Items
.943 .956 3
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale 
Variance if 
Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q36 smoking - subjective norm 
converted
17.23 6.948 .893 .807 .945
Q43 smoking - subjective norm 17.36 4.880 .900 .815 .912
Q46 smoking - subjective norm 17.34 4.940 .930 .866 .882
Perceived Behavioural control - PreQ given to control group 1.
Reliability Statistics_______________________
Cronbach's
Alpha
Cronbach's 
Alpha Based on 
Standardized 
Items N of Items
.814 .922 2
Item-Total Statistics
Scale Corrected Item- Squared
Scale Mean if Variance if Total Multiple Cronbach's Alpha
Item Deleted Item Deleted Correlation Correlation if Item Deleted
Q14 pre PBC reverse scored 7.79 5.660 .855 .731
a
Q16 converted pre PBC-reversed 8.41 1.435 .855 .731 a
a. The value is negative due to a negative average covariance among items. This violates reliability model assumptions. 
You may want to check item codings.
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Perceived behavioural control -  exercise more. 
Reliability Statistics________________________________
Cronbach's Alpha Cronbach's Alpha Based on Standardized Items N of Items
.528 .558 4
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q55 exercise - PBC (controlability) 15.50 13.401 .118 .024 .653
Q57 exercise - PBC (controlability) 14.93 12.962 .336 .136 .442
reverse scored
Q52 exercise - PBC (self-efficacy) 16.31 11.748 .381 .306 .397
converted
Q58 exercise - PBC (self-efficacy) 15.85 11.595 .505 .351 .304
Perceived behavioural control - Lose weight. 
Reliability Statistics_____________________________
Cronbach’s Alpha Cronbach's Alpha Based on Standardized Items N of Items
.528 .533 4
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q68 lose weight - PBC (controlability) 14.53 11.418 .212 .050 .560
Q70 lose weight - PBC (controlability) 14.15 12.940 .240 .059 .515
reverse scoring
Q66 Lose weight - PBC (self-efficacy) 16.54 10.599 .387 .263 .392
converted
Q71 lose weight - PBC (self-efficacy) 15.51 10.148 .453 .286 .332
7:
Perceived behavioural control -  stop smoking.
Reliability Statistics
Cronbach's Alpha Cronbach’s Alpha Based on Standardized Items N of Items
.562 .545 4
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q42 smoking - PBC (controlability) 12.33 14.225 .158 .055 .624
Q44 smoking - PBC (controlability) 12.15 13.303 .309 .172 .520
reverse scored
Q40 smoking - PBC (self-efficacy) 16.16 11.361 .365 .223 .474
converted
Q45 smoking - PBC (self-efficacy) 14.40 8.242 .587 .366 .235
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Appendix 52. Cronbach's Alpha to assess internal reliability of the Positive and Negative 
Affect Schedule (PANAS).
Baseline I Pre-intervention Positive affect.
Reliability Statistics
Cronbach's
Alpha Cronbach's Alpha Based on Standardized Items N of Items
.781 .786 5
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q3 Pre PANAS + Alert 14.45 6.179 .552 .323 .741
Q5 Pre PANAS + Inspired 14.66 6.205 .525 .290 .750
Q7 Pre PANAS + 14.41 5.847 .610 .395 .721
Determined
Q8 Pre PANAS + Attentive 14.37 6.091 .626 .409 .720
Q10 Pre PANAS + Active 14.54 5.807 .490 .242 .769
Baseline I Pre-intervention Negative affect.
Reliability Statistics
Cronbach's
Alpha
Cronbach's 
Alpha Based on 
Standardized 
Items N of Items
.728 .729 5
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach’s 
Alpha if Item 
Deleted
Q1 Pre PANAS - Upset 8.37 5.493 .534 .289 .668
Q2 Pre PANAS - Hostile 8.74 5.794 .363 .170 .726
Q4 Pre PANAS - Ashamed 8.86 5.343 .478 .238 .685
Q6 Pre PANAS - Nervous 8.19 4.884 .505 .341 .676
Q9 Pre PANAS - Afraid 8.57 4.824 .575 .381 .645
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Post-intervention Positive affect.
Reliability Statistics
Cronbach's
Alpha
Cronbach's 
Alpha Based on 
Standardized 
Items N of Items
.849 .853 5
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q22 post PANAS + Alert 13.98 10.385 .616 .494 .830
Q24 post PANAS + Inspired 14.26 9.844 .660 .476 .818
Q26 post PANAS + 14.02 9.415 .745 .582 .795
Determined
Q27 post PANAS + 13.88 9.950 .732 .604 .802
Attentive
Q29 post PANAS + Active 14.42 9.764 .570 .343 .847
Post-intervention Negative affect.
Reliability Statistics
Cronbach's
Alpha
Cronbach's 
Alpha Based on 
Standardized 
Items N of Items
.884 .886 5
Item-Total Statistics
Scale Mean if 
Item Deleted
Scale Variance 
if Item Deleted
Corrected Item- 
Total 
Correlation
Squared
Multiple
Correlation
Cronbach's 
Alpha if Item 
Deleted
Q20 post PANAS - upset 6.03 7.227 .731 .573 .857
Q21 post PANAS - Hostile 6.22 8.033 .688 .533 .869
Q23 post PANAS - 6.19 8.026 .679 .478 .870
Ashamed
Q25 post PANAS - Nervous 5.90 6.712 .756 .628 .853
Q28 post PANAS - Afraid 6.02 6.913 .780 .655 .845
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Appendix 53. One-way ANOVAs for intention to change behaviour.
Intention to exercise more.
Tests of Between-Subjects Effects
Dependent Variable:Total exercise intention score
Source Type III Sum of 
Squares Df Mean Square F Sig.
Partial Eta 
Squared
Corrected Model 2.915a 3 .972 .655 .580 .002
Intercept 22577.541 1 22577.541 15232.323 .000 .944
Cond ition_al location 2.915 3 .972 .655 .580 .002
Error 1332.509 899 1.482
Total 23953.778 903
Corrected Total 1335.424 902
a. R Squared = .002 (Adjusted R Squared = -.001)
Intention to lose weight.
Tests of Between-Subjects Effects
Dependent Variable:Total lose weight intention score
Source Type III Sum of 
Squares Df Mean Square F Sig.
Partial Eta 
Squared
Corrected Model 5.458a 3 1.819 .710 .546 .002
Intercept 19484.166 1 19484.166 7599.572 .000 .894
Condition_alk>cation 5.458 3 1.819 .710 .546 .002
Error 2304.901 899 2.564
Total 21820.444 903
Corrected Total 2310.359 902
a. R Squared = .002 (Adjusted R Squared = -.001)
Intention to stop smoking.
Tests of Between-Subjects Effects
Dependent Variable:Total smoking intention score (mean)
Source Type III Sum of 
Squares Df Mean Square F Sig.
Partial Eta 
Squared
Corrected Model 10.9693 3 3.656 1.436 .239 .053
Intercept 1309.154 1 1309.154 514.060 .000 .870
Cond ition_al location 10.969 3 3.656 1.436 .239 .053
Error 196.096 77 2.547
Total 1540.667 81
Corrected Total 207.064 80
a. R Squared = .053 (Adjusted R Squared = .016)
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Appendix 54. One-way ANOVAs for understanding of risk information.
Level of understanding.
Tests of Between-Subjects Effects
Dependent Variable:level of understanding as a scale
Source Type III Sum of 
Squares Df Mean Square F Sig.
Partial Eta 
Squared
Corrected Model .486a 3 .162 .944 .419 .003
Intercept 1066.692 1 1066.692 6209.803 .000 .874
Condition_allocation .486 3 .162 .944 .419 .003
Error 154.426 899 .172
Total 1225.000 903
Corrected Total 154.913 902
a. R Squared = .003 (Adjusted R Squared = .000)
Confidence in understanding.
Tests of Between-Subjects Effects
Dependent Variable:confidence in understanding scores log transformed reflected back
Source Type III Sum of 
Squares df Mean Square F Sig.
Partial Eta 
Squared
Corrected Model .189a 3 .063 1.108 .345 .004
Intercept 60787.106 1 60787.106 1066784.136 .000 .999
Condition_allocation .189 3 .063 1.108 .345 .004
Error 51.226 899 .057
Total 60970.079 903
Corrected Total 51.416 902
a. R Squared = .004 (Adjusted R Squared = .000)
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Appendix 55. One-way ANOVAs for positive and negative affect
Positive affect.
Tests of Between-Subjects Effects
Dependent Variable:Total post Positive Affect score
Source Type III Sum of 
Squares df Mean Square F Sig.
Partial Eta 
Squared
Corrected Model 7112.245a 4 1778.061 253.603 .000 .530
Intercept 10.470 1 10.470 1.493 .222 .002
Tota l_Pre_Positi ve_affect 7070.636 1 7070.636 1008.476 .000 .529
Condition_allocation 33.552 3 11.184 1.595 .189 .005
Error 6296.063 898 7.011
Total 294362.000 903
Corrected Total 13408.308 902
a. R Squared = .530 (Adjusted R Squared = .528)
Negative affect.
Tests of Between-Subjects Effects
Dependent Variable:Total post negative affect log transformed
Source Type III 
Sum of 
Squares df
Mean
Square F Sig.
Partial Eta 
Squared
Corrected Model 6.101a 4 1.525 74.050 .000 .248
Intercept .127 1 .127 6.142 .013 .007
Pre_Negative_affect_log_transformed 6.085 1 6.085 295.386 .000 .248
Condition_allocation .048 3 .016 .776 .507 .003
Error 18.498 898 .021
Total 671.045 903
Corrected Total 24.600 902
a. R Squared = .248 (Adjusted R Squared = .245)
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Appendix 56. One-way ANOVA for worry about future risk of heart disease.
Tests of Between-Subjects Effects
Dependent Variable:Q30 post worry
Source Type III Sum of 
Squares df Mean Square F Sig.
Partial Eta 
Squared
Corrected Model 344.425a 4 86.106 146.173 .000 .394
Intercept 25.946 1 25.946 44.046 .000 .047
Q11 344.018 1 344.018 584.000 .000 .394
Condition_allocation .038 3 .013 .021 .996 .000
Error 528.986 898 .589
Total 5037.000 903
Corrected Total 873.411 902
a. R Squared = .394 (Adjusted R Squared = .392)
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Appendix 57. One-way ANOVAs for intention to change behaviour split by risk category. 
Intention to exercise more.
Tests of Between-Subjects Effects
Dependent Variable:Total exercise intention score (mean)
risk dichotomised Source Type III Sum of 
Squares df
Mean
Square F Sig.
Partial Eta 
Squared
Low Corrected Model 4.875a 3 1.625 1.095 .350 .004
Intercept 18720.189 1 18720.189 12618.332 .000 .944
Condition_allocation 4.875 3 1.625 1.095 .350 .004
Error 1103.777 744 1.484
Total 19842.000 748
Corrected Total 1108.652 747
Moderate Corrected Model 2.656b 3 .885 .596 .618 .012
or High Intercept 3843.819 1 3843.819 2589.809 .000 .945
Condition_alk>cation 2.656 3 .885 .596 .618 .012
Error 224.116 151 1.484
Total 4111.778 155
Corrected Total 226.771 154
a. R Squared = .004 (Adjusted R Squared = .000)
b. R Squared = .012 (Adjusted R Squared = -.008)
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Intention to lose weight
Tests of Between-Subjects Effects
Dependent Variable:Total lose weight intention score (mean)
risk dichotomised Source Type III Sum of 
Squares df
Mean
Square F Siq.
Partial Eta 
Squared
Low Corrected Model 9.141a 3 3.047 1.178 .317 .005
Intercept 16055.380 1 16055.380 6209.097 .000 .893
Condition_allocation 9.141 3 3.047 1.178 .317 .005
Error 1923.823 744 2.586
Total 17993.333 748
Corrected Total 1932.964 747
Moderate Corrected Model 9.579b 3 3.193 1.314 .272 .025
or High Intercept 3433.103 1 3433.103 1412.926 .000 .903
Condition_allocation 9.579 3 3.193 1.314 .272 .025
Error 366.897 151 2.430
Total 3827.111 155
Corrected Total 376.476 154
a. R Squared = .005 (Adjusted R Squared = .001)
b. R Squared = .025 (Adjusted R Squared = .006)
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Intention to stop smoking.
Tests of Between-Subjects Effects
Dependent Variable:Total smoking intention score (mean)___________
risk dichotomised Source Type III 
Sum of 
Squares df
Mean
Square F Sig.
Partial
Eta
Squared
Low Corrected Model 6.582a 3 2.194 .752 .527 .048
Intercept 718.964 1 718.964 246.322 .000 .846
Condition_allocation 6.582 3 2.194 .752 .527 .048
Error 131.346 45 2.919
Total 898.111 49
Corrected Total 137.927 48
Moderate Corrected Model 12.121b 3 4.040 2.047 .130 .180
or High Intercept 449.400 1 449.400 227.690 .000 .890
Condition_allocation 12.121 3 4.040 2.047 .130 .180
Error 55.265 28 1.974
Total 642.556 32
Corrected Total 67.385 31
a. R Squared = .048 (Adjusted R Squared = -.016)
b. R Squared = .180 (Adjusted R Squared = .092)
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Appendix 58. One-way ANOVAs for understanding of risk information split by risk
category.
Level of understanding.
Tests of Between-Subjects Effects
Dependent Variable:level of understanding as a scale
risk
dichotomised
Source Type III Sum of 
Squares df
Mean
Square F Sig.
Partial Eta 
Squared
Low Corrected Model .374a 3 .125 1.022 .382 .004
Intercept 840.756 1 840.756 6889.249 .000 .903
Cond ition_al location .374 3 .125 1.022 .382 .004
Error 90.797 744 .122
Total 934.000 748
Corrected Total 91.171 747
Moderate or Corrected Model 2.027b 3 .676 1.743 .161 .033
High Intercept 229.177 1 229.177 591.396 .000 .797
Condition_allocation 2.027 3 .676 1.743 .161 .033
Error 58.515 151 .388
Total 291.000 155
Corrected Total 60.542 154
a. R Squared = .004 (Adjusted R Squared = .000)
b. R Squared = .033 (Adjusted R Squared = .014)
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Confidence in understanding
Tests of Between-Subjects Effects
Dependent Variable.confidence in understanding scores log transformed reflected back
risk
dichotomi
sed
Source
Type III Sum 
of Squares df
Mean
Square F Sig.
Partial Eta 
Squared
Low Corrected Model .229a 3 .076 1.359 .254 .005
Intercept 50255.940 1 50255.940 894844.581 .000 .999
Condition_allocation .229 3 .076 1.359 .254 .005
Error 41.784 744 .056
Total 50352.997 748
Corrected Total 42.013 747
Moderate Corrected Model .208b 3 .069 1.229 .301 .024
or High Intercept 10426.225 1 10426.225 184453.486 .000 .999
Condition_allocation .208 3 .069 1.229 .301 .024
Error 8.535 151 .057
Total 10617.081 155
Corrected Total 8.744 154
a. R Squared = .005 (Adjusted R Squared = .001)
b. R Squared = .024 (Adjusted R Squared = .004)
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Appendix 59. One-ways ANOVA for positive and negative affect split by risk category.
Positive affect.
Tests of Between-Subjects Effects
Dependent Variable:Total post Positive Affect score
risk dichotomised Source Type III Sum of 
Squares df
Mean
Square F Sig.
Partial Eta 
Squared
Low Corrected Model 6213.4683 4 1553.367 233.708 .000 .557
Intercept .448 1 .448 .067 .795 .000
Total_Pre_Positive_affect 6163.268 1 6163.268 927.280 .000 .555
Condition_allocation 29.963 3 9.988 1.503 .213 .006
Error 4938.429 743 6.647
Total 249953.000 748
Corrected Total 11151.897 747
Moderate or Corrected Model 791.596b 4 197.899 23.998 .000 .390
High Intercept 64.312 1 64.312 7.799 .006 .049
Total_Pre_Positive_affect 736.397 1 736.397 89.299 .000 .373
Condition_allocation 38.818 3 12.939 1.569 .199 .030
Error 1236.959 150 8.246
Total 44409.000 155
Corrected Total 2028.555 154
a. R Squared = .557 (Adjusted R Squared = .555)
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Negative Affect.
Tests of Between-Subjects Effects
Dependent Variable:Total post negative affect log transformed
risk Source 
dichotomised
Type III 
Sum of 
Squares df
Mean
Square F Sig.
Partial
Eta
Squared
Low Corrected Model 4.666a 4 1.167 62.868 .000 .253
Intercept .094 1 .094 5.071 .025 .007
Pre_Negative_affect_log_transformed 4.637 1 4.637 249.915 .000 .252
Condition_allocation .048 3 .016 .866 .458 .003
Error 13.787 743 .019
Total 533.601 748
Corrected Total 18.453 747
Moderate Corrected Model 1.557b 4 .389 16.964 .000 .311
or High Intercept .029 1 .029 1.282 .259 .008
Pre_Negative_affect_log_transformed 1.537 1 1.537 66.961 .000 .309
Cond ition_al location .000 3 .000 .005 1.000 .000
Error 3.443 150 .023
Total 137.444 155
Corrected Total 5.000 154
a. R Squared = .253 (Adjusted R Squared = .249)
b. R Squared = .311 (Adjusted R Squared = .293)
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Appendix 60. One-way ANOVA for worry about future risk of heart disease split by risk
category.
Tests of Between-Subjects Effects
Dependent Variable:Q30 post worry
risk dichotomised Source Type III Sum 
of Squares df
Mean
Square F Sig.
Partial Eta 
Squared
Low Corrected Model 224.292a 4 56.073 108.017 .000 .368
Intercept 29.243 1 29.243 56.332 .000 .070
Q11 223.270 1 223.270 430.099 .000 .367
Condition_allocation .182 3 .061 .117 .950 .000
Error 385.702 743 .519
Total 3594.000 748
Corrected Total 609.995 747
Moderate Corrected Model 78.310b 4 19.578 33.712 .000 .473
or High Intercept 5.643 1 5.643 9.718 .002 .061
Q11 76.418 1 76.418 131.589 .000 .467
Cond ition_al location 1.740 3 .580 .999 .395 .020
Error 87.109 150 .581
Total 1443.000 155
Corrected Total 165.419 154
a. R Squared = .368 (Adjusted R Squared = .364)
b. R Squared = .473 (Adjusted R Squared = .459)
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Appendix 61. ANOVA Planned comparisons -  Bar graph versus Pictogram. 
Intention to exercise more.
________  Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total exercise intention Assume equal variances 1 -.01 .113 -.110 899 .913
score Does not assume equal 1 
variances
-.01 .112 -.111 459.463 .912
Intention to lose weight.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total lose weight intention Assume equal variances 1 -.03 .149 -.181 899 .856
score Does not assume equal 
variances
1 -.03 .150 -.180 457.367 .858
Intention to stop smoking.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total smoking intention Assume equal variances ... 1 .91 .475 1.915 77 .059
score (mean) Does not assume equal 1
variances
.91 .483 1.880 43.950 .067
Level of understanding.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
level of understanding as a Assume equal variances 1 .00 .039 .040 899 .968
scale Does not assume equal 
variances
1 .00 .039 .039 458.245 .969
Confidence in understanding (log transformed reflected back).
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
confidence in understanding Assume equal variances 1 -.0163 .02221 -.735 899 .462
scores log transformed Does not assume equal 1 
reflected back variances ~
-.0163 .02214 -.737 460.467 .461
728
Positive affect.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total post Positive Affect Assume equal variances 1 .50 .359 1.402 899 .161
score Does not assume equal 
variances
1 .50 .358 1.407 451.798 .160
Negative affect (log transformed).
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total post negative affect Assume equal variances 1 .0071 .01538 .463 899 .644
log transformed Does not assume equal 
variances
1 .0071 .01504 .473 459.818 .636
Worry about future risk of heart disease.
  Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Q30 post worry Assume equal variances 1 -.03 .092 -.324 899 .746
Does not assume equal 1 
variances
-.03 .089 -.335 460.507 .738
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Appendix 62. ANOVA Planned comparisons -  Bar graph versus Pictogram split by risk 
category.
Intention to exercise more.
  Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low T . . Assume equal variancesTotal exercise 1 .00 .126 .015 744 .988
intention Does not assume equal . 
variances
score (mean)
.00 .122 .015 373.712 .988
Moderate or -p , a Assume equal variancesTotal exercise 1 -.06 .264 -.219 151 .827
High intention ^oes not assume equal . 
variances
score (mean)
-.06 .272 -.213 83.479 .832
Intention to lose weight.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total lose weight Assume equal variances 1 -.02 .166 -.150 744 .881
intention score 
(mean)
Does not assume equal 
variances
1 -.02 .164 -.152 372.983 .879
Moderate Total lose weight Assume equal variances 1 -.01 .338 -.044 151 .965
or High intention score 
(mean)
Does not assume equal 
variances
1 -.01 .378 -.039 81.475 .969
Intention to stop smoking.
Contrast Tests
risk dichotomised Contrast Contrast
Value of 
Contrast
Std.
Error t df
Sig.
(2-
tailed!
Low Total smoking intention Assume equal variances 1 .26 .732 .361 45 .72(
score (mean) Does not assume equal 
variances
1 .26 .635 .417 22.342 .68
Moderate or High Total smoking intention Assume equal variances 1 1.25 .620 2.018 28 .05:
score (mean) Does not assume equal 
variances
1 1.25 .635 1.968 17.904 .06'
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Level of understanding.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low level of understanding as Assume equal variances .05 .036 1.372 744 .171
a scale Does not assume equal 
variances “
.05 .038 1.309 373.046 .191
Moderate or level of understanding as Assume equal variances -.22 .135 -1.651 151 .101
High a scale Does not assume equal 
variances ~
-.22 .128 -1.734 83.101 .087
Confidence in understanding.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low confidence in understanding 
scores log transformed
Assume equal 
variances
1 -.0378 .02442 -1.547 744 .122
reflected back Does not assume 
equal variances
1 -.0378 .02388 -1.582 373.993 .114
Moderate or 
High
confidence in understanding 
scores log transformed
Assume equal 
variances
1 .0715 .05150 1.389 151 .167
reflected back Does not assume 
equal variances
1 .0715 .05515 1.297 83.426 .198
Positive affect
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Li Low Total post Positive Assume equal variances 1 .72 .398 1.817 744 .070
0 Affect score Does not assume equal variances 1 .72 .391 1.848 367.073 .065
1 Moderate or Total post Positive Assume equal variances 1 -.31 .783 -.400 151 .690
- High Affect score Does not assume equal variances 1 -.31 .830 -.377 79.879 .707
h
5
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Negative affect (log transformed).
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2> 
tailed)
Low Total post negative Assume equal variances 1 .0075 .01622 .465 744
affect log transformed Does not assume equal 
variances
1 .0075 .01605 .470 374.962 .631
Moderate Total post negative Assume equal variances 1 -.0038 .03934 -.096 151
or High affect log transformed Does not assume equal 
variances
1 -.0038 .03696 -.103 80.652 .911
Worry about future risk of heart disease.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Q30 post worry Assume equal variances 1 -.10 .093 -1.080 744 .280
Does not assume equal 
variances
1 -.10 .092 -1.098 371.529 .273
Moderate or Q30 post worry Assume equal variances 1 .20 .225 .874 151 .384
High Does not assume equal 
variances
1 .20 .207 .951 71.676 .345
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Appendix 63. ANOVA Planned comparisons -  Bar graph versus Metonym. 
Intention to exercise more.
_____________________________________  Contrast Tests
Contrast
Value of 
Contrast
Std.
Error t df
Sig.
(2-
tailed)
Total exercise intention Assume equal variances 1 .11 .112 1.003 899 .316
score Does not assume equal 
variances
1 .11 .115 .983 462.566 .326
Intention to lose weight.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total lose weight intention Assume equal variances 1 .12 .148 .807 899 .420
score Does not assume equal 
variances
1 .12 .149 .803 465.522 .423
Intention to stop smoking.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total smoking intention Assume equal variances 1 .70 .535 1.300 77 .197
score (mean) Does not assume equal 
variances
1 .70 .454 1.534 33.669 .134
Level of understanding
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
level of understanding as a Assume equal variances 1 -.04 .038 -.932 899 .352
scale Does not assume equal 1
variances
-.04 .039 -.912 465.728 .362
Confidence in understanding (log transformed and reflected back)
Contrast Tests______________
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
confidence in understanding Assume equal variances 1 -.0336 .02205 -1.522 899 .128
scores log transformed Does not assume equal 1 
reflected back variances
-.0336 .02233 -1.502 466.331 .134
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Positive affect
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total post Positive Affect Assume equal variances 1 .04 .356 .109 899 .913
score Does not assume equal 1 
variances
.04 .360 .108 457.771 .914
Negative affect (log transformed).
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total post negative affect Assume equal 1 
log transformed variances
.0028 .01528 .185 899 .853
Does not assume 1 
equal variances ~
.0028 .01533 .185 464.476 .853
Worry about future risk of heart disease.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df Sig. (2-tailed)
Q30 post worry Assume equal variances 1 .02 .091 .203 899 .839
Does not assume equal 1 
variances
.02 .094 .196 464.184 .845
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Appendix 64. ANOVA Planned comparisons -  Bar graph versus Metonym split by risk 
catergory.
Intention to exercise more.
______________________________________ Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total exercise Assume equal variances 1 .19 .124 1.549 744 .122
intention Does not assume equal 
score (mean) variances
1 .19 .126 1.529 381.121 .127
Moderate Total exercise Assume equal variances 1 -.26 .270 -.980 151 .329
or High intention Does not assume equal 
score (mean) variances
1 -.26 .277 -.954 79.019 .343
Intention to lose weight.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total lose Assume equal variances 1 .24 .164 1.473 744 .141
weight intention Does not assume equal 
score (mean) variances
1 .24 .163 1.480 383.295 .140
Moderate Total lose Assume equal variances 1 -.48 .345 -1.399 151 .164
or High weight intention Does not assume equal 
score (mean) variances
1 -.48 .355 -1.361 80.334 .177
Intention to stop smoking.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total smokinq Assume equal variances 1 -.11 .780 -.142 45 .887
intention Does not assume equal 
score (mean) variances
1 -.11 .565 -.197 17.334 .846
Moderate or Total smokinq Assume equal variances 1 1.44 .811 1.781 28 .086
High intention Does not assume equal 
score (mean) variances
1 1.44 .598 2.415 9.752 .037
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Level of understanding.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low level of Assume equal variances 1 .01 .036 .267 744 .789
understanding 
as a scale
Does not assume equal 
variances
1 .01 .036 .260 383.869 .795
Moderate or level of Assume equal variances 1 -.28 .138 -2.002 151 .047
High understanding 
as a scale
Does not assume equal 
variances
1 -.28 .140 -1.975 74.239 .052
Confidence in understanding.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low confidence in 
understanding scores
Assume equal 
variances
1 -.0408 .02412 -1.691 744 .091
log transformed reflected 
back intention score 
(mean)
Does not assume 
equal variances
1 -.0408 .02399 -1.700 383.485 .090
Moderate 
or High
confidence in 
understanding scores
Assume equal 
variances
1 -.0224 .05266 -.426 151 .671
log transformed reflected 
back
Does not assume 
equal variances
1 -.0224 .05490 -.408 79.938 .684
Positive Affect.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total post Assume equal variances 1 .36 .393 .921 744 .357
Positive Affect 
score
Does not assume equal 
variances
1 .36 .401 .904 373.989 .367
Moderate Total post Assume equal variances 1 -1.22 .801 -1.528 151 .129
or High Positive Affect 
score
Does not assume equal 
variances
1 -1.22 .747 -1.639 80.691 .105
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Negative affect (log transformed)
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total post Assume equal variances 1 .0002 .01602 .015 744 .988
negative affect 
log transformed
Does not assume equal 
variances
1 .0002 .01613 .015 383.994 .988
Moderate Total post Assume equal variances 1 -.0024 .04022 -.060 151 .952
or High negative affect 
log transformed
Does not assume equal 
variances
1 -.0024 .04165 -.058 68.006 .954
Worry about future risk of heart disease.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Q30 post Assume equal variances 1 -.04 .092 -.390 744 .697
worry Does not assume equal 
variances
1 -.04 .096 -.374 383.831 .709
Moderate Q30 post Assume equal variances 1 .08 .230 .354 151 .724
or High worry Does not assume equal 
variances
1 .08 .241 .338 57.498 .737
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Appendix 65. ANOVA Planned comparisons -  Bar graph versus Bar graph with pre­
intervention questionnaire.
Intention to exercise more.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total exercise intention Assume equal variances 1 .03 .115 .301 899 .764
score Does not assume equal 
variances
1 .03 .114 .303 444.909 .762
Intention to lose weight.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total lose weight intention Assume equal variances 1 .10 .151 .651 899 .515
score Does not assume equal 1 
variances ~
.10 .149 .659 446.831 .511
Intention to stop smoking.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total smoking intention Assume equal variances _ 1 -.27 .511 -.527 77 .600
score (mean) Does not assume equal 1 
variances -
-.27 .496 -.543 35.903 .591
Level of understanding as a scale.
Contrast Tests
Contrast
Value of 
Contrast
Std.
Error t df
Sig.
(2-
tailed)
level of understanding as a Assume equal variances 1 -.03 .039 -.782 899 .434
scale Does not assume equal 1
variances ~
-.03 .038 -.803 450.526 .423
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Confidence in Understanding (log transformed and reflected back) 
__________________________________________ Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
confidence in understanding Assume equal variances 1 -.0025 .02248 -.112 899 .911
scores log transformed 
reflected back
Does not assume equal 
variances
1 -.0025 .02268 -.111 446.108 .912
Positive affect
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Total post Positive Affect Assume equal variances _ 1 -.37 .363 -1.015 899 .311
score Does not assume equal 1 
variances ~
-.37 .348 -1.058 445.011 .290
Negative affect (log transformed).
Contrast Tests
Contrast
Value of 
Contrast
Std.
Error t df
Sig.
(2-
tailed)
Total post negative affect Assume equal variances 1 -.0114 .01557 -.732 899 .464
log transformed Does not assume equal 1 
variances ~~
-.0114 .01579 -.722 438.956 .471
Worry about future risk of heart disease.
Contrast Tests
Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Q30 post worry Assume equal variances 1 .03 .093 .354 899 .723
Does not assume equal 1 
variances ~~
.03 .094 .349 445.421 .727
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Appendix 66. ANOVA Planned comparisons -  Bar graph versus Bar graph with pre­
intervention Questionnaire split by risk catergory.
Intention to exercise more.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total exercise Assume equal variances 1 -.02 .126 -.196 744 .845:
intention 
score (mean)
Does not assume equal 
variances
1 -.02 .125 -.199 366.764 .843:
Moderate Total exercise Assume equal variances 1 .31 .277 1.108 151 ,27a
or High intention 
score (mean)
Does not assume equal 
variances
1 .31 .274 1.119 75.524 .267
Intention to lose weight.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total lose Assume equal variances 1 .01 .167 .055 744
weight 
intention 
score (mean)
Does not assume equal 
variances
1 .01 .166 .055 365.909 .95(1
Moderate Total lose Assume equal variances 1 .53 .354 1.499 151 ,13d
or High weight 
intention 
score (mean)
Does not assume equal 
variances
1 .53 .314 1.691 76.116 .09!
Intention to stop smoking.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total smoking Assume equal variances 1 .69 .780 .891 45 .37:
intention 
score (mean)
Does not assume equal 
variances
1 .69 .637 1.089 17.995 .29*
Moderate Total smoking Assume equal variances 1 -1.17 .668 -1.752 28 .09)
or High intention 
score (mean)
Does not assume equal 
variances
1 -1.17 .704 -1.663 12.764 .12:
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Level of understanding.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low level of Assume equal variances 1 -.05 .036 -1.340 744 .181
understanding 
as a scale
Does not assume equal 
variances
1 -.05 .035 -1.397 368.067 .163
Moderate level of Assume equal variances 1 .07 .141 .470 151 .639
or High understanding 
as a scale
Does not assume equal 
variances
1 .07 .147 .451 65.727 .653
Confidence in understanding.
Contrast Tests
isk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
_ow confidence in understanding Assume equal variances 1 .0109 .02456 .446 744 .656
scores log transformed Does not assume equal 
reflected back variances 
understanding as a scale
1 .0109 .02482 .441 364.305 .659
Moderate confidence in understanding Assume equal variances 1 -.0461 .05400 -.854 151 .395
Dr High scores log transformed Does not assume equal 
reflected back variances
1 -.0461 .05103 -.904 77.999 .369
Positive Affect.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total post Assume egual variances 1 -.44 .400 -1.094 744 .275
Positive Affect Does not assume equal 
score variances
1 -.44 .374 -1.170 368.857 .243
Moderate Total post Assume equal variances 1 -.49 .821 -.595 151 .553
or High Positive Affect Does not assume equal 
score variances
1 -.49 .837 -.584 70.344 .561
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Negative affect (log transformed).
  Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Total post Assume equal variances 1 -.0152 .01631 -.933 744 .351
negative 
affect log 
transformed
Does not assume equal 
variances
1 -.0152 .01658 -.918 368.340 .35?
Moderate Total post Assume equal variances 1 .0298 .04124 .723 151 .47
or High negative 
affect log 
transformed
Does not assume equal 
variances
1 .0298 .04091 .729 64.448 .46!
Worry about future risk of heart disease.
Contrast Tests
risk dichotomised Contrast Value of 
Contrast
Std.
Error t df
Sig. (2- 
tailed)
Low Q30 post Assume equal variances 1 .06 .094 .669 744 .50
worry Does not assume equal 
variances
1 .06 .096 .652 370.899 .51
Moderate or Q30 post Assume equal variances 1 .12 .236 .488 151 .62
High worry Does not assume equal 
variances
1 .12 .219 .528 58.589 .59
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Appendix 67. Correlation Matrices for intention to exercise more, lose weight and stop 
smoking as dependent variables.
Intention to exercise more.
    Correlations
Mean 
intention to 
exercise 
more
Post
Positive
Affect
Post 
Negative 
Affect log 
transformed
Post Worry Level of 
understanding
Risk
dichotomised
Pearson
Correlation
Mean intention to exercise 
more
1.000 .332 -.121 -.058 -.041 .001
Post Positive Affect .332 1.000 -.177 -.174 .034 -.130
Post negative affect log 
transformed
-.121 -.177 1.000 .427 -.039 .216
Post Worry -.058 -.174 .427 1.000 -.108 .335
Level of understanding -.041 .034 -.039 -.108 1.000 .144
Risk dichotomised .001 -.130 .216 .335 .144 1.000
Sig. (1- 
tailed)
Mean intention to exercise 
more
.000 .000 .041 .108 .493
Post Positive Affect .000 .000 .000 .154 .000
Post negative affect log 
transformed
.000 .000 .000 .122 .000
Post Worry .041 .000 .000 .001 .000
Level of understanding .108 .154 .122 .001 .000
Risk dichotomised .493 .000 .000 .000 .000
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Intention to lose weight.
Correlations
Mean 
intention to 
lose weight
Post
Positive
Affect
Post 
Negative 
Affect log 
transformed
Post Worry Level of 
understanding
Risk
dichotomis
Pearson
Correlation
Mean intention to lose 
weight
1.000 .170 -.003 .057 -.081 .020
Post Positive Affect .170 1.000 -.177 -.174 .034 -.130
Post negative affect log 
transformed
-.003 -.177 1.000 .427 -.039 .216
Post Worry .057 -.174 .427 1.000 -.108 .335
Level of understanding -.081 .034 -.039 -.108 1.000 .144
Risk dichotomised .020 -.130 .216 .335 .144 1.000
Sig. (1- 
tailed)
Mean intention to lose 
weight
.000 .470 .044 .008 .275
Post Positive Affect .000 .000 .000 .154 .000
Post negative affect log 
transformed
.470 .000 .000 .122 .000
Post Worry .044 .000 .000 .001 .000
Level of understanding .008 .154 .122 .001 .000
Risk dichotomised .275 .000 .000 .000 .000
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Intention to stop smoking.
Correlations
Mean 
intention to 
stop smoking
Post
Positive
Affect
Post 
Negative 
Affect log 
transformed
Post Worry Level of 
understanding
Risk
dichotomised
Pearson
Correlation
Mean intention to stop 
smoking
1 . 0 0 0 .269 -.093 -.033 -.019 .092
Post Positive Affect .269 1 . 0 0 0 -.230 -.213 . 0 1 0 -.031
Post negative affect log 
transformed
-.093 -.230 1 . 0 0 0 .447 -.068 .231
Post Worry -.033 -.213 .447 1 . 0 0 0 -.167 .182
Level of understanding -.019 . 0 1 0 -.068 -.167 1 . 0 0 0 .240
Risk dichotomised .092 -.031 .231 .182 .240 1 . 0 0 0
Sig. (1- 
tailed)
Mean intention to stop 
smoking
.008 .203 .386 .432 .207
Post Positive Affect .008 .019 .028 .466 .391
Post negative affect log 
transformed
.203 .019 . 0 0 0 .275 .019
Post Worry .386 .028 . 0 0 0 .069 .052
Level of understanding .432 .466 .275 .069 .016
Risk dichotomised .207 .391 .019 .052 .016
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Appendix 68. Coefficient tables for intention to exercise more, lose weight and stop smoking as dependent variables.
Intention to exercise more.
Coefficients8
Model Unstandardized
Coefficients
Standardized
Coefficients
t Sig.
95.0% Confidence 
Interval for B Correlations
Collinearity
Statistics
B Std. Error Beta
Lower
Bound
Upper
Bound
Zero-
order Partial Part Tolerance VIF
1 (Constant) 3.621 .319 11.339 . 0 0 0 2.994 4.247
Total post Positive Affect score .104 . 0 1 0 .329 10.260 . 0 0 0 .084 .124 .332 .324 .321 .951 1.051
Total post negative affect log -.607 .258 -.082 -2.358 .019 -1.113 - . 1 0 2 - . 1 2 1 -.078 -.074 .802 1.247
transformed
Q30 post worry .006 .045 .004 . 1 2 2 .903 -.083 .094 -.058 .004 .004 .733 1.364
level of understanding as a scale -.191 .094 -.065 -2.025 .043 -.376 -.006 -.041 -.067 -.063 .951 1.052
risk dichotomised .223 . 1 1 0 .069 2.031 .043 .008 .439 . 0 0 1 .068 .064 .844 1.184
a. Dependent Variable: Total exercise intention score
746
Intention to lose weight.
Coefficients8
Model Unstandardized
Coefficients
Standardized
Coefficients
95.0% Confidence Interval 
for B Correlations Collinearity Statistics
B Std. Error Beta t Sig.
Lower
Bound
Upper
Bound
Zero-
order Partial Part Tolerance VIF
1 (Constant) 3.293 .438 7.513 . 0 0 0 2.433 4.153
Total post Positive Affect score .078 .014 .188 5.611 . 0 0 0 .051 .105 .170 .184 .183 .951 1.051
Total post negative affect log 
transformed
- . 1 1 1 .353 - . 0 1 1 -.315 .753 -.805 .582 -.003 - . 0 1 1 - . 0 1 0 .802 1.247
Q30 post worry . 1 2 0 .062 .074 1.939 .053 - . 0 0 1 .242 .057 .065 .063 .733 1.364
level of understanding as a 
scale
-.326 .129 -.084 -2.517 . 0 1 2 -.579 -.072 -.081 -.084 -.082 .951 1.052
risk dichotomised .145 .151 .034 .964 .335 -.151 .441 . 0 2 0 .032 .031 .844 1.184
a. Dependent Variable: Total lose weight intention score
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Intention to stop smoking.
Coefficients8
Model Unstandardized
Coefficients
Standardized
Coefficients
95.0% Confidence 
Interval for B Correlations Collinearity Statistics
B Std. Error Beta t Sig.
Lower
Bound
Upper
Bound Zero-order Partial Part Tolerance VIF
1 (Constant) 2.622 1.389 1.887 .063 -.146 5.390
Total post Positive Affect .097 .043 .261 2.283 .025 . 0 1 2 .182 .269 .255 .252 .929 1.076
score
Total post negative affect log 
transformed
-.702 1.148 -.078 -.612 .543 -2.989 1.585 -.093 -.070 -.067 .756 1.323
Q30 post worry .040 .197 .026 . 2 0 2 .841 -.353 .433 -.033 .023 . 0 2 2 .753 1.329
level of understanding as a 
scale
-.191 .420 -.053 -.455 .650 -1.028 .645 -.019 -.053 -.050 .894 1.118
risk dichotomised .412 .388 .126 1.062 .291 -.361 1.185 .092 . 1 2 2 .117 .863 1.159
a. Dependent Variable: Total smoking intention score (mean)
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Appendix 69. Multiple Regression Analysis to predict intention to exercise more.
Model Summary**
Model
R R Square
Adjusted R 
Square
Std. Error of the 
Estimate
1 .349a . 1 2 2 .117 1.144
a. Predictors: (Constant), risk dichotomised, Total post Positive Affect 
score, level of understanding as a scale, Total post negative affect log 
transformed, Q30 post worry
b. Dependent Variable: Total exercise intention score
Coefficients8
Model Unstandardized
Coefficients
Standardized
Coefficients
95.0% Confidence 
Interval for B Correlations Collinearity Statistics
B
Std.
Error Beta t Sig.
Lower
Bound
Upper
Bound
Zero-
order Partial Part Tolerance VIF
1 (Constant) 3.621 .319 11.339 . 0 0 0 2.994 4.247
Total post Positive Affect score .104 . 0 1 0 .329 10.260 . 0 0 0 .084 .124 .332 .324 .321 .951 1.051
Total post negative affect log 
transformed
-.607 .258 -.082 -2.358 .019 -1.113 - . 1 0 2 - . 1 2 1 -.078 -.074 .802 1.247
Q30 post worry .006 .045 .004 . 1 2 2 .903 -.083 .094 -.058 .004 .004 .733 1.364
level of understanding as a scale -.191 .094 -.065 -2.025 .043 -.376 -.006 -.041 -.067 -.063 .951 1.052
risk dichotomised .223 . 1 1 0 .069 2.031 .043 .008 .439 . 0 0 1 .068 .064 .844 1.184
a. Dependent Variable: Total exercise intention score
Appendix 70. Multiple Regression Analysis to predict intention to lose weight.
Model Summary*3
Model
R R Square Adjusted R Square
Std. Error of the 
Estimate
1 .209a .044 .038 1.570
a. Predictors: (Constant), risk dichotomised, Total post Positive Affect score, level of understanding as 
a scale, Total post negative affect log transformed, Q30 post worry
b. Dependent Variable: Total lose weight intention score
Coefficients8
Model Unstandardized
Coefficients
Standardized
Coefficients
95.0% Confidence Interval 
for B Correlations Collinearity Statistics
B Std. Error Beta t Sig.
Lower
Bound
Upper
Bound
Zero-
order Partial Part Tolerance VIF
1 (Constant) 3.293 .438 7.513 . 0 0 0 2.433 4.153
Total post Positive Affect score .078 .014 .188 5.611 . 0 0 0 .051 .105 .170 .184 .183 .951 1.051
Total post negative affect log 
transformed
- . 1 1 1 .353 - . 0 1 1 -.315 .753 -.805 .582 -.003 - . 0 1 1 - . 0 1 0 .802 1.247
Q30 post worry . 1 2 0 .062 .074 1.939 .053 - . 0 0 1 .242 .057 .065 .063 .733 1.364
level of understanding as a 
scale
-.326 .129 -.084 -2.517 . 0 1 2 -.579 -.072 -.081 -.084 -.082 .951 1.052
risk dichotomised .145 .151 .034 .964 .335 -.151 .441 . 0 2 0 .032 .031 .844 1.184
a. Dependent Variable: Total lose weight intention score
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Appendix 71. Multiple Regression Analysis to predict intention to stop smoking.
Model Summaryb
Model R R Square Adjusted R Square Std. Error of the Estimate
1 .299a .089 .028 1.586
a. Predictors: (Constant), risk dichotomised, Total post Positive Affect score, level of understanding as a scale, Total post 
negative affect log transformed, Q30 post worry
Coefficients9
Model Unstandardized
Coefficients
Standardized
Coefficients
t Sig.
95.0% Confidence 
Interval for B Correlations Collinearity Statistics
B Std. Error Beta
Lower
Bound
Upper
Bound Zero-order Partial Part Tolerance VIF
1 (Constant) 2.622 1.389 1.887 .063 -.146 5.390
Total post Positive Affect .097 .043 .261 2.283 .025 . 0 1 2 .182 .269 .255 .252 .929 1.076
score
Total post negative affect log -.702 1.148 -.078 -.612 .543 -2.989 1.585 -.093 -.070 -.067 .756 1.323
transformed
Q30 post worry .040 .197 .026 . 2 0 2 .841 -.353 .433 -.033 .023 . 0 2 2 .753 1.329
level of understanding as a -.191 .420 -.053 -.455 .650 -1.028 .645 -.019 -.053 -.050 .894 1.118
scale
risk dichotomised .412 .388 .126 1.062 .291 -.361 1.185 .092 . 1 2 2 .117 .863 1.159
a. Dependent Variable: Total smoking intention score (mean)
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Appendix 72. Paired T-tests for changes in positive and negative affect and worry after
viewing cardiovascular risk.
Positive Affect.
Paired Samples Test
Paired Differences
Std. Std. Error
95% Confidence 
Interval of the 
Difference Sig. (2- 
tailed)Mean Deviation Mean Lower Upper t df
Pair 1 Total Pre Positive Affect 
score - Total post Positive 
Affect score
.470 2.656 .088 .296 .643 5.313 902 . 0 0 0
Negative Affect.
Paired Samples Test
Paired Differences
Mean
Std.
Deviation
Std. Error 
Mean
95% Confidence 
Interval of the 
Difference
t df
Sig. (2- 
tailed)Lower Upper
Pair 1 Total Pre Negative affect log 
transformed - Total post 
negative affect log 
transformed
.16817 .14670 .00488 .15859 .17775 34.449 902 . 0 0 0
Worry about future risk of heart disease.
Paired Samples Test
Paired Differences
Mean
Std.
Deviation
Std. Error 
Mean
95% Confidence 
Interval of the 
Difference
t df
Sig. (2- 
tailed)Lower Upper
Pair 1 Q11 Pre Worry - Q30 post 
worry
.656 .876 .029 .598 .713 22.494 902 . 0 0 0
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Appendix 73. Paired T-tests for changes in positive and negative affect and worry after
viewing cardiovascular risk split by risk category.
Positive and negative affect.
Paired Samples Test
risk dichotomised Paired Differences
Std.
Std.
Error
95% Confidence 
Interval of the 
Difference
Sig.
(2 -
tailed)Mean Deviation Mean Lower Upper t df
Low Pair
1
Total Pre Positive Affect 
score - Total post Positive 
Affect score
.404 2.580 .094 .219 .589 4.279 747 . 0 0 0
Pair
2
Total Pre Negative affect 
log transformed - Total 
post negative affect log 
transformed
.18539 .13972 .00511 .17536 .19542 36.289 747 . 0 0 0
Moderate 
or High
Pair 1 Total Pre Positive Affect 
score - Total post 
Positive Affect score
.787 2.980 .239 .314 1.260 3.288 154 . 0 0 1
Pair 2 Total Pre Negative affect 
log transformed - Total 
post negative affect log 
transformed
.08506 .15151 .01217 .06102 .10910 6.989 154 . 0 0 0
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Worry about future risk of heart disease. 
_____________________________________ Paired Samples Test
risk dichotomised Paired Differences
t df
Sig. (2- 
tailed)Mean
Std.
Deviation
Std.
Error
Mean
95% Confidence 
Interval of the 
Difference
Lower Upper
Low Pair 1 Q11 Pre Worry 
- Q30 post 
worry
.731 .870 .032 .669 .794 22.997 747 . 0 0 0
Mod Pair 1 Q11 Pre Worry 
erate - Q30 post 
or worry 
High
.290 .814 .065 .161 .419 4.443 154 . 0 0 0
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Appendix 74. Paired T-tests for changes in positive and negative affect and worry after
viewing cardiovascular risk split by condition.
Affect.
Paired Samples Test
1coco
o allocation Paired Differences
Std.
Std.
Error
95% Confidence Interval 
of the Difference
Sig.
(2 -
tailed)Mean Deviation Mean Lower Upper t df
Bargraph 
with pre-Q
Pair 1 Total Pre Positive Affect 
score - Total post Positive 
Affect score
.561 2.766 .190 .187 .936 2.955 2 1 1 .003
Pair 2 Total Pre Negative affect 
log transformed - Total 
post negative affect log 
transformed
.18281 .15134 .01039 .16232 .20330 17.589 2 1 1 . 0 0 0
Bargraph
only
Pair 1 Total Pre Positive Affect 
score - Total post Positive 
Affect score
.286 2.676 .172 -.053 .626 1.661 240 .098
Pair 2 Total Pre Negative affect 
log transformed - Total 
post negative affect log 
transformed
.16052 .14593 .00940 .14200 .17904 17.076 240 . 0 0 0
Pictogram Pair 1 Total Pre Positive Affect 
score - Total post Positive 
Affect score
.748 2.540 .170 .412 1.084 4.386 2 2 1 . 0 0 0
Pair 2 Total Pre Negative affect 
log transformed - Total 
post negative affect log 
transformed
.16747 .14754 .00990 .14795 .18698 16.912 2 2 1 . 0 0 0
Metonym Pair 1 Total Pre Positive Affect 
score - Total post Positive 
Affect score
.307 2.629 .174 -.036 .650 1.764 227 .079
Pair 2 Total Pre Negative affect 
log transformed - Total 
post negative affect log 
transformed
.16332 .14222 .00942 .14476 .18188 17.340 227 . 0 0 0
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Worry about future risk of heart disease.
Paired Samples Test
Condition_allocation
Paired Differences
Mean
Std.
Deviation
Std. Error 
Mean
95% Confidence Interval of 
the Difference
t df
Sig.
(2 -
tailed)Lower Upper
Bargraph with pre-Q Pair 1 Q11 Pre Worry
- Q30 post 
worry
.656 1 . 0 0 2 .069 .520 .791 9.527 2 1 1 . 0 0 0
Bargraph only Pair 1 Q11 Pre Worry
- Q30 post 
worry
.643 .897 .058 .529 .757 11.125 240 . 0 0 0
Pictogram Pair 1 Q11 Pre Worry
- Q30 post 
worry
.676 .803 .054 .569 .782 12.531 2 2 1 . 0 0 0
Metonym Pair 1 Q11 Pre Worry
- Q30 post 
worry
.649 .796 .053 .545 .753 12.309 227 . 0 0 0
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Appendix 75. Correlation between level of understanding and confidence in
understanding.
Parametric
Correlations
confidence in understanding 
scores log transformed 
reflected back
level of understanding 
as a scale
confidence in understanding Pearson Correlation 1 -.107**
scores log transformed Sig. (2-tailed) . 0 0 1
reflected back N 903 903
level of understanding as a Pearson Correlation -.107** 1
scale Sig. (2-tailed) . 0 0 1
N 903 903
**. Correlation is significant at the 0.01 level (2-tailed).
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Appendix 76. Correlation between level of understanding and confidence in
understanding split by risk dichotomised.
Correlations
risk dichotomised confidence in 
understanding 
scores log 
transformed 
reflected back
level of 
understanding 
as a scale
Low confidence in understanding scores log Pearson Correlation 1 -.173**
transformed reflected back Sig. (2-tailed) . 0 0 0
N 748 748
level of understanding as a scale Pearson Correlation -.173** 1
Sig. (2-tailed) . 0 0 0
N 748 748
Moderate or confidence in understanding scores log Pearson Correlation 1 -.013
High transformed reflected back Sig. (2-tailed) .875
N 155 155
level of understanding as a scale Pearson Correlation -.013 1
Sig. (2-tailed) .875
N 155 155
**. Correlation is significant at the 0.01 level (2-tailed).
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Appendix 77. Correlation between level of understanding and intention to change
behaviour.
Intention to exercise more.
___________    Correlations
level of 
understanding 
as a scale
Total exercise 
intention score 
(mean)
level of understanding as a Pearson Correlation 1 -.041
scale Sig. (1-tailed) .108
N 903 903
Total exercise intention Pearson Correlation -.041 1
score (mean) Sig. (1 -tailed) .108
N 903 903
Intention to lose weight.
Correlations
level of 
understanding 
as a scale
Total lose 
weight intention 
score (mean)
level of understanding as a Pearson Correlation 1 -.081“
scale Sig. (1-tailed) .008
N 903 903
Total lose weight intention Pearson Correlation -.081“ 1
score (mean) Sig. (1 -tailed) .008
N 903 903
**. Correlation is significant at the 0.01 level (1-tailed).
Intention to stop smoking.
Correlations
level of 
understanding 
as a scale
Total smoking 
intention score 
(mean)
level of understanding as a Pearson Correlation 1 -.019
scale Sig. (1-tailed) .432
N 903 81
Total smoking intention Pearson Correlation -.019 1
score (mean) Sig. (1 -tailed) .432
N 81 81
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Appendix 78. Correlation between level of understanding and intention to change
behaviour split by risk category.
Intention to exercise more.
Correlations
risk dichotomised level of 
understanding 
as a scale
Total exercise 
intention score 
(mean)
Low level of understanding as a Pearson Correlation 1 -.026
scale Sig. (1-tailed) .240
N 748 748
Total exercise intention Pearson Correlation -.026 1
score (mean) Sig. (1 -tailed) .240
N 748 748
Moderate or High level of understanding as a Pearson Correlation 1 -.090
scale Sig. (1 -tailed) .133
N 155 155
Total exercise intention Pearson Correlation -.090 1
score (mean) Sig. (1-tailed) .133
N 155 155
Intention to lose weight.
Correlations
risk dichotomised level of 
understanding 
as a scale
Total lose 
weight intention 
score (mean)
Low level of understanding as a Pearson Correlation 1 -.104**
scale Sig. (1-tailed) . 0 0 2
N 748 748
Total lose weight intention Pearson Correlation -.104** 1
score (mean) Sig. (1-tailed) . 0 0 2
N 748 748
Moderate or High level of understanding as a Pearson Correlation 1 -.043
scale Sig. (1-tailed) .300
N 155 155
Total lose weight intention Pearson Correlation -.043 1
score (mean) Sig. (1-tailed) .300
N 155 155
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Correlations
risk dichotomised level of 
understanding 
as a scale
Total lose 
weight intention 
score (mean)
Low level of understanding as a Pearson Correlation 1 -.104**
scale Sig. (1-tailed) . 0 0 2
N 748 748
Total lose weight intention Pearson Correlation -.104** 1
score (mean) Sig. (1-tailed) . 0 0 2
N 748 748
Moderate or High level of understanding as a Pearson Correlation 1 -.043
scale Sig. (1-tailed) .300
N 155 155
Total lose weight intention Pearson Correlation -.043 1
score (mean) Sig. (1-tailed) .300
N 155 155
**. Correlation is significant at the 0.01 level (1-tailed).
Intention to stop smoking.
Correlations
risk dichotomised level of 
understanding 
as a scale
Total smoking 
intention score 
(mean)
Low level of understanding as a Pearson Correlation 1 -.111
scale Sig. (1-tailed) .225
N 748 49
Total smoking intention Pearson Correlation -.111 1
score (mean) Sig. (1 -tailed) .225
N 49 49
Moderate or High level of understanding as a Pearson Correlation 1 .018
scale Sig. (1-tailed) .461
N 155 32
Total smoking intention Pearson Correlation .018 1
score (mean) Sig. (1 -tailed) .461
N 32 32
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Appendix 79. Relationship between intention to change behaviour and worry about
future risk of heart disease.
Intention to exercise more.
ANOVA
Total exercise intention score (mean)____________
Sum of 
Squares df
Mean
Square F Sig.
Between (Combined) 5.946 4 1.487 1.004 .404
Groups Linear Term Unweighted .514 1 .514 .347 .556
Weighted 4.492 1 4.492 3.034 .082
Deviation 1.454 3 .485 .327 .806
Quadratic Term Unweighted .587 1 .587 .397 .529
Weighted 1.275 1 1.275 .861 .354
Deviation .179 2 .090 .060 .941
Within Groups 1329.477 898 1.480
Total 1335.424 902
Intention to lose weight.
ANOVA
Total lose weight intention score (mean)___________
Sum of 
Squares df
Mean
Square F Sig.
Between (Combined) 13.904 4 3.476 1.359 .246
Groups Linear Term Unweighted 5.958 1 5.958 2.330 .127
Weighted 7.473 1 7.473 2.922 .088
Deviation 6.432 3 2.144 .838 .473
Quadratic Term Unweighted 1.008 1 1.008 .394 .530
Weighted 4.338 1 4.338 1.697 .193
Deviation 2.093 2 1.047 .409 .664
Within Groups 2296.455 898 2.557
Total 2310.359 902
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Intention to stop smoking.
ANOVA
Total smoking intention score (mean)
Sum of 
Squares df
Mean
Square F Siq.
Between (Combined) 4.225 4 1.056 .396 .811
Groups Linear Term Unweighted .648 1 .648 .243 .624
Weighted .223 1 .223 .084 .773
Deviation 4.002 3 1.334 .500 .684
Quadratic Term Unweighted .398 1 .398 .149 .700
Weighted 1.174 1 1.174 .440 .509
Deviation 2.827 2 1.414 .530 .591
Within Groups 202.840 76 2.669
Total 207.064 80
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Appendix 80. Relationship between intention to change behaviour and worry about future risk of heart disease split by risk category. 
Intention to exercise more.
ANOVA
Total exercise intention score (mean)
risk dichotomised Sum of Squares df Mean Square F Sig.
Low Between Groups (Combined) 7.010 4 1.753 1.182 .317
Linear Term Unweighted .689 1 .689 .465 .496
Weighted 6.368 1 6.368 4.295 .039
Deviation .643 3 .214 .144 .933
Quadratic Term Unweighted .336 1 .336 .226 .634
Weighted . 0 0 1 1 . 0 0 1 . 0 0 1 .981
Deviation .642 2 .321 .216 .805
Within Groups 1101.641 743 1.483
Total 1108.652 747
Moderate or High Between Groups (Combined) 6.484 4 1.621 1.104 .357
Linear Term Unweighted .343 1 .343 .234 .629
Weighted . 0 0 2 1 . 0 0 2 . 0 0 1 .973
Deviation 6.482 3 2.161 1.471 .225
Quadratic Term Unweighted 1.419 1 1.419 .966 .327
Weighted 2.346 1 2.346 1.598 .208
Deviation 4.136 2 2.068 1.408 .248
Within Groups 220.287 150 1.469
Total 226.771 154
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Intention to lose weight.
ANOVA
Total lose weight intention score (mean)_________________________________
risk dichotomised Sum of Squares df Mean Square F Siq.
Low Between Groups (Combined) 9.890 4 2.472 .955 .431
Linear Term Unweighted 3.820 1 3.820 1.476 .225
Weighted . 0 0 0 1 . 0 0 0 . 0 0 0 .992
Deviation 9.889 3 3.296 1.274 .282
Quadratic Term Unweighted 4.785 1 4.785 1.849 .174
Weighted .447 1 .447 .173 .678
Deviation 9.443 2 4.721 1.824 .162
Within Groups 1923.075 743 2.588
Total 1932.964 747
Moderate or High Between Groups (Combined) 35.062 4 8.766 3.851 .005
Linear Term Unweighted 29.286 1 29.286 12.867 . 0 0 0
Weighted 31.077 1 31.077 13.654 . 0 0 0
Deviation 3.985 3 1.328 .584 .627
Quadratic Term Unweighted 3.305 1 3.305 1.452 .230
Weighted 3.898 1 3.898 1.713 .193
Deviation .087 2 .044 .019 .981
Within Groups 341.414 150 2.276
Total 376.476 154
Intention to stop smoking.
ANOVA
Total smoking intention score (mean)
risk dichotomised Sum of Squares df Mean Square F Siq.
Low Between Groups (Combined) 1.936 4 .484 .157 .959
Linear Term Unweighted .013 1 .013 .004 .948
Weighted .583 1 .583 .189 . 6 6 6
Deviation 1.353 3 .451 .146 .932
Quadratic Term Unweighted .417 1 .417 .135 .715
Weighted .054 1 .054 .017 .896
Deviation 1.299 2 .650 . 2 1 0 .811
Within Groups 135.991 44 3.091
Total 137.927 48
Moderate or High Between Groups (Combined) 13.420 4 3.355 1.679 .184
Linear Term Unweighted 1.955 1 1.955 .978 .331
Weighted .030 1 .030 .015 .904
Deviation 13.390 3 4.463 2.233 .107
Quadratic Term Unweighted 1.428 1 1.428 .714 .405
Weighted 4.199 1 4.199 2 . 1 0 1 .159
Deviation 9.190 2 4.595 2.299 . 1 2 0
Within Groups 53.966 27 1.999
Total 67.385 31
Appendix 81. Paired T-tests to assess within group changes to intention to change 
behaviour scores for control group 1 (pre and post intervention). 
Intention to exercise more.
Paired Samples Test______________________________
Paired Differences
t df
Sig. (2- 
tailed)Mean
Std.
Deviation
Std.
Error
Mean
95% Confidence 
Interval of the 
Difference
Lower Upper
Pair 1 Q13 pre intention reverse scored - 
Total exercise intention score 
(mean)
1.203 1.766 . 1 2 1 .964 1.442 9.915 2 1 1 . 0 0 0
Intention to lose weight.
Paired Samples Test
Paired Differences
t df
Sig.
(2 -
tailed)Mean
Std.
Deviation
Std. Error 
Mean
95% Confidence 
Interval of the 
Difference
Lower Upper
Pair 1 Q13 pre intention reverse scored - 
Total lose weight intention score 
(mean)
1.513 1.892 .130 1.256 1.769 11.641 2 1 1 . 0 0 0
Intention to stop smoking.
Paired Samples Test
Paired Differences
t df
Sig.
(2 -
tailed)Mean
Std.
Deviation
Std.
Error
Mean
95% Confidence Interval 
of the Difference
Lower Upper
Pair 1 Q13 pre intention reverse scored - 
Total smoking intention score 
(mean)
1.930 1.871 .429 1.028 2.832 4.496 18 . 0 0 0
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Appendix 82. Paired T-tests to assess within group changes to intention to change 
behaviour scores for control group 1 (pre and post intervention) split by risk 
dichotomised.
Intention to exercise more
____________________________________ Paired Samples Test
risk dichotomised Paired Differences
t df
Sig.
(2 -
tailed)Mean
Std.
Deviation
Std.
Error
Mean
95% Confidence 
Interval of the 
Difference
Lower Upper
Low Pair 1 Q13 pre intention reverse 
scored - Total exercise 
intention score (mean)
1.23836 1.79409 .13410 .97374 1.50299 9.235 178 . 0 0 0
Moderate or P a irl Q13 pre intention reverse 
High scored - Total exercise 
intention score (mean)
1 . 0 1 0 1 0 1.61908 .28185 .43600 1.58420 3.584 32 . 0 0 1
Intention to lose weight.
____________________________________ Paired Samples Test
risk dichotomised Paired Differences
t df
Sig.
(2 -
tailed)Mean
Std.
Deviation
Std.
Error
Mean
95% Confidence Interval 
of the Difference
Lower Upper
Low P a irl Q13 pre intention
reverse scored - Total 
lose weight intention 
score (mean)
1.57728 1.91667 .14326 1.29458 1.85998 1 1 . 0 1 0 178 . 0 0 0
Moderate P a irl Q13 pre intention 
or High reverse scored - Total 
lose weight intention 
score (mean)
1.16162 1.73630 .30225 .54595 1.77728 3.843 32 . 0 0 1
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Intention to stop smoking.
Paired Samples Test
risk dichotomised Paired Differences
t df
Sig.
(2 -
tailed)Mean
Std.
Deviation
Std.
Error
Mean
95% Confidence 
Interval of the 
Difference
Lower Upper
Low P a irl Q13 pre intention
reverse scored - Total 
smoking intention score 
(mean)
1.88889 1.84409 .53234 .71721 3.06057 3.548 1 1 .005
Moderate P a irl Q13 pre intention 
or High reverse scored - Total 
smoking intention score 
(mean)
2 . 0 0 0 0 0 2.06380 .78004 .09131 3.90869 2.564 6 .043
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Appendix 83. Independent T-tests to compare intention to change behaviour scores for
those who requested a copy of their risk output results and those that did not
Independent Samples Test
Levene's Test 
for Equality of 
Variances t-test for Equality of Means
Sig. (2- 
tailed)
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Difference Difference Lower Upper
Total exercise 
intention score 
(mean)
Equal variances 
assumed 
Equal variances 
not assumed
1.520 .218 -1.348 
-1.440
901
212.295
.178
.151
-.149
-.149
. 1 1 1
.104
-.367
-.354
.068
.055
Total lose 
weight intention 
score (mean)
Equal variances 
assumed 
Equal variances 
not assumed
4.366 .037 -1.881 
-2.080
901
220.331
.060
.039
-.274
-.274
.146
.132
-.560
-.533
. 0 1 2
-.014
Total smoking 
intention score 
(mean)
Equal variances 
assumed 
Equal variances 
not assumed
.555 .458 1.263
1.292
79
23.620
. 2 1 0
.209
.565
.565
.447
.437
-.325
-.338
1.455
1.468
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Appendix 84. Independent T-tests to compare intention to change behaviour scores for those who requested a copy of their risk output
results and those that did not split by risk dichotomised.
Independent Samples Test
risk dichotomised Levene's Test for 
Equality of 
Variances t-test for Equality of Means
Sig.
(2 -
tailed)
Mean Std. Error
95% Confidence 
Interval of the 
Difference
F Sig. t df Difference Difference Lower Upper
Low Total exercise intention score 
(mean)
Equal variances assumed 
Equal variances not assumed
.622 .431 -1.513
-1.618
746
140.272
.131
.108
-.197
-.197
.130
. 1 2 2
-.453
-.438
.059
.044
Total lose weight intention score 
(mean)
Equal variances assumed 
Equal variances not assumed
2.706 . 1 0 0 -1.086
-1.179
746
142.050
.278
.240
-.187
-.187
.172
.159
-.525
-.500
.151
.127
Total smoking intention score 
(mean)
Equal variances assumed 
Equal variances not assumed
.801 .375 .399
.421
47
17.634
.692
.679
.234
.234
.586
.555
-.944
-.935
1.412
1.402
Moderate or Total exercise intention score 
High (mean)
Equal variances assumed 
Equal variances not assumed
1.561 .213 -.108
-.114
153
81.898
.914
.909
-.024
-.024
. 2 2 0
.209
-.458
-.439
.411
.391
Total lose weight intention score Equal variances assumed 
(mean) Equal variances not assumed
1.797 .182 -1.765
-1.983
153
94.525
.080
.050
-.495
-.495
.281
.250
-1.050
-.991
.059
. 0 0 0
Total smoking intention score 
(mean)
Equal variances assumed 
Equal variances not assumed
. 0 0 0 .984 1.650
1.503
30
5.202
.109
.191
1.153
1.153
.699
.767
-.274
-.797
2.580
3.103
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Appendix 85. Pearson product-moment correlation coefficients to examine the
relationship between direct and indirect measures of intention to change behaviour.
Intention to exercise more.
Correlations
Copy of risk 
output 
requested?
Total exercise 
intention score 
(mean)
Copy of risk output Pearson Correlation 1 .045
requested? Sig. (2-tailed) .178
N 903 903
Total exercise intention Pearson Correlation .045 1
score (mean) Sig. (2-tailed) .178
N 903 903
Intention to lose weight.
Correlations
Copy of risk 
output 
requested?
Total lose 
weight intention 
score (mean)
Copy of risk output Pearson Correlation 1 .063
requested? Sig. (2-tailed) .060
N 903 903
Total lose weight intention Pearson Correlation .063 1
score (mean) Sig. (2-tailed) .060
N 903 903
Intention to stop smoking.
Correlations
Copy of risk 
output 
requested?
Total smoking 
intention score 
(mean)
Copy of risk output Pearson Correlation 1 -.141
requested? Sig. (2-tailed) . 2 1 0
N 903 81
Total smoking intention Pearson Correlation -.141 1
score (mean) Sig. (2-tailed) . 2 1 0
N 81 81
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Appendix 86. Pearson product-moment correlation coefficients to examine the 
relationship between direct and indirect measures of intention to change behaviour split 
by risk category.
Intention to exercise more
    Correlations
risk dichotomised Copy of risk 
output 
requested?
Total exercise 
intention score 
(mean)
Low Copy of risk output Pearson Correlation 1 .055
requested? Sig. (2-tailed) .131
N 748 748
Total exercise intention Pearson Correlation .055 1
score (mean) Sig. (2-tailed) .131
N 748 748
Moderate or High Copy of risk output Pearson Correlation 1 .009
requested? Sig. (2-tailed) .914
N 155 155
Total exercise intention Pearson Correlation .009 1
score (mean) Sig. (2-tailed) .914
N 155 155
Intention to lose weight
Correlations
risk dichotomised Copy of risk 
output 
requested?
Total lose 
weight intention 
score (mean)
Low Copy of risk output Pearson Correlation 1 .040
requested? Sig. (2-tailed) .278
N 748 748
Total lose weight intention Pearson Correlation .040 1
score (mean) Sig. (2-tailed) .278
N 748 748
Moderate or High Copy of risk output Pearson Correlation 1 .141
requested? Sig. (2-tailed) .080
N 155 155
Total lose weight intention Pearson Correlation .141 1
score (mean) Sig. (2-tailed) .080
N 155 155
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Intention to stop smoking.
Correlations
risk dichotomised Copy of risk 
output 
requested?
Total smoking 
intention score 
(mean)
Low Copy of risk output Pearson Correlation 1 -.058
requested? Sig. (2-tailed) .692
N 748 49
Total smoking intention Pearson Correlation -.058 1
score (mean) Sig. (2-tailed) .692
N 49 49
Moderate or High Copy of risk output Pearson Correlation 1 -.289
requested? Sig. (2-tailed) .109
N 155 32
Total smoking intention Pearson Correlation -.289 1
score (mean) Sig. (2-tailed) .109
N 32 32
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Appendix 87. Correlation matrices to assess the assumptions of multicolinearity and singularity.
Intention to exercise more.
n= 903
Mean 
intention to 
exercise 
more
Mean attitude 
towards 
exercising 
more
Mean perceived 
behavioural 
control for 
exercising more
Mean 
subjective 
norms for 
exercising 
more
Risk category 
(dichotomised)
Mean intention to exercise more
r
1 . 0 0 0
r r r r
Mean attitude towards exercising more .509*** 1 . 0 0 0 - - -
Mean perceived behavioural control for 
exercising more .701*** 4 4 4 *** 1 . 0 0 0 - -
Mean subjective norms for exercising 
more .071* .103*** .005 1 . 0 0 0 -
Risk category (dichotomised)
. 0 0 1 .006 -.069* .042 1 . 0 0 0
*** Significant (1-tailed) correlation at p<0.001 
* Significant (1-tailed) correlation at p<0.05
Intention to lose weight.
n= 903 
Mean intention to lose weight
Mean 
intention to 
lose weight
r
1 . 0 0 0
Mean attitude 
towards 
losing weight
r
Mean perceived 
behavioural 
control for 
losing weight 
r
Mean 
subjective 
norms for 
losing weight 
r
Risk category 
(dichotomised)
r
Mean attitude towards losing weight .761*** 1 . 0 0 0 - - -
Mean perceived behavioural control for 
losing weight .336*** .084** 1 . 0 0 0 - -
Mean subjective norms for losing weight .415*** .569*** -.159*** 1 . 0 0 0 -
Risk category (dichotomised)
. 0 2 0 .063* -.038 .070* 1 . 0 0 0
*** Significant (1-tailed) correlation at p<0.001 
** Significant (1 -tailed) correlation at p<0.01 
* Significant (1-tailed) correlation at p<0.05
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Intention to stop smoking.
n= 81
Mean 
intention to 
stop 
smoking
Mean attitude 
towards 
stopping 
smoking
Mean perceived 
behavioural 
control for 
stopping 
smoking
Mean 
subjective 
norms for 
stopping 
smoking
Risk category 
(dichotomised)
r r r r r
Mean intention to stop smoking
1 . 0 0 0 - - - -
Mean attitude towards stopping smoking .591*** 1 . 0 0 0 - - -
Mean perceived behavioural control for 
stopping smoking .483*** .363*** 1 . 0 0 0 - -
Mean subjective norms for stopping 
smoking .310** .277** -.035 1 . 0 0 0 -
Risk category (dichotomised) .092 .067 -.036 .135 1 . 0 0 0
*** Significant (1-tailed) correlation at p<0.001 
** Significant (1-tailed) correlation at p<0.01
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Appendix 88. M ultip le Regression Analysis to assess the sub components of the TPB -  intention to exercise more.
Intention to  exercise more.
Model Summary5
Model
R R Square
Adjusted R 
Square
Std. Error of the 
Estimate
1 .738a .544 .542 .82356
a. Predictors: (Constant), risk dichotomised, Total exercise attitude 
score, Total exercise subjective norm score, Total exercise PBC score
b. Dependent Variable: Total exercise intention score (mean)
Correlations
Model Unstandardized
Coefficients
Standardized
Coefficients
95.0% Confidence 
Interval for B Correlations Collinearity Statistics
B
Std.
Error Beta t Siq.
Lower
Bound
Upper
Bound
Zero-
order Partial Part Tolerance VIF
1 (Constant)
Total exercise attitude
.663
.256
.219
.027 .240
3.024
9.454
.003
. 0 0 0
.233
.203
1.093
.309 .509 .301 .213 .791 1.264
score
Total exercise PBC .665 .028 .597 23.647 . 0 0 0 .610 .721 .701 .619 .533 .796 1.256
score
Total exercise .048 .026 .042 1.835 .067 -.003 .099 .071 .061 .041 .986 1.014
subjective norm score 
risk dichotomised .124 .073 .039 1.704 .089 -.019 .268 .0 0 1 .057 .038 .992 1.008
a. Dependent Variable: Total exercise intention score (mean)
Appendix 89. Multiple Regression Analysis to assess the sub components of the TPB -  intention to lose weight. 
Intention to lose weight.
Model Summary1*
Model
R R Square
Adjusted R 
Square
Std. Error of the 
Estimate
1 .810a .657 .655 .93979
a. Predictors: (Constant), risk dichotomised, Total lose weight PBC 
score, Total lose weight attitudes score, Total lose weight subjective 
norm score
b. Dependent Variable: Total lose weight intention score (mean)
Model Unstandardized
Coefficients
Standardized
Coefficients
95.0% Confidence 
Interval for B Correlations Collinearity Statistics
B Std. Error Beta t Siq.
Lower
Bound
Upper
Bound Zero-order Partial Part Tolerance VIF
1 (Constant)
Total lose weight
1.304
.660
. 2 1 1
.023 .703
6.189
28.870
. 0 0 0
. 0 0 0
.890
.615
1.717
.705 .761 .694 .564 .644 1.553
attitudes score 
Total lose weight PBC .439 .031 .286 14.081 . 0 0 0 .378 .501 .336 .425 .275 .928 1.077
score
Total lose weight .061 .024 .061 2.499 .013 .013 .108 .415 .083 .049 .632 1.582
subjective norm score 
risk dichotomised -.075 .083 -.018 -.897 .370 -.238 .089 . 0 2 0 -.030 -.018 .993 1.007
a. Dependent Variable: Total lose weight intention score (mean)
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Appendix 90. Multiple Regression Analysis to assess the sub components of the TPB -  intention to stop smoking. 
Intention to stop smoking.
Model Summaryb
Model
R R Square
Adjusted R 
Square
Std. Error of the 
Estimate
1 ,688a .474 .446 1.19717
a. Predictors: (Constant), risk dichotomised, Total smoking PBC score, 
Total smoking subjective norm score, Total smoking attitude score
b. Dependent Variable: Total smoking intention score (mean)
Coefficients3
Model Unstandardized
Coefficients
Standardized
Coefficients
t Sig.
95.0% Confidence 
Interval for B Correlations Collinearity Statistics
B
Std.
Error Beta
Lower
Bound
Upper
Bound Zero-order Partial Part Tolerance VIF
1 (Constant) -.584 .902 -.648 .519 -2.380 1.212
Total smoking attitude score .541 .125 .406 4.317 .000 .292 .791 .591 .444 .359 .782 1.278
Total smoking PBC score .519 .136 .345 3.816 .000 .248 .790 .483 .401 .317 .846 1.181
Total smoking subjective norm .245 .107 .203 2.297 .024 .033 .458 .310 .255 .191 .890 1.123
score
risk dichotomised .163 .275 .050 .594 .554 -.384 .711 .092 .068 .049 .979 1.022
a. Dependent Variable: Total smoking intention score (mean)
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Appendices 91. Example of the report generated by Google Analytics.
Gocgle Analytics
Analytics Settings j View Reports:
88 Dashboard 
J i Intelligence * * *
www.myheartrisk.co uk *
cherryannwaldron@googlemaH.com | Sellings | My Account | Help | Sign Out
T1My Analytics Accounts: | wwwmyheartnsk couk » j
4  Visitors
Overview 
Benchmarking 
Map Overlay 
New vs. Returning 
Languages 
'•Visitor Trending
Absolute Unique Viators 
Pageviews 
Average Pageviews 
Time on Site 
Bounce Rate
Export »  1 3  Email 88 Add to Dashboard
Overview »
Visits for all visitors
| V  V isits
800
Advanced Segments All V a is  -
Feb 2, 2010-Feb 2, 2011
Graph h r
I
u Aup2S___________Sep 27
1,184 Visits 3.23 Visits I Day
► Viator Loyaty Tuesday. February 2.2010 0 00% (0)
► Browser Capabilities Wednesday. February 3.2010 0 00% (0)
► Network Properties
t  Mobile
Thursday. February 4.2010 0 00% (0)
User Defined Friday. February S. 2010 0.00% (0)
Custom Variables Saturday. February 6.2010 0 00% (0)
^ T ra ff ic  Sources
□  Content
Sunday. February 7.2010 0.00% (0)
P  Goals Monday. February 8.2010 0 00% (0)
Tuesday. February 9.2010 0 00% (0)
0 Custom Reporting Wednesday. February 10. 2010 0 08% (1)
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My Customizations
ED Custom Reports 
(§ ) Advanced Segments 
J it  intelligence b«u  
E3  Email
Help Resources
®  About this Report 
(? ) Conversion Unversly 
(? ) Common Questions
Thursday. February 11. 2010 
Friday. February 12.2010 
Saturday. February 13.2010 
Sunday. February 14. 2010 
Monday. February 15.2010 
Tuesday, February 16.2010 
Wednesday, February 17.2010 
Thursday. February 18.2010 
Friday. February 19.2010 
Saturday. February 20.2010  
Sunday. February 21.2010  
Monday, February 22.2010
4 22% (50)
7 26% (86)
3.63% (43)
2.87% (34)
10.39% (123)
1.77% (21)
6.25% (74)
0.08% (1)
0.08% (1)
0.08% (1)
0.08% (1)
161.82% (732)
©2011 Google | Analytics Home | Terms of Setvice | Privacy Policy | Contact us | Analytics Blog (in English)
Google Analytics cherryannwoMron@googleiniiH.com | Settings | My Account | Help | Sign Out
| www.myheartrisk.co.uk » | | www myheartnsk co uk *  J
B8 Dashboard 
JL Intelligence ®*“  
3  Visitors
.Traffic Sources
Overview 
Direct TrsTflc 
Referring Sites 
Search Engines
A l Traffic Sources
► AdWorda 
Keywords 
Campaigns 
Ad Versons 
□  Content 
P  Goals
G Custom Reporting
My Customizations 
0  Custom Reports 
®  Advanced Segments 
JU_ Intelligence s«t*
13 E mail
Help Resources
®  About this Report
Export ▼ | [3  Emar 08 Add to Dashboard '• Vauakze
Overview >
All Traffic Sources
V isits
Advanced Segments AJI Visits »
Feb2. 2010-Feb2. 2011 -
Graph t j y : Q n i *
May 18
All traffic sources sent 1,184 visits via 48 sources and mediums
Show Source M edium  Z
Goal Sett
Visits
1,184
H of She Total 100.00H
Pages/Visit
1.09
Site Avg 1.09(0.00%)
Avg Time on Site
00:00:14
Site Avg 00:00:14 (0.00%)
% New Visits
94.26%
Site Avg 94.26% (0.00%)
Bounce Rate
92.40%
Site Avg 92.40% (0.00%)
Source/Medum None iT] Visits 4* Pages/Vet A vg  Tims on S«e % New Visits Bounce Rate
1. (direct)/(none) 460 110 00 00 13 9322% 91 74%
2. twitter com / referral 266 1 03 00:00:12 93 30% 96.31%
3. nett>oardctac.uk/referrsl 140 104 00:00:12 90.43% 96.43%
4. badsclence.net 1 referral 130 100 00:00.20 100.00% 94 93%
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(? ) Conversion University 
(? ) Common Questions
5. goo9 le.com / referral
6 . google / organic
7. google.co.uk / referral
8 . facebook.com / referral
B. dellcious.com 1 referral
10. twittergadget.com / referral
11. iconfactory.com / referral
12. healthandwellnesstirnes.com / referral
13. noticeboard.cf.ac.uk / referral
14. bit ly/forexmarket / referral
15. decisionlaboratory.com / referral
16. gotm et com / referral
17. netvibes.com / referral
18. uk.m9 .bt.mall.yahoo.com / referral
19. aluguel-de-computsdores.gobnet.com 1 referral
2 0 . brizzly.com 1 referral
2 1 . estabttzador-e-nobreak.gobnet.com / referral
22 google.com au / referral
23. mobile.twitter.com / referral
24. search.bt com / referral
25. sol/organic
28. ask / organic
29 1.14 00:00:13
25 1.12 00:00:19
23 1.00 0 0 :00:00
20 1.15 00:0027
16 1.12 00:00:07
10 1.00 0 0 :00:00
8 1.25 00:00:08
4 1.00 0 0 :00:00
4 1.00 0 0 :00:00
3 2.00 0 0 :00:00
3 1.33 0 0 :00:00
3 2.67 0 0 :00.00
3 1.00 0 0 :00:00
3 1.00 0 0 :00:00
2 2.50 00 :00:00
2 3.00 00:08:32
2 2.00 0 0 :00:00
2 1.00 0 0 :00:00
2 1.00 0 0 :00:00
2 1.00 0 0 :00:00
1 1.00 0 0 :00:00
1 1.00 0 0 :00:00
96.55% 89.66%
84.00% 92.00%
100.00% 100.00%
95.00% 85.00%
100 00% 87 50%
100.00% 100.00%
100.00% 75.00%
100.00%  100.00%
75.00% 100.00% r
0.00% 0.00%
66.67% 66.67%
0.00% 0.00%
100.00% 100.00% 9
100.00% 100.00%
0.00% 0.00%
100.00% 50.00%
0.00% 50.00%
100 00% 100 00%
100.00% 100.00%
100.00% 100.00%
100.00% 100.00%
100.00% 100.00%
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27. belMriHered.com /  referral 1 1.00 00:00:00 100.00* 100 00%
28 M ly/forw  ebmaalers /  referral 2.00 00:00:00 0.00% 0 00%
» . camera-dlgdal golbnet.com /  referral 1 1.00 00:00:00 0.00% 100 00%
30. fragmentadora-de-papelgolbnet com / referral 1 3.00 00:00.01 000% 0 00%
31. google.be / referral 1 1.00 00 00:00 100 00% 100 00%
32. google co.nz 1 referral 1 1.00 00:00:00 100 00% 100 00%
33. google ea / referral 1 1.00 00:00:00 100 00% 100 00%
34. google le /  referral 1 1.00 00:00:00 100.00% 100 00%
35. hootsudecom /  referral 1 1.00 00:00:00 100 00% 100.00%
36 Ki gmodulea com / referral 1 100 00 00:00 100 00% 100 00%
37. mdeldoua com / referral 1 1.00 00:00:00 100 00% 100 00%
38 mnetvlbea com/ referral 1 1.00 00:00:00 100 00% 100.00%
39 mouae-e-teclado.golbnet.com /  referral 1 3.00 00:00:00 0.00% 0 00%
40. my.yahoo.com / referral 1 1.00 00:00:00 100.00% 100 00%
41. aaarch.eky.com /  referral 1 2.00 00 06:26 100.00% 0 00%
42. aeeamlc.com /  referral 1 1.00 00 00:00 100.00% 100 00%
43. smartphone golbnet com /  referral 1 3.00 00:00:00 0 00% 0.00%
44. an125w anti 25 mad Jve com /  referral 1 1.00 00:00:00 100 00% 100 00%
45 themetroguy golbnet com / referral 1 1.00 00:00:00 0.00% 100.00%
46 vakriebenandkids blogepot.com/ referral 1 1.00 00.00:00 100.00* 100 00%
47 webma* aolcom / referral 1 1.00 00 00:00 100 00% 100 00%
48 webmad (vernal couk / referral 1 1.00 00:00:00 100 00% 100 00%
F*er Source/Medium containing » Go Advanced Filter Go to 1 Show rowa 100 "  1 - 48 of 48 1 (
•  2011 Google | Analytics Home | Terms of Service | Privacy Policy | Contactus | Analytics Blog (in English)
Appendices 92. Example of the report generated by AW Stats.
myheartrisk.co.uk
Summary
W han:
Monthly history 
Days of month  
Days o f week 
Hours 
w h o :
Countries 
Full list 
Hosts 
3  Full list 
~  Last visit
Unresolved IP  Address 
Robots/Spiders visitors 
Full list 
Last visit 
Navigation:
Visits duration 
File type  
Viewed 
Full list 
Entry 
Exit
Operating Systems 
Versions 
Unknown 
Browsers 
Versions 
Unknown 
R eferrers:
Origin
’ Referring search engines 
3  Referring sites 
Search
Search Keyphrases 
Search Keywords 
O thers:
Miscellaneous 
HTTP Statu 5 codes 
Pages not found
Last Update: 
Reported period:
Reported period  
First visit 
Last visit
Viewed traffic *
02 Feb 2011 - 23 :4 0  
F eb v  2 0 1 0  v  OK
Month Feb 2 0 1 0  
19 Feb 2010  - 0 0 :04  
28 Feb 2010 - 23 :07
i vis iters 
421
A
■ ' E y
Summary
Number of visits 
401
(1 .1 6  visits/visitor)
Pages
3963
(1 2 .1 4  Pages/Visit)
Not viewed traffic *
*  Not viewed traffic includes traffic generated by robots, worms, or replies with special HTTP status codes.
Monthly history
Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec 
2010  2 010  2010  2010  2010  2 010  2 0 1 0  2 010  2010  2 010  2 0 1 0  2010
Month Uniquevisitors
Number of 
visits Pages Hits Bandwidth
Jan 2010 0 0 0 0 0
Feb 2010 421 491 5963 6347 171 .63  MB
Mar 2010 729 1054 14811 13756 3 6 2 .21  MB
Apr 2010 346 499 6654 7043 166.53 MB
May 2010 216 343 5097 5310 103 .42  MB
Jun 2010 75 111 644 745 14.00  MB
Jul 2010 34 68 81 113 1.21 MB
Aug 2010 42 64 371 391 6 .6 5  MB
Sep 2010 49 130 244 264 2 .4 6  MB
Oct 2010 34 76 247 258 2 .2 3  MB
Nov 2010 32 122 143 136 6 4 7 .5 0  KB
Dec 2010 31 153 175 184 5 0 8 .03  KB
Total 2029 3113 34430 36571 8 3 1 .30  MB
6 347
(1 2 .9 2  Hits/Visit)
■ ■ ■ ■ ■
171.63  MB
(3 3 7 .9 4  KB/Visit)
785
S tatis tic* fo ri
m yheartrisk.co.uk
Summary
W ham
Monthly history 
Days of month 
Days o f week 
Hours 
Who:
Countries 
Full list 
Hosts 
3  Full list 
Last visit
Unresolved IP  Address 
Robots/Spiders visitors 
2  Full list
2  Last visit 
N a v ig a tio n !
Visits duration 
File type 
Viewed
Full list
Entry
Exit
Operating Systems 
Versions
3  Unknown 
Browsers
Versions 
' Unknown 
Its ferrors i 
Origin
Referring search engines  
Referring sites 
Search
Search Keyphrases 
Search Keywords 
Others:
Miscellaneous 
HTTP Status codes 
Pages not found
Last Update: 
R eported period:
Back to m ain page
02 Feb 201X - 23 :40 
Feb v  2 0 1 0  v  0K
Visitors domains/countries
D om ains/ Countries H it. Bandwidth
?
•
Unknown
Commercial
IP
com
3093
1383
3341
1437
103.41 MB 
30 .82  MB
s United Kingdom uk • 2 0 •7 3 2 2 .48  MB
X
f115
arpa 244 242 7 .7 3  MB =
• N etw o rk net ce 73 a .23  MB i
B USA Educational edu >7 39 4 7 4 .2 2  KB 1
w Canada ca 33 34 4 7 3 .4 7  KB f
“ Netherlands nl 33 34 4 7 4 .9 3  KB 1
D Portugal P* 32 33 4 7 4 .3 4  KB I
■ Qermany da 11 12 444.B 3 KB 1
: : Denm ark dk 3 4 4 4 4 .4 3  KB 1
Others 0 0 0
Advanced W eb Statistics # 93 (build 1 .9 4 3 ) - Created by awatats
A
myheartnsk.co.uk
S u m m a ry
W h e n :
M onth ly  history  
D ays o f m o n th  
D ays o f w eek  
Hours  
W h o :
C ountries  
3  Full list 
Hosts  
3  Full list 
3  Last visit
31 U n reso lved  IP  Address  
R o b o ts /S p id ers  visitors  
' Full list 
3  Last visit 
N a v ig a tio n :
V isits  dura tio n  
File typ e  
Viewed  
3  Full list 
3  Entry 
3  Exit 
O p era tin g  S ystem s  
3  Versions  
3  Unknown  
Browsers 
3  V ersions  
3  Unknow n  
R e fe rre rs :
Orig in
3  R eferrin g  search en g in e s  
3  R eferrin g  s ites  
Search  
3  Search K eyphrases  
' Search Keywords 
O th e rs :
M iscellaneous  
HTTP Status  codes  
Pag es  n o t found
Links from an external page (other web sites except search engines)
T o ta l:  3 7  d iffe re n t p a g e s -u r l
h ttp  ://w w w . bad science. n e t
h ttp ://w w w .b a d s c ie n c e .n e t/2 0 1 0 /0 2 /h o w d o -y o u -re g u la te -K W j/
h ttp ://d e lic io u s .c o m /b c n g o ld a c re
h ttp : // lo n g u rl.o rg
h ttp ://d e lic io u s .c o m /b e n g o ld a c re /
h ttp ://tw itte r .c o m
h ttp ://b M tte r.c o m /g ly n e lw y n
h ttp : //w m m r.b a d s c ie n c e .n e t/2 0 1 0 /0 1 /o h -i-fo u n d -y o u -a -n e w jo b /
h ttp ://w w w .b a d s c ie n c e .n e t/2 0 1 0 /0 2 /g u n s -d o n t-k ill-p e o p lc -p u p p ie s -...
h ttp ://w w w .b a d s c ie n c e .n e t/a b o u t-d r-b e n -g o ld a c re /u p c o m in g -ta lk s -r ...
h ttp : / /d lv r . l t /2 3 V 6
h ttp ://w w w .fa c e b o o k .c o m /h o m e .p h p
h ttp ://w w m .b a d s c ie n c e .n e t/2 0 1 0 /0 1 /th e -w a k e fie ld -m m r-v e rd ic t/
h t tp : / /w w w .b a d s c ie n c e .n e t /2 0 1 0 /0 2 /h o w d o -y o u -re g u la te -w u /a m o re - l.. .
h ttp ://v w N w .ta lk ta lk .c o .u k /s e a rc h /re s u its .h tm l
h ttp ://fe e d s .d e lid o u s .c o m /v 2 /rs s /b e n g o ld a c re
h ttp ://w w m r.b a d s d e n c e .n e t/2 0 0 6 /1 2 /h o m e o p a th y -v id e o -s tre a m /
h ttp : / /fa c e b o o k .tw e e tm e m e .c o m /u s e r /z e n b u ffy
h ttp ://w w w .b a d s d e n c e .n e t /2 0 1 0 /0 1 /if -y o u -w a n t- to -b e -tru s te d -m o re ...
h ttp : //w w w .b a d s d e n c e .n e t /1 0 0 7 /0 1 /
h ttp ://w w w .b a d s d e n c e .n e t/a b o u t-d r-b e n -g o ld a c re /tw itte r /
h ttp ://w w w .d e d s io n la b o ra to ry .c o m /n e w s .p h p
h ttp ://v rw w .b a d s d e n c e .n e t/w h a t-is -th e -m in ib lo g /
h ttp ://w w w .b a d s d e n c e . n e t /2 0 0 6 /1 1 /3 2 4 /
h ttp ://tw itte r.c o m /J R B trip
h ttp ://tw ttte r .c o m /s e a rc h
h ttp : //n o t ic e b o a rd . cf. a c . u k /a  rc h iv e /ite m s . var
h ttp ://w w w .b a d 5 c ie n c e .n e t/h o w -to -u s e -th is -w e b s ite /th e -b a d -s c ie n c ...
h t tp : / /w w w .b a d s c ie n c e .n e t/2 0 0 9 /1 0 /ja b s -a s -b a d -a s -th e -c a n c e r /
h ttp ://vm m r.b lo g lin es.co m /m yb lo g s_d isp lay
h ttp : //v m m r.b a d s d e n c e .n e t/2 0 1 0 /0 2 /m o m e n ts -o f-g e n iu s /
http  : / / i d o . u s /1 eq tvg
h ttp : //v m m r .b a d s d e n c e .n e t /2 0 0 7 /ll/f re e -e n e rg y /
h ttp ://v m m r.b a d s d e n c e .n e t/in d e x .p h p
h ttp ://tw itte r .c o m /h o m e
h ttp ://tw itte r .c o m /b e n g o ld a c re
http://vm m r.netvibes.com
H H H I M H m m m m n
103 3 1 .3  44 103 3 1 .3  44
21 1 0 .3  44 21 1 0 .3  44
10 3  94 10 3 44
9 4 .3  94 9 4 .3  44
9 4 .3  44 9 4 .3  44
3 2 .3  44 3 2 .3  44
3 1 .3  % 3 1 .3  44
3 1 .3  44 3 1 .3  44
2 1 44 2 1 44
2 1 % 2 1 44
2 1 44 2 1 44
2 1 44 2 1 44
2 1 44 2 1 44
2 1 44 2 1 44
2 1 44 2 1 44
2 1 44 2 1 44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  % 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .5  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
1 0 .3  44 1 0 .3  44
A d v a n c e d  W e b  S ta tis tic s  0 .0 3  (bu tfd  1 .0 4 3 )  -  C re a te d  by aw stats
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